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Governance
The Laboratory is governed by a Board of Trustees of up to 35 members which meets three or four times
a year. Authority to act for the Board of Trustees between meetings is vested in the Executive Committee
of the Board of Trustees. The Executive Committee is composed of the Officers of the Board and any
other members who may be elected to the Executive Committee by the Board of Trustees. Additional
standing and ad hoc committees are appointed by the Board of Trustees to provide guidance and advice
in specific areas of the Laboratory's operations.
Representation on the Board of Trustees itself is divided between business and community leaders
and scientists from major educational and research institutions.
The Laboratory is chartered as an educational and research institution by the Board of Regents of the
Education Department of the State of New York. It is authorized to operate a graduate program under
the name "Cold Spring Harbor Laboratory, Watson School of Biological Sciences" and thereat to confer
the degrees of Doctor of Philosophy (Ph.D.), Master of Science (M.S.), and Doctor of Science (Sc.D.),
Honorary.
It is designated as a "public charity" under Section 501(c)(3) of the Internal Revenue Code.
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Rollin Hotchkiss (1911-2004)
Trustee, Cold Spring Harbor Laboratory,
1954-1966 and 1974-1978
Rollin Hotchkiss was trained as an organic chemist at Yale. He was one of the first to change voca-
tions to the rapidly growing field of microbial genetics. After joining the Rockefeller Institute for Medical
Research, Rollin worked with Rene Dubos on the first antibiotics: gramicidin and tyrocidin.
Unfortunately, they were toxic and could only be used topically. Yet it was due to this project that Rollin
and I met. In 1945, my teacher from the Bronx High School of Science took me to Rockefeller, because
my lab project was to isolate gramicidin. I never dreamt that I would one day be a colleague of his.
When Avery, MacLeod, and McCarty-all at Rockefeller-claimed that, in pneumococcus, DNA acted
like genetic material, it caught Rollin's eye. When Avery retired, MacLeod went to NYU, and McCarty went
to head the rheumatic fever department in The Rockefeller Hospital, Rollin took up the essential question:
How much protein was in the transforming DNA? He found it to be less than .02 of the material-not
much protein. Moving on, he took advantage of mutants resistant to sulfanomides. He generalized the
phenomenon as they would transform and indicated that DNA was generic genetic material.
With his first wife, Shirley, Rollin had two children: Paul and Cynthia. His second wife, Magda, is a
scientist, and they worked together until he retired in 1983.
Rollin was a fun person, always playful. If he had one problem it was that it
was difficult to talk with him "mano a mano." He mumbled and talked inter-
minably. One of my students used to take a stopwatch when he went to talk
to Rollin. On the other hand, Rollin gave the most clear and witty speeches; I
always felt that I was incompetent when we spoke in tandem. Rollin had five
graduate students who have all done well. The senior people were P. Model,
A. Tomasz, and myself. We will all miss him.
Recker Reading Room, Blackford Hall, 1992 The dedication of Delbruck Laboratory, 1981
Photos courtesy of the Cold Spring Harbor Laboratory Archives
VIII
Norton Zinder, Ph.D.
Professor Emeritus
The Rockefeller University
Ralph Landau (1916-2004)
Ralph Landau was born in Philadelphia, Pennsylvania on May 19, 1916. As a high school student
there, he read a newspaper article about the new and glamorous field of chemical engineering and
immediately decided it was the career for him. As a scholarship student at the University of
Pennsylvania, he received a Bachelor of Science in chemical engineering in 1936 and a Ph.D. in
chemical engineering from Massachusetts Institute of Technology five years later. Just before com-
pleting his doctorate, he married Claire in 1940.
Ralph took a position in 1941 with M.W. Kellogg, one of the first engineering firms that special-
ized in design and development for the oil refining and chemical industries. Within a few years, he
was named head of the chemical department of Kellex Corp., a Kellogg subsidiary, and charged
with building a large-scale facility at Oak Ridge, Tennessee, to aid in the efforts of World War II.
There, he was responsible for the separation of uranium 235, needed for the atomic bomb, from its
predominant isotope, and for designing the equipment to produce fluorine, a highly reactive sub-
stance needed to make the uranium hexafluoride used in the gaseous diffusion process.
After the war, Ralph joined Harry Rehnberg, a construction engineer he met at Oak Ridge, and
started Scientific Design Company in 1946. The firm eventually became one of the most success-
ful engineering and design firms worldwide, developing and commercializing nearly a dozen
processes for producing petrochemicals. Ralph served as Executive Vice President of Scientific
Design, then as Chairman and CEO of Halcon International (later Ha Icon SD Group), and co-found-
ed Oxirane Company with Atlantic Richfield Corp. The company developed many invaluable sub-
stances and held several significant patents, but it is most noted for its process for terepthalic acid,
the co-product route for the production of propylene oxide, and the development of ethylene glycol
by thermal hydration-the chief component of antifreeze and used in the process of making Dacron
polyester fiber.
In 1983, Ralph turned his sights to education, serving as a consulting professor of economics at
the Stanford Institute for Economic Policy and, the following year, joining Harvard University's
Kennedy School of Government as a research fellow.
Ralph's influence spanned the world. The recipient of more than 50 awards and honors, he
received both the Fuels and Petrochemicals Division Heritage Award and the John Fritz Medal of
the American Institute of Chemical Engineers, in addition to the Chemical Industry Medal, the Perkin
Medal, the Winthop-Sears Award for Chemical Entrepreneurship, and the Founders Award of the
National Academy of Engineering. In 1985, Ralph received the National Medal of Technology, and
in 1997, he was awarded the first Othmer Gold Medal of the Chemical Heritage Foundation. He was
a life member of the M.I.T Corporation, a senior trustee of Caltech, a trustee of the University of
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Pennsylvania, and former chair of the Princeton University School of Engineering Advisory Council.
Ralph was awarded honorary degrees from New York Polytechnic, Clarkson College, Ohio State,
and the University of Pennsylvania.
Ralph and I first met in May 1982 upon our jointly receiving honorary degrees from Clarkson
College. Apparent immediately was his keen intelligence and likeable self-confidence in making gov-
ernmental bodies and economic systems operate more effectively. To my surprise, I learned he and
his family had a weekend home on Long Island Sound in Asharoken, only 10 miles from the Lab. In
July, he and his wife Claire first came to the Lab, with Liz and I soon after spending a delightful
evening at their family beach compound. Initially, I feared that he had too many prior obligations to
consider being one of our Board of Trustees. But upon being asked, he showed no hesitancy, join-
ing us at our November 1982 meeting.
As a founding member of our Commercial Relations Committee, he helped devise our first poli-
cies for commercializing lab discoveries and inventions. He also gave much sound advice for
mounting our first Capital Fund Drive (The Second Century Campaign). By his being on the Caltech
Board, he was a friend of Arnold Beckman and able to play a key role in facilitating the gift from the
Beckman Foundation that made possible the construction of our Neuroscience Center. His great-
est long-term legacy to us though was the inclusion of his family in the mission of Cold Spring
Harbor Laboratory. His daughter, Laurie Landeau, remains an active member of the Laboratory
community, serving both on our Board of Trustees and the Corporate Advisory Board of the Dolan
DNA Learning Center.
Ralph and Claire lived life to its fullest, later having a home in San Francisco as well as New York
City. From their Russian Hill apartment looking down on San Francisco Bay, Ralph could easily move
to and from his faculty apartment and office on the Stanford campus. A high point of every year was
the anniversary dinner party held at Lutece, then New York's premier French restaurant presided
over by the legendary chef, Andre Soltner. Liz and I felt most honored to be included on many of
these sparkling occasions.
The last several years of Ralph's life were marked by medical complications that restricted his
past ability to joyously zip through life. Happily, his brain never slowed down, and he retained the
capacity to reflect intelligently on the world's problems until his life ended on April 5, 2004.
Ralph's friendship to many leading academic institutions, his impact on the world of chemical
engineering, and his strong values of scholarship, philanthropy, and integrity positively changed
the lives of many in the United States and abroad. We will cherish his memory for many years to
come.
James D. Watson
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David B. Pall (1914-2004)
David Pall was born in Thunder Bay, Ontario, Canada on April 2, 1914. Growing up on a farm with no
central heating or plumbing in rural Saskatchewan, he learned to read by deciphering the comic strips
in the daily newspaper. By age five, he began volume one of A History of the World, a foreshadow of
the quest for knowledge that would direct his entire life. In high school, he was deeply influenced by
Madam Curie, the biography of the chemist Marie Curie, about her discovery that liquids, particularly
water, were often contaminated by infectious bacteria, which could be killed by boiling or reduced in
number by filtration.
In 1939, he graduated with a Ph.D. in Physical Chemistry from McGill University as the highest-rank-
ing graduate student in Canada. David moved to New York City and was in dire need of friends and
anxious to meet a suitable girl to marry. A friend suggested that he phone Hester Blatt, a young
chemist. David telephoned Hester but reached her younger sister, Josephine, instead. Josephine
responded positively to his call, and on February 3, 1940, the two were married. During the next 12
years, they had three children, Stephanie, William, and Ellen.
In 1941, with the United States at war, David's laboratory had one of only three electron micro-
scopes in existence worldwide and was requisitioned by the U.S. military to work on the highly confi-
dential "Manhattan Project," to develop the atomic bomb. Working with a group of Ph.D.s at Columbia
University, David was able to make several significant contributions to a secret project that separated
the metal uranium into its two isomers-U232 and U235-the latter heavier, which was used to make
the bomb.
With the end of World War II, David realized that he might be able to use some of the technology
he developed to improve aircraft reliability by creating stainless steel filters for oil used in the hydraulic
system-a key component for landing gear and ailerons. With $3000 financing provided by his McGill
friend, Abraham Appel, he founded in 1946 the Micro Metallic Corporation located in a storefront in
Forest Hills. By building a furnace to melt stainless steel powder and developing a new method by
which to mold the porous sheets, David developed the first successful, economically viable stainless
steel filter for aircraft. He quickly moved to larger space in Brooklyn and began producing his filters for
the Air Force's F-106, allowing the then-conceptual plane to finally reach production. Key to David's
later success was his 1950 recruitment of his neighbor, accountant Abe Krasnoff, who ran the com-
mercial aspects of his ever-growing company that became the Pall Corporation in 1957 after moving
to Glen Cove on Long Island.
In the late 1950s, David's wife, Josephine, was diagnosed as anemic, and her physician arranged
for her to have monthly donations of transfused blood. The doctor advised David that after about 12
months, her immune system would reject the transfused blood and she would die-as she did in 1959.
The 12-month "limit" was caused by white cells contained in the donated blood, which were recog-
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nized as "foreign bodies" in the recipient. David devoted his time to learning about the components and
functions of human blood and the use of webs of plastic fiber for filtration, and he quickly began devel-
opment on a filter to remove white cells from transfused blood.
David organized a group of Pall Corporation volunteers to donate blood, which was then passed
through experimental masses of plastic fibers. White blood cell counts were then taken to determine
the fibers' efficiency in removing white cells. Using the data so obtained, David designed and con-
structed filters for use when patients are given donated blood. The filters removed substantially all of
the white cells from transfused blood. Use of David's filters rapidly became mandatory for blood dona-
tions, launching a substantial increase in Pall Corporation sales and earnings. More important, thou-
sands of lives have been saved from his thoughtful invention.
During his active years with the corporation, David Pall acquired about 180 U.S. patents issued with
his name as the inventor. In 1998, he retired from Pall Corporation as chairman, exiting a business with
sales in excess of $1 billion. In 1990, he was awarded the prestigious National Medal of Technology by
President George H.W. Bush. The medal is the United States' highest honor in technology and is
awarded to recognize exceptional contributions to the well being of the nation through technological
innovation and commercialization.
In 1960, David married Helen Rosenthal Stream, and her two daughters, Jane and Abigail, became
his own. Together they developed a major collection of American and European art that graced their
home in Roslyn Estates, Long Island. Although Liz and I first met the Palls in 1972, it was not until 1987
that our lives seriously intersected. A chance July meeting at the North Shore Hospital dedication of
the Marks-Boas Research Building gave David the opportunity to seek my help. Helen had a serious
blood disorder that might be cured by treatment with GCSF, a newly discovered growth factor being
developed by the new California biotech company Amgen. My help was sought to let Helen be the first
idiopathic neutropenia patient so treated. Knowing I was soon to be in Los Angeles, I arranged after-
ward to go to Amgen and ask its president George Rathman to let Helen receive GCSF at Memorial
Hospital. He happily consented, and her neutropenia soon disappeared. A very grateful David joined
our Board of Trustees that November. A year later, I was most pleased when David asked me to join
the Board of the Pall Corporation, of which I still am a member. David and Helen gave generously to
the Second Century Campaign, later giving monies that allow us to attach the Pall name to a new
upper campus cabin used by the attendees of our meetings and courses.
A most cherished feature of Helen and David's marriage was their biannual visits to St. Moritz in
Switzerland's Engedine. There they stayed at the massive Suvretta House, whose opulent blue
Peacock Room mirrored the gilded lives of the hotel's immediate uphill Iranian royal family neighbors.
Being in Switzerland transformed Helen from a breast cancer survivor into an accomplished langlaufer
(cross-country skier). David in turn became an expert skier who went straight downhill through his early
80s. I witnessed them so much at home on snow when my first appearance at the World Economic
Forum allowed me afterward to take the 2-hour trip by train that separated St. Moritz from Davos. The
following year Liz and I went to Switzerland to be their guests for a weeklong holiday, taking care to
bring the formal dress expected of those dining in the Peacock Room. Several more invitations to
Davos allowed me again to show my inexpertise on snow with my son Duncan, then working in
Moscow, joining us in February 1996. David, sensing Duncan's outfit not up to Suvretta standards, gift-
ed him with a blue blazer appropriate to the night.
Helen's strong health was the first to go, her coming down with Parkinson's disease before being
diagnosed with the colon cancer from which she died in 1998. Coping with Helen's final months was
a great burden for David, whose then untypical memory lapses soon metamorphosed into the awful-
ness of the Alzheimer's disease from which he died on September 21, 2004 at the age of 90.
David Pall's more than 70 years of intellectual inquiry and discovery generated an extraordinary wide
array of Pall products which have much improved peoples' lives throughout the world. We will long
remember a man whose firm heart and keen mind stayed on course.
James D. Watson
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PRESIDENT'S REPORT
Throughout its history, research in the biological and biomedical sciences has been driven by the
passion, intellect, and vision of individual scientists. Even when collaboration produced a great dis-
covery or advance, the investigators concerned brought their unique perspective to the team
effort. A large proportion of the research funds provided by the National Institutes of Health (NIH)
supports investigator-initiated research. The extent of this support and the pool of available scien-
tific talent are among the chief reasons that the United States has led international biomedical
research for many decades. But there are disturbing signs that this lead is being undermined.
Breakthroughs in science are unpredictable. Little did we know that research on flower pigments
in the early 1990s or investigation of gene expression in soil worms in 1998 would make possible
one of the most surprising biological discoveries in recent times: the ability of small RNA molecules
to control gene expression by interfering with either gene transcription or protein synthesis. Now
RNA interference (RNAi) is being studied in many laboratories. Greg Hannon and his Cold Spring
Harbor colleagues have made important insights into its biochemistry by identifying many of the key
enzymes involved in producing small RNAs in the cells which guide destruction of the mRNA that
is translated into protein. Recent collaborative studies with Leemor Joshua-Tor on the structure of
one of these enzymes have indicated how RNAi-directed suppression of mRNA works.
Understanding the biochemistry of RNAi has allowed Greg to develop libraries of RNAi-based mol-
ecules that can selectively turn off the expression of any human, mouse, or rat gene. These libraries
are powerful tools for biomedical research and have attracted the interest of biotech and pharma-
ceutical companies. A collaboration between teams of Cold Spring Harbor scientists led by Greg
Hannon and Scott Lowe has shown that the small RNAi molecules can be expressed in animal cells
to control gene expression in specific tissues or produce genetically defined tumors for identifying
and validating cancer therapy targets. RNAi technology has made possible a new era of genetic
analysis in mammalian cells and has stimulated the formation of biotechnology companies using
RNAi to screen for new therapies and even the application of RNAi molecules as drugs. Their suc-
cess would be yet another example of the importance of basic research to medical and industrial
development.
Sometimes, the execution of investigator-initiated ideas requires large numbers of scientists to
work in a coordinated manner. The development of radar during World War II by a team of scien-
tists assembled at the Massachusetts Institute of Technology and led by Alfred Loomis, as chron-
icled in Jennet Conant's book Tuxedo Park, is an excellent example. This successful, team-driven
science followed the breakthrough British discovery of the resonant cavity magnetron, but the
team approach was essential to moving the science from basic discovery to important application.
Team science has emerged in biological research, most notably in the Human Genome Project
where, first, many scientists reached a consensus that obtaining the complete sequence of human
DNA would be good for all of research and, second, international teams of scientists worked col-
lectively from 1990 to 2003 to achieve a goal that has transformed how we do biology.
During the past year, I have been engaged in planning such an approach to the improvement
of cancer diagnosis and treatment. Asked by the director of the National Cancer Institute, Andrew
von Eschenbach, to advise on the best application of new technologies, a small committee chaired
by Lee Hartwell and Eric Lander has produced a report that was presented in draft form to the
National Cancer Advisory Board in September 2004 and in final form in February 2005. The com-
mittee, and many of its advisors, strongly favors the establishment of a national, team-based effort
to identify all of the major cancer-causing genes in the approximately 50 major types of human
cancer. The approach taken in this Human Cancer Genome Project is the collection of tumor sam-
ples from patients who have undergone treatment and identify in their cancer genome the genetic
alterations. Such alterations include point mutations in the DNA-coding and -noncoding regions of
genes, or amplifications and deletions of genes or segments of chromosomes. We even envisioned
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identifying the epigenetic changes in cancer genomes that might lead to the lack of expression of
a particular tumor suppressor gene. All of this information, if collected from enough patients, com-
pared with data from conventional pathology, and correlated with clinical outcomes, could be used
for the diagnosis and prognosis of tumors, helping to guide oncologists to the best available cur-
rent treatment. Such DNA-based diagnosis and prognosis relies on the too few therapeutic
approaches now available for treating cancer. Importantly, the identification of genes that are over-
active in human tumors may suggest new targets for cancer therapy that could be validated using
the new RNAi technology. Within a few years, DNA-based diagnosis of human cancer could be in
routine clinical use. But will there be enough research funds to make this happen?
Research is supported by the NIH from discretionary funds voted by Congress. Because of the
large current federal budget deficits, discretionary spending is now more limited than in recent years,
and the latest NIH budget did not keep pace with inflation. Because of existing commitments to 4-
year grants, funding for new work is being progressively reduced. Already only one in six applications
to the National Cancer Institute (NCI) will be funded, and this proportion may drop to the historic lows
of 10% that were experienced in the late 1980s. If a career in science comes to be seen as worry-
ing about obtaining necessary resources, more than accomplishing goals, fewer talented young
Americans will apply to science graduate schools. It is already the case that many foreign graduate
students are reluctant to study in the United States at the present time because of restrictions on
visas and travel. The effect of these trends on all of biomedical research in this country may be chal-
lenging and long-lasting. At a minimum, we will be unable to move forward with sufficient speed on
high priorities such as in the use of genome information to diagnose and treat cancer.
Restrictions on funding are coinciding with attacks on some kinds of research, particularly in the
high-profile area of embryonic stem cell research. Federal support for human embryonic stem cell
research is not possible, prompting individual states to fund independent research initiatives.
However, specialists in developmental and regenerative biology who live and work in states that
lack such support will not easily be able to contribute to this complex area of research, despite
their expertise and their potential to improve stem cell science. Even more troublesome are restric-
tions placed on universities. Because research on human embryonic stem cells cannot be per-
formed in a building where federal research funds are being used, universities and research insti-
tutions must build isolated research facilities for embryonic stem cell research, at a cost of many
tens of millions of dollars that more logically could support the research itself.
The pressures of limited funding and the political debate about some aspects of biology have
led some advocates of biomedical research, often people without training in science, to overstate
their case, making claims that research is ripe for major advances in regenerative therapy or hint-
ing that cures are just around the corner. This is almost certainly not true for human embryonic
stem cell research. Such blind advocacy is dangerous for the research enterprise, raising false
expectations for those afflicted with a disease or disability. But support for this type of research is
absolutely necessary because if it is not done, we will never realize the potential that exists.
A widely anticipated report from the National Academy of Sciences is expected in early 2005 to
establish guidelines for the advancement of human embryonic stem cell research and I hope that
it will be the basis for more rational thinking in this overheated debate. We will only find out if truly
valuable treatments will emerge from this or any other promising area of biomedical research if in
the future, research is allowed to move forward with adequate funds, we have sufficient ability to
attract talent, and there is a reduction in political interference.
Some areas of research, however, are ripe for major inroads in diagnosis and perhaps therapy.
Certain types of cancer fall into this category. The success in targeting therapy to molecularly char-
acterized tumors is the wave of the future and now requires coordination and funds. If academia
can pull together to approach complex medical problems as a coordinated community, like it did
with sequencing the human genome, then we will have made a significant advance in the sociol-
ogy of science. Such an approach to science, however, should still respect the unique talents of
those involved because even in large-scale and coordinated research efforts, individual scientists
will generate the ideas to get the job done.
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HIGHLIGHTS OF THE YEAR
Research
Genomics and Bioinformatics
By using a powerful and sensitive genome research method they initially developed for can-
cer gene discovery, Mike Wig ler and his colleagues have uncovered what is likely to be one
of the most significant sources of normal genetic variation in the human
genome. They are now using the same method to begin to study the genetic
basis of mental illness and brain disorders including autism, schizophrenia,
and Parkinson's disease.
The method, called ROMA (for representational oligonucleotide microarray
analysis), was developed by Rob Lucito and Mike Wig ler. When used in can-
cer research, ROMA compares the DNA harvested from normal cells and
tumor cells. Such "normal-to-tumor" comparisons have already revealed sev-
eral chromosomal amplifications (excess copies of DNA segments) and dele-
tions (missing DNA segments) associated with breast, ovarian, and pancreat-
ic cancer, as well as leukemia and lymphoma. The identification of these
genetic alterations provides the basis for a better understanding of cancer
biology and for developing improved diagnostic and therapeutic measures.
In the course of that work, when "normal-to-normal" comparisons of DNA from different
individuals were carried out as an experimental control, Mike's lab uncovered several large-
scale variations in the human genome that they dubbed copy-number polymorphisms or
CNPs. We are all supposed majority of cells in
our body-one from mom and one from dad. But it is now clear that we all have alterations
to this Mendelian pattern: Some people have only one copy of a gene due to a deletion, and
others have more than two copies due to amplifications of a particular part of a chromo-
some. In part to aid their cancer gene discovery efforts, Mike, CSHL Senior Fellow Jonathan
Sebat, and their colleagues have mapped more than 80 such CNPs in the human genome
and found that, on average, the genomes of two individuals differ by about a dozen CNPs.
Many more of these CNPs will be discovered.
Mike believes that many CNPs are likely to be associated with inherited susceptibility to
neurological and cardiovascular diseases, diabetes, cancer, obesity, or other disorders. His
lab has recently set out to use ROMA to search directly for the genetic basis of autism, schiz-
ophrenia, and Parkinson's disease. Dr. Scott Powers, once a postdoctoral fellow at Cold
Spring Harbor Laboratory, returned as a faculty member this year from industry to ramp up
the applications of ROMA to cancer gene discovery.
Mike Wigler
Molecular and Structural Biology
RNA interference (RNAi) has emerged as a widespread biological regulatory mechanism, as
a powerful tool for both basic and applied research, and as a therapeutic strategy of enor-
mous potential. In organisms from fungi and flies to plants and humans, RNAi has an essen-
tial multifaceted role in controlling gene expression. Small endogenous RNA molecules pro-
duced in the cell, or similar RNAs designed and introduced into cells by scientists, shut off
the expression of genes either by blocking transcription of the gene or by blocking the trans-
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Leemor Joshua-Tor
lation of the genetic code into protein. One of the best-studied RNAi
mechanisms is the quashing of gene expression through the cleavage
and destruction of templates for protein synthesis called messenger
RNA, a biochemical process worked out in Greg Hannon's laboratory.
Until recently, however, the identity of the molecular scissors that
actually cut messenger RNA during RNAi has remained elusive. A col-
laborative effort led by molecular biologist Greg Hannon and X-ray
crystallographer Leemor Joshua-Tor has solved this puzzle by reveal-
ing that a protein called Argonaute2 provides the cutting action or
"Slicer" activity of RNA'.
Greg and his colleagues focused on sorting out the functions of
four distinct yet related mammalian Argonauts proteins (Argonaute1,
2, 3, and 4). With a biochemical approach, they found that only
Argonaute2 is part of the multisubunit molecular machine that comprises Slicer activity. To
extend these findings, Greg's group showed that messenger RNA cleavage by RNAi is abol-
ished in mouse cells lacking Argonaute2 and that DNA encoding human Argonaute2 could
restore Slicer activity in mouse cells lacking Argonaute2. These results were consistent with
the idea that Argonaute2 itself provides the Slicer activity of RNAi. However, the possibility
that a different protein provides Slicer activity could not be ruled out.
The work of Leemor Joshua-Tor's group clinched the case that Argonaute2 provides the
Slicer activity of RNA'. Leemor and her colleagues were studying an Argonaute protein from
the archaebacterium, Pyrococcus furiosus, by using X-ray crystallography (a method that
reveals the three-dimensional structure of molecules at the atomic level). Determining a pro-
tein's structure by X-ray crystallography frequently provides valuable, if not decisive, clues
about how that protein functions.
When the three-dimensional structure of P furiosus Argonaute emerged from their data
and was compared to other proteins of known structure and function, Leemor's group soon
noticed that part of P furiosus Argonaute was the spitting image of the "RNase H" family of
proteins, whose members were known to cut RNA. With guidance from Leemor, Greg's lab
did a final experiment based on the P furiosus Argonauts structure that confirmed
Argonaute2 as the protein that provides the Slicer activity of RNAi in mammals. Other infor-
mation led Leemor to propose a model that explains precisely how Argonauts binds and cuts
messenger RNA during RNAi.
The discoveries by Greg, Leemor, and their colleagues are a significant advance toward a
comprehensive understanding of one of the most intriguing biological phenomena to be
uncovered in recent years.
Cell Biology
In 1958, five years after he helped discover the double helix structure of DNA, Francis Crick
coined the term "Central Dogma" to characterize the cellular processes whereby DNA is
transcribed into RNA and RNA is translated into protein. Since then, researchers have typi-
cally explored individual aspects of these processes in isolation by developing separate sys-
tems for studying transcription and translation. David Spector and his colleagues have devel-
oped the first system for viewing how the Central Dogma unfolds in its entirety, from DNA to
RNA to protein, within living cells.
David and postdoctoral fellow Susan Janicki developed a multicomponent, fluorescence
microscopy imaging system in which the DNA near an inducible gene is labeled green, the
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messenger RNA encoded by the gene is labeled yellow, and the protein
encoded by the messenger RNA is labeled blue. The system was then
used to capture time-lapse images in live cells as the inducible gene was
switched on: First, the DNA architecture in the region of the gene became
less compacted. Next, RNA appeared, was spliced in the nucleus, and
subsequently exported to the cytoplasm. Finally, the protein appeared.
Although scientists know that protein production involves regulated
interactions among many molecules that carry out transcription, RNA
splicing, translation, and other processes, they have been unable until
now to simultaneously track all of the products of these processes as
they are produced and move within living cells.
David and his colleagues have used their system to detect specific
events that transform the architecture of chromosomes from a transcrip-
tionally silent state to an actively transcribed state. This work has revealed fundamental infor-
mation about how genes are switched on and off in the context of living cells. The system is
being used by many researchers to explore how a variety of dynamic processes involving
DNA, RNA, and protein are regulated in normal cells, as well as how those processes or their
regulation might be altered in cancer or other diseases.
David Spector
Neuroscience
The ability to form long-lasting memories shapes who we are and most often enriches (but
sometimes impairs) our lives. Understanding the molecular and cellular principles that under-
lie learning and memory is one of the principal goals of our neuroscience
program. This year, faculty members Roberto Malinow and Tony Zador
collaborated in a study of a form of associative, "Pavlovian" learning
known as fear conditioning.
In humans, fear conditioning involves the association of an otherwise
neutral stimulus (e.g., a particular place or sound) with an unpleasant
experience. In experimental animals, in which a tone might be paired with
a foot shock, a "freezing" response is used to measure fear. In both
humans and animals, long after the initial learning period, the neutral
stimulus alone elicits fear.
Roberto's group-in collaboration with Hollis Cline, Karel Svoboda,
Linda Van Aelst, and others-has previously uncovered several of the
molecular "rules" that govern long-term potentiation (LTP), a process
whereby synpases become strengthened, that has emerged as a lead-
ing candidate mechanism for long-term memory.
Those studies focused on a brain region called the hippocampus.
They revealed that the controlled movement of neurotransmitter recep-
tors called AMPA (a-amino-3-hydroxy-5-methyl-4-isoazole) receptors
into synapses is likely to be a key event in the formation of memory.
Importantly, these studies also led to the development of a number of
powerful tools that Roberto and Tony used in their recent work.
A region of the brain called the amygdala is known to be required for
learning and memory formation during fear conditioning. By using a recom-
binant version of AMPA receptors that specifically tags newly strengthened
synapses, Roberto and Tony first tested whether fear conditioning in rats
Roberto Malinow
Tony Zador
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leads to the strengthening of synapses in the amygdala. They found that as many as one third
of the neurons in the amygdala strengthen synapses in response to fear conditioning.
This finding indicates that rather than being restricted to a comparatively small proportion
of neurons, long-term memories are widely distributed among a large proportion of neurons.
However, on the basis of other evidence (see below), Roberto and Tony do not believe that
this wide distribution of memory-associated synaptic changes serves to make memories
resistant to being disrupted (e.g., by brain damage or other perturbations). To test whether
the strengthening of synapses in the amygdala is required for learning, the researchers used
a different recombinant version of AMPA receptors-one that blocks the strengthening of
synapses. They found that blocking synapse strengthening in the amygdala during fear con-
ditioning disrupts the learning process that leads to memory formation.
Interestingly, Roberto and Tony also discovered that blocking synapse strengthening in as
few as approximately 10-20% of the relevant neurons was sufficient to impair memory for-
mation. This finding contradicts the conventional view that widely distributed memories are
tolerant to perturbation and will change the thinking of many neuroscientists in this field.
Short-term or "working" memory is also an important process that enables us to interact
in meaningful ways with others and comprehend the world around us on a moment-to-
moment basis. A classic, albeit purely practical, example of short-term or "working memo-
ry" is our ability to look up a telephone number, remember it just long enough to dial it, and
then promptly forget it. However, working memory is believed to be fundamental to many
other cognitive processes, including reading, writing, holding a conversation, playing or lis-
tening to music, decision-making, and thinking rationally in a general sense.
Carlos Brody is exploring how neurons interact with one another to form
neural networks that underlie working memory and other rapid and flexible
cognitive processes. As part of an ongoing collaboration with Ranulfo Romo
(Universidad Nacional Autonoma de Mexico), Carlos' group is developing
mathematical models for interpreting data collected by his collaborators, who
use animals (macaque monkeys) to perform a simple task that involves work-
ing memory. In one version of the task, Romo's animals were trained to com-
pare an initial stimulus (a vibration applied to a fingertip) with a second stim-
ulus applied a few seconds later and to immediately provide a "yes" or "no"
answer to the question: Was the first vibration faster than the second?
This behavior requires the animals to load the initial stimulus into their
working memory ("loading phase"), hold information about that stimulus in
Carlos Brody their working memory ("memory phase"), compare that information to the
second stimulus, and then make a decision based on the comparison ("decison phase").
At the outset of the study, Carlos and postdoctoral fellow Christian Machens hoped to
develop a mathematical model-based on known properties of "spiking" neurons-that
would explain how the brain carries out just the memory phase of the behavior. To their sur-
prise, the simple "mutual inhibition" model they developed yielded a neural network architec-
ture that explains not only the memory phase, but also the loading phase and the decision
phase of the behavior. The model makes several predictions about the neurological basis of
working memory that can be tested to confirm the likelihood that the model is a significant
advance toward understanding fundamental properties of brain structure and function.
The human brain is estimated to contain 100 billion neurons (the number one followed
by 11 zeros). Because a typical neuron forms approximately 1000 synaptic connections to
other neurons, the total number of synapses in the brain is estimated to be 100 trillion (the
number one followed by 14 zeros). The thin projections from neurons that form connections
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with one another (axons and dendrites) can be thought of as the biological "wiring" of the
brain.
Neuroscientists already know that brain neurons can and do form specific rather than ran-
dom connections with one another to generate the observed wiring diagram of the brain.
However, the precise patterns of such nonrandom connections, how the patterns are
formed, and how these patterns underlie the brain's extraordinary information processing
capacity are important questions that CSHL researchers are addressing in various ways.
Dmitri Chklovskii and his colleagues are using statistical analysis and mathe-
matical modeling-coupled with in vivo, experimental observations-to search
for recurrent, nonrandom patterns of local connectivity within the vast thickets of
brain wiring diagrams. Finding such patterns would be strong evidence for the
presence of functional modules (e.g., local cortical circuits) that process informa-
tion. This year, Dmitri and his colleagues have potentially uncovered such func-
tional modules by using two complementary approaches.
In one study, they chose the nematode worm Caenorhabditis elegans as a rel-
atively simple model system. Previous studies had determined that this organism
has 302 neurons and had partially mapped which neurons connect with which.
However, these studies did not characterize nonrandom patterns of connectivity
in a rigorous way. When Dmitri and his colleagues completed the worm's wiring
connectivity map and considered all 13 possible patterns of connectivity that can
occur among three neurons (one such "triplet" pattern being "neuron A connects to B, B
connects to C, and A connects to C"), they found that three particular patterns, including the
one above, stood out as appearing far more frequently in the C. elegans nervous system
than they would by chance. They also discovered that some triplet patterns were less com-
mon than predicted by chance. Taking the analysis a step further, Dmitri and his colleagues
found that among all 199 possible quadruplet patterns of connectivity that can occur among
four neurons, one particular pattern stood out in C. elegans as appearing more frequently
than it would by chance.
Significantly, Dmitri and his colleagues considered whether the frequent connectivity pat-
terns or "motifs" that they discovered might be accounted for by previously known principles
of neurobiology. They found no such explanation for the existence of the motifs, indicating
that further analysis of the motifs may reveal important information about nervous system
structure and function.
Because it was based purely on anatomical data collected by electron microscopy,
Dmitri's C. elegans study did not include information about the strengths of connections
between neurons. Therefore, to extend his findings into the physiological realm, Dmitri col-
laborated with researchers at Brandeis University. The Brandeis group had previously col-
lected one of the largest electrophysiological data sets of its kind ever recorded-measure-
ments of the connectivity of some 3000 individual neurons in the rat visual cortex.
Dmitri recognized that the Brandeis data could be used to explore his ideas concerning
functional modules in the brain. He and his colleagues detected some of the very same non-
random patterns of connectivity in the rat brain that they had observed in C. elegans. More
importantly, they found that most connections formed by neurons in the rat visual cortex are
weak and that the stronger connections (-17% of all connections) account for as much as
half of the total synaptic strength of a particular network. In part because more strongly con-
nected neurons fire more reproducibly, Dmitri proposes that strong cortical synapses-with
particular connectivities-act as a network "scaffold" that is likely to generate reproducible
patterns of activity and have an important role in brain function.
Dmitri Chklovskii
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Cold Spring Harbor Laboratory Board of Trustees
At our November Board of Trustees meeting, we traditionally honor those who are conclud-
ing their service with us. This occasion was notable this year, since we said a special good-
bye and thank you to our chairman William R.
Miller, who led the Board through two 3-year
terms. He will now join us at future Board meet-
ings as our newest honorary trustee.
Following Bill's departure, the Board unani-
mously elected Eduardo G. Mestre as our new
Chairman, Lola Grace as our vice chair, and
Edward Travaglianti as our secretary/treasurer.
Their vision and experience will help CSHL to
expand its research and educational goals, espe-
cially in the fields of cancer and neuroscience.
Eduardo, a member of the CSHL Board of
Trustees since 2001, is currently vice chairman of
Evercore Partners, a leading investment and
advisory firm, where he is responsible for the
firm's corporate advisory practice. Lola, manag-
ing director of Sterling Grace Capital Manage-
ment, previously served as the treasurer and sec-
retary of our Board as well as chair of the finance
and audit committees and a member of the
Dolan DNA Learning Center committee. Ed,
President of Commerce Bank Long Island and a 34-year veteran of
commercial banking in the metropolitan New York market, joined the
CSHL Board of Trustees in 2003.
Susan Hockfield, a scientific trustee since 1998, concluded her term
as a scientific trustee of the Laboratory after being named the 16th
President of Massachusetts Institute of Technology-the first woman in
the institution's history. Although it is sad to see her leave, we are proud
of Susan, who first came to know CSHL as a research scientist here in
the 1980s. Scientific trustee Charles J. Sherr, M.D., Ph.D., and individ-
ual trustees Charles Harris and Howard Solomon also concluded their
terms in November.
We welcomed new scientific trustees Laurence Abbott, Ph.D., of the Volen Center at
Brandeis University, and Robert E. Wittes, M.D., physician in chief at Memorial Sloan-
Kettering Cancer Center. Laurie Landeau, V.M.D., Nancy Marks, and Jerome Swartz, Ph.D.,
joined the Board as individual trustees this year.
Charles Harris Susan Hockfield
William R. Miller Charles J. Sherr
Howard Soloman
Watson School of Biological Sciences Commencement Convocation
Founded with the mission to bestow the Ph.D. degree in biology in an unprecedented 4
years, the Watson School of Biological Sciences achieved its goal on April 25, 2004 when
Amy A. Caudy, Ira Hall, Patrick J. Paddison, Emiliano Rial Verde, Elizabeth E. Thomas, and
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Niraj Harish Tolia became the first graduates of the School. This
outcome is owed to the generosity of our benefactors and to the
dedication of the faculty, administration, and the outstanding stu-
dents we successfully recruited.
Awards and Honors
CSHL Professor Lincoln Stein was named the 2004 laureate of the
Benjamin Franklin Award in Bioinformatics. The Benjamin Franklin
Award in Bioinformatics is a humanitarian award presented annu- Patrick Paddison, Ira Hall, Elizabeth Thomas,
ally by Bioinformatics.org to an individual who has, in his or her Niraj To lia, Amy Gaudy, and Emiliano Rial Verde
practice, promoted free and open access to the methods and materials used in the scientif-
ic field of bioinformatics. Recipients are chosen based on nominations and votes by his/her
peers-the more than 8000 members of the organization.
CSHL neuroscientist Karel Svoboda was the 2004 recipient of the Society for
Neuroscience Young Investigator Award. The prize is awarded each year at the
Society's annual meeting to an outstanding neuroscientist who has received an
advanced professional degree within the past 10 years. He was also selected
by Popular Science magazine as one of its "Brilliant Ten" young scientists in the
United States for 2004.
Recognized for his "promise of becoming a leader in research in the cure and
treatment of cancer, cerebral palsy, and multiple sclerosis," Senthil Muthuswamy
was named a Rita Allen Foundation Scholar. The Rita Allen Award is only award-
a tenure
track for no more than three years.
The CSHL Press book, George Beadle, An Uncommon Farmer: The Emergence of
Genetics in the 20th Century, by Paul Berg and Maxine Singer, was selected by the American
Library Association for inclusion in its "Outstanding Academic Titles" (OAT) list for 2004.
Outstanding Academic Titles are chosen from among more than 7000 books reviewed "for
their excellence in scholarship and presentation, the significance of their contribution to the
field, and their value as important-often the first-treatment of their subject." Comprising
less than 3% of the 23,000 plus titles submitted, Outstanding Academic Titles have been
called "the best of the best."
DNA Interactive (DNAI) DVD, produced by the Dolan DNA Learning Center (DNALC) in
association with The Red Green and Blue Company (RGB) and Windfall Films, was named
"Best Offline Factual" at the British Academy of Film and Television Arts (BAFTA) Interactive
Entertainment Awards ceremony-the British version of the
Oscars-in February. In its sixth year, the BAFTA Best Offline
Factual award is given to "the most imaginative and effective use
of offline interactivity to explore the factual world." The DNAi DVD
was recognized as "an unusually rich and deep experience, stim-
ulating personal exploration of the history, science, issues, and
future of the genome from the unique perspective of the people
involved in its research."
In April, my colleague and friend Tom Kelly of the Memorial
Sloan-Kettering Cancer Center and I were awarded the Alfred P.
Sloan, Jr. Prize, one of three awards given annually by the
Karel Svoboda
DNA Interactive DVD
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General Motors Cancer Research Foundation (GMCRF). The Sloan Prize recognizes the
most outstanding recent contribution in basic science related to cancer research.
The Sabin Vaccine Institute honored CSHL Chancellor James D. Watson, Ph.D., with the
Sabin Humanitarian Award at their Salute to Lifesaving Discoveries benefit dinner in May. The
awards program is a yearly tradition for the Institute and extols the contributions made by
scientists, philanthropists, and humanitarians who share in some aspect of the goals of
advancing vaccine science for the benefit of humanity.
The United States Rice Genome Consortia, Cooperative State Research, Education, and
Extension Service (Tucson, Arizona)-of which Cold Spring Harbor Laboratory is a principal
member-were honored with the U.S. Department of Agriculture (USDA)'s Secretary's
Award, presented by Agriculture Secretary Ann M. Veneman at the 58th Annual Secretary's
Honor Awards Ceremony on June 25. Considered the highest award the USDA can bestow,
the members of the United States Rice Genome Consortia were honored in the "Enhancing
Economic Opportunities for Agricultural Producers" category for leading the United States
partnership in the multinational achievement to decode the rice genome to advance knowl-
edge, improve nutrition, and alleviate world hunger. W. Richard McCombie, Melissa Kramer,
Lance Palmer, Robert Martienssen, Maureen Bell, Sujit Dike, Lidia Nascimento, Andrew
O'Shaughnessy, and Lori Spiegel are among the members of the CSHL staff involved in this
project.
Development
Capital and Program Contributions
Private funding is essential to our research programs, enabling successful and innovative
projects not yet eligible for public funding. For this reason, we are especially grateful to those
supporters who made major gifts in 2004 to our cancer and neuroscience research pro-
grams. We gratefully acknowledge donors of $100,000 or more to our cancer program: the
De Matteis Family Foundation, a first-time grant for colon cancer research; The Miracle
Foundation; The Breast Cancer Research Foundation; and one anonymous donor.
Our neuroscience program was also generously supported, and we acknowledge donors
to that program, including Jo-Ellen and Ira Hazen, The Seraph Foundation, The Dart
Foundation, The G. Harold and Leila Y. Mathers Charitable Foundation, and the St. Giles
Foundation. We also received a special gift this year from Trustee Jerome Swartz, and his
Swartz Foundation, which provided more than $215,000 for the establishment of the The
Swartz Center for Computational Neuroscience and additional research support in brain
structure and neuroscience research. The Swartz Center has become an integral part of our
strong neurobiology program, supporting both research and neuroscience programs. The
Thomas Hartman Foundation for Parkinson's Research also pledged $4.4 million over the
next 5 years to support Parkinson's research at CSHL and to establish The Thomas Hartman
Parkinson's Research Laboratory. We also received significant and continued support from
The Simons Foundation, to fund autism research at CSHL.
Robertson Research Fund
The Robertson Research Fund has been the primary in-house support for our scientists for
more than three decades. During 2004, Robertson Funds supported research in the labs of
Josh Dubnau, Masaaki Hamaguchi, Leemor Joshua-Tor, Alexei Koulakov, Adrian Krainer, Yuri
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Lazebnik, Wolfgang Lukowitz, Bud Mishra, Partha Mitra, Scott Powers, Cordula Schulz, and
Michael Wig ler.
Watson School of Biological Sciences
Now in its second phase of funding and led by Robert D. Lindsay, the Watson School has
received additional support in 2004 for the Dean's Chair, fellowships, and lectureships,
enabling the Watson School to continue to grow and influence the field of biological sci-
ences. We appreciate new gifts of $100,000 or more made this year by Mr. and Mrs. Robert
D. Lindsay and Family, Curt Engelhorn, and The Seraph Foundation, as well as ongoing sup-
port received from Bristol-Myers Squibb Company, Mr. and Mrs. Alan E. Goldberg, the
Florence Gould Foundation, and the Lita Annenberg Hazen Foundation.
The Dolan DNA Learning Center
Thanks to a very generous gift from The Dana Foundation, the Dolan DNALC has embarked
on creating Genes to Cognition (G2C) Online: A Network-driven Internet Site on Modern
Brain Research, an Internet portal exploring the genes of cognition and learning. In addition,
the Dolan DNALC received significant support from the Pfizer Foundation to continue its
Pfizer Leadership Institute in Human and Genomic Biology.
Carnegie Building
We are continuing plans to renovate the existing Carnegie Library to enhance its ability to
serve the Laboratory community. This project received significant support this year from
alumni Philip A. Sharp, Ph.D.; Drs. Joan Brooks and James Garrels; and Thomas P. Maniatis,
Ph.D.; and from The Koshland Foundation and The Lehrman Institute.
Capital Campaign
As CSHL prepares to embark on a capital campaign to raise funding for new research space,
we are very grateful to significant gifts received to support the buildings intended for the
southwest corner of our campus. In 2004, we received pledges from Mrs. Leslie C. Quick,
Jr., for a cancer research facility named for her husband, and a pledge from the Wendt Family
Charitable Foundation of Community Foundation Sonoma County for a neuroscience
research facility. Mrs. William L. Matheson made a significant gift in 2003 for this project, to
name a facility for her late husband. CSHL also received significant support for these pro-
jects from Gillian and Eduardo Mestre and Mrs. George N. Lindsay. We will continue to plan
this campaign throughout 2005.
Additional Support
The Laboratory was fortunate to receive support for many ongoing projects in 2004. The
Joseph G. Goldring Foundation made a significant gift to support research, and the Louis
Morin Charitable Trust made a significant contribution to support the work of Drs. Leemor
Joshua-Tor, Josh Dubnau, and David Spector. We received support from the Estates of
Elisabeth S. Livingston, Florence Strelkowski, and Adele C. Diaz to complete our housing
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project at Uplands Farm, and Dr. and Mrs. Walter C. Meier, through the Banbury Fund, made
a significant gift to restore and renovate Robertson House on our Banbury campus. Mr. and
Mrs. Charles E. Harris II made a gift this year to support capital projects, and the Roy J.
Zuckerberg Family Foundation provided support for consultants in fund-raising and devel-
opment. We are very grateful to these close supporters for their continued generosity.
Breast Cancer Groups
A crucial component to our breast cancer research program is the support we receive from
local grassroots breast cancer groups who provide direct research support for our program,
in addition to a myriad of patient care and educational services to thousands of constituents.
This year, we were fortunate to receive support from Long Islanders Against Breast Cancer
(L.I.A.B.C.); 1 in 9: The Long Island Breast Cancer Action Coalition; Breast Cancer H.E.L.P.,
Inc.; the New York State Grand Lodge Order Sons of Italy; EA.C.T. (Find a Cure Today); The
Elisabeth McFarland Fund; The Long Island 2 Day Walk to Fight Breast Cancer; The Judi
Shesh Memorial Foundation; the Long Beach Breast Cancer Coalition; and The WALK for
Women Breast Cancer Fund. We also gratefully acknowledge continued support from The
Breast Cancer Research Foundation. The generous support we receive from these groups,
year after year, is truly propelling our breast cancer research.
Benefit for the Brain
John Sebastian and the J-Band played to a packed Grace Auditorium on October 30, 2004
at the first "Benefit for the Brain." The event realized a net profit of more than $225,000 for
John Sebastian
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Kay Jamison signing a copy of Exuberance for Joan Spiro.
CSHL's Alzheimer's and Parkinson's research, thanks to the efforts of William S. Robertson
and the Banbury Fund, who underwrote the event, and event co-chairs Edward Travaglianti
and Kathy Di Maio and their committee. The event honored Monsignor Thomas J. Hartman,
founder of The Thomas Hartman Foundation for Parkinson's Research.
Exuberance: The Passion for Life
On December 5, Dr. Kay Redfield Jamison, best-selling author and internationally renowned
authority on mood disorders, discussed the feeling of exuberance and how it fuels our most
important creative and scientific achievements at the Dolan DNALC. Sponsored by Arthur
and Joan Spiro, this event benefited the educational opportunities hosted annually at the
DNALC.
Library and Archives
The Library and Archives enjoyed a very exciting year in 2004. A major goal of the Library is
to provide scientists with digital access to all publications vital to their research. In response
to the expanding scope of science research performed at the Laboratory, the Library sub-
scribed to many new journal titles this year. In addition, the Library purchased an electronic
book collection composed of 134 e-books. In 2004, an SFX system was installed that elec-
tronically interconnects the Library's resources so that patrons can navigate the entire Library
collection through one interface. Within the past year, the Interlibrary Loan office implement-
ed Ariel, an advanced electronic delivery service that allows the Library to receive requested
articles as PDFs via e-mail.
The Library's Advisory Committee, composed of professors, postdocs, and Watson
School students, convened this year to discuss library services and resources. In 2004, the
Library collaborated on particular projects with other medical and academic libraries at The
Rockefeller University, Harvard University, and the Marine Biological Laboratory at Woods
Hole. The Library, represented by director Mila Pollock, was also invited to the Annual Nature
Publishing Group International Library Committee to take part in discussions of interest to
today's library market.
In 2004, the Archives were fortunate to acquire the personal collection of Elof Carlson, a
prominent geneticist and professor at Stony Brook University. The Oral History Office has
also continued to expand, now comprising more than 100 scientific interviews, half of which
are already accessible online. In 2004, the Sloan Foundation formally recognized the digital
archives project, the Memory Board, an online forum in which the lab community documents
the history of the Laboratory by contributing first-hand accounts, reminiscences, original
materials, photos, and video clips. The Sloan Foundation will support the redesign of the
Memory Board and advocate its use as a model that other institutions could adapt for doc-
umenting their own history. Conceived by librarian and archivist Mila Pollock, the Memory
Board has attracted much attention and many interesting anecdotes. The exhibition Building
Blocks of CSHL was created this year and will be on display at Blackford Hall for two years
and online in digital format. This project explores the history of the buildings at CSHL (and
the life of its community) through documents, photos, and personal memories. This year, the
Library's exhibit Honest Jim: Watson the Writer moved to the Charite Universitatsmedizin in
Berlin, Germany and will be exhibited in Moscow, Russia next year.
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Building Projects
The Laboratory continues to improve and expand its facilities and, during 2004, undertook
several construction and renovation projects. Several projects were completed in the
Demerec building, including alteration and renovation of laboratory spaces and the con-
struction of a new tissue culture laboratory. Grace Auditorium received attention as well, with
a complete remodeling of the bookstore to accommodate DNA Stuff -the Laboratory's
bookstore and nonprofit retail operation. The Laboratory also continued its project to replace
the HVAC systems in Grace and Harris and to update the emergency power system that
supplies those buildings.
A major renovation of the James building was begun in 2004, updating laboratory, sup-
port, and office spaces to meet the increased demands on the building's facilities the
Laboratory has experienced in recent years. Work was begun on the Banbury pool, which
had been leaking badly for years. The entire pool has been reconstructed, and final work is
to be completed by the spring of 2005.
The Laboratory has continued to improve its student and scientist housing program. The
housing project at Uplands Farm is nearing completion and will provide much-needed hous-
ing close to the main campus. The last of the apartments in the Hooper building was reno-
vated, and the Weghorn House, which lies at the northern tip of the campus, was purchased
and will be renovated in 2005.
A major milestone in 2004 was the approval of the Laboratory's updated Master Plan and
its Upper Campus project by the Village of Laurel Hollow. This approval came at the end of
a 2-year process and has paved the way for the Laboratory to break ground on the largest
construction project it has ever undertaken in Spring 2005.
100 Years of Genetics at Cold Spring Harbor
In 1904, the Carnegie Institution of Washington founded a Station for Experimental Evolution
at Cold Spring Harbor, launching a century of genetics that placed CSHL at the forefront of
biomedical research. The occasion was marked by a very special 2004 Cultural Series filled
with engaging lectures and inspiring music and art.
Public Lectures
April 19 Mark Hallett, Vice President of the American Academy of Neurology: How
Your Brain Recovers from a Stroke.
May 11 Vincent Li, Director of the Angiogenesis Foundation: Prevention and
Reversal of Skin Cancer and Other Skin Diseases.
May 18 Carter Burwell, award-winning composer: From Cold Spring Harbor to the
Coen Brothers: A Composer's Journey.
May 24 Andrew Solomon, award-winning author of The Noonday Demon: An Atlas
of Depression: Depression Too, Is a Thing with Feathers.
Sept. 28 Zach Mainen, CSHL Associate Professor, and Sharron McCarthy, Director
of the Society of Wine Educators: Demystifying the Sommelier: The Art and
Science of Wine Tasting.
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Sylvia Nasar
Antoine Tamestit
October 5 Sylvia Nasar, author of A Beautiful Mind: Genius, Madness, Recovery.
December 7 Richard Stone, Britain's youngest royal portrait artist: Painting England's
Queen and DNA's Dean.
Concerts
April 24
May 1
May 8
May 22
September 11
October 2
October 9
October 16
Exhibits
The Molinaro-Levy Project, piano and harmonica
Yunjie Chen, piano
Mikhail Simonyan and Alexei Podkorytov, violin and piano
Hsing-ay Hsu, piano
Dmitri Berlinksky and Elena Baksht, violin and piano
Vassilis Varvaresos, piano
Alexandre Bouzlov, cello
Antoine Tamestit, viola
From July 9 to August 1, 2003-2004 Artist-in-Residence Eduardo De Soignie displayed his
work, Paintings From Another Domain, in Bush Lecture Hall. Inspired by his Cuban roots, De
Soignie's work is influenced by artists such as Jose Bedia and Tomas Esson.
Events
Gavin Borden Visiting Fellows
The 10th annual Gavin Borden Fellow Lecture, created by Jim Watson in memory of Gavin
Borden, publisher of Molecular Biology of the Cell, was held on March 17 in Grace
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Richard Losick and Bruce Stillman at the Gavin Borden Lecture
Auditorium. Dr. Richard Losick, the Maria Moors Cabot Professor of Biology at Harvard
University, spoke on "Cell fate, polarity, and cannibalism in bacteria." Dr. Losick is interna-
tionally acclaimed for his research on microbial development and is developing computer-
based animations and video for teaching introductory molecular biology.
Symposium
The 69th Annual Cold Spring Harbor Laboratory Symposium, "Epigenetics," was oversub-
scribed again this year with nearly 500 scientists from around the world in attendance. The
Dorcas Cummings Lecture, in memory of long-time Laboratory friend and former Director of
the Long Island Biological Association Dorcas Cummings, was given by David Haig of
Harvard University on the subject of "The Divided Self-Brains, Brawns, and the Superego."
This endowed lecture is traditionally open to friends and neighbors of the Laboratory and is
followed by dinners generously hosted in the homes of our neighbors for our visiting scien-
tists and faculty and staff.
Other Lectures
Winship Herr ("Why Our Cells Multiply") and Nick Tonks ("Plague, Pox, and Phosphatases")
participated in our lecture series for fourth- to sixth-grade students and their parents, co-
hosted with the Cold Spring Harbor School District, at the Dolan DNALC.
Huntington Hospital continued to host their fall/spring lecture series on cardiovascular
health and related diseases in Grace Auditorium.
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Laboratory Employees
New Staff
Scott Powers returned to CSHL in October as Associate Professor and Director of the
Human Cancer Genome Center in the Cancer Genome Research Center. Scott came from
Tularik Genomics Division, which was initially a company spun out from the Laboratory to use
RDA (representational difference analysis) technology to identify cancer genes. Scott
received his graduate degree from Columbia University and performed seminal work as a
postdoc with Mike Wig ler on the study of RAS genes in yeast.
David Wu joined Scott as a Research Investigator at the Human Cancer Genome Center.
David received his graduate degree from Berkeley and as a postdoc with Aziz Sancar devel-
oped the first biochemical system for mammalian DNA repair with purified proteins.
Promotions
Dr. Lilian Clark Gann became Dean of the Watson School of Biological Sciences on July 1.
Lilian joined the Laboratory in March 1999 as Assistant Dean of the Watson School and was
promoted to Associate Dean in January 2002. She received her Ph.D. from the University of
St. Andrews, Scotland in 1988, for her studies on DNA-protein interactions in transcription-
al control elements of DNA tumor viruses, and her M.B.A. from the University of Westminster,
London in 1996. Since her arrival at CSHL, Lilian had played a crucial role in the develop-
ment of the School's innovative Ph.D. program, while also enhancing the educational and
training environment of CSHL for students and postdoctoral fellows in general. Her unique
background in science, education, and business made her an obvious choice to develop and
oversee the programs of the Watson School. She was joined by Dr. Bill Tansey who was
appointed as director of graduate studies in the Watson School of Biological Sciences and
Lita Annenberg Hazen Professor of Biological Sciences on the same day.
A number of other faculty members were promoted in 2004, including Dmitri Chklovskii to
Associate Professor, Zachary Mainen to Associate Professor, Ravi Sachidanandam to Senior
Computer Scientist, Lincoln Stein to Professor, Karel Svoboda to Professor, Yi Zhong to
Professor, and Anthony Zador to Associate Professor. Ira Hall and Patrick Paddison were
both named CSH Fellows.
Departures
Dr. Winship Herr stepped down as Dean of the Watson School of Biological Sciences effec-
tive July 1 to concentrate his efforts on his research. Beginning in 1995, Winship spear-
headed the effort that resulted, in September 1998, in the Laboratory's accreditation as a
Ph.D. degree-granting institution by the Board of Regents of the University of the State of
New York, on behalf of the State Education Department. This enabled the establishment of
the Watson School of Biological Sciences. Soon thereafter, Winship became the Founding
dean of the Watson School. During the last 5 years, we have seen the School grow and
become one of the most innovative programs in the country, attracting outstanding students.
Winship has nurtured and shaped the Watson School in its first formative years, culminating
in our first commencement convocation this spring. In the coming year, he and Nouria
Hernandez will move to Nouria's native Switzerland to become professors at a new institute
in Lausanne. I thank Winship for his remarkable effort in establishing a graduate school at
Cold Spring Harbor and for his sound advice to me. The establishment of a graduate school
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has transformed Cold Spring Harbor Laboratory and will have a long-lasting effect on the
intellectual environment here.
Nei lay Dedhia, Research Investigator; David Helfman, Professor; Terence Strick, CSH
Fellow; and Jerry Yin, Associate Professor, all departed the Laboratory in 2004. David spear-
headed the understanding of cancer progression through his research on the cell biology of
cell architecture and I wish him the best as he continues his research at the University of
Miami Cancer Center.
Long-term Service
The following employees celebrated milestone anniversaries in 2004:
30 years
25 years
Lane Smith
Maureen Berejka, Judith Cuddihy, Katya Davey, James Hope, John Meyer,
James Parsons, Susan Schultz, Bruce Stillman
20 years Carmelita Bautista, Dessie Carter, Robert Gensel,
Mary Ellen Goldstein, Daniel Miller, Robert Pace, Steven Tang
15 years Leslie Allen, James Bense, Sharon Bense,
Charlene De Poto, Janice Douglas, Jan Eisenman,
Helena Johnson, Robert Martienssen, Jacqueline Matura, Alison McDermott,
Eleanor Sidorenko, Halina Swidzinski, Ryszard Swidzinski, Spencer Teplin
1st row, left to right: Eleanor Sidorenko, James Bense, Sharon Bense, Charlene De Poto,
Susan Schultz, Carmelita Bautista, Jan Eisenman, Katya Davey
2nd row, left to right: Rob Gensel, James Parsons, Mary Ellen Goldstein, Alison McDermott, Maureen Berejka,
Daniel Miller
3rd row, left to right: John Meyer, James Watson, Spencer Teplin, Helena Johnson, Dessie Carter
4th row, left to right: Bruce Stillman, James Hope, Steve Tang
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CSHL team at the Long Island Walk to D'Feet ALS.
Community Outreach
In May, Laboratory employees Sandy Neuwald, Lisa Manche, Carla Margulies, Barbara Misk,
Kathryn Borowski, Barbara Purcell, and Theresa Saia served dinner at the Ronald McDonald
House in nearby New Hyde Park, which provides temporary housing to families of seriously
ill children at the Schneider Children's Hospital. In June, Shuly Avraham, Jason Evans, Kim
Gronachan, Jo Leonardo, Jianli Li, Erin Maroney, Liya Ren, Theresa Saia, and Doreen Ware
planted six flats of flowers at Haven House, a homeless shelter in Huntington Station, pur-
chased with money donated by CSHL employees. A CSHL Team also participated in the
Long Island Walk to D'Feet ALS (Lou Gehrig's disease) for the The ALS Association Greater
New York Chapter at Eisenhower Park in East Meadow on September 26.
Cold Spring Harbor Laboratory is a vibrant and dynamic institution, and like all such insti-
tutions involved in the increasingly expensive research in the genomic age, we are even more
dependent on support from individuals and foundations to enable us to remain one of the
leading research centers in the world. As we move forward, we need the type of support that
can be used to ensure that our scientists have the facilities and resources to achieve their
goals. Increasingly at Cold Spring Harbor, our research focuses on how to use all the accu-
mulated knowledge to develop new ideas for diagnosing and treating human disease. I thank
all those who have supported our efforts to date, helping us to make Cold Spring Harbor
Laboratory a truly unique education and research center.
Bruce W. Stillman, Ph.D., F.R.S.
President
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CHIEF OPERATING
OFFICER'S REPORT
There are many positives to report about the Laboratory's performance in 2004. The research
and academic programs continued to flourish. The endowment funds enjoyed another out-
standing year of investment returns and appreciation. Operating results exceeded forecasts
and the budget was balanced after depreciation expense. The latter, however, was accom-
plished only with rigorous management of administrative expenses and some extraordinary
factors.
Drs. Watson and Stillman have been heard to say, over the last year, that the research pro-
gram at the Laboratory is more exciting now than it has ever been in their experience. Having
now worked at Cold Spring Harbor Laboratory for 38 and 26 years, respectively, their obser-
vations carry considerable weight. Powerful technologies and techniques, developed here at
Cold Spring Harbor, allow for rapid identification of genes associated with various cancers as
well as psychiatric diseases such as autism, depression, and schizophrenia. The promise of
the "DNA Biopsy" for tailoring therapy to an individual's specific genetic alteration is extraordi-
nary and suddenly attainable.
Our academic programs remain strong and continue to expand. Cold Spring Harbor
Laboratory Meetings and Courses are the most sought after in the world of biology; they
attracted a record number of attendees in 2004. The Cold Spring Harbor Laboratory Press,
which continues to publish high-quality scientific books and journals, had an excellent year as
well. The Dolan DNA Learning Center is fulfilling its mission of providing unique educational
experiences for middle and high school students via hands-on laboratory and Internet instruc-
tion. The Banbury Center continues to attract scholars from around the world to its special-
ized scientific conferences. The innovative Watson School of Biological Sciences celebrated
its first commencement in 2004, awarding the degree of Ph.D. to six outstanding students, all
of whom completed their degrees in the requisite four years. Honorary degrees were award-
ed to former Laboratory Trustees Joan Steitz (Professor of Molecular Biophysics and
Biochemistry at Yale), Shirley Tilghman (President of Princeton), and, most fittingly, to James
D. Watson.
Forecasting the Laboratory's operating revenue is a challenging task due to the varied
nature of the revenue streams and shifts in timing that are difficult to anticipate. Consequently,
a relatively conservative approach is taken in the budgeting process as we project income
from grants, meetings, book sales and advertising, unrestricted fund-raising, and technology
licensing activities. We anticipated another difficult year in 2004 and forecasted a deficit from
operations of $775,000 after $5.7 million in depreciation expense. Fortunately, results were
better than expected, and a balanced budget was achieved for the year. Operating and pro-
gram income rose to $95.4 million, an 8% increase over 2003. Indirect cost revenue on grants
was ahead of forecast and the Cold Spring Harbor Laboratory Press exceeded expectations
on stronger book and journal sales combined with printing cost reductions. It should be point-
ed out, however, that one accounting change involving the allocation and timing of certain
expense items had the extraordinary effect of improving the reported bottom line results for
the year by approximately $200,000.
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It is certainly satisfying to be able to report a balanced budget, particularly after experienc-
ing substantial operating deficits in the two prior years. This, however, was not easily achieved
and required aggressive management of expenses, including caps and deferrals of adminis-
trative salary increases. Although such steps were necessary and prudent, they present very
real difficulties for hundreds of loyal employees whose lives are very much affected by rising
fuel prices, property taxes, and other cost of living pressures that outpace their compensation
increases.
Investment returns on our endowment funds were exceptionally strong for the second con-
secutive year. The total managed portfolio returned 12.1% for the calendar year versus our
benchmark index of 8.2%. Our total equity portfolio was up 15.7%, considerably ahead of the
10.9% appreciation in the Standard & Poor's. The fixed-income portfolio also outperformed
the indexes, returning 5.1% for the year. At year-end, the market value of the endowment
funds totaled $235 million after following our long-held policy of spending no more than 4%
annually. The Investment Committee has functioned well and has worked throughout the year
with our advisor, Merrill Lynch Consulting Group, to review and refine the asset allocation
model and strategy. To diversify and lessen correlation in the equity portfolio, three new man-
agers were added-two in international equities and one in the alternative asset/hedge fund
category. We express our gratitude to Lola Grace for her years of hard work as
Secretary/Treasurer of the Board and Chair of this committee. At year-end, she passed the
baton to Ed Travaglianti, who has assumed these important roles with equal wisdom and
enthusiasm.
One of the reasons for the ongoing success and vitality of the Laboratory is the wonderful
support it receives from the local community. The Cold Spring Harbor Laboratory Association
has a long history of volunteer outreach and involvement with the Lab. Its directors work hard
to communicate the Laboratory's mission, welcome scientists into the local community, orga-
nize events, and raise unrestricted funds to support critical research. Trudy Calabrese has
completed a particularly successful term as president of this important organization. Under her
inspired leadership, we enjoyed another year of wonderful concerts, dinners, and lectures and,
at the same time, surpassed the $1 million threshold with our Annual Fund for the second con-
secutive year. We thank Trudy for her dedication to the Laboratory, and we welcome her suc-
cessor, Joe Donohue.
A great deal of progress was made over the course of the year toward the Laboratory's
plans to construct a cluster of new research buildings on the main campus. Chief Facilities
Officer Art Brings worked very effectively with the diligent, but cooperative, Village of Laurel
Hollow Board of Trustees to obtain approval for the project. It was a complex process involv-
ing the preparation of an amazingly detailed environmental impact statement that required
review by numerous local and state agencies. By year-end, the necessary approvals were in
place and a building permit should be forthcoming early in 2005. Ground breaking on the site
is planned for the spring.
Clearly, critical expansion plans cannot be realized without major private financial support.
Last year, we acknowledged the generous pledge from long-time friend Mardi Matheson for
funds to construct one of the cancer research buildings. Her generosity, along with a $20 mil-
lion pledge from the State of New York, allowed us to confidently move forward with the pro-
ject. In 2004, we received two additional major gifts toward the initiative, also from long-time
friends of Cold Spring Harbor. Jean Quick, wife of late CSHL Trustee Leslie Quick, pledged
$10 million for the second cancer research building. Ongoing support and involvement from
families like the Quicks and the Mathesons is immensely gratifying. Mrs. Quick's gift was fol-
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lowed, at the end of the year, by another $10 million pledge from former CSHL Trustee and
pharmaceutical industry executive Henry Wendt and his wife Holly. In addition, Trustees Bob
Lindsay and Howard Solomon made seven-figure contributions to the effort. We express our
tremendous gratitude to these individuals for their generosity and commitment to the institu-
tion and its future.
The Laboratory could not function effectively without a strong Board of Trustees. Five val-
ued members of this body-Charles Harris; Susan Hockfield, Ph.D.; Charles J. Sherr, M.D.,
Ph.D.; Howard Solomon; and William Miller-completed their terms at year-end. We are truly
grateful for their years of service, advice, and dedication. We express particular gratitude to
Bill Miller who served on the board for 15 years, the last six as chairman. His devotion of time,
energy, wisdom, and resources to Cold Spring Harbor Laboratory has been of immeasurable
value to the institution. We are pleased that he was immediately elected as an Honorary
Trustee and welcome his continued involvement. We also welcome and look forward to work-
ing with newly elected Trustees Laurence Abbott, Ph.D.; Robert Wittes, Ph.D.; Laurie Landau,
V.M.D.; Nancy Marks; and Jerome Swartz, Ph.D. It is comforting to see smooth and seamless
leadership transition on the board. We thank Eduardo Mestre for assuming chairmanship of
the Board and look forward to his leadership.
It is exciting to embark on a new stage in the growth of Cold Spring Harbor Laboratory-
new directions in promising areas of research, expanding facilities, and a growing student
body. There is much to look forward to and much planning to be done, but there are also sig-
nificant challenges to be faced. Our funding requirements for capital projects, endowment,
and research are substantial. We are, for the time being, enjoying relatively robust financial
markets and economic conditions that create a positive environment for fund-raising. On the
other hand, the federal budget deficit is necessitating a belt-tightening that will have a major
impact on National Institutes of Health (NIH) funding for biomedical research. After years of
double-digit increases in the pool of research support, the NIH budget will now contract in real
terms over the next several years. Fewer federal grants-the lifeblood of research institu-
tions-will be awarded. At the same time, the cost of doing good science is increasing dra-
matically. This set of circumstances will require us to do a number of things extremely well. We
must continue to attract the best scientists to Cold Spring Harbor Laboratory and maintain an
environment where they can do exceptional work. At the same time, we must aggressively
pursue private sources of funding for research in addition to attracting significant federal sup-
port.
Success in these areas is essential not only to the realization of the Laboratory's scientific
mission, but also to the well being of our dedicated staff. Our administrative staff is lean and
faces increasing demands and pressures as the scope of activity expands. The institution can-
not function without this talented team of people and we must reward them appropriately. This
will be accomplished only if we are successful in attracting new sources of funding. We are
confident it can be done but know that it will be hard work.
Dill Ayres
Chief Operating Officer
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See previous page for photos of the following scientific staff.
Row 1: Izolda Mileva; Galen Collins; Ileng Ramachandran, Prakash Kumar;
Maria Simone Temporal; Sabrina Boettcher, Michael Golding
Row 2: Albert Mel lick; Rotem Karni; Shih-Chieh (Jack) Lin; Nishi Sinha;
Hans Guido Wendel; Rebecca Ewald, Jennifer Bestman
Row 3: Chih-Chi Yuan; Xiaoyun Wu; Shweta Tyagi; ; Catherine Cormier
Miguel Zaratiegui, Derek Goto; Keisha John; ; Supriya Gangadharan;
Hao-Chi Hsu
Row 4: Marissa Nolan; Farida Emran; Fuqiang Geng; Fabio Nogueira; Juan
Encinas; Stephen Schuck
Row 5: Elvin Garcia; Christopher Johns; Theresa Zutavern;
Vincenzo De Paola
Row 6: Allen Ludwig; David Mu; Alexandra Lucs; Peter O'Brien;
Daniel Nolan; Jennifer Meth
Row 7: Amitabh Mohanty; Evan Santo; Jason Williams; Maria Yuneva;
Vanisree Velamoor; Pranav Sharma
CANCER: GENE EXPRESSION
Discoveries by Leemor Joshua-Tor and Greg Hannon made a significant advancement toward a compre-
hensive understanding of one of the most intriguing biological phenomena to be uncovered in recent
years: RNA interference (RNAi). Through X-ray crystallography, Joshua-Tor and her colleagues have deter-
mined the atomic, three-dimensional structure of an RNAi component called Argonaute. When the 3-D
structure of Argonaute emerged from their data and was compared to other proteins with known struc-
tures and functions, Joshua-Tor's group found that part of Argonaute was the spitting image of the
"RNAse H" family of proteins, whose members were known to cut RNA. In collaboration with Greg
Hannon's group, a final experiment based on the Argonaute structure clinched the case for Argonaute2
as being the protein that provides the Slicer activity of RNAi in mammals. Other information led Joshua-
Tor's group to propose a model that explains precisely how Argonaute binds to and cuts messenger RNA
during RNAi.
Winship Herr uses the herpes simplex virus to study a human protein called host-cell factor 1 (HCF-1).
HCF-1 was first identified as a key factor in herpesvirus replication. However, Herr recently showed that
HCF-1 is involved in other steps of the cell division process: Without HCF-1, human cells often do not
complete the division process, and even if they do, the daughter cells frequently receive unequal numbers
of each chromosome. This and other findings indicate that the HCF-1 protein is required for the efficient
alignment and sorting of chromosomes into daughter cells during cell division.
Jacek Skowronski studies how an AIDS virus protein called Nef commandeers the protein sorting and
signaling machineries of human T cells. He has recently identified several T-cell proteins that associate with
Nef and is exploring how these protein-protein interactions contribute to viral pathology. Skowronski's
work has revealed a potentially effective strategy for developing improved anti-HIV therapies.
Even the relatively well-understood pathways of messenger RNA biosynthesis continue to surprise sci-
entists with new twists. Nouria Hernandez has discovered two new components of the "RNA polymerase
III" transcription machinery by biochemically reconstituting the process with purified proteins. Her group's
work led to the definition of a set of minimum factors required for transcription and revealed a surprising
role for a protein called actin in the process. The role of actin as a component of the cell's structural scaf-
folding (the cytoskeleton) has long been known, making its emergence as a factor required for transcrip-
tion by RNA polymerase III an intriguing discovery. Hernandez's group also discovered an unexpected role
for an enzyme called casein kinase II in RNA polymerase-Ill-mediated transcription.
In addition to his studies of proteins involved in messenger RNA processing, Rui-Ming Xu investigates
the shapes and functions of proteins that are important for the assembly and remodeling of "higher-order
chromatin structure" or structures that result from the wrapping of DNA into specifically coiled architec-
tures. Xu's group has recently used X-ray crystallography to determine the three-dimensional shapes of
two proteins (Orc1-Sir1 and Sir3) that help determine chromatin structure and thereby have significant
impacts on gene expression and other DNA-related processes.
Adrian Krainer's group explores how identical pre-messenger RNA molecules can be alternatively
spliced to ultimately produce different proteins. Part of Krainer's work involves the study of a family of pre-
mRNA splicing factors called SR proteins, which bind to specific sites on pre-mRNA and recruit the splic-
ing machinery to those sites. Krainer and his colleagues recently discovered a role for a particular SR pro-
tein in mRNA "surveillance." They found that high levels of the SR protein promote the destruction of
defective messenger RNAs, thus preventing the production of defective proteins. In other work, they char-
acterized a novel kind of splicing mutation in the LKB1 tumor suppressor gene that causes Peutz-Jeghers
syndrome and susceptibility to cancer.
William Tansey studies a potent growth control protein called Myc. When hyperactive and/or present in
excess of its normal levels, Myc contributes to cancer. Tansey and his colleagues have recently focused
on a little-studied subdomain of Myc called Myc box III (MbIII). They found that Mblll is important for induc-
ing tumor formation in a mouse model of B-cell lymphoma. Moreover, they discovered that through Mblll,
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the Myc protein can impede a natural anticancer function of cells called programmed cell death. These
findings establish that the oncogenic capacity of Myc is directly linked to its ability to block programmed
cell death.
Michael Myers is taking the accumulated understanding of genes and proteins to the next level by iden-
tifying how proteins interact with one another to form the complex, dynamic networks that ultimately deter-
mine cell biology. His group is determining the global architecture of protein interaction networks and
revealing why these networks are robust (error tolerant) and adaptable. Myers is also investigating how
protein interaction networks are altered in cancer and what key molecular "nodes" of the networks might
be the best targets for cancer therapy.
Kenneth Chang, research investigator, Greg Hannon's lab.
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MECHANISMS OF TRANSCRIPTION
N. Hernandez F. Emran K. Samudre Y. Sun
P. Hu A. Saxena S. Wu
B. Ma M. Shanmugan C.-C. Yuan
T. Oztaskin
RNA polymerase III (pol III) synthesizes a collection
of essential RNA molecules that are themselves com-
ponents of the protein synthetic and RNA processing
machineries, such as the ribosomal 5S RNA genes,
tRNA genes, and other genes including the U6 small
nuclear RNA (snRNA) gene. Because most pol III
transcripts are both abundant and stable, pol III tran-
scription is highly regulated with cell growth and pro-
liferation. In resting cells, only the small number of
pol III transcripts that decay over time must be
replaced, and pol III activity is low. In contrast, in
rapidly dividing cells, an entire complement of the
abundant 5S, tRNA, and other molecules must be syn-
thesized in just one generation time, and pol III tran-
scription is highly active. Indeed, pol III transcription
is invariably up-regulated in malignant cells.
pol III recognizes three main classes of promoter
structures. Classes I and II are present in the 5S RNA
and tRNA genes, respectively, and are gene-internal.
Class III is present in the U6 snRNA gene and other
genes and is gene-external. The class III core promot-
ers consist of two essential elements, a proximal
sequence element (PSE) and a TATA box. Until recent-
ly, the factors required for pol III transcription from
these various types of promoters were poorly defined
in higher eukaryotic cells. However, in the previous
year, we developed a well-defined in vitro transcription
system for transcription of the type-3 human U6 pro-
moter. The system consists of recombinant snRNA-
activating protein complex (SNAP), a PSE-binding
factor composed of five types of subunits, which we
express in insect cells with the baculovirus system;
recombinant Brf2-TFIIIB, a TATA-box-binding activi-
ty composed of the TATA-box-binding proteinTBP, the
TFIIB-related factor Brf2, and the SANT domain pro-
tein Bdp 1 , all expressed in Escherichia coli; and a
highly purified pol III complex, which we isolated
from HeLa cells expressing a doubly tagged pol III
subunit. When combined, these factors are sufficient to
direct several rounds of correctly initiated and termi-
nated transcription from the U6 promoter. The only
nonrecombinant factor in the system is the pol III com-
plex, and so we have focused on the characterization of
the factors present in this complex besides pol III sub-
units that might contribute to transcription activity.
Besides pol III subunits, the pol III complex we
purified contained spectrin, a-myosin, clathrin, a-
actinin 4, HSC70, P-tubulin, I3-actin, and calmodulin,
as detected by mass spectrometry analysis. On the
other hand, a number of other proteins such as topoi-
somerase 1, PC4, NF-1, the La polypeptide, and CK2
have been implicated in pol III transcription by other
investigators. To determine the role, if any, of such
proteins in pol III transcription, we subjected the pol
III complex to one additional purification step over a
"mini Q" column. We found that (3- actin, P-tubulin,
and calmodulin continued to copurify with pol III. Of
the factors implicated in pol III transcription by others,
we could detect CK2 in the pol III complex. We then
set out to determine whether these two factors might
have a role in pol III transcription.
CK2 is a nuclear and cytoplasmic protein kinase
present in all cell types, composed of two regulatory ((3)
and two catalytic subunits, of which two isoforms that
are 85% identical exist in human cells (a and a'). CK2
has been implicated in pol III transcription in both yeast
and human cells, where it has been reported to have a
positive effect on transcription. We found that CK2 is
associated not only with pol III, but also with the U6
promoter in vivo as shown by chromatin immunopre-
cipitations. We observed that CK2 activity was required
for in vitro transcription and that it was required prior
to transcription initiation. This last observation, cou-
pled with our ability to reconstitute transcription from
well-defined, separate components, allowed us to ask
which factor(s) needed to be phosphorylated by CK2
for active transcription. Our results revealed that it was
the pol III complex itself that needed to be phosphory-
lated to be active. Since, in our experiment, CK2 could
be active only before the start of transcription, and
since once phosphorylated, pol III could direct several
rounds of transcription, the phosphorylation event
appeared to be a switch that somehow converted pol III-
from an inactive to an active state.
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In its function of pol III phosphorylation, CK2 has
a positive effect on transcription. In addition, howev-
er, we also found that CK2 phosphorylation of the
Brf2-TFIIIB components inhibited pol III transcrip-
tion, even if pol III itself was phosphorylated. We then
set up to identify which of the three Brf2-TFIIIB com-
ponents-TBP, Brf2, or Bdpl -was the target of this
negative regulation. For this purpose, we simply treat-
ed each component separately either with CK2 fol-
lowed by inhibitor, which allowed phosphorylation, or
with an inhibitor followed by CK, which prevented
phosphorylation, thus keeping all of the reagents in
the reactions constant. In addition, we treated pol III
with CK2 followed by inhibitor, since we knew CK2
phosphorylation of pol III is required for transcrip-
tion, and SNAP, with inhibitor followed by CK2,
since we knew that SNAP, did not need to be phos-
phorylated by CK2 in vitro for activity. The factors
were then used for reconstitution of U6 transcription
in vitro. The results were clear-cut and showed that
CK2 treatment of Bdpl, but not Brf2 or TBP, inhibit-
ed U6 transcription. We then showed that Bdpl is
indeed phosphorylated by CK2, and we mapped the
phosphorylation sites to one or several of five serines
and threonines.
We then asked what the in vivo relevance of this
negative regulation might be. We found that Bdpl
becomes highly phosphorylated during mitosis.
Extracts from mitotic cells were transcriptionally
inactive and could be reactivated by addition of a CK2
inhibitor and recombinant, unphosphorylated Bdpl.
By fluorescent microscopy as well as through bio-
chemical fractionation, we determined that during
mitosis, Bdpl dissociates from the chromatin, and this
phenomenon was inhibited by treatment of the cells
with the CK2 inhibitor 4,5,6,7-tetrabromobenzotria-
zole (TBB). One model that incorporates these obser-
vations, shown in Figure 1, proposes that pol III
repression during mitosis occurs in part through CK2
phosphorylation of Bdpl, which perhaps results in
Bdp1 dissociation from the chromatin.
The observation that inhibition of CK2 in mitotic
extracts together with addition of Bdpl restored tran-
scription was striking, because we had observed pre-
viously that in extracts from actively growing cells,
addition of a CK2 inhibitor repressed transcription.
Indeed, we then showed that in extracts from S-phase
cells, which are very active for pol III transcription,
addition of a CK2 inhibitor also repressed transcrip-
tion. This suggests a model in which CK2 has differ-
ent roles at different stages of the cell cycle, as illus-
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trated in the figure. In M phase, it represses transcrip-
tion by phosphorylating Bdpl, whereas in phases of
the cell cycle when pol III transcription is active, for
example, S phase, it activates transcription by phos-
phorylating an unknown target. Since CK2 phospho-
rylation of the pol III complex is required for active
transcription, this unknown target may well be the pol
III complex itself.
As mentioned above, another protein that we
found to be associated with pol III was 0-actin. I3-actin
has been extensively studied as a cytoplasmic
cytoskeletal protein that has roles in intracellular traf-
ficking as well as in driving changes in cellular shape
associated with cell motility, cytokinesis, endocytosis,
and cell adhesion. 0-actin is, however, also a nuclear
protein, and in this cellular compartment, it is thought
to have roles in the constitution of the nucleoskeleton,
in RNA processing and export, and in transcription.
So, when we found 0-actin tightly associated with pol
III, we asked whether it might also be present on the
U6 promoter in vivo. Indeed, we could localize I3-actin
on this promoter by chromatin immunoprecipitations.
To determine the role of I3-actin in pol III transcrip-
tion, we then set out to identify conditions under
which 13-actin might dissociate from the rest of the
enzyme. One of the conditions we tested was treat-
ment of cells with the genotoxic agent methane
methylsulfonate (MMS), a treatment known to inhibit
pol III transcription. We found that in IMR90 cells
(but not in HeLa cells), such a treatment resulted in
dissociation of I3-actin from the enzyme, and this
enzyme missing 0-actin was inactive in the reconsti-
tuted U6 transcription assay. To regain activity, we
FIGURE 1 CK2: A molecular switch for the regulation of U6 pol
III transcription.
then needed not only to treat pol III with CK2, but
also to add recombinant 13-actin. These results estab-
lished a direct role for 3 -actin in pol III transcription.
Remarkably, concomitant with our results, two reports
appeared showing that 0-actin is required for pol I and
pol II transcriptions, and is part of the pol II initiation
complex. Thus, 0-actin, a protein extensively studied
as a cytoplasmic cytoskeletal protein having roles in
intracellular trafficking and cell shape changes,
appears to correspond also to a transcription factor
used by all three RNA polymerases.
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TRANSCRIPTIONAL REGULATION
W. Herr D. Aufiero H. Ding C. Papazoglu
A. Bubulya Y. Liu S. Tyagi
A.L. Chabes M. Mangone X. Zhao
We all originate from a single cell that contains two
complete sets of instructions-one from each par-
ent-encoding how we should develop into a human
being. Those instructions direct the cells to proliferate
and at the appropriate time to differentiate into the
approximately 250 different types of cells that make
up an individual. Cells proliferate via repeated cycles
of cell growth and division, and they differentiate by
expressing specific sets of genes that permit them to
perform specific functions. Both processes involve
intricate patterns of regulation of gene expression,
which often result from the regulation of gene tran-
scription. In eukaryotes, the genes are packaged into
chromatin and the regulation of gene transcription
involves the ability of transcriptional activators and
repressors to direct changes in the structure of chro-
matin and to recruit one of three nuclear RNA poly-
merases-pol I, pol II, and pol III-to specific pro-
moters.
Because viruses frequently target and reveal the
roles of critical cellular regulators of host-cell process-
es, we have used herpes simplex virus (HSV), a preva-
lent human pathogen, to probe transcriptional regula-
tion in human cells. The infecting HSV virion contains
a protein called VP16 that initiates the viral lytic pro-
gram by activating viral-gene transcription. Upon
infection, VP16 associates with two cellular factors-
POU-homeodomain transcription factor called Oct-1
and the host-cell factor HCF-1-to form a transcrip-
tional activating complex, called the VP16-induced
complex. Recently, our efforts have focused on (1)
how the basal transcriptional machinery responds to
transcriptional regulators like VP16 and (2) the cellu-
lar functions of HCF-1. Below are described our stud-
ies reported this year.
A NONCONSERVED SURFACE OF THE TFIIB
ZINC-RIBBON DOMAIN HAS A DIRECT ROLE
IN RNA POLYMERASE II RECRUITMENT
This project continues to make contributions to our
understanding of the mechanisms by which the basal
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transcriptional machinery responds to sequence-spe-
cific activators. Last year, we described how the
TATA-binding protein TBP interacts with the TFIIB
family of basal RNA polymerase II (pol II) and RNA
polymerase III (pol III) transcription factors, of which
TFIIB itself is the sole member involved in pol II
transcription. TFIIB is highly conserved and is essen-
tial for accurate pol II transcription. It consists of a
single polypeptide with two conserved structural
domains, an amino-terminal zinc-ribbon structure
(TFIIBzR) and a carboxy-terminal core. Thomas
Tubon, in collaboration with William Tansey (CSHL),
analyzed the role of the amino-terminal region of
human TFIIB in transcription in vivo and in vitro. He
identified a small nonconserved surface of the TFIIBzR
that is required for pol II transcription in vivo and dif-
ferent types of basal pol II transcription in vitro.
Consistent with a general role in transcription, this
TFIIBzR surface is directly involved in recruitment of
pol II to a TATA-box-containing promoter. Curiously,
although the amino-terminal human TFIIBzR domain
can recruit both the human and yeast Saccharomyces
cerevisiae pol II, the yeast TFIIB amino-terminal
region recruits yeast pol II but not human pol II. Thus,
a critical process in transcription from many different
promoters-pol II recruitment-has changed in
sequence specificity during eukaryotic evolution.
These experiments were particularly satisfying
because after studying the regulation of transcription
by pol II for more than 20 years, it was the first time
that our laboratory has directly addressed the role of
regulatory interactions with pol II, the enzyme actual-
ly responsible for the process whose regulation we
have been studying.
A SWITCH IN MITOTIC HISTONE H4
LYSINE 20 METHYLATION STATUS
IS LINKED TO M-PHASE DEFECTS
UPON LOSS OF HCF-1
With each year, our studies of HCF-1 grow in excit-
ing new directions, leading to the result that, as this
year closes, our research is entirely focused on
understanding the structure and function of this key
regulator of the human cell cycle. HCF-1 is a highly
conserved and abundant chromatin-associated pro-
tein. It exists as a heterodimeric complex of associ-
ated amino (HCF-10- and carboxy (HCF-1c)-termi-
nal subunits that result from proteolytic processing
of a large precursor protein. Studies of a mutant
hamster cell line called tsBN67 have shown previ-
ously that HCF-1 has a role in both G, -phase pro-
gression and cytokinesis. Last year, we described
how the G1 -phase and cytokinesis roles of HCF-1 are
performed by separate HCF-1 subunits: The HCF-1N
subunit promotes passage through the G, phase,
whereas the HCF-1c subunit promotes proper cytoki-
nesis. These results suggest that HCF-1 links the
regulation of exit from mitosis as defined by proper
cytokinesis and the G, phase of cell growth, possibly
by coordinating reactivation of gene expression after
mitosis.
Until this year, the known role of HCF-1 in M
phase, which involves both chromosome segregation
in mitosis and cytoplasmic separation during cytoki-
nesis, has been limited to the cytokinesis step. This
year, in an extensive analysis of the role of the HCF-
1 subunit in M phase, Eric Julien showed that this
subunit is required for multiple steps in mitosis as
well. Loss of the HCF- 1 subunit leads to a switch
from monomethyl to dimethyl lysine 20 of histone H4
(H4-K20) and defective chromosome alignment and
segregation. Consistent with these activities, the
HCF- lc subunit can associate with chromatin inde-
pendently of the HCF-1N subunit and regulates, either
directly or indirectly, the expression of the H4-K20
methyltransferase PR-Set7. Indeed, up regulation of
PR-Set7 expression upon loss of HCF-1 leads to
improper mitotic H4-K20 methylation and cytokine-
sis defects. These results establish the HCF- 1 sub-
unit as an important M-phase regulator and suggest
that H4-K20 methylation status contributes to chro-
mosome behavior during mitosis and proper cytoki-
nesis.
As an example of the M-phase defects that can
occur in the absence of the HCF- lc subunit, Figure 1
shows a cell that is being induced to proliferate by the
HCF-1N subunit in the absence of the HCF- lc subunit.
In this case, a cell is attempting to divide into three-
rather than two!-daughter cells. We do not know
whether it succeeded to divide. We look forward to
performing live-cell microscopy to determine the fate
of such three-way divisions of cells.
FIGURE 1 A mitotic human cell attempting to divide into three
aneuploid daughters as a result of a defective HCF-1 gene. The
cell was stained with anti-tubulin antibody. The darker regions
in the center of each daughter represent the nuclei. The differ-
ent sizes of the nuclei are indicative of aneuploidy.
HCF-1 ASSOCIATES WITH THE MIXED-LINEAGE
LEUKEMIA (MLL) PROTO-ONCOPROTEIN,
A HUMAN TRITHORAX GROUP HISTONE METHYL-
TRANSFERASE
Last year, we reported the association of HCF-1 with
a histone methyltransferase (HMT) complex related to
the yeast Set 1 HMT. This year, along with Akihiko
Yokoyama, Michael L. Cleary, and collaborators
(Stanford University), we extended the characteriza-
tion of HCF-1 interaction with HMTs by showing that
HCF-1 interacts with the product of the mixed-lineage
leukemia (MLL) proto-oncogene. The gene that
encodes MLL is mutated by chromosomal transloca-
tion in a variety of human leukemias. The MLL pro-
tein is a homolog of the Drosophila melanogaster
trithorax protein that displays intrinsic histone methyl-
transferase activity and functions genetically to main-
tain embryonic homeobox (Hox) gene expression.
Biochemical purification of MLL by A. Yokoyama and
M. Cleary demonstrated that it associates with HCF-1
and the related protein HCF-2. Joanna Wysocka and
Deborah Aufiero confirmed the association with
HCF-1 and further showed that MLL interacts with the
HCF-1 Kelch domain, the same domain responsible
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for HCF-1 association with Setl. These results link
HCF-1 to the maintenance of stable patterns of gene
expression as well as to oncogenesis.
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STRUCTURAL BIOLOGY OF NUCLEIC ACID
REGULATORY PROCESSES
L. Joshua-Tor C. Cho T. Hu S. Smith
E. Enemark P.R. Kumar J.J. Song
H. He P. O'Farrell N. To lia
We study the molecular basis of cell regulatory
processes by using the tools of structural biology and
biochemistry to examine proteins and protein com-
plexes associated with these processes. X-ray crystal-
lography enables us to obtain the three-dimensional
structures of individual proteins and their interactions
with other molecules. Biochemistry and molecular
biology allow us to study properties that can be corre-
lated to protein structure and function. Our efforts
largely center on protein complexes involved in nucle-
ic acid regulatory processes.
Mechanisms of RNAi
J.J. Song, N. Iota, S. Smith [in collaboration with
G.J. Hannon, Cold Spring Harbor Laboratory]
The introduction of exogenous double-stranded RNA
(daRNA) into a cell can trigger the gene silencing
process called RNA interference or RNAi. An RNase
III family enzyme, Dicer, initiates silencing by releas-
ing approximately 20 base duplexes, with 2-nucleotide
3' overhangs called siRNAs. The RNAi pathway also
mediates the function of endogenous, noncoding reg-
ulatory RNAs called microRNAs (miRNAs). Both
miRNAs and short interfering RNAs (siRNAs) guide
substrate selection by similar effector complexes
called the RNA-induced silencing complex (RISC).
These contain single-strand versions of the small RNA
and additional protein components. Of those, the sig-
nature element, which virtually defines a RISC, is a
member of the Argonaute family of proteins.
Argonaute proteins are defined by the presence of
PAZ and PIWI domains. In a central RNAi pathway,
guided by the siRNA, RISC directs the cleavage of
mRNA substrates. However, the nuclease responsible
for cleavage, dubbed "Slicer," has so far escaped iden-
tification.
There has been remarkable progress in unraveling
the components of the RNAi machinery, but to get a
true mechanistic understanding of this process, how
these components fit together, and how they function,
we must understand how they work at a molecular
level. Therefore, we embarked on structural and bio-
chemical studies of key proteins in the RNAi pathway,
the protein-RNA and protein-protein interactions
involved.
In an effort to further our understanding of the role
of Argonaute in RNAi, this past year, we determined
the crystal structure of the full-length Argonaute pro-
tein from Pyrococcus furiosus at 2.25 A resolution
(Fig. 1). The structure reveals a crescent-shaped base
made up of the amino-terminal, middle, and PIWI
domains. The PAZ domain is held above the base by a
"stalk"-like region. The PIWI domain is similar to
RNase H, with conserved active site aspartate
residues, strongly implicating Argonaute as "Slicer."
Several known characteristics of mRNA cleavage by
RISC are consistent with an RNase-H-like enzyme.
The architecture of the molecule and placement of the
PAZ and PIWI domains define a groove for substrate
PAZ
PIWI
FIGURE 1 The crystal structure of Argonauts from P furiosus.
Ribbon representation of Argonauts showing the amino-termi-
nal domain, the "stalk, the PAZ domain, the middle domain, and
the PIWI domain.
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binding. Based on the structure of PAZ with a "mini-
siRNA," we could model the siRNA binding with its
3' end in the PAZ cleft and the siRNA-mRNA double
helix extending into the groove, and suggest a mecha-
nism for siRNA guided mRNA cleavage. The notion
that RISC "slicer" activity resides in Argonaute itself
was tested in a mammalian system by mutational
analysis of hAgo2 in collaboration with Greg
Hannon's laboratory. Conserved active site aspartates
in hAgo2 were altered and the mutants lost nuclease
activity while retaining siRNA binding. This supports
the model in which Argonaute itself functions as the
Slicer enzyme in the RNAi pathway.
The DNA-binding and Assembly of the
Papillomavirus Initiator Protein El
E. Enemark, H. He, A. Auster [in collaboration with
A. Stenlund, Cold Spring Harbor Laboratory]
Papillomaviruses are a large family of closely related
viruses that give rise to warts in their hosts. Infection
of the genital tract by the human papillomaviruses
(HPV) from this group represents one of the few firm-
ly established links between viral infection and the
development of cervical cancer, as HPV DNA is
found in practically all cervical carcinomas. The El
protein belongs to a family of multifunctional viral
proteins whose main function is related to viral DNA
replication. These proteins bind to the origin of DNA
replication, melt the DNA duplex, possess DNA heli-
case activity, and recruit other cellular replication pro-
teins such as DNA polymerase a and replication fac-
tor A (RPA). Most likely, different oligomeric forms
of El are responsible for the different activities, and
the sequential assembly El complexes ensures an
ordered transition between these different activities.
Ultimately, El forms a hexameric ring helicase on
each strand that serve as replicative DNA helicases
that unwind the DNA in front of the replication fork.
In collaboration with Arne Stenlund's group here
at CSHL, we embarked on structural studies to pro-
vide high-resolution structural information about El,
its DNA-binding activity, and its assembly on DNA,
which would provide general insight into the bio-
36
chemical events that are involved in viral DNA repli-
cation. They can also provide a basis for the develop-
ment of clinical intervention strategies. Second, the
viral DNA replication machinery itself represents an
obvious target for antiviral therapy and detailed infor-
mation such as high-resolution structures of viral pro-
teins required for replication will greatly facilitate the
development and testing of antiviral agents.
Previously, we have solved the structures of the El
DNA-binding domain from bovine papillomavirus
(BPV) both unbound and in two stages of assembly on
the origin (dimer and tetramer). During the past two
years, we have extended our characterization of DNA
binding by El to include human papillomavirus type
18 (HPV-18). HPV-18 is a high-risk strain of papillo-
mavirus that causes cervical carcinoma, one of the
most frequent causes of cancer death in women world-
wide. In particular, HPV-18 causes adenocarcinoma,
which is associated with poor prognosis. We deter-
mined the crystal structure of the monomeric HPV-18
El DNA-binding domain refined to 1.8 A resolution
and demonstrated biochemically that the analogous
residues required for El dimerization in BPV-1 and
the low-risk HPV type 11 are also required for HPV-
18 El. We also found evidence that the HPV-18 El
DNA-binding domain does not share the same
nucleotide and amino
DNA recognition as BPV-1 and HPV-11 El.
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MECHANISMS OF CONSTITUTIVE AND ALTERNATIVE
PRE-mRNA SPLICING
RNA splicing is an essential step in the expression of
most eukaryotic protein-coding genes. The spliceo-
some selects and pairs authentic splice sites with
extremely high fidelity, which requires precise inter-
pretation of limited and dispersed sequence informa-
tion present throughout introns and exons. In humans,
about 75% of genes are expressed via alternative splic-
ing, giving rise to multiple protein isoforms. The
choice of alternative splice sites is commonly regulat-
ed to alter gene expression, either tissue-specifically
or in response to a developmental program or to sig-
naling pathways. The fact that multiple protein iso-
forms can be expressed from individual genes demon-
strates that the classical "one gene-one enzyme" par-
adigm is no longer valid and provides an explanation
for the unexpectedly small number of genes uncovered
by genome-sequencing projects.
Both constitutive and alternative splicing mecha-
nisms involve numerous protein components, as well
as RNA components that are part of small nuclear
ribonucleoprotein (snRNP) particles. The work in our
lab focuses primarily on the identification and molec-
ular characterization of protein factors and sequence
elements that are necessary for the catalysis and fideli-
ty of splicing and/or for the regulation of alternative
splice site selection. We are interested in how the
spliceosome correctly identifies the exons on pre-
mRNA, and how certain point mutations in either exon
or intron sequences cause aberrant splicing, leading to
various genetic diseases. A brief summary of three of
our recently published studies is given below.
INVOLVEMENT OF SR PROTEINS IN mRNA
SURVEILLANCE
In the course of experiments aimed at addressing the
relationship between premature termination codons
(PTCs) and splice site selection, we uncovered a role
for SR proteins in nonsense-mediated mRNA decay
P. Smith
Q.-S. Zhang
Z. Zhang
(NMD). SR proteins are factors required for splicing,
and they also regulate alternative splicing in a concen-
tration-dependent manner. NMD is a quality-control
pathway that down-regulates mRNAs with PTCs.
Model minigenes were constructed to test the effect of
PTCs placed between two alternative 5' splice sites on
5' splice site selection (Fig. 1). In transiently trans-
fected cells, the distal 5' splice site was selected by
default, in both the presence and absence of the PTCs
(not shown). We overexpressed various SR proteins
(e.g., SF2/ASF and SC35) to promote use of the prox-
imal 5' splice site and observed dramatically different
results in the presence of PTCs, depending on which
SR protein was overexpressed. As expected, both
SF2/ASF and SC35 promoted use of the proximal site
with the wild-type minigene to equivalent extents
(lanes 3 and 5); however, when a PTC was present, no
proximal SF2/ASF overex-
pression (lane 4), whereas SC35 overexpression
resulted in proximal splicing at the same level as with
the wild-type construct (lane 6). Abrogating NMD in
various ways, including cycloheximide treatment,
down-regulation of hUPF1 or hUPF2 by RNA inter-
ference, or expression of dominant-negative hUPF1,
rescued expression of the proximal spliced mRNA
with a PTC in the presence of SF2/ASF (not shown).
Many natural alternatively spliced mRNA isoforms
possess PTCs, and our studies suggest that the extent
of their expression depends on the coexpression of the
particular SR proteins that promote the appropriate
alternative splicing events, as well those that do or do
not trigger their degradation by NMD. PTCs also arise
from nonsense and frameshift mutations, as well as
from splicing mutations that change the reading
frame. We found that transient overexpression of
some, but not all, SR proteins strongly enhances the
degradation of standard NMD substrates, i.e., consti-
tutively spliced transcripts with a PTC. Although this
effect on the NMD pathway was elicited most strong-
ly by SF2/ASF, which is a shuttling SR protein, we
also observed it with a mutant version of the protein
that is retained in the nucleus.
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FIGURE 1 Effect of different SR proteins on sensitivity to a PTC in the context of alternative splicing. Model human f3-globin genes were
constructed with an internal duplication (gray) spanning the 5' splice site in the first intron and short flanking exonic and intronic seg-
ments. The mutant construct (M) has a stop codon after each 5' splice site, which interrupts the reading frame when the proximal (down-
stream) 5' splice site is selected. The wild-type construct (W) has no premature termination codons (PTCs). He La cells were transfected
with W and M constructs, and cotransfected with plasmids for overexpression of SF2/ASF or SC35. A GFP plasmid was also cotrans-
fected as an internal reference for transfection efficiency, RNA recovery, and loading. The transiently expressed globin transcripts were
analyzed by RPA, with a probe spanning the first exon, the duplicated region, and partial intron-1 sequences. fl-globin and GFP probes
were used simultaneously; undigested probes (P) are shown in lane 1, corresponding to <1% of the amount of probe used in each RPA
reaction. The bands corresponding to I3-globin pre-mRNA, proximal and distal spliced mRNAs, and GFP, are indicated. For simplicity,
the diagrams show only the first two exons and first intron of 13-globin. (m): DNA markers.
NOVEL LKB1 SPLICING MUTATION ASSOCIATED
WITH PEUTZ-JEGHERS SYNDROME
In collaboration with N. Resta, A. Stella, and G.
Guanti (University of Bari, Italy), we characterized a
novel splicing mutation associated with Peutz-Jeghers
syndrome (PJS). PJS is an autosomal dominant disor-
der associated with gastrointestinal polyposis and
increased cancer risk. PJS is caused by germ-line
mutations in the tumor suppressor gene LKB1, which
encodes a protein kinase. One familial mutation,
IVS2+1A>G, alters the second intron 5' splice site,
which has sequence features of a U12-type AT-AC
intron. This rare type of intron normally begins with
either A or G. We found that in patients, LKB1 RNA
splicing occurs from the mutated 5' splice site to sev-
eral cryptic, noncanonical 3' splice sites immediately
38
adjacent to the normal 3' splice site. In vitro splicing
analysis demonstrated that this aberrant splicing is
mediated by the U12-dependent spliceosome. These
results indicate that the minor spliceosome can use a
variety of 3' splice site sequences to pair to a given 5'
splice site, albeit with tight constraints for maintaining
the 3' splice site position. The unusual splicing defect
associated with this PJS-causing mutation uncovered
interesting differences in splice site recognition
between the major and minor pre-mRNA splicing
pathways.
REGULATION OF HNRNP Al SHUTTLING BY
PHOSPHORYLATION
Heterogeneous nuclear ribonucleoprotein (hnRNP) A 1
is an abundant RNA-binding protein involved in the
regulation of alternative splicing and other cellular
processes. hnRNP Al is mainly nuclear, although it
shuttles rapidly between nuclear and cytoplasmic
compartments. Genotoxic stress, such as osmotic
shock, activates the MKK3/6-p38 signaling pathway,
which in turn results in accumulation of hnRNP Al in
the cytoplasm. This effect modulates alternative splic-
ing regulation in vivo-by decreasing the level of
nuclear hnRNP Al-and correlates with increased
hnRNP Al phosphorylation. In collaboration with J.
Caceres (Edinburgh), M. Myers (CSHL), and J.
Moscat (Madrid), we have now characterized the mol-
ecular mechanism involved in the cytoplasmic accu-
mulation of hnRNP Al in cells subjected to osmotic
shock. This treatment results in serine-specific phos-
phorylation within a carboxy-terminal peptide,
dubbed the "F-peptide," which is adjacent to the M9
motif that mediates bidirectional transport of hnRNP
Al. Analysis of mutants in which the F-peptide serines
were replaced by aspartic acids or alanines showed
that F-peptide phosphorylation is required for the sub-
cellular redistribution of hnRNP Al in cells subjected
to osmotic shock. Furthermore, we showed that F-pep-
tide phosphorylation modulates the interaction of
hnRNP Al with transportin Trn 1 . These findings sug-
gest that the phosphorylation of F-peptide by signaling
pathways regulates the rate of hnRNP Al nuclear
import.
PUBLICATIONS
Muraki M., Ohkawara B., Hosoya T., Onogi H., Koizumi J.,
Koizumi T., Sumi K., Yomoda J., Murray M.V., Kimura H.,
Furuichi K., Shibuya H., Krainer AR., Suzuki M., and
Hagiwara M. 2004. Manipulation of alternative splicing by a
newly developed inhibitor of Clks. J. BioL Chem. 279:
24246-24254,
Zatkova A., Messiaen L, Vandenbroucke I., Wieser R., Fonatsch
C., Krainer AR., and Wimmer K. 2004. Disruption of exon-
ic splicing enhancer elements is the principal cause of exon
skipping associated with seven nonsense or missense alle-
les of NF1 . Hum. Mutat. 24: 491-501.
Zhang Z. and Krainer A.R. 2004. Involvement of SR proteins in
mRNA surveillance. MoL Cell 16: 597-607.
In Press
Allemand E., Guil S., Myers M., Moscat J., Caceres J.F., and
Krainer A.R. 2005. Regulation of heterogeneous nuclear
ribonucleoprotein Al transport by phosphorylation in cells
stressed by osmotic shock. Proc. Natl. Acad. Sc!. 102:
3605-3610.
Coutinho G., Xie J., Du L., Brusco A., Krainer AR., and Gatti
R.A. 2005. Functional significance of a deep intronic muta-
tion in the ATM gene and evidence for a new alternative
exon, 28a. Hum. Mutat. 25: 118-124.
Hastings M.L., Resta N., Traum D., Stella A., Guanti G., and
Krainer A.R. 2005. An LKB1 AT-AC intron mutation causes
Peutz-Jeghers syndrome via splicing at noncanonical cryp-
tic splice sites. Nat. Struct. Mol. Biol. 12: 54-59.
Roca X., Sachidanandam R., and Krainer A.R. 2005.
Determinants of the inherent strength of human 5' splice
sites. RNA (in press).
Rotem Karni, postdoc, Adrian Krainer's lab.
39
PROTEOMICS
M. Myers R. Bish L.L. Schmidt
G. Pegoraro C. van der Meijden
D. Perkowski
The completion of the human genome has ushered in
a new age of biological discovery. This accomplish-
ment has essentially identified all of the players gov-
erning human biology. The important work of assign-
ing functions to this myriad of proteins has become
one of the principal tasks of modern biology. Although
many functions will be assigned using genetics or
bioinformatics, the majority of this functional charac-
terization will be performed by proteomics.
The goal of our laboratory is to understand how
proteins and protein complexes regulate cellular
behavior. In the environment of a cell, almost all of the
proteins can be found in a highly interactive network.
Our laboratory is focused on understanding the global
architecture of this network and how this network gen-
erates robustness (error tolerance) and adaptability to
the system and how this network is altered to produce
and survive complex diseases, such as cancer.
Optimization of Protein Identification
D. Perkowski, L.L. Schmidt
Protein identification is the major tool of proteomics.
We have been optimizing mass spectrometry (MS) for
protein identification. MS has many advantages over
other techniques for protein identification, especially its
sensitivity. However, the improved sensitivity comes at
a price, as the sample preparation becomes increasing-
ly important to ensure success. We have been optimiz-
ing a number of parameters to increase this success rate.
As part of the optimization, we have found that
nanoscale chromatography gives the best sensitivity.
Using conventional chromatography media (packed beds
of small, functionalized beads), we have been fabricating
our own nanoscale (75 -gm internal diameter) columns
that operate at flow rates of 200-500 nl/min. The sensi-
tivity and resolution of these nanoscale columns are
related to their internal diameter. However, the internal
pressures required for chromatography increase dramat-
ically as diameter decreases, limiting the practical utility
of miniaturizing conventional chromatography media.
To overcome the pressure problem, we have developed a
mesoporous, monolithic chromatography medium that is
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well suited for miniaturization. Monolithic medium is
composed of a single highly cross-linked entity that is
formed during the polymerization of silicas (sol-gels) or
organic polymers (plastics). Initially, we incorporated
octadecyl (C18) or octyl (C8) functional groups into our
monoliths in order to create a reverse-phase resin, and we
are currently working on producing monoliths with addi-
tional functionality, such as those that can be used for
ion-exchange chromatography.
A significant loss in signal occurs due to poor ion
transfer between the nanocolumns and the mass spec-
trometer. We have optimized a number of parameters
to improve our electrospray interface. In collaboration
with Patrik Kallback (GE Healthcare), we have devel-
oped a novel high-voltage interface that maximizes
electrical contact with the column effluent, resulting in
a more robust ionization at lower voltages. In addition,
this interface is resistant to fouling. One of the draw-
backs of chromatography-coupled electrospray inter-
faces is that the voltage must be adjusted during the
analysis in order to maintain a single, stable Taylor
cone. To improve Taylor cone stability, we have adapt-
ed a static nanospray chip to our system. Importantly,
the nanospray chip improves the potential difference
between the column effluent and the mass spectrome-
ter, resulting in stable Taylor cone formation through-
out the chromatography run.
Monitoring Posttranslational
Modifications
L.L. Schmidt, D. Perkowski
One of the challenges in the postgenomic era is to
understand how proteins are regulated by posttransla-
tional modifications. These modifications are respon-
sible for controlling the activity of proteins and ulti-
mately determining how a cell responds to its environ-
ment. Phosphorylation is considered to be the most
common posttranslational modification, and its wide
use as a regulatory mechanism has been attributed to
its reversible nature. Alterations in protein phosphory-
lation have been shown to be the hallmark of many
pathological conditions including cancer and diabetes.
Therefore, efficient identification of phosphorylated
proteins, as well as mapping the specific phosphoryla-
tion sites, has become one of the primary goals of pro-
teomics. We have been attempting to develop sensitive
and robust MS methods for characterizing this impor-
tant posttranslational modification. Characterization of
phosphorylated residues is complicated by three attrib-
utes of phosphorylation: (1) phosphorylation suppress-
es peptide detection by MS, (2) phosphorylation is
generally substoichiometric, and (3) phosphorylated
residues readily undergo neutral loss of the phosphoryl
group. We have expended a significant effort exploring
why phosphorylation suppresses peptide signals during
MS. Conventional wisdom dictates that the poor signal
of phosphopeptides was due solely to their strong neg-
ative charge. Our analysis indicated that this is not the
case. For example, phosphorylated peptides are equal-
ly suppressed regardless of whether positive or nega-
tive ions are detected, and sulfated peptides (which
carry a similar negative charge) do not exhibit the same
suppression as their phosphorylated cousins. Our
results suggest that the suppression of phosphopeptides
is likely the result of a combination of the poor volatil-
ity of phosphoric acid and/or instability of the phos-
phopeptides in the gas phase. In fact, the suppression
due to phosphorylation can be alleviated by altering the
ionization conditions to improve volatility and stability
during the ionization process.
"Small World" Proteomics
C. van der Meijden, G. Pegoraro [in collaboration
with R. Sachidanandam, Cold Spring Harbor Laboratory]
We have modeled the data from several high-through-
put protein interaction screens as a network. We have
chosen to model these data as a network because it is
one of the only ways to make sense of these large and
complicated data sets. In this model, each protein is
treated as a node, and the interactions are treated as
links between the nodes. In this way, the yeast protein
network ends up looking very similar to the network of
computers that make up the World Wide Web or the
network of human social interactions that make this a
"small world." On the basis of the network properties of
the yeast protein network, we have been able to classi-
fy the yeast network as a scale-free network, in which
only a fraction of the proteins are responsible for mak-
ing the lion's share of the connections. One prediction
from the network model is that these highly connected
proteins are essential for yeast viability. In fact, we find
that this is the case, as essential proteins are highly
enriched in the pool of highly connected proteins.
Importantly, not all highly connected genes are essen-
tial, and we are focusing on trying to understand the
differences between these proteins and those which are
essential. The overall goal of this study is to understand
how these protein networks provide adaptability to
genetic alterations, such as loss or duplication of a node
(gene) that occurs during tumorigenesis. Importantly,
nongenotoxic stresses, such as high salt or nutrient
depletion, increase the spontaneous mutation rate in
yeast and in a number of other organisms. The stress-
induced mutations are believed to provide a mechanism
for rapid adaptation to changing environmental condi-
tions. We are currently investigating whether the essen-
tial genes are protected from these mutations, and we
have discovered that the essential and nonessential
genes have different genomic distributions.
We were hoping that our analysis of the yeast pro-
teome network would reveal properties of mammalian
networks and perhaps even how these networks get
reprogrammed during tumorigenesis. One of the
lessons from our work in yeast was that even this rela-
tively small-scale network (6000 genes) was incredibly
complex, suggesting that it would be difficult to make
inroads into the tumor-specific network. We have cho-
sen to take advantage of adeno-associated virus (AAV)
to help us get a handle on the tumor-specific network.
AAV has no known pathology in humans and has actu-
ally been described as having tumor-suppressive activ-
ity. We hope that an exploration of AAV-dependent
tumor suppression would uncover important hubs in
the tumor-specific network. Using MS, we have identi-
fied a number of host-cell proteins that associate with
AAV-Rep68, an AAV protein required for viral replica-
tion. We have found that Rep68 associates with a num-
ber of proteins involved in DNA damage response
(Ku70, Ku80, and DNA-dependent protein kinase). We
have also found that AAV-Rep68 associates with
ANP32B, a poorly characterized protein of uncertain
function. Importantly, microarray data has demonstrat-
ed that ANP32B and AAV-Rep68 act synergistically to
effect host-cell gene transcription.
PUBLICATIONS
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CELL SIGNALING IN HIV PATHOGENESIS
J. Skowronski M. Gierszewska M. Kwofie
K. Hrecka Z. Thakkar
L. Kozaczkiewicz
Our interest lies in understanding the molecular mech-
anisms underlying the pathogenesis of AIDS and, in
particular, understanding the functional consequences
of interactions between viral proteins and the cellular
regulatory machinery. The main focus of our research
is to understand the functions of Nef, a regulatory pro-
tein of human and simian immunodeficiency viruses
(HIV and SIV) that is an important determinant of vir-
ulence. We directed a major effort toward the identifi-
cation of mechanisms and downstream effectors that
mediate the effect of Nef on protein sorting and signal
transduction machineries. and our experiments have
been focused in two areas. First, we have focused
heavily on the isolation and identification of cellular
proteins that mediate the effects of Nef on signal trans-
duction and endocytic machineries. This has led
recently to purification and microsequencing of sever-
al cellular factors that associate with Nef in T lym-
phocytes. Importantly, we found that Nef targets a crit-
ical molecular switch that regulates Rac GTPases
downstream from chemokine- and antigen-initiated
signaling pathways. This interaction enables Nef to
influence multiple aspects of T-cell function, and thus
provides an important mechanism by which Nef
impacts pathogenesis by primate lentiviruses. We have
also begun to verify selected novel interactions and to
address their relevance to previously known and pos-
sibly novel functions of Nef, as well as to AIDS patho-
genesis. Second, we continued studies to address the
relevance of individual Nef activities for rate of pro-
gression of lentiviral replication in vivo. To this end,
we completed the studies of the impact of down-mod-
ulation of class I major histocompatibility complex
(MHC) by Nef on antiviral immune response and
found that this Nef function indeed limits in important
ways the generation of virus-specific CDS+ T cells in
the infected host.
IDENTIFICATION AND CHARACTERIZATION OF NOVEL
Nef EFFECTORS
Nef is a small adaptor protein that acts through associ-
ations with large protein complexes. We recently puri-
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fied to near homogeneity Nef and its associated pro-
tein complexes from T-cell and monocyte lines stably
expressing Nef using an immunoaffinity purification
protocol and identified their components by mass
spectroscopy. This approach allowed us to detect a
series of polypeptides with apparent molecular masses
ranging from 20 kD to more than 250 kD that copuri-
fied with HIV-1 and SIV Nef proteins. Next, we deter-
mined their sequences by mass spectroscopic analysis,
in collaboration with Michael Myers here at the CSHL
Protein Chemistry Shared Resource. This led to the
identification of several common polypeptides associ-
ated with both 7.AH Nef and 239.AH Nef, including
subunits of the DOCK2- ELMO1 -Rac2 complex and
additional polypeptides involved in control of various
housekeeping functions of a cell. During the last year,
we have continued to study these associations. We have
also characterized in detail the complex comprising
Nef and isoforms of N-myristoyltransferase (NMT).
Nef ASSOCIATES SELECTIVELY WITH ISOFORM 1
OF NMT
All known functions of Nef require that it be myris-
toylated at its amino terminus. This reaction is cat-
alyzed by NMTs, which transfer myristate from myris-
toyl coenzyme A (myristoyl-CoA) to the amino-termi-
nal glycine of substrate proteins. Two NMT isoforms
(NMT-1 and NMT-2) are expressed in mammalian
cells. Interestingly, NMT-1 but not NMT-2 was identi-
fied as one of relatively abundant cellular proteins that
associated with both HIV-1 and SIV Nef. The Nef-
NMT-1 complex is most likely a transient intermediate
of the myristoylation reaction of Nef because its for-
mation requires the amino-terminal myristoylation
signal in Nef and is modulated by agents that affect the
size of the myristoyl-CoA pool in the cell. We also
examined two other proteins that bear an amino-ter-
minal myristoylation signal, HIV-1 Gag and Hck pro-
tein tyrosine kinase. Surprisingly, we found that Gag
bound preferentially the NMT-2 isoform, whereas Hck
bound mostly to NMT-1. Recognition of different
NMT isoforms by these viral and cellular substrate
proteins suggests nonoverlapping roles for these
enzymes in vivo and reveals a potential for the devel-
opment of inhibitors that target the myristoylation of
specific viral substrates more selectively.
ANTIVIRAL IMMUNE RESPONSE AND SIV
VIRULENCE
Presentation of antigens derived from viral proteins
expressed in infected cells by class I MHC molecules
to competent effector T cells is the key event required
for the recognition and elimination of infected cells by
the immune system of the host. We showed previous-
ly that Nef proteins down-regulate expression of class
I MHC complexes by inducing their endocytosis from
the cell surface. Down-regulation of class I MHC
expression could be very important for the establish-
ment of persistent SIV/HIV infection once strong
antiviral responses develop in the infected host, but
whether it is so has been a subject of controversy.
To address directly the role of this Nef function as
well as a broader issue of the role of antiviral immune
response in immunodeficiency virus infection and
progression to AIDS, we studied in detail class I MHC
down-regulation by Nef protein derived from a patho-
genic SIVmac strain. First, we identified mutations in
the carboxy-terminal domain of SIVmac 239 Nef that
selectively disrupt class I MHC down-regulation, hav-
ing no detectable effect on other functions of Nef such
as the down-regulation of CD4 and CD3 surface
expression, and the stimulation of SIV virion infectiv-
ity and induction of SIV replication from peripheral
blood mononuclear cells (PBMCs) infected in the
absence of stimulation. Second, we constructed sever-
al mutant Nef proteins with small deletions in the car-
boxy-terminal region (NefA239 -240, Nef238stop/
fs/fs). These mutations still selectively disrupted only
class I MHC down-regulation, but are less likely to
revert in vivo than point mutations. These mutants
turned out to be powerful reagents to study the impor-
tance of class I MI-IC down-regulation for SIV repli-
cation in the context of a functional immune system in
rhesus macaques. Then, to define the effect of these
selective mutations on anti-SIV immune response we
collaborated with Dr. R.C. Desrosiers (New England
Primate Center, Harvard) who infected rhesus mon-
keys with SIVmac viruses carrying nefA239-240,
nef238stop/fs/fs and, as controls, SIVmac viruses
containing wild-type nef, or a nef mutant with a 181 -
nucleotide deletion that abrogates all known function-
al activities of Nef.
Nef LIMITS ANTIVIRAL RESPONSE BY COB* T CELLS
The ability of CD8+ T lymphocytes from infected
monkeys to react with antigenic peptide and an MHC
I tetramer corresponding to the Mamu-A*01-restrict-
ed Gag181-189 epitope CTPYDINQM was moni-
tored. The four monkeys infected with the SIV strains
carrying the MHC-selective nef mutations exhibited
higher levels of CD8+ T-cell cellular responses than the
four monkeys infected with the parental wild-type
SIV239 at 4-14 weeks after infection. These differ-
ences were statistically significant. Differences
became less discernible by 16-20 weeks postinfection.
CD8+ T-cell responses were significantly higher in
monkeys that received the MHC-selective mutant
SIVs than in monkeys that received parental SIV239,
from 4 to 14 weeks postinfection. Stronger CD8+
antiviral responses would be expected to translate into
lower viral loads, but we were unable to demonstrate
any statistically significant differences in viral loads
among the groups, excluding of course the SIVAnef
animals. It seems likely that the evolution of restored
MHC down-regulating activity minimized the magni-
tude and duration of any effects of the mutations on
viral load. The number of monkeys used was neces-
sarily limited, and significant differences may have
been observed with much larger numbers of monkeys.
A controlling immune response is likely to consist
of multifactorial components; the effects of the MIIC
activity of Nef influenced the levels of only one of
these multifactorial components: virus-specific CD8+
cellular responses. SIV destruction of virus-specific
CD4+ helper cells may have limited the effectiveness
of increased numbers of virus-specific CD8+ T cells
that resulted from the loss of MHC down-regulating
activity. Nonetheless, although we were not able to
demonstrate significant differences in viral load, the
selective pressure for sequence change to restore
MHC down-regulating activity clearly indicates that
the absence of this activity did serve to limit the repli-
cation of the virus at least somewhat.
CLASS I MHC DOWN-REGULATION BY MUTANT Nef
PROTEINS IS RESTORED THROUGH SELECTION OF
SECOND-SITE COMPENSATORY MUTATIONS
To address the normalization in numbers of Gag-spe-
cific CD8+ T cells at later timepoints, we next deter-
mined the evolution of sequence changes in nef over
time. nef sequences present at 16 and 32 weeks postin-
fection were amplified by polymerase chain reaction
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(PCR) of DNA from cells infected with recovered
virus. Little variation was observed in the week-16
samples from the two control animals infected with the
wild-type virus. In contrast, greater levels of variation
were observed in the monkeys infected with the MHC-
selective mutants at 16 weeks. In all clones analyzed at
16 and 32 weeks after infection in our current study,
the difficult-to-revert NefA239-240 and Nef 238stop/
fs/fs mutations were retained, forcing the virus to try to
compensate by changing residues elsewhere in the Nef
protein. The changes in Nef progressively increased
the ability to down-regulate MHC from weeks 0 to 16
to 32 such that by week 32 the ability to down-regulate
MHC class I was similar to that of the parental
SIVmac 239 Nef. Based on the large number of
sequence changes and the time required to restore full
MHC down-regulating activity, the virus was clearly
under strong selective pressure over a prolonged peri-
od to restore the activity; this provides unambiguous
evidence for the contribution of MHC down-regulation
to the ability of SIV to replicate in monkeys. The abil-
ity to restore the activity by sequence changes quite
distant in the linear sequence is testimony to the
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remarkable flexibility and multiplicity built into the
Nef protein structure.
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TRANSCRIPTIONAL CONTROL AND THE UBIQUITIN-
PROTEASOME SYSTEM
W. P. Tansey A. Daulny M. Muratani
E. Ezhkova S. Salghetti
F. Geng K. Tworkowski
A. Girard L. Wang
J. Kurland
Correct regulation of gene expression is mediated, in
part, by the action of sequence-specific transcription
factors that bind to control elements within genes and
stimulate the recruitment and activity of RNA poly-
merase II (pol II). The importance of transcription fac-
tors to the control of normal cellular processes is evi-
denced by the fact that many transcription factors are the
products of oncogenes and tumor suppressors.
Oncoprotein transcription factors such as Myc, for
example, drive the expression of a battery of genes
required for cell cycle progression and cell growth.
Ectopic expression of Myc leads to uncontrolled prolif-
eration and eventually tumorigenesis, and deregulated
Myc levels are commonly found in a variety of human
cancers. Indeed, it has been estimated that fully one third
of cancer deaths in the United States can be attributed to
aberrant expression or activity of the Myc protein.
Consistent with their potent growth-promoting
properties, the activity of proteins such as Myc are
tightly limited within the cell. Perhaps one of the most
striking ways in which transcription factor function is
restricted is via their rapid proteolysis. Indeed, tran-
scription factors-most notably those involved in
responding to a transient signal from outside the
nucleus-are generally unstable proteins that are
destroyed by the ubiquitin (Ub)-proteasome system.
Our research is targeted toward understanding how
transcription factors such as Myc are destroyed by the
Ub-proteasome system, and the significance of this
destruction to the regulation of gene expression.
CONNECTION BETWEEN TRANSCRIPTION FACTOR
ACTIVITY AND DESTRUCTION
Although transcriptional activation and Ub-mediated
proteolysis are two processes that have apparently
very little in common, research from a number of lab-
oratories, including our own, has revealed that these
two processes come together to control gene activity.
Our efforts in this area began with the observation
that, within Myc, the element that signals Myc ubiqui-
tylation (the so-called "degron") overlaps precisely
with the domain that activates transcription (the tran-
scriptional activation domain, or TAD). Subsequent
studies have revealed that the overlap of TADs and
degrons occurs in most unstable transcription factors,
that the relationship between these elements is inti-
mate, and that, in some cases, the ability of an activa-
tor to engage the Ub-proteasome system is essential
for transcription activation. Together with other find-
ings demonstrating that Ub ligases can function as
transcriptional coactivators, that some general tran-
scription factors have Ub ligase activity, and that com-
ponents of the proteasome have a nonproteolytic role
in transcriptional elongation and chromatin modifica-
tions, these observations suggest a deep mechanistic
connection between the transcription and ubiquitin
systems that we are anxious to explore.
Research in our laboratory is divided into two par-
allel, but complementary, strands. To understand the
basic mechanisms through which Ub-dependent trans-
actions regulate gene expression, we study model tran-
scription factors in the yeast Saccharomyces cerevisi-
ae. To probe the significance of the Ub-transcription
connection to mammalian cell growth control, we ask
how the basic mechanisms we learn about from our
yeast studies apply to regulation and activity of the
Myc oncoprotein.
TWO DISTINCT MODES OF UB-MEDIATED
PROTEOLYSIS DIFFERENTIALLY REGULATE
THE YEAST TRANSCRIPTION FACTOR Ga14
Our previous studies have revealed that some tran-
scription factors must be ubiquitylated to activate tran-
scription. We have interpreted this requirement to be a
type of a "licensing" mechanism, whereby the activity
of transcription factors is limited to a narrow window
of time between when it is ubiquitylated and when it is
ultimately destroyed by the proteasome. Interestingly,
in this scenario, Ub ligases-the enzymes that mediate
transcription factor ubiquitylation-serve as essential
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transcriptional coactivators. The concept that a Ub lig-
ase can stimulate the activity of a protein that it ulti-
mately destroys is very different from traditional
views, where the Ub system acts to terminate protein
function when no longer required. Although the
licensing model accounts for the close relationship
between transcription factor activity and destruction,
and for the growing number of Ub ligases that have
been shown to have transcriptional coactivator func-
tion, this model cannot explain all regulation of tran-
scription factors by the Ub system. The tumor sup-
pressor transcription factor p53, for example, is ubiq-
uitylated via the Mdm2 Ub ligase, and it is clear that
Mdm2 antagonizes p53 activity. Similarly, we have
shown that Myc activity is stimulated by a Ub ligase
called Skp2, whereas other groups have shown that
the Ub ligase Fbw7 destroys Myc and blocks its func-
tion. Clearly, therefore, the regulation of transcription
factors by components of the Ub system is complex.
To resolve some of this complexity, we asked how
the native yeast transcription factor Ga14 -which acti-
vates genes required for galactose utilization-inter-
acts with the Ub system under conditions in which it is
inactive (growth in media containing raffinose as a
carbon source) versus active (galactose carbon source).
Our hypothesis was that the Ub system may regulate
transcription factors differently depending on their
activity. To this end, we developed a method that would
allow us to hone in on transcriptionally active popula-
tions of Ga14 protein. We took advantage of observa-
tions made by the Ptashne, Hopper, and Sadowski lab-
oratories that revealed that Gal4 is phosphorylated by
pol-II-associated kinases as a consequence of activat-
ing transcription. Although these phosphorylation
events are not themselves required for transcription,
we reasoned that we could use them-and their char-
acteristic effects on the electrophoretic mobility of
Ga14-to identify pools of Ga14 that we could verify
had functionally interacted with the transcription
machinery. Under inactive (raffinose) conditions,
Western blotting reveals two Ga14 isoforms, termed a
and b (Fig. 1A). Under active (galactose) conditions,
isoforms a and b persist, but a new isoform, termed c,
appears. Gal4c formation is mediated by basal factor-
associated kinases and (unlike Gal4a and b) is
absolutely dependent on the ability of Ga14 to activate
transcription. We conclude that Gal4c corresponds to
the pool of Ga14 that either is activating or has activat-
ed transcription. Gal4a/b, in contrast, correspond to
inactive Ga14 protein. Having distinguished these pop-
ulations of Ga14 in this way, we asked how each Ga14
population interacts with the Ub system.
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When yeast are grown under noninducing (raffi-
nose) conditions, Gal4a/b are moderately ustable, with
an approximate half-life of 20 minutes (Fig. 1B). The
turnover of Gal4a/b is mediated by the Ub system and
is critically dependent on a Ub ligase called Grrl. In
the absence of Grrl, Gal4a/b are stable, and Ga14 pro-
tein accumulates. Interestingly, disruption of Grrl
stimulates Ga14 activity, resulting in ectopic GAL gene
activation, even in raffinose media (Fig. IC). These
findings suggest that Grrl normally acts to restrict
Ga14 function and are consistent with traditional views
of how the Ub system controls protein activity (e.g.,
the p53-Mdm2 relationship).
When yeast are grown under inducing (galactose)
conditions, however, a different pattern of behavior is
observed (Fig. 1D). Gal4a/b are stabilized, whereas the
active Gal4c isoform is extremely unstable, turning
over with a half-life of just a few minutes. Destruction
of Gal4c is mediated by the Ub-proteasome system and
is dependent on a Ub ligase called Dsgl. In the absence
of Dsgl, Gal4c is stable, and the active isoform accu-
mulates. Our studies have shown that Dsgl is essential
for Ga14 ubiquitylation under galactose growth condi-
tions and that Dsgl binds to chromatin at sites overlap-
ping with the Ga14 protein, suggesting that Dsgl medi-
ates Ga14 ubiquitylation and destruction at target gene
promoters. The role of Dsgl in GAL gene activation is
intriguing: In the absence of Dsgl, Ga14 can stimulate
transcription of its target genes, but the resulting RNAs
are not translated (Fig. 1EF). The translational defects
of these RNAs are related to defects in the postinitia-
tion phosphorylation of RNA pol II, and the inability of
pol II complexes to mature and to functionally associ-
ate with RNA processing machinery (e.g., capping
enzyme). These findings are consistent with the licens-
ing model, because Dsgl is functioning as a Ga14 coac-
tivator, and argue that Ub-mediated destruction of Ga14
(and possibly other components of the transcriptional
apparatus) is required to drive important transitions
that define different steps in the transcription process
(initiation, elongation, mRNA processing, etc.).
In summary, these studies of Ga14 reveal that a sin-
gle transcription factor can be dealt with by the Ub
system in very different ways, depending on whether
it is activating transcription. Furthermore, our results
demonstrate that the Ub system regulates an unex-
pected step in transcription, where RNAs are signaled
to become functional messenger RNAs. Finally, our
findings imply that Ub-mediated proteolysis may have
important roles in other transitions required for the
"transcription cycle." As pol II transcribes genes, its
complement of interacting proteins must change not
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FIGURE 1 Two modes of proteolysis regulate Gal4 function. (A) Tracking active pools of Ga14 protein. Western
blot, showing patterns of Ga14 phosphoisoforms that can be observed in media containing either raffinose (Raf;
inactive) or galactose (Gal; active) as a carbon source. Formation of the Gal4c isoform is tightly connected to tran-
scriptional activation. (8) The F-box protein Grrl is required for Gal4a/b turnover in raffinose media. Wild-type or
congenic
-null yeast were grown in raffinose media, cyclohexamide was added to inhibit protein synthesis,
and protein samples were taken at the indicated time points ("cyclohexamide chase"). Gal4a/b disappear quick-
ly in wild-type yeast, but persist in the girl -null cells. (C) Deletion of Grrl results in ectopic activation of a GAL1-
lacZ reporter gene. p-galactosidase activity was assayed from wild-type and Agrrl yeast growing in raffinose-con-
taining media. (D) The F-box protein Dsgl is required for Gal4c turnover in galactose media. Cyclohexamide
chase. In galactose media, Gal4a/b are stable (top panel), but Gal4c disappears quickly following inhibition of pro-
tein synthesis. Gal4c turnover depends on the presence of the Dsgl gene. (E) Deletion of Dsgl results in a fail-
ure to functionally activate a GALl-lacZ reporter gene. Western blotting was used to detect P-galactosidase pro-
tein induced by either Ga14 (odd-number lanes) or a synthetic activator in which the Ga14 TAD was replaced with
the Myc TAD (Gal4[D]-Myc; even-number lanes). In the absence of Dsgl, Gal4c accumulates (top panel lane 7;
a-HA), but there is no detectable induction of p-galactosidase protein (lower panel lane 7; a(3 -gal). The Ga14-Myc
activator is unaffected by loss of Dsgl. (F) Deletion of Dsgl results in an accumulation of RNAs from the GALl-
lacZ reporter. RNA was isolated from the same cells assayed in E, and lacZ RNAs quantified by reverse tran-
scription, real-time polymerase chain reaction (PCR). Despite the failure to detect p-galactosidase protein in Adsg 1
cells, lacZ RNAs accumulate to high levels in these yeast.
only during the elongation checkpoint, but also during
events involved in termination and 3"-end processing,
and when pol II encounters a site of DNA damage. The
involvement of proteolysis in these transitions would
not only actively drive disassembly of these complex-
es, but would ensure that events important for RNA
processing and polymerase disengagement occur in an
irreversible manner. Perhaps, therefore, as in the cell
cycle, proteolysis provides an unequivocal signal of
directionality to the transcription process.
REGULATION OF Myc ONCOPROTEIN FUNCTION
BY THE UB SYSTEM
The intimate connection between transcription factor
activity and destruction provides us with a unique
opportunity to learn more about how Myc protein
functions. Our thesis is that, if activity and destruction
are linked, then we should be able to use one of these
activities to learn about the other. Recently, for exam-
ple, we identified a novel element in Myc that is
required for its rapid proteolysis. The connection
between transcription factor activity and destruction
prompted us to ask whether this element is also
required for Myc function. In collaboration with the
Lowe laboratory here at CSHL, we showed that this
element is indeed required for cellular transformation
by Myc and appears to function by attenuating the nat-
ural ability of Myc to induce apoptosis. We have now
identified several proteins that interact specifically
with this region of the Myc molecule and are pursuing
the connection of these proteins to the regulation of
apoptosis. In a similar vein, again in collaboration
with the Lowe laboratory, we have examined the activ-
ity of various cancer-associated Myc mutants that we
showed a number of years ago block Myc destruction
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at a postubiquitylation stage. Curiously, these mutants
allow Myc to transform cells without the requirement
for loss of p53, suggesting that blocking Myc destruc-
tion does not simply lead to overexpression of Myc
protein, but rather results in a qualitative shift in Myc
behavior. The ability of stabilized forms of Myc to cir-
cumvent the apoptotic response further emphasizes
the intimate connection between Myc activity and
turnover, and suggests that further study of Myc
destruction will reveal fundamental aspects of how
Myc promotes oncogenesis.
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STRUCTURAL BIOLOGY
R.-M. Xu Y. Huang P. -C. Lin
H.-C. Hsu J. Min
Z. Li
Our research is directed toward understanding the
molecular mechanisms by which eukaryotic genes are
regulated at both the transcriptional and posttranscrip-
tional levels. We continue to focus our research on
structural studies of proteins involved in mRNA pro-
cessing and proteins that are important for the assem-
bly and remodeling of high-order chromatin struc-
tures. During 2004, we determined the structures of an
Orclp-Sirlp complex and the amino-terminal domain
of Sir 3p, which are part of our systematic investiga-
tion of the molecular mechanism of epigenetic control
of gene expression in yeast.
In the budding yeast Saccharomyces cerevisiae,
cryptic mating-type genes, HML and HMR, are epige-
netically silenced. The silent HM loci are flanked by
specific cis-acting DNA sequences called the E and I
silencers, which contain binding sites for DNA-bind-
ing proteins, the origin recognition complex (ORC),
Rap 1p and Abflp. Silencing at the HM loci also
requires four silent information regulator (SIR) pro-
teins, Sirlp-4p. Orclp, the largest subunit of ORC,
interacts with Sirlp, and this interaction is important
for the establishment of silencing. In collaboration
with Bruce Stillman, we have previously solved the
crystal structure of the Sirlp-interacting amino-termi-
nal domain of Orclp (Orc1N), which contains a
bromo-adjacent homology (BAH) domain found in
many chromatin-associated proteins.
We have determined a 2.5 A cocrystal structure of
the amino-terminal domain of Orclp in complex with
the Orclp-interacting domain (OID) of Sirlp. The
structure reveals that Sirlp OID has a bilobal struc-
ture-an a/13 amino-terminal lobe and a carboxy-ter-
minal lobe resemble the fold of the Tudor domain
"royal family" members, which have been implicated
in binding histone tails. The amino-terminal lobe of
Sirlp binds in a shallow groove between a helical sub-
domain and the BAH domain of Orclp (Fig. 1). The
structure is useful for understanding the specificity of
Orclp-Sirlp interaction and the mechanism for the
establishment of silencing.
We have also determined the structure of the
amino-terminal domain of Sir3p (Sir3N), which shares
FIGURE 1 Crystal structure of the Orcl N-Sirl p OID complex.
The structures are shown in a ribbon representation.
significant sequence homology with Orc1N. The two
homologous domains have similar but distinct func-
tions in transcriptional silencing, and the mechanism by
which Sir3N functions in silencing is not understood.
The 1.9 A resolution structure reveals that Sir3N shares
a very similar overall structure with that of Orc1N; nev-
ertheless, the amino-terminal tails of Sir3N and Orc1N
have significantly different conformations, despite
100% sequence identity of the first eight residues
between the two proteins. In the Orc1N structure, the
amino-terminal tail is involved in interacting with
neighboring molecules. This region of Sir3N is impor-
tant for silencing and the same region is also involved
in protein-protein interactions between the two mole-
cules within the same asymmetric unit. It is possible
that homodimeric interaction between the two Sir3
amino-terminal domains is important for silencing.
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FIGURE 2 Sir3N packs into a super-helical polymer in the crystal-a view along the super
helical axis.
In the crystal lattice, the Sir3N dimer in the asym-
metric unit packs with symmetry-related molecules to
form a contiguous left-handed super helix. Figure 2
shows a view of the crystal packing along the super-
helical axis. Three "strands" of parallel protein dimers
wrap around each other to form a tubular architecture.
The inner diameter of the super helix is approximate-
ly 80A. The pitch of the super helix is approximately
197 A. Although the organization of the super helix in
the crystal lattice is under a rather artificial condition
of crystal packing, nevertheless, packing interactions
can sometimes stabilize weak and transient interac-
tions that might be difficult to detect in solution. It is
interesting to note that the minimal diameter of a
nucleosome core particle is about 85-90 A.
Considering the physiological function of Sir3p in
spreading along the chromatin, it is possible that Sir3p
coats the nucleosomes within the silent chromatin
domain in a fashion similar to the one observed in the
crystal packing.
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In addition to the structural characterization of
yeast silencing protein complexes, we are continuing
our analyses of RNA-splicing factors and various mul-
tiprotein complexes of the spliceosome. Our overall
goal is to determine the structures of a number of
spliceosomal components that will enable us to assem-
ble the structures together to gain insights into struc-
ture and function of the large and complex splicing
"machine."
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CANCER: GENETICS
Despite tight control of DNA replication, errors inevitably creep in. Most are corrected, but some go unre-
paired and lead to mutations or changes in the cell's genetic code. Eli Hatchwell is using genomic screen-
ing methods to compare large chunks of human DNA to detect the rare mutations that occur during the
cell divisions that produce eggs and sperm. These mutations lead to nonheritable or "sporadic" genetic
disease in offspring. Traditionally, these mutations have been difficult to detect, but Hatchell's method has
been successful in uncovering these rare events. Understanding such sporadic genetic diseases helps
researchers understand the origin of more common disorders.
The gain ("amplification") or loss ("deletion") of DNA segments has emerged as a major driving force of
cancer. Michael Wig ler and Rob Lucito have developed a powerful method for measuring such differences
in copy number between normal and cancer cells. By using their method, called representational oligonu-
cleotide microarray analysis (ROMA), Wig ler and Lucito have identified a number of genes that have pre-
viously undiscovered roles in the biology of cancer. For example, to gain a better understanding of how
primary tumors spread or metastasize to other regions of the body (a frequently lethal process), Lucito is
using ROMA to compare the DNA of premetastatic and postmetastatic ovarian tumors. In addition to their
findings from studying breast, prostate, colon, pancreatic, and other cancers, Wig ler, Lucito, and their col-
leagues have identified a region of DNA that is specifically amplified in half of the postmetastatic ovarian
cancers they analyzed. This observation identifies a prime molecular target for therapies to halt the spread
of not only primary ovarian tumors, but also of other cancers.
By using a technology on which ROMA is based, Scott Powers and his colleagues previously identi-
fied a gene-called PPM1D-that was amplified and upregulated in 15% of the breast cancer specimens
they analyzed. Whether PPM1D had any role in a larger patient population was unknown. Recently, how-
ever, Powers has shown that Ras- and ErbB2-induced breast tumor formation is significantly impaired in
PPMID- deficient mice. This finding suggests that if particular challenges can be overcome, small mole-
cule or other inhibitors of PPM1D could form a new class of broad-spectrum cancer therapies.
The p63 gene is related to p53-a tumor suppressor gene implicated in more than half of all human
cancers. In an effort to investigate the role of p63 both in normal development and tumor formation, Alea
Mills has developed a series of mouse models that provide systems for investigating p63's role in vivo. The
models her group has generated include animals with the complete absence of p63, those in which the
timing and tissue specificity of p63 expression can be precisely controlled, and others with specific p63
amino acid mutations that correlate with "hot-spot" mutations in p53 in human cancers. These animal
models are a powerful tool for exploring the role of p63 in development, stem cell maintenance, and can-
cer. In other work that also uses animal models for studying cancer biology, Mills is deleting specific
regions of the mouse genome that correspond to a region of the human genome that is frequently delet-
ed in a variety of cancers.
RNA interference (RNAi) has emerged as a widespread biological regulatory mechanism, as a power-
ful tool for both basic and applied research, and as a therapeutic strategy of enormous potential. In organ-
isms from fungi and flies to plants and humans, RNAi has an essential, multifaceted role in controlling gene
expression. Greg Hannon, a pioneer of RNAi research, continues to identify new components of the RNAi
pathway and to determine how they function. Recently, he and his colleagues have begun to unravel how
"microRNAs"-small, noncoding RNAs that regulate gene expression through RNAi-are matured. This
involves the action of the "Microprocessor complex" and a newly discovered component of that complex,
called Pasha. In other work, a collaboration between Hannon and Leemor Joshua-Tor (see below) led to
the identification of Argonaute2 as the key catalytic component of RNAi. Finally, Hannon has collaborated
with Dick McCombie here at CSHL, Steve El ledge of Harvard, and colleagues at Merck and OSI
Pharmaceuticals to develop large-scale RNAi libraries that will eventually enable scientists to shut off vir-
tually every gene in the human and mouse genomes for a wide variety of cancer research and other bio-
medical applications.
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In part of his recent work, Scott Lowe used RNAi to study the p53 tumor suppressor pathway. His
group showed that suppressing the production of "PUMA" (a target of p53 action) by RNAi dramatically
accelerated the development of lymphoma in mice. These findings indicate that despite the large number
of genes controlled by p53, disruption of a single p53 effector can largely disable p53 tumor suppressor
functions in some contexts. In other research, Lowe's group showed that a particular two-drug combina-
tion therapy leads to the complete remission of a mouse model of B-cell lymphoma in all of the treated
animals. Because the therapy targets pathways that are involved in the majority of human tumor types, it
establishes a new paradigm for treating many forms of human cancer and has entered clinical trials.
In addition to its use as a research tool, RNAi is showing promise as a potential therapy. Vivek Mittal
studies "angiogenesis" or the recruitment of a new blood vessel supply to the sites of tumors. Mittal's
group has demonstrated that RNAi directed at a key factor involved in blood vessel formation can delay
tumor growth. They are examining the molecular pathways that are involved in the mobilization of cells that
form blood vessels and are hopeful that their approach will aid the development of anti-angiogenesis ther-
apies for cancer and other diseases.
Programmed cell death or "apoptosis" is carried out by specialized molecular machinery that rids pre-
cancerous cells from the body. One hallmark of cancer is that the apoptosis machinery is inactivated by
mutation in a tumor cell. Selectively restoring the ability of cancer cells to kill themselves via apoptosis is
therefore an attractive therapeutic strategy. Yuri Lazebnik is exploring the possibility that cancer cells might
in fact carry the seeds of their own destruction on the basis of his paradoxical discovery that under cer-
tain conditions, some oncogenes can trigger programmed cell death. His group is continuing to investi-
gate therapies for cancer based on selectively restoring apoptosis in cancer cells.
Masaaki Hamaguchi is investigating the function of a gene called DBC2 (for deleted in breast cancer)
that he previously discovered was missing from or inactive in a large proportion of breast and lung can-
cers. By both decreasing or increasing production of the Dbc2 protein in human cell cultures, Hamaguchi
and his colleagues found that two cellular networks react significantly to changes in Dbc2 protein levels.
One of the networks regulates growth through cell cycle control and programmed cell death. The other
network is related to cytoskeleton and membrane trafficking. These findings reveal new targets for treat-
ing cancers that lack Dbc2 protein expression.
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ANALYSIS OF A TUMOR SUPPRESSOR GENE
M. Hamaguchi S. Goldman J.L. Meth V. Siripurapu
E. Greenberg C.B. Meyer C.A. Sorensen
N. Kobayashi R. Shudo
Our lab is interested in the discovery and characteriza-
tion of cancer-related genes, especially tumor suppres-
sor genes that are ablated in cancer cells. The identifi-
cation of these genes and subsequent studies into their
biological functions have provided vast new insights
into the development of cancer. A great deal is now
known about the relationship between cancer develop-
ment and cellular functions. We are characterizing
DBC2 (deleted in breast cancer 2) that is likely to be a
tumor suppressor gene for sporadic breast cancer.
Activation of DBC2 in a breast cancer cell line result-
ed in growth arrest of the cells, whereas naturally
occurring DBC2 mutants do not suppress tumor
growth. The ultimate goal of our research is elucida-
tion of the tumor suppression mechanisms of DBC2
and development of new cancer therapy based on the
findings.
DBC2 and Gene Expression
M. Hamaguchi, V. Siripurapu, N. Kobayashi, J.L. Meth
Clarification of the physiological functions of DBC2
will provide clues to understand the mechanisms of
breast cancer development since more than half of
breast cancers were found to exploit inactivation of
DBC2. To identify biological pathways that involve
DBC2, the functions of cellular genes are monitored
while DBC2 activity is manipulated. We apply two
molecular biological technologies to control DBC2
activity: an inducible gene expression system and
RNA interference (RNAi). In the inducible gene
expression system, DBC2 is placed under a promoter
that can be activated by an insect hormone, ecdysone,
or its homolog, Muristerone A. When the inducer is
administered, DBC2 will be expressed. The gene
expression level is proportional to the quantity of the
inducer. Since these chemicals do not normally exist
in mammalian cells, they will not affect expression of
the other mammalian genes. Reversely, DBC2 expres-
sion can be suppressed by using RNAi. We have
demonstrated that carefully designed short RNA frag-
ments can inhibit DBC2 translation effectively in var-
ious types of cells, resulting in inactivation of DBC2.
We can now study consequences of DBC2 ablation at
the cellular level by using this system.
One of our approaches is a microarray analysis
that allows us to monitor a large number of genes at
the same time. DNA microarrays contain thousands of
DNA probes in a small area, e.g., 1 inch x 2 inch, on a
glass slide. When a sample DNA is incubated with a
microarray chip, DNA fragments in the sample
hybridize with corresponding probes. As a result, the
signal intensity of a probe represents the amount of the
matching sequences in the sample. When cDNA from
a specimen is used as a sample, gene expression levels
can be profiled. This is particularly useful when we
analyze global changes in gene expression.
Using methods described above, DBC2 expression
was manipulated and gene expression profiles were
examined. Approximately 700 genes were found to be
affected by altered DBC2 expression. The gene list
was overlaid onto a huge cellular pathway map in a
database so that we could identify biological pathways
influenced by DBC2. We have successfully discovered
four cellular pathways that are significantly disturbed
by DBC2 expression (Table 1). They are related to
apoptosis, cell cycle control, membrane trafficking,
and cytoskeleton (Siripurapu et al.). This discovery is
particularly important because a gene family,
RHOBTB, where DBC2 belongs, has not been charac-
terized; it would provide a framework for functional
studies of this potentially important gene family.
DBC2 and Protein-Protein Interaction
M. Hamaguchi, N. Kobayashi, R. Shudo,
S. Goldman [in collaboration with N. Sato,
Tokyo Metropolitan Institute of Medical Science]
In addition to the global approach described above, we
are studying predicted functional domains of DBC2 to
understand the biological roles of DBC2.
Computational analysis revealed that DBC2 contains
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TABLE 1 Networks with high scores ( >10)
Networks Functions Score Genes
AATF, ATF2, BRCA1, CBX5, CCNE1, CCNE2, CD44*,
CDK2, CHAF1A, CHK *, DDIT3, DHFR", FBLN1 *, FEN1,
FN1, FTH1, ID2, IL6, ITGA2, ITGA5, LIG1, MAX, MCM6,
MFAP1, PCNA, POLD3, RB1, RBBP7, RPA1, RRM1,
TFAP2C, TFDP1 (TRANSCRIPTION FACTOR Dp1)",
UBE2I, UBTF, WEE1
ACTR2, ACTR3, BET1, BET1 L, CDC42, CDC42EP5, CEP2,
COPB, COPG, GOLGB1, GOSR2, MSF, NEDD5, NSF,
PNUTL1, RAB4A *, RAB5A, RBET1, SEC22A, SEPT6, SEPT8,
SLY1P, SNAP25 *, STX16, STX4A, SYBL1, SYPL, TAP2,
TGFBR3, VAMP2, VDP,VPS45A, WAS, WASPIP, YKT6
ARHGEF12, ATM, CASP3, CASP7, CAV2, CCND3, CD59,
CDC2L2, CSPG6, EIF2S1, GCLC, GCLM, GNA11, GNA13,
GNAI2, GNAI3, GNAQ, GNB1, GNB5, GSN, LGN, NUMA1,
PCDH7, PIK3CA, PPP1CA, PPP1R3C, PRKR, RAD21*,
RDX, SMC1L1, SREBF2, SRF, TARBP2, TAX1BP1, WEE1
ACTB, CASK, CASP3, CDH1, CDH2, CTNNB1, EPB41L1*,
FGF1, FGF10, FGF2, FGF7, FGFR1, FGFR2 *, FMR1, FOSL1,
FXR2, GRIK2, GSK3B, GYS1, HERPUD1, ITPR1*, JUP,
MYO5A, MY05C, PPP1R2, PSEN1, RBBP4, SDC1, SDC2,
SERPINE1, SERPINE2, SMARCA3, SMARCA4, U2AF1
Cell cycle control 47 35
S phase
G, /S transition
Apoptosis
Proliferation
Cytoskeleton
Assembly of Golgi
Membrane trafficking
Fusion
Cell death
Apoptosis
Morphology
Autophagy
Apoptosis
Differentiation
Mitogenesis
Growth
Proliferation
15 18
14 17
12 16
Focus genes are shown in bold type. Asterisks indicate genes that belong to multiple networks.
putative protein-protein interaction domains (BTB).
We utilized immunoprecipitation and a yeast two-
hybrid system to isolate interacting partners. Golgin-
84 was identified as one of the candidates. Subcellular
localization studies revealed that some DBC2 proteins
migrate around the Golgi apparatus where Golgin-84
resides. Additionally, we found that DBC2 localiza-
tion seems not to be affected by Brefeldin A (BFA)
which disturbs Golgi structure, whereas BFA causes
redistribution of Golgin-84 to cytoplasm, more specif-
ically, the endoplasmic reticulum. This indicates that
DBC2 is not a constituent of the Golgi apparatus itself
and that the interaction between DBC2 and Golgin-84
requires integrity of the Golgi apparatus. Although
DBC2 physically interacts with Golgin-84 in both
yeast and mammalian cells, their functional relation-
ship remains unclear.
Transcriptional Regulation of DBC2
M. Hamaguchi [in collaboration with N. Sato, Tokyo
Metropolitan Institute of Medical Science]
Transcriptional regulation of DBC2 was investigated
since DBC2 expression is extinguished in approximate-
54
ly half of breast and lung tumors whereas its expression
is detected in other types of cancer. To study transcrip-
tional regulation of DBC2, we first determined the pre-
cise location of DBC2 promoters. Upstream genomic
sequences of the DBC2 gene were screened by compu-
tational analysis, leading to the isolation of four candi-
date promoter sequences. They were then tested by a
luciferase assay in which DNA fragments with promot-
er activity turn on a reporter gene (luciferase) and there-
fore are identified. All predicted promoter sequences
demonstrated strong promoter activities in all cells test-
ed (Fig. 1). Since the most common mechanism to sup-
press promoters is methylation of the promoter region,
we are screening cancer cell lines for methylation status
of these DBC2 promoters.
DBC2 and Cell Cycle Control
M. Hamaguchi, V. Siripurapu, C,B. Meyer, C.A. Sorensen
We discovered that DBC2 negatively regulates the
CCND1 protein that is essential for the cell cycle con-
trol at G1 /S transition. It also down-regulates CCNE,
which is downstream from CCND1. Certain onco-
genes involved in breast cancer development such as
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FIGURE 1 Luciferase assay. Four candidate promoter sequences
through D) were tested with Dual Glo Luciferse Assay kit and
EG&G Berthold Lumat LB9507. NC and PC indicate negative and
positive controls provided by the supplier. Plus and minus indicate
sense and antisense, respectively. The ordinate represents signal
ratios between Firefly and Renilla. All four sense sequences
demonstrated very strong promoter activities.
ras /c-erb -B2 depend entirely on CCND1 to connect to
the cell cycle machinery and some do not. If DBC2
demonstrates anti-tumor activity via CCND1, it is
conceivable that cancer cells will display different sen-
sitivity against DBC2. In fact, DBC2 expression caus-
es growth arrest of a cancer cell line with CCND1
amplification, although it does not affect the growth of
a cell line driven by an oncogene c-myc. This finding
warrants further questions: Are tumor cells using
CCND1, such as cancers driven by ras and c-erb-B2
oncogenes, sensitive to DBC2? Can CCND1 or CCNE
reactivation rescue the sensitive phenotype? How does
DBC2 suppress CCND1? These questions must be
answered because they are directly related to the con-
trol of tumor growth by DBC2.
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RNA INTERFERENCE: MECHANISMS AND APPLICATIONS
G. Hannon M. Carmell M. Dus J. Liu F. Rivas
K. Chang M. Golding E.P. Murchison J. Silva
A. Dent L. He Y. Qi D. Siolas
Several years ago, work in a free-living nematode,
Caenorhabditis elegans, uncovered a previously
unknown biological response through which an organ-
ism exposed to double-stranded RNA specifically
silenced genes that share homology with that nucleic
acid. This phenomenon, called RNA interference
(RNAi), has since been shown to be an evolutionarily
conserved pathway, present in organisms ranging from
fungi to plants to mammals. We have striven to under-
stand the mechanistic basis of this response using bio-
chemical approaches in several systems, including
Drosophila and mammalian cells. We have identified
numerous components of this pathway, including the
key initiating enzyme, Dicer and components of the
RISC (RNA-induced silencing complex) effector
machinery. Studies this year have begun to unravel
how initial processing steps for microRNAs
(miRNAs), the endogenous noncoding RNAs that reg-
ulate gene expression through the RNAi pathway, are
matured. This involves the action of the Microproces-
sor complex and a newly discovered component of
that complex, called Pasha. We have also continued to
focus on the inner workings of RISC. Working with
Leemor Joshua-Tor here at CSHL, we have identified
the key catalytic component of RISC as Argonaute2.
Our efforts to understand the biological function of the
RNAi machinery in mammals have continued to bear
fruit with the creation of a number of animals that lack
Argonaute family members. A subset of these mutant
animals die early in development. Additionally, as pre-
dicted from our biochemical studies, mice lacking
Argonaute2 are unable to mount an experimental
RNAi response. An analysis of the phenotypic defects
in these animals may reveal key aspects of the role of
RNAi in normal development.
Exploiting our understanding of RNAi biochem-
istry, we have developed powerful tools for experi-
mental manipulation of gene expression in mam-
malian cells and animals. With the help of Dick
McCombie here at CSHL, Steve Elledge at Harvard,
and colleagues at Merck (CSHL alumnus Michelle
Cleary) and OSI (Julie Kan), we have developed a
large-scale library of RNAi-inducing vectors that
presently covers two thirds of all genes in the human
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and mouse genomes. We hope to complete the devel-
opment of these tools next year.
Last year saw a number of changes to the labora-
tory. Patrick Paddison graduated and accepted a posi-
tion as a Cold Spring Harbor Fellow. Jian Du accepted
a position at Lily, and Kim Scobie started graduate
school at Columbia. We were joined by two graduate
students: Monica Dus from the Watson School of
Biological Science and Sihem Cheloufi from Stony
Brook University. Mike Golding and Yijun Qi joined
as postdoctoral fellows.
MECHANISMS OF RNA!
Drosha and Pasha:
The Microprocessor
A. Denli
RNAi is involved in numerous phenomena in the cells,
one of which is the regulation of endogenous genes by
host-encoded transcripts, microRNAs. miRNAs' jour-
ney to the RNA-induced silencing complex (RISC)
starts in the nucleus, where they are transcribed as
long RNAs, which are often up to kilobases long. A
nuclear RNase III enzyme, Drosha, is responsible for
the initial cleavage of these long transcripts into
imperfect hairpins called pre-miRNAs. These RNAs
move into the cytoplasm via exportin-5, where they
are further processed into mature miRNAs by Dicer.
These mature miRNAs are incorporated into RISC,
which regulates genes by either translational inhibition
or mRNA cleavage. To bring this pathway into better
focus, I have taken a biochemical approach to identify
new components. By using a candidate gene approach
supported by biochemical purifications, we identified
a Drosha-associated protein, Partner of Drosha
(Pasha), and characterized the complex in which they
reside, which we named Microprocessor. We have also
shown that Pasha is required for miRNA metabolism
in flies, humans, and worms. I am currently working
on identification of other proteins in the Microproces-
sor complex.
Argonaute2 Is the Catalytic
Engine of RNAi
J. Liu
Double-stranded RNA in most eukaryotic cells trig-
gers a sequence-specific gene silencing response
known as RNAi, carried out by the RISC. RISC con-
tains two signature components, small interfering
RNAs (siRNAs) and Argonaute family proteins. RISC
functions through several distinct mechanisms:
mRNA cleavage and degradation, translational repres-
sion, and chromatin modification. We recently showed
that the multiple Argonaute proteins present in mam-
mals are both biologically and biochemically distinct,
with a single mammalian family member, Argo-
naute2, being responsible for mRNA cleavage activi-
ty. A nuclease domain within Argonaute contributes
the "Slicer" activity to RISC and provides the catalyt-
ic engine for RNAi. I am carrying out further studies
of the RISC complex to identify additional compo-
nents of the effector complex, identify and validate the
physiological targets of miRNAs, and dissect the
mechanism of gene silencing by miRNAs.
Reconsitution of RISC from
Purified Components
I . Hivas
Previously, our laboratory, in collaboration with Dr.
Leemor Joshua-Tor here at CSHL, presented genetic,
biochemical, and structural studies implicating
Argonaute proteins as the catalytic core of the RNAi
effector complex, RISC. Site-directed mutagenesis of
the putative active site of human Argonaute2, deter-
mined in collaboration with Joshua-Tor's laboratory by
using structural information from the PIWI domain of
an archeal Argonaute, Pyrococcus furiosus Ago, inac-
tive Slicer activity strongly suggested that Argonaute2
is the elusive endonuclease in RISC. To definitely
demonstrate that this is the case, working with Niraj
Tolia in the Joshua-Tor lab, we have now shown that
recombinant human Argonaute2, purified from bacte-
ria, can combine with an siRNA to form minimal
RISC that accurately cleaves substrate RNAs.
Recombinant RISC shows many of the enzymatic
properties of RISC purified from human or Drosophila
cells in terms of Km, lcca Vm., and Mg2+ dependence,
but also surprising features. It shows no stimulation by
ATP, suggesting that factors promoting product release
are missing from the recombinant enzyme. The RISC
reconstitution system reveals that the siRNA 5' phos-
phate is important for the stability and the fidelity of
the complex but is not essential for the creation of an
active enzyme. These studies demonstrate that
Argonaute proteins catalyze mRNA cleavage within
RISC and provide a source of recombinant enzyme for
detailed biochemical studies of the RNAi effector com-
plex. Following the observation that the activity of
recombinant Agog was not augmented by ATP, which
is consistent with the existence of an ATP-dependent
product release factor in vivo, I have now focused on
the identification of this activity, a putative helicase
that we have provisionally termed "Twister."
Biochemical Specialization of
Arabidopsis Dicers
Y. Qi
In Arabidopsis, there are four Dicer-like (DCL)
enzymes and ten Ago proteins. Although extensive
genetics analyses have yielded significant amounts of
information on the genetic aspects of RNA silencing
in plants, information about biochemical basis of these
processes is mostly lacking.
In the past year, we developed protocols to assay
Arabidopsis Dicer and RISC activities in vitro. We
investigated the biochemical properties of two
Arabidopsis DCLs and found that they have distinct
properties. DCL1 produces 21-nucleotide small RNAs,
whereas DCL3 produces 24-nucleotide small RNAs.
Such different-sized small RNAs have previously been
linked to different silencing outcomes through genetic
studies and through the use of plant viral inhibitors of
silencing. We also showed that Ago 1 is the plant
"slicer." It is the first foray into the biochemical dis-
section of RNAi pathways in Arabidopsis and provides
a foundation for exploiting the rich genetic resources
that have been developed in this system for under-
standing the intricacies of RNA silencing in plants.
Role of Vig and PIWI Proteins in RNAi
M. Dus
Our lab recently showed that Argonaute proteins are
not only one of the hallmarks of RNAi, but also the
very catalytic core of this process. In almost all organ-
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isms where RNAi has been studied, this family of pro-
teins is further subdivided into members that present
closer homology with either Drosophila PIWI or
AG01. Although our understanding of the "AGOs" is
rapidly developing, knowledge of the functions of the
PIWI family members is still lacking. The aim of my
research is to uncover the biochemical functions of the
PIWI subfamily using flies and mice as model sys-
tems. In particular, I will test the involvement of these
proteins in transposon regulation and heterochro-
matin. Furthermore, I am trying to dissect the cyto-
plasmic and nuclear functions of Vasa intronic gene
(VIG), especially focusing on its role in heterochro-
matin formation.
BIOLOGICAL FUNCTIONS OF THE
RNA! MACHINERY
Function of Argonaute Family
Members in Mammalian Development
M. Carmel]
Argonaute family members have been shown to be
essential for RNAi/PTGS (posttranscriptional gene
silencing) in several organisms, including Neurospora
(QDE-2), Arabidopsis (AGO1), and C. elegans (rde-1).
Argonautes are core components of RISC complexes
and function both in mRNA destruction and in transla-
tional inhibition. Interestingly, Argonaute genes have
also been implicated in control of development in sev-
eral organisms. It is unknown what roles of the RISC
complex are mediated by Argonaute family members,
and whether developmental phenotypes result from
loss of discrete regulatory functions or from a more
general misregulation of silencing mechanisms. To
address the role of Argonautes in the mammalian sys-
tem, conventional mouse knockouts of the Argonaute
gene family are under way. This year, we have shown
that the multiple Argonaute proteins present in mam-
mals are both biologically and biochemically distinct,
with a single mammalian family member, Argonaute2,
being responsible for mRNA cleavage activity. This
protein is essential for mouse development, and cells
lacking Argonaute2 are unable to mount an experimen-
tal response to siRNAs. Analyses of other Argonaute
knockouts, including Ago3 and Miwi2, reveal other
discrete biological roles, with Ago3 being nonessential
and Miwi2 being important for spermatogenesis.
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Genetic Studies of RNAi
in Mouse Embryonic
Stem Cells
E.P. Murchison
In mouse, Dicer is encoded by a single locus whose
protein product is required for the production of small
RNAs involved in RNAi and related phenomena. To
further characterize the role of RNAi in genome regu-
lation in mammals, we created conditional Dicer
mouse embryonic stem (ES) cells in which the only
remaining copy of Dicer can be deleted by expression
and activity of Cre recombinase.
We find that upon loss of Dicer, ES cells fail to
proliferate, revealing a requirement for Dicer activity
and Dicer products in the sustained growth of these
cells. As expected, ES cells lacking Dicer are unable to
carry out posttranscriptional gene silencing in
response to double-stranded RNA and cannot produce
mature miRNAs. Furthermore, Dicer-deficient ES
cells accumulate centromere-derived transcripts, anal-
ogous to the situation seen in Schizosaccharomyces
pombe, but retain centromere methylation. We are cur-
rently characterizing these phenotypes with the hope
of uncovering the underlying cause of the proliferation
phenotype. In addition, we are using the conditional
ES cells to generate Dicer conditional mice.
An miRNA as a Potential
Human Oncogene
L. He
I have been examining potential roles of miRNAs in
tumor formation. To date, more than 200 miRNAs
have been described in humans. Although there is
circumstantial evidence suggesting that these regula-
tory, noncoding RNAs have a role in tumor develop-
ment, it still remains largely obscure whether a
micron can function as an oncogene. Work of a for-
mer postdoc, Scott Hammond, led us to focus our
efforts on a particular miRNA cluster, miR17-92.
Working with new faculty member Scott Powers, we
compared B-cell lymphoma samples and cell lines to
normal tissues and found that substantially increased
levels of the mature miRNAs from the miR17-92
locus are often found in these cancers. Notably, the
gene encoding this miRNA polycistron is present in
the region of DNA amplification found in human B-
cell lymphomas. Enforced expression of the miR17-
92 cluster cooperates with c-myc, accelerating tumor
development in a mouse B-cell lymphoma model, an
experiments carried out with Scott Lowe's lab here at
CSHL. Tumors derived from hematopoietic stem
cells (HSCs) expressing mir 1 7-92 and c-myc are dis-
tinguished by an absence of the apoptosis that is oth-
erwise prevalent in c-myc-induced lymphomas. Our
studies indicate that noncoding RNAs, specifically
miRNAs, can modulate tumor formation and impli-
cate the miR17-92 cluster as a potential human onco-
gene.
APPLICATION OF RNAi AS A GENETIC
TOOL IN MAMMALS
Synthetic shRNAs as Highly
Potent RNAi Triggers
D. Siolas
Designing highly potent silencing triggers is key to
successful application of RNAi in mammals Recent
studies suggested that assembly of RNAi effector
complexes (RISC) is coupled to Dicer cleavage. I
therefore examined whether transfection of optimized
Dicer substrates might give an improved RNAi
response. Dicer cleavage of chemically synthesized
short hairpin RNAs (shRNAs) with 29-bp stems and
2-nucleotide 3' overhangs produced predictable
homogeneous small RNAs comprising the 22 bases at
the 3' end of the stem. Consequently, direct compar-
isons of synthetic siRNAs and shRNAs that yield the
same small RNA became possible. Synthetic, 29-mer
shRNAs were found to be more potent inducers of
RNAi than siRNAs. Maximal inhibition of target
genes can be achieved at lower concentrations, and
silencing at 24 hours is often greater. These studies
provide an improved methodology for experimental
silencing in mammalian cells using highly potent
RNAi triggers. This remains a critical issue both for
cell culture studies and for potential therapeutic use in
vivo. Mapping the predominant 22-nucleotide
sequence that appears in RISC from each of these
shRNAs now permits the combination of this more
effective triggering method with rules for effective
siRNA design.
Using RNAi to Understand Epigenetic
Control of Gene Expression
M. Golding
Since arriving in May, my research has focused on
applying the shRNA library to studies of epigenetic
gene silencing. Here, I hope to conduct several screens
that will further our understanding of the genetic fac-
tors involved in the process of gene silencing. Several
model systems are being used to study the processes
of epigenetic gene silencing as they relate to tumor
suppressor gene silencing, double-stranded RNA-
directed DNA methylation, and genomic imprinting.
The first phase of my project sought to determine
which promoter elements were best suited to driving
the new mir30-based shRNA expression constructs.
Several different vectors were built to test which pro-
moter types were most effective both in transient
transfection and in stable integration. Concurrent with
studies of the different promoter elements, assays to
measure the expression of several candidate genes
were developed using TaqMan real-time polymerase
chain reaction (PCR). shRNA constructs targeting
these genes were placed in the vector system described
and the mRNA expression levels of their targets were
monitored by real-time RT-PCR. This created a reli-
able system with which to quantitatively monitor the
efficacy of the different vector designs.
The second phase of my studies has sought to find
a reliable system in which to study epigenetic gene
silencing. Initial trials have begun to look at tumor
suppressor gene silencing and the potential synergistic
effects of the shRNA library with a new class of drugs
termed HDAC inhibitors. Trials using the drug SAHA
have begun. Concurrent with these studies, we are col-
laborating with Colin Stewart (National Institutes of
Health) using the shRNA library in studies of genom-
ic imprinting.
Using RNAi to Discover Targets for
Combination Drug Therapy
J. Silva
RNAi suppression studies are one of the most infor-
mative approaches to identify gene function. Using the
shRNA library that we have previously developed, I
am performing loss-of-function screens to uncover
59
genes involved in the acquisition of tumor features. I
am interested in two different processes: modulation
of the p53 response (activation or attenuation upon a
stress stimulus) and anchorage-independent growth.
Additionally, I am conducting a screen to discover new
genes that enhance the response to anti-EGF (epider-
mal growth factor) receptor therapy (Tarceva). Finally,
in collaboration with Despina Siolas, I am exploring
the possibility of using RNAi technology to reveal
synthetic-lethal interactions with the most commonly
alterated genes in cancer (p53, ras, Rb, p16).
Microarray-based Methods
for Analyzing Genetic Screens
in Mammals
K. Chang
DNA microarray analysis has come a long way since
its introduction by Patrick Brown (Stanford
University, Palo Alto, California) and colleagues in the
early 1990s. In recent years, advancements in the area
of chip fabrication have paved the way for the devel-
opment of high-density oligonucleotide microarrays.
Its applications have revolutionized the field of
genomics. During the past year, we have been devel-
oping the use of such microarrays in loss-of-function
RNAi screens in mammalian cells. The creation of our
RNAi library has made it possible, for the first time,
to perform synthetic-lethal analyses in animal cells in
ways similar to those that have made yeast such an
amenable model organism. In our approach, stable
populations expressing pools of shRNAs are made by
transducing library cassettes into target cells. Upon
selection, cells depleted or enriched from a popula-
tion, following treatment (e.g., drug, siRNA knock-
down, or left untreated), can be tracked using "DNA
bar codes" (24 mers or 60 mers fabricated on DNA
microarrays) associated with specific shRNAs such
that any gain or loss in copy number is a direct conse-
quence of the expressed shRNA on the cell. Using this
approach, we have been successful monitoring copy
changes reproducibly in mouse and human cells using
defined pool complexities. In addition, we have been
testing other methods for tracking cells using "RNA
bar codes," which can also be used to prevalidate the
effectiveness of our RNAi library.
We are currently applying this paradigm in syn-
thetic-lethal screens to elucidate drug action (e.g.,
Tarveva, Velcade, SAHA, and Rapamycin) and to gain
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new insight into the biology of genetic diseases. This
is an exciting time as this will be a promising new
approach for drug discovery and tailoring therapies for
cancer and other genetic diseases, and a new tool for
functional genomics.
PUBLICATIONS
Carmell M.A. and Hannon G.J. 2004. RNAse III enzymes and
the initiation of gene silencing: Just PAZzing through? Nat.
Struct. Mol. Biol. 11: 214-218.
Gaudy A.A. and Hannon G.J. 2004. Induction and biochemical
purification of RNA-induced silencing complex from
Drosophila S2 cells. Methods Mol. Biol. 265: 59-72.
Cleary M., Kilian K., Wang Y., Bradshaw J., Ge W., Cavet G.,
Paddison P.J., Chang K., Sheth N., Leproust E., Coffey
E.M., Burchard J., Linsley P., and Hannon G.J. 2004.
Production of complex libraries of defined nucleic acid
sequences using highly parallel in situ oligonucleotide syn-
thesis. Nat. Methods 1: 241-248.
Denli A., Ketting R., Plasterk R.H.A., and Hannon G.J. 2004.
Gripper collaborates with Drosha in the maturation of
miRNAs. Nature 432: 231-235.
Dike S., Balija V.S., Nascimento L.U., Zuan Z., Ou J., Zutavern
T., Palmer L., Hannon G., Zhang M.Q., and McCombie
W.R. 2004. The mouse genome: Experimental examination
of gene predictions and transcriptional start sites. Genome
Res. 14: 2424-2429.
Du J. and Hannon G.J. 2004. Suppression of p160ROOK
bypasses cell cycle arrest following Aurora-A/STK15 deple-
tion. Proc. NatL Acad. Sci. 101: 8975-8980.
Gupta S., Schoer R.A., Egan J.E., Hannon G.J., and Mittal V.
2004. Inducible, reversible and stable RNA interference in
mammalian cells. Proc. Natl. Acad. Sci. 101: 1927-1932.
Hannon G.J. and Conklin D.S. 2004. RNA interference by short
hairpin RNAs expressed in vertebrate cells. Methods Mol.
Biol. 257: 255-266.
Hannon G.J. and Rossi J.J. 2004. RNAi: Unlocking the poten-
tial of the human genome. Nature 431: 371-378.
He L. and Hannon G.J. 2004. microRNAs: Small RNAs with a
big role in gene regulation, Nat. Rev. Genet. 5: 522-531.
Hemann Zilfou J.T., Zhao Z., Burgess D., Hannon G.J.,
and Lowe S.W. 2004. Suppression of tumorigenesis by the
p53 target PUMA. Proc. Nett Acad. Sci. 101: 9333-9338.
Liu J., Carmell M.A., Rivas F.V., Marsden C.G., Thomson J.M.,
Song J., Hammond S.M., Joshua-Tor L., and Hannon G.J.
2004. Argonaute2 is the catalytic engine of mammalian
RNAi. Science 305: 1437-1441.
Murchison E.P. and Hannon G.J. 2004. miRNAs on the move:
miRNA biogenesis and the RNAi machinery. Curr. Opin.
Cell Biol. 16: 223-229.
Paddison P.J., Gaudy A.A., Sachidanadan R., and Hannon G.J.
2004. Short hairpin activated gene silencing in mammalian
cells. Methods Mol. Biol. 265: 85-100.
Paddison Pl., Cleary M., Silva J.M., Chang K., Sheth N.,
Sachidanidan R., and Hannon G.J. 2004. Cloning of short
hairpin RNAs for gene knockdown in mammalian cells. Nat.
Methods 1: 163-167.
Paddison P.J., Silva J.M., Conklin D.S., Schlabach M., Li M.,
Aruleba S., Balija V., O'Shaughnessy A., Gnoj L., Scobie
K., Chang K., Westbrook T., Cleary M., Sachidanandam
R., McCombie W.R., El ledge S.J., and Hannon G.J. 2004.
A resource for large-scale RNAi based screens in mam-
mals. Nature 428: 427-431.
Silva J., Chang K., Hannon G.J., and Rivas F.V. 2004. RNA-
interference-based functional genomics in mammalian
cells: Reverse genetics comes of age. Oncogene 23:
8401-8409.
Silva J.M., Mizuno H., Brady A., Lucito R., and Hannon G.J.
2004. RNAi microarrays: High-throughput loss-of-function
genetics in mammalian cells. Proc. Natl. Acad. Sci. 101:
6548-6552.
Siolas D., Lerner C., Burchard J., Ge W., Paddison P.J., Linsley
P., Hannon G.J., and Cleary M. 2004. Synthetic shRNAs as
highly potent RNAi triggers. Nat. Biotech. 23: 227-231.
Song J., Smith S.K., Hannon G.J., and Joshua-Tor L. 2004.
Crystal structure of Argonaute and its implications for RISC
slicer activity. Science 305: 1434-1437.
Svoboda P., Stein P., Anger M., Bernstein E., Hannon G.J., and
Schultz R.M. 2004. RNAi and expression of retrotrans-
posons MuERV-L and IAP in preimplantation mouse
embryos. Dev. Biol. 269: 276-285.
In Press
Kan J.L.C., Griffin G., and Hannon G.J. 2005. Mining the
genome with RNAi to select cancer drug targets. Drug
Discovery Today (in press).
Rivas F.V., Tolia N.H., Song J., Aragon J.R, Liu J., Hannon G.J.,
and Joshua-Tor L. 2005. Purified Argonaute2 and an
siRNA form recombinant human RISC. Nat. Struct. Mol.
Biol. (in press).
Michael Golding, postdoc, Greg Hannon's lab.
61
SPORADIC HUMAN GENETIC DISEASE
E. Ha-taw/en B. GI dor T. Lee
C. Hub ley I. Mileva
S. Kantarci J. Roohi
We are interested in the application of modern
methodologies to the analysis of sporadic human
genetic disorders. Approximately 2-3% of all new-
borns have a disorder that is at least partially genetic
in origin; of these, approximately 50% are sporadic
and, by definition, not amenable to linkage analysis.
Historically, whole-genome analysis was based on
examination of chromosomes using light microscopy.
Although highly successful, this approach is limited
by a maximum resolution of 10 Mb. It is now known
that many disorders are associated with genomic copy-
number variation of much smaller segments (e.g.,
velocardiofacial syndrome [VCFS] which is associat-
ed with heterozygous deletions of 3 Mb).
Array-based comparative genomic hybridization
(aCGH) for the genome-wide detection of copy-num-
ber fluctuations is now possible using a variety of for-
mats, including oligo, cDNA (PCR product), and large
clone (based on bacterial artificial chromosomes
[BACs]) DNA microarrays. We have generated BAC
microarrays over the last 3 years, at increasing densi-
ty, and our current arrays contain a complete tile of the
human genome (19,000 BACs), with an average
expected resolution of 100 kb. These were designed in
collaboration with James Gergel and were generated
by collaborators at Roswell Park Cancer Institute
(RPCI, Dr. Norma Nowak and colleagues). We contin-
ue to focus on specific areas:
Autistic spectrum disorder
Congenital heart disease
Complex phenotypes and de novo, apparently, bal-
anced translocations
Development of methods to validate putative
aCGH variations
Development of methods to generate haploidy from
diploidy, in order to more effectively analyze het-
erozygous changes
Genome-wide array-based analysis of DNA methy-
lation, with particular reference to monozygotic
(MZ) twins.
We were sorry to have had to say goodbye last year to
Dr. Sibel Kantarci, a postdoc who was with us for
almost 3 years, and who is currently pursuing a career
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in clinical molecular genetics at Massachusetts
General Hospital, Boston. In addition, our valued
Level III Technician, Cindy Lee, who was instrumen-
tal in setting up our BAC aCGH technology, left at the
start of 2004, to pursue a career as an embryologist at
New York University. We were pleased to welcome
Izolda Mileva, an experienced technician from the
Greenwood Genetic Center in South Carolina, and
Jasmin Roohi, an M.D. Ph.D. student from Stony
Brook University, who is our first Cody Center Fellow.
Autism Spectrum Disorder
J. Roohi
We are collaborating with workers at the Cody Center,
Stony Brook, in an interdisciplinary study of a cohort of
patients diagnosed with autism spectrum disorder
(ASD). In addition to detailed diagnostic interviews/
questionnaires by experts on autism, all individuals
undergo examination by a medical geneticist (Dr. David
Tegay) in order to search for dysmorphic features. All
patients undergo standard chromosome analysis and
testing for Fragile-X type A (FRAXA). To date, approx-
imately 80 patients have been assessed. What has
become very clear already is how heterogeneous this
disorder is-fully 50% of patients were dysmorphic or
had physical stigmata reminiscent of genetic syn-
dromes. To some extent, this is not altogether surpris-
ing, given the number of distinct syndromes known to
result in autistic features (FRAXA, Angelman syn-
drome, Rett syndrome, etc.). It is therefore clear that
ASD should be viewed as a "catch-all" diagnosis for a
large group of heterogeneous disorders whose common
endpoint is the autistic phenotype. In a sense, the ASD
label is likely to disappear in the future with improved
phenotypic dissection, as has occurred in other complex
disorders whose etiologies are beginning to be under-
stood (e.g., mental retardation, now considered too gen-
eral a designation to be useful). It is also important to
realize that the application of any genomic technology
to unravel ASD, in the absence of a parallel clinical/phe-
notypic analysis, is unlikely to yield answers on its own.
In addition to our medical genetics examinations,
a selected group of patients are to undergo detailed
imaging analysis, in collaboration with Dr. Benveniste
and colleagues at Brookhaven National Laboratory.
We have been applying aCGH using BAC arrays to
our cohort of ASD patients and have already detected
many genomic copy-number abnormalities. The chal-
lenge is to (1) validate these changes and (2) estimate
whether any validated changes represent population
variants or are specific to ASD.
See below for some of our approaches to address-
ing both challenges.
Congenital Heart Disease
I. Mileva
We have a long-standing interest in the genetics of
congenital heart disease (CHD); 1% of all newborns
have CHD. Of these, only 3% are Mendelian and the
majority of the remaining 97% are of unknown etiol-
ogy, with one major exception. Velocardiofacial syn-
drome (VCFS) is a significant cause of CHD, explain-
ing approximately 20% of all conotruncal defects (and
probably 10% of all CHD). VCFS is known to be
caused by submicroscopic deletions at chromosome
22q11 (3 Mb in 90% of patients, 1.5 Mb in -10%). It
therefore seems reasonable that other genomic copy-
number alterations will be found in patients with CHD
who are chromosomally normal and negative for
22q11 deletions.
We have recently secured funding from Harrison's
Heart Foundation, a private charity devoted to funding
research into this understudied area. We have active
collaborations with two major centers of excellence,
from whom we obtain DNA samples on well-charac-
terized individuals with CHD: Dr. Piers Daubeney at
The Brompton Hospital, London, and Dr. Steve
Webber at The Children's Hospital, Pittsburgh. To date,
we have obtained samples from 150 patients with CHD
and are planning to study these with our new tiling
path BAC arrays during the course of this next year.
Complex Phenotypes and
De Novo Translocations
S. Kantarci, I. Mileva, B. Gildor
We collaborate actively with Dr. Helga Toriello
(Spectrum Health, Grand Rapids, Michigan), a distin-
FIGURE 1 PCR of the "junction fragment" generated by a de
novo 2.2 Mb microdeletion in a patient with developmental
delay reveals at least four distinct bands, suggesting that the
deletion is mosaic at the molecular level.
guished dysmorphologist, who supplies us with sam-
ples from chromosomally normal individuals with
complex disorders. In one such individual, we have
uncovered a de novo 2q31 deletion that we have stud-
ied in detail and demonstrated to be 2.2 Mb in size.
Analysis of the breakpoint regions in this patient has
revealed that the deletion is mosaic at the molecular
level, there being four distinct junction fragments pre-
sent in DNA isolated from peripheral blood. This is the
first such example of which we are aware (see Fig. 1).
De novo translocations may provide important
clues to the etiology of certain phenotypes. In one
such example which we have studied in depth, we have
cloned a novel gene that is interrupted by a de novo
t(2;22) translocation in a patient with Joubert
Syndrome. Studies are under way to search for muta-
tions in this gene in Joubert Syndrome patients who
are chromosomally normal.
Validating aCGH-detected
Changes/Determining
Population Frequencies
J. Roohi
There are two major problems to consider:
Validating changes suggested by aCGH.
Determining whether validated changes are specif-
ic to the phenotype being investigated or whether
they represent variants in the normal population.
Recent work from a number of groups suggests
that most normal individuals harbor at least a dozen
copy-number changes, when compared to the consen-
sus human genome sequence. Clues to this reality
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have been present historically, including our own dis-
covery 3 years ago of a heterozygous microdeletion,
182 kb in size, which we demonstrated to be present in
5% of all normal individuals. It is imperative that the
new technologies be used to study a large number of
normals to determine which genomic copy-number
alterations are population variants and, if so, at what
frequency they occur in different populations. Such
studies were conducted in the 1960s when chromo-
some analysis was performed on 10,000 unselected
newborns, in order to determine the frequencies of
various aneuploidies.
Although FISH (fluorescent in situ hybridization)
remains the mainstay of validating changes suspected
on aCGH, this method is neither easily scaleable nor
always possible, as it relies on the availability of living
cells. Molecular methods for validating such changes
include the use of polymorphic markers, but this
method suffers from a general lack of knowledge of
population heterozygosity and the possibility of lack
of informativeness in a given individual.
We have recently attempted to use real-time (quan-
titative) polymerase chain reaction (PCR) to validate
heterozygous deletions and have had significant suc-
cesses. Our aim is to continue to optimize qPCR for
this purpose, in order to screen large numbers of indi-
viduals with the relevant phenotype and an equal num-
ber of controls. We are also developing methodologies
that will allow the simultaneous interrogation of thou-
sands of individuals to determine their status for a
given copy-number alteration.
Development of Methods to
Generate Haploidy from Diploidy
C. Hubley
Once copy-number fluctuations are validated, it is
often of interest to study these in greater detail to
determine precise genomic boundaries and to under-
stand possible genomic structural predispositions to
rearrangement. Liquid DNA is diploid (unless isolated
from the germ line) and it is problematic to separate
the two alleles for further study. A traditional approach
to separating chromosomal homologs is the generation
of somatic cell hybrids. This method, although robust,
is extremely time-consuming and labor-intensive.
We are experimenting with the separation of chro-
mosome homologs by universal amplification of dilu-
tions of chromosome suspensions generated from
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patients of interest. Chromosomes are diluted to final
concentrations of approximately 23 chromosomes per
well in a 96-well plate, and the material is amplified
using multiple displacement amplification with the
highly processive enzyme phi29. PCR analysis of the
amplified material is then used to determine whether
the two homologs have been separated in different
wells of the same plate. Our results to date are encour-
aging, both in terms homolog separation and in our
ability to avoid contamination with exogenous DNA.
Genome-wide Array-based Analysis
of DNA Methylation, with Particular
Reference to Monozygotic Twins
E. Hatchwell
The underlying causes of phenotypic variation in
human genetic disorders are still largely not under-
stood. "Genetic background" is often invoked to
explain variation in nonidentical individuals, but this
appears not to be relevant to monozygotic (MZ) twins
(although somatic mutations cannot be excluded). One
possible source of phenotypic variation in MZ twins is
the epigenome-the state of the genome unrelated to
DNA sequence variation. Preliminary evidence sug-
gests that MZ twins may vary greatly in their methy-
lation. Such studies have, however, been limited in the
past to the examination of specific genes.
We have embarked on the design and optimization
of a genome-wide array, based on the generation of
oligonucleotides, in collaboration with NimbleGen.
Our arrays are based on the use of small HpaII frag-
ments from the human genome. HpaII cleaves at
CCGG, only when the internal C is not methylated. By
recovering small HpaII fragments from the genome, it
is possible to obtain a genome-wide picture of DNA
methylation. Our array design is now ready and we
shall study sets of MZ twins, both normal and discor-
dant, for a given phenotype (reading ability; a collabo-
ration with Ian Craig, Institute of Psychiatry, London).
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THE ORIGIN AND VIABILITY OF CANCER CELLS
Y. Lazebnik C. Cormier A. Matapurkar
D. Duelli X. Opitz-Araya
S.-C. Lin M. Yuneva
Our research focuses on two questions: How are nor-
mal cells converted into cancer cells? How can cancer
cells be killed by manipulating with the mechanisms
that control their viability?
CELL FUSION AS A CAUSE OF CANCER
AND ITS VARIABILITY
Our interest in the first question was triggered by an
accidental observation that cells in tissue culture fuse
with each other. Studies of published reports on cell
fusion revealed that cell fusion is a process that
induces aneuploidy, a hallmark of cancer cells, and
further increases cell diversity by combining, segre-
gating, and rearranging epigenetic and other regulato-
ry networks of the fusion partners. A century ago, the
observation that cells fusion causes aneuploidy led to
a hypothesis, which has been evolving, that accidental
cell fusion can produce cancerous cells. If cell fusion
can indeed lead to cancer, one question is how this
fusion is induced.
In the body, fused cells come from two sources:
physiological and aberrant cell fusion. Physiological
cell fusion is a part of normal development that is
required to produce the zygote and several types of
multinuclear somatic cells. Importantly, with the
exception of the zygote, cells produced by physiologi-
cal cell fusion are terminally differentiated and do not
proliferate. Aberrant cell fusion can be caused by a
variety of agents, including viruses, chemicals, and
fibers, such as asbestos, or by abnormal expression of
cellular proteins.
Viruses are of particular interest as pathological
fusogens because they are ubiquitous, diverse, ampli-
fiable, can persist in cells inconspicuously, and have
been implicated in carcinogenesis. Survival and pro-
liferation of fused cells, most of which die or arrest in
cell cycle, depend on many factors that are largely
unclear and appear to include cell type and prolifera-
tion status of the parental cells. Given these con-
straints, the question is whether virus-induced cell
fusion can result in proliferating cells that have the
potential to become cancerous.
While investigating why a cell line is fusogenic,
we found that the cells released exosomes that con-
tained the Mason-Pfizer monkey virus (MPMV), a
pathogen that is found in primates, including humans.
The fusion occurred shortly after exposure to the virus
and was unaffected by AZT, an inhibitor of reverse
transcriptase, which excluded the requirement of the
virus integration. However, the fusion was also pre-
vented by 7-irradiation, which implied a requirement
for an intact viral genome. To reconcile these observa-
tions, we proposed a model that interaction of MPMV
with cells induces release of an activity, which we
named 4i, that fuses uninfected cells. We provided evi-
dence in support of this model.
Because proliferation is an absolute requirement
for oncogenic transformation, we tested whether cells
fused by 41 proliferated. We found that cells destined to
die could instead produce transformed proliferating
progeny if fused by 0. In particular, we found that
neighboring cells that are destined to die could instead
produce transformed progeny if the cells are fused by
a virus that happened to be nearby.
Overall, we proposed how a retrovirus can gener-
ate proliferating abnormal cells without becoming part
of them. A current view is that retroviruses transform
cells by introduction of oncogenes or by modifying
normal gene expression through integration into the
host genome. This concept implies that if a virus is an
etiological agent of cancer, cancer cells must carry or
have carried the viral genome. Our model implies that
a virus may produce cancer cells without infecting
them, a notion that may help to understand better the
numerous correlative links between retroviruses and
human cancers.
METABOLIC CHANGES INDUCED BY ONCOGENES AS
A BASIS FOR KILLING CANCER CELLS
The second part of our research is based on the notion
that understanding how cancer cells are generated may
not provide a clue on how to kill them. Therefore, we
are exploring differences between normal and cancer
cells that allow for their selective or preferential
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killing of cancer cells. In a search for these differ-
ences, we have been focusing on apoptosis and, in par-
ticular, on its regulation by nutrients.
Apoptosis is a type of cell death that is carried out
by specialized cellular machinery. The current knowl-
edge is sufficient to design and implement tools that
kill cells quickly and efficiently by inducing apopto-
sis. However, the major problem is how to induce
apoptosis in cancer cells selectively. One approach to
solving this problem is to learn how apoptosis is
induced by oncogenic transformation. This approach
is based on a paradoxical observation that some onco-
genes, including myc and adenovirus E1A, either
induce apoptosis or sensitize cells to cytotoxic agents,
including those used for chemotherapy. One implica-
tion of this observation is that some oncoproteins are
pro-apoptotic activities specific for transformed cells.
If true, then understanding how the apoptotic machin-
ery is regulated by oncogenes may help us to develop
ways to kill cancer cells selectively.
Caspases are proteases that are activated at the onset
of apoptosis and cause death by cleaving a number of
proteins in a coordinated manner. Caspase activation
occurs in two steps. At the first step, pro-apoptotic sig-
nals lead to autocatalytic activation of caspases that are
called initiators. Activated initiator caspases process
effector caspases, which in him cause cell collapse by
cleaving a specific set of substrates. Each initiator cas-
pase is activated in response to a subset of signals, indi-
cating that a prerequisite for understanding how a spe-
cific signal activates apoptosis is finding the initiator
caspase that mediates it. We have been investigating
which caspases are involved in apoptosis, and studying
how they are activated, how this activation leads to cell
death, and what prevents this activation in drug-resistant
cells. The ultimate goal is to understand how caspases
can be activated selectively in cancer cells.
A prevailing approach for activating caspases in
cancer cells is cell damage that induces activation of
the apoptotic machinery. For largely historical rea-
sons, this damage usually involves DNA, a molecule
that is identical chemically in normal and transformed
cells, and modifications of which often cause muta-
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tions, some of which lead to cancer. An evolving alter-
native approach to selective killing of cancer cells is
based on exploiting metabolic differences between
normal and cancerous cells.
Our way of developing this approach was to inves-
tigate how expression of E1A or Myc affects metabo-
lism of human cells, and, in particular, how these
oncogenes change dependence of the cells on major
nutrients. We found that, in contrast to previous stud-
ies, expression of Myc does not affect sensitivity of
the cells to glucose withdrawal, as both normal cells
and cells that express Myc die without this nutrient,
and cell death has no signs of apoptosis. However, we
found that depletion of glutamine induces apoptosis in
cells that express Myc but does not affect viability of
normal cells. Previously, glutamine depletion and glu-
tamine analogs that interfere with metabolism of this
amino acid were exceptionally efficient in mouse
models of cancer and were used in the clinic but were
abandoned because of their toxicity. We thought that
by understanding how glutamine deficiency causes
cell death in transformed cells, we would be able to
suggest how to retain the therapeutic benefits of the
previous treatments but avoid their toxicity.
During this year, we determined the pathway of
apoptosis involved and began to analyze how a deple-
tion of glutamine can activate this pathway. We evalu-
ated several possibilities suggested by previous stud-
ies, such as interference with energy metabolism or
protein synthesis, and found that none of them can
explain our observations. We are currently investigat-
ing other options.
Overall, our studies continued to use simple exper-
imental systems in order to understand how cancer
cells can be killed selectively.
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REGULATION OF APOPTOSIS AND SENESCENCE
BY CANCER GENES
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Apoptosis is a genetically controlled form of cell death
that is important for normal development and tissue
homeostasis. Senescence produces "genetic death" in
that the senescent cell is incapable of further propaga-
tion. Both processes are frequently disrupted in cancer
cells, implying that each can limit tumor development.
Moreover, radiation and many chemotherapeutic
agents can induce either apoptosis or senescence, rais-
ing the possibility that the integrity of these pro-
grammed responses influences the outcome of cancer
therapy in patients. The goal of our research is to
understand how cancer genes control apoptosis and
senescence in normal cells, and how mutations that dis-
rupt these processes impact tumor development and
therapy. Our approach emphasizes genetics, and we
have increasingly relied on new types of animal mod-
els and gene manipulation technologies to study tumor
development and cancer therapy in vivo.
Control of Apoptosis by
Oncogenes and Tumor
Suppressor Genes
A. Bric, D. Burgess, E. Cepero, E. de Stanchina,
R. Dickins, M. Hemann, M. McCurrach, L. Zander,
J. Zilfou [in collaboration with G. Hannon and
W. Tansey, Cold Spring Harbor Laboratory;
D. Livingston, Dana Farber Cancer Center; and
former laboratory member A. Samuelson]
Normal cells possess intrinsic tumor suppressor mech-
anisms that limit the consequences of aberrant prolif-
eration (for review, see Lowe et al. 2004). For exam-
ple, deregulated expression of the c-Myc or disruption
of the Rb (retinoblastoma) pathway in normal cells
can force aberrant S-phase entry and predispose cells
to apoptotic cell death. This increased sensitivity to
apoptosis acts in part via the p53 tumor suppressor
pathway and limits tumor development. We have pre-
viously shown that oncogenes can engage the ARF-
H. Wendel
M. Yang
L. Zender
J. Zilfou
p53 pathway to promote apoptosis and that disruption
of this pathway cooperates with oncogenes to promote
oncogenic transformation in vitro and tumor develop-
ment in vivo. We are currently interested in identifying
additional components of these programs and in
understanding how they function in a "tumor suppres-
sor network."
The adenovirus E1A oncoprotein promotes prolif-
eration and transformation by binding cellular pro-
teins, including members of the Rb protein family, the
p300/CBP transcriptional coactivators, and the
p400/TRRAP chromatin-remodeling complex. E1A
also promotes apoptosis, in part, by engaging the
ARF-p53 tumor suppressor pathway described above.
This year, we completed a study showing that E1A
induces ARF, p53, and promotes apoptosis in normal
fibroblasts by physically associating with Rb and a
p400/TRRAP complex and that its interaction with
p300 is largely dispensable for these effects
(Samuelson et al. 2005). We further showed that E1A
increases p400 expression and, conversely, that sup-
pression of p400 using stable RNA interference
reduces the levels of ARF, p53, and apoptosis in E1A-
expressing cells. Therefore, whereas E1A inactivates
Rb, it requires p400 to efficiently promote cell death.
These results identify p400 as a regulator of the ARF-
p53 pathway and a component of the cellular machin-
ery that couples proliferation to cell death.
Like E1A, the cellular c-Myc oncoprotein drives
proliferation and cell death. This year, we collaborated
with William Tansey to characterize the role of a high-
ly conserved, but little studied, element within the cen-
tral region of c-Myc, termed "Myc box III" (MbIII).
We show that MbIII is important for transcriptional
repression by Myc and for transformation both in vitro
and in a mouse model of lymphomagenesis (Herbst et
al. 2005). Curiously, disruption of MbIII decreases
transformation activity by increasing the efficiency
with which Myc can induce, apoptosis, suggesting that
MbIII is a negative regulator of programmed cell
death. These findings reveal a role for MbIII in Myc
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functions and establish that the oncogenic capacity of
Myc is linked directly to its ability to temper the apop-
totic response. We are continuing to study Myc activ-
ity in vivo and, in particular, are studying the onco-
genic properties of naturally occurring myc point
mutants found in Burkitt's lymphoma.
An important aspect of our research in apoptosis
continues to explore the biological roles of p53 in
tumor suppression. p53 regulates diverse antiprolifer-
ative processes such that cells acquiring p53 muta-
tions have impaired cell cycle checkpoints, senes-
cence, apoptosis, and genomic stability. This year, we
used stable RNA interference (RNAi) to examine the
role of PUMA, a p53 target gene and pro-apoptotic
member of the Bc12 family, in p53-mediated tumor
suppression. PUMA short hairpin RNAs (shRNAs)
efficiently suppressed PUMA expression and p53-
dependent apoptosis but did not impair nonapoptotic
functions of p53 (Hemann et al. 2004). Like p53
shRNAs, PUMA shRNAs promoted oncogenic trans-
formation of primary murine fibroblasts by the
ElA/ras oncogene combination and dramatically
accelerated myc-induced lymphomagenesis without
disrupting p53-dependent cell cycle arrest. However,
the ability of PUMA to execute p53 tumor suppressor
functions was variable because, in contrast to p53
shRNAs, PUMA shRNAs were unable to cooperate
with oncogenic ras in transformation. These results
demonstrate that the p53 effector functions involved
in tumor suppression are context-dependent and, in
some settings, depend heavily on the expression of a
single effector. Additionally, they demonstrate the
utility of RNAi for evaluating putative tumor suppres-
sor genes in vivo.
Control of Cellular
Senescence
D. Burgess, E. de Stanchina, M. Narita, M. Narita,
S. Nunez, J. Zilfou [in collaboration with G. Hannon,
Cold Spring Harbor Laboratory; and David Livingston,
Dana Farber Cancer Institute; also involving former
laboratory members E. Querido and G. Ferbeyre]
Cellular senescence was originally described as the
process that accompanies replicative exhaustion in
cultured human fibroblasts, and it is characterized by
a series of poorly understood markers. Senescent cells
remain metabolically active but are unable to prolifer-
ate and display changes in gene expression that could
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alter tissue physiology. As such, they are genetically
"dead" and cannot contribute to tumor development.
Although "replicative" senescence is triggered by
telomere attrition and can be prevented by telomerase,
an identical endpoint can be produced acutely in
response to activated oncogenes, DNA damage, oxida-
tive stress (Lowe et al. 2004), and suboptimal cell cul-
ture conditions. These observations have led us to pro-
pose that senescence acts in parallel with apoptosis as
a cellular response to stress. Indeed, based on this
analogy, much of our work on senescence is guided by
our past experience on apoptosis.
We continue to identify and characterize new fac-
tors that modulate senescence. For example, we previ-
ously showed that the promyelocytic leukemia (PML)
gene is up-regulated during senescence and now have
extended these observations by showing that PML is a
p53 target gene that contributes to both senescence
and apoptosis (de Stanchina et al. 2004). Our results
identify a new element of PML regulation and estab-
lish PML as a mediator of p53 tumor suppressor func-
tions. Recent work indicates that the role of PML in
mediating p53 responses may extend to many tissues
and cell types. We also worked with David Livingston
to characterize the role of the p400 protein in regulat-
ing cellular senescence. This study showed that p400
is a component of the p53 cell-cycle-arrest pathway,
having a key role in regulating the transcription of p21
(a cyclin-dependent kinases inhibitor). Notably, acute
depletion of p400 expression using RNAi led to pre-
mature senescence of untransformed human fibrob-
lasts in a p53/p21-dependent manner (Chan et al.
2004). Taken together with our studies on apoptosis,
these data imply that p400 acts as a central player in
cellular decisions that couple proliferation to cell
death and senescence.
We are also interested in identifying components
of the senescence "machinery," i.e., molecules that
contribute to the irreversibility of the arrest. We
recently reported that some senescent human fibrob-
lasts accumulate a novel type of chromatin structure
(named senescence-associated heterochromatic foci,
SAHF) that is dependent on the Rb tumor suppressor
and is associated with the stable silencing of E2F tar-
get genes (see comment in Narita and Lowe 2004). To
gain insights into the chromatin changes linked with
senescence, we have begun a proteomics analysis to
identify molecules that selectively associate with chro-
matin in senescent cells. As we identify new chro-
matin-associated proteins, we will progress toward in
vivo studies, where we hope to deconstruct the process
using forward and reverse genetic approaches. Here,
our interactions with the Hannon lab on stable RNAi
technology are crucial for our future plans.
Evolution of Genomic Instability
in Human Tumors
M. Hemann, J. Zilfou [in collaboration with E. Hernando,
C. Cordon-Cardo, W. Gerald, and R. Benezra, Memorial
Sloan-Kettering Cancer Center; and former laboratory mem-
ber Z. Nahle]
Aneuploidy is a hallmark of advanced human cancers,
yet the molecular defects underlying this trait, and
whether they are a cause or a consequence of the
malignant phenotype, are not clear. For several years,
we have studied the role of p53 in controlling chromo-
somal stability, and the relevance of this function for
p53 tumor suppressor activities. This year, we began to
study the role of the Rb protein in controlling genomic
integrity (Hernando et al. 2004). Notably, mutations
that disable the Rb pathway are also common in human
cancers. These mutations promote tumor development,
in part, by deregulating the E2F family of transcription
factors, leading to uncontrolled cell cycle progression.
We showed that the mitotic checkpoint protein Mad2 is
a direct transcriptional target of E2F and, as a conse-
quence, is aberrantly overexpressed in cells with
defects in the Rb pathway. Concordantly, Mad2 is over-
expressed in several tumor types, where it correlates
with high E2F activity and poor patient prognosis.
Generation of Rb pathway lesions in normal and trans-
formed cells produces aberrant Mad2 expression and
mitotic defects leading to aneuploidy. Remarkably, Rb
inactivation requires Mad2 up-regulation to fully pro-
duce ploidy alterations. Our results reveal how chro-
mosome instability can arise as a byproduct of defects
in cell cycle control that compromise the accuracy of
mitosis and identify a new mechanism of genomic
instability that may contribute to the high frequency of
aneuploidy observed in advanced human cancers.
Molecular Genetics of Drug
Sensitivity and Resistance
E. Cepero, M. Hemann, S. Ray, C. Rosenthal, A.,
M. Spector, H. Wendel, M. Yang, L. Zender, J. Zilfou
[in collaboration with C. Cordon-Cardo, Memorial
Sloan-Kettering Cancer Center; J. Pelletier, McGill
University; S. Kogan, University of California, San
Francisco; also with former laboratory member
J. Fridman]
A major goal of our research is to understand the bio-
logical and molecular basis of drug sensitivity and
resistance in tumors. Conventional approaches to
identify factors that dictate treatment sensitivity often
rely on human tumor cell lines treated in vitro or as
ectopic xenografts. As an alternative approach, we are
using transgenic mouse models to study drug action in
spontaneous tumors. One system exploits the Eli-mye
transgenic mouse, which develops B-cell lymphomas
at short latency with high penetrance. Using this sys-
tem, we have identified a number of biologic and
genetic determinants of treatment sensitivity in vivo
(for review, see Lowe et al. 2004).
This year, we examined how constitutive signaling
by Akt compared to Bcl -2 overexpression in promot-
ing oncogenesis and drug resistance in vivo (Wendel et
al. 2004). We showed that Akt, like Bc1-2, cooperates
with Myc during lymphomagenesis, in part by evading
p53 action, leading to highly disseminated lymphomas
that are pathologically indistinguishable. We also
showed that the mTOR inhibitor rapamycin (which
interferes with one of several pathways downstream
from Akt) synergizes with conventional therapy in
lymphomas expressing Akt but not those expressing
Bcl -2. Interestingly, enforced expression of eIF4E,
which acts downstream from mTOR to regulate trans-
lation initiation, recapitulated Akt's ability to promote
oncogenesis and drug resistance, although eIF4E-
expressing lymphomas were refractory to rapamycin.
These results have important ramifications for
understanding Akt action in oncogenesis and drug
resistance and for considering the use of targeted ther-
apeutics in the clinic (see commentary by McCormick,
Nature 428 267 [2004]). First, our study provided the
first demonstration that Akt and eIF4E could promote
drug resistance in vivo, and thus implied that transla-
tional regulation via eIF4E can be important for Akt-
mediated survival signaling. Second, the similarities
between Akt an Bcl -2 (a purely anti-apoptotic protein)
provided a formal demonstration that, despite the
diverse impact Akt signaling has on cell physiology, its
anti-apoptotic functions are crucial for oncogenesis.
Third, our observation that Akt- mediated chemoresis-
tance (but not that produced by Bcl -2 and eIF4E) could
be reversed by rapamycin showed for the first time that
small molecules capable of reversing apoptotic defects
can restore drug sensitivity in tumors. However, they
also underscored the importance of tailoring cancer
therapy based on tumor genotype.
We continue to study how Akt signaling influences
tumor development, drug resistance, and rapamycin
sensitivity and are testing a number of novel "target-
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ed" therapies in the Eµ -myc model in order to deter-
mine whether any can reverse or circumvent the drug
resistance produced by p53 loss. Finally, we began a
multi-institutional effort to use mouse AML (acute
myelogenous leukemia) models to uncover drug resis-
tance mechanisms and to evaluate new therapies, with
the goal of translating this information to human
patients. We are excited about the potential of the pro-
gram, as it provides all of the elements necessary to
validate the use of new mouse models as preclinical
test systems and translate this information into clini-
cal trials. Finally, we have developed a new mouse
model of hepatocellular carcinoma that should allow
us to extend our analyses to epithelial malignancies.
PUBLICATIONS
de Stanchina E., Querido E., Narita M., Davuluri R., Pandolfi
RP, Ferbeyre G., and Lowe S.W. 2004. PML is a direct
p53 target that modulates p53 effector functions. MoL Cell
13: 523-535.
Hemann M.T., Zilfou J. Zhao Z., Burgess D.J., Hannon G.J.,
and Lowe S.W. 2004. Suppression of tumorigenesis by the
p53 target PUMA. Proc. Natl. Acad. Sci. 101: 9333-9338.
Hernando E., Nahle Z., Juan G., Diaz-Rodriguez E., Alaminos
M., Hemann M., Michel L., Mittal V., Gerald W., Benezra R.,
Lowe SM., and Cordon-Cardo C. 2004. Rb inactivation
promotes genomic instability by uncoupling cell cycle pro-
gression from mitotic control. Nature 430: 797-802.
Lowe SM., Cepero E., and Evan G. 2004. Intrinsic tumor sup-
pression. Nature 432: 307-315.
Narita M. and Lowe S.W. 2004. Executing cell senescence. Cell
Cycle 3: 244-246.
Wendel H.G. and Lowe S.W. 2004. Reversing drug resistance
in vivo. Cell Cycle 3: 847-849.
70
Wendel H.G., de Stanchina E., Fridman J.S., Malina A., Ray S.,
Kogan S., Cordon-Cardo C., Pelletier J., and Lowe S.W.
2004. Survival signalling by Akt and elF4E in oncogenesis
and cancer therapy. Nature 428: 332-337.
In Press
Chan H.M., Narita M., Lowe S.W., and Livingston D.L. 2005.
The p400 E1A-associated protein participates in fibroblast
lifespan maintenance. Genes Dee (in press).
Fernandez Y., Verhaeguen M., Miller T.P., Rush J.L., Steiner P.,
Opiariti A.W., Jr., Lowe SM., and Soengas M.S. 2005.
Differential regulation of noxa in normal melanocytes and
melanoma cells by proteosome inhibition: Therapeutic
implications. Cancer Res. (in press).
Gruber J., Fei P., Finnberg N., Rodolph D., Bric A., Burns T.F.,
Ajuhua H., Page R., Wu G.S., Chen Y., Bernhard E.J.,
Lowe S.W., Mak T.W., and EI-Deiry M.S. 2005. DR5 knock-
out mice are compromised in radiation-induced apoptosis.
Mot Cell. Biol. (in press).
He L., Thomson J.M., Hemann MT, Hernando E., Mu D.,
Goodson S., Powers S., Lordon-Cardo C., Lowe S.W.,
Hannon G.J., and Hammond S. 2005. A microRNA poly-
cistron as a potential human oncogene. Nature (in press).
Helmrich A., Lee S., O'Brien P., Dorken B., Lowe S.W., Schrock
E., and Schmitt C.A. 2005. Chromosomal aberrations in
INK4a/ARF defective primary lymphomas predict drug
responses in vivo. Oncogene (in press).
Hemann M.T. and Lowe S.W. 2005. p53 links cancer genetics
to cancer therapy. In 25 years of p53 research (ed. K.
Wiman). Kluwar, The Netherlands. (In press.)
Herbst A., Hemann M.T., Tworkowski K.A., Salghetti S.E., Lowe
S.W., and Tansey W.P. 2005. An anti-apoptotic function of
Myc important for oncogenesis. EMBO Rep. (in press).
Samuelson A.V., Narita M., Chan H., Jin J., Stanchina E.,
McCurrach M., Narita M., Fuchs M., Livingston D.M., and
Lowe S.W. 2005. p400 is required for MA to promote
apoptosis. J. Biol. Chem. (in press).
GENOMIC MICROARRAY ANALYSIS OF CANCER
R. Lucito A. Brady 0. Dovirak
T. Auletta S. EI -ftesi
S. Chen
This work was carried out in collaboration with M.
Wig ler, J. Healy, and A. Reiner here at CSHL.
Mutation of the genome is central to the development
and progression of cancer. Mutations occur in the
genome of precancerous cells and accumulate, alter-
ing gene function until the growth of these cells goes
unchecked. The genes responsible for cancer must be
identified if we are to understand the cellular pathways
that get subverted to allow the cell to become cancer-
ous. We have developed a genomic microarray tech-
nique, representational oligonucleotide microarray
analysis (ROMA), to identify copy-number fluctua-
tions, which borrows the methodology of complexity
reducing representations developed for RDA (repre-
sentational difference analysis) to increase hybridiza-
tion efficiency and increase signal to noise. A repre-
sentation is a reproducible sampling of the genome,
produced by first cleaving the genome with a restric-
of adaptors, and
polymerase chain reaction (PCR) amplification. BglII
representations of tumor and normal that are differen-
tially labeled are compared on such an array to identi-
fy copy-number fluctuations. The array is composed
of oligonucleotides based on the sequence of the
human genome. We are using microarrays photochem-
ically synthesized by Nimblegen Systems, Inc.
Currently, we are using arrays with 85,000 probes dis-
tributed throughout the genome and soon will be mov-
ing to an array of 390,000 probes.
We have begun surveying the genome of several
cancer types to identify regions that have undergone
increased or decreased gene copy number, namely,
amplifications or deletions, since these changes can be
used as markers for the location of oncogenes or tumor
suppressor genes, respectively. Regions are being
informatically searched for gene candidates and then
functional analysis of these candidates is being carried
out to determine which genes have oncogenic poten-
tial. Once identified, these gene functions can be inves-
tigated to understand their role in the path to tumorige-
nesis. In addition, by analyzing the regions alongside
clinical data, we will determine if there are any regions
or combination of regions that correlate with clinical
outcome. The application of this type of an array spans
many areas of biology, from cancer to genetic diseases.
We will be using this microarray method to categorize
the mutations that occur primarily in two tumor types
initially, pancreatic and ovarian cancer.
PANCREATIC CANCER
There will be an estimated 30,000 cases of pancreatic
cancer this year. Of those, 29,700 patients will suc-
cumb to the disease. Although the number of cases is
low in comparison to several other cancers, such as
colon, lung, or breast cancer, the survival rate for pan-
creatic cancer is one of the lowest. Treatments can
extend survival or alleviate pain but seldom cure the
patient. In fact, the mean survival time is approxi-
mately 6 months. Because lifespan after diagnosis is
very short, the number of patients that receive tumor
resections is very low. This translates to few samples
available for analysis. Because of this, we are collabo-
rating with many clinicians to put together a useful
tumor bank of pancreatic tissue for analysis by
ROMA. Currently, we are collaborating with Dr.
Ralph Hruban of the Johns Hopkins University School
of Medicine, Dr. Daniel Von Hoff of the Arizona
Cancer Center, Dr. Vijay Yajnic of Mass General, and
Dr. Murray Abrams of Memorial Sloan-Kettering
Cancer Center who will be providing pancreatic spec-
imens and invaluable clinical information and exper-
tise. To date, we have analyzed approximately 50 sam-
ples and have confirmed that many of the known
mutated regions are altered in this set; for example, the
INK4a-ARF locus, DPC4, p53, and c-myc are all
lesions commonly identified in this type of tumor. In
addition, there are other less-characterized regions
deleted (2p23, 3p, 8p23, 10p15, and 12p) and ampli-
fied (1q12, 1q42-43, 2q32, 3q26, 8q, 12q, and 19q)
frequently in this cancer, and we are continuing to
study these regions to identify possible gene candidate
tumor suppressors and oncogenes.
We also have two ongoing projects utilizing
ROMA to study other aspects of pancreatic cancer.
The first is the study of changes that have occurred in
pancreatic metastasis. One of our collaborators, Dr.
Christine Iacabuzzo, has developed a unique program
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within Johns Hopkins Medical Center-a rapid autop-
sy program whereby cancer tissue specimens are
rapidly ressected from patients postmortem. These
samples are then transferred to mice to grow as
xenografts. We have analyzed seven primary tumors
and from two to four metastases for each tumor. The
metastases are from liver, lung, lymph node, etc. We
have found that the metastases have almost identical
copy-number patterns. However, there are several
regions that are different among the samples of prima-
ry to metastases. The samples of primary that we are
analyzing are most likely a heterogeneous population
of cells that made up the original primary tumor.
Interestingly, it appears that there are also regions that
are altered more in the metastases than in the primary,
possibly suggesting that the metastases had this region
altered and were selected as the metastases. We have
identified gene candidates within these regions and are
attempting to functionally perform characterization
assays to determine the role they have in metastasis.
A second project is an attempt to identify if there
are possible copy-number polymorphisms (CNPs),
small changes in the genome found in apparently nor-
mal people, which correlate with the genetic suscepti-
bility of pancreatic cancer. Johns Hopkins Medical
Center has a bank of DNA from normal individuals
who have a higher risk of developing pancreatic can-
cer. This increased risk is based on the fact that these
individuals have more than one family member who
has developed pancreatic cancer, a normally rare can-
cer. The DNA samples from these patients are ana-
lyzed by ROMA and the CNPs are identified. These
are then compared to data of CNPs found in a normal
population to remove all those that are found com-
monly in a set of patients who do not have an
increased risk of pancreatic cancer. We have found
one interesting CNP that is deleted in one family with
increased risk of pancreatic cancer as compared to the
reference population. This deletion is very close to the
INK/ARF locus, but does not delete any genes within
this locus. More specifically, a cluster of interferon
genes are deleted. Our clinical collaborators have seen
homozygous deletion of this region without deletion
of INK/ARF in some patients with pancreatic cancer.
We are continuing to characterize this region with the
help of our clinical collaborator Dr. Ralph Hruban.
OVARIAN CANCER
We are also focusing on the analysis of ovarian cancer
using ROMA. Ovarian cancer has a relatively high
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incidence and an approximately 50% survival rate. In
many patients, the cancer is diagnosed late, often hav-
ing metastasized, with the first symptom being an
accumulation of fluid in the abdominal cavity. There
have been few genes discovered that are involved in
the progression of ovarian cancer. We will be collabo-
rating with Dr. Michael Pearl of Stony Brook
Univerrsity for access to tissue and clinical informa-
tion. We will also be performing ROMA on a tumor
set of approximately 200 ovarian cancer samples to
identify gene-copy-number fluctuations to identify
candidate tumor suppressor and oncogenes.
At present, we have analyzed 75 tumors and have
compiled the data to identify regions commonly
amplified or deleted. We have identified uncharacter-
ized regions commonly amplified (1q21, 3q26, 6p,
11q13, 12p, and 20p13) and regions that are deleted
frequently (1p35, 3p26, 4p15, 4q34, 5q14, 5q34, 6q22,
9q22, 12q, 13q13, 16q, 19p, and 22q13). We have
characterized these regions for gene content and have
chosen several to move further for gene characteriza-
tion as described below.
We have also analyzed a set of ovarian tumors
obtained from Dr. Anne-Lise Borresen-Dale from the
Norwegian Radium Hospital. This tumor set has
already been analyzed by Dr. Patrick Brown and col-
leagues for expression analysis. This analysis was able
to separate the tumors into two distinct sets that corre-
lated with the clinical findings of survival. We have
recently finished the analysis of these tumors and are
now informatically analyzing the data to determine if
the copy-number fluctuations can be also used to iden-
tify the same two groups of patients.
Mouse Cancer Analysis by ROMA
T. Auletta, S. Chen, A. Brady [in collaboration with S. Lowe,
Cold Spring Harbor Laboratory; S. Powers, Tularik, Inc;
S. Orsulik, Massachusetts General Hospital]
We have developed a mouse ROMA array and have
begun analysis of mouse copy number differences in
the model systems and liver cancer in collaboration
with Dr. Scott Lowe. We have performed mouse
ROMA on ten liver cancer samples and have identi-
fied several alterations. Three of the tumors have an
amplification of a region of chromosome 9 near the
centromere. In collaboration with Dr. Scott Powers,
the human syntenic region of the mouse chromosome
was searched for amplification within a ROMA data
set of approximately 50 primary human tumor sam-
ples. This region was also found to be amplified with-
in the human data set and the genes within this region
are now being functionally characterized by Dr. Scott
Lowe's group to determine if one gene has oncogenic
activity.
Since this model system for analysis of cancer has
worked well, we have begun a similar project for ovar-
ian cancer. We already have 75 primary tumor samples
analyzed and will be analyzing another 30 shortly. We
have initiated a collaboration with Dr. Sandra Orsulik
who has developed a mouse model of ovarian cancer.
We have analyzed ten mouse ovarian cancer samples,
comparing the data from mouse tumors with those of
human tumors, and we are currently looking for com-
mon syntenic regions that are mutated.
Gene Candidate Characterization
C. Flutter, S. Chen [in collaboration with S. Powers, Tularik,
Inc.; R. McCombie and L. Van Aelst, Cold Spring Harbor
Laboratory]
Regions identified from the above studies are moving
forward with the identification and functional charac-
terization of gene candidates. If we are to characterize
the candidate genes' abilities to affect cellular growth,
it is imperative that we have the full-length genes and
are aware of splice variants. If one gene were being
studied, this could easily be handled by more standard
techniques. However, this approach will not be suffi-
cient for multiple regions, each with multiple candi-
date genes. We are collaborating with Dr. Richard
McCombie who has extensive experience in genomic
sequencing, and his group has developed a systematic
approach in which gene discovery is performed by
integrating existing gene annotation and gene predic-
tions into an experimental pipeline geared to (1) con-
firm the existence of genes, (2) identify the transcrip-
tion start site and termination site, and (3) determine if
the gene annotation is correct regarding possible
splice variants.
We are currently focusing on two regions of ampli-
fication, one present in ovarian cancer and the other in
pancreatic cancer. The region found in ovarian is
found to be amplified in approximately 80% of tumors
that are aneuploid. Generally, these are the most
aggressive tumors clinically. Within the data set that
we are studying, the amplifications vary widely in
dimension and amplitude. Most often, the amplifica-
tion is very large and uninformative from a positional
cloning standpoint. However, one specific tumor had
amplified a relatively small region of 3Mb and an
amplitude of approximately tenfold; 17 gene candi-
dates from this region were identified. This is a large
number of candidates to study for functional charac-
terization and validation. We have begun first steps in
developing high-throughput genomic approaches to
the functional characterization of the gene candidates
within the regions studied by using RNA interference
(RNAi) studies utilizing the short hairpin RNA
(shRNA) library constructed in Dr. Hannon's lab here
at CSHL. Cell lines having this region amplified will
be infected with shRNA constructs and growth assays
will be performed. This approach is also being taken
with a region frequently amplified in pancreatic can-
cer. One advantage that we have for this region is a cell
line that was produced from the very tumor that had a
focal amplification of this region, by Dr. Chris
Iacobuzio of the Johns Hopkins University School of
Medicine. This tumor cell line will be a valuable tool
for gene validation studies for this region.
Methylation-specific Oligonucleotide
Microarray Analysis
0. Dovirak, S. Chen, A. Brady, J. Healy
In addition to genetic mutation, such as amplification
and deletion, there are epigenetic mechanisms used to
influence the transcriptional activity of a gene. One
such mechanism is methylation of the cytosines pre-
sent in the DNA of the transcriptional control region,
which often suppresses the expression of the gene. It
has been known that methylation of DNA has been
involved in the silencing of gene expression in
imprinting and in cancer. Recent advances including
technical as well as the sequencing of the genome have
made detection of methylation at loci more reliable
and accurate. However, few methods can identify
methylation changes over the entire genome. We have
adapted ROMA to methylation detection oligonu-
cleotide microarray analysis (MOMA). Currently, we
are utilizing this to survey the changes that occur in
cancer, but in principle, this method would have appli-
cations for identifying methylation differences
involved in imprinting or other syndromes that do not
involve genetic mutation.
We have taken advantage of several enzymes that
discriminate methylated and unmethylated cytosines
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(MOMA). For example, a sample can be treated with
two restriction enzymes, McrBC, which cleaves at
(G/A)mC (N40_3.) (G/A)mC, and Mspl, which cleaves
at all sites of CCGG, in effect depleting the represen-
tation of fragments that have methylated CpGs. A sec-
ond aliquot of the same sample is mock-digested for
McrBC and digested with HpaII, which is an
isoschizomer of MspI (recognizes the same sequence),
but cleavage is blocked if the cytosine is methylated.
The two differently processed samples are then com-
pared.
We have analyzed several cell lines and tumors for
methylation changes, and have made several interest-
ing observations. First, reports of global hypomethy-
lation in cancer appear to be correct. We have com-
pared the methylation pattern of tumor samples to sev-
eral normal tissue samples, either a heterogeneous
population of skin or embryonic fibroblasts. We
observe large pockets of hypomethylation in the
tumor in comparison to the normal. In contrast, there
is only sporadic hypermethylation of the tumor
genome. The one type of region we recurrently
observe as hypermethylated in cancer are regions of
genomic amplification. We have further investigated
this by amplifying the DHFR locus in response to
methotrexate. Initially, the response of cells is to over-
express the DHFR gene, but with increased amounts
of methotrexate, the cells genomically amplify the
region. Once the region is genomically amplified, the
regions becomes hypermethylated. However, the
hypermethylation does not affect the expression level
of the genes within the amplified region. Apparently
there is a difference between methylation of total
genome CpGs and islands of CpGs. Interestingly, in
other cell lines and tumors that have amplifications,
only with high-level amplifications do we see corre-
sponding hypermethylation of the genomic region.
High-level amplification is often amplified in the cell
as double minutes (DMs), regions of the genome that
are excised and form a circular piece of DNA. If these
DMs have origin of replications, they autonomously
replicate sorting randomly during cytokinesis. We are
currently testing whether hypermethylation only
occurs in amplified regions that are DMs or if hyper-
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methylation occurs in high-level amplifications within
the chromosome, usually termed HSRs, or homoge-
neously staining regions. In the future, we will be uti-
lizing the tools we have developed to tease out the
members of the methylation pathway that are respon-
sible for this phenomenon.
We are continuing to develop this method. We
have redesigned the array to represent known CpG
islands as well as CG-rich regions of the genome, to
make an array that is more specific for methylation
detection and transcription control. It is becoming
clear that methylation silencing has an important role
in cancer, and we intend to marry both the ROMA and
MOMA techniques. Both mutation and methylation
have an effect on the level of gene transcription, a
good example being the deletion of one copy of the
INK/ARF locus and the hypermethylation of several of
the CpG islands within this locus, specifically that in
front of the p16 gene. By analyzing those regions of
the genome that have been physically mutated,
whether amplified or deleted, and those regions of the
genome that are differentially methylated, we will
obtain a more complete picture of the cancer cell.
Ultimately, all of these data will be incorporated
together and analyzed alongside the clinical informa-
tion to determine if any genetic or epigenetic factors
correlate to clinical outcome.
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MAMMALIAN FUNCTIONAL GENOMICS
A. Mills A. Bagchi W. Keyes
E. Garcia C. Papazoglu
X. Guo Y. Wu
Our laboratory generates novel mouse models for
characterizing mammalian gene function in vivo. By
investigating normal developmental processes, we
are able to better understand molecular mechanisms
that contribute to human diseases such as cancer. The
link between mammalian development and cancer is
at the heart of understanding how to design more
effective cancer therapies that do not have adverse
side effects.
We are able to tailor-make mouse strains in an
effort to model specific human diseases. For exam-
ple, we can add or remove genes, we can "cut, copy,
and paste" specific regions of a chromosome, and we
can even make subtle changes within a chosen gene.
This ability to manipulate the mouse genome makes
it possible to address a diverse array of biological
questions to investigate gene function. In addition,
these mouse models are invaluable for understanding
pathogenesis and for designing novel treatments for
human disease.
In our laboratory, we use gene targeting in embry-
onic stem cells to generate mouse strains that have
precise modifications of the genome. We are using
two different approaches to achieve this goal: (1) ana-
lyzing the role of groups of genes within specific
regions of the genome, and (2) analyzing the role of
individual genes known to be associated with human
disease. The first approach uses chromosome engi-
neering to generate mouse strains that have precise
chromosome rearrangements that correlate with those
found in human diseases. These mouse strains are use-
ful for providing disease models and for determining
the function of genes within specific regions of the
genome. The second research emphasis in the labora-
tory is to perform an in-depth exploration of a single
gene known to cause several human disease syn-
dromes. This gene, p63, is related to the p53 tumor
suppressor gene-a gene that is mutated in approxi-
mately one half of all human cancers. Understanding
the molecular and genetic mechanisms of p63 action
will allow us to gain insight into the processes of
development, cancer, and aging.
Generation of Megabase
Chromosome Rearrangements:
Human Chromosome 1p
A. Bagchi, Y. Wu
Goals: To generate mouse models that mimic human
cancer syndromes and to functionally annotate genes
mapping to human chromosome 1p.
Chromosome rearrangements such as deletions, dupli-
cations, and inversions are associated with a multitude
of human diseases. These chromosome abnormalities
are complex because they affect large numbers of
genes within specific chromosomal regions. To under-
stand how these rearrangements cause disease, we are
generating mouse strains that have the same
rearrangement as those found in human patients.
Defined chromosome rearrangements are made using
chromosome engineering-an approach that com-
bines the power of gene targeting with Cre /loxP tech-
nology. The similarities between the human and mouse
genome make it possible to generate mouse models of
hereditary and spontaneous diseases. We are currently
using this approach to generate models of hereditary
cancer syndromes. We are focusing our efforts on
human chromosome 1p-a region containing several
as yet unidentified tumor suppressor genes. A diverse
array of human tumors have deletions at 1p, suggest-
ing that genes underlying the tumorigenic process are
located in this region of the genome. We are generat-
ing models of hereditary cancer by creating mouse
strains that have the same deletions as those found in
human tumors. We first make specific deletions in
embryonic stem cells, and then use these cells to gen-
erate mouse models that transmit the modified allele
to their progeny. To make this approach feasible on a
genome-wide scale, we have created a system that
greatly reduces the effort required for generating
gene-targeting constructs. This system is composed of
two genomic libraries of essentially premade gene-tar-
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geting vectors that contain all of the features required
for generating Cre-induced chromosome rearrange-
ments. In addition, constructs isolated from these
libraries contain genes that alter the coat color of mice
that harbor them; this feature has the advantage that
mice containing a specific rearrangement in their
genomes are visibly distinguishable from normal
mice. This greatly reduces the cost and labor required
for maintaining these mouse colonies, and also allows
these models to be implemented in genetic screens.
Within the past year, we have begun to develop
novel approaches for determining gene function and for
modeling human tumorigenesis. The first approach is to
model human spontaneous cancers using a conditional
chromosome engineering approach for generating spe-
cific chromosome deletions somatically. This strategy
will allow us to design mouse models that more accu-
rately reflect human spontaneous cancers in which a
genomic alteration within a rare somatic cell leads to
tumor formation. Another approach that we have been
developing in a collaborative effort with David
Largaespada's laboratory (University of Minnesota,
Minneapolis) combines chromosome engineering with
transposon-mediated mutagenesis. The strategy makes
it possible to thoroughly examine a defined genomic
interval to uncover novel cancer genes.
Analyzing the Role of Specific Disease
Genes: The p63 Gene
E. Garcia, X. Guo, W. Keyes, C. Papazoglu
Goal: To uncover molecular and genetic mechanisms
whereby p63 regulates development, cancer, and
aging.
The p53 tumor suppressor gene has an important role
in human cancer. Indeed, approximately one half of all
human cancers have either lost p53 altogether or have
inactivated it by mutation. Mice designed to lack p53
are viable and develop tumors at a very early age.
Thus, p53-deficient models are extremely valuable for
investigating the molecular and genetic events associ-
ated with tumor formation.
We discovered p63-a gene that is strikingly sim-
ilar to the p53 tumor suppressor gene. We used gene
targeting to create mice that lackp63; these mice have
severe developmental defects that affect craniofacial,
limb, and skin development. Mice that inherit a non-
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functional p63 gene are lacking specific structures,
such as hair, teeth, mammary and sebaceous glands,
nails, and prostate. These observations provided an
important clue that led to the discovery that mutations
in p63 cause five different human developmental dis-
ease syndromes that are characterized clinically by a
spectrum of malformations affecting development of
the limbs, skin, and the craniofacial region. How
mutations in p63 bring about the striking abnormali-
ties in these patients is currently unknown.
We are investigating p63's role in morphogenesis
of the ectoderm and its related structures. Although
mice lacking p63 altogether have been useful for
determining that p63 is essential for embryogenesis,
these mice have such profound developmental abnor-
malities that they die shortly after birth. To be able to
determine how p63 functions in the adult, specifical-
ly with regard to aging and cancer, we have generated
a conditional p63 model that allows us to first gener-
ate viable mice and then to ablate p63 within specific
tissues at particular stages of development. Using this
approach, we are able to inactivate p63 within specif-
ic tissues. This is the first system that provides a tool
for directly analyzing the role ofp63 in the adult.
We have also generated mouse models that mimic
the human developmental disease syndrome
Ectrodactyly, Ectodermal dysplasia, Clefting (EEC)
syndrome. EEC is caused by specific mutations in the
DNA-binding domain of p63; interestingly, these
mutations correlate precisely with cancer-causing
mutations in the p53 gene. To model EEC, we used
gene targeting to replace the normal copy ofp63 with
a version of p63 that has an EEC mutation. Mice car-
rying the EEC mutation have a phenotype that corre-
lates with the clinical features found in EEC patients.
Further characterization of this model will allow us to
more thoroughly understand the underlying cause of
the pathogenesis of EEC and will form a basis for bet-
ter treatment of patients afflicted with this disease.
In a collaborative effort with Gerry Cunha's labo-
ratory (University of California, San Francisco), we
used the p63 mouse models we have developed to
determine that p63 dictates epithelial cell fate (Fig. 1).
When tissue recombination experiments between
ectoderm and mesenchyme were performed, it was
shown that p63 expression drives the uncommitted
Mullerian epithelial cell to commit to the cervicovagi-
nal lineage, whereas in p63's absence, these cells were
destined to become uterine epithelia. The ability to
drive epithelial cell fate highlights p63's master role in
differentiation.
Mullerian
epithelia +p63 -p63
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FIGURE 1 p63 dictates epithelial cell fate. The female reproduc-
tive tract is lined with two distinct types of epithelia. The cervico-
vaginal epithelia that line the cervix and vagina perform a protec-
tive role, whereas the uterine epithelia that line the uterus perform
a glandular/secretory role. Although these two types of epithelia
are distinct, they arise from a common precursor: the Mullerian
epithelial cell. In response to p63 activation, these undifferentiat-
ed cells commit to the cervicovaginal lineage, whereas in p63's
absence, these cells are destined to differentiate into uterine
epithelia. Tissue recombination experiments indicate that p63 is
a master controller of this differentiation program.
Our analysis of the different p63 models that we
have developed have recently uncovered an unantici-
pated link between cancer and aging. We found that
unlike p53-deficient mice, mice with compromised
p63 levels were not cancer-prone. In fact, we found
that reduced levels of p63 functioned to decrease
tumor incidence in the highly cancer-prone p53-com-
promised mouse. Indeed, the rare tumors that devel-
oped in p63-compromised mice were molecularly and
histologically distinct from those of p53-deficient
mice. Thus, p63 does not have a role in tumor sup-
pression equivalent to that of p53. In fact, decreased
p63 function appears to be tumor protective.
Although we found that p63-deficient mice were
not tumor prone, we discovered that they aged prema-
turely. Mice with decreased p63 levels had a 23%
reduction in life span relative to wild-type mice and
showed features of accelerated aging. When we ana-
lyzed the effect of ablating p63 specifically within the
skin of adult mice, we found that aging was dramati-
cally accelerated: These mice developed baldness,
skin defects, curvature of the spine, weight loss, etc.
Interestingly, we found that p63 loss correlated with a
striking increase in the number of senescent cells, both
in vitro and in vivo. Thus, p63 deficiency appears to
provide tumor protection at the cost of accelerating the
aging process.
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TUMOR ANGIOGENESIS
V. Mittal D. Nolan S. Gupta
A. Mellick E. Heikamp
W. Xue
The presence of several genetic and epigenetic alter-
ations in the genome of a cancer cell has compromised
the effectiveness of anticancer therapeutics. In con-
trast, the genetically stable tumor-associated vascula-
ture, intrinsic for the survival, proliferation, and
metastasis of a majority of tumors, has been regarded
as an attractive target for cancer therapy. However,
clinical trials with antiangiogenic factors for the treat-
ment of human cancer have not been as effective, sug-
gesting that tumor angiogenesis might be orchestrated
by a more complex set of growth factors and collabo-
ration with as yet unrecognized cell types. Identifying
and targeting these cells may be vital key to success-
ful antiangiogenic therapy.
Indeed, emerging evidence suggests that bone-
marrow-derived endothelial progenitor cells (EPCs)
contribute to de novo blood vessel formation in the
adult. EPCs are mobilized from the bone marrow into
the peripheral circulation, recruited, and incorporated
into sites of active neovascularization during tissue
ischemia, vascular trauma, or tumor growth. Notably,
preclinical and pioneering clinical studies have shown
that introduction of these progenitor cells can restore
tissue vascularization after ischemic events in limbs,
retina, and myocardium. These initial findings have
provoked extensive follow-up studies-some casting
doubts on the biological significance and even the
contribution of the progenitor cells to the tumor vas-
culature.
Little is known about the critical role of EPCs in
the progression of tumors, and many questionsremain
to be addressed to understand the molecular and cellu-
lar mechanisms governing EPC mobilization, differ-
entiation, and incorporation into functional tumor vas-
culature. For example, what constitutes a homoge-
neous EPC population in the total bone marrow? How
are the EPCs mobilized into the peripheral circulation
in response to tumor growth factors, and how do they
home in to the sites of the tumor and incorporate into
the functional vasculature? Will blocking the mobi-
lization and incorporation of EPCs prevent tumor pro-
gression? In the last year, the focus of research in our
laboratory has been to answer some of these challeng-
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ing questions by applying powerful genomic technolo-
gies to mouse genetic models.
To understand how tumors direct the expansion,
mobilization, and incorporation of EPCs into the func-
tional tumor neovasculature, we have established a
robust murine bone marrow transplantation (BMT)
model. In this transplant model, green fluorescent pro-
tein (GFP)-marked donor bone-marrow-derived EPCs
are transplanted into lethally irradiated recipients and
tracked in the peripheral blood and in the tumor vas-
culature in vivo. Four weeks posttransplantation, fluo-
rescence-activated cell sorting (FACS) analysis of
blood showed greater then 85% GFP cells, indicating
efficient reconstitution of recipient hematopoiesis by
the donor cells. We first investigated whether the
transplanted EPCs can be mobilized from the bone
marrow into the peripheral circulation in response to
tumor challenge. Upon tumor challenge, a sevenfold
increased mobilization of GFP+ VEGFR2+ cells that
lacked the myelomonocytic marker CD1 lb /CD45 was
observed as compared to unchallenged mice. We next
evaluated whether these mobilized circulating
endothelial precursor (CEP) cells were able to home in
and incorporate into functional vessels in the tumor.
Microscopic analysis of tumor sections for colocaliza-
tion of GFP and multiple endothelial cell and pericyte
markers (e.g., PECAM, VE-cadherin, NG2, and
PDGF) showed significant incorporation of GFP+
transplanted cells into the tumor vasculature. A more
detailed quantitation suggested that approximately
60% of these cells are derived from the donor bone
marrow. These cells were present in multiple architec-
tural forms, such as in tubes, vessels, single cells, and
strings of cells. Detailed characterization ofthese cells
is in progress. Optical sectioning of serial sections
confirmed the colocalization of GFP and CD31 sig-
nals within the same individual cell, suggesting that
the incorporated endothelial cell was derived from the
transplanted EPCs.
We were next interested in understanding if the
contribution of the bone marrow precursors had any
biological significance in angiogenesis-mediated
tumor growth and metastasis. Toward this goal, we
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FIGURE 1 Blocking EPC-mediated tumor angiogenesis by
RNAi in vivo. (4) Tumor growth in wild-type, nonspecific shRNA
and Id/-specific shRNA transduced lineage negative bone mar-
row cells. (8) Tumors on day 14 in mouse transplanted with
bone marrow precursors expressing a nonspecific shRNA (left),
and an /dl -shRNA (right). (C) RT-PCR analysis showing fold
suppression of Idl, Id3, and a myelomonocytic marker CD45
mRNA in bone marrow as a result of Idl shRNA. The compari-
son is with the bone marrow expressing a nonspecific shRNA.
identified that transcription factors Idl and Id3 were
up-regulated in tumorNEGF-challenged bone mar-
row precursors. We asked if up-regulation of Id gene
expression was critical for EPC-mediated tumor
angiogenesis and would suppression of Id gene
expression by RNA interference block EPC function.
Effective short hairpin RNAs (shRNAs) targeting Idl
and Id3 mRNA were identified by using a rapid and
quantitative screening approach developed previously
in the laboratory (Kumar et al., Genome Res. 13: 2333
[2003]). shRNA-mediated suppression of Id gene
expression resulted in a dramatic reduction in
endothelial tube formation in matrigel assays, pheno-
copying the angiogenic defect observed in Id knock-
out mice.
Strikingly, animals with bone marrow transduced
with lentivirus-mediated Idl- specific shRNA showed
significant delay in tumor growth (40% reduction), as
compared to animals transplanted with bone marrow
expressing a nonspecific shRNA or wild-type animals
that had not undergone bone marrow transplantation.
The tumors were next characterized to determine the
impact of shRNA-mediated Id gene suppression on the
contribution of donor-derived cells in establishing the
neovasculature. Analysis of tumor sections showed a
dramatic reduction in GFP± endothelial cells in the
presence of Idl shRNA, when compared to animals
carrying wild-type GFP' bone marrow or nonspecific
shRNA expressing bone marrow. RT-PCR (reverse
transcriptase-polymerase chain reaction) analysis of
bone marrow cells showed that the Idl- specific
shRNA caused a dramatic reduction in the levels of
Idl mRNA in vivo. Suppression of Id/ did not affect
normal hematopoiesis (levels of CD45 mRNA, a
myelomonocytic marker remained unchanged), in
agreement with published observations.
In summary, we now have evidence that not only
supports and extends the concept for the incorporation
of bone marrow precursor cells in the tumor neoves-
sels, but also establishes their functional importance in
angiogenesis-mediated tumor growth. We have identi-
fied genes that mediate recruitment of bone marrow
precursors to the site of active angiogenesis. Strikingly,
shRNAs targeting these genes in the bone marrow pre-
cursors resulted in a rapid delay in tumor growth as a
result of reduced bone marrow contribution to tumor
neovascularization.
We are currently identifying pure EPC populations
resident in the total bone marrow, dissecting the role of
the Id pathway, and exploiting EPCs to serve as cellu-
lar vehicles for delivering effective therapeutics in the
form of (1) DNA-encoded inhibitory shRNAs, target-
ing proangiogenic genes (e.g., components of the Id
pathway), and (2) other therapeutic cargos (e.g., sui-
cide genes and antiangiogenic gene products), directly
and specifically to the sites of the tumor neovascula-
ture to inhibit its growth and metastasis.
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CANCER GENES
S. Powers D. Mu
In October of this past year, we started our laboratory
and began looking in human tumors for genomic alter-
ations that are likely to be causally involved in cancer
progression.
Besides our own initiatives, we are keyed up by the
interactive and collaborative spirit of CSHL, and
began what we expect will be productive collabora-
tions with different groups here at CSHL. Our first
collaborative effort was with Robert Lucito and Scott
Lowe, who had previously teamed up to look at sec-
ondary genetic alterations that occur in mouse liver
tumors initiated by overexpression of MYC in combi-
nation with suppression of p53. Rob and Scott had
found a recurrent amplicon in mouse tumors that
looked virtually identical to an amplicon we discov-
ered in human liver tumors. We are hopeful that this
result is an indication that other human genetic lesions
we discover can be functionally examined in the right
tissue type and in the appropriate environment, rather
than relying solely on human cancer cell line models
for functional analysis.
Our first initiative was to demonstrate the utility of
ROMA (representational oligonucleotide microarray
analysis) in breast cancer gene discovery. Using data
we generated ourselves, together with data from Mike
Wigler's laboratory here at CSHL, we tracked down a
novel recurrent amplicon at chromosomal region
17822. This amplicon is found in some breast tumors
that do not harbor ERBB2/HER2 amplification, but
more often, it is found in tumors harboring
ERBB2 /HER2 amplification. We are utilizing short
hairpin RNA (shRNA) from Greg Hannon's library
here at CSHL to examine the effects of shRNA-medi-
ated knockdown of overexpressed genes from the
amplicon in appropriate breast cancer cell lines, and
collaborating with Senthil Muthaswamy (also at
CSHL) to examine the effects of overexpressing this
candidate oncogene along with ERBB2 in the mouse
model his group has developed for breast cancer.
We also initiated ROMA analysis of gene-dosage
effects in colon cancer. Based on our initial look at 75
colon tumors and cell lines, the major application in
colon cancer gene discovery will be identification of
candidate tumor suppressors. We say this because
unlike breast cancers, which often have highly local-
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ized amplicons that can pinpoint candidate amplified
oncogenes, colon tumors often have many highly
localized deletions, many of which appear to be
homozygous. Curiously, we did not find localized
deletions that affected either APC or TP53, the two
most prevalently mutated cancer genes in colon can-
cer. Nor did we find any larger deletions affecting
these genes, which implies that the allelic loss which
accompanies point mutations in these two suppressor
genes occurs by a mechanism that does not affect
DNA copy number. However, we did find localized
deletions that affected DPC4 and MSH2 (Fig. 1), two
well-established tumor suppressor genes.
We are thus optimistic that we can identify novel
colon cancer tumor suppressors. As a cautionary note,
the cancer field is littered with candidate tumor sup-
pressor genes that are not commonly accepted as being
clinically or functionally relevant. A major challenge
this coming year will be to focus our research so that
we can identify truly relevant tumor suppressor genes.
One of the major hopes people have for the utility
of ROMA is that it will lead to the development of
DNA-based diagnostic tests that can provide early
detection or help guide specific treatment choices.
Currently, DNA-based diagnostic tests for early detec-
tion of colon cancer catch a little over 50% of what is
10
: -MSH2 deletion
Chromosome 2 Nucleotide Position
FIGURE 1 Chromosomal plot of DNA copy number along
chromosome 2 for a colon tumor sample. Note the sharp dele-
tion affecting only MSH2.
captured by the standard invasive test, which is not
enough to change clinical practice. The current DNA-
based test detects sequence variation in four well-
established colon cancer genes (including TP53,
KRAS, and APC) and could be greatly strengthened by
including detection of the most commonly homozy-
gously deleted regions discovered by ROMA.
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MAMMALIAN CELL GENETICS
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This year marks a major turning point in the develop-
ment of our laboratory. Traditionally, we have been a
cancer research laboratory. Even during the period
when the major problems we studied were embodied
in model organisms-the yeasts, Saccharomyces cere-
visiae and Schizosaccaromyces pombe-our effort
was to understand abnormal growth regulation as a
consequence of altered signal transduction. Although
cancer is still one of our major efforts, we have taken
on a new problem, the genetics of complex human dis-
eases. Representational oligonucleotide microarray
analysis (ROMA), the tool we developed for exploring
"copy-number differences" between normal and can-
cer genomes, can equally well be used to explore the
genetic differences among humans that may predis-
pose individuals to medical disorders.
ROMA reveals that there are large differences in
the number of genes in individual human genomes.
One distinction of the complex metazoans is the size
of gene families. Species evolve, at least in part, by
gene duplication followed by specialization. It should
not surprise us that we find this process alive and well
in humans (Sebat et al. 2004). What does surprise us,
given the intense scrutiny of the human genome by
other methods, is that its extent was not previously
appreciated. We expect to find differences in the num-
ber of copies of genes that account for disease suscep-
tibilities, and we are determining if these differences
contribute to autism.
BREAST CANCER AND LEUKEMIAS
We have now examined the abnormalities in a modest
series of primary breast cancers. The bulk of our study
comes from our collaborator Anders Zetterberg at the
Karolinska Institutet in Stockholm, Sweden, who has
framed the following question: Can we correlate the
prognosis of a cancer with its genomic profile? The
simple answer appears to be yes. There are more
genomic lesions in the patients that succumb to their
cancers than in those that survive, as well as specific
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loci that when unperturbed appear to correlate with
survival. We seek to extend and confirm these obser-
vations in a larger series of experiments.
The same set of experiments have confirmed imbal-
ances at well-known loci that contain oncogenes and
tumor suppressor genes, but they have also revealed
common imbalances at loci where there are not known
candidate tumor genes. We are in the process of prepar-
ing to determine by correlation analysis specific pat-
terns of imbalances that might suggest the pathways
that are disturbed in cancer development, and the order
in which these disturbances arise. Preliminary results
indicate that a few very common lesions characterize
the early stages of breast cancers.
In a collaboration with Nick Chiorazzi at North
Shore-L.I.J. Research Institute, we have taken similar
approaches to study chronic lymphocytic leukemia
(CLL). There are fewer lesions present in CLL than in
advanced stage breast cancer, but again, as in early
stage breast cancer, there are a few common lesions. We
wish to extend these studies to a larger series, to gain a
foothold in predicting the outcome of the disease.
LARGE-SCALE POLYMORPHISM IN HEALTHY
AND IMPAIRED HUMANS
As reported last year, we have applied our methods to
the comparison of genomes from apparently healthy
humans and humans with various disorders. There are
a large number of extensive regions of copy-number
variation between any two humans, approximately
equal amounts of deletions and duplications. We have
now examined on the order of several hundred indi-
viduals and find that we detect on the order of a dozen
differences of 100 kb and larger between any two peo-
ple. These regions contain one gene on average. We
estimate that we see about half the lesions of this size
or larger, and lesions that are smaller largely escape
our present methods. Although copy-number polymor-
phisms exist throughout the chromosomes, they are
conspicuously rare on the X chromosome and on the
gene-rich chromosome 19.
A statistically significant difference appears to exist
between autistic individuals and normal control popu-
lations: There is an increase both in the total amount of
genome lost in autistics and in the size of their largest
deletions. This is a property of the population as a
whole, not one of individuals per se. Nevertheless, we
do see genetic differences in autistics at specific loci,
and in particular at loci that have been previously linked
to mental disorders such as Tourrette's Syndrome and
obsessive-compulsive disorders.
Considerably more effort is required to validate
the significance of the differences we observe. We
will soon apply similar methods to schizophrenia,
congenital heart disease, and a variety of other human
impairments.
TECHNOLOGY DEVELOPMENT
As before, we strive to improve both the resolution of
our methods and their range of application. These
efforts are largely focused on two objectives: increas-
ing the density of probes that can be arrayed, and thus
the total number of loci that can be observed, and
diminishing the number of cells required for analysis.
The former goal will enable us to screen smaller
lesions that might upset gene function, and we are
pursuing technology development in combination
with NimbleGen Systems, the company that fabricates
our arrays. A number of computational-algorithmic
problems have needed to be solved, as well as the
development of new laboratory protocols. In terms of
"miniaturization," we have preliminary results indi-
cating clear success with as few as 100 cells, and
analysis of single cells is not beyond our reach. Such
methods would enable us to examine the role of
somatic rearrangement in aging, development, and in
the evolution of the malignant phenotype.
All of our methods must transpire in a milieu of
computationally based informatics processing, and so
an increasingly large percentage of our effort is
expended on creating mathematical tools for data
analysis, and creating environments in which the large
number of experiments and results of analysis can be
viewed. Foremost in these efforts has been the devel-
opment of reliable methods of "segmentation"
(Daruwala et al. 2004; Olshen et al. 2004; Sebat et al.
2004). In these matters, we have been aided by collab-
orators (see authors of publications). The results of
segmentation are validated by fluorescent in situ
hybridization in collaboration with Dr. Anders
Zetterberg's group at the Karolinska Institutet.
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CANCER: CELL BIOLOGY
The most basic requirement of living organisms is their ability to copy themselves by duplicating their
genetic material and then dividing it up into two new daughter cells through cell division. Each human cell
contains about six feet of DNA that must be precisely coiled and tightly condensed into chromosomes
before cell division can take place. Tatsuya Hirano studies how cells organize and manage chromosome
structure in preparation for cell division. His current studies are focusing on two protein complexes, called
condensin I and II, that have key roles in compacting DNA and ensuring that each daughter cell receives
one, and only one, copy of each chromosome. Hirano recently collaborated with CSH Fellow Terence
Strick to precisely measure the forces that act on DNA as it is compacted by condensin I. They discoverd
that condensin I actively compacts DNA through an energy-dependent process that reversibly introduces
loops along the DNA.
Bruce Stillman is focusing in part on how cells are able to efficiently copy or "replicate" their chromo-
somal DNA in preparation for cell division. To copy their DNA, cells rely on large complexes of proteins that
recognize specific regions within the genome as start sites or "origins" of DNA replication. Stillman stud-
ies a protein complex called the origin recognition complex (ORC) that attaches specifically to those sites
and then triggers DNA replication. Recent work in his lab has established that particular ORC proteins
have additional roles in coordinating chromosome duplication with cell division. In cancer cells, the mech-
anisms that regulate cell division are compromised. Therefore, Stillman's findings concerning how normal
cells coordinate chromosome duplication and cell division are revealing clues to how these processes go
awry in cancer.
Viruses are masters of cellular manipulation. By studying how the human papillomavirus co-opts the
DNA replication machinery of the cells it infects into making more virus, Arne Stenlund is uncovering
mechanisms that govern human DNA replication. He has revealed how the viral initiator protein El recog-
nizes and engages the origin of DNA replication and has demonstrated that the El protein binds tightly to
the origin through two different DNA-binding activities present in the same protein.
David Spector and his colleagues have developed the first system for viewing how "the Central Dogma"
of biology unfolds in its entirety-from DNA to RNA to protein-within living cells. The researchers creat-
ed a fluorescence microscopy imaging system in which the DNA near an inducible gene is labeled green,
the messenger RNA encoded by the gene is labeled yellow, and the protein encoded by the messenger
RNA is labeled blue. The system is then used to capture time-lapse images as the inducible gene is
switched on: First, the DNA architecture in the region of the gene becomes less compacted. Next, RNA
appears, is spliced in the nucleus, and subsequently exported to the cytoplasm. Finally, the protein
appears. Spector's group has used the system to detect specific events that transform the architecture of
chromosomes from a transcriptionally silent "off" state to an actively transcribed "on" state. This work has
revealed fundamental information about how genes are switched on and off in normal cells and is being
used to investigate how the production of RNA and proteins is altered in cancer or other diseases.
Understanding how cancer cells grow and spread requires studying their interactions with the cells that
surround them in three-dimensional space. To this end, Senthil Muthuswamy uses three-dimensional cell
cultures (in contrast to traditional two-dimensional cultures) that mimic the normal glandular structures of
human breast tissue. He then activates cancer-promoting genes and studies how this activation disrupts
normal breast tissue architecture and cell growth controls. When Muthuswamy's group activated the
ErbB2 oncogene, they noticed that cells lost the normal junctions between neighboring cells, began to
proliferate, and generated a disorganized mass of cells. Muthuswamy is exploring the role of these
changes in cell architecture in the early stages of invasive breast cancer.
Like Muthuswamy, David Helfman (now at the University of Miami) explores how cancer cells manage
to break free from their biological moorings and metastasize to other parts of the body. In collaboration
with Andrei Bakin (Roswell Park Cancer Institute), Helfman's group recently showed that hyperactivating
the Ras oncogene pathway disrupts the formation of cytoskeletal elements that normally prevent cells
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from spreading to other parts of the body. These findings could ultimately lead to the development of new
strategies for preventing the spread of cancer cells.
Many times, proteins that are first described as having a role in a particular process turn out to be
important for other, seemingly unrelated processes. Linda Van Aelst has previously revealed how pro-
teins-called Rho and Rac GTPases-function in cell proliferation, cell/cell adhesion, and tumor invasive-
ness. Recently, Van Aelst and her colleagues discovered a role for regulators of Rho and Rac GTPases in
brain development. They found that oligophrenin-1, an activator of Rho GTPase known to be involved in
X-linked mental retardation, is required for the proper shape and functioning of brain neurons. In related
work, Van Aelst has established that DOCK7, a newly discovered activator of Rac GTPases, is required
during early stages of brain development for the projections from neurons called axons to form properly.
Nicholas Tonks and his colleagues were the first to show that abnormalities in proteins called protein
tyrosine phosphatases (PTPs) can lead to cancer. Tonks has uncovered roles for PTPs in virtually every
aspect of the life of a cell from proliferation, to cell motility, to cell architecture. Recently, Tonks has been
studying a process whereby cell signaling results in the production of reactive oxygen species (ROS). The
production of reactive oxygen species typically leads to the inactivation of PTPs, thereby removing the
"brakes" that PTPs normally provide and allowing particular signaling pathways to proceed. Tonks is inves-
tigating these mechanisms and their therapeutic implications for cancer and other diseases.
Santhosh Vadivelu, postdoc, Bruce Stillman's lab.
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THE CYTOSKELETON IN CANCER
D.M. Helfman L. Connell
After almost 23 years at Cold Spring Harbor
Laboratory, I took a faculty position in July 2004, at
the Sylvester Comprehensive Cancer Center and
Department of Cell Biology and Anatomy in the
Miller School of Medicine at the University of Miami.
I first arrived at Cold Spring Harbor in the fall of 1981
as a postdoctoral fellow, and for more than two
decades, it has been an exciting and rewarding envi-
ronment in which to carry out research. It was a priv-
ilege to be part of such a unique place, and I wish only
the best in the future for the Laboratory and its mem-
bers. Although I cannot mention all of the people
whom I had the pleasure to interact with, I would like
to take this opportunity to thank my postdoctoral advi-
sors Jim Feramisco and Steve Hughes for giving me
the opportunity to work in their labs at a time when
molecular biology was not done using kits, Jim
Watson for his support during my early years as a staff
member, and Barbara McClintock and Yasha Gluzman
for their friendship and words of wisdom.
My lab is focused on understanding various
aspects of oncogene-mediated changes in actin fila-
ment dynamics of tumor cells. Alterations in the actin-
based cytoskeleton are an integral part of the neoplas-
tic phenotype. We are investigating the signaling path-
ways by which specific components of actin structures
are targeted and deregulated by oncogenes and, more
importantly, how the accompanying changes in actin
filament organization contribute mechanistically to
oncogenesis. Studies from our lab have demonstrated
that alterations in the actin cytoskeleton result from
activation and inactivation of specific signaling path-
ways that are part of the oncogenic program. These
studies are providing valuable new insights into the
regulation of the actin cytoskeleton by oncogenes and
how changes in the actin cytoskeleton contribute to
enhanced cell motility and invasiveness, as well as
aberrant signaling of cancer cells. Furthermore, spe-
cific components of the cytoskeleton might serve as a
target for the development of prognostic, diagnostic,
and therapeutic targets in cancer. Below is a brief
description of our studies.
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Role of TGF-{3 Signaling in
Oncogenesis and Tumor
Suppression via Regulation
of Actin Filament Dynamics
in Breast and Cervical Cancers
D.M. Helfman
The transforming growth factor-I3 (TGF-(3) signaling
pathway is a major cellular growth inhibitory and
proapoptotic pathway in normal epithelial, endothelial,
hematopoietic, and other cell types. However, clinical
and experimental studies indicate that metastatic can-
cers of the breast and other tissues express elevated lev-
els of TGF-I3 that appear to support the metastatic
behavior of tumor cells. This apparent paradox has been
associated with a progressive decline in the antitumori-
genic function and a gain of pro-tumorigenic activities
of TGF-I3, including induction of epithelial to mes-
enchymal transition (EMT), tumor cell migration and
invasion. The actin cytoskeleton has a central role in the
regulation of cellular processes linked to metastasis,
including cell proliferation, apoptosis, anchorage-inde-
pendent cell growth, cell migration, and invasion.
Prolonged exposure of normal epithelial cells with
TGF-I3 results in the formation of stress fibers and
focal adhesions, accompanied by inhibition of cell
motility and induction of apoptosis. Thus, the loss of
TGF-13-induced stress fibers is an essential characteris-
tic of a prometastatic conversion of TGF-13 function.
Establishing the cellular targets involved in TGF-I3 sig-
naling is critical to understanding cancer progression.
During the past year, in collaboration with Dr. Andrei
Bakin (Roswell Park Cancer Institute, Buffalo, New
York), we discovered a critical role for a family of actin-
filament-binding proteins-tropomyosins (TMs) -
required for TGF-I3 regulation of the actin cytoskeleton
in breast and cervical cancers. We demonstrated that
expression of TMs mediated by Smad and p38Mapk
signaling is required for TGF-13 regulation of stress
fibers and inhibition of cell motility. We showed that
the oncogenic Ras-ERK pathway antagonizes TGF-P
induction of stress fibers by suppressing expression of
TMs. These results suggest that loss of TGF-P-
induced stress fibers is an essential characteristic of a
pro-metastatic conversion of TGF-P function and that
the aberrant regulation of TMs is a critical feature in
breast cancer. We hypothesize that the loss of TGF-P
induction of stress fibers is an essential characteristic
of a pro-metastatic conversion of TGF-P function and
that restoration of this response represents a potential
target for the development of effective antimetastatic
therapies.
Distinct Roles of MLCK and ROCK
in the Regulation of Epithelial
Cell Survival
L. Connell
Recent studies have demonstrated the importance of
intact actin filaments for cell survival. Myosin II acti-
vation is essential for stress fiber and focal adhesion
formation and is implicated in integrin-mediated sig-
naling events. To determine the role of myosin II in
cell survival, we studied whether inhibition of myosin
light-chain kinase (MLCK) or Rho-kinase (ROCK)
leads to apoptosis in both normal and ras-transformed
MDCK and MCF-10A epithelial cells. Treatment of
cells with pharmacological inhibitors of MLCK (ML-
7 and ML-9), or expression of dominant-negative
MLCK, led to apoptosis in normal and transformed
cells. In contrast, treatment of cells with the ROCK
inhibitor (Y-27632) did not induce apoptosis in these
cells. Apoptosis following inhibition of myosin II acti-
vation through MLCK is likely meditated through the
death receptor pathway because expression of CrmA
or a dominant-negative FADD (Fas-associated death
domain) blocked apoptosis. In addition, apoptosis
observed after MLCK inhibition is inhibited by pre-
treatment of cells with integrin-activating antibodies,
suggesting the participation of an integrin-dependent
signaling pathway. These studies demonstrate a novel
role for MLCK in the generation of antiapoptotic sig-
nals in both untransformed and transformed epithelial
cells and support previous work suggesting distinct
cellular roles for ROCK- and MLCK-dependent regu-
lation of actomyosin contractility.
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HIGHER-ORDER CHROMOSOME DYNAMICS
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The long-term goal of our research program is to
understand the molecular mechanisms of mitotic chro-
mosome segregation in eukaryotic cells. Our current
efforts are focused on studying two multiprotein com-
plexes, cohesin and condensin, that have central roles
in sister chromatid cohesion and condensation, respec-
tively. At the heart of the two complexes lie members
of a large family of chromosomal ATPases, the struc-
tural maintenance of chromosomes (SMC) family.
SMC proteins are also conserved in bacterial and
archaeal species, implicating the existence of an evo-
lutionarily conserved theme of higher-order chromo-
some organization and dynamics. To gain insight into
how SMC proteins work both in vitro and in vivo, we
take multidisciplinary approaches including biochem-
istry, cell biology, genetics, and biophysics.
Spatial and Temporal Regulation
of Condensins I and II
T. Ono, T. Hirano In collaboration with Y. Fang and
D. Spector, Cold Spring Harbor Laboratory]
Our previous studies showed that vertebrate cells have
two different condensin complexes (condensins I and
II) that make distinct contributions to metaphase chro-
mosome architecture. During the past year, we have
shown that the spatial and temporal distribution of
condensins I and II are differentially regulated during
the cell cycle in HeLa cells. Condensin II is predomi-
nantly nuclear during interphase and contributes to
early stages of chromosome assembly in prophase. In
contrast, condensin I is sequestered in the cytoplasm
from interphase through prophase and gains access to
chromosomes only after the nuclear envelope breaks
down in prometaphase. The two complexes alternate
along the axis of metaphase chromatids, but they are
arranged into a unique geometry at the centromere/
kinetochore region, with condensin II enriched near
the inner kinetochore plate. This region-specific dis-
tribution of condensins I and II is severely disrupted
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upon depletion of aurora B, although their association
with the chromosome arm is not. Depletion of con-
densin subunits causes defects in kinetochore struc-
ture and function, leading to aberrant chromosome
alignment and segregation. Our results suggest that
the two condensin complexes act sequentially to initi-
ate the assembly of mitotic chromosomes and that
their specialized distribution at the centromere/kineto-
chore region may have a crucial role in placing sister
kinetochores into the back-to-back orientation.
Real-time Detection of
Single-DNA-Molecule
Compaction by Condensin I
T. Hirano [in collaboration with T. Kawaguchi and
Harbor Laboratory]
To understand how condensin I works at a mechanis-
tic level, we have performed single-molecule DNA
nanomanipulation experiments. In these experiments,
a linear DNA molecule is tethered at one end to a glass
surface and at the other end to a small magnetic bead.
Permanent magnets are used to pull on and rotate the
bead, allowing us to quantitatively control the mechan-
ical constraints applied to the DNA. The three-dimen-
sional position of the magnetic bead is determined
using video microscopy and real-time particle tracking
algorithms, allowing us to determine the end-to-end
extension of the DNA. By using this sophisticated
device, we demonstrated for the first time that con-
densin I, purified from Xenopus egg extracts, physi-
cally compacts DNA in an ATP-hydrolysis-dependent
manner. A mitotically activated form of condensin, but
not its interphase form, supports this compaction reac-
tion. Discrete and reversible DNA compaction events
are observed in the presence of competitor DNA when
the DNA is subjected to weak stretching forces (F =
0.4 pN). The distribution of step sizes is broad and dis-
plays a peak at approximately 60 nm (-180 bp) as well
as a long tail. Increasing the force to F = 10 pN drives
the system toward step-wise reversal of compaction.
The distribution of step sizes observed upon disrup-
tion of condensin-DNA interactions displays a sharp
peak at about 30 nm (-90 bp) as well as a long tail
stretching out to hundreds of nanometers. Our results
suggest that the condensin complex may induce DNA
compaction by dynamically and reversibly introduc-
ing and stabilizing loops along the DNA.
Biochemical and Structural
Dissection of Condensins I and II
I. Onn, M. Hirano, T. Hirano
Previous studies from our laboratory demonstrated
that condensin I, purified from either Xenopus egg
extracts or human tissue culture cells, is able to intro-
duce positive superhelical tension into DNA in an
ATP-dependent manner. However, functional contri-
bution of each subunit to this activity remains to be
determined. Moreover, it is unknown whether the
newly discovered condensin II may have an activity
similar to that of condensin I. To address these ques-
tions, we are taking two complementary approaches.
First, we purify condensins I and II separately from
He La cells and compare and contrast biochemical
activities associated with these native complexes.
Effects of Cdkl -dependent phosphorylation on these
activities are also investigated. Second, we reconsti-
tute condensins I and II from their recombinant sub-
units by using the baculovirus expression system. We
have successfully constructed a panel of recombinant
viruses that express individual subunits of the human
complexes. Pairwise coexpression experiments, fol-
lowed by specific immunoprecipitation, are in
progress to make a comprehensive map of subunit-
subunit interactions. Protocols are also being estab-
lished for expressing and purifying holo- and sub-
complexes of condensins I and II.
Mitotic and Nonmitotic Functions
of Condensins in Xenopus
Egg Extracts
N. Aono, T. Hirano
Accumulating lines of evidence from a number of
model organisms suggest that the fundamental roles
of condensins in chromosome organization and
dynamics are far beyond the condensation of chromo-
somes during mitosis. We have started to explore non-
mitotic functions of condensins by using Xenopus egg
cell-free extracts. An initial effort is focused on asking
whether condensins may be involved in the DNA
replication and damage checkpoint pathways, as has
been implicated from a genetic study in fission yeast.
We are now testing how checkpoint kinases behave in
response to double-strand DNA breaks, in the extracts
that have been mock depleted or depleted of con-
densins. We are also interested in understanding how
the two different condensin complexes, condensins I
and II, are differentially regulated throughout the cell
cycle. Potential roles of Cdk and non-Cdk mitotic
kinases are being tested in the cell-free extracts.
Functional Contribution of Pds5
Proteins to Cohesin-mediated
Cohesion
A. Losada, T. Hirano
The cohesin complex has a central role in sister chro-
matid cohesion during mitosis and meiosis. Previous
genetic studies in fungi identified Pds5/BimD/Spo76
as an additional factor implicated in cohesion. During
the past year, we have performed the biochemical and
functional characterization of two Pds5-like proteins,
Pds5A and Pds5B, from vertebrate cells. In HeLa
cells, Pds5 proteins physically interact with cohesin
and associate with chromatin in a cohesin-dependent
manner. Depletion of the cohesin subunit Scc I by
RNA interference (RNAi) leads to the assembly of
chromosomes with severe cohesion defects. A similar
yet milder set of defects is observed in cells with
reduced levels of Pds5A or Pds5B. In Xenopus egg
extracts, mitotic chromosomes assembled in the
absence of Pds5A and Pds5B display no discernible
defects in arm cohesion, but centromeric cohesion is
apparently loosened. Unexpectedly, these chromo-
somes retain an unusually high level of cohesin. Thus,
Pds5 proteins seem to affect the stable maintenance of
cohesin-mediated cohesion and its efficient dissolu-
tion during mitosis. We propose that Pds5 proteins
have both positive and negative roles in sister chro-
matid cohesion, possibly by directly modulating the
dynamic interaction of cohesin with chromatin.
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Scc2 Couples Replication Licensing Regulation of Centromeric
to Sister Chromatid Cohesion Cohesion
P. Gillespie, T. Hirano
Previous genetic studies in yeast showed that Scc2, a
HEAT-repeat containing protein, is required for the
loading of cohesin onto chromatin. We have identified
two isoforms of Scc2 in humans and Xenopus (termed
Scc2A and Scc2B), which are encoded by a single
gene but have different carboxyl termini created by
alternative splicing. Both Scc2A and Scc2B bind to
chromatin concomitant with cohesin during DNA
replication in Xenopus egg extracts. Simultaneous
immunodepletion of Scc2A and Scc2B from the
extracts impairs the association of cohesin with chro-
matin, leading to severe defects in sister chromatid
pairing in the subsequent mitosis. The loading of Scc2
onto chromatin is inhibited in extracts treated with
geminin, but not with p21c1n, suggesting that this step
depends on replication licensing but not on the initia-
tion of DNA replication. Upon mitotic entry, Scc2 is
removed from chromatin through a mechanism that
requires cdc2 but not aurora B or polo-like kinase. Our
results suggest that vertebrate Scc2 couples replica-
tion licensing to sister chromatid cohesion by facilitat-
ing the loading of cohesin onto chromatin.
Reconstitution of a Recombinant
Cohesin Complex
P. Gillespie, T. Hirano
Despite recent progress in our understanding of the
diverse cellular functions of cohesin, it remains elu-
sive how this complex might work at a mechanistic
level. To study the action of cohesin in great detail, we
have reconstituted a four-subunit cohesin complex
from its recombinant subunits by using the bac-
ulovirus protein expression system. We have also
introduced a set of mutations into the SMC core sub-
units that would block the SMC ATPase cycle at three
different stages. Ongoing functional assays using the
wild-type and mutant complexes should address how
the mechanical cycle of cohesin is coupled to its cat-
alytic cycle. Critical comparison between the actions
of cohesin and condensin will also be of great impor-
tance to obtain a comprehensive molecular picture of
chromosome mechanics in eukaryotes.
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R. Gandhi, T. Hirano
In vertebrate cells, most (if not all) of cohesin disso-
ciates from chromosome arms during mitotic
prophase, whereas a subpopulation of cohesin
remains at centromeres until the metaphase-anaphase
transition. We are interested in understanding how
centromeric cohesion and arm cohesion are differen-
tially regulated during the cell cycle. It is most likely
that a large number of factors are involved in this reg-
ulation. Such factors may include direct modulators
of cohesin (Scc2 and Pds5), inner centromeric pro-
teins (e.g., Sgo/Mei-5332 and aurora B) and hete-
rochromatin components (e.g., HP1). By combining
cell biological and pseudogenetic (RNAi) approaches,
we are trying to dissect this regulatory network in
human tissue culture cells. This project will con-
tribute to our understanding of the molecular mecha-
nism that ensures the high-fidelity transmission of
chromosomes during mitosis.
Mechanistic Analysis
of a Bacterial SMC
Protein Complex
M. Hirano, T. Hirano
SMC proteins are conserved not only in eukaryotes,
but also in most (if not all) bacterial and archaeal
species. We have been using the Bacillus subtilis SMC
protein as a model system for studying the basic
mechanism of action of SMC proteins. An emerging
theme is that the action of SMC proteins is highly
dynamic and plastic, possibly involving a diverse array
of intramolecular and intermolecular protein-protein
interactions. During the past year, we have construct-
ed and characterized a large number of mutant pro-
teins that allow us to dissect the complex behaviors of
SMC proteins in vitro. In particular, we have success-
fully identified key amino acid residues that are essen-
tial for SMC's DNA binding. The information from
this project will be useful for studying the actions of
condensin and cohesin, because most of the key
residues identified in the bacterial SMC protein are
invariable among eukaryotic SMC proteins.
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EPITHELIAL CELL BIOLOGY AND CANCER
S. Muthuswamy V. Aranda A. Rosenberg
T. Haire I. Sujka
A. Lucs B. Xiang
M. Moore L. Zhang
EARLY EVENTS IN BREAST CANCER
Disruption of epithelial cell architecture and loss of
proliferation control are thought to be early events in
cancer. Changes in tissue architecture and prolifera-
tion rates are the primary tools used by pathologists to
categorize early lesions. Although we understand a
great deal about the mechanisms that control prolifer-
ation, our understanding of the mechanisms that con-
trol epithelial cell architecture is limited.
In epithelial cells lining glandular structures (e.g.,
breast, prostate, pancreas, thyroid, endometrium, and
cervix), proteins and cell-cell junction complexes are
distributed asymmetrically in the apical-basal axis, a
property referred to as epithelial cell polarity. Various
aspects of epithelial polarity are lost early in carcino-
genesis. Moreover, highly metastatic carcinomas dis-
play a complete loss of apical-basal polarity. Identifi-
cation of the mechanisms that govern loss of epithelial
architecture may provide us with important insights
into initiation and progression of carcinoma and may
lead to identification of novel targets for diagnosis and
treatment of early-stage cancers.
Normal breast epithelial cells, present in glandular
structures in vivo, have low proliferation rates, where-
as epithelial cells present in hyperplastic lesions or
carcinoma have higher proliferation rates, suggesting
that proliferation control is lost early in carcinoma.
Mammary epithelial cells (MECs) grown in three-
dimensional (3D) matrices form structures that share
properties with resting acini in vivo such as low pro-
liferation rates and empty central lumen space. In con-
trast, breast-tumor-derived cells neither form acini-
like structures nor undergo proliferation arrest when
placed under 3D culture conditions, suggesting that
the mechanisms that regulate 3D morphogenesis are
lost during transformation.
The ErbB family of oncogenic receptor tyrosine
kinases contains four members; namely, ErbB I (epi-
dermal growth factor receptor/human epidermal
growth factor receptor [HER]), ErbB2 (HER-2/Neu),
ErbB3, and ErbB4. ErbB2 overexpression and/or
amplification has been implicated in a number of
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epithelial cancers, including those of the breast, ovary,
and prostate. Amplification of ErbB2 is observed in
20-30% of breast cancers and is correlated with poor
clinical prognosis in node-positive patients.
Herceptin, an antibody targeted against ErbB2, is
used as a therapeutic agent in adjuvant settings for
patients who have breast cancers that express high lev-
els of ErbB2. Despite the compelling evidence for the
role of the ErbB family in breast cancer, it has been
challenging to decipher the signaling and biological
specificities of ErbB receptor activation because lig-
and binding induces both homo- and heterodimeriza-
tion among the ErbB receptors, thus resulting in com-
binatorial interactions and complicating our ability to
determine how different ErbB dimers transform mam-
mary epithelia. To investigate how specific ErbB dim-
mers regulate transformation of epithelial cells, we
have developed a method to control dimerization and
activation of ErbB receptors without contribution
from endogenous receptors.
In addition, we have adapted cell culture approach-
es either to generate 3D acini-like epithelial structures
or to generate suspended layers of epithelia. Both cul-
ture methods are characterized by the presence of a
single layer of polarized, proliferation-arrested epithe-
lial cells akin to those observed in resting ducts in
vivo. Using a combination of controlled dimerization
and modified cell culture systems, we investigate how
activation of oncogenes, such as ErbB2, deregulates
proliferation control and epithelial architecture.
How Is Epithelial Cell Polarity
Lost during Transformation?
T. Haire, V. Aranda
In normal polarized epithelia, the boundary between
the apical and basolateral membranes is defined by the
presence of at least three classes of transmembrane
proteins, namely, Occludins, Claudins, and Junctional
adhesion molecules (JAM), collectively referred to as
the apical junction complex (AJC). The mechanism by
which AJCs are positioned during polarization of
epithelial cells involves a molecular complex contain-
ing the mammalian homolog of Caenorhabditis ele-
gans, partitioning-defective 3 (mPar3)/mPar6/atypical
protein kinase C/CDC42 or Rac (referred to as the Par
complex). Consistent with this view, overexpression
of mPar6, an inactive form of aPKC, active versions
of CDC42 or Rac, cause either a delay or disrupt for-
mation of AJC. Although the Par protein complex is
critical for establishment of cell polarity, it is not
known whether it is affected by oncogenic changes
that disrupt polarity during cancer progression.
We have defined the steps for oncogene-induced
disruption of polarity and, in doing so, discovered that
mislocalization of an AJC-associated protein, ZO-1,
begins at junctions that involve three cells (tricellular
junctions) and not bicellular junctions. We have also
shown that almost 60% of primary human breast can-
cers overexpressing ErbB2 have aberrant localization
of ZO-1 at tricellular corners, suggesting that we have
uncovered a novel target for oncogene action both in
vitro and in vivo. We are now investigating the mech-
anisms by which oncogenes such as ErbB2 disrupt
epithelial cell polarity.
Regulators of Epithelial Cell
Polarity and Oncogenesis
M. Moore, A. Rosenberg
Studies in Drosophila melanogaster, C. elegans, and
mammals have identified three protein complexes that
are important for establishment of epithelial cell
polarity, namely, the Par protein complex (Par3/Par6/
aPKC/CDC42), which regulates formation of apical
junctions; the Crumbs complex (Crumbs/Pals/PATJ),
which regulates apical polarity; and the Scribble com-
plex (Scribble, Discs large [Dig] and Lethal [2] giant
larvae [Lg1]), which regulates basolateral polarity.
Loss-of-function mutation analyses in Drosophila
suggest that epithelial architecture can induce uncon-
trolled proliferation of epithelial cells. For instance,
mutation of genes that control epithelial cell polarity
such as lgl, dlg, and scrib not only result in loss of
epithelial cell polarity, but also induce dramatic over-
growth of epithelial cells of imaginal disc and follicu-
lar epithelium. In addition, a loss-of-function muta-
tion in the Drosphila Fat gene (fly homolog of human
E-cadherin) results in neoplastic growth. These obser-
vations argue that proper epithelial architecture serves
as a proliferation control signal in vivo and that loss of
such a signal results in uncontrolled proliferation.
We are analyzing the role regulators of polarity
have in human breast cancer by investigating whether
polarity genes are amplified or deleted in breast can-
cers and whether they effect transformation of mam-
mary epithelial cells in cell culture and mouse models.
How Does ErbB2 Induce Disruption
of Epithelial Cell Polarity?
A. Lucs
Activation of ErbB2 induces disruption of apical-basal
polarity of epithelial monolayers. Dimerization of
ErbB2 results in phosphorylation of five tyrosine
residues in its cytoplasmic tail. These phosphotyrosine
residues are the primary mediators of ErbB2's trans-
forming ability and have been previously shown to dif-
ferentially regulate transformation of cells in culture
and induce tumors in mice. To understand how ErbB2
disrupts epithelial cell polarity, the five autophospho-
rylation tyrosine residues were mutated to phenylala-
nine residues and are being analyzed for their ability
to disrupt polarity.
How Does ErbB2 Reinitiate Proliferation
in Growth-arrested 3D Acini?
B. Xiang
Amplification/overexpression of ErbB2 occurs in
almost 50% of ductal carcinoma in situ (DCIS) of the
breast. We identified MCF-10A as a human breast
epithelial cell line that harbors genomic changes
observed in early lesions and hence serve as a good
model for ErbB2 overexpression. Using MCF-10A
cells overexpressing ErbB2, we investigated the mech-
anism by which activation of ErbB2 induces cell cycle
progression. We demonstrated that MCF-10A cells
undergo a G1 -phase cell cycle arrest during 3D mor-
phogenesis and activation of ErbB2-induced prolifera-
tion by increasing cyclin E/Cdk2 activity, but not
cyclin Dl/Cdk4 activity. ErbB2 increased Cdk2 activ-
ity by coordinately up-regulating cyclin E and down-
regulating the cell cycle inhibitor p27''P'. RNA-inter-
ference-mediated knockdown of cyclin E and Cdk2,
but not cyclin DI and Cdk4, inhibited the ability of
ErbB2 to disrupt 3D acini structures. Activation of
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ErbB2 also regulated cyclin E expression in two
genetically diverse cell lines (S1 and SkBr3) grown
under 3D culture conditions. In addition, overexpres-
sion of ErbB2 correlated with high levels of cyclin E,
and not cyclin DI, in a panel of breast-cancer-derived
cell lines. Thus, using a breast epithelial cell culture
model for DCIS, we demonstrate that cyclin E is a tar-
get for ErbB2-induced proliferation in premalignant
breast cancer.
Do ErbB Homodimers and Heterodimers
Differentially Regulate Epithelial
Cell Proliferation and Polarity?
L. Zhang, B. :Kong
Several ErbB ligands, such as EGF, TGF-a,
Amphiregulin, NRG1, Cripto, and receptors ErbB I,
ErbB2, and ErbB3, have been shown to be overex-
pressed in number of carcinomas, including those of
the breast and prostate. Expression of high levels of
ErbB2 is thought to favor homodimeric interactions
among ErbB2 receptors. However, ErbB2/ErbB3 het-
erodimers have been shown to be more aggressive in
their transforming ability, and more recent observa-
tions suggest that ErbB2 and ErbB3 are co-overex-
pressed in breast cancer, suggesting a strong role for
the ErbB2/ErbB3 heterodimer.
It is not known whether ErbB dimers differ in their
ability to transform polarized, proliferation-arrested
epithelial cells. We have modified our dimerization
strategy such that we can induce formation of het-
erodimers between two members of the ErbB receptor
family using small-molecule ligands. We have gener-
ated cell lines in which we can induce either homod-
imers or heterodimers within a single cell by chosing
different types of dimerizing ligands. We plan to
investigate whether receptor dimers differentially reg-
ulate epithelial cell polarity and proliferation.
Rapid Mouse Models to Study
Oncogene-Tumor Suppressor Gene
Interactions in the Mammary Gland
B. Xiang, L. Zhang, A. Rosenberg, I. Sujka
Mouse models serve as valuable tools to study tumor
initiation, progression, and treatment. Transgenic
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mouse models of breast cancer have provided signif-
icant insight into our understanding of oncogenic
potential, tumor latency, and the relationship
between genes and tumor histology. Conventional
transgenic and knockout mice do not lend themselves
to large-scale analyses of gene interactions due the
time and money required for generating multiple
genetic combinations. In the era of RNA interference
(RNAi), we are in a position to down-regulate
expression of genes without having to generate
mouse strains by the long process of homologous
recombination. In addition, RNAi allows us to down-
regulate large numbers of genes, and more impor-
tantly, it empowers us with the ability to generate
hypomorphic alleles akin to the gene products with
reduced activity observed in human tumors.
Although generating transgenic mammary glands, in
an otherwise wild-type animal, by transplanting cells
engineered in culture into developing mammary
glands has been attempted in the past, the use of this
technology to study gene interactions has not gained
general acceptance in part due to the technical chal-
lenges associated with delivering transgenes into pri-
mary epithelial cells in culture.
We have optimized the culture conditions to effi-
ciently transduce retrovirus-expressing transgenes and
in addition, use short hairpin RNA (shRNA)-express-
ing vectors to down-regulate expression of genes.
Transplantation of engineered cells resulted in mam-
mary structures that express the transgene (GFP) and,
more importantly, combined overexpression of onco-
genic Ras and down-regulation of the tumor suppres-
sor p53 resulted in formation of tumors within 12
weeks, demonstrating that we can rapidly generate
transgenic mammary glands and analyze gene interac-
tions during mammary tumorigenesis.
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CELL BIOLOGY OF THE NUCLEUS
D.L. Spector P. Bubulya
M. Camiolo
Y.-C. Chen
L. Denis
Y. Fang S.M. Janicki
S. Hearn I. Kumaran
M. Hubner K.V. Prasanth
Most cellular processes can trace their beginnings to
the nucleus where a gene is activated, resulting in the
production of an RNA molecule that must get
processed and transported to the cytoplasm. Although
much biochemical information is available regarding
many of the factors involved in gene expression, the
spatial and temporal aspects of gene expression and
the dynamics of the nuclear domains that the gene
expression machinery occupies are less well under-
stood. During the past year, we have focused a signif-
icant amount of our efforts on two main areas: (1)
characterizing the establishment of the gene expres-
sion machinery in daughter nuclei after mitosis and (2)
examining a new paradigm for the regulation of gene
expression through a nuclear retained RNA.
ESTABLISHMENT OF THE GENE EXPRESSION
MACHINERY IN DAUGHTER NUCLEI AFTER MITOSIS
Upon completion of mitosis, daughter nuclei assemble
all of the nuclear organelles necessary for the imple-
mentation of nuclear functions. We have been interest-
ed in how the nuclear speckle pattern (interchromatin
granule clusters, IGCs) is established in daughter
nuclei because these nuclear domains contain a signif-
icant fraction of the machinery essential for gene
expression (Saitoh et al. 2004).
During the past year, we found that upon entry into
daughter nuclei, members of two different classes of
a
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pre-mRNA splicing factors, small nuclear ribonucleo-
protein particles (snRNPs) and serine-arginine (SR)
proteins, do not immediately colocalize in nuclear
speckles (Bubulya et al. 2004). SR proteins accumu-
lated in patches around active nucleolar organizing
regions that we refer to as NOR-associated patches
(NAPs), whereas snRNPs were enriched at other
nuclear regions. NAPs formed transiently, persisting
for 15-20 minutes (Fig. 1) before dissipating as
nuclear speckles began to form in G1. In the absence
of RNA polymerase II transcription, NAPs increased
in size and persisted for at least 2 hours, with delayed
localization of SR proteins to nuclear speckles. In
addition, SR proteins in NAPs are hypophosphorylat-
ed, and the SR protein kinase Clk/STY colocalizes
with SR proteins in NAPs, suggesting that phosphory-
lation releases SR proteins from NAPs and their initial
targets are transcription sites.
In mammalian cells, it is not clear how pre-mRNA
processing factors are activated to a splicing-compe-
tent state in newly forming nuclei that have not yet
assembled nuclear speckles. Our current observations
suggest that regions surrounding NORs are important
sites for initially segregating SR proteins away from
other splicing factors, to modify them or to allow them
to interact before association with pre-mRNA tran-
scripts or nuclear speckles. This raises questions for
future study regarding how SR proteins and snRNPs
follow two separate pathways to eventually become
targeted to the same speckle regions within daughter
FIGURE 1 YFP-SF2/ASF localization was followed by confocal microscopy during telophase in living HeLa cells(a-d),
where it transiently accumulates in bright NAPs (a-c, arrows) that persist for approximately 15-20 min, then disappear (c)
as YFP-SF2/ASF localizes to nuclear speckles (c-d, arrowheads). (From Bubulya at al. 2004.) Bar, 5 gm.
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nuclei. It will be important to determine if SR proteins
and snRNPs first meet at transcription sites before
recycling of complexes through nuclear speckles. It
also raises questions about how different nuclear com-
partments assemble/disassemble and communicate
with one another as nuclear domains are established
after mitosis.
The results of this study are key to building a time
line of nuclear compartment assembly following mito-
sis. They also bring to light the fact that, in general,
constituents of nuclear bodies, including pre-rRNA
processing factors, components of Cajal bodies and
PML bodies, and pre-mRNA processing factors, do
not immediately localize to and/or assemble their res-
ident bodies in daughter nuclei. Instead, there is a lag
phase following mitosis as nuclear proteins first enter
daughter nuclei and accumulate temporarily with pro-
teins of similar function(s) before nuclear bodies (i.e.,
nuclear speckles and Cajal bodies) are established in
G1. These transient associations of subsets of proteins
may be necessary for modification/maturation, or par-
tial assembly of multimolecular subcomplexes before
localization to nuclear bodies in G1. The subsequent
organization of nuclear compartments such as nuclear
speckles would then provide further modification/
maturation and recycling/maintenance of protein
complexes during interphase.
A NUCLEAR RETAINED RNA REGULATES THE LEVEL
OF ITS PROTEIN-CODING PARTNER
In addition to harboring the cells' genome, the nucle-
us contains distinct substructures in the form of spe-
cialized domains/compartments that are characterized
by the absence of delineating membranes, but contain
defining sets of proteins (for review, see Spector,
Annu. Rev. Cell Biol. 9: 265 [1993] and I Cell Sci.
114: 2891 [2001]; Prasanth and Spector, in press). A
dynamic interplay between these domains and/or their
constituents and the genome is thought to foster the
efficient progression of gene expression. The central
dogma of molecular biology holds that genetic infor-
mation normally flows from DNA to RNA to protein.
As a consequence, it has been assumed that genes
generally encode proteins and that proteins fulfill not
only structural and catalytic functions, but also most
regulatory functions in cells. However, early studies
demonstrated that RNA can execute functions without
being translated into protein. Such RNAs include
housekeeping RNAs (ribosomal RNA, transfer RNA,
and uridine-rich small nuclear RNAs and small nucle-
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olar RNAs [snRNAs and snoRNAs, respectively]),
regulatory RNAs (small interfering RNAs that partic-
ipate in the RNAi pathway, microRNAs that function
primarily as modulators of mRNA translation and sta-
bility, naturally occurring antisense transcripts and X-
inactive-specific transcript [XIST] associated with the
inactive X chromosome in female mammals), and cat-
alytic RNAs (telomerase RNA and ribozymes).
Earlier studies from our laboratory have identified
a nuclear population of poly(A)+ RNA that is not
chased into the cytoplasm upon termination of tran-
scription. We have been interested in identifying and
characterizing the RNA species in this nuclear popu-
lation of RNA. Because these RNAs, for the most part,
are not diffusely distributed throughout the nucleo-
plasm, we were also interested in identifying the
nuclear domains to which they are localized.
We biochemically purified interchromatin granule
clusters and associated nuclear domains from mouse
liver nuclei, and constructed a cDNA library from
poly(A)+ RNA. Clones were sequenced and those that
did not show significant similarity to annotated pro-
tein-coding genes were further characterized by RNA
fluorescence in situ hybridization (RNA-FISH) in var-
ious mouse cell lines. Our screen was to identify RNAs
that presented interesting localization patterns that
were different from what would be expected for pro-
tein-coding transcripts. One of the identified cDNA
clones localized in a micropunctate nuclear distribu-
tion, and in a population of cells, it also localized to a
subnuclear domain referred to as paraspeckles.
Northern blot and genomic analysis revealed that this
clone encodes a -9-kb nuclear-retained poly(A)+ RNA,
transcribed from the mouse cationic amino acid trans-
porter 2 (mCAT2) gene, hence named CAT2 tran-
scribed nuclear-RNA (CTN-RNA). The mCAT2 gene
also encodes the protein coding mCAT2 mRNA. Both
of these transcripts share all protein-coding exons
(exons 2-11) and all introns are properly spliced.
However, CTN-RNA is transcribed from promoter A
and utilizes the distal most poly(A) site, whereas
mCAT2 mRNA is transcribed predominantly from pro-
moters D and E, and utilizes the proximal poly(A) site.
CTN-RNA shows tissue-specific expression; elevated
levels are observed in liver, brain, and lung.
Interestingly, CTN-RNA exhibits adenosine-to-inosine
editing (A to I) in its 3' UTR (untranslated region),
which is likely involved in its nuclear retention.
Knockdown of CTN-RNA using antisense oligonu-
cleotides designed from the 5' UTR or 3' UTR of
CTN-RNA, which do not overlap with mCAT2 mRNA,
also resulted in the knockdown of mCAT2 transcripts,
suggesting that the nuclear-retained CTN-RNA posi-
tively regulates the levels of the protein-coding mCAT2
mRNA. This regulation may occur through the seques-
tration of destabilizing factors by CTN-RNA. Since
mCAT2 mRNA and CTN-RNA share all protein-cod-
ing exons, they could compete for binding of such fac-
tors. Therefore, the knock down of CTN-RNA may
allow access of these factors to the mCAT2 transcripts,
resulting in their degradation. These data suggest an
interesting paradigm whereby a nuclear-retained RNA
regulates the level of a protein-coding mRNA.
The cellular function of the mCAT2 protein pro-
vides some insight into why its mRNA may be highly
regulated. The mCAT2 protein is a cell surface recep-
tor that is a member of the cationic amino acid trans-
porter family of proteins involved in the uptake of
extracellular L-arginine, which is essential for sus-
tained NO (nitric oxide) production via nitric oxide
synthase 2 (NOS2 or iNOS). However, overproduction
of NO has been shown to have a pivotal role in inflam-
matory responses. Persistent activation of iNOS can
lead to the production of toxic levels of NO, resulting
in several diseases including multiple sclerosis, HIV-
induced dementia, Huntington's disease, Parkinson's
disease, stroke, and amyotrophic lateral sclerosis. This
highlights the importance of the cellular uptake of L-
arginine as a method of regulating inducible NO
biosynthesis. Furthermore, a lack of L-arginine in cells
causes the production of superoxide via the iNOS
pathway resulting in cell death. Because the NO path-
way is induced in cells under various stress conditions
including viral infection and wound healing as a part
of a cellular defense mechanism, it may have evolved
a "rapid response" mechanism for regulating the level
of mCAT2 mRNA in cells.
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MOLECULAR BIOLOGY OF PAPILLOMAVIRUSES
A. Stenlund A. Lee
S. Schuck
The papillomaviruses are a group of viruses that infect
and transform the basal epithelium inducing prolifera-
tion of the cells at the site of infection. The resulting
tumors (warts) are in most cases benign and will usu-
ally regress after some time, but certain types of
human papillomaviruses (HPVs) give rise to tumors
that are prone to progress toward malignancy, espe-
cially frequently cervical carcinoma. Indeed, HPV
infection appears to be a necessary cause of invasive
cervical carcinoma and thus represents one of the few
firmly established links between viral infections and
the development of cancer.
An impediment to the study of papillomaviruses
has been the inability to define simple in vitro cell cul-
ture systems for analysis of the viral life cycle. These
viruses normally require specialized differentiating
cells that only with difficulty can be generated in cell
culture. However, for bovine papillomavirus type 1
(BPV-1), a convenient cell culture system exists where
viral gene expression, oncogenic transformation, and
viral DNA replication can be studied. Thus, BPV has
become a useful model for these aspects of the viral
life cycle. The DNA replication properties of the
papillomaviruses show some unique and interesting
characteristics. As part of their normal lifecycle, these
viruses can exist in a state of latency, which is charac-
terized by maintenance of the viral DNA as a multi-
copy plasmid in infected cells. The copy number of the
viral DNA is tightly controlled and the viral DNA is
stably inherited. Papillomaviruses therefore provide a
unique opportunity to study plasmid replication in
mammalian cells. In addition, the viral DNA replica-
tion machinery represents one of the most promising
targets for antiviral therapy.
In previous years, we have reported the character-
ization of the papillomavirus replicon and the identifi-
cation of the viral components that are required for
viral DNA replication. In recent years, we have direct-
ed our attention toward the biochemical events that are
associated with initiation of DNA replication. We are
studying the biochemical properties of the viral El
and E2 proteins and how these two proteins interact
with the viral origin of DNA replication and with the
cellular replication machinery to generate initiation
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complexes. Our studies demonstrate that the El pro-
tein has all the characteristics of an initiator protein,
including on recognition, DNA-dependent ATPase
activity, and DNA helicase activity. The transcription
factor E2, whose precise function in DNA replication
has remained more elusive, appears to serve largely as
a loading factor for El. Through direct physical inter-
actions with both El and the ori, E2 provides sequence
specificity for the formation of the initiation complex.
ASSEMBLY OF A DOUBLE HEXAMERIC HELICASE
Initiation of DNA replication requires binding of the
initiator to the ori, initial opening of the DNA duplex
(melting), as well as the assembly and loading of the
El replicative helicase at the replication fork. For
many years, it has been possible to reproduce the sum
of these activities in vitro in assays such as the form-
U assay, and notably in cell-free DNA replication sys-
tems. Since the El protein clearly is capable of pro-
viding all of the activities required for initiation and
carry out these functions in sequence, proteins such as
El have held great promise as a means to achieve a
precise molecular understanding of how DNA replica-
tion is initiated in a system of low complexity. In addi-
tion, since the end product is a double hexameric heli-
case, information about El assembly would clarify
how such enzymes are formed. Currently, it is not
known how double hexameric helicases are assembled,
how they engage their substrates, or how they proces-
sively unwind double-stranded DNA, although many
different models have been proposed. A contributing
reason for the limited understanding is the uncertainty
about what constitutes a bona fide substrate for a
replicative DNA helicase. Most helicases have there-
fore been characterized on artificial model substrates
of uncertain relevance. A great advantage of the viral
initiator proteins is that they, in the process of assem-
bly, generate the substrate for the helicase, obviating
the need for artificial substrates.
Unfortunately, although the El double hexamer
has long been recognized as the replicative DNA heli-
case, and therefore the end product of the assembly
process, only limited information about steps preced-
ing double hexamer formation exists. Consequently,
how and when in the assembly process melting of the
template occurs, whether specific precursors are
required for double hexamer formation, and what role
nucleotide binding and hydrolysis have, are all
unknown. The electrophoretic mobility-shift assay
(EMSA) has been a particularly powerful tool for
understanding how protein complexes form on DNA,
and we have therefore in the past year developed
EMSAs to analyze the El complexes that form on the
viral origin of DNA replication. By using very pre-
cisely defined conditions, we have been able to reca-
pitulate the sequence of events that are required for
the assembly of the double hexameric helicase. The
El protein binds initially as a dimer. Upon ATP bind-
ing, El forms a novel double trimeric complex.
Formation of this complex depends on cooperation of
two different DNA-binding activities, present in the
DNA-binding domain (DBD) and the helicase
domain, respectively. ATP binding, but not hydrolysis,
is required for formation of the double trimer. The
double trimer melts the DNA, providing the first
example of a defined complex capable of melting
double-stranded DNA. Hydrolysis of the bound ATP
triggers formation of a double hexamer, using the
double trimer as a precursor. The double hexamer has
the capacity to unwind the partially melted DNA in an
ATP-dependent manner, providing the opening
required for initiation of DNA synthesis.
MUTATIONAL ANALYSIS OF THE El DBD SURFACE
The DBD of the El protein clearly is responsible for
the highly site-specific DNA binding that the El pro-
tein is capable of, which in turn is responsible for
recognition of the origin of DNA replication in the
viral genome. Furthermore, on the basis of both struc-
tural and biochemical studies of the El DBD, the
DBD also provides the dimerization surface for the E 1
protein and also contains an interaction surface for the
DBD from the E2 protein. In addition, based on imag-
ing analysis of, for example, SV40 T antigen, it is like-
ly that the El DBD has an active part in the formation
of large complexes such as the double hexamer, which
is the replicative DNA helicase. To identify additional
functions in the DBD, we have performed a complete
surface mutagenesis of the E1 DBD. Based on the
high-resolution structure of the E 1 DBD, we have sub-
stituted approximately 70 surface residues for alanine,
avoiding areas known from the structural analysis to
be involved in DNA binding and dimerization. After
screening these El mutants for expression and for in
vivo DNA replication activity, we were able to identi-
fy 18 mutants with defects in DNA replication. Six of
these were defective for interaction with E2, and the
remaining 12 mutants showed unimpaired interaction
with E2 and consequently were defective for DNA
replication for other reasons. To determine what bio-
chemical functions might be defective in these
mutants, we expressed and purified the 12 mutant El
proteins and tested them in five different in vitro
assays related to DNA replication. None of the
mutants showed a defect in either the ATPase or the
nonspecific DNA helicase activities, indicating that
the protein structure was not greatly affected by the
mutations and that most likely, the ability to form
hexameric structures is unaffected by the mutations.
However, all 12 mutants had severe defects for in vitro
DNA replication as well as defects in melting activity
and in fragment unwinding activity. By using our
recently developed EMSAs, we have been able to test
these mutants directly for the formation of double
trimers and double hexamers. Of the 12 mutants, 5 had
defects in double hexamer formation, indicating that
the DBD has an active part in the assembly of the dou-
ble hexamer. Interestingly, however, mutations that
affect dimerization by the E1 DBD are not severely
defective for double hexamer formation, indicating
that the double hexamer is unlikely held together by
this dimer interaction.
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DNA REPLICATION AND CHROMATIN INHERITANCE
B. Stillman A. Chabes J. Mendez Y.-J. Sheu S. Vadivelu
V. Ellison S.G. Prasanth K. Siddiqui P. Wendel
M. Hoek M. Rossmann C. Speck Z. Zhang
A. Mazurek
Our research focuses on the inheritance of chromo-
somes and chromatin structures in eukaryotic cells.
The primary interest is how DNA replication occurs,
how it is regulated, and how it is coordinated with
other events such as chromosome segregation during
mitosis. Most of our research now focuses on the
mechanism of initiation of the process that duplicates
the genome which encodes our genetic information.
The focus of this research is the origin recognition
complex (ORC) which binds to DNA sequences that
localize where DNA replication begins along chromo-
somes. ORC binds a number of proteins during the
cell division cycle, and together, they coordinate the
chromosome duplication process.
Our previous studies have shown that ORC inter-
acts with a regulatory protein called Cdc6 in an ATP-
dependent manner and that this interaction changes
year, we have investigated this reaction in more detail
and have identified a new regulatory role for origin
DNA sequences in controlling ORC function. The
addition of Cdc6 protein to the ORC-DNA complex
causes a dramatic change in the way both ORC and
Cdc6 bind to DNA. ORC normally binds to about 48
by in the origin DNA and protects them from digestion
in vitro by deoxyribonuclease I (DNase I). Upon addi-
tion of Cdc6, and only in the presence of ATP, the
DNase I footprint is greatly extended to about 85 bp,
resembling the region of the origin that binds proteins
in vivo during the G, phase of the cell cycle, prior to
the initiation of DNA replication. ATP hydrolysis by
ORC is required for formation of the extended foot-
print over the origin DNA since mutant versions of
ORC or Cdc6 that lack ATPase activity cannot support
the reaction. Furthermore, nonhydrolyzable analogs of
ATP fail to support formation of the extended foot-
print, even though they do support Cdc6 binding to
ORC on origin DNA. In collaboration with Huilin Li's
group at the Brookhaven National Laboratory, we
have begun to investigate the structure of ORC, the
ORC-Cdc6 complex, and the structure of these com-
plexes bound to DNA.
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What is interesting about these reactions at the ori-
gin of DNA replication is the dual role of specific
DNA sequences in the control of events prior to the
initiation of DNA replication. Stephen Bell's laborato-
ry (MIT) has shown that when ORC is bound to the
origin of DNA replication, the ORC ATPase activity is
suppressed. We have now shown that when Cdc6 is
added to the origin, the ORC ATPase activity is acti-
vated and the ATPase requires specific DNA
sequences in the origin, particularly the B1 and B2
elements in the origin. These two DNA elements are
the region of the origin where the extended footprint
occurs. Thus, in one circumstance, ORC ATPase is
suppressed by the origin DNA sequences, and later,
when Cdc6 binds, ORC ATPase activity is activated by
the same origin sequences. We think that this ATPase
switch is required to load the minichromosome main-
tenance (MCM) proteins onto the origin to form the
prereplicative complex (pre-RC) that renders the ori-
gin competent for subsequent initiation of DNA repli-
cation in the S phase of the cell cycle. These results
also imply that ORC ATPase activity is cell-cycle-reg-
ulated since Cdc6 is only present in yeast cells from
mitosis until the cell commits to a new round of cell
division.
In human cells, the regulation of ORC is more
complicated. We have demonstrated that ORC is not a
stable complex in the cell division cycle, but that dif-
ferent complexes exist at different times. Neverthe-
less, just like in yeast cells, continually proliferating
human cells form the pre-RC as they exit mitosis in a
process that requires ORC, Cdc6, Cdtlp, and the
MCM proteins. In collaboration with Steve Reed's
laboratory (Scripps Research Institute), we investigat-
ed the regulation of MCM loading onto chromatin by
cyclin E.
Cyclin E is often overexpressed in human cancer
cells and patients with such tumors, particularly those
with breast carcinomas who have a poor outcome for
survival. Steve Reed's laboratory has shown that cells
that overexpress cyclin E accumulate genomic abnor-
malities that could cause additional mutations in the
DNA and accelerate cancer progression. In collabora-
tion with his laboratory, we have demonstrated that
overexpression of cyclin E causes a reduction in the
loading of Mcm4 protein, one of the key pre-RC com-
ponents. As a result, such cells progress through the
G, phase of the cell cycle with fewer pre-RCs and this
in turn causes slow progression through S phase. We
have suggested that progression through S phase with
a low number of competent origins of DNA replica-
tion may cause some cells to enter mitosis without
completing DNA replication, resulting in chromoso-
mal abnormalities.
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PROTEIN TYROSINE PHOSPHATASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
N.K. Tonks J.N. Andersen N. Gorovits A. Piccini
D.A. Buckley A. Hague Z. Yao
H.H. Chen S. Hinton M. Ye
R.L. Del Vecchio G. Lin L. Zhang
The phosphorylation of tyrosyl residues in proteins is
a key component of the regulation of signaling path-
ways that control many fundamental physiological
processes including cell proliferation and differentia-
tion. Protein phosphorylation is a reversible, dynamic
process in which the net level of phosphate observed
in a target substrate reflects the activity of the kinases
that phosphorylate it and the protein phosphatases that
catalyze the dephosphorylation reaction. We study the
family of protein tyrosine phosphatases (PTPs),
which, like the kinases, comprise both transmem-
brane, receptor-linked forms as well as nontransmem-
brane, cytoplasmic species and represent a major fam-
ily of signaling enzymes. We are integrating a variety
of experimental strategies to characterize the physio-
logical function of members of the PTP family.
Disruption of normal patterns of tyrosine phosphory-
lation has been implicated in several human diseases.
Therefore, insights into the mechanisms involved in
modulating PTP function may ultimately yield impor-
tant information to help counter such diseases.
During the last year, two graduate students,
Aftabul Hague and Guang Lin, from the MCB
Program at Stony Brook carried out rotation projects
and have joined the lab to conduct their Ph.D. studies.
THE COMPOSITION AND DIVERSITY
OF THE PTP FAMILY
Since the human genome sequence became available,
one emphasis of the lab has been to define the compo-
sition of the PTP family. We have now cataloged the
human PTP genes and more recently extended our
genomic sequence analysis to other organisms. The
PTPs, which are defined by the active site signature
motif HC(X)5R are divided into two broad categories:
the classical, pTyr-specific phosphatases and the dual
specificity phosphatases (DSPs). The DSPs are opera-
tionally defined as members of the PTP family that
have the capability of dephosphorylating both pTyr
and pSer/pThr residues in vitro. Nonetheless, in terms
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of physiological function, the "DSPs" may actually
show preference for either Tyr or Ser/Thr residues.
Some DSPs even target nonprotein substrates such as
inositol pholipids and RNA. This study was initiated as
a collaboration with Dr. Niels Peter Moller and his col-
leagues at Novo Nordisk in which we determined that
the total number of classical PTP genes in humans is
38. We have found direct orthologs of each of these
human PTP genes in the mouse genome. In contrast,
we have also discovered 12 PTP pseudogenes that are
unique to humans. Interestingly, some of these pseudo-
genes yield transcripts; however, they would only pro-
duce truncated/mutated proteins, the function of
which, if any, is unclear. We have continued these
genomic analyses independently, most recently pub-
lishing a "Practical Guide to Bioinformatics and Data
Resources for Computational Analysis of PTPs" in
which we define the classical PTPs in a variety of
organisms. Furthermore, we have extended this study,
in collaboration with Ravi Sachidanandam and his col-
leagues here at CSHL, to search the human genome
sequence for DSPs that are related to VH1, the proto-
typic DSP, a 20-kD protein that is a virulence factor of
Vaccinia virus. This proved to be a greater challenge
than our similar analysis of the classical PTPs because,
although they contain the active site signature motif,
the DSPs are less well-conserved overall and therefore
harder to identify on the basis of their sequence than
the classical PTPs. We have identified 43 human VH1-
like DPSs, all but one of which are also found in
mouse. Similar searches have been performed in vari-
ous other genome sequences, including Drosophilia
melanogaster, Caenorhabditis elegans, Fugu rubripes,
and Arabidopsis thaliana, to shed light on the evolu-
tionary history of the PTP superfamily. These data are
currently being prepared for publication. In summary,
the PTP family in humans is encoded by 106 genes as
follows: 38 classical PTPs, 43 VH1-like DSPs, and,
from other published studies, 3 cdc25s, 16 mytobular-
in-like phosphatases, 1 low-molecular-weight PTP, 2
inositol-4- phosphatases, and 3 Sac domain inositol 5-
phosphatases. In comparison, there are 90 human PTK
genes, illustrating comparable levels of complexity
between the two families. However, it is important to
remember that this reflects the minimal level of com-
plexity, with diversity being enhanced by such mecha-
nisms as alternative mRNA splicing, alternative pro-
moter usage, proteolytic processing, etc. Nonetheless,
this provides a foundation for future studies aimed at
profiling PTP sequences at the protein level.
To facilitate research on the PTPs within the sig-
nal transduction community, we are making our analy-
sis of the PTP family available as a Web-accessible
resource at two locations: http://ptp.cshl.edu and a
replica site at http://science.novonordisk.com/ptp.
This resource contains our database of PTP accession
numbers, multiple sequence alignments, phylogenetic
trees, structure files, annotated molecular graphics
files, chromosomal mapping data, analysis of exon
structure, pseudogenes, and disease linkages. The PTP
database can be searched by key words or by sequence
similarity using our BLAST server, which also pro-
vides a tool for phylogenetic classification of anony-
mously submitted sequences based on PTP domain
homology and neighbor joining trees. This is proving
to be a popular resource, and we are continuing to
update the site with the goal of maintaining it as the
definitive source of information on the PTP family for
the scientific community.
RECEPTOR PTPli AND ENDOTHELIAL
CELL FUNCTION
PTPp, is a receptor PTP, the extracellular segment of
which consists of one Ig (immunoglobin) domain, four
FN III (fibronectin type III) repeats, and a MAM (Mu,
A5 and Meprin homology) domain, the latter being a
conserved domain unique to PTP t, x, p, X, and some
cell adhesion molecules. Previously, we had shown that
PTP1.1 is a homophilic adhesion protein, such that the
ligand for one molecule of PTP1.1 is the extracellular
segment of another PTPu molecule expressed on the
surface of an apposing cell. Furthermore, we identified
the Ig domain as being necessary and sufficient for
binding. We have also demonstrated that PTPp, inter-
acts with cadherin-catenin cell adhesion complexes and
may regulate the adhesive properties of classical cad-
herins by dephosphorylating cell junction proteins.
PTPµ is expressed predominantly in endothelial cells.
In subconfluent cell cultures, PTPµ resides in an intra-
cellular membrane pool; however, as culture density
increases and cell contacts form, the phosphatase is
localized to sites of cell-cell contact and its expression
level increases. These characteristics of PTPp., which
are consistent with a role in cell-cell adhesion, suggest
that control of subcellular localization and protein level
are important mechanisms to regulate the function of
this phosphatase. Furthermore, we noted that overex-
pression of PTPpt in a bovine aortic endothelial cell
line, GM7372, reduced cell number in culture. These
effects were most pronounced when cell density was
low, the condition that coincides with low levels of
endogenous PTPu, and resulted from increased apopto-
sis, rather than decreased proliferation. To gain a better
understanding of the regulation of PTPµ function, we
explored further a structure-function analysis of the
enzyme, focusing on the extracellular segment, in par-
ticular the importance of the conserved Ig domain, con-
taining the homophilic binding site. We observed that
the deletion of the Ig domain greatly reduced the local-
ization of PTPu to cell-cell contacts and resulted in dis-
persal of the mutant protein across the cell surface.
Similar results were observed in endothelial and epithe-
lial cells, suggesting that the localization of the enzyme
was a property of the PTP itself and not a phenomenon
unique to particular cells. In addition, deletion of the Ig
domain affected localization of PTPii in subconfluent
cells, when homophilic binding to another PTPu mole-
cule on an apposing cell is not possible, leading to an
accumulation of the PTP at the cell periphery in the
region occupied by focal adhesions. This apparent
localization coincided with changes in the morphology
of focal adhesions, as well as in the distribution of
cytoskeletal components such as vinculin, paxillin, and
actin. These effects were accompanied by increased
apoptosis; in fact, deletion of the Ig domain enhanced
the apoptotic effect of PTP1.1 to the highest levels seen
with any of the mutant constructs tested. This study
therefore illustrates the critical role of the Ig domain in
regulation of the localization of PTP1.t and the impor-
tance of such control for the maintenance of normal
cell physiology.
The vascular endothelium represents a barrier that
regulates paracellular movement of macromolecules
into extravascular compartments. This paracellular
pathway of macromolecular flux is controlled in part
by tyrosine phosphorylation of adherens junction (AJ)
proteins, which integrate cell-cell contact and actin
cytoskeleton. Enhanced tyrosine phosphorylation is
associated with increased trans-endothelial flux (i.e.,
decreased barrier function). Several AJ proteins are
known to be tyrosine-phosphorylated, such as VE-cad-
herin and catenins, but the mechanistic links between
tyrosine phosphorylation and barrier function remain
to be defined. In collaboration with Dr. Simeon
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Goldblum (University of Maryland) we have been
exploring potential roles for PTPli in regulating AJ
tyrosine phosphorylation and barrier function in pul-
monary vascular endothelial cells. We observed that
the PTI4t was expressed in postconfluent human pul-
monary artery and lung microvascular endothelial cells
(HMECs), where it was almost exclusively restricted to
cell-cell boundaries. Ablation of PTP1.1 expression by
RNA interference dramatically impaired barrier func-
tion. Conversely, overexpression of wild-type PTPix
enhanced barrier function. These data are consistent
with PTPµ exerting a regulatory influence over barrier
function. We have been trying to identify physiological
substrates of PTI,t to explore the mechanisms under-
lying these effects. In light of its association with clas-
sical cadherins, we tested whether there was an inter-
action between PTP11 and VE-cadherin. We observed
direct binding between the recombinant proteins in
vitro and colocalization and coimmunoprecipitation of
PT131.t and VE-cadherin from HMECs. Interestingly,
overexpression of PTPI.t in HMECs led to a decrease in
tyrosine phosphorylation of VE-cadherin, with speci-
ficity indicated by the fact that there were no changes
in tyrosine phosphorylation of 13 catenin. Whether this
is the critical regulatory event in the control of barrier
function remains to be established.
THE DUAL SPECIFICITY PHOSPHATASES
Many of the 43 DSPs we defined in our analysis of the
human genome sequence are uncharacterized.
Phylogenetic analyses divided these enzymes into
three classes, revealing characteristics that were used
to prioritize further studies. Currently, we are focusing
on the following.
Jsp-1
Multiple DSPs have been identified that have the abil-
ity to dephosphorylate and inactivate various MAP
kinases, constituting a complex response network for
attenuation of MAPK-dependent signals. We identi-
fied a novel DSP and observed, contrary to expecta-
tion, that it had the capacity to activate Jnk specifical-
ly, hence, JSP-1 (Jnk stimulatory phosphatase 1). In
addition, we observed enhanced phosphorylation of
MKK-4, which phosphorylates and activates Jnk.
Furthermore, expression of a dominant-negative
mutant form of MKK-4 abolished the activation of Jnk
by JSP-1, suggesting a site of action of the phos-
phatase upstream of MKK-4 in the Jnk signaling cas-
cade. This study illustrates a new potential tier of con-
trol of the Jnk signaling pathway and a novel aspect of
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the role of protein phosphatases in the control of
MAPK signaling. This raised the possibility that JSP-
1 may offer a different perspective to the study of var-
ious inflammatory and proliferative disorders associ-
ated with dysfunctional Jnk signaling. We have now
generated JSP-1 knockout mice, which are born in
Mendelian ratios, and we are characterizing their phe-
notype. Thus far, we have observed that ablation of
JSP-1 leads to attenuation of the inflammatory
response to Gram-negative bacterial endotoxin, sug-
gesting an important role in the innate immune sys-
tem. The mechanistic basis for this effect is currently
under investigation. In addition, preliminary results
indicate that following treatment of JSP-1--/- mice
with MPTP (1-methy1-4-pheny1-1,2,4,6-tetrahydropy-
ridine), the activation of Jnk is attenuated compared to
wild-type controls. MPTP is a neurotoxin that repli-
cates most of the neuropathological features of
Parkinson's disease. Currently, we are investigating
the mechanism by which JSP-1 regulates the Jnk path-
way in this context and the extent to which manipula-
tion of JSP-1 may influence neurodegeneration in
Parkinson's disease.
Two Distinct DSPs Encoded in Alternative Open
Reading Frames of a Single Gene at Human
Chromosone 10q22.2
We identified a gene located on chromosome 10q22.2,
which utilizes alternative open reading frames (ORFs)
to encode TMDP (testis and skeletal specific DSP) and
a novel enzyme that we term MDSP (muscle restricted
DSP). This gene organization is conserved in mice.
Although this is reminiscent of the p 1 6Ink4/p19Arf
locus, to our knowledge, this is the first example of a
gene from which two distinct proteins of the same fam-
ily are expressed using alternative ORFs. We demon-
strated that both MDSP and TMDP are restricted to
specific tissues, skeletal muscle and testis, respective-
ly. Expression of both proteins was markedly increased
at approximately the third week after birth and contin-
ued to increase gradually into adulthood, implying that
the physiological functions of both DSPs are specific
to the mature organs. More recently, we have found that
MDSP may be overexpressed in certain tumors, and we
are currently focusing on a functional characterization
of the enzyme.
DUSP23
The gene for this DSP is located at chromosome
1q22.23, a region that is associated with amplifica-
tions, translocations, and other abnormalities in multi-
ple cancers. Our phylogenetic analysis assigned this
DSP to a class of phosphatases that could be consid-
ered the most ancient of the PTPs, due to their rela-
tionship with enzymes found in bacteria and Archaea,
perhaps indicative of a role in a fundamental cell func-
tion. Preliminary data suggest that this DSP may be
amplified in certain breast tumors. Using RNA inter-
ference (RNAi), we have shown that disruption of its
expression inhibits proliferation and transition
through the cell cycle. The mechanistic basis for these
effects is under investigation.
PTP OXIDATION AND THE ROLE OF PTP1B AND
TC45 IN INSULIN SIGNALING
One emphasis of the lab remains the characterization
of two nontransmembrane PTPs that are now known
to exert selective effects on signal transduction in
vivo-PTP1B, the prototypic member of the PTP fam-
ily, and its closest relative, TCPTP. TCPTP exists in
two alternatively spliced forms that share the same cat-
alytic domain but differ in the sequence at the carboxyl
terminus of their regulatory segments. Like its closest
relative PTP1B, TC48 is targeted to the cytoplasmic
face of membranes of the endoplasmic reticulum,
whereas TC45 is located in the nucleus in the basal
state, but translocates to the cytosol in response to
stimuli. Although much attention has focused on the
role of PTP1B in dephosphorylating the insulin recep-
tor (IR), we have made an exciting breakthrough with
the demonstration of a role for TC45 in the regulation
of insulin signaling. We have shown that insulin
induces production of reactive oxygen species. Using
our modified "in-gel" PTP assay, we demonstrated that
PTP1B and the 45 -kD spliced variant of TCPTP were
rapidly and reversibly oxidized and inhibited in
response to insulin in Rat 1 fibroblasts. Our hypothesis
is that tyrosine-phosphorylation-dependent signaling,
induced by stimuli such as insulin, may be fine-tuned
by transient oxidation and inhibition of those PTPs that
normally function to attenuate the signaling response
(Fig. 1). PTP1B is well established as an antagonist in
insulin signaling. Using RNAi to ablate TC45 in Rat 1
and HepG2 cells, we demonstrated that small interfer-
ing RNA (siRNA) to TC45 enhanced insulin-induced
activation of PKB/AKT and led to hyperphosphoryla-
tion of the IR [3 subunit. Using the substrate trapping
mutant form of TCPTP (D182A) in HepG2 and 293
cells, we observed that the 13 subunit of the IR is a
ROS
S-
PTP
(active)
P
P
S-OH
S-
PTP
PTP
(inactive) PTP -N
inactive)
P
P
P
S-
PTP
FIGURE 1 Regulation of protein tyrosine phosphatase (PTP) activity by reversible oxidation. Ligand-dependent
activation of a receptor protein tyrosine kinase (RTK) triggers the production of reactive oxygen species (ROS).
ROS oxidizes the active site Cys residue of members of the PTP family, converting it from a thiolate ion (the active
form) to sulfinic acid and then to a cyclic sulfenamide, with concomitant conformational changes at the active
site. Oxidation results in inhibition of PTP activity, thereby promoting tyrosine phosphorylation. However, oxida-
tion of the PTPs is transient. Restoration of PTP activity following reduction back to the thiolate form of the active
site Cys residue terminates the tyrosine-phosphorylation-dependent signal. A variety of growth factors, hor-
mones, and cytokines induce ROS production and stimulate tyrosine phosphorylation. We are developing meth-
ods to identify the PTPs that become oxidized in response to a physiological stimulus as a way of establishing
links between particular PTPs and the regulation of defined signaling pathways.
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direct substrate of TCPTP. Furthermore, blotting of
immunoprecipitates of IR 13 from siRNA-treated cells
with phospho-specific antibodies indicated that TC45
displays preferential recognition of particular sites
within the receptor.
We have explored further the effects of PTP and
TC45 on insulin signaling using fibroblasts (MEFs)
derived from PTP1B-/- and TCPTP-/- mice, in col-
laboration with Tony Tiganis (Monash University,
Australia). Ablation of PTP resulted in enhanced,
insulin-induced phosphorylation of both IR [3 and
IRS-1, in contrast to TCPTP-/- MEFs in which hyper-
phosphorylation of IR 13 occurred in the absence of an
effect on IRS-1. Furthermore, whereas PKB phospho-
rylation was elevated/prolonged in cells that lacked
either PTP or TCPTP, compared to their wild-type
or reconstituted counterparts, Erk 1/2 phosphorylation
was enhanced only in PTP1B-/- cells. These data sug-
gest that the two PTPs may exert differential effects on
insulin signaling. To explore further the mechanism of
action of these PTPs, we examined the phosphoryla-
tion status of IR [3 using phospho-specific antibodies
to Y1162/63, from the activation loop of the IR PTK,
and Y972, a site that contributes to the recruitment of
IRS-1. Insulin-induced phosphorylation of both sites
was enhanced in the absence of PTP1B; however, the
kinetics of phosphorylation were similar in the pres-
ence or absence of the PTP, peaking at 2 minutes and
declining rapidly thereafter. In contrast, phosphoryla-
tion of Y1162/63 was not altered at early time points
of insulin stimulation in the absence of TCPTP;
instead, phosphorylation was sustained over a pro-
longed time course out to 100 minutes, compared to
TCPTP+/+ cells in which phosphorylation had
declined to baseline by this time. In addition, we
observed that phosphorylation of Y972 was enhanced
in TCPTP-/- MEFs early in the time course of insulin
stimulation, when Y1162/63 phosphorylation was not
altered significantly, indicating that TCPTP exerts dif-
ferential, independent effects on these two phosphory-
lation sites. The effects of these PTPs can be distin-
guished further using RNAi to suppress TCPTP
expression in PTP1B-/- MEFs. In PTP1B-/- MEFs,
we observed that insulin-induced phosphorylation of
PKB declined at 40-60 minutes, whereas phosphory-
lation was maintained for at least 100 minutes follow-
ing RNAi-induced suppression of TCPTP in these
cells. In contrast, suppression of TCPTP did not alter
the time course of Erk2 activation, illustrating speci-
ficity and that the ablation of TCPTP did not produce
a general enhancement of signaling. Furthermore, we
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observed that suppression of TCPTP by RNAi in
PTP1B-/- MEFs led to prolonged phosphorylation of
Y1162/63 in IR [3. These observations illustrate that in
a cellular context, PTP and TCPTP are not redun-
dant, but rather act in a coordinated manner to exert
differential effects in the regulation of IR 13 phospho-
rylation and signaling in vivo.
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RAS AND RHO GTPASES AND THE CONTROL OF
SIGNAL TRANSDUCTION
L. Van Aelst B. Boettner V. Velamoor
E.-E. Govek M. Uchida
J. Janas M. Zhao
R. Packer
Our research focuses on signal transduction pathways
involving members of the Ras and Rho GTPases and
the physiological processes that they regulate. Ras and
Rho family members have been documented to have
key roles in cellular activities controlling cell growth
control, differentiation, and morphogenesis. Altera-
tions that affect normal Ras and Rho function have
been found to result in the development of several dis-
ease processes, including cancer, as well as inflamma-
tory and neurological disorders. To understand how
alterations in Ras and Rho signaling components con-
tribute to these disease processes, it is essential to
comprehend their normal functions at both a molecu-
lar and a cellular level. Efforts in my laboratory have
focused on defining the role and mechanisms by
which Ras and Rho family members exert their effects
on specific aspects of tumorigenesis and on neuronal
development. Below are highlighted the main projects
that have been carried out during the past year.
ROLE OF RAP1 SIGNALING
IN EPITHELIAL MIGRATION AND
CELL-CELL ADHESION
The Rapl protein, a member of the Ras family, was
originally identified as an antagonist of oncogenic
Ras, but more recent studies indicate that the function
of Rapl is largely independent of Ras. Rapl is funda-
mental for the maintenance of cell-cell contacts
between nascent epithelial cells and promotes cell
movement. Importantly, a growing body of evidence
suggests a dysregulation of Rapl signaling in malig-
nant processes. The signaling pathways mediating
these effects of Rapl remain largely unknown. We pre-
viously described the identification of the mammalian
junctional protein AF-6 as a Rapl-interacting protein.
To demonstrate the physiological relevance of this
interaction, we decided to carry out functional analy-
ses of their orthologs (DRapl and Canoe) in the more
genetically tractable Drosophila system. We found
that both DRapl and Canoe are required for epithelial
migration events in the embryo and that Canoe acts as
a downstream effector of DRapl in this process.
Together, these experiments show that Canoe/AF-6 is
a "bone fide" effector of Rapl in the process of epithe-
lial migration.
More recently, we identified a Drosophila Rapl-
specific exchange factor, DPDZGef, which is respon-
sible for Rapl activation in migrating embryonic
epithelia. Genetic and biochemical experiments
showed that the DPDZGef gene is indispensable for
epithelial migration in the embryo and that it activates
the Rapl /Canoe pathway. Interestingly, the mam-
malian counterpart of the DPDZGef protein has been
described to interact with the adherens junctional pro-
tein, 0-catenin and, like AF-6/Canoe, localizes to cell-
cell junctions. Our data reveal a novel Rapl-dependent
pathway key in regulating epithelial cell migration and
adhesive processes that likely is conserved across
species.
ROLE OF DOK PROTEINS IN LEUKEMIA
SUPPRESSION
p62"k (also called Dok-1) was cloned as a major phos-
phorylation substrate of the p2106o""' oncoprotein in
CML (chronic myelogenous leukemia) blasts. This
protein was termed Dok (downstream of kinases),
since it was also found to be a common substrate of
many receptor and cytoplasmic tyrosine kinases.
Subsequently, four additional Dok family members
have been identified. Among them, Dok-1 and Dok-2
share in common the ability to bind to a negative reg-
ulator of Ras, Ras-GAP, suggesting that they may
serve critical, but possibly redundant, functions. In last
year's Annual Report, we reported that Dok-1 acts as a
negative regulator of growth-factor-induced cell pro-
liferation and that it does so at least in part by nega-
tively influencing the Ras/MAPK pathway. We also
reported that Dok-1 inactivation causes a significant
shortening of the latency of the fatal myeloprolifera-
tive disease induced by p2106cr-ab1. These findings
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implicated a role for Dok-1 in the negative regulation
of p210ber-a' signaling and leukemogenesis.
Dok-1 (or Dok-2) single knockout (KO) mice did
not show gross aberrant phenotypes and displayed
normal steady-state hematopoiesis. This observation
suggested that the two proteins could exert redundant
function(s). In collaboration with Dr. Pandolfi's group
(Memorial Sloan-Kettering Cancer Center), we
recently characterized Dok-1/Dok-2 double KO
(DKO) mice. Concomitant Dok-1 and Dok-2 inactiva-
tion resulted in aberrant hematopoiesis and Ras/MAP
kinase activation. Inactivation of both genes increased
the proliferative potential of myeloid bone marrow
(BM) cells and protected them from growth-factor-
deprivation-induced cell death. DKO BM cells dis-
played elevated levels of Ras and MAPK upon GM-
GSF stimulation. Strikingly, all Dok-1/Dok-2 DKO
mutants spontaneously developed transplantable
CML-like myeloproliferative disease, likely resulting
from increased cellular proliferation and reduced
apoptosis. These findings reveal a critical role for
Dok 1 and Dok2 in the control of the hematopoietic
compartment homeostasis.
REGULATORS OF RHO GTPASES CONTROLLING
KEY ASPECTS OF NEURONAL FUNCTION AND
DEVELOPMENT
Accumulating data indicate that the Rho family of
GTPases and their regulatory molecules have critical
roles in many aspects of neuronal development, par-
ticularly in determining neuronal morphology via
their various actions on the actin cytoskeleton. Given
their importance in neuronal processes, it is therefore
not surprising that mutations in genes encoding a
number of regulators and effectors of the Rho-
GTPases are associated with diseases affecting the
nervous system. Aberrant Rho signaling has been
shown to underlie various forms of mental retardation
as well as defects in axon regeneration. We have been
focusing on two regulators of the Rho GTPases,
oligophrenin-1 and DOCK7, for which we demon-
strated roles in dendritic morphogenesis and axon for-
mation, respectively.
Oligophrenin-I (OPHN1) codes for a protein that
has a Rho-GAP domain shown to negatively regulate
Rho family members. It was originally identified by
the analysis of a balanced translocation t(X;12)
observed in a female patient with mental retardation
(MR). Subsequently, a mutation within the OPHN1-
coding sequence was identified in a family with non-
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syndromic X-linked MR (MRX 60). In both cases,
OPHN1 mutations were associated with a loss of or
dramatic reduction in, mRNA product. More recent
studies have also reported the presence of OPHN1
mutations in families with MR associated with epilep-
sy and/or cerebellar hypoplasia. Until recently, noth-
ing was known about the function of OPHN1 in the
brain.
Upon characterizing the localization of OPHN1,
we found that the protein is expressed in neurons in
major regions of the brain, including the hippocampus,
cortex, and cerebellum, and is present in axons, den-
drites, and dendritic spines. We obtained evidence for
the requirement of OPHN1 in dendritic spine morpho-
genesis of hippocampal neurons. Using RNA interfer-
ence and antisense approaches, we showed that knock-
down of OPHN1 levels in CA1 pyramidal neurons in
hippocampal slices results in a significant decrease in
dendritic spine length and that this spine length pheno-
type is mediated by the Rho/Rho-kinase pathway. In
addition, we recently demonstrated a biochemical
interaction between OPHN1 and Homer, a postsynap-
tic adapter molecule involved in spine morphogenesis
and synaptic transmission. An interaction between
OPHN1 and Homer raises the intriguing possibility
that OPHN1 acts downstream from glutamatergic
receptors to regulate RhoA activity in spines, and thus
spine morphogenesis. Our future experiments are
geared toward addressing these interactions and their
functional significance in determining dendritic spine
morphology, calcium signaling, and synaptic plasticity.
Together, our studies will provide insight as to how
OPHNI mutations compromise cognitive function.
DOCK7 is novel Rac-interacting protein we
recently identified in a search for regulators of Racl.
Specifically, we conducted yeast two-hybrid (YTH)
screens, using a human fetal brain library with the
dominant-negative mutant form of Racl, Rac1N17, as
bait. Further analysis showed that DOCK7 specifical-
ly associates with and activates Rac GTPases. Blast
searches revealed that DOCK7 is a member of the
DOCK180-related superfamily of proteins, which
emerged as novel activators of the Rho GTPases.
Among the DOCK180 family members, DOCK180
and DOCK2 have been most extensively studied.
DOCK180 has crucial roles as upstream activators of
Rac in cytoskeletal remodeling, cell migration, and
phagocytosis, and DOCK2, in lymphocyte homing to
lymphoid tissues.
We began the characterization of DOCK7 by
determining its presence, distribution, and subcellular
localization in the brain. We found that DOCK7 is
highly expressed in major regions of the brain during
early stages of development. Moreover, we observed
that in hippocampal neurons, DOCK7 becomes selec-
tively localized to the axon as the neuron polarizes,
suggesting a role for this protein in the early steps of
axon formation, and hence in neuronal polarization.
Using a culture of dissociated primary hippocampal
neurons as a model system, we demonstrated that this
is indeed the case. Ectopic expression of DOCK7
resulted in the formation of multiple axons, whereas
knock down of DOCK7 protein levels prevented axon
formation. Our preliminary data support a model in
which a DOCK7 protein complex triggers local Rac
activation resulting in altered cytoskeletal dynamics,
which is key for axon formation and elongation.
Together, our studies contribute to defining the mole-
cular mechanisms by which neurons acquire their
polarity, which is crucial for nearly every aspect of
neuronal function. These studies may also shed light
on axon regeneration processes.
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NEUROSCIENCE
By using a wide variety of powerful approaches, CSHL neuroscientists are making extraordinary
progress in understanding nervous system structure and function on many levels-from genes, to pro-
teins, to synapses, to the vast networks of brain neurons that ultimately make us who we are.
Several scientists here are using the fruit fly Drosophila to systematically study various neurological
processes, most-if not all-of which also occur in humans or are relevant to human biology or dis-
ease. Yi Zhong is using the power of Drosophila molecular genetics to study the pathology of human
Alzheimer's disease. Last year, he found that producing the human amyloid-p peptide 442 in the fruit
fly brain was sufficient to cause nerve cell death, "plaque" formation, and age-dependent memory loss
reminiscent of Alzheimer's disease. Zhong is now using these "Alzheimer's flies" to explore the mech-
anisms underlying 442-induced age-dependent memory loss and neurodegeneration.
Tim Tully's group has recently obtained evidence from their Drosophila studies that confirms a pre-
viously controversial role for proteins called NMDA (N-methyl-o-aspartate) receptors in Pavlovian learn-
ing and long-term memory formation. Because NMDA receptors function in the brains of both flies and
humans, Tully's findings reveal a fundamental, evolutionarily conserved role for these receptors in ver-
tebrate and invertebrate learning and memory.
By studying a Drosophila memory mutant called radish, Josh Dubnau has uncovered the first clues
about the molecular and anatomical basis of a form of long-lasting memory-also present in humans-
known as anesthesia-resistant memory. Dubnau's group found that the radish gene encodes a partic-
ular enzyme (phospholipase-A2), and that the enzyme is present in a novel anatomical region of the fly
brain not previously associated with learning and memory. These discoveries enable the researchers to
explore many new aspects of the molecular and cellular basis of anesthesia-resistant memory.
Using rodents, Karel Svoboda focuses on understanding the mechanism of memory formation. He
has developed laser-based tools that can rapidly measure changing neural circuits. Svoboda's group
has discovered that neural networks in the mammalian cortex (the portion of the brain that processes
sensory experience) wire up in a highly directed and precise fashion in response to experience. These
findings suggest that cortical neural circuits respond to sensory experience in a tightly controlled and
predictable pattern.
Josh Huang studies how the brain forms neural networks that respond to GABA, the primary
inhibitory neurotransmitter or "off switch" for neurons. His research revealed that GABA synapses in the
visual cortex (the part of the brain that processes visual signals) develop "automatically" by genetically
encoded mechanisms, without sensory input. Subsequently, Huang's group found that after the basic
GABA synapses are in place, they undergo a long period of maturation that is shaped by sensory expe-
rience. Part of Huang's ongoing research is uncovering the molecular mechanisms that allow GABA
synapses to change according to experience.
A complete understanding of brain function requires the comprehensive mapping of the brain's
microcircuitry. In other words, the detailed three-dimensional geometry of individual neurons must be
fully documented, as must the patterns of connections between the neurons and the strengths of those
connections. Dmitri Chklovskii has discovered strongly preferred patterns of connectivity or "scaffolds"
within the wiring diagram of the rat brain. The patterns are likely to correspond to modules that have
an important role in brain function not only in rats, but also in humans.
Alexei Koulakov has developed a theoretical model of the visual system that predicts how axons
(nerve cell projections that propagate signals) can work in coordinated groups. The model approxi-
mates the relative strengths of the connections between axons and their targets. The model fits in vivo
experimental observation and makes testable predictions about neural network structure and function.
Chklovskii and Koulakov have also collaborated to develop a method for mapping brain microcir-
cuitry. They created software that automatically aligns images of successive slices of brain tissue cap-
tured by electron microscopy. This state-of-the-art software generates three-dimensional views of the
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complete microcircuitry of the region analyzed.
Holly Cline studies the development of neural connections in the brain and spinal cord in tadpoles,
which have the advantage of being transparent, allowing Cline and her colleagues to watch the ner-
vous system develop using time-lapse microscopy. Combining this imaging approach with gene trans-
fer methods led Cline's group to the discovery that a protein called CPG15 controls the development
of synaptic connections between motor neurons in the spinal cord and muscles. Cline had previously
shown that this same protein performs a similar function in the brain. Her continuing work will examine
these and other key aspects of brain development and plasticity.
Grigori Enikolopov studies the molecular events that guide the generation of new neurons in the
brain. In particular, he is interested in the role of the versatile signaling molecule nitric oxide (NO), which
guides stem cells as they develop into mature neurons. Using Drosophila, amphibians, and mice as
model systems, Enikolopov and his colleagues have examined how NO controls neurogenesis during
development and in adulthood. In other preclinical studies, they are manipulating NO signals to expand
bone marrow hematopoietic stem cells for medical applications. The researchers are also studying the
effects of therapeutic drugs on the generation of new neurons in the adult brain with the goal of coax-
ing stem cells to replace neurons that die due to neurodegenerative disorders such as Parkinson's dis-
ease.
Lee Henry is working to understand the unique processes that control how taste buds develop. By
developing pioneering methods for analyzing the minute quantities of genetic instructions (messenger
RNA) produced by single cells, he is profiling how changes in gene expression patterns enable prog-
enitor cells to develop into taste receptor cells. These changes in gene expression patterns are pro-
viding valuable clues concerning the development, structure, and function of taste buds.
Anthony Zador is one of a number of CSHL scientists who are exploring the unique computational
style the brain uses to solve hard computations that remain far beyond the reach of the fastest digital
computers. Zador is approaching this problem by studying "selective auditory attention" or the ability of
the brain to focus its conscious awareness on particular sounds. Most of what is known about the audi-
tory cortex (the part of the brain that interprets sound) comes from studies of anesthetized animals. To
understand selective auditory attention, however, the cortex of unanesthetized animals must be studied.
Zador has developed methods for studying the activity of neurons in the auditory cortex of awake
rodents. His group has found that the diversity of neural responses in awake rodents is much greater
than that in anesthetized rodents, and they are currently elucidating the causes of this diversity.
In other work this year, Zador collaborated with Roberto Malinow in a study of a form of associa-
tive, Pavlovian learning known as fear conditioning. By using a recombinant version of AMPA (a-amino-
3-hydroxy-5-methyl-4-isoazole) receptors that specifically tags newly strengthened synapses, the
researchers found that up to one third of the neurons in the amygdala strengthen their synapses in
response to fear conditioning. This indicates that rather than being restricted to a small subset of neu-
rons, long-term memories are widely distributed among a large proportion of neurons. Malinow and
Zador also discovered that blocking synapse strengthening in as few as 10-20% of the relevant neu-
rons was sufficient to impair long-term memory formation. This finding contradicts the conventional
view that widely distributed memories are tolerant to perturbation and will transform the accepted wis-
dom in the field.
Short-term or "working" memory is an important process that enables us to interact in meaningful
ways with others and to comprehend the world around us on a moment-to-moment basis. Working
memory is believed to be fundamental to many cognitive processes including reading, writing, holding
a conversation, playing or listening to music, decision making, and thinking rationally in a general sense.
Carlos Brody's group is exploring how neurons interact with one another to form neural networks that
underlie working memory. Based on behavioral studies of decision making and mathematical model-
ing with "spiking neurons," the researchers have discovered a surprisingly simple network architecture
that supports all three neurological phases of decision-making behavior (loading phase -memory
phasedecision phase). The model is a significant advance toward understanding a fundamental
property of brain function.
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Zach Mainen is combining behavioral studies, recordings of neuronal microcircuit activity, and com-
putational methods to explore aspects of learning, goal-directed behavior, and pathologies including
schizophrenia, obsessive-compulsive disorder, and Parkinson's disease. By studying the activity of
ensembles of brain neurons in awake behaving rats, Mainen's group has uncovered clues about how
brain circuits normally function to process information, as well as how they may malfunction in the
aforementioned pathologies.
Partha Mitra combines theoretical, experimental, and computational approaches to understanding
brain function. In one study, Mitra is exploring how birds learn to sing as a means of uncovering prin-
ciples that govern brain development, learning, and memory across the board, including in humans. By
recording and analyzing all of the vocalizations that young zebra finches make as they learn to sing,
Mitra and his colleagues have discovered that when the birds awaken from sleep, they are dramatical-
ly worse singers than they were the previous day. In addition, individual birds who are the least tuneful
during their "morning rehearsals" eventually become the best singers of all. More work is required to
explain this "one step back, two steps forward" effect of sleep on the brain circuits that consolidate
vocal learning. For now, a useful analogy is the tempering of steel, in which to gain its ultimate struc-
ture and strength, the metal is first weakened. Vocal learning in songbirds bears similarities to human
speech acquisition: Novice birds go through a period of "screeching" before learning to imitate songs
accurately, much as babies babble before grasping words. Therefore, the new research highlights the
need for a quantitative study of the effects of sleep on learning in humans.
Stephanie Dennison, lab tech, Josh Dubnau's lab.
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COMPUTATIONAL SYSTEMS
C.D. Brody S. Chakraborty C. Machens
C. Hollweg A. Penel
Our lab is interested in how neurons interact with each
other to form networks that underlie flexible cognitive
acts, such as decision-making and short-term memory.
We are also interested in how time and temporal pat-
terns are sensed and represented in the brain. During
2004, Carlos Brody (PI) and Christian Machens (post-
doc) completed a theoretical model for understanding
how properties of neuronal responses can be flexibly
modulated. We devised practical, experimentally fea-
sible tests of the model and further generalized the
theoretical framework to a variety of architectures of
networks of neurons Amandine Penel (postdoc) and
Chris Hollweg (technician) used a new psychophysical
reporting procedure to assess perception of temporal
intervals. The procedure was successfully validated by
testing, and confirming, a surprising set of predictions
that followed from applying a signal detection analysis
to the procedure's results. Santanu Chakraborty
(Watson School graduate student) continued his col-
laboration with David Tank (Princeton), studying net-
work properties of neurons in the goldfish brain that
support the short-term memory of eye positions. He
found slow oscillating patterns in these neurons'
responses and devised a simple model that accounts
for the unexpected presence of these oscillations.
Carlos Brody provided assistance to Sandra Kuhlman
(postdoc, Huang laboratory, CSHL) in the develop-
ment of a model that describes interactions between
inhibitory mechanisms and synaptic plasticity rules
during ocular dominance column formation.
A Robust Neural Model of
Two-stimulus-interval
Discrimination
C. Machens, C. Brody
In our daily lives, our minds can flit from thought to
thought with remarkable speed and flexibility. A sim-
plified task that requires rapid shifts between different
mental actions is known as two-stimulus-interval dis-
crimination. Subjects must first perceive a brief stim-
ulus (f1), maintain it in working memory for several
seconds, and then compare it with a brief second stim-
ulus (12) to immediately decide which of the two stim-
uli was larger. On the basis of electrophysiological
data from awake behaving monkeys, recorded by
Ranulfo Romo (UNAM, Mexico), we developed a
simple model, based on two mutually inhibitory popu-
lations of neurons, that captures the three phases of the
task within a single framework. This model required a
precise tuning of its synaptic parameters.
In a further exploration of the framework underly-
ing the model, we are now using ideas regarding
robust short-term memory that were put forth by Alex
Koulakov and Adam Kepecs here at CSHL, among
others, to now make the neurons of our previous
model both heterogeneous and hysteretic. This has led
to a spiking neural network model of sequential dis-
crimination that (1) is more robust against changes in
its synaptic parameters and (2) displays a larger vari-
ety of behaviors across different neurons, in compari-
son to our original model. Surprisingly, this variety of
behaviors reproduces much (but not all) of the variety
found in experimental data recorded during a sequen-
tial discrimination task.
Human Time Perception
in Sequences
A. Penel, C. Hollweg
We have developed a new psychophysical task for the
investigation of time perception in sequences. It
involves participants' spatial translation of their tem-
poral representation: After hearing a sequence of three
sounds, they have to position a vertical line within a
horizontal bar representing the sequence's first and
last sounds. With sequences that are 1 second long and
a second tone distributed uniformly within this inter-
val, pilot data had shown a categorization of respons-
es to two 500-msec intervals when the second tone
was presented within a range centered around 500
msec after the first sound. An experiment conducted
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with sequences 1 second and 1.2 seconds confirmed
this categorization to an equal subdivision of the
sequence when the second tone is presented around
the midpoint.
From the data obtained, predictions could be gen-
erated for a classical psychophysical task. Data con-
firming these predictions were a necessary condition
for the validation of the new "spatial translation of
temporal representation" method. More precisely, in a
task in which participants had to compare two
sequences presented successively (say whether in the
second sequence, compared to the first, the middle
sound was played closer to the first or to the last
sound), heightened sensitivity was predicted at the
categorization zone's boundaries. A second experi-
ment confirmed these predictions. This work shows
that the perception of a time interval in a sequence is
fundamentally different from that of the same interval
presented in isolation. It provides the first evidence
for temporal categorical perception and shows that the
human brain favors a temporally regular (isochrone)
representation of sequences.
Network Interactions in the
Goldfish Oculomotor System
S. Chakraborty [in collaboration with David Tank, Princeton]
We are studying the underlying architecture of a sys-
tem of neurons in the goldfish called the oculomotor
integrator. Understanding the mechanism by which
neurons in this system generate persistent firing in
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response to a transient burst of input could be impor-
tant in understanding short-term memory-like behav-
ior in many other systems.
We have analyzed the firing rate data from pairs of
oculomotor neurons and combined it with modeling to
predict the nature of synapses involved in connecting
them. We also see evidence of underlying oscillations
in the firing of these neurons despite being persistent
on average. Currently, we are building models to
understand what kinds of underlying neural circuits
could give rise to the observed oscillations in an effort
to predict the circuits that are responsible for persis-
tent activity in the goldfish.
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PRINCIPLES OF BRAIN DESIGN
D.B. Chklovskii B. Chen A. Stepanyants
A. Nikitchenko Q. Wen
S. Song
Full understanding of the brain seems impossible
without a comprehensive account of neuronal cir-
cuits. As the pattern of synapses between neurons
underlies information processing in neuronal circuits,
we must describe this pattern and discover the basic
principles underlying synaptic connectivity. As the
shape of a single neuron affects transformations per-
formed on its inputs, for example, through its electro-
tonic properties, we must describe neuronal shapes
and understand their significance. Full understanding
of development also requires a comprehensive
description of neuronal shape and synaptic connectiv-
ity; they are, after all, the objective of development.
We focus on understanding synaptic connectivity and
neuronal shape with the goal of discovering basic
principles of brain design and function. We pursue
this goal on several levels through developing auto-
mated image processing algorithms and creative data
analysis and building a theoretical framework based
on engineering principles.
RECONSTRUCTION OF THE C. ELEGANS WIRING
DIAGRAM FROM ELECTRON MICROSCOPY
Because synapses are submicron objects, they can be
unequivocally detected only with electron microscopy
(EM). However, describing synapses of even a single
neuron requires reconstructing neuropil over several
hundred microns. In principle, this range of scales can
be covered by serial section EM. In practice, however,
neuronal circuit reconstructions are rare because this
technique is laborious and time-consuming. The most
extensive reconstruction, that of the Caenorhabditis
elegans nervous system, relied on approximately 104
serial sections and took about 10 years. Even this
reconstruction was not completed-the exact synaptic
connectivity of the ventral cord has never been pub-
lished. We are finalizing the C. elegans reconstruction
by using White's EM photographs and lab notebooks,
as well as newly obtained EM photographs (in collab-
oration with D. Hall, Albert Einstein College of
Medicine). This reconstruction is all but complete and
provides the first "proof of principle" connectivity
matrix of the full nervous system.
HIGH-THROUGHPUT AUTOMATED EM
Reconstructions on the scale larger than C. elegans
cannot be done manually and require high-throughput
automated EM, which could be based on one of the
following technologies: transmission EM, high-volt-
age EM tomography, and serial block-face scanning
EM. With serious efforts to develop high-throughput
EM currently under way in several laboratories, we
expect that the leading candidate will emerge in the
next couple of years. Meanwhile, we are developing
automated reconstruction algorithms that will be nec-
essary to handle gigantic data sets to be generated by
high-throughput EM (in collaboration with A.
Koulakov, CSHL). A successful algorithm must pro-
duce a connectivity matrix of neuronal circuits such as
the one for C. elegans. In addition, it must extract the
shapes of neurons and the locations of individual
synapses. Although this project is extremely challeng-
ing, we believe that this is the right time for it because
of recent developments in digital image processing,
continuing improvements in computer performance,
and the existence of high-level programming environ-
ments such as MATLAB.
AUTOMATED ALIGNMENT OF SERIAL SECTIONS
The crucial first step for reconstructions using transmis-
sion EM and, to a lesser extent, for the other two tech-
nologies, is alignment of serial sections. The need for
alignment arises from irregular placement of the sections
on the grid and from their physical distortion, including
stretching and shear. Traditionally, such alignment isper-
formed manually and is rather time-consuming, espe-
cially if significant distortion is present. We developed
an automatic algorithm for section alignment that over-
comes distortion (including nonlinear). Currently, we
perform alignment of real-life stacks of hundreds ofser-
ial EMs for our collaborators. If funding becomes avail-
able, we will build a Web site for automated reconstruc-
tion open to the neuroscience community.
SEGMENTATION OF EMs AND 3D ASSEMBLY
In our approach, we first segment images into cross sec-
tions of individual neurons in 2D and then string them
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together in 3D. Traditionally, 2D segmentation is done
by manually tracing contours of the objects of interest.
Our algorithm performs segmentation automatically
and for the whole volume at once. One of the challenges
was to overcome a nonuniform contrast across the
image. The next step of the reconstruction is to assem-
ble 2D cross sections into 3D shapes of axons and den-
drites. We have developed an automatic algorithm based
on evaluating proximity and similarity of the 2D cross
sections. To validate our algorithm, we compare the
results of automatic reconstructions with those done
manually by the experts on the same data set (Fig. 1).
Development of the automated reconstruction algo-
rithms follows a hybrid approach. We aim to maximal-
ly automate reconstruction while retaining manual con-
trol over the process, using convenient monitoring and
editing tools. Eventually, experience gained with our
manual tools will be incorporated into the automatic
algorithm. We expect that fully reconstructing a ner-
vous system of an organism, such as Drosophila, will
make an impact on neurobiology comparable to that of
sequencing DNA on molecular biology.
STATISTICAL DESCRIPTION OF SYNAPTIC
CONNECTIVITY
Although a complete description of neuronal circuits
can only be achieved with EM, there are several rea-
sons other approaches must be pursued in parallel.
First, the complete reconstruction of a complex circuit
such as the mammalian cortical column is many years
away, yet demand already exists (among experimental-
ists and theorists) for an approximate description of
circuitry. Second, synaptic connectivity varies among
animals and within one animal over time and EM can-
not be applied in vivo and on a large enough scale to
explore variability. Third, EM is not well suited to
detect differential gene expression, an important mark-
er of neuronal class and cell processes. This is why, in
parallel with reconstructions from EM serial sections,
we analyze light microscopy and electrophysiology
data. Such description must necessarily be statistical,
or probabilistic, because the presence of a synapse can-
not be unequivocally established (in light microscopy)
and because only a small subset of neurons can be
probed in each experiment, meaning that data from dif-
ferent brains must be somehow combined.
We are assembling geometric connectivity maps
using light microscopic 3D reconstructions of axonal
and dendritic arbors. This approach is based on the con-
cept of potential synapse, a location in neuropil where
an axon and a dendrite come within a certain distance
so that a synapse can be formed by growing a spine or
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Manual reconstruction Automatic reconstruction
FIGURE 1 Dendrite segment reconstructed by our automatic
algorithm compared with the manual reconstruction by the experts
(J. Fiala and K. Harris, http://synapses.mcg.edu). Although the
general quality of automatic reconstruction is reasonable, some
discrepancies are present. We are developing manual editing tools
for online correction of the automatic reconstruction.
a bouton. The exact distance depends on the type of a
synapse that can exist. If the dendrite is spiny, the dis-
tance is given by the spine length (-2 pm). Otherwise,
the distance between the dendritic and axonal centroids
is given by the sum of their radii. Using 3D reconstruc-
tions of neurons from different cortical layers, we cal-
culate geometric input and output maps. Such maps
show the number of potential synapses expected
between neurons at given locations. As expected, these
maps exhibit layer specificity in potential synaptic con-
nectivity. Yet, the potential connectivity domain is rather
wide, a few
ated with the cortical column. Therefore, potential
synaptic connectivity within a cortical column is close
to all-to-all. In other words, any two neurons within a
cortical column can make a synapse if they need to.
GEOMETRIC CONNECTIVITY MAP IS A USEFUL
STARTING POINT FOR DESCRIBING SYNAPTIC
CONNECTIVITY
As potential synapse is a necessary condition for an
actual synapse, the number of potential synapses pro-
vides an upper bound on the number of actual synaps-
es. Geometric connectivity maps are particularly sig-
nificant in view of the structural plasticity in adult
neocortex: Actual synapses can appear and disappear
while potential synapses stay put. Therefore, an invari-
ant description of synaptic connectivity should be
done on the level of potential synapses.
COMPARISON OF GEOMETRIC CONNECTIVITY
MAPS WITH MAPS FROM PHOTOSTIMULATION
EXPERIMENTS
Although potential synaptic connectivity provides a
convenient description of a neuronal circuit, activity of
neurons is still determined by the currents injected at
the actual synapses. To understand how potential
synaptic connectivity is related to actual, we are col-
laborating with the Svoboda laboratory here at CSHL;
they use laser-scanning photostimulation to measure
the spatial distribution of functional input to individ-
ual neurons in L2/3. Photostimulation results were
compared with geometrical maps obtained from quan-
titative morphological reconstructions of labeled neu-
rons. With this approach, we were able to test whether
neuronal morphology and the overlap of dendrites and
axons predict functional circuits. It turns out that for
most individual projections (e.g., between layer 4 and
layer 2/3), geometry predicts functional inputs up to a
single scale factor: synaptic strength per potential
synapse. This factor, however, varies from projection
to projection and exceptionally within a projection.
STATISTICAL ANALYSIS OF FUNCTIONAL
CONNECTIVITY
Another approach to describe connectivity is by elec-
trophysiologically recording from neuron pairs.
Because the number of cells from which recordings
can be made is limited, this approach is necessarily
based on sampling. Analysis of an exceptionally large
data set of recordings (in collaboration with S. Nelson,
Brandeis University) has revealed that within a cortical
column, connectivity is highly nonuniform. Distribu-
tion of connection strength, as measured by the average
EPSP amplitude, has a heavy tail. We found that 17%
of connections contribute 50% of synaptic weight. In
addition, these connections are highly clustered, form-
ing a skeleton of stronger connections in the sea of
weaker ones (Fig. 2). This description contrasts strong-
ly with the random or uniform connectivity assump-
tions made by many computational neuroscientists
when analyzing network dynamics.
SEARCH FOR ENGINEERING PRINCIPLES OF BRAIN
DESIGN AND FUNCTION
As demonstrated by the C. elegans example, a synap-
tic connectivity matrix (or a statistical description) is
not by itself sufficient to understand brain function.
Additional experimental data are needed, such as, for
example, electrophysiological recordings. However,
electrophysiological experiments in C. elegans are
notoriously difficult, perhaps, explaining why nervous
system function has not been understood despite the
unprecedented completeness of the anatomical data.
Yet the situation is changing quickly, thanks to geneti-
cally encodable calcium indicators, which allow mon-
itoring neuron and muscle activity in vivo. We are
combining anatomical information with calcium
imaging experiments to understand how undulatory
locomotion is generated and controlled in C. elegans
(in collaboration with J. Pierce-Shimomura, Univer-
sity of California, San Francisco, and C. Bargmann,
The Rockefeller University). Unlike most computa-
tional neuroscientists, who begin modeling neuronal
dynamics by assuming a circuit, we have an advantage
of knowing the actual circuit. In addition, our theoret-
ical predictions can be tested relatively easily in C.
elegans, making it an excellent model system.
IN DEVELOPING A THEORETICAL DESCRIPTION OF
NEURONAL CIRCUITS, IT IS IMPORTANT TO CHOOSE
AN APPROPRIATE LEVEL OF ABSTRACTION
Such choice must rely on our (rather rudimentary)
understanding of the basics of circuit function. For
example, how much of circuit functionality is
described by the connectivity matrix? What is the sig-
nificance of neuronal layout and shape? How impor-
tant is the location of synapses on the neuron? Why are
some connections implemented with chemical synaps-
es and others, with gap junctions? To help answer these
questions, we study neuronal circuits from the engi-
neering point of view, which includes answering why
questions. As biological systems have evolved over
hundreds of millions of years, design tradeoffs are
embedded in the blueprint of such systems. It is thus
natural that a theoretical approach to biology must
incorporate aspects of constrained optimization.
FIGURE 2 Local cortical circuits can be described as a skele-
ton of stronger connections (bold) immersed in the sea of
weaker ones (black; unidirectionals are dashed, bidirectional
are solid). Strong connections are likely to influence network
dynamics disproportionately.
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Particular success has been enjoyed by the wiring opti-
mization principle, which is rooted in Cajal's laws of
wiring economy. By using this principle, we are able to
explain many aspects of brain design, such as neuronal
placement, dimensions of axons, dendrites, and the
existence of spines, as well as the segregation of the
neocortex into the gray and white matter.
WHAT IS THE ROLE OF AXONAL AND DENDRITIC
ARBORS IN INFORMATION PROCESSING?
Since C. elegans neurons do not have elaborate arbors,
we addressed this question in the context of cortical
neurons. We find that wiring up of a highly intercon-
nected network such as the cortical column is a diffi-
cult problem. Solution of such a problem in the allot-
ted volume requires all the major features of neuronal
morphology, such as axon and spiny dendrites.
Therefore, one need not look further to find a reason
for their existence. We are extending this work to
understand branching and specific placement of
synapses. Comparing optimization predictions with
anatomy will help us to understand the functional sig-
nificance of neuronal shape.
STATISTICAL SEARCH FOR NEURONAL MODULES IN
WIRING DIAGRAMS
Another difficulty with using the connectivity matrix is
that such representation of the neuronal circuit is too
detailed for comprehensive understanding. In an
attempt to simplify the description of the neuronal cir-
cuit, we search for multineuron modules (smaller than
invertebrate ganglia or vertebrate nuclei and cortical
columns). The advantage of modular description is
illustrated by electrical engineering, where a description
of a circuit in terms of operational amplifiers, logical
gates, and memory registers is often preferred to that
showing each transistor, resistor, and diode. However,
unlike electrical engineers who designed these modules
themselves, neurobiologists need to discover such mod-
ules. Specifically, we search for a few neuron connec-
tivity patterns that are statistically overrepresented in C.
elegans relative to the expectations from the random
matrix ensemble. We performed similar analysis on the
neocortical connectivity data, obtained by sampling.
Interestingly, we have found that similar patterns, which
we call motifs, are overrepresented in both C. elegans
and the rat neocortex. In particular, reciprocally con-
nected neuronal pairs are four times more common than
expected by chance. Several triplet connectivity pat-
terns are overrepresented in both C. elegans and the cor-
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FIGURE 3 We discovered similar overrepresented connect vity
patterns, or motifs, in rat neocortex and C. elegans. These motifs
may reflect general computational constraints on the circuits.
tex (Fig. 3). A notable exception is the feedback loop
(#11), which is overrepresented only in the neocortex. In
the future, we plan to determine the significance of
these motifs for circuit function.
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BRAIN DEVELOPMENT AND PLASTICITY
H.T. Cline C. Aizenman
C. Akerman
J. Bestman
K. Bronson
K. Burgos
M. Chen
S.-L. Chiu
J. Demas
R. Ewald E. Rial Verde
K. Haas E. Ruthazer
A. Javaherian P. Sharma
K. Jensen K.V. Thirumalai
My lab is interested in determining the function of
experience in regulating brain development. It is now
commonly understood that sensory experience shapes
the development of circuits within the brain and that
experience during brain development governs brain
connectivity, perception, cognition, and behavior.
Nevertheless, the experience-dependent cellular and
molecular mechanisms that operate to establish and
modify brain connections during development are
poorly understood. By understanding the basic mech-
anisms governing brain development, we expect to
garner critical information of the origins of nervous
system dysfunction, as seen in many neurological dis-
orders.
We examine the structural and functional develop-
ment of the visual system in amphibian tadpoles. These
animals are transparent, which allows us to observe
directly the development of the brain in living animals.
In addition, we assess neuronal function using electro-
physiological assays of synaptic connectivity and
synaptic plasticity. We combine these studies with gene
transfer methods that allow us to test the function of
genes of interest in brain development. Given the high
degree of conservation of mechanisms related to brain
development and plasticity, our work will identify key
regulatory mechanisms governing brain plasticity
across species. Below is a representative project com-
pleted in the laboratory during the last year.
STRUCTURAL DEVELOPMENT OF MOTOR
NEURON AXONS USING TIME-LAPSE
IN VIVO IMAGING
The development of motor neuron axon arbors gov-
erns the connectivity between the central nervous sys-
tem and the musculature. Once the motor neuron axon
reaches the target, the growing axon branches and
forms synapses. In many cases, it is thought that exu-
berant connections are made and that these are pruned
to shape the final axon arbor and neuromuscular con-
nections. The development of the motor neuron axon
arbors has been characterized as a sequence of events
in which the axons initially branch exuberantly, fol-
lowed by a period of synapse and branch elimination;
however, the initial phase of axon arbor elaboration
and synaptogenesis has not been directly observed in
vivo. The possibility that motor axon innervation of
the periphery could develop through a dynamic
process of branch addition, maintenance, and retrac-
tion, concurrent with the formation of synaptic con-
nections, has not been addressed. To test this hypothe-
sis, we collected time-lapse images of motor neuron
axons as they elaborated complex arbors and formed
neuromuscular synapses.
We found that motor neuron axon terminal arbors
show continuous branch dynamics over 3 days of
time-lapse imaging. Using a combination of cyan-flu-
orescent protein-tagged synaptophysin (synapto-
physin-CFP) and yellow fluorescent protein (YFP) to
visualize the dynamics of presynaptic structures and
axon branches and Texas-Red-tagged a-bungarotoxin
(TR-aBTX) to label postsynaptic acetylcholine recep-
tors (AChR), we show that new branches emerge from
sites of presynaptic specialization, the majority of
which are apposed to AChR. The new branches form
neuromuscular synapses. These data suggest that
mechanisms that govern neuromuscular synaptogene-
sis also have an important role in regulating motor
neuron axon arbor development.
To probe the role of synaptogenesis in controlling
axon arbor development, we tested whether a protein
called candidate plasticity gene 15 (CPG15, also
known as Neuritin) affects this process. We previously
demonstrated that CPG15 enhances the development
of visual system connections by increasing the elabo-
ration of optic tectal cell dendrites, retinal axon arbors,
and the strength of retinotectal synapses. CPG15 is
expressed in the developing motor neurons. CPG15
expression enhances the development of motor neuron
axon arbors by promoting neuromuscular synaptogen-
esis and by increasing the addition of new axon
branches. These data indicate that motor neuron axon
elaboration and synaptogenesis are concurrent and
iterative.
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GENETICS OF MEMORY IN DROSOPHILA
J. Dubnau A. Altick
A. Blum
S. Dennison
The long-term goal of our research is to understand
memory. Dissection of complex behaviors such as
memory and learning will require a multidisciplinary
approach that will include discovery and manipulation
of the relevant genetic, cellular, and anatomical path-
ways, as well as computational modeling of how infor-
mation is processed in the brain. Work in genetic
model systems such as Drosophila can contribute to
our understanding in two main ways. First, by enabling
discovery of genes and genetic pathways underlying
behavior, genetic model systems provide entry points
for subsequent interventionist experiments. Second,
systematic manipulation of gene function in relevant
anatomical loci of the brain allows a conceptual inte-
gration of findings from cellular and behavioral neu-
roscience.
We use the Drosophila model system, which offers
an economy of scale to discover and develop hypothe-
ses in a relatively cost-effective and rapid manner.
Then, given the remarkable evolutionary conservation
of genetic, cellular, and behavioral functions, these
hypotheses can be pursued in mammalian model sys-
tems.
Gene Discovery with DNA Microarrays
J. Dubnau [in collaboration with T. Tully and N. Sinha,
Cold Spring Harbor Laboratory]
In collaboration with the Tully lab, we have used a
combination of behaviorally specific training proto-
cols and expression profiling with DNA chips to iden-
tify transcriptional responses during memory consoli-
dation (Dubnau et al., Curr. Biol. 13: 286 [2003]). We
have used this approach to compare gene expression
profiles after spaced training, which induces both
short-term and protein-synthesis-dependent long-term
memory, and massed training, which only induces
short-lived memory. We have identified a large num-
ber of candidate memory genes differentially
expressed at three different retention intervals after
spaced versus massed training. Using real-time poly-
merase chain reaction (PCR) follow-up assays, we
have confirmed differential expression for a growing
number of these transcripts. This effort has identified
candidate memory genes (CMGs), which serve as
entry points for molecular genetic investigation of
gene function in memory. Ultimate confirmation that
a gene is involved in memory formation rests with the
demonstration that in vivo modulation (disruption) of
the gene alters that process with some specificity.
With that aim in mind, we are focusing on local trans-
lational control, one of several pathways suggested
from the array experiments. Our genetic studies
already support a role in memory for several compo-
nents of this pathway. These include staufen and oskar,
which are known components of a cellular mRNA
localization machinery in oocytes, and pumilio, which
is a translational repressor protein. A large number of
the known components of the mRNA localization
machinery, as well as of the apparatus for regulating
cytoplasmic polyadenylation-stimulated translational
control, also are differentially expressed.
Drosphila 4E-BP
A. Altick, J. Dubnau [in collaboration with L. Grady
and T. Tully, Cold Spring Harbor Laboratory]
thor, which encodes a fly homolog of 4E-BR a trans-
lational regulator, is one of the CMGs induced by
spaced training relative to massed training. 4E-BPs
bind to 4E, the cap-binding protein, thereby inhibiting
translation. Upon phosphorylation, however, 4E-BPs
are removed from the complex, allowing 4G to inter-
act with 4E, and translation initiation to occur. We
have demonstrated that a hypomorphic mutation in
thor yields a defect in long-term memory measured 24
hours after spaced training (Fig. 1). Importantly, learn-
ing and shorter-term forms of memory, which are
believed to be protein-synthesis-independent, are nor-
mal in these mutant animals. We now are using a dom-
inant-negative transgenic form of thor to block 4E-
BP-mediated translation. This transgene, which con-
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FIGURE 1 thor is a long-term memory mutant. thorl mutant
animals display normal levels of memory measured 2 minutes
after a single training session. In contrast, thorl mutants exhib-
it defective long-term memory. Memory is reduced in thorl
mutants when measured 24 hours after ten sessions of spaced
training (10XSp), but not after ten sessions of massed training
(1 OXMa).
tains an amino acid substitution at the site of phos-
phorylation, blocks 4E-BP-mediated translation by
constitutively binding 4E. This transgenic approach
will allow us to acutely inactivate 4E-BP-mediated
translation during memory formation and also will
provide the means to spatially restrict expression to
distinct neuroanatomical loci.
Genetic Dissection of
Anesthesia-resistant Memory
A. Blum, J. Dubnau
In both vertebrate and invertebrate animals, anesthetic
agents cause retrograde amnesia for recently experi-
enced events. In contrast, older memories are resistant
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to the same treatments. In Drosophila, anesthesia-
resistant memory (ARM) and long-term memory
(LTM) are genetically distinct forms of long-lived
memory that exist in parallel for at least 1 day after
training. ARM is disrupted in radish mutants but is
normal in transgenic flies overexpressing a CREB
repressor transgene. In contrast, LTM is normal in
radish mutants but is disrupted in CREB repressor
transgenic flies. Until now, nothing was known about
the molecular, genetic, or cell biological pathways
underlying ARM. We have identified radish as a phos-
pholipase-A2, providing the first clue about signaling
pathways underlying ARM in any animal (Chiang et al.
2004). An enhancer-trap allele of radish (C133) also
provides an entry point to study the anatomical circuits
underlying ARM. rshci"-driven reporter expression
does not label mushroom bodies, which are the prima-
ry anatomical focus of olfactory memory research in
Drosophila. Instead, rse133-driven expression reveals a
number of novel neuronal types, several of which pro-
ject into mushroom bodies. Transgenic expression of
PLA2 driven by the rslicn3 Ga14 driver restores normal
levels of ARM to radish mutants, whereas transient
disruption of neural activity in rshc133 neurons inhibits
memory retention. Identification of radish as a phos-
pholipase-A2 and the neural expression pattern of this
enhancer trap significantly broaden our understanding
of the biochemistry and anatomy underlying olfactory
memory in Drosophila. These findings also are consis-
tent with pharmacological studies of PLA2 signaling in
memory formation in vertebrate animals. Our current
efforts are focused on a biochemical characterization
of the radish PLA2, as well as an anatomical dissection
of the neural circuits in which radish functions.
Reversible Disruption of
Synaptic Transmission
J. Dubnau, A. Blum, S. Denison in collaboration
with A.S. Chiang, Taiwan]
To map the neural circuits required for memory for-
mation, storage, and retrieval, we are using a tempera-
ture-sensitive dynamin transgene, which disrupts
synaptic transmission reversibly and on a time scale of
minutes. We are using a panel of Ga14 enhancer dri-
vers to focus expression of this dynamin transgene
within specific subpopulations of neurons. With this
approach, we are now able to reversibly silence repro-
ducibly specific groups of neurons in vivo. We already
FIGURE 2 Anatomical dissection of anesthesia-sensitive and
anesthesia-resistant memory (ARM). (Top panels) GFP reporter
expression in several neurons that participate in the circuitry
underlying olfactory memory. (Left panel) Dorsal-paired medial
neuron massively innervates the axonal outputs of the mushroom
bodies. (Middle panel) Dorsal-anterior-lateral neuron sends fibers
into parts of the posterior superior protocerebrum, including the
mushroom body dendritic field. (Right panel) Ventral-anterior-
medial neurons innervate the alpha lobes of the mushroom bod-
ies (gray). (Bottom panel) Expression of the temperature-sensitive
dynamin transgene under control of Ga14 drivers permits focused
transient inhibition of dynamin-dependent activity in specific neu-
ronal subtypes. Three Ga14 lines were used: one that expresses
in DPM and DAL, one that expresses in VAM, and a third that
expresses in mushroom bodies. In the case of the DPM and DAL
line as well as the VAM line, transient heating to the restrictive
temperature (H) causes a partial amnesia measured 3 hours after
training (compare control treatment (C] with heat shifted [H]). In
contrast, this heat shift has no effect on a control strain or on a
line that expresses the dynamin transgene in mushroom bodies.
Application of a cold-shock anesthesia cold-shock treatment
completely erases anesthesia-sensitive memory, providing a pure
measure of ARM. Use of cold shock in combination with the heat
shift (HC) reveals an anatomical dissection of anesthesia-sensitive
memory from anesthesia-resistant memory. In the DPM/DAL expressing animals, this combination treatment erases all memory, sug-
gesting that the memory disrupted by dynamin alone (H) is ARM. In contrast, the combined treatment in VAM neurons reveals that a
significant portion of the memory remaining after the dynamin effect is ARM. Thus, inhibition of VAM-dynamin mostly disrupts anes-
thesia-sensitive memory.
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have demonstrated a role for synaptic transmission in
mushroom body (MB) neurons during memory
retrieval, but surprisingly not during acquisition or
storage of early memory (Dubnau et al., Nature 411:
476 [2001]). These data suggest that the synaptic plas-
ticity underlying olfactory associative learning initial-
ly reside in MB dendrites and/or upstream of the MB
and that the resulting alterations in synaptic strength
modulate MB output during memory retrieval. But
virtually nothing is known about the neural circuitry
involved in the subsequent consolidation of short-
term, middle-term, anesthesia-resistant, or CREB-
dependent long-term memory phases-and nothing is
known about the circuitry of memory retrieval.
In collaboration with A.S. Chiang, we have identi-
fied a number of Ga14 enhancer lines that yield
expression in neurons that send projections into differ-
ent substructures of the MB. These identified MB
"extrinsic" neurons constitute a significant fraction of
the inputs, outputs, and modulation of MB. With the
dynamin method, we now can functionally manipulate
these neuronal populations as well as a number of
additional neuroanatomical loci identified by reporter
expression from a panel of approximately 60 memory
mutants (Dubnau et al., Cum Biol. 54: 238 [2003]).
Using this method of reversible neuronal disruption,
we already have demonstrated an anatomical dissec-
tion of the requirements for dynamin-dependent activ-
ity during formation and storage of anesthesia-sensi-
tive versus anesthesia-resistant memory (Fig. 2).
Ongoing efforts are focused on filling in the rest of the
circuitry for these "early" memory phases, as well as
for long-term memory and for memory retrieval.
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STEM CELLS, SIGNAL TRANSDUCTION, AND DIFFERENTIATION
G. Enikolopov J. Encinas L. Manganas K. Ravi
J. Hemish T. Michurina J. Roig
B. Kuzin B. Mish V Scheinker
M. Maletic-Savatic N. Peunova
Stem cells have a unique ability to self-renew and to
produce progenitor cells that eventually generate dif-
ferentiated cells. This cascade of transitions from stem
cells to their differentiated progeny is under dynamic
control, ensuring a rapid response to demands for
more cells due to stress, damage, or altered environ-
ment. We use flies, frogs, and mice as models to study
signals that regulate distinct steps in the differentiation
cascade and mediate the interactions between the stem
cells and their microenvironment. Our main focus is
on stem cells in the adult brain. We have generated
several models to study how stem cells decide to give
rise to progenitors and, ultimately, neurons. We also
use these models to study how disease and therapeutic
drugs affect adult neurogenesis.
Much of our interest is related to a versatile sig-
naling molecule, nitric oxide (NO). We found that, in
addition to its numerous other tasks such as fighting
infection, regulating blood pressure, and mediating
neurotransmission, NO controls cell proliferation and
differentiation. In several developmental settings, NO
suppresses cell division, helping to control the balance
between proliferation and differentiation. For instance,
we have found that NO acts as an negative regulator of
cell division in the adult mammalian brain, such that
by experimentally reducing NO levels, we can
increase the number of neural stem/progenitor cells in
the adult brain. Our findings highlight the role of NO
as an essential negative regulator of cell proliferation
in the differentiation cascade. We are now beginning
to dissect the genetic and molecular interactions
between NO and the signaling pathways that control
stem cell division and differentiation.
STEM CELLS IN THE ADULT BRAIN
Stem and progenitor cells receive specific cues that
control their self renewal and their transition through
differentiation cascades. We are interested in stem
cells in the adult organism and the signaling molecules
that control the division of stem and progenitor cells
and guide them toward their differentiated fate. To fol-
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low neuronal differentiation, we generated a series of
transgenic reporter mouse lines in which neural stem
and early progenitor cells of the embryonic and adult
brain are marked by the expression of the green, cyan,
and red fluorescent proteins (GFP, CFP, RFP) which
are under control of the nestin gene regulatory ele-
ments. We found that these labeled cells faithfully
report the status of neural stem cells after exposure to
drugs or in response to gene ablation.
We also found that in some nonneural tissues of
our model animals, fluorescence marks stem/progeni-
tor cells for these tissues. For instance, we found that
nestin-GFP-expressing cells can be found in the bulge
region of the hair follicle, where stem cells for the fol-
licle are located. By a number of criteria, these cells
indeed behave as progenitor population of the hair; in
addition, they can generate progeny of diverse lineage,
including neurons. We used transcriptional profiling
to confirm the neural potential of these cells and to
determine their relation to other types of stem cells.
We now study the ability of nestin-expressing cells
from nonneural tissues to reveal their neural potential
both in vitro and in vivo, after transplantation into the
developing and adult mouse brain.
An important focus of our studies remains the role
of NO as a regulator of adult neurogenesis. We have
recently found that NO acts to suppress the generation
of new neurons in the adult brain. In a pharmacologi-
cal approach, we blocked production of NO by intro-
ducing inhibitors of NO synthase (NOS) into the ven-
tricles of the adult brain. In a genetic approach, we
generated a null mutant for the neuronal NOS gene. In
both models, the number of new cells generated in
neurogenic areas, the olfactory subependyma and the
dentate gyrus, was strongly augmented. Importantly,
increased proliferation of progenitor cells did not alter
the fate of the extra cells. Our results reveal a role for
NO as an essential negative regulator controlling pro-
duction of new neurons in the adult brain. This finding
parallels our recent results indicating that NO also acts
as a negative regulator of stem/progenitor cells in the
bone marrow. It also suggests a strategy for enhancing
neurogenesis in the damaged central nervous system.
At the same time, it is unclear which steps within the
neural differentiation cascade are controlled by NO: It
may control the last steps in the cascade (for instance,
permitting advanced precursors cells to proceed with
an extra division) or it may act upon stem or very early
progenitor cells, accelerating their rate of division.
Furthermore, it is not known whether NO is produced
in the differentiating cells themselves, or in neighbor-
ing cells (thus acting on stem or differentiating cells in
a transcellular fashion). We now use our reporter lines
(described above) to determine whether deficit of
NOS activity changes the number of neural stem/
progenitor cells in the adult brain or affects more
advanced neuronal precursors. Our results point to a
specific step in the differentiation cascade that is con-
trolled by NO. We are now applying a similar strategy
to investigate how therapeutic drugs and selected
genes affect adult neurogenesis and to determine their
points of action within the neuronal differentiation
cascade.
NO AND EARLY XENOPUS DEVELOPMENT
Vertebrate body plan is shaped during embryogenesis
through precise coordination of cell proliferation and
morphogenetic cell movements. We investigated the
role of NO in early Xenopus development using gain-
and loss-of-function approaches by microinjecting
either mRNA encoding Xenopus NOS (XNOS) or a
chemical NO donor; conversely, we blocked NOS
activity by injecting either mRNA encoding a domi-
nant-negative form of XNOS, or chemical NOS
inhibitors. Our results show that NO suppresses cell
division and regulates cell movements during early
development of Xenopus. Excess NO production
decreases cell proliferation in the embryo. In contrast,
deficits in NO production result in excessive cell pro-
liferation in the ectoderm and distortion of cell move-
ments that underlie normal axis extension and neural
tube closure during gastrulation and neurulation. At
later stages, the deficit of NO leads to profound
defects in organogenesis. We have identified molecu-
lar targets and pathways used by NO to control cell
cycle and cell motility. Our results indicate that NO-
RhoA-ROCK signaling mediates both convergent
extension and cell division. Concurrent control by NO
helps ensure that the crucial processes of cell prolifer-
ation and morphogenetic movements are coordinated
during early development.
NO AND DROSOPHILA DEVELOPMENT
NO is an essential regulator of Drosophila develop-
ment and physiology: It has been implicated in visual
system development, immunity, behavior, response to
hypoxia, osmoregulation, and regulation of cell cycle
progression during development. We found a novel
mode of regulation of NOS function that employs
endogenously produced truncated protein isoforms of
Drosophila NOS (DNOS). These isoforms inhibit NOS
enzymatic activity in vitro and in vivo, reflecting their
ability to form complexes with the full-length DNOS1
protein. Truncated isoforms suppress the antiprolifera-
tive action of DNOS1 in the eye imaginal disc, yield-
ing hyperproliferative phenotypes in pupae and adult
flies. We found that NO regulates the cell cycle by act-
ing upon the retinoblastoma pathways, suppressing the
effect of RBF and enhancing the effect of E2F. Our
results indicate that endogenous products of the DNOS
locus act as dominant-negative regulators of NOS
activity during Drosophila development, pointing to a
novel mechanism for the regulation of NO production
in animal cells. More generally, negative control of
homodimeric enzymes by endogenous truncated iso-
forms may represent an important regulatory mecha-
nism controlling development and physiology.
In a related collaborative study with Michael
Regulski and Tim Tully here at CSHL, a wide screen for
lethal EMS-induced mutations around the DNOS locus
produced a set of lethal mutations in five complemen-
tation groups, the largest group corresponding to
DNOS. Sequence analysis of the genomic DNA of one
of these lines identified a single nucleotide transition
which created a Gly1942Glu substitution. This residue
is conserved across all known NOS proteins; although
it does not fall into the active center of enzyme, its
mutation abolishes the enzymatic activity of DNOS.
These results provide the first direct evidence that NOS
function is indispensable for development.
PUBLICATIONS
Davidoff M.S., Middlendorff R., Enikolopov G., Rietmacher D.,
Holstein A. -F., and Muller D. 2004. Progenitor cells of the
testosterone-producing Leydig cells revealed. J. Cell. Biol.
167: 935-944.
Michurina T., Krasnov P., Balazs A., Nakaya N., Vasilieva T.,
Kuzin B., Khrushchov N., Mulligan R.C., and Enikolopov G.
2004. Nitric oxide is a regulator of hematopoietic stem cell
activity. Mo/. Ther 10: 241-248.
Mignone J.L., Kukekov V., Chiang A.S., Steindler D., and
Enikolopov G. 2004. Neural stem and progenitor cells in
125
nestin-GFP transgenic mice. J. Comp. Neurol. 469:
311-324.
Regulski M., Stasiv Y., Tully T., and Enikolopov G. 2004.
Essential function of nitric oxide synthase in Drosophila.
Curr. Biol. 14: R881-882.
Seaberg R.M., Smukler S.R., Kieffer T.J., Enikolopov G., Asghar
Z., Wheeler M.B., Korbutt G., and van der Kooy D. 2004.
Clonal identification of multipotent precursors from adult
mouse pancreas that generate neural and pancreatic lin-
eages. Nat. Biotechnol. 22: 1115-1124.
Stasiv Y., Kuzin B., Regulski M., Tully T., and Enikolopov G.
2004. Regulation of multimers via truncated isoforms: A
126
novel mechanism to control nitric oxide signaling. Genes
Dev. 18: 1812-1823.
In Press
Encinas J.M., Manganas L., and Enikolopov G. 2005. Nitric
oxide and multiple sclerosis. Cum. Neur. Neurosci. Rep. 5:
(in press).
Packer M., Hemish J., Mignone J., John S., Pugach I., and
Enikolopov G. 2005. Transgenic mice expressing nNOS in
the adult nervous system. Cell. Mol. Biol. 50: (in press).
Kandasamy Ravi, postdoc, Grisha Enikolopov's lab.
CONSTRUCTION AND PLASTICITY OF THE GABAERGIC CIRCUITS
Z.J. Huang J.-R. Ango C. Wu
B. Chattopadhyaya P. Wu
G. diCristo H. Yang
S. Kulhman
Much progress in neuroscience in the past few
decades has been made in understanding information
coding, storage, and plasticity in the brain. Gluta-
matergic synapses on principal neurons-with their
vast numbers, elaborate electrobiochemical signaling
machinery, and capacity for modification- have been
a major focus of investigation. On the other hand, per-
ceptual and cognitive processes also require large
neural networks to dynamically retrieve and combine
various stored information, and to relate them to
incoming sensory input, usually with high speed and
temporal precision, on the order of tens of millisec-
onds. Evidence in the past few years increasingly sug-
gests that the GABAergic system is particularly effec-
tive in regulating the precise timing of electrical sig-
naling both within a principal neuron and among pop-
ulations of principal neurons. Networks of
GABAergic interneurons have been hypothesized to
entrain populations of principal neurons and thus
impose a coordinated "context" for the "content" car-
ried by networks of principal neurons during percep-
tion, cognition, movement control, learning, and mem-
ory. Aberrant GABAergic functions have been impli-
cated in devastating neurological and psychiatric dis-
orders such as epilepsy and schizophrenia.
Our laboratory is studying the assembly, plasticity,
and function of the GABAergic inhibitory network in
mammalian brain. We focus on the following three
areas: (1) mechanisms of subcellular organization of
distinct classes of GABAergic synapses; (2) mecha-
nisms of neuronal activity-dependent plasticity of
GABAergic synapses; and (3) role of GABAergic
function in critical-period plasticity in primary visual
cortex. Combining cell-type-specific transcriptional
promoters, bacterial artificial chromosome (BAC)
transgenic reporter mice, and high-resolution imaging,
our laboratory has established powerful in vivo and in
vitro systems to visualize and manipulate defined
classes of GABAergic interneurons. Our progress in
the past year is beginning to define the logic and out-
line of the construction of GABAergic circuits in the
mammalian brain.
Subcellular Synapse Organization
Is Independent of
Experience-driven Pruning
G. diCristo, C. Wu
The subcellular spatial organization of GABAergic
innervation is crucial for the temporal precision in their
regulation of neuronal excitability, integration, and
synchrony. Since subcellular synapse targeting is pre-
ceded by a largely genetically determined axon guid-
ance process and followed by synapse formation and
experience-driven plasticity, it is not obvious whether
this intermediate step of circuit assembly is directed
mainly by genetic programs or experience-dependent
refinement. By combining cell-type-specific promot-
ers, BAC engineering, and 2-photon imaging, distinct
classes of GABAergic synapses and their postsynaptic
pyramidal neurons were visualized in primary visual
cortex and in organotypic cultures of transgenic mice.
We show that the subcellular organization of periso-
matic and dendritic-targeted GABAergic innervations
in organotypic cultures was indistinguishable com-
pared to that in primary visual cortex. Therefore, sub-
cellular targeting of GABAergic synapses is likely
guided by cell surface molecular labels and experi-
ence-independent forms of neuronal activity.
Subcellular Organization of
GABAergic Synapses Directed
by L1CAMs and Ankyrin-based
Membrane Skeletons
J.-R. Ango, H. Yang, P. Wu
We are defining the molecular signals underlying sub-
cellular synapse targeting. We have discovered so far
that the ankyrinG -based membrane cytoskeleton is the
key molecular machinery which, through subcellular
recruitment of the Ll family immunoglobulin cell
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adhesion molecules (IgCAMs), directs GABAergic
innervation to the axon initial segment-the site of
action potential initiation. Importantly, both ankyrin
and L1CAM families contain multiple members
localized to distinct subcellular compartments. We
have significant evidence that CHL 1 (a close homolog
of L1) is involved in targeting a different class of
GABAergic synapses to neuronal dendrites. Together,
these results led us to propose a general hypothesis:
Members of L1CAMs recruited to subcellular
domains by different ankyrins may constitute a set of
"compartmental code" in principal neurons to direct
subcellular organization of GABAergic synapses.
An important implication of these discoveries is
that subcellular segregation of GABAergic synapses
is superimposed on an elaborate subcellular organiza-
tion of ion channels. Such spatial alignment of bio-
physical properties and synaptic inputs, in some cases
upon the same macromolecular complex, may confer
the ultimate temporal precision of neuronal signaling
within and among neurons. These studies suggest an
unexpected link from subcellular molecular organiza-
tion, neuronal connectivity, to network properties. In
addition, there should be a family of receptors on dif-
ferent classes of GABAergic neurons to "read" the
compartmental code.
Neuronal Activity-dependent
Plasticity of GABAergic
Synapses and Circuits
B. Chattopadhyaya, G. diCristo, C. Wu
Although precision and speed of transmission are
prominent features of at least certain classes of
GABAergic neurons, it has been well documented that
experience and injury profoundly alter the connectiv-
ity and function of GABAergic synapses. The logic
and mechanism of neuronal activity-dependent plas-
ticity of the GABAergic network are poorly under-
stood.
Using high-resolution imaging of a defined class of
GABA synapses, we discovered that following the ini-
tial targeting to a defined subcellular domain, there is a
prolonged maturation of GABA innervation, character-
ized by elaboration of multiple terminals and prolifera-
tion of synapses. This maturation process can proceed
to a substantial extent in an organotypic culture system,
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but it is regulated by level/pattern of neuronal activity
and sensory experience during a restricted postnatal
period in visual cortex. Using "single-cell genetics" in
organotypic cultures, we are making significant
progress in understanding the molecular mechanism of
activity-dependent morphologic plasticity of a major
class of GABA synapses. First, we discovered that,
although GABA transmission is "inhibitory," GABA
synthesis and signaling are essential in synaptic miser -
vation and maturation (Fig. 1). This unexpected finding
suggests that in addition to its role as an inhibitory neu-
rotransmitter, GABA has a key role in axon branching,
synapse proliferation, target coverage, and thus the con-
struction of circuits. Second, we discovered that the Fyn
tyrosine kinase, neural cell adhesion molecule
(NCAM), and its polysialic acid (PSA) modification all
have a role in the morphologic plasticity of GABAergic
presynaptic terminals. These results begin to suggest a
pathway in which activity-dependent regulation of
GABA synthesis and signaling through the GABAB
receptors and G proteins could regulate Fyn kinase
activity, which then modulates the voltage-gated calci-
um channel and therefore Ca" dynamics in presynaptic
terminals. The spatial and temporal dynamics of Ca"
signaling have been shown to trigger a variety of mor-
phogenic events.
Our studies suggest that the logic and mechanism
of the plasticity of GABAergic synapses may be fun-
damentally different from that of the glutamatergic
excitatory synapses. For example, synapse specificity
in the plasticity of glutamatergic synapses is the basis
for information coding and storage. However, the plas-
ticity of the GABAergic synapses that we observed is
not restricted to particular terminals, but "cell wide"
and, in this sense, global. These results have important
implications in the function of GABAergic plasticity
on neural network activities.
GABAergic Transmission
and Critical-period Plasticity
in Visual Cortex
S. Kuhlman
During early postnatal life, visual deprivation alters
synaptic transmission in visual cortex such that binoc-
ular cortical neurons cease to respond to stimulation of
the deprived eye. Long-term depression (LTD)
FIGURE 1 GABA synthesis and signaling influence the construction of GABAergic
circuits. (Left) A wild-type basket interneuon projects highly exuberant local axon
arbors and branches, which bear dense synaptic boutons (arrow). Deletion of a
GABA synthetic enzyme in a single basket cell (right) greatly reduces its axon termi-
nal branches and synaptic boutons, and thus the innervation of its target neurons.
induced via spike-timing-dependent plasticity (STDP)
rules has been implicated in competition-based
Hebbian plasticity and selective weakening of
deprived input. However, the precise mechanisms by
which input from the two eyes compete within the cor-
tical circuit for control of postsynaptic action potential
is not known. GABAergic transmission has been
implicated in the temporal precision of spike genera-
tion and is necessary for ocular dominance (OD) plas-
ticity, but the cellular mechanism is obscure.
We hypothesize that rapid and transient recruit-
ment of GABAergic inhibition by open eye input
suppresses the deprived pathway from driving post-
synaptic spikes, resulting in synaptic depression via
STDP rules. We developed a two-pathway stimula-
tion paradigm at layer 4 to layer 2/3 connections in
visual cortical slices and demonstrated that there is a
developmental shift in the interaction of converging
synaptic inputs, from summation/coordination to
suppression/competition. This developmental
increase of competition is in part mediated by the
maturation of GABAergic inhibition, which dynami-
cally regulates spike generation. Modeling studies
further suggest that mature GABA transmission pro-
motes depression of uncorrelated synaptic inputs. We
propose that GABAergic inhibition recruited by cor-
related input is a potent competitive mechanism to
suppress spike probability of uncorrelated input,
thereby engaging molecular cascades leading to
synaptic depression. This study reveals a plausible
GABAergic mechanism in critical-period plasticity,
which is distinguishable from (but regulates) the
well-known "core plasticity machinery" at gluta-
matergic synapses and neurons.
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Genetic Logic of GABAergic
Cell Types and Gene
Expression Profiles
J.-R. Ango, P. Wu [in collaboration with Dr. S. Nelson,
Brandeis University]
We continue to generate BAC transgenic mice which
label different classes of interneurons with fluorescent
proteins. We have initiated a new effort to characterize
gene expression profiles in several classes of
GABAergic interneurons. This was made possible by
developing a procedure to manually purify GFP-
labeled interneurons from our BAC transgenic reporter
mice. A systematic understanding of gene expression
profiles among different classes of interneurons
throughout development and in response to stimulation
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will yield fundamental insight into the logic of the
design and function of the GABAergic system.
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BIOPHYSICAL BASIS FOR NEURAL COMPUTATION
A. Koulakov M. Nikitchenko
D. Tsigankov
Neurons in the brain display the sort of duality that has
inspired philosophers for many centuries. On the one
hand, neural networks process information. In doing
so, they represent our ideas, feelings, and thoughts. On
the other hand, information is processed by a finely
tuned physiological apparatus, extremely sophisticated
per se. It is not even clear what level of function of the
nervous system is more complex, information process-
ing or physiological organization. In our lab, we
attempt to connect these two features of the nervous
system. We argue that the latter often provides cues
about the former and vice versa, and that these two
components cannot be understood without one another.
Hysteretic Model for
Neural Integrator
M. Nikitchenko, A. Koulakov
Persistent firing is a likely candidate for the neural
correlate of short-term memory. In some cases, the
variable stored in memory is continuous in nature.
Examples of such variables include position of an
object in the sensory space and tension of a muscle, or
variables representing accumulated sensory evidence.
Such variables are encoded in persistent neuronal fir-
ing, which has a graded set of values. Perhaps the best-
studied system of this type is the oculomotor neural
integrator. Graded persistent activity in this system is
likely to be maintained by positive feedback. This
poses a basic problem of robustness, since mistuning
of the feedback leads to instabilities, which are hard to
avoid in realistic systems. It was hypothesized that the
problem of robustness could be solved by introducing
hysteresis into neuronal responses. A recent study in
the goldfish oculomotor integrator (Aksay et al.,
Cerebr. Cortex 13: 1173-1184 [2003]) may determine
whether hysteretic mechanism of robustness is indeed
used. Two basic observations are made about history
dependence of neuronal responses in this system: (1)
firing rate of one neuron versus the other exhibits hys-
teresis and (2) the size of this hysteresis varies from a
pair of cells to a pair of cells. In this study, we devel-
op a mathematical approach, which allows us to
address these observations. We derive a kinetic equa-
tion, which can describe an ensemble of hysteretic
units effectively and accurately. Using this approach,
we consider dynamics of an ensemble of hysteretic
units with different values of hysteresis, similarly to
the experiments in goldfish. We conclude that such an
ensemble exhibits history dependence of firing rates,
including hysteresis in the firing rate of one cell ver-
sus the other. Thus, experimental observation number
one, cited above, may follow from observation number
two. This conclusion follows from entanglement of the
distribution function of activated units in the phase
space of the system. We confirm this conclusion by
studying an integrator based on a single neuron with
100 hysteretic dendritic compartments.
Complete Structure of Topographic
Maps in Ephrin-A-deficient Mice
D. Tsigankov, A. Koulakov
Axons of retinal ganglion cells establish orderly pro-
jections to the superior colliculus of the midbrain.
Axons of neighboring cells terminate proximally in
the superior colliculus, thus forming a topographical-
ly precise representation of the visual world.
Coordinate axes are encoded in retina and in the target
through graded expression of chemical labels.
Mapping based on chemical labels alone does not
yield required specificity of connections. Additional
sharpening is provided by electrical activity, which is
correlated between neighboring axons. In this work,
we propose a quantitative model that allows combin-
ing the effects of chemical labels and correlated activ-
ity in a single approach. Using this model, we study a
complete structure of two-dimensional topographic
maps in mutant mice, in which one of the labels,
encoding a horizontal retinal coordinate (ephrin-A), is
reduced/eliminated. We show that topographic maps
in ephrin-A-deficient mice display granular structure,
with the regions of smooth mapping separated by lin-
ear discontinuities reminiscent of fractures observed
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Retina SC, ephrin-/-
FIGURE 1 Topographic maps in ephrin-A2/A5 -/- knockout
mice are analyzed by a computational model that includes chem-
icals labels and correlated activity-based refinement. The result-
ing map contains domains of continuous mapping separated by
linear discontinuities similar to fractures in orientation preference
maps in other mammals, with more complex organization of visu-
al maps. Thus, a loss-of-function experiment becomes a gain-of-
function experiment. SC indicates superior colliculus.
in the maps of preferred orientation. We also demon-
strate the presence of point singularities, similar to
pinwheels in orientation maps.
Activity and Competition in
Surgically Manipulated
Retinotectal/Collicular Maps
D. Tsigankov, A. Koulakov
We analyze a theoretical model of retinotectal/collicu-
lar map development in surgically manipulated sys-
tems. Our model is based on the total affinity of reti-
nal ganglion cell axons to their targets in tectum. This
total affinity includes chemoaffinity, activity-depen-
dent Hebbian contribution, and competition for posi-
tive factors in the target. We show that many observed
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phenomena may be described in the same framework
in terms of the interplay of different contributions to
the total axonal affinity. Thus, after removal of a part
of the retina or tectum, the final topographic map is
stretched or compressed. This behavior results in our
model from the axonal competition for positive fac-
tors, which is similar to one considered for the neuro-
muscular junctions, and chemoaffinity. The competi-
tion maximizes the number of branches for each axon,
ensuring approximately the same number of them for
every axon. Chemoaffinity arranges these connections
in a topographically precise order. In another experi-
ment, when lesions are made in the contralateral reti-
na, the sprouting capacity of the ipsilateral axons is
increased after chronic NMDA (N-methyl-D-aspar-
tate) receptor blockade. In our description, this phe-
nomenon appears to be due to interplay between the
axonal competition and activity-dependent Hebbian
contribution to the total affinity. The activity block
eliminates the competitive advantage of the contralat-
eral axons and leads to the increased sprouting capac-
ity of the ipsilateral axons. Finally, if the part of the
tectum is surgically reimplanted after a 180° rotation,
as was done in goldfish, the activity-independent and
-dependent mechanisms may themselves oppose one
another. The resulting map within the reimplanted
region is reversed if the region size is greater than
some critical value, and it is unchanged otherwise.
Thus, we propose the description that unites the activ-
ity-independent and -dependent mechanisms of the
retinotectal/collicular map formation together with
axonal competition within the same framework.
Automatic Alignment of
Serial-section Electron
Micrographs
A. Koulakov [in collaboration with D. Chklovskii, Cold Spring
Harbor Laboratory]
Electron microscopy (EM) of ultrathin serial sections
produces a series of misaligned micrographs. This
happens because sections are placed on the grid some-
what irregularly and because the sections are subject
to physical distortions. Therefore, the three-dimen-
sional reconstruction requires section alignment, or
registration. We designed an algorithm for fully auto-
matic registration of stacks of serial-section EM
images. Our algorithm is based on sequential pairwise
alignment of neighboring images in the stack. One of
the images in the pair remains unchanged during the
alignment procedure (reference), whereas the other is
transformed using linear (shift, rotation, magnifica-
tion, and shear) and polynomial (2nd and 3rd degree)
transformations. The quality of alignment is assessed
using a measure of similarity between the reference
and transformed images. As a measure of similarity,
we use normalized cross-correlation. To perform
alignment automatically, we maximize cross-correla-
tion with respect to the parameters of transformations.
To implement the search of the optimal set of parame-
ters, we use two popular optimization methods: simu-
lated annealing and genetic algorithm. In this work,
we compare the performance of the annealing and
genetic procedures on the stack of EM images and
compare various types of spatial transformations: lin-
ear, 2nd, and 3rd degree polynomial. The same method
with small modifications can be used to repair images
containing substantial tears and folds. We describe an
algorithm and show results of fully automatic recovery
of such images.
Analysis of Mitral Cell Odor
Responses in Behaving Mice:
Spikes and Oscillations
A. Koulakov [in collaboration with D. Rinberg,
F. 011inger, and A. Gelpering, Monell Chemical
Senses Center, Philadelphia]
We performed extracellular recordings in the olfacto-
ry bulb of awake behaving mice. The water-deprived
mice were trained in a computer-controlled olfactome-
ter to discriminate odorants. A microdrive with three
electrodes that could be moved independently by three
micromotors was implanted to record from the olfac-
tory bulb. Responses of cells from the mitral cell layer
were recorded from three electrodes simultaneously
together with behavioral events.
We addressed the question of how neuronal
responses recorded in behaving mice contribute to
odor discrimination. We distinguished three compo-
nents of the responses recorded simultaneously on all
electrodes: breathing pattern at approximately 3-4 Hz,
oscillations of the local field potential (LFP) at 50-60
Hz, and neuronal action potentials. We observed the
following: (1) Firing rate and LFP oscillations are
modulated by behavioral events and correlated with
the stimulus. This information can be used to discrim-
inate the odorants. (2) The amplitude of LFP oscilla-
tions is modulated by the breathing pattern. (3) The
timing of action potentials is correlated with the phase
of LFP oscillations. (4) Oscillations on different elec-
trodes are correlated but not identical. These observa-
tions provide insights into invariants and variability in
neural representations of olfactory stimuli.
Mitral Cell Responses in Awake and
Anesthetized Mice
A. Koulakov [in collaboration with D. Rinberg, F. 011inger, and
A. Gelpering, Monell Chemical Senses Center, Philadelphia]
The vast majority of our knowledge about the function
of neurons in the mammalian olfactory bulb was
obtained in anesthetized preparations. A few record-
ings from mitral cells in behaving animals suggest that
neuronal dynamics is quite different in behaving ani-
mals compared to anesthetized animals.
A microdrive with three electrodes that can be
moved independently by three micromotors was
implanted to record from the mouse olfactory bulb.
The water-deprived mouse was previously trained in a
computer-controlled olfactometer to discriminate
multiple odors. The implanted microdrive allows us to
record activity of individual cells for 1-5 days. After a
behavioral session, a mouse is anesthetized, and the
responses of the same cells that were recorded in the
awake animal are recorded in the anesthetized animal.
Recording of mitral cell activity in anesthetized
and awake states showed a striking difference. First,
the spontaneous activity in the awake state was much
higher and did not show an obvious synchronization
with the breathing. Second, the odor tuning of the
mitral cells was much broader in the anesthetized
state. A cell responsive to an odor onset in the anes-
thetized state did not respond to the same odor in the
awake state. Third, the same cells changed their activ-
ity in the awake state in response to behavioral cues.
A simple phenomenological model is proposed to
explain our results, and implications for the olfactory
code in the awake animal are discussed.
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THE NEURAL ORGANIZATION OF OLFACTORY BEHAVIOR
Z.F. Mainen V. Egger
C. Feierstein
H. Gurden
A. Kepecs
M. Quirk
S. Ranade
D. Sosulski
N. Uchida
H. Zariwala
Our laboratory is interested in the neural basis of
mammalian behavior. We focus on understanding the
nature of the electrical activity of single neurons, the
chief currency through which genes and molecules
express themselves in the functioning brain. We are
using the rodent olfactory system as a model for
studying neural coding, the problem of how informa-
tion is represented in neuronal spike trains. We view
neural coding in the broader framework of decision
making, that is, how neurons work together to select
one of a repertoire of possible motor actions on the
basis of experience, current goals, and sensory data.
We are especially interested in the temporal coordina-
tion of activity between neurons and between regions
of the brain that are necessary for coherent and direct-
ed action. Our principal experimental technique is
chronic multi-electrode recordings from rodents
trained to perform sensory discrimination tasks. We
are actively developing new ways of monitoring and
controlling both behavior and neural activity. We are
also using intrinsic optical imaging to study the link
between electrical activity (information) and metabol-
ic activity (energy) in the brain and two-photon imag-
ing and whole-cell recording to study the synaptic and
electrical properties of individual neurons. To help
understand the relationship between neural and behav-
ioral phenomena, we are using neural network and sta-
tistical theories that can be expressed in computation-
al models and are thereby related to our data. Our
long-term goal is to apply these approaches and
insights to human psychiatric disease, especially
schizophrenia.
Psychophysical Constraints on
Olfactory Coding
N. Uchida
How is odor information coded in the brain?
Psychophysical experiments can have a crucial role in
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elucidating neural coding because behavior is the ulti-
mate readout of the neural code. Reaction time exper-
iments, in which the time it takes to make a decision is
measured, can provide particularly crucial constraints
on the temporal aspects of neural coding. Olfaction is
sometimes thought of as a slow sense, and thus it has
been proposed that relatively slow temporal process-
ing might play a role in odor coding. We recently test-
ed this idea using an odor mixture discrimination task
in rats (Fig. 1). We found that across a wide range of
conditions, rats discriminated odors very rapidly, with
a median odor sampling duration of <300 ms (Uchida
and Mainen Nat. Neurosci. 6: 1224 [2003]). Mea-
surement of the rats' sniffing activity revealed that
optimal performance was achieved with a single sniff
at theta frequency (8-10 Hz). Since this original study,
we have continued to systematically explore parame-
ters of the task that might impact the speed and accu-
racy of olfactory decisions. These studies have led us
to focus on the contribution of motivation in deter-
mining choice behavior (see below).
In a related set of experiments, we tested the rat's
behavioral strategy in an odor mixture discrimination
task. After training, rats were tested using probe stim-
uli that possessed different absolute odor component
concentrations but identical odor component ratios as
the stimuli used in the training set. Performance was
predicted by a ratio-based discrimination strategy but
not by alternatives such as an intensity-based discrim-
ination strategy. This result indicates that molar ratios
of the components of a mixture are the critical deter-
minants of choice in this task. We propose that odor
quality is coded by the ratio of receptors that bind the
different odorants present in a stimulus, that is, a "ratio
coding" scheme based on how many receptors bind to
molecules of odor A versus how many bind molecules
of odor B when a mixture containing odors A and B is
presented. To understand how ratio coding might arise
from ensemble activity in the olfactory bulb and cor-
tex, we are currently recording spike activity in behav-
ing rats using multi-electrode techniques.
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FIGURE 1 Two-alternative odor mixture discrimination task. (4)
A rat performing odor discrimination task. Rats can perform this
task with 200 ms of odor sampling regardless of discrimination
difficulties. (B) Mixture stimuli. Two odors were mixed with vari-
ous proportions and rats were trained to report the dominant
component by making left or right a choice. (C) Typical perfor-
mance in odor mixture discrimination tasks.
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Effects of Sensory and Reward
Experience on Olfactory Decisions
H. Zariwala, N. Uchida, A. Kepecs
Although one might think of the job of the rat in our
task as determining the identity of the odors it is pre-
sented, behavioral ecology suggests that the rat is try-
ing to obtain as much water as fast as it can. That is,
animals make foraging decisions to maximize reward
and minimize work. Therefore, to understand the deci-
sions that rats make in this task, one must consider the
sensory information in the context of the incentives
afforded by the task. We have begun to systematically
investigate how olfactory decisions are influenced by
an animal's experience with stimuli and rewards, with
the goal of elucidating the underlying neural mecha-
nisms of how this influencing occurs. We find that
sensory-guided decisions can be rapidly biased by
changes in the relative value of the two reward alter-
natives present in our task.
In a recent study, we examined the effect of chang-
ing the stimulus context on a rat's performance. We
found that rats substantially improved their perfor-
mance when a single difficult stimulus pair was pre-
sented repeatedly in a session compared to the stan-
dard condition in which the whole range of easy and
difficult mixtures is interleaved. This effect reversed
immediately when stimulus context was switched
back, indicating a rapid and transient underlying plas-
ticity. Interestingly, the performance gain was
achieved without an increase in response time: There
was no speed/accuracy tradeoff.
Dynamic Reinforcement-based Learning
in Perceptual Decision Making
N. Uchida
Because environments can change dynamically, the
ability to rapidly update behavioral strategies is crucial
for survival. Recently, neuroscientists have begun to
study adaptive decision making using statistical learn-
ing theory. This mathematical framework provides a
theory for describing the optimal learning and execu-
tion of choice behavior. In particular, reinforcement
learning models show how reinforcement history can
be used to update a choice strategy to lead to a more
adaptive strategy (i.e., policy). In these models, the
role of uncertainty is critical. In an uncertain environ-
ment, i.e., one in which outcomes are hard to predict
and prediction errors are large, adaptation may occur
quickly. We tested how the uncertainty affected the
performance of the odor mixture discrimination task
by examining the effect of trial history on the perfor-
mance. Strikingly, we found substantial effects of the
recent previous experience of stimulus and reward.
Animals were dynamically adjusting or updating their
decision strategy even after extensive training.
Essentially, what was happening was that rats biased
their decisions to the recently rewarded direction, a so-
called "win-stay" strategy. More surprisingly, this
effect was much greater after rats were rewarded for
an uncertain discrimination than for an easy discrimi-
nation. Thus, dynamic learning depended not only on
history of reward but on uncertainty as well.
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Control of Sniffing: Active Sensation
and Olfactory Behavior
A. Kepecs, N. Uchida
Olfaction depends critically on an active motor
process, sniffing, which draws air across the nasal
epithelium. Respiration is proximally controlled by a
central pattern generator (CPG) in the brain stem, but
little is known about the central regulation of the res-
piratory rhythm during behavior.
Nasal thermocouples (small temperature-sensing
probes) allow us to monitor respiration in freely
behaving animals. Using this method, we are examin-
ing the regulation of respiration in rats performing a
two-alternative olfactory discrimination task. We
examine its frequency and phase in relation to odor
sampling, and also to motor and reward events.
Respiration frequency varied over a wide range (<2 Hz
to >12 Hz) during the course of a behavioral session,
systematically changing in relation to significant
behavioral events such as entry into the odor sampling
or reward ports. Interestingly, rather than a continuous
distribution of frequencies, discrete frequency modes
were observed. Rats invariably switched to a theta fre-
quency mode (8-10 Hz) shortly before (self-initiated)
odor port entry and remained tightly locked to this fre-
quency mode throughout odor presentation. The
switch between different modes occurred very rapidly,
almost always within a single respiration cycle.
Interestingly, the timing of respiration was related not
only to the sensory demands of odor sampling but also
to other motor processes. In particular, the timing of
head retractions from the odor and choice ports was
precisely coordinated with the respiratory cycle. These
observations reveal a powerful and rapid top-down
control of respiratory CPGs, allowing both expecta-
tions to direct sensory acquisition as well as the coor-
dination of respiratory and motor processes.
Single Unit Encoding of
Goal-directed Behavior in
Orbitofrontal Cortex
C. Feierstein, M. Quirk, N. Uchida
Every day we face the need to make decisions: We
choose between different alternatives to achieve
desired goals. This is the essence of "goal-directed"
behavior. Making a decision is a complex process that
depends on integrating information about the environ-
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ment, the alternative actions and their consequences,
and choosing what is more likely to result in the
accomplishment of our goal. We are interested in
understanding the neural basis of decision-making and
goal-directed behavior. In particular, we study olfacto-
ry-guided decisions. We are using chronic multi-elec-
trode recording techniques to monitor the activity of
ensembles of neurons in rats performing a two-alter-
native odor discrimination task (Fig. 1). Our studies
have focused on the orbitofrontal cortex (OFC) and
associated cortical and subcortical areas.
Orbitofrontal cortex is a region of the prefrontal
cortex critical to incorporating predictions about
expected outcomes (e.g., rewards) into decision mak-
ing. Previous work shows that single OFC neurons dif-
ferentially encode odors and visual stimuli according
to associated rewards and punishments, but it is not
known whether OFC neurons encode motor or
response variables that would be required to learn the
links between actions and their consequences or to
make goal-directed choices. We find that a large frac-
tion of OFC neurons are indeed tuned for response
direction, either alone or in combination with stimulus
or reward tuning. Analysis of error trials showed that
single OFC neurons dynamically integrated olfactory
(sensory) and spatial (response) information in a way
that allows them to predict the outcome of a trial or to
remember the stimulus associated with a delivered
reward. As a population, OFC neurons are predomi-
nantly tuned for correct stimulus-response associa-
tions in task-trained animals and thereby correctly
model the contingencies of the task. Our findings sug-
gest that in the rat OFC, circuits not only link stimuli
and reward but, like other areas of the prefrontal cor-
tex, process information about the relationships
between stimuli and actions.
Local Network Interactions in
Prefrontal Microcircuits
M. Quirk, C. Feierstein
Although much is known about the cellular and synap-
tic components of cortical circuits, considerably less is
known about how these circuits behave in the func-
tioning brain. Using multi-electrode recording tech-
niques, we are able to isolate action potentials arising
from multiple cells within a small local volume of tis-
sue (diameter <100 um). By applying these recordings
to the prefrontal cortex of rats performing our two-
alternative olfactory discrimination task (Fig. 1), we
are studying how information is represented within
these microcircuits during the formation of a binary
perceptual decision. In contrast to the typical colum-
nar organization of primary sensory areas, even near-
by cells display diverse response properties. The het-
erogeneity of responses across cells recorded in the
same electrode was comparable to that of cells across
electrodes, indicating that salient task variables
(including stimulus, response, and reward informa-
tion) represented in prefrontal cortex are available
locally within individual microcolumns. To begin to
characterize the functional architecture of a cortical
microcircuit during a behavioral task, we analyzed
pair-wise statistical interactions of the spike trains of
simultaneously recorded cells. We find strongly
enhanced interactions between neighboring neurons
compared to distal neurons, suggesting that local
inputs contribute to firing properties of cells.
Interestingly, the spike trains of neighboring neurons
are very often anticorrelated. The function of this inhi-
bition seems to be twofold. First, inhibition between
cells with opposite tuning properties promotes a form
of "winner-take-all" competition essential for effec-
tive decision making. Second, inhibition between cells
with similar tuning profiles provides a mechanism for
effectively controlling the temporal flow of informa-
tion within the circuit by limiting the number of cells
active at a given moment in time. Together, these
observations suggest a local circuit mechanism by
which prefrontal cortex learns stimulus-response
associations and uses them for decision making.
Neural Mechanisms of
Context-dependent Decisions
D. Sosulski, M. Quirk
One of the biological foundations of cognitive flexi-
bility-the ability to adapt one's behavior and think-
ing in the face of new or rapidly changing circum-
stances-is the brain's ability to integrate sensory
information from several modalities, create an inter-
nal representation of the environment, and use this
representation to subsequently guide its selection of
behavioral response in a given situation. It has long
been known that the prefrontal cortex is critical in sit-
uations when mappings exist between a single stimu-
lus and a number of behavioral responses whose
appropriateness depends on the current situation;
however, the mechanisms by which the brain actually
selects among possible behavioral responses remains
unclear. To investigate the neural mechanisms by
which stimulus-response association information and
information about context interact in prefrontal cortex,
we established a context-dependent decision-making
task that requires rodents to respond in different ways
to a stimulus, depending on the spatial context in
which they experience it. In addition, we have recent-
ly started to use multi-electrode arrays to simultane-
ously record the activity of many single neurons in rats
performing this context-dependent decision task. By
analyzing how neurons that code for different stimu-
lus-response associations are modulated by spatial
context, we hope to gain some insight into how the
brain integrates information about learned responses
and the environment, and uses this information to suc-
cessfully guide its behavior in a world that is continu-
ally in flux.
Inter-areal Coordination among Brain
Regions during Olfactory Decisions
A. Kepecs
The brain has many interconnected areas specialized
to carry out different functions. As with any complex
network, it is essential for the brain to coordinate the
activity of these many regions and to do so dynami-
cally. For instance, if you were asked to switch from
writing down what you are hearing to what you are
smelling, your brain would have to dynamically mod-
ulate the flow of information between its auditory,
olfactory, and motor areas, turning off an auditory-
motor pathway and turning on an olfactory-motor
pathway. Yet the long-range wiring of the brain is
essentially fixed. How then do neural networks in the
brain accomplish dynamic and flexible routing of
information? Or, to put it another way, how does the
massively parallel and asynchronously operating brain
coordinate its operation?
Although there is no global clock, similar to those
in computers, oscillations in neural activity have been
widely observed at specific frequencies and in identi-
fied behavioral states. If large-scale coherent neural
activity could be established across areas and dynam-
ically controlled, specificity in neural communication
could be achieved. This leads to the suggestion that
transient and dynamic oscillatory synchronization
between brain regions is used to differentially route
and thus coordinate information flow. To examine this
idea we are recording local field potentials (represent-
ing the summed coherent activity in local neuronal
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populations) simultaneously from the olfactory bulb,
olfactory cortex, and hippocampus in rats performing
an olfactory discrimination task (Fig. 1). We are using
spectral analysis to examine how features of the local
field potentials correspond to different behavioral
epochs and the nature of the relationship between
oscillations in different regions. Strong theta (4-10
Hz) oscillations appear at all sites during the task,
whereas beta (15-30 Hz) frequency oscillations are
transient, occurring specifically around the time of
choice in the olfactory bulb and ventral hippocampus.
Interestingly, the ventral hippocampus shows differen-
tial coordination with different anatomical partners:
theta band coherence with the dorsal hippocampus and
transient beta band coherence with the olfactory bulb.
These findings are beginning to paint a broad-scale
picture of the spatiotemporal organization of inter-
areal coordination during olfactory discrimination.
Olfactory Discrimination
in Mice
S. Ranade, N. Uchida
We have developed and extensively characterized the
behavior of rats during the performance of a two-alter-
native olfactory discrimination task (Fig. 1). However,
to harness the power of transgenic gene manipulation
technologies for use in the study of the neural basis of
decision making and other cognitive functions, it is
important to develop behavioral paradigms suitable
for use with mice, for which many genetic models and
manipulations currently exist. With this goal in mind,
we have trained mice to perform a two-alternative
olfactory discrimination task. We find that, similar to
rats, mice can perform this task with high accuracy
(>95% total score) and they require only 4-6 sessions
(1000 trials) to reach criterion performance (>85%).
Performance remains stable over days and even
months. In addition, the reaction time (odor sampling
time) of mice performing the two-alternative task is
very similar to rats (-300 ms). Using this well-con-
trolled behavioral task we can explore different
aspects of brain function from sensation to action. In
collaboration with Karel Svoboda's group here at
CSHL, we are applying transgenic technologies to
inducibly inhibit neural activity in restricted popula-
tions of olfactory sensory neurons. This approach will
enable us to examine the effect of specific manipula-
tions of sensory input on an animal's perception as
assayed by his performance.
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Neural and Metabolic Activity in
Olfactory Glomeruli
H. Gurden, S. Ranade, N. Uchida
Neural activity is mirrored by metabolic activity,
which in turn causes physiological signals that can be
detected using functional imaging techniques. The
mechanisms that link these processes are the subject
of intense interest. We are investigating the link
between odor-evoked neural activity and intrinsic opti-
cal signals (IOS) in the olfactory glomeruli. IOS are
used for studying the representation of odors, but we
hope to clarify how to interpret IOS as a readout of
glomerular activity and the mechanisms that link neur-
al activity to metabolism and functional imaging sig-
nals.
We used in vivo imaging and simultaneous local
pharmacology to study how sensory-evoked neural
activity is transduced into IOS in the well-defined cir-
cuitry of the olfactory glomerulus. Odor-evoked IOS
were tightly coupled to release of glutamate and were
strongly modulated by exogenous and endogenous
activation of presynaptic dopamine and y-amino-n-
butyric acid (GABA)-B receptors. Surprisingly, IOS
were independent of postsynaptic transmission
through ionotropic glutamate receptors. Instead, IOS
depended on the activation of astrocytic glutamate
transporters. Thus, glutamate uptake by astrocytes is
an important pathway by which neural activity is cou-
pled to functional imaging signals and through which
metabolic and information processing networks share
information in the brain.
Calcium Dynamics Underlying
Dendritic Integration in Olfactory
Bulb Granule Cells
V. Egger [in collaboration with K. Svoboda, Cold Spring
Harbor Laboratory]
In the mammalian olfactory bulb, axonless granule
cells process synaptic input and output reciprocally
within large spines. The nature of the calcium signals
that underlie the pre- and postsynaptic function of
these spines is largely unknown. Using two-photon
imaging in acute rat brain slices and glomerular stim-
ulation of mitral/tufted cells, we observed two forms
of action potential-independent synaptic Ca" signals
in granule cell dendrites. Weak activation of mitral/
tufted cells produced stochastic Ca" transients in
individual granule cell spines. These transients were
strictly localized to the spine head, indicating a local
passive boosting or spine spike. Ca" sources for
these local synaptic events included NMDA recep-
tors, voltage-dependent calcium channels and Ca"-
induced Ca" release from internal stores. Stronger
activation of mitral/tufted cells produced a low-
threshold Ca' spike (LTS) throughout the granule
cell apical dendrite. This global spike was mediated
by T-type Ca" channels and represents a candidate
mechanism for subthreshold lateral inhibition in the
olfactory bulb. The coincidence of local input and
LTS in a spine resulted in summation of local and
global Ca' signals, a dendritic computation that
could endow granule cells with subthreshold associa-
tive plasticity.
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TRANSMISSION AND PLASTICITY IN MAMMALIAN CENTRAL
SYNAPSES
R. Malinow A. Barria H.W.H.G. Kessels B. Li
J. Boehm M. Klein S. Rumpel
I. Ehrlich C. Kopec W. Wei
R. Huganir J. LeDoux
This laboratory is directed toward an understanding of
synaptic function, synaptic plasticity, and synaptic
dysfunction. Through such an understanding, we hope
to elucidate how learning and memory are achieved
and how diseases corrupt them.
This year, we continued to examine the regulation
of a-amino-3-hydroxy-5-methyl -3-isoazole (AMPA)
and N-methyl-o-aspartate (NMDA) receptors at
synapses that may underlie plasticity and the malfunc-
tion that could lead to diseases. Some of our studies
our summarized below.
Postsynaptic Receptor Trafficking
Underlying a Form of Associative
Learning
S. Rumpel, J. LeDoux, R. Malinow [in collaboration with
A. Zador, CSHL]
To elucidate the molecular, cellular, and circuit changes
that occur in the brain during learning, we investigated
the role of a glutamate receptor subtype in fear condi-
tioning. In this form of learning, animals associate two
stimuli, such as a tone and a shock. In this study, we
found that fear conditioning drives AMPA-type gluta-
mate receptors into the postsynapse of a large fraction of
neurons in the lateral amygdala, a brain structure essen-
tial for this learning process. Furthermore, memory was
reduced if AMPA receptor (AMPA-R) synaptic incorpo-
ration was blocked in as few as 10-20% of lateral amyg-
dala neurons. Thus, the encoding of memories in the lat-
eral amygdala is mediated by AMPA-R trafficking, is
widely distributed, and displays little redundancy.
NMDA-R Subunit Composition
Controls Synaptic Plasticity
by Regulating Binding to CaMKII
A. Barria, R. Malinow
Calcium entry through postsynaptic NMDA-Rs and
subsequent activation of calcium/calmodulin-depen-
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dent protein kinase II (CaMKII) are events that trigger
synaptic plasticity in many brain regions. Upon acti-
vation, CaMKII can associate with NMDA-Rs, but the
physiological role of this interaction is not well-under-
stood. In this study, we tested if association between
active CaMKII and synaptic NMDA-Rs is required for
synaptic plasticity. We used organotypic hippocampal
slices in which long-term potentiation (LTP) requires
CaMKII activity and NR2B, an NMDA-R subunit that
binds with high affinity to CaMKII. We found that
switching synaptic NR2B-containing NMDA-Rs with
those containing NR2A, a subunit that shows low
affinity for CaMKII, dramatically reduces LTP.
Expression of NR2A with mutations that increase
association to active CaMKII recovered LTP. Finally,
driving into synapses NR2B with mutations that
reduce association to active CaMKII prevented LIP.
We conclude that association between active CaMKII
and NR2B is required for hippocampal LTP in this
early developmental period. The switch from NR2B to
NR2A content in synaptic NMDA-Rs normally
observed in many brain regions may control plasticity
by reducing the binding of active CaMKII.
Spine Enlargement Precedes
AMPA-R Exocytosis during LTP
C. Kopec, B. Li, W. Wei, J. Boehm, R. Malinow
The changes in synaptic morphology and receptor
content that underlie neural plasticity are poorly
understood. In this study, we used a pH-sensitive
green fluorescent protein (GFP) to tag recombinant
glutamate receptors and showed that chemically
induced LTP drives robust exocytosis of AMPA-Rs
onto dendritic spines. In contrast, the same stimulus
produced a small reduction of NMDA-Rs from spines.
LTP produced a similar modification of small and
large spines. Interestingly, during LTP induction,
spines increased in volume before surface incorpora-
tion of AMPA-Rs, indicating that distinct mechanisms
underlie changes in morphology and receptor content.
Differential Subcellular
Overexpression of AMPA-R
Subunits in CA1 Neurons
H.W.H.G. Kessels, M. Klein, R. Malinow
The role of AMPA-type glutamate receptors in synap-
tic plasticity can be studied by the introduction of
recombinant AMPA subunits in glutamatergic neu-
rons. Here we show that although transient expression
of AMPA subunits leads to considerable overproduc-
tion in neuronal somata of organotypic hippocampal
slices, at dendrites, they remain close to endogenous
levels. These results provide evidence for a tightly
controlled transport mechanism of AMPA-R complex-
es traveling from soma to dendritic compartments.
Direct Phosphorylation by PKC
at a Novel Site on an AMPA-R
Subunit GIuR1 Controls Synaptic
Incorporation during LTP
J. Boehm, R. Huganir, R. Malinow
Incorporation of G1uR1- containing AMPA-Rs into
synapses has an important role in several forms of
neural plasticity. A number of signaling pathways
have been identified, but the direct modifications of
G1uR1 that control its synaptic incorporation have not
been found. Previous studies indicate that activation
of protein kinase C (PKC) is required to generate LTP,
a leading model of synaptic plasticity. However, the
targets of PKC responsible for LTP have not been
determined. We find that G1uR1 Ser-818, which is
highly conserved evolutionarily, is phosphorylated by
PKC in vitro and by LTP in hippocampal slices. Acute
phosphorylation by PKC at GluRl Ser-818 as well as
molecular mimicking phosphorylation at this site dri-
ves G1uR1 into synapses. Preventing GluR1 Ser-818
phosphorylation blocks LTP and PKC-driven synaptic
incorporation of GluRI. Thus, GluRl Ser-818 is
rapidly phosphorylated by PKC during LTP induction
and is required for its incorporation into synapses.
PSD-95 Controls AMPA-R Incorporation
during Long-term Potentiation and
Experience-driven Synaptic Plasticity
I. Ehrlich, R. Malinow
The regulated delivery of AMPA-type glutamate
receptors to synapses is an important mechanism
underlying synaptic plasticity. Here we ask if the
synaptic scaffolding protein PSD-95 participates in
AMPA-R incorporation during two forms of synaptic
plasticity. In hippocampal slice cultures, expression of
PSD-95-GFP increases AMPA-R currents by selec-
tively delivering GluR 1 -containing receptors to
synapses, thus mimicking LTP. Mutational analysis
shows that the amino terminus of PSD-95 (including
the first two PDZ domains) is necessary and sufficient
to mediate this effect. Further supporting a role in
synaptic plasticity, wild-type PSD-95 occludes LTP,
and dominant-negative forms block LTP. Moreover,
we demonstrate that PSD-95 participates also in
AMPA-R delivery during experience-driven plasticity
in vivo. In barrel cortex from experience-deprived ani-
mals, expression of PSD-95-GFP selectively increases
AMPA-R currents, mimicking experience-driven plas-
ticity. In nondeprived animals, PSD-95-GFP produces
no further potentiation, indicating common mecha-
nisms between PSD-95-mediated potentiation and
experience-driven synaptic strengthening. A domi-
nant-negative form of PSD-95 blocks experience-dri-
ven potentiation of synapses. Pharmacological analy-
sis in slice cultures reveals that PSD-95 acts down-
stream from other signaling pathways involved in LIP.
We conclude that PSD-95 controls activity-dependent
AMPA-R incorporation at synapses via PDZ interac-
tions not only during LTP in vitro, but also during
experience-driven synaptic strengthening by natural
stimuli in vivo.
PUBLICATIONS
Ehrlich I. and Malinow R. 2004. PSD-95 controls AMPA-recep-
tor incorporation during long-term potentiation and experi-
ence-driven synaptic plasticity. J. Neurosci. 24: 916-927.
In Press
Rumpel S., Ledoux J., Zador A., and Malinow R. 2005.
Postsynaptic receptor trafficking underlying a form of asso-
ciative learning. Science (in press).
141
INTEGRATIVE SYSTEMS NEUROBIOLOGY
P.P. Mitra P. Andrews
H. Bokil
H. Maniar
Partha Mitra (previously located at Bell Laboratories,
Lucent Technologies) joined the faculty at CSHL in
the fall of 2003 when this research effort began.
Hemant Bokil is a postdoctoral fellow continuing his
work on signal processing applications to neurobio-
logical time series with special emphasis on neural
prostheses. Hiren Maniar, a postdoctoral fellow, is
working as part of a consortium funded by the Human
Frontiers Science Foundation on the role of neural
synchrony in integration across sensory modalities.
Peter Andrews joined the group in August 2004 after
finishing his Ph.D. in physics and a postdoc at Yale
University, where he was responsible for the program-
ming and data analysis for the QUEST quasar survey.
Peter is performing the dual role of providing software
infrastructure for the group, as well as participating in
the open source software project Chronux to develop
software for neurobiological data analysis.
Apart from this group of core personnel, our
research effort includes close collaborative ties with
multiple research groups both locally and globally. A
collaborative effort with Niko Schiff and Keith Purpura
at the Weill Medical School of Cornell University,
where Partha is an adjunct associate professor, involves
electrophysiology in the awake behaving macaque. A
second research effort on how zebra finches learn their
song vocalizations is being carried out in collaboration
with Ofer Tchernichovski at City College of New York.
Recently, this research effort has been broadened into a
consortium of zebra finch researchers based in four dif-
ferent universities. A third collaboration is with the
group of Rodolfo Llinas at New York University
Medical College. A fourth consortium-based research
effort to study cross-modal integration between the
senses is funded by the Human Frontiers Science
Program, including the laboratories of Shinsuke
Shimojo (California Institute of Technology), Pascal
Fries (EC. Donders Research Center at Nijemegen),
Shiny' a Nishida at the Nippon Telegraph and Telephone
Corporation Labs in Japan, and Alan Johnston at
University College, London in the United Kingdom.
Our basic research philosophy is to bring computa-
tional and theoretical tools to bear on biological ques-
142
tions in general and neurobiological questions in par-
ticular, to make sense of biological complexity and to
provide understanding and potential therapies for dis-
ease. There are two basic branches to the research: neu-
roinformatics and theoretical engineering. The former
involves the application of statistical and computation-
al tools to neurobiological data, primarily single-chan-
nel and multichannel time series, including point
processes (spike trains) and brain imaging data. The
applications are geared toward exploratory analysis of
large volumes of data, as well as confirmatory analysis
for testing of specific hypotheses. This is a continuing
research effort that reflects several years of work and is
associated with a course entitled "Neuroinformatics"
held each summer at the Marine Biological Labora-
tories in Massachusetts. The second branch of research
deals with the question of theoretical principles under-
lying the design of biological systems. Since biological
organisms are evolved to perform their tasks robustly
under uncertain circumstance, in terms of both the
environment and parametric uncertainty in compo-
nents making up the system, it is expected that the
mathematical theories developed by engineers to help
design man-made systems that perform under similar-
ly challenging circumstances may also apply to these
systems. The goal of this research is to identify the
engineering principles most germane to biology and to
study selected examples drawn from different levels of
the organizational hierarchy.
Chronux: Open Source Software for
Analyzing Neurobiological
Time Series Data
H. Bokil, P. Andrews
The nervous system stores and executes behaviors and
adapts these behaviors to the environment through
sensory monitoring. Studies of the activity of the ner-
vous system consist primarily of monitoring the
dynamics of units at different levels of hierarchy of the
system, ranging from single neurons measured electri-
cally to large groups of neurons monitored indirectly
through a variety of imaging methodologies. The rel-
evant measurements consist of single or multichannel
time series data, in the form of continuous or point
processes. Therefore, the statistical analysis of time
series data is central to studying the nervous system.
During the last several years, our research has
involved the development of algorithmic and compu-
tational tools for the analysis of multichannel time
series data from the neurosciences. We are now encod-
ing these tools into an open source software package
entitled Chronux. This project will proceed in stages
and involve the development of a high-quality numer-
ical analysis library, data I0 and management utilities,
and a user interface that provides experimental neuro-
scientists access to advanced analysis tools. The pro-
ject will proceed in stages, where we move from the
current implementation of the relevant routines as
MATLAB toolboxes, to a fully open source and self-
contained software. Although there are a number of
signal processing libraries available, the goal of this
effort is to develop domain-specific tools that will aid
neuroscience research. We expect that tools such as
these will be critical to advancing our understanding
of systems neuroscience.
The past year has seen substantial improvements
made to Chronux. On the algorithmic side, we have
added routines that provide robust estimates of firing
rates based on local regression methods. We have also
created the Chronux "knowledge environment," which
is a Web-based tool for documenting Chronux and
collaboratively working on algorithm development.
We continue to work on developing new statistical
tools for time series analysis, and recent advances
include extensions of some standard measures from
spectral analysis to particular cases relevant to neuro-
biological data analysis. We have recently presented a
review of the growing field of neural time series
analysis (Brown et al. 2004).
Temporal Structure in Neural Activity
during Working Memory
P.P. Mitra [in collaboration with K. Purpura and N. Schiff,
Weill Medical School, Cornell University]
Holding items in short-term memory is thought to
correspond to appropriate holding patterns of electri-
cal activity in the brain. An experimental model sys-
tem much studied in this regard involves memory sac-
cades in awake behaving macaques, where the subject
remembers a target location during a memory period
and performs a visual saccade to the target on an
appropriate cue. Area LIP, on the lateral bank of the
intraparietal sulcus, is known to encode intended sac-
cade directions. Individual neurons may be found in
this area which show a transiently elevated firing rate
during the memory period of a saccade memory task,
with tuning to the direction of the intended saccade.
In collaborative work with Richard Andersen's lab
at Caltech, we have previously discovered that in addi-
tion to the firing rates, the dynamics of the neural
activity, as reflected in spectral measures, also shows
tuning to intended saccade direction. This project has
been transferred to the Weill Medical School of
Cornell University, where it is being carried out in col-
laboration with K. Purpura and N. Schiff. In the previ-
ous year, we completed the setup phase of the new lab-
oratory and began recording from one monkey with
dual chambers over the parietal and frontal cortices.
Preliminary recordings from the frontal eye fields
show behaviorally tuned spectral structure in the neur-
al activity, analogous to the original findings for
recordings from area LIP. These results were presented
at the annual Society for Neuroscience meeting (2004).
Song Learning in the Zebra Finch
P.P. Mitra [in collaboration with 0. Tchernichovskt,
City College of New York]
The neural substrate and evolutionary origins of linguis-
tic behavior in humans is of great biological interest, but
difficult to study, since there are no other species where
the acoustic communication behavior is seen to exhibit
the same level of syntactic complexity. Therefore, there
has been great interest in studying what has been termed
the faculty of language in a broad sense, one aspect of
which is the ability to learn vocalizations. This last is
itself infrequently found in animals-a reason why
songbirds, which exhibit learning of complex vocal
repertoires, have been the subject of intensive study. The
species of choice in this research is the zebra finch,
where all aspects of the song system have been scruti-
nized, ranging from the sensory motor circuitry in the
brain to the production apparatus. We have developed
techniques for detailed quantification of song develop-
ment, through the analysis of continuously acquired
acoustic signals from birds subjected to a controlled
training protocol.
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In this ongoing research project, Sebastien
Dergnaucourt, a postdoc in the Tchernichovski laborato-
ry, has demonstrated that sleep affects song learning,
particularly in the early stages: It appears that song per-
formance degrades after night sleep during the first few
weeks after exposure to the song model. This "morning
deterioration" is absent in the adult bird. Somewhat
counterintuitively, the birds that show the largest morn-
ing deterioration also show the best final imitation.
Although we do not yet fully understand the mechanis-
tic basis of this effect, we have demonstrated that it is
directly related to sleep: The effect was seen to occur
after induction of sleep using melatonin. It is known that
the zebra finch brain exhibits a replay of the neural pat-
terns associated with song during sleep, leading to the
hypothesis that the observed deterioration reflects an
active process that occurs during sleep. This work was
recently reported in Nature (Deregnaucourt et al. 2005).
Vocal Development in Infants
P.P. Mitra
Given the success of the extensive longitudinal record-
ings of song from the developing zebra finch, we have
started a study of human vocal development. The idea
is to carry out longitudinal recordings of infant vocal-
izations over an extended period and to analyze the
resultant data to quantify the vocal development.
Similar studies in the past have relied on human tran-
scriptions of infant sounds, or sparse recordings. The
current study will increase the coverage in terms of
recordings and will develop automated tools for analy-
sis and quantification.
Source Localization of Neural
Activity in MEG and EEG
H. Maniar, P.P. Mitra
Noninvasive imaging techniques have a critical role in
studies pertaining to cognitive processes and in deter-
mining pathological conditions in the human brain.
Ideally, the imaging technique would concurrently
exhibit both high temporal and spatial resolution.
Techniques based on hemodynamic changes, such as
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PET, SPECT, and especially fMRI, have a relatively
high spatial resolution but poor temporal resolution. In
contrast, techniques measuring neural electrical activity
such as MEG and EEG have high temporal resolution,
but a spatial resolution dependent on the inverse
methodology. We have been working on the computa-
tional implementation of a new inverse methodology,
entitled Local Basis Expansions, for localization of
neural activity. This work is part of the Human Frontiers
Science Program consortium effort with Shinsuke
Shimojo, Pascal Fries, and others, where our methods
will be employed to localize broadband oscillatory
activity in MEG and EEG measurements. The tool will
eventually be made part of the Chronux platform.
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EXPERIENCE-DEPENDENT PLASTICITY OF SYNAPSES AND
SYNAPTIC CIRCUITS
K. Svoboda B. Burbach
I. Bureau
V De Paola
N. Gray
C. Harvey
A. Holtmaat
A. Karpova
T. O'Connor
L. Petreanu
T. Sato
V Scheuss L. Wilbrecht
G. Shepherd R. Yasuda
A. Sobczyk C. Zhang
G. Tervo H. Zhong
R. Weimer K. Zito
The functional properties of the brain must change in
response to salient sensory experiences. The nature of
these changes at the level of synapses, neurons, and
their networks, also known as the engram, is unknown.
We are dissecting the mechanisms of experience-depen-
dent plasticity in the developing and adult neocortex.
Neocortical tissue is dauntingly complex: 1 mm3
contains nearly a million neurons, each of which con-
nects to thousands of other neurons. To probe neurons
and synapses within the intact network, we build and
use sensitive tools. 2-photon laser-scanning microscopy
(2PLSM) allows us to image single synapses in intact
tissues and to track changes in intracellular calcium and
signal transduction events. Excitation of neuronal ele-
ments by focal uncaging of neurotransmitters allows us
to probe the connectivity of neural networks with high
efficiency. We combine these optical methods with
electrophysiological measurements of synaptic currents
and potentials and molecular manipulations of neurons.
We use both in vivo measurements to address sys-
tem level questions and in vitro methods to get at
detailed mechanisms. As a model system, we use the
rodent barrel cortex, where whiskers are represented
in a topographic manner, with information from each
whisker represented by a small cortical region (barrel).
Whisker maps are shaped by experience during devel-
opment and reshaped in the adult. The cellular mech-
anisms underlying sensory map plasticity are likely to
share mechanisms with those underlying learning and
memory in other brain regions and other species.
[Ca21 Signaling in Single
Dendritic Spines
V Scheuss, ArSobnyk
Long-term changes in synaptic efficacy are triggered
by N-methyl-o-aspartate (NMDA) receptor-mediated
increases in [Ca'] in the postsynaptic neuron. We have
developed a variety of assays to learn about the molec-
ular pathways of Ca' influx, including the counting of
individual Ca' permeable channels and receptors in
spines. W have recently discovered that different spines
are preferentially populated with different types of
NMDA receptors (NMDA-Rs) (NR2A vs. NR2B).
Interestingly, these different types of receptors have
different Ca' permeabilities, indicating that NMDA-
Rs in synapses have the ability to regulate their Ca"
permeability independent of their conductance.
[Ca21-dependent Signaling
in Single Dendritic Spines
R. Yasuda, C. Harvey, H. Zhong
Postsynaptic Ca' activates diverse Ca"-dependent sig-
nal transduction mechanisms. We have designed high-
sensitivity fluorescence resonance energy transfer
(FRET) sensors for Ras and MAPK activation.
Fluorescence lifetime imaging microscopy (FLIM)
allows us to image Ca'-dependent signal transduction
cascades activated by synaptic transmission in dendrites
and spines. We can for the first time study the biochem-
ical dynamics of Ca"-dependent Ras signaling in neu-
ronal microcompartments. For example, we find that
Ras acts as a Ca2tdependent switch and that activation
of single synapses can lead to local activation of Ras.
Experience-dependent Plasticity
in the Adult Cortex In Vivo
A. Holtmaat, L. Wilbrecht, V. DePaola [in collaboration
with G. Knott, Lausanne]
Sensory representations in the adult brain are stable,
yet we are able to learn. Which neural elements are
plastic in the neocortex, especially in response to
novel sensory experience? Answers to these questions
are fundamental to the mechanisms of plasticity and
the memory capacity of the brain. Our approach has
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been to image structural dynamics in vivo. A break-
through was the development of long-term (months)
time-lapse imaging at the level of individual synapses
in the adult cortex of transgenic mice together with
retrospective serial-section electron microscopy.
We find that the large-scale arborization of axons
and dendrites is stable, but that neurons display a rich
repertoire of micrometer-level structural plasticity of
dendritic spines, axonal terminals, and axonal branch
tips. Plasticity differs among cell types. We have
focused on understanding the plasticity of L5B neu-
rons. L5B spines consist of two distinct populations:
small "transient" spines that live for days and large
"persistent" spines that live much longer (months).
Under baseline conditions, at least half of the transient
spines have synapses. Induction of plasticity by trim-
ming a subset of whiskers transiently (-1-4 days)
increases spine turnover, followed by stabilization
(after -1 week) with new persistent synapses.
Circuit Mechanisms of
Experience-dependent Plasticity
G. Shepherd, I. Bureau, L. Petreanu [in collaboration
with M. Chklovskii, Cold Spring Harbor Laboratory]
The wiring diagram is fundamental to understanding
cortical function and plasticity. However, little quanti-
tative information about functional circuits is avail-
able. What are the sources of input to a neuronal sub-
type in a particular layer and column and what are
their relative strengths? Which connections change
with novel sensory experience?
We developed laser-scanning photostimulation
(LSPS) into a quantitative and rapid tool for circuit analy-
sis. In brain slices, we mapped the excitatory circuits
impinging onto L2/3 neurons. We discovered "septal"
columns between the "barrel" columns. These columnar
systems are part of parallel thalamocortical circuits. To
determine if morphology can predict functional circuits
between excitatory neurons, we directly compared func-
tional LSPS maps with "geometric circuits" computed
from quantitative reconstructions of axons and dendrites.
Functional connections were accurately predicted by
geometry within a particular projection (with interesting
exceptions), but the ratio of functional to geometric con-
nectivity differed greatly (>20-fold) between projections.
What is the cellular basis for the differences between
these projections? The synaptic weight per synapse? The
density of synapses per wire length? The fraction of con-
nected neurons or the number of synapses between con-
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nected neurons? To address these and related questions,
we will develop novel approaches for circuit mapping
with single-cell resolution.
Also using LSPS, we measured the functional and
anatomical development of cortical columns, finding
remarkable specificity, without detectable "overgrowth
and pruning." We further performed an unbiased search
for experience-dependent synaptic pathways during
development. The strengths of excitatory L4->L2/3
connections changed with opposing signs in barrel and
septal columns, explaining previously observed recep-
tive field changes. The identification of these pathways
is allowing us to determine the cellular mechanisms of
experience-dependent synaptic plasticity.
Development of
Thalamocortical Axons
R. Weimer [in collaboration with C. Portera-Cailliau,
University of California, Los Angeles]
The development of mammalian cortical axons has
been studied extensively in histological preparations.
However, important questions about axonal develop-
ment require time-lapse imaging. What is the balance
between growth and pruning? How rapid are growth
and pruning? Do all axons develop with similar
sequences or are there multiple strategies for axon elab-
oration? To address these issues, we have used 2-photon
time-lapse microscopy to image axons in GFP (green
fluorescent protein) transgenic mice during the first 3
weeks of postnatal development. This period spans the
arrival of thalamocortical (TC) axon collaterals to layer
1, the presence and disappearance of Cajal-Retzius
(CR) neurons, cortical neuronal migration, and barrel
cortex critical periods. The elaboration of local axonal
arbors relies on a careful balance of growth and pruning
of axon segments that favors overall growth only slight-
ly. Pruning involved either retraction of small axon seg-
ments (tens of micrometers) or fragmentation of much
larger branches (hundreds of micrometers). The dynam-
ics of axonal arbors of CR and TC neurons differed pro-
foundly. TC axonal branch tips lack distinct growth
cones and grow rapidly in straight paths, with frequent
intersitial branch additions. The axon tips of CR axons
have large growth cones with numerous long filopodia
and grow slowly following tortuous paths. Given the
identical terrain upon which CR and TC axons grow,
these two distinct modes of growth likely reflect differ-
ent intrinsic growth programs for long-range projection
neurons versus local interneurons.
Cellular Mechanisms of
Synapse Development
K. Zito
Most of the excitatory synapses in the cortex occur on
dendritic spines, small protrusions extending from
neuronal dendrites. To determine if spine growth is
associated with synapse formation, we studied
Neurabin-I (NrbI), a neuronal specific actin-binding
protein. A severely truncated GFP-NrbI caused a dra-
matic increase (more than twofold) in the number of
spines. Using electron microscopy, we found that Nrb
is concentrated at sites of cell-cell contact and that
morphological changes reflect an increase in the num-
ber of synapses. Nrb truncations drove the polymer-
ization of spine actin to favor spine growth and
synapse formation.
Molecular Methods to Reversibly
Inactivate Synapses In Vivo
A. Karpova, G. Tervo, N. Gray, B. Burbach
Inducible and reversible silencing of selected neurons
in vivo is critical to understanding the structure and
dynamics of brain circuits. We have developed mole-
cules for inactivation of synaptic transmission
(MISTs) that can genetically be targeted to allow the
reversible inactivation of neurotransmitter release.
MISTs consist of modified presynaptic proteins that
interfere with the synaptic vesicle cycle when cross-
linked by small molecule "dimerizers." MISTs based
on the vesicle proteins VAMP2/Synaptobrevin and
Synaptophysin induced rapid (-10 min) and reversible
block of synaptic transmission in cultured neurons and
brain slices. In transgenic mice expressing MISTs in
Purkinje neurons, administration of dimerizer reduced
learning and performance of the rotarod behavior.
MISTs allow for specific, inducible, and reversible
lesions in neuronal circuits and may provide treatment
of disorders associated with neuronal hyperactivity.
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NEUROGENETICS OF MEMORY IN DROSOPHILA
T. Tully J. Barditch Y. Hua D. Leong M. Regulski
F. Bolduc K. lijima-Ando J. Luo N. Sinha
L. Grady J. Kui C. Margulies S. Xia
Studies on Pavlovian learning in many animals have
revealed remarkably similar behavioral properties of
associative learning. Surprisingly, Pavlovian learning
in fruit flies also displays these behavioral properties,
suggesting a common underlying mechanism. Neural
architecture of the Drosophila brain bears no resem-
blance to mammalian brains, of course, which sug-
gests that the behavioral "homology of function" must
result from conserved cellular/molecular mechanisms.
Consistent with this view, several genes and genetic
pathways have been identified to function in both ver-
tebrate and invertebrate associative learning, including
CREB and cAMP signaling, staufen, and regulation of
local protein translation.
We have established a role for N-methyl-D-aspar-
tate (NMDA) receptors (NMDA-Rs) in Drosophila
learning and long-term memory (LTM) formation.
The Drosophila genome carries homologs of verte-
brates NRI and NR2, subunits of which must coassem-
ble to form functional NMDA channels in vertebrates.
Similarly, dNR1 and dNR2 must be coexpressed to
form voltage-dependent NMDA-responsive channels
in flies (see Fig. 1). Flies homozygous for either of
two P-element insertion mutations of dNR1 display
moderate defects in olfactory associative learning,
5 mM NMDA
0 [Mg"] = 0 mM
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-100
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FIGURE 1 Drosophila NMDA-R function is voltage dependent
in the presence of magnesium, a key property of vertebrate
NMDA-Rs.
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which can be rescued via transgenic expression of
wild-type dNR1. Acute expression of anti-RNA for
dNR1 in adult flies disrupts 1-day memory after
spaced but not massed training, indicating a specific
disruption of CREB-dependent LTM. NR1 and NR2
appear to be expressed widely throughout the adult
brain, with preferential expression in a few novel neu-
rons. These data demonstrate an evolutionarily con-
served role for NMDA-Rs in associative learning and
memory.
MUTANTS AND MICROARRAYS
More recent investigations of NMDA-R function in
Drosophila have been accomplished by engineering
transgenic flies carrying an upstream activation
sequence (UAS)-driven anti-NR1 RNAi (RNA interfer-
ence) transgene. We have crossed these transgenic flies
with MB (mushroom body) GAL4 drivers to determine
the role of NMDA-Rs in MBs. Preliminary data suggest
that acute disruption (using hs-GAL4) of NR1 in this
manner yields defects specific to middle-term memory
(MTM), but does not affect learning or LTM.
We continue experiments using DNA microarrays
to detect gene expression changes associated with
LTM formation. To date, we have done follow-up Q-
PCR (quantitative polymerase chain reaction) on 137
candidate memory genes (CMGs) and have confirmed
51, yielding a true-positive "hit rate" of 37%. Our ulti-
mate goal is to provide in vivo validation that these
confirmed CMGs are involved in adult memory for-
mation. To this end, we have developed a method to
screen short interfering RNA (siRNA) sequences for
target genes in cultured S2 cells, using branched-DNA
methodology. Foldback RNAi transgenes are then con-
structed with a DNA sequence surrounding the effec-
tive siRNA sequence. These foldback RNAi constructs
are cloned into a UAS-driven vector, which we have
constructed to optimize the expression of these RNAi
constructs in vivo. So far, we have generated trans-
genic flies for NR1 (a positive control for our UAS-
driven vector system) and have identified effective
siRNA sequences for slmb, aur, and thor. Transgenic
flies carrying RNAi constructs for these genes are cur-
rently being generated and will be induced in adults
(using hs-GAL4) to assess an acute role for each CMG
in memory formation.
In collaboration with Gengxin Chen in Michael
Zhang's lab and Qing-Shuo Zhang in Adrian Krainer's
lab here at CSHL, we have developed a bioinformatics
approach to identify candidate genes carrying a nanos
response element (NRE) in their mRNA transcripts, to
which PUMILIO likely binds. On the basis of our pre-
viously published work, CMGs that also carry NREs
are likely to represent genes, the transcripts of which
are involved in the local control of protein translation
during LTM formation. This approach serves to
expand the pumilio/staufen pathway to include addi-
tional genes and molecular mechanisms.
In collaboration with Dr. Yi Zhong and co-workers
at CSHL, we have shown that Notch functions during
LTM formation in Drosophila. Interestingly, overex-
pression of Notch leads to enhanced memory forma-
tion in a manner similar to that for overexpression of
the CREB activator (see Publications below). These
observations again identify additional genes that may
impinge on the pumilio/staufen pathway.
CIRCUITS AND PHASES
We continue spatiotemporal experiments, which reveal
where in the adult brain CREB-dependent memory
formation occurs. To date, we have determined that
UAS-driven expression of a CREB-repressor trans-
gene, using several different MB GAL4 drivers, does
NOT block LTM formation. Conversely, we have iden-
tified one enhancer GAL4 line driving expression of
UAS-CREB-r (repressor) in central complex that does
block spaced training-specific 1-day memory (LTM).
We are currently characterizing additional enhancer
GAL4 drivers with overlapping expression in central
complex, including some of the enhancer GAL4 lines
identified by us as memory mutants.
We have developed a new method to cell-sort GFP
(green fluorescent protein)-expressing neurons from
dissociated adult brains. To maximize the protocol, we
expressed GFP in MBs, sorting dissociated cells into
GFP' versus GFP- subsets. Under these conditions, Q-
PCR reveals a 512-fold higher GFP expression in
GFP' versus GFP- cells. Q-PCR-derived expression of
CREB, Adfl, fasll, and rut were -.8-, -.5-, 8-, and 2-
fold higher in GFP' versus GFP- cells. On the basis of
published immunostaining observations, we expect to
observe no differences in expression for CREB and
Adfl and preferential expression of fasII and rut in
MB cells. We are currently repeating and extending
these results and perfecting our cell-sorting method. If
proven reliable, this new methodology will allow
important new molecular and biochemical experi-
ments on cell types identified to be involved in differ-
ent aspects of memory formation (see above).
GENETIC MODELS OF DISEASE
In vertebrate systems, STAUFEN is known to associ-
ate with Fragile-X protein (FMRP) in neural granules.
On the basis of this observation, we have begun to
study the fly homolog of FMRP. To date, we have
shown that FMRI mutants are defective in olfactory
learning, and this learning deficit can be rescued by
transgenic expression of a genomic construct. We are
currently evaluating an acute role for FMRI in memo-
ry formation.
We also have begun to study a Drosophila model
of Parkinson's disease. In many vertebrate manifesta-
tions of this form of heritable neurodegeneration, neu-
rons overexpress a-synuclein. Similarly, transgenic
overexpression of a-synuclein yields neurodegenera-
tion in flies. Accordingly, we have begun DNA
microarray studies in cultured Drosophila cells over-
expressing a-synuclein to identify candidate genes
involved in this form of neurodegeneration.
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NEURAL SUBSTRATE OF SELECTIVE AUDITORY ATTENTION
IN THE CORTEX
A. Zador H. Asan H. Oviedo
M. DeWeese S. Rumpel
T. Hromadka L.-H. Tai
G. Otazu M. Wehr
We use a combination of theoretical and experimental
approaches to study how the brain computes. The
brain is able to solve hard computations that remain
far beyond the reach of the fastest computers. Our goal
is to understand this computation at the synaptic, cel-
lular, behavioral, and algorithmic levels.
One example of such a hard computation is the
"cocktail party problem." When we tune in to one
voice at a cocktail party, and tune out the others-a
task that remains beyond the capacity of modern com-
puters-we are engaging in a form of selective audito-
ry attention. Our ability to attend selectively is not
limited to the auditory domain: Analogous tasks
demand selective attention in the visual and even
somatosensory domains. In monkeys, visual attention
selectively enhances neural activity even in the earliest
stages of visual cortical processing. This enhancement
is surprising because the areas associated with these
first stages of visual processing have traditionally
been thought of as representing the sensory world
faithfully, in a way that depends only on the properties
of the sensory input itself. The discovery of attention-
al modulation overturns the notion that the peripheral
sensory cortex is a passive "TV screen" available for
viewing by a "homunculus" buried deep within the
cortex.
The specific projects in our laboratory fall into
two main categories. First, we are interested in how
neurons represent auditory stimuli, and how these
representations are computed from the cochlear
inputs half a dozen synapses away. To address these
questions, we are using electrophysiological and
imaging approaches in anesthetized rats, as well as
computational approaches, to characterize the prop-
erties of natural sounds. Second, we are interested in
how these representations are modified dynamical-
ly-within seconds to hours or longer-in awake
behaving rats by attention and other forms of learn-
ing.
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Variability of Coding in the
Auditory Cortex
M. DeWeese
Computers rely on extremely precise, low-noise com-
ponents to compute, whereas the components that
make up neural circuits appear to be very noisy.
Nevertheless, brains outperform computers on the
kinds of hard computational problems required for
survival in the real world. To understand how brains
compute in the presence of such high levels of appar-
ent noise, we are characterizing the sources of vari-
ability (i.e., noise) in single neurons. Using in vivo
whole-cell patch-clamp recording techniques, we are
examining the trial-to-trial variability of the postsy-
naptic potential (PSP) elicited by brief tone pips. In
some neurons, trial-to-trial variability in the PSP is
small, consistent with "private" sources limited to only
the neuron under study; but for other neurons,
"shared" sources of variability produce circuit-wide
fluctuations in the synaptic drive to the neuron and its
neighbors, greatly increasing the apparent noise in the
PSP. These stimulus-independent correlations could
provide a substrate for feedback underlying cognitive
processes, such as attention and motivation.
Sparse Synchronous Inputs Drive
Neurons in Auditory Cortex In Vivo
M. DeWeese, T. Hromadka
Cortical neurons receive most of their synaptic drive
from other cortical neurons. This fact imposes a strong
constraint on models of cortical activity: The dynam-
ics of one neuron's spiking output must be consistent
with the ensemble activity of the population of neu-
rons that synapse onto it. The usual solution to this
self-consistency constraint posits that both excitatory
and inhibitory neurons fire asynchronously, varying
their rates only slowly; according to this model, sub-
threshold fluctuations in membrane potential should
be well-described by a random walk. However, based
on our experiments using the in vivo whole-cell patch-
clamp technique, we have developed an alternate
model in which inputs are organized into synchronous
volleys; according to this model, subthreshold fluctu-
ations should be small most of the time, punctuated by
large excursions corresponding to the arrival of vol-
leys. Our results show that activity is organized into
synchronous volleys superimposed on a relatively
quiet background. This observation has implications
for coding and computation. In particular, the correla-
tions we have found among the synaptic population
are precisely what is required for sparsely encoded
signals to successfully propagate from one stage of
cortical processing to the next.
Separation of Sound
Sources by Awake
Behaving Animals
G. Otazu, L.-H. Tai
Sounds in the natural world rarely occur in isolation,
but rather as part of a mixture. To survive, the audito-
ry system must be able to attend selectively to one
sound source and ignore others-and it does so more
effectively than any artificial system yet devised. To
understand how this is performed, we are using a
multi-electrode recording (tetrode) technology to
monitor the activity of many neurons simultaneously
in awake, behaving rodents performing an auditory
discrimination task.
Synaptic Mechanism Underlying
Tone-shock Learning
S. Rumpel [in collaboration with R. Malinow,
Cold Spring Harbor Laboratory]
Does learning change the strength of neuronal con-
nections in the brain? Insertion of new postsynaptic
AMPA (a- amino -3- hydroxy -5- methyl -4- isoazole)
receptors has been identified as a major process lead-
ing to increased synaptic strength. However, these
results have been obtained primarily in cultured neu-
rons, and the relationship of these processes to learn-
ing in the intact animal has remained unclear. To elu-
cidate the molecular, cellular, and circuit changes that
occur in the brain during learning, we investigated the
role of a glutamate receptor subtype in fear condition-
ing. In this form of learning, animals associate two
stimuli, such as a tone and a shock. We have found that
fear conditioning drives AMPA-type glutamate recep-
tors into the postsynapse of a large fraction of neurons
in the lateral amygdala, a brain structure essential for
this learning process. Furthermore, memory is
reduced if AMPA receptor synaptic incorporation is
blocked in as few as 10-20% of lateral amygdala neu-
rons. Thus, the encoding of memories in the lateral
amygdala is mediated by AMPA receptor trafficking,
is widely distributed, and displays little redundancy.
We are currently extending these results to the audito-
ry cortex.
Synaptic Mechanisms of
Forward Masking in
Rat Auditory Cortex
M. Wehr
In the auditory cortex, brief sounds elicit a powerful
suppression of responsiveness known as forward
masking. Forward masking has usually been attributed
to synaptic (GABAergic) inhibition. We are using
whole-cell recordings in vivo to assess the role of
synaptic inhibition to forward masking in the auditory
cortex. We are measuring the excitatory and inhibito-
ry synaptic conductances elicited by brief sounds pre-
sented at intervals from tens to hundreds of millisec-
onds. We find that inhibitory conductances rarely last
longer than 50-100 msec, whereas spike responses
and synaptic inputs remain suppressed for hundreds of
milliseconds, indicating that at these longer intervals,
mechanisms other than inhibition dominate. We con-
clude that postsynaptic inhibition contributes to for-
ward masking for only the first 50-100 msec after a
stimulus and that long-lasting suppression in cortical
cells is instead due to other mechanisms such as
synaptic depression.
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Sparse Representations for the
Cocktail Party Problem
H. Asari [in collaboration with B. Pearlmutter, National
University of Ireland, Maynooth]
To extract the behaviorally relevant information
imbedded in natural acoustic environments, animals
must be able to separate the auditory streams that orig-
inate from distinct acoustic sources (the "cocktail
party problem"). The auditory cortex has several
orders of magnitude more neurons than does the
cochlea, so that many different patterns of cortical
activities may faithfully represent any given pattern of
cochlear activity. We have been exploring the hypoth-
esis that the cortex exploits this excess "representa-
tional bandwidth" by selecting the sparsest representa-
tion within an overcomplete set of features. We have
constructed a model showing how sparseness can be
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used to separate sources perceived monaurally. The
model makes testable predictions about the dynamic
nature of representations in the auditory cortex. Our
results support the idea that sparse representations
may underlie efficient computations in the auditory
cortex.
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NEURAL BASIS OF LEARNING AND MEMORY IN DROSOPHILA
Y. Zhong H.-F. Guo K. lijima
I. Hakker A. Mamiya
F. Hannan Y. Wang
I.S. Ho
We are interested in the neural basis of learning and
memory and are taking an approach of combining
functional analyses with genetic manipulation in the
study of Drosophila. Currently, we are pursuing two
major projects: First, we are establishing Drosophila
models for studying genes involved in human neu-
rodisorders that impair learning and memory. In par-
ticular, we are interesting in genes known to contribute
to neurofibromatosis 1 (Nfl) and Alzheimer's disease.
Nfl patients are identified by neurofibromas and other
symptoms including learning defects. We are investi-
gating a hypothesis that the tumor-suppressor gene
Nfl not only acts as a Ras-specific GTPase-activating
protein (GAP), but also is involved in mediating G
protein- and Ras-stimulated activation of adenylyl
cyclase (AC); NF1-dependent AC pathways are
required for learning and memory. For Alzheimer's
disease, we have shown that overexpression of AP
peptides in Drosophila is able to recapitulate many
aspects of clinical manifestations, including age-
dependent learning defects, late onset of neurodegen-
eration, and accumulation of AP deposits. We are now
attempting to understand the molecular basis for AP
toxicity. Second, we are investigating how odors are
encoded by population neuronal activity in the fly
brain and will ultimately study learning and memory
at the level of population neural activity. Such study is
carried out in living flies via optical recordings. The
specific projects are described below.
Genetic Dissection of NPI-regulated
Pathways in Drosophila
F. Hannan, I.S. Ho, I. Hakker
NF1 is an inherited disorder that affects 1 in 3500
people worldwide. A large number of different muta-
tions are seen in NF1 patients, including some
changes that only alter a single amino acid out of the
whole NF1 protein, yet still result in NF1 disease.
Several of these missense mutations have been recon-
structed in our lab and introduced into Nfl mutant
Drosophila. These mutated human NF 1 s can over-
come some cAMP-dependent defects in Nfl mutant
flies, including small body size and learning defects,
indicating that the cAMP pathway is not affected by
these mutations.
Two mutations in the GAP-related domain (GRD),
however, show defective long-term memory even
though learning is normal in these flies. This suggests
that learning and memory may be differentially regu-
lated in flies by NF1 acting through cAMP and Ras
pathways, respectively. Verification of this hypothesis
will provide important insights into the mechanism
whereby NF1 affects learning. We propose to generate
more missense mutants and some large deletion
mutants, to look at their effects in Nfl mutant flies, to
try to pinpoint the region(s) associated with cAMP
activity versus Ras activity.
We have also recently identified a novel pathway
for NF1-dependent AC activation in flies that involves
growth factor stimulation of Ras. This pathway
requires both Ras and NF1 activity to stimulate cAMP
production. A second pathway requiring NF1 (but not
Ras) activates the rutabaga AC which is critical for
learning in flies. The mutant human NF 1 s provide an
important resource for studying the role of NF1 in this
new pathway because many other components of the
pathway cannot be fully knocked out in flies since they
have lethal effects.
A Drosophila Model of
Alzheimer's Disease
K. lijima
Alzheimer's disease (AD) is a neurodegenerative dis-
order characterized clinically by the progressive
decline in memory accompanied by histological
changes, including neuronal loss and the formation of
neurofibrillary tangles (NFTs) and senile plaques
(SPs). The accumulation of A1342 peptide, the major
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component of SPs, has been hypothesized as the pri-
mary event in AD pathogenesis. Multiple pathogenic
mutations have been identified in 13-amyloid precursor
protein (APP), Presenilinl (PS1), and Presenilin2
(PS2) genes in familial AD (FAD) and indicated that
all of these mutations caused excessive accumulation
of A1342. Therefore, decreasing the level of A1342 as well
as its toxicity in the brain would be one of the most
promising strategies among mechanism-based therapy
for AD. However, little is known about the molecular
mechanisms underlying memory defects and neurode-
generation caused by Af342.
To address this question at animal level, we used
the fruit fly Drosophila as a model organism. In addi-
tion to the state-of-the-art genetic tools, a number of
behavioral tasks such as learning and memory enable
us to monitor disease progression during aging. We
have demonstrated for the first time that the trans-
genic Drosophila expressing human A1342 can faithful-
ly reproduce AD-like phenotypes, including adult
onset, progressive AL342 amyloidosis, olfactory memo-
ry defects, and severe neuronal loss. This fly model is
especially unique in terms of its extensive cell death,
which is observed in AD patients but rarely in existing
mouse AD models. This study strongly supports the
idea that excessive accumulation of A1342 is sufficient
to cause memory defects and neuronal cell death
resembling AD and suggests that the molecular basis
underlying the A1342 toxicity can be conserved in the
fruit fly. We are using this fly AD model to conduct
several approaches to understand the molecular and
cellular mechanisms underlying A1342-induced memo-
ry defects and neurodegeneration.
Visualization of Olfactory
Learning and Memory in
Mushroom Bodies
Y. Wang, A. Mamiya
The Drosophila mushroom body (MB) is a higher
brain center that is crucial to associative olfactory
learning and memory. It is a symmetrical structure,
consisting of about 2500 intrinsic neurons in each
brain hemisphere. There are three types of morpho-
logically distinct MB intrinsic neurons, also called
Kenyon cells (KCs), in which axons are bundled sep-
arately into respective a/13, a'/13', and y lobes. Using a
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green fluorescent protein (GFP)-based Ca2+ sensor, G-
CaMP, we have attempted to visualize learning-and-
memory-associated changes in neuronal activities in
the MB. Two different systems have been employed:
an immobilized living fly and an isolated brain. In the
living fly system, MB neuronal activities are moni-
tored while the fly is being trained and tested for learn-
ing and memory. The training follows a classical
Pavlovian paradigm, in which odor stimulation is
given to the fly paired with electric shock to its legs.
Neuronal activities in the MB are imaged through a
tiny window cut in the fly head. In the isolated fly
brain system, the aversive olfactory learning is mimic-
ked by paired stimulation of the antennal nerve (AN)
and the ventral nerve cord (VNC). This system also
allows mimicking association between olfaction and
other sensory modalities, such as visual and taste stim-
ulations.
After pairing of the stimulation of the AN and
VNC, activities in the y and pi' lobes are enhanced in
response to stimulation of the AN alone. This
enhancement can last up to 1 hour. Multiple sessions
of paired stimulation of the AN and VNC with an
interval of 5-10 minutes lead to significant enhance-
ment of activities in the a' lobe in response to stimu-
lation of the AN alone. Our finding is consistent with
a behavioral study which suggests that the a and a'
lobes are involved in long-term memory, whereas the
7 lobe is required for short-term memory.
Role of Akt in Synaptic
Plasticity and Learning
H.-F. Guo
Long-term modification of synaptic strength is
important for refining neuronal circuits and is
believed to be the cellular substrate for learning and
memory. The Drosophila larval neuromuscular junc-
tion (NMJ) is a well-established preparation enabling
quantitative analyses of synaptic physiology at iden-
tifiable synapses. Various forms of short-term synap-
tic plasticity have been demonstrated at the
Drosophila NMJ, but long-term plasticity such as
long-term potentiation (LTP) and long-term depres-
sion (LTD) has not been shown. Identification and
characterization at the Drosophila NMJ would enable
the use of powerful Drosophila genetic tools for ana-
lyzing long-term plasticity and provide additional
function assays for studying functions of learning and
memory genes.
We have extensively explored long-term plasticity
at the Drosophila NMJ. To this end, we have identified
and characterized synaptic LTD at these glutamatergic
synapses. We found that applying tetanic stimulation
(tetanus) of defined frequency and duration can reli-
ably induce robust LTD. The level of depression is
dependent on tetanus frequency and Ca" concentra-
tion. The LTD is primarily due to presynaptic changes.
Genetic analysis indicates that Akt is essential for
LTD, which is greatly impaired in akt mutants, and the
impairment was rescued by acutely induced expres-
sion of the akt transgene. In addition, preliminary data
suggest that Akt is also important for Drosophila
olfactory learning.
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PLANT DEVELOPMENT AND GENETICS
From roots and stems to leaves and flowers, plants have evolved into an astonishing variety of forms
tailored by their ecological niches. Exploring the genetic programs that enable plants to develop from
seed to maturity reveals information that not only advances biological knowledge in general, but also
has potentially significant applications in agriculture, forestry, horticulture, and environmental conserva-
tion.
Soon after a pollen fertilizes an ovum, the resulting plant zygote begins to specialize, dividing asym-
metrically to produce two distinctly different daughter cells. Each of these cells then takes on a spe-
cialized role: The larger of the two cells will grow to nourish and support the embryo proper, which
develops from the smaller of the two cells. Wolfgang Lukowitz is teasing apart the molecular steps that
mediate this specialization event. He has identified a series of three proteins that appear to form part
of a signaling pathway, which ensures normal development of the zygote and its daughter cell deriva-
tives. One of the proteins probably associates with a cell surface receptor, another is an enzyme that
coordinates biological signaling within cells, and the third protein activates gene expression inside the
cell. According to Lukowitz's research, these three proteins form the basis of an important signaling
cascade that is likely to be triggered by an as-yet-undiscovered signal emanating from outside the
zygote.
Once the plant has begun to send up shoots, form leaves, and eventually flower, a new set of sig-
nals must be transmitted as the plant grows. David Jackson studies the transport of regulatory pro-
teins through "plasmodesmata" or channels through which biological signaling molecules can be trans-
ported from cell to cell. He is identifying segments of proteins or "motifs" that act as molecular board-
ing passes, allowing only proteins that bear the motif to be transported through the channel. Jackson
and his colleagues have defined the characteristics of the first such motif that enables cell-to-cell pro-
tein transport through plasmodesmata. In other work, they have identified genes that control a plant's
ability to make branches and regulate the geometries in which its leaves are positioned. Jackson's
studies of these "architectural" genes (abphyll, ramosa3, and fasciated ear2) are revealing fundamen-
tal principles of plant growth and form, and may be useful genetic tools for crop improvement.
Marja Timmermans studies how unspecialized stem cells are instructed to take on specialized roles,
for example, as parts of the (very different) top layers versus bottom layers of leaves. She and her col-
leagues are exploring the functions of several gene products (e.g., Leafbladelessl and Rolled leafl) in
this "dorsoventral axis" stem cell patterning process in maize (corn). Interestingly, Timmermans has dis-
covered that the Rolled leafl gene is regulated through RNA interference (RNAi) by short strands of
specialized RNA called microRNAs (miRNAs). miRNAs are emerging as major, previously unrecognized
players in a wide variety of organisms and biological processes. Timmermans has shown that particu-
lar miRNAs restrict production of the Rolled leafl gene to the top layers of leaves. Her findings reveal
that by regulating other genes, miRNAs can act as a developmental signal that ultimately determines
the shapes of developing maize leaves. The similarity of these findings to those made through the study
of the distantly related plant, Arabidopsis, indicates that the control of plant development by RNAi has
been highly conserved in evolution.
Part of Rob Martienssen's work involves investigating the role of RNAi in establishing silent chro-
mosome architecture, gene regulation, and plant development. His group has shown that miRNAs
restrict production of the PHABULOSA transcription factor to the top layers of Arabidopsis leaves,
where it has a role in leaf polarity. In addition, Martienssen's group directly established a role for RNAi
in plant development by showing that mutations in a known component of the RNAi machinery called
Argonaute yield striking developmental defects, namely, plants with "inside-out" leaves and flowers.
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CELL-FATE DECISIONS IN THE EARLY PLANT EMBRYO
W. Lukowitz S. Alabaster
S. Kotkin
J. Williams
In almost all higher plants, the early stages of embryo
development follow a predictable sequence of cell
divisions and cell-shape changes. This pattern reflects
coordinated fate decisions that lay down the reference
points of the plant's body plan. Our goal is to identify
and understand the genetic network regulating this
process. We are working with the small weed
Arabidopsis, which has proven to be a productive and
inexpensive experimental model with good compara-
bility to economically important species.
A MAP Kinase Pathway Promoting
Extraembryonic Fate
W. Lukowitz, S. Alabaster
Plant embryo development begins with an asymmetric
division of the zygote. This division results in a first
and fundamental fate decision that sets the stage for all
subsequent patterning events: The small apical daugh-
ter cell will produce the embryo, whereas the large
basal daughter cell will mainly form the extraembry-
onic suspensor.
Our previous work has revealed that the decision
between embryonic versus extraembryonic cell fate is
regulated by the MAPKK kinase gene YDA (see Fig.
1). Loss of YDA activity essentially eliminates forma-
FIGURE 1 The YDA MAPKK kinase is part of a
molecular switch regulating formation of the
extraembryonic suspensor. The suspensor, a file
of cells highlighted with stars in B, normally sup-
ports the developing embryo pushing it toward
the center of the immature seed. Loss of YDA
function results in suspensorless embryos that
remain in close contact with the seed coat (A).
Hyperactive versions of YDA suppress develop-
ment of the embryo, often to the extent that only
a stalk of cells is formed (C). All panels show an
optically cleared immature seed viewed using
Nomarski microscopy. Bar, 50 gm.
tion of the extraembryonic suspensor. Conversely,
hyperactive forms of YDA suppress formation of the
embryo, often to the extent that all daughters of the
zygote appear suspensor-like. On the basis of these
findings, we have proposed that YDA acts as part of a
molecular switch: YDA is active in the zygote and
required for its normal elongation. After the asymmet-
ric division of the zygote, YDA activity is turned off in
the apical cell and its daughters, which in turn become
free to develop the pro-embryo. YDA remains active in
the basal cell and its daughters to promote formation
of the suspensor.
Our genetic screens have identified mutations in
two other genes, SSP and GRD, which suppress sus-
pensor development in a manner similar to loss of
YDA. This similarity made it seem likely that all three
genes operate in the same signaling pathway. A genet-
ic analysis is consistent with this view. Double
mutants of yda with ssp or grd do not have a more
severe phenotype than yda single mutants.
Furthermore, dominant hyperactive versions of YDA
can suppress the phenotype associated with ssp muta-
tions, but have little effect on the phenotype associat-
ed with grd mutations. The simplest explanation for
these observations is that SSP acts upstream of YDA,
whereas GRD acts downstream from YDA.
We have recently succeeded in cloning the SSP
and GRD genes by a map-based approach. SSP
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encodes a cytoplasmic serine-threonine kinase of the
Pelle/receptor-like superfamily. This superfamily con-
stitutes by far the largest group of protein kinases in
plants (with more than 600 genes in Arabidopsis) and
contains almost all plant receptor kinases. Plant recep-
tor-like kinases form a monophyletic group with ani-
mal kinases of the Pelle family. Drosophila Pelle and
its mammalian counterparts, the interleukin-1 recep-
tor-associated kinases (IRAKs), interact with cell sur-
face receptors of the Toll/interleukin-1 receptor fami-
ly, which regulate such diverse processes as embryon-
ic patterning and innate immune recognition. In mam-
mals, activation of IRAKI triggers activation of trans-
forming growth factor-13-activating kinase 1 (TAK1),
which in turn triggers a MAP kinase cascade as well
as redistribution of the transcription factor NFiB to
the nucleus. By analogy, SSP might mediate signal
transduction from an as yet unknown cell surface
receptor to the YDA MAPKK kinase. This idea is sup-
ported by the sequence-based prediction that SSP is
myristoylated at its amino terminus and thus likely
peripherally associated with the plasma membrane.
The GRD gene encodes an RWP-RK protein.
RWP-RK proteins constitute a small family of puta-
tive transcription factors that have only been found in
green algae and higher plants. The first RWP-RK gene
described in the literature was minus dominance (mid)
from the unicellular alga Chlamydomonas. The mid
gene dominantly determines the mating type of
gametes. It is present in mating -type cells, but absent
in mating-type cells. Introduction of mid into mating-
type cells is sufficient to make them differentiate as
minus gametes. The second RWP-RK gene reported
was nodule inception (nin) from the legume Lotus
japonicus. The nin gene regulates a developmental
fate decision triggered by the environment, namely,
the symbiontic interaction between Lotus roots and
Mesorhizobium bacteria that results in the formation
of nitrogen-fixing nodules. One of the first steps in
nodule formation involves signaling from the bacteria
to the roots via a secreted lipochitosaccharide, termed
Nod-factor. The nin gene is thought to act downstream
from the cell surface receptors for Nod-factor to pro-
mote formation of infection threads and inception of
nodules.
The defining feature of RWP-RK proteins is a
conserved sequence stretch around a core of invariant
RWP-RK residues (Pfam02042 motif). This sequence
contains a leucine zipper motif and shares some simi-
larity with the DNA-binding/dimerization domain of
bZIP and bHLH transcription factors, but it does not
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comply with a strict consensus of either class. Because
of this similarity, it has been suggested that RWP-RK
proteins function as transcriptional regulators.
Taken together, our results have allowed us to
develop a tentative outline of the signaling pathway
regulating extraembryonic cell fate in Arabidopsis. At
the center of the proposed pathway is a MAP kinase
cascade that includes the YDA gene product and oper-
ates downstream from an as yet unknown cell surface
receptor. This receptor is most likely triggered by an
extracellular stimulus. The receptor-like cytoplasmic
kinase SSP probably functions in association with or
downstream from the receptor complex to activate
YDA. Targets of the YDA MAP kinase cascade likely
include transcription factors that execute suspensor-
specific developmental programs. A candidate target
is the putative transcription factor GRD.
We hope that a more complete analysis of the mol-
ecules involved in the YDA signal transduction path-
way will eventually allow us to understand important
aspects about the logic behind early plant develop-
ment. For example, what is the nature of the signal that
triggers the pathway, and where does it originate (per-
haps in the endosperm surrounding the zygote, or the
maternal tissue of the seed coat)? How is down-regu-
lation of the pathway in the apical cell and its daugh-
ters tied into the asymmetric division of the zygote?
Role of the YDA MAPKK Kinase
Gene in Maintaining the Stem
Cell Population of the Shoot
Apical Meristem
W. Lukowitz, S. Kotkin in collaboration with G.V. Reddy and
E.M. Meyerowitz, California Institute of Technology]
Plant growth is dependent on the continuous produc-
tion of new organs, such as leaves, flowers, or lateral
shoots. All aerial organs of higher plants are initiated
at the tips of shoots by an elaborately organized group
of cells termed shoot apical meristem. At the tip of the
shoot apical meristem is a small population of stem
cells. The size of this stem cell population is thought
to be regulated by a feedback loop between the stem
cells themselves and the cells directly below them,
referred to as the organizing center. Stem cells secrete
the small protein CLV3 that is perceived by a cell sur-
face receptor complex, including CLV1 and CLV2,
and represses transcription of the homeodomain gene
WUS. As a consequence, WUS expression is limited to
FIGURE 2 Hyperactive version of the MAPKK kinase YDA
affects development of the apical shoot meristem. Two small
leaves have been produced by the shoot apical meristem of a
5-day-old wild-type seedling (4). No small leaves are visible in a
5-day-old seedling expressing a hyperactive version of YDA (B).
The cotyledons of this seedling are fused, forming a narrow hol-
low where the meristem should be located. Both panels show
scanning electron micrographs. Bar, 200 um.
a few cells within the organizing center. These cells, in
turn, are thought to provide inductive signals that are
required to maintain the stem cells in an undifferenti-
ated state. It has been proposed that a MAP kinase cas-
cade mediates transduction of the CLV signal from the
cell surface to the nucleus. However, experimental
evidence for this claim is largely lacking, and no can-
didate genes have been reported that might function in
such a cascade.
We have begun to examine whether the MAPKK
kinase YDA operates in the CLV signal transduction
pathway. The project was triggered by the incidental
observation that seedlings harboring a hyperactive ver-
sion of YDA often fail to form true leaves or do so with
a substantial delay compared to wild type. Sean
Kotkin, a student in the Partners for the Future pro-
gram, was able to substantiate this observation by scan-
ning electron microscopy (see Fig. 2). Hyperactive
forms of YDA frequently cause fusion of the embryon-
ic leaves. The affected seedlings show a narrow hollow
at their apex and fail to produce visible organs for
many days. Both features are indicative of a defect in
the shoot apical meristem. Loss of YDA function
appears to cause an opposite phenotype, namely, a
much enlarged shoot apical meristem.
In collaboration with Venu Reddy in the lab of
Elliot Meyerowitz at Caltech, we are developing the
tools to forcibly induce YDA activity in subsets of cells
within the shoot apical meristem. We will follow the
effect of these manipulations by imaging cell divisions
and marker gene expression in the growing meristems
over time. These experiments should allow us to test
specific predictions derived from the premise that
YDA operates in the CLV pathway.
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PLANT DEVELOPMENTAL GENETICS AND FUNCTIONAL
GENOMICS
R. Martienssen K. Arney
J.-M. Arroyo
M. Byrne
D. Garcia
D. Goto
C. Kidner
Z. Lippman
B. May
P. Rabinowicz
U. Ramu
D. Roh M. Tanurdzic
M. Ronemus U. Umamaheswari
R. Shen M. Vaughn
J. Simorowski M. Zaratiegui-Biurrun
A. Tang
Epigenetic mechanisms regulate transposon silencing,
gene control, and stem cell function in plants, which
provide a useful model for higher eukaryotes. Stem
cell function and axis formation in Arabidopsis
depend on asymmetric leaves] and argonaute, which
has an important role in RNA interference. We have
demonstrated that spatially restricted small RNA can
guide leaf polarity via AGO1. In fission yeast, RNA
interference of centromeric transcripts regulate his-
tone modification, and we have found similar tran-
scripts in Arabidopsis, where small RNA, DNA
methylation, and chromatin remodeling regulate hete-
rochromatin through transposons and repeats. During
the last year, Pablo Rabinowicz, Mary Byrne, and
Catherine Kidner left for faculty positions at The
Institute for Genome Research (TIGR), the John Innes
Institute, and Edinburgh University, respectively, and
senior technician Juana-Mari Arroyo returned to
Spain. We were joined by postdoctoral fellows Mikel
Zaratiegui-Biurrun, Milos Tanurdzic, and Damien
Garcia, as well as by our URP, Kat Arney.
Spatially Restricted microRNA
Directs Leaf Development
via ARGONAUTE1
C. Kidner, M. Ronemus, K. Arney, D. Garcia,
R. Martienssen
microRNAs (miRNAs) are endogenous small RNA
molecules that regulate the expression of matching
genes via RNA interference (RNAi). In animals, this
regulation occurs by translational control, but in
plants, more perfectly matched miRNAs promote site-
specific cleavage of the target by argonaute proteins.
In Arabidopsis, the homeodomain HD-ZIP III genes
PHABULOSA (PHB) and PHAVOLUTA (PHI/) are
expressed on the adaxial (upper) side of leaf primordia
where they direct cell fate. They are targets of the
miRNAs miR165 and miR166. We have used in situ
hybridization to show that miR165 accumulates on the
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abaxial side of the leaf primordia where it cleaves
PHB and PHV mRNA (Fig. 1). This pattern of expres-
sion changes during development, implicating miRNA
in signaling between the meristem and the leaf pri-
mordium. argonaute) (ago]) mutants are defective in
RNAi and have a pleiotropic phenotype. Leaves and
flowers are adaxialized and PHB mRNA accumulates
throughout the leaf primordium, whereas miR165 is
ectopically expressed in the adaxial domain (Fig. 1).
Thus, AGO1 regulates both accumulation and function
of miRNA, perhaps accounting for enhancement of
both loss-of-function and gain-of-function alleles of
PHB-related genes in ago]. We have examined the
expression of thousands of genes in normal and
mutant lines of Arabidopsis using microarrays.
Several families of related genes have substantially
altered expression in the RNAi mutants, and many of
these genes match miRNA. However, not all miRNA
targets are altered in abundance, perhaps reflecting the
tissue-specific expression of miRNA. Some up-regu-
lated genes may be silenced by second-strand synthe-
sis and degradation in addition to mRNA cleavage.
Weak alleles of ago] have different phenotypes in dif-
ferent Arabidopsis accessions. We are mapping the
genetic loci responsible for these variations. The iden-
tification of such modifiers will give us new insight
into the role of RNAi in natural diversity in plants.
Role of ASYMMETRIC LEAVES1
in Leaf Polarity and Stem Cell Fate
M. Byrne, D. Garcia, C. Kidner, J.M. Arroyo,
R. Martienssen
Hox genes in animals are expressed in discrete domains
in early development, responding to a suite of mor-
phogens responsible for axis specification. Gene
expression patterns subsequently come under epigenet-
ic control, retaining a memory of early patterning long
after the signaling responsible has ceased. In plants,
TALE class homeobox genes, such as SHOOTMERIS-
FIGURE 1 miRNA directs leaf polarity via AG01. In Arabidopsis,
miRNA miR165 corresponding to the homeodomain gene
PHABULOSA (PHB) is restricted to the abaxial side of wild-type
leaves (4), but it is also found in the meristem in early embryos (C).
miR165 is more widely distributed in strong ago] mutant leaves
(D). This pattern restricts PHB expression in wild type, but not in
ago] where PHB is uniformly expressed (E) and directs leaf polar-
ity. The precursor alone (minus the miRNA) cannot be detected in
control hybridizations (8). The weak allele ago] -12 (hairy) has a
leucine residue substituted for an absolutely conserved histidine
in the PIWI domain. It has inside-out organs, resulting in ectopic
ovules (F) and trumpet-shaped leaves (G). These phenotypes
resemble miRNA-resistant dominant alleles of PHB.
TEMLESS, BREVIPEDICELLUS, and BELLRINGER,
are expressed in the early embryo where they specify
the shoot apical meristem, from which postembryonic
organs derive. These genes interact in a negative regu-
latory network with the SANT domain gene ASYM-
METRIC LEAVES] and the LOB domain gene ASYM-
METRIC LEAVES2 to maintain the distinction between
meristem cells and leaf founder cells in postembryonic
development. PHB, PHV, and REVOLUTA belong to
another class of homeobox genes, the HD-ZIPIII class,
and are expressed on the upper side of the leaf, as well
as in meristematic domains. Elsewhere in the plant,
RNAi helps to silence these genes via ARGONAUTEI
and miRNA, as described above. These two systems
interact genetically, and we are exploring the mecha-
nism of this interaction via enhancer analysis of asl .
Loss of adaxial modifiers called PIGGYBACK result in
ectopic lamina outgrowths on the adaxial leaf surface in
as], but have little effect in wild-type backgrounds.
Loss of proximodistal modifiers, on the other hand,
results in a palmate compound leaf. These modifiers
demonstrate a role for AS I in both proximodistal and
dorsoventral axis specification.
Genomic Analysis of RNAi
in Fission Yeast
D. Goto, M. Zaratiegui-Biurran, D. Roh, M. Vaughn,
R. Martienssen [in collaboration with T. Volpe, NorthWestern
University; T Cech, University of Colorado; J. Bahler, Sanger
Center; and G. Thon, University of Copenhagen]
We previously demonstrated that RNAi of centromer-
ic repeat transcripts in fission yeast S. pombe was
required for chromatin modification and centromere
function, and we are extending these studies to the rest
of the genome. ago]- (argonaute), dcrl- (dicer) and
rdrl- (RNA-dependent RNA polymerase) mutants
have very similar microarray profiles: Few genes are
up-regulated, suggesting a limited role for miRNA, but
centromeric small interfering RNA (siRNA) matches a
recQ homolog found at the telomeres. Silencing of
this gene depends on Ago I and Dcr I , but not on Rdrl,
and is presumably posttranscriptional. Transcripts
from retrotransposable elements are only slightly up-
regulated in RNAi mutants despite the loss of H3mK9
from their long terminal repeats (LTRs). Microarray
profiles of RNAi mutants were similar to those from
the H3K9 methyltransferase clr4-, but profiles from
other silencing mutants had more widespread effects.
These results are in agreement with our observations
in Arabidopsis that transposon silencing can be main-
tained independently of RNAi. We are currently using
tiling arrays of fission yeast heterochromatin to more
precisely map centromeric transcripts as well as chro-
matin modifications.
Several genes involved in RNAi and heterochro-
matic silencing are found in the genome of fission
yeast but not in baker's yeast Saccharomyces cerevisi-
ae, suggesting that other RNAi genes may be coelim-
inated. We used phyletic profiling of five higher
eukaryote genomes, the two yeast species, and several
other fungal species to predict likely Schizosaccharo-
myces pombe participants in RNAi-mediated silenc-
ing. We refined this candidate list by using protein
interaction data from higher eukaryotes to identify S.
pombe proteins, many of which were hypothetical pro-
teins, that might interact with the RNAi machinery.
These and other analyses have been used to construct
an enhanced S. pombe model organism database.
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Transposable Elements, Epigenetic
Control, and the Origin of
Heterochromatin
Z. Lippman, M. Vaughn, B. May, R. Martienssen [in
collaboration with W.R. McCombie and V Mittal,
Cold Spring Harbor Laboratory; J. Carrington, Oregon
State University; R.W. Doerge, Purdue University;
and V. Co lot, INRA/CNRS Evry, France]
Transposable elements and related tandem repeats are
large components of eukaryotic genomes and are
enriched in heterochromatic regions. The transcriptional
activity of these sequences is suppressed by epigenetic
silencing mechanisms that involve the covalent modifi-
cation of DNA and associated histones. In particular,
methylation of cytosine residues in DNA and of histone
H3 Lys-9 are evolutionarily conserved modifications
involved in heterochromatin silencing. In the fission
yeast S. pombe, which lacks DNA methylation, histone
H3 Lys-9 methylation and silencing of centromeric
repeats are regulated by RNAi. In plant genomes, DNA
methylation is primarily restricted to transposons and
related repeats. In an effort to determine if RNAi, Lys-9
methylation, and DNA methylation are mechanistically
linked in repeat sequence silencing, epigenetic mutants
in Arabidopsis thaliana affecting each process were
assayed for silencing defects and compared to wild-type
plants as well as to each other. Transposons and tandem
repeats, but not genes, were selectively enriched in both
DNA methylation and histone H3 Lys-9 methylation,
which correlated with the presence of siRNA. Despite
their similar localization in cytologically defined hete-
rochromatin, different classes of transposons were sub-
jected to different forms of epigenetic regulation, sug-
gesting the existence of multiple silencing pathways or
complexes. The chromatin remodeling gene Decrease in
DNA Methylationl (DDM1), the maintenance CG
methyltransferase (MET1), and the type I histone
deacetylase Silencing I (SIL1) are required to maintain
most transposon silencing, and DDM1 and MET1 fur-
ther influence the accumulation of siRNA.
Reestablishment of silencing occurred when met] and
sill were backcrossed to wild type, but only when
siRNA was retained in the mutants, suggesting a role for
siRNA for silencing in cis. Genes with transposons
inserted within or near them were under transposon con-
trol and, consequently, regulated by DDM1, MET], and
RNAi. For example, transposons and tandem repeats
integrated near the imprinted genes FWA and MEDEA
correspond to siRNA and contribute to silencing,
although their role in imprinting is still unclear.
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Arabidopsis Centromeric Repeat
Transcripts
B. May, Z. Lippman, R.Martienssen in collaboration with
D. Spector, Cold Spring Harbor Laboratory]
Centromeres interact with the spindle apparatus to
enable segregation of chromosomes into daughter
cells and are typically flanked by many thousands of
satellite repeats interspersed with retrotransposons.
Although the function of these repeats is unclear, cen-
tromere selection has a strong epigenetic component.
Yeast centromeres are much simpler, but those of S.
pombe are also flanked by heterochromatic repeats
whose transcription contributes to centromere func-
tion via RNAi. We have investigated the transcription
and modification of centromeric repeats in A.
thaliana, which unlike yeast has methylated DNA.
One strand of the 180-bp satellite repeat arrays is tran-
scribed, and the transcripts remain associated with het-
erochromatin. These transcripts are posttranscription-
ally silenced by RNAi and histone modification, but
not by the canonical CpG DNA methyltransferase
MET1. Other 180-bp repeats are transcribed from both
strands and silenced by MET], SILl, and DDM1.
Centromeric transcripts of the first class are inherited
epigenetically. Those of the second class are also
inherited epigenetically from ddml, which loses
siRNA, but not from met] and sill, which retain
siRNA. Histone H3 Lys-9 methylation depends on
AGO] as well as on the histone modification machin-
ery. Cytological examination has yet to reveal the
presence of lagging chromosomes at anaphase in any
of these mutants, although some lose a comparable
proportion of histone H3 Lys-9 methylation to fission
yeast mutants that display chromosome segregation
defects. It is possible that differences in plant and
yeast cell division mechanisms are responsible.
Chromatin Modification, DNA
Replication, and Polyploidy
M. Tanurdzic, Z. Lippman, P. Rabinowicz, M. Vaughn,
R. Martienssen [in collaboration with L. Comai,
University of Washington; T. Osborn, University of
Wisconsin; W. Thompson, North Carolina State
University; J. Murray, Cambridge University; and
R.W. Doerge, Purdue University]
Polyploidy in plants results in a variety of genetic and
epigenetic changes in gene expression from generation
to generation following the establishment of allopoly-
ploids. The mechanisms that underlie these changes are
important in the short term (hybrid vigor) as well as in
the long term, as polyploids are stabilized during evolu-
tion. We are profiling chromatin modifications that may
underlie novel gene expression in synthetic allopoly-
ploids derived from crosses between tetraploid A.
thaliana and tetraploid A. arenosa, as well as those
derived from crosses between doubled haploids of
Brassica oleracea and B. rapa. We have found that
changes in heterochromatin are relatively modest, but
that some genes and some transposons are activated in
the allotetraploids. We are also comparing diploid chro-
matin modification profiles to the pattern of replication
of chromosomal DNA. By labeling synchronized cells
with BrdU, and immunoprecipitating the replicated
DNA at different time points, we can determine the
approximate location of chromosomal origins in these
cells. We will compare these profiles to gene expression,
DNA methylation, and chromatin modification profiles.
Development of Informatics Resources
for the Arabidopsis Genome
M. Vaughn, R. Martienssen
We have constructed a model organism database sys-
tem for A. thaliana based on PostgreSQL, Apache, and
Perl. This resource integrates gene information derived
from the reference TIGR genome releases; third party
annotations provided by TAIR, MIPS, and others; and
notes derived from published and in-house analyses.
Annotations can be queried by a simple Web form or,
for more expressivity, via a Perl interface which imple-
ments BioPerl objects. This system is very flexible and
has been extended to treat features from our genomic
tiling arrays, the Affymetrix AtGenome 1 and ATH1
arrays, the TAMU 26k 60-mer array, and the Salk
Institute whole-genome array as computational features
mapped onto the genome. Values are assigned to the
array features based on normalized hybridization val-
ues from any number of experiments, facilitating com-
parison of equivalent features across microarray plat-
forms and experiments. Other computations, such as
copy number, small RNA homology, MPSS tag abun-
dance, and insertional mutant flanking sequence loca-
tions also extend the default genome annotation. We
have taken full advantage of the open-source Generic
Genome Browser platform (from L. Stein, Cold Spring
Harbor Laboratory) to construct a Web-based visual-
ization tool to present the data contained in the annota-
tion and microarray database as an easy-to-interpret,
track-based image ( http : / /chromatin.cshl.org/ddml/).
The integrated visualization of annotation, computa-
tion, and profiling data has allowed scientists from Cold
Spring Harbor Laboratory, INRA/CNRS Plant
Genomics Research Unit (Evry, France), and the NSF
Functional Genomics of Polyploidy project to explore
questions of epigenomic context.
Methylation Filtration of Sorghum and
Other Plant Genomes
P. Rabinowicz, R. Martienssen [in collaboration with
W.R. McCombie, Cold Spring Harbor Laboratory,
and Orion Genomics LLC, St Louis, Missouri]
Methylation filtration (MF) is a gene-enrichment tech-
nology that has been successfully applied to sorghum
and maize, where gene enrichment is proportional to
genome size. We have applied MF to a broad variety of
plant species spanning a wide range of genome sizes.
Enrichment for genes was observed in all species test-
ed, from nonvascular to vascular plants, but differences
between the expected and the observed level of enrich-
ment were noted. In wheat and pine, only a low level of
gene enrichment was observed, which may reflect an
abundance of methylated pseudogenes in these recent
polyploids. Sorghum bicolor is a close relative of
maize and is a staple crop in Africa and much of the
developing world because of its superior tolerance of
arid growth conditions. We have generated sequence
from the hypomethylated portion of the sorghum
genome. At least 90% of the genes have been tagged
with an average coverage across more than 60% of
their length after generating a raw coverage of less than
300 Mb of the 735-Mb genome. Methylation filtration
preferentially captures exons and introns, promoters,
miRNAs, and simple sequence repeats and minimizes
interspersed repeats, thus providing a robust view of
the functional parts of the genome. Thousands of hypo-
thetical gene predictions in rice and Arabidopsis are
supported by the sorghum set.
Functional Genomics with Transposons
in Maize and Arabidopsis
B. May, M. Vaughn, D. Roh, J. Simorowski, J.-M. Arroyo,
R. Shen, A. Tang, U. Ramu, R. Martienssen [in collaboration
with W.R. McCombie, L. Stein, and D. Spector, Cold Spring
Harbor Laboratory, and E. Lam, Rutgers University]
Our collection of Arabidopsis gene-trap and enhancer
trap transposon lines has grown to more than 37,700
individual insertions, about half of which have been
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mapped to the genome by polymerase chain reaction
(PCR) and sequencing. The resulting knockouts, along
with phenotypic and expression data, are made avail-
able to the public via TRAPPER (http://genetrap.cshl.
org), an interactive database and ordering system. We
have expanded this system to include gene-trap trans-
posons with /ad-GFP chromosome charting beacons
that enable chromosomal locations to be visualized in
the nucleus. We continue to serve the maize commu-
nity through MTM (maize-targeted mutagenesis), an
efficient system for site-selected transposon mutagen-
esis. MTM selects insertions in genes of interest from
a library of 45,000 plants using PCR. Pedigree, knock-
out, sequence, phenotype, and other information are
stored in a powerful interactive database (mtmDB)
that enables analysis of the entire population as well as
handling knockout requests. By monitoring Mutator
activity, we conclude that more than one half of all
mutations arising in this population are suppressed on
losing Mutator activity. More than 200 orders were
filled for maize and Arabidopsis lines in 2004.
Arabidopsis BRCA2
J. Simorowski, U. Ramu, R. Martienssen
The breast cancer susceptibility 2 gene BRCA2 has
been studied extensively and has been found inmam-
mals, birds, plants, and fungi. Mutations in the human
ortholog predispose the patient to breast and ovarian
tumors. The model plant A. thaliana has two copies of
BRCA2 in its genome, and we have been studying the
phenotypes corresponding to insertional mutagenesis
of these genes. Using our collection of gene-trap lines,
as well as mutant lines from other collections, we have
created BRCA2 double mutants. Although the single
homozygous BRCA2 plants are phenotypically nor-
mal, the double homozygous plants have a marked
reduction in fertility, ranging from semisterile to fully
sterile. Double heterozygous mutant plants are pheno-
typically similar to wild-type and single mutant plants.
We are investigating triple mutants between the
BRCA2 lines and BRCA2-interacting genes, such as
RADS], which encodes a protein involved in DNA
repair that interacts directly with BRCA2 during
recombination.
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PLANT CELL SIGNALING AND GENETICS
D. Jackson Y. Benitez K. Lau N. Satoh-Nagasawa
P. Bommert B.H. Lee J. Wang
M. Cilia J. Linder P. Yin
M. Jan A. Mohanty
Our research aims to understand fundamental mecha-
nisms in developmental biology, and how morphology
and architecture arise and are maintained in biological
systems. We use plants as a convenient model system
because of their ease of genetic manipulation, inter-
esting developmental strategies, and applications to
agriculture and our food supply. In the past year, we
have concentrated on the isolation of novel genes that
regulate development and have invested efforts to
characterize the function of recently sequenced plant
genomes. In an era where we can now predict the iden-
tity of all genes required to make a plant, such tech-
nologies are increasingly important. They will allow
us to understand the "big picture" of interacting pro-
teins and pathways that create the integrated organism.
We also continue to advance our understanding of
signaling pathways that regulate stem cell fate and
development. We have found novel mutants in cell-to-
cell protein trafficking and are pursuing their isola-
tion. We also identified genetic interactions regulating
stem cell proliferation in the maize inflorescence and
isolated a novel phosphatase gene that controls inflo-
rescence branching. As plant development is also inti-
mately associated with hormonal signaling, we are
investigating a novel role for cytokinin hormones in
stem cell proliferation and leaf patterning.
Isolation of the RAMOSA3 Gene
of Maize by Positional Cloning
N. Satoh-Nagasawa, J. Linder in collaboration with
N. Nagasawa and H. Sakai, DuPont Agriculture and
Nutrition, Wilmington, Delaware]
Inflorescence branching is a major yield factor in
many crops and is determined by the activities of
shoot meristems. Because of our general interest in
inflorescence development and shoot meristem orga-
nization, and the importance of inflorescence branch-
ing in development of maize as a crop, we have been
continuing the characterization of the ramosa3 (ra3)
mutant, which has enhanced inflorescence branching.
We observed ra3 ear development by scanning elec-
tron microscopy and found that, in general, RA3 func-
tions to impose determinacy and identity on the dif-
ferent meristem types in the inflorescences. Although
the inflorescence meristems are normal, the spikelet
pair, spikelet, and floral meristems are all more inde-
terminate and have converted or delayed identity in
ra3 mutants compared to wild type.
Double-mutant analyses suggest that RA3 acts
synergistically with another branching gene, RA2,
because the double mutants are much more severe
than either single mutant. To more fully understand the
role of RA3 in inflorescence development, we used the
emerging genomic resources in maize to isolate the
gene by positional cloning. RA3 encodes a protein
with a highly conserved phosphatase domain, suggest-
ing that it acts in a signal transduction cascade to reg-
ulate meristem determinacy and identity. This class of
phosphatases has been implicated in stress protection
and in metabolic signaling, and our discovery is the
first indication that these proteins are also involved in
developmental regulation.
Reverse transcriptase-polymerase chain reaction
(RT-PCR) and in situ hybridization experiments indi-
cate that RA3 is expressed in the developing inflores-
cences, in a cup-shaped domain at the base of the
meristems (Fig. 1A). This expression pattern allows
us to hypothesize that RA3 may process a signal that
moves into the meristem to regulate determinacy and
identity. RA3 also has an interesting genomic organi-
zation; sequencing of a RA3 BAC clone indicates that
the adjacent gene is a RA3 homolog, which we called
sister of RA3 (SRA). However, there is only a single
ortholog of RA3 in rice, which leads us to imagine an
interesting evolutionary story whereby RA3 may have
evolved a developmental role relatively recently.
Since there are limited studies at the interface
between metabolic control and development, analysis
of RA3 may give unique insights into the mechanisms
of branching in maize inflorescences as well as in
other crop plants.
165
FIGURE 1 Patterns in plant development. (A) The RAMOSA3 gene is expressed in cup-shaped domains (arrows) at the base of
meristems and may process a signal that regulates their determinacy. (8) ABPHYL1 is expressed in stripes in the shoot apical meris-
tem (arrowheads). (C) Subcellular localization of a YFP-tagged Arabidopsis protein of unknown function shows that it localizes to the
nuclei of root tips. Bar, 20 gm.
Studies of Maize Phyllotaxy
B.H. Lee, J. Wang
Mutations in the cytokinin-inducible response regulator
homolog ABPHYLI (ABPHI) in maize result in decus-
sate phyllotaxy, where leaves are initiated in opposite
pairs. This is very distinct from the normal pattern,
where leaves are initiated singly in an alternating pat-
tern. To gain insight into the functions of this gene fam-
ily in regulating leaf patterns across different plant
species, we are now using the model dicot Arabidopsis.
Mutants defective in Arabidopsis cytokinin-inducible
response regulators and other cytokinin signaling com-
ponents have been obtained, and their developmental
phenotypes are being monitored.
Auxin is another classical plant hormone that has
long been coupled with cytokinins in its mechanism of
action, and it has also been implicated in the regulation
of phyllotaxy. To examine the interaction between
auxin and cytokinin in the regulation of phyllotaxy,
two approaches are being used. First, we are analyzing
the ABPHI expression domain in auxin polar transport
mutants or auxin polar transport inhibitor (N-1-naph-
thylphthalamic acid [NPA])- treated plants. ABPHI is
expressed in stripes in the meristem that predict the
position of leaf initiation (Fig. 1B). Our preliminary in
situ hybridization data suggest that NPA treatment
alters the ABPHI expression domain in the meristem.
An ABPHI antibody has been made and will be also
used for this expression domain analysis. Second,
using an anti-PINFORMED1 antibody, we will also
investigate the expression patterns of putative polar
auxin transport proteins in abphl mutants. To facilitate
the studies of the ABPHI expression domain, an
ABPHI yellow fluorescent protein (YFP) transgenic
maize line is being generated. The YFP has been inter-
nally integrated in-frame into the ABPHI- coding
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sequence under the control of its own promoter, using
the fluorescent tagging of full-length proteins (FTFLP)
method developed in our lab.
To identify additional factors involved in the con-
trol of phyllotaxy, we are characterizing another maize
phyllotaxy mutant, abph2. The abph2 mutant shoot
meristem size appears to be bigger than that of the
wild type, and the ABPHI expression domain is
enlarged. These results suggest that ABPH2 might
function in the same phyllotaxy regulatory pathway as
ABPHI. We are planning to map ABPH2, with the
goal of isolating the gene by positional cloning.
Toward Characterization of the
Arabidopsis, Maize, and Rice
Proteomes by Native Expression
of Tagged Full-length Proteins
A. Mohanty [in collaboration with M. Myers and
W.R. McCombie, Cold Spring Harbor Laboratory]
Arabidopsis thaliana, the first plant to have its genome
completely sequenced, has more than 29,000 predicted
genes. However, to this date, less than 10% of the gene
activities have been verified experimentally, and there
are only very limited reports of systematic analysis of
gene function. To address this problem, we have devel-
oped high-throughput methodologies to tag genes for
functional analysis, including subcellular localization
and identification of interacting proteins. Our first use
of this approach, termed FTFLP, aims to analyze
expression patterns and subcellular localization of
Arabidopsis gene products in planta. Our FTFLP-
based approach offers two significant advantages: (1)
It produces internally tagged full-length proteins that
are likely to exhibit their correct intracellular localiza-
tion, and (2) it yields information about the tissue
specificity of gene expression, by the use of native pro-
moters. To demonstrate how FTFLP may be used for
characterization of the Arabidopsis proteome, we
tagged a series of known proteins with diverse subcel-
lular targeting patterns, as well as several proteins with
unknown function, and unassigned subcellular local-
ization (Fig. 1C). The results are available through a
Web database (http://aztec.stanford.edu/gfp/).
Recently, we have applied this methodology to the
economically important crops rice and maize. Rice is
the first cereal crop plant to have its genome com-
pletely sequenced. However, the function of only a
handful of rice genes is known. For the rice-tagging
project, we are using a plant-optimized tandem affini-
ty purification (TAP) tag with the aim to study pro-
tein-protein interactions. We are currently generating
TAP-tagged lines for purification of the protein com-
plexes, with the aim of making a comprehensive pro-
tein interaction map. We are also applying the fluores-
cent tagging approach to maize, to generate fluores-
cent-protein-tagged lines for developmental and
genomics studies. It is expected that our study will
pave the way for deciphering the function of a large
number of plant genes at the cellular level.
Molecular Genetic Characterization
of Plant Intercellular Channels
Y. Benitez, M. Cilia, M. Jan, J. Wang, P. Yin [in collaboration
with J.Y. Kim, Gyeongsang National University, Korea)
The intercellular transport of metabolites, the spread of
RNAi (RNA interference), and viral movement are all
processes regulated by the permeability of plasmodes-
mata (PD) channels. PDs are also involved in regulat-
ing symplastic communication during development
and plant cell fate. Despite their importance, we under-
stand very little about the mechanisms regulating either
targeted or nontargeted movement through PD. Our
group has invested significant effort in screens to iso-
late genes involved in PD transport pathways and in the
identification of signals for PD targeting.
In the last year, we reported the isolation of a num-
ber of mutants arrested in the intercellular movement
of the green fluorescent protein (GFP) named gfp
altered trafficking (gat, pronounced "gate"). We have
characterized two of these so far; gad, for which we
have two alleles, is recessive and has severe develop-
mental phenotypes. In contrast, gat3 is dominant and
morphologically normal. The gat mutants were isolat-
ed based on their block in GFP transport out of the
conductive phloem tissues, but they also differ in GFP
movement, and perhaps in PD size exclusion limit, in
nonphloem tissues. For instance, gad is also impaired
in GFP movement between epidermal cells compared
with wild-type seedlings. However, GFP moves nor-
mally between gat3 epidermal cells. We also observed
PDs indirectly using the marker PD41, a GFP- partial
cDNA fusion that labels PDs in wild-type seedlings.
gat] mutant seedlings showed only diffuse PD41 GFP
fluorescence at the cell periphery, suggesting that PDs
are disrupted in this mutant. gad mutants make only
one or two small leaf primordia and have reduced
expression of a meristem regulatory gene (STM).
We are now fine mapping two of the gat mutants,
in order to identify which genes are disrupted. We have
mapped gat] to a small region of chromosome 2
around the marker THY1, and gat2, which has a phe-
notype similar to that of gatl, to chromosome 1. In the
meantime, we continue in-depth analysis of the gat
mutants. We will assess movement of RNAi signals or
of low-molecular-weight dyes and observe PD struc-
ture in the mutants by transmission electron
microscopy or using fluorescent markers to understand
the roles of the GAT genes in cell-to-cell transport.
We also designed a new approach to ask what pro-
portion of Arabidopsis proteins are capable of targeted
trafficking through PD, to identify additional PD-traf-
ficking signals, and to isolate mutants in targeted
ficking of KNOTTED1 (KN1). KN1 was the first plant
developmental protein found to traffic through PD, and
it is now the founding member of a growing class of
noncell autonomous developmental proteins. For this
aim, we will use a novel system that we developed to
easily monitor protein trafficking by phenotypic screen-
ing of leaf hairs or trichomes (Fig. 2A,B). We hope that
this approach will provide genome-wide insight into the
prevalence of targeted PD trafficking and identify short
trafficking signals that could be useful in targeting pre-
dictions or to regulate the trafficking of other proteins.
Regulation of Meristem Size and
Seed Yield in Maize
P. Bommert, K. Lau, J. Wang
Plant growth is characterized by reiterative develop-
mental events that depend on the activity of meristems.
The aerial part of the plant body is elaborated from the
shoot apical meristem (SAM), which produces leaves,
stems, and axillary meristems in a repetitive manner.
Established during embryogenesis, the SAM serves as
a reservoir of stem cells during the plant life cycle. It
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FIGURE 2 Morphology and plant development. The glabrousl mutant of Arabidopsis lacks leaf hairs or trichomes (4). We devised
a scheme to complement this mutation using cell-to-cell trafficking of the GL1 protein fused to KN1, which results in trichome pro-
duction (8). In C, a greatly enlarged maize ear meristem is produced by a combination of mutations in tdl and fea2 genes. These
genes may regulate yield through controlling seed number on the ear.
can be divided morphologically and functionally into a
central zone (CZ), in which the stem cells are located,
and a surrounding peripheral zone (PZ), where cells
become incorporated into lateral organ primordia.
In Arabidopsis, analysis of fasciated mutants has
identified some of the genes involved in maintaining
the balance between stem cell fate in the CZ and the
onset of differentiation in the PZ. Mutations in genes
in the CLAVATA signaling pathway lead to increased
cell numbers in meristems. The current working
model postulates that the CLAVATA3 ligand is secret-
ed from stem cells and binds to a receptor complex
CLAVATA2, and other signal
transduction molecules. Activation of the receptor
results in the restriction of transcription of
WUSCHEL, a positive regulator of stem cell identity.
We are investigating the role of the thick tassel
dwarfl (tdl) and fasciated earl (fea2) genes in maize,
which encode CLAVATA1 and 2 orthologs. Both
mutants develop severely enlarged inflorescence
meristems, indicating that they function in a manner
similar to CLV1 and 2 in Arabidopsis. The phenotypic
analysis of tdl, fea2 double mutants, however, demon-
strated that tdl and fea2 do not act exclusively in a
receptor complex to regulate meristem size (Fig. 2C).
To gain insight into the nature of the receptor com-
plex, we plan to isolate the fea2 complex by using a
transgenic FEA2 TAP-tagged maize line. A construct
containing the FEA2-coding sequence fused to a
plant-optimized TAP tag has been generated and is
currently being transformed into maize.
Besides this biochemical approach, we also address
the question of whether fea2 has a role in the evolution
of maize, especially with respect to the cob structure of
maize, which is unique among the grasses. In teosinte,
the ancestor of maize, the seeds are arranged in two
alternating rows, whereas modern maize lines have up
to 18 rows of seeds. Seed row number is dependent on
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the number of meristems, called spikelet pair meristems
(SPMs), initiated by the inflorescence meristem. It is
tempting to speculate that the number of SPMs is direct-
ly dependent on the size of the inflorescence meristem.
Our analysis of inflorescence meristem size and seed
row number in different maize inbred lines supports this
assumption, as we observe a significant positive corre-
lation. To address whether allelic variation in the fea2
gene also has an impact on seed row number, we are
performing a high-resolution QTL analysis using a
maize recombinant inbred population. Our analysis of
several independent data sets indicates that indeed, allel-
ic variation in fea2 may regulate seed row number, as
one of the most significant QTLs is located on chromo-
some 4, corresponding to the fea2 map position.
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ANALYSES OF GENES INVOLVED IN MERISTEM
FUNCTION AND LEAF INITIATION
This work was done in collaboration with M. Scanlon,
University of Georgia, Athens; P Schnable, Iowa State
University, Ames; B. Buckner and D. Janick-Buckner,
Truman State University Kirksvile, Missouri.
One of the most intriguing aspects of plants is their
ability to generate organs postembryonically. The
growing tip of a plant, referred to as shoot apical
meristem (SAM), contains a population of stem cells
that divide to maintain the SAM and to generate
daughter cells from which lateral organs, such as
leaves and flowers, arise. These different cell types are
organized in distinct histological and functional
domains. For instance, the stem cells are located at the
most apical tip in the so-called central zone, whereas
lateral organ founder cells are located on the flanks of
the SAM (Fig. 1). In addition, meristems comprise
distinct epidermal and subepidermal cell layers.
Traditional genetic analyses have identified several
genes that are required for meristem function or for
the development of lateral organs from the SAM. Such
studies have also shown the importance of this meris-
tematic organization for normal plant development.
To identify novel and potentially redundant or
essential genes that function in discrete domains of the
SAM or developing leaf primordia, we are using a
technique called laser capture microdissection (LCM).
LCM allows the isolation of transcripts from specific
cell types within a tissue or organ. For use in LCM,
target tissues are fixed, sectioned, and immobilized
onto microscope slides. Cells of interest are dissected
and separated from the rest of the tissue using a laser
beam. RNA is then extracted from the captured cells
and used in microarray analyses to compare global
gene expression patterns between different cell popu-
lations. During the past year, we have optimized the
LCM technique, which was originally designed for the
dissection of animal cells, for use on the small-cell-
wall-encapsulated cells within the plant SAM. We
have found that acetone-fixed and paraffin-embedded
SAMs preserve tissue integrity without compromising
the efficiency of LCM and subsequent RNA isolation.
RNA collected from as few as a thousand cells was
sufficient for the preparation of cDNA for use in
microarray analyses of gene expression.
We are using maize as our experimental system
because of the relatively large size of its vegetative
meristem when compared, for instance, to Arabidopsis.
However, maize has the disadvantage that its genome
project is still at an early stage. To identify genes that
should be represented on the microarrays, we have also
initiated a "small" expressed sequence tag (EST) pro-
ject. We have currently sequenced nearly 10,000 ESTs
from meristem-enriched cDNA libraries, and the ulti-
mate goal is to generate approximately 35,000 3' ESTs.
We intend to compare global expression patterns
between approximately 20 different functional meris-
tematic and leaf primordia domains, or experimental
conditions. Examples of the types of comparisons are as
follows: (1) between the expression profiles of the stem
FIGURE 1 Genetic interactions between stem cells and their differentiating
descendants in the incipient leaf. Adaxial/abaxial patterning of lateral organs
requires two meristem-derived signals. One signal, which may exert its effects
via the START lipid-sterol-binding domain of HD-ZIPIII proteins, is derived
from the stem cells in the SAM (*). The miR166 signal initially accumulates
immediately below the incipient leaf but gradually spreads into the abaxial
domain, thus restricting hd-zipIll expression to the adaxial side. hd-ziplIl
expression also depends on Ibll , which may act via the stem-cell-derived sig-
nal. hd-zip111 genes specify adaxial fate and signal back to the SAM to main-
tain stem cell function.
stem cell
signal -4 lb/1
hd-ziplIl
miR166
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cells, their immediate derivatives in the SAM, and the
initials of lateral organs; (2) between the different tissue
layers of the SAM; (3) between different stages of leaf
development; (4) between the upper and lower surfaces
of developing leaves; and (5) between SAMs and/or
leaf primordia from developmental mutants and wild-
type plants. Our initial results indicate that nearly 1300
genes are differentially expressed among the SAM,
young leaf primordia, and older leaf tissues. Potential
differentially expressed genes will be verified by more
traditional expression analyses such as real-time
reverse transcriptase-polymerase chain reaction (RT-
PCR) and in situ hybridization. The function of genes
of particular interest will be determined using function-
al genomics resources available in maize and
Arabidopsis. Even though this project is still in its
infancy, it will soon provide novel insight into meristem
function and organogenesis.
ADAXIAL/ABAXIAL PATTERNING OF
LATERAL ORGANS IN MAIZE
Signaling between the different cell populations with-
in the meristem is important for stem cell function. In
addition, stem cell function and meristem mainte-
nance rely on signals from differentiating cells within
developing organs. A positive feedback loop exists
between stem cells in the SAM and their differentiat-
ing derivatives in the leaf. Early studies indicated that
a stem-cell-derived signal sets up adaxial/abaxial
polarity in lateral organs, which leads to distinct upper
and lower leaf surfaces. This past year, we have shown
that adaxial/abaxial patterning also requires a
microRNA (miRNA) signal that originates within the
meristem (Fig. 1). Both signals act on members of the
class III homeodomain leucine zipper (hd-zipIII) fam-
ily, which specify upper cell fate but are also required
for SAM formation and maintenance.
The semidominant Rolled leafl (Rid]) mutant
from maize is characterized by an upward curling of
the leaf blade due to adaxialization or partial reversal
of leaf polarity. We have cloned the rldl gene and
found that it encodes a member of the HD-ZIP III
family of proteins. rldl is normally expressed in the
central zone of the SAM, in vasculature and, consis-
tent with a role for rldl in adaxial cell fate specifica-
tion, in nondetermined cells on the adaxial side of leaf
primordia. The meristematic expression pattern of
rldl was unaffected in Rldl, but we observed that rldl
is misexpressed on the abaxial side of Rldl mutant
leaves. These and other observations indicate that
polarized hd-zipIII expression is essential for the for-
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mation of distinct upper and lower leaf surfaces.
However, our in situ hybridization analysis showed
that rldl and other hd-zipIH family members are
expressed uniformly throughout the leaf founder cells.
We were able to show that polarized hd-zipIII expres-
sion is subsequently set up by an miRNA-directed
RNA-interference-like process.
Transcripts of the hd- zipIII genes contain a comple-
mentary site for miRNA165 (miR165) and miR166.
miRNAs are endogenous small (-22 mer) noncoding
RNAs that mediate the cleavage or translational repres-
sion of target transcripts containing a complementary
sequence, and thus control gene expression posttran-
scriptionally. We found that all four dominant Rldl alle-
les result from a single nucleotide change in this site.
This, together with the misexpression of rldl in the
Rldl mutant, suggests that miRNAs mediate the cleav-
age of rldl transcripts on the abaxial side of leaf pri-
mordia. In other words, miR165/166 may specify abax-
ial cell fate by restricting expression of rldl and other
hd-zipIII genes to the adaxial side. To test directly
whether miRNAs can establish patterns of tissue differ-
entiation during development, we used in situ
hybridization to determine a precise cellular expression
pattern for miR166. We found that rldl and miR166
exhibit complementary expression patterns in develop-
ing leaf primordia consistent with a role for miR166 in
the spatial regulation of rldl transcripts. More impor-
tantly, our in situ hybridization data indicated that the
peak of miR166 expression occurs just below the
domain in which miR166 acts on the hd-zipIII genes
and that an expression gradient of miR166 is estab-
lished in developing leaves. These observations led us
to suggest that miR166 is mobile, and this offers the
intriguing possibility that miRNAs can function as mor-
phogen-type signals in development. We are currently
studying the basis for this dynamic expression pattern
of miR166, by determining the cis- and trans-acting
factors required for miR166 expression and possible
movement.
As mentioned above, adaxial/abaxial patterning
requires a second meristem-derived signal. This stem
cell signal is essential for adaxial cell fate and is
thought to act via the HD-ZIPIII proteins, which con-
tain a START-like lipid-sterol-binding domain. As a
first step toward identifying the potential adaxializing
signal, we have purified the START domain from
RLD1 and are using biochemical approaches to deter-
mine which lipid-sterols bind to this START domain.
In addition, we are taking a genetic approach to iden-
tify genes that produce, convey, or respond to the stem
cell signal. Recessive mutations in leafbladeless I
(lbll) cause the formation of abaxialized leaves, sug-
gesting that lb 11 is required for adaxial cell identity.
Expression of the hd-zipIII genes in the SAM and on
the adaxial side of leaf primordia is reduced in lb 11,
indicating that lb 11 acts upstream of rldl and other hd-
zipIII family members. Interestingly, the level and pat-
tern of rldl expression in the vasculature of lbll are
not affected. Because vascular hd- zipIII expression is
also controlled by miR166, these observations suggest
that lbll controls hd-zipIII expression independent of
miR166. We are in the process of cloning the Ibll gene
using transposon-tagging and map-based approaches.
In the past few years, genetic analyses in several
diverse plant species have shown that a signal for the
adaxial side of the leaf is required to maintain the SAM
and its stem cell population. We have isolated several
mutant alleles of lbll. The most severe alleles fail to ini-
tiate a SAM during embryogenesis. Mutant embryos
lack hd- zipIII expression. In addition, these embryos
fail to express knotted], which encodes a homeodomain
protein known to be required for meristem function in a
wide variety of plant species. By studying the genetic
pathway involving 1b11, rldl, and miR166, we hope to
improve our understanding of the interdependence of
stem cells and their differentiating descendants and the
role of miRNAs as developmental signals.
REPRESSION OF STEM CELL FATE
DURING ORGAN DEVELOPMENT
This work was carried out with contributions from
Arooba Alam and Samantha Meyerhoz, Locust Valley
High School.
knotted] and other members of the knox homeobox
gene family are required for meristem initiation and
maintenance. These genes are expressed in the indeter-
minate cells of the SAM but are excluded from deter-
minate leaf founder cells. Moreover, down-regulation
of knox genes is essential for normal leaf development.
Misexpression of knox genes within developing leaves
leads to cell division and differentiation defects, not
unlike tumor formation in animals. The rough sheath2
(rs2) gene from maize and the ASYMMETRIC
LEAVES] (AS1) gene from Arabidopsis encode orthol-
ogous MYB-domain proteins that act as negative regu-
lators of knox gene expression. On the basis of expres-
sion and genetic analyses, we proposed that these pro-
teins act as epigenetic regulators to keep knox genes in
an "off" state in developing lateral organs, thus pre-
venting differentiating cells from reverting into indeter-
minate stem cells. Our recent observations confirm this
hypothesis. We have shown that RS2 and AS1 form
highly conserved repressor complexes that include the
zinc finger transcription factor ASYMMETRIC
LEAVES2 (AS2), an RNA-binding protein named
RIK, and the histone chaperone HIRA and may recruit
protein phosphatase 2A to the knox loci. HIRA proteins
are histone chaperones that have a role in both euchro-
matic and heterochromatic gene silencing in yeast and
animals. The mechanism by which HIRA establishes
euchromatic gene silencing is unknown. HIRA is a
unique histone chaperone because it can incorporate or
exchange nucleosomes and histone variants indepen-
dent of DNA synthesis. In addition, HIRA can interact
with histone deacetylases. Both these activities could
lead to changes in local chromatin state. We are cur-
rently testing whether knox gene silencing is associated
with changes in chromatin organization or histone
modifications.
To establish that the AS 1 complex binds directly to
the knox loci, we have generated transgenic lines that
express a fusion protein comprising the DNA-binding
domain of the floral transcription factor LEAFY (LFY-
DB) and the non-MYB domain of AS I . More than half
of the plants carrying this transgene failed to form
flowers, which is typical of strong /fi, mutants. Control
plants expressing the LFY-DB alone were normal, sug-
gesting that LFY-DB expression does not cause a dom-
inant-negative phenotype. Replacement of the LFY
activation domain with the non-MYB domain of AS 1
thus blocks activation of LFY targets. This suggests
that AS1 acts as a transcriptional corepressor and may
bind directly to the knox genes. We therefore used chro-
matin immunoprecipitation to determine which regions
of BP, one of the knox genes, mediate AS1 complex
binding. We have identified three regions within the BP
gene that interact with the AS1 complex. We are cur-
rently defining these cis-acting sequences more pre-
cisely and are analyzing which proteins in the AS1
complex mediate these interactions.
We are also using the reverse genetic resources
available in Arabidopsis to determine the roles of the
AS1-interacting proteins in plant development, partic-
ularly in knox gene regulation. Loss-of-function muta-
tions in AS2 are known to affect knox gene silencing
during leaf development. We have isolated mutations in
the Arabidopsis RIK and HIRA proteins. Loss-of-func-
tion mutants in RIK are indistinguishable from wild
type. In contrast, weak mutant alleles of hira develop
leaf and floral defects that resemble the defects
observed in the as] and as2 mutants. Moreover, hira
mutant leaves misexpress several knox genes. AS2
expression is unaffected in hira mutants and ASI tran-
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script levels are increased, indicating that the defects in
hira do not result from loss of ASI or AS2. Double-
mutant analysis revealed that hira enhances the asl
and as2 mutant defects. Taken together, our observa-
tions suggest AS1 and AS2 assemble into a protein
complex that targets HIRA and possibly other chro-
matin remodeling proteins to the knox loci in organ
founder cells. As a result, stem cell fate remains
repressed in determinate differentiating cells of devel-
oping lateral organs. Deletion of HIRA in humans con-
tributes to the DiGeorge syndrome, which is thought to
arise from developmental defects in the neural crest.
Thus, HIRA may also have a role in the repression of
stem cell fate in animals. Our studies could therefore
highlight fundamental properties of establishing/main-
taining determinacy in plants and animals.
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BIOINFORMATICS AND GENOMICS
Genome research has always involved the determination of the complete DNA sequences of organ-
isms, the development of methods for assigning meaning to particular DNA, RNA, and protein
sequences, and the exploration of how changes in gene expression govern normal biology and con-
tribute to a variety of pathological states including cancer. As the fields of bioinformatics and genome
research expand and mature, scientists are perfecting their ability to detect and decipher the funda-
mental patterns and other properties of the nucleic acids and proteins that ultimately shape all of life.
This work involves the use of mathematics, statistics, and computer science to answer a wide variety
of biological questions.
W. Richard McCombie's group, in collaboration with the Zhang, Martienssen, and Hannon labs, has
developed a method to identify and verify the positions of genes within both plant and animal genomes.
Using this method, the scientists discovered significant errors in what were considered "well-annotat-
ed" mouse genes. Similar work with rice showed that many of the rice genes that were considered full-
length gene sequences in the rice genome database may instead represent only a fraction of the true
number of rice genes.
Andrew Neuwald's group has developed software that detects subtle similarities between proteins
of unknown function and proteins that have well-defined functions. Neuwald's group used the software
to compare three distantly related protein families and to identify important structural similarities among
the families that had previously been overlooked.
One of Lincoln Stein's interests includes creating software that compares DNA sequences and
reveals common patterns that diverse organisms use to carry out similar life processes. For example,
Stein has created software that enables scientists to compare the genomes of the major cereal crops
(rice, wheat, corn, and oats) and thereby reveal beneficial genetic variants in one of these crops that
might be exploited in the others. The results of these comparisons help plant breeders to develop new
varieties with improved abilities to withstand disease, changes in climate (e.g., drought), and a variety
of other adverse conditions. In other work that explored the genomic basis of "speciation" (i.e., the for-
mation of new species), Stein took advantage of the newly completed genome sequence of the round-
worm C. briggsae. (With some 500,000 species [after insects], roundworms comprise the second
largest group of animals on Earth.) Stein's group compared the C. briggsae genome with that of the
more commonly studied roundworm, C. elegans, both of which diverged from a common ancestor
approximately 100 million years ago. Through this work, Stein and his colleagues have provided a com-
prehensive view of how genome evolution leads to the formation of new species.
Michael Zhang's group has developed a set of software tools for locating transcription-factor-bind-
ing site (TFBS) motifs-DNA sequences where gene regulators attach themselves and activate the
series of events that lead to protein production. Obtaining a complete view of the types and locations
of such binding sites, as Zhang's work enables, is crucial for understanding how and when genes are
turned on and off in response to various biological and pathological cues.
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SEQUENCING OF THE RICE GENOME
This work was done in collaboration with Rod Wing
(University ofArizona, Tuscon).
We have been collaborating with the Arizona Genome
Institute (AGI) as part of a larger collaboration to
sequence the genome of Oryza sativa, more common-
ly known as rice. The larger collaboration, the
International Rice Genome Research Program
(IRGSP), has been focused on completing a finished-
quality sequence of the Nipponbare strain of rice. This
is a strain of rice that is grown commonly in temper-
ate regions such as Japan, as opposed to the more trop-
ical strains of rice, such as Indica, which are more
commonly grown in Southeast Asia. Several other
large-scale sequencing projects have been under way
by other groups on both Nipponbare and Indica. These
groups, as well as ours, have produced and released
draft-quality sequences of both the Nipponbare strain
and an Indica strain. None of these sequences are of
finished quality.
We and the other U.S. group, The Institute for
Genomic Research, were funded to sequence chromo-
somes 3 and 10. We completed the sequence of chro-
mosome 10 previously and were on schedule to com-
plete chromosome 3 in 2004. It became clear, however,
that several other groups around the world, whose com-
pletion schedule was moved forward due to competi-
tion, would be unlikely to complete their assigned
regions in 2004. Moreover, a number of very difficult
regions of the rice genome (such as heterochromatic
sequences derived from pericentric regions) were par-
ticularly vexing for some of the groups participating in
the project due to their relative lack of experience in
dealing with such regions. As a result, we received addi-
tional funding and were assigned to finish regions on
chromosomes 5, 9, and 11. We were also assigned the
task of more globally attacking the remaining regions of
gaps in the sequence. Finally, we were to carry out a
training exercise in Asia, where we would work to pro-
vide additional training, particularly in dealing with dif-
ficult regions, to other finishers in the IRGSP.
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In 2004, we completed on schedule our region of
chromosome 3 and began the analysis of the region in
preparation for a publication describing the sequence
of that chromosome. We also completed our assigned
regions on chromosomes 5, 9, and 11. These regions
are also being analyzed. We participated in the global
analysis of the genome as well. These analysis efforts
and the publications ensuing from them will continue
into 2005.
As part of this effort, we finished 10,689,516
bases in 2004. This ranged widely from month to
month, with the early part of the year having much
higher monthly totals since we were pushing to com-
plete the bulk of the sequencing by the deadline. Since
this was finished, we focused primarily on difficult
clones, thereby reducing the amount of sequencing
that was completed each month. We are still working
on a small number of such clones.
In addition to BAC (bacterial artificial chromo-
some) clones assigned to the minimal tiling path of the
rice genome by our collaborators at AGI, there are a
number of clones (2200) that are not assigned to a
position in the genome. This happens in any large
genome project, and the clones comprise a range of
factors from contaminating DNA to legitimate clones
that are too repetitive to map uniquely within the
genome. To begin resolving these unassigned clones,
we made four subclone libraries, each containing 96
pooled BAC clones, and we randomly sequenced 5244
of the subclones from each library. Analysis of the
resulting sequence indicated that a high percentage of
the sequence reads represented unique DNA that was
probably derived from rice. As a result, we have begun
sequencing a number of these clones individually at
low coverage and finishing those clones that appear to
be actual rice clones which had not been sequenced.
This approach has already filled several gaps in the
genome, and we will be continuing it into 2005.
We also successfully carried out the finishing
training workshop. This workshop was patterned after
segments of the postgraduate course in DNA sequenc-
ing that we taught at CSHL for a number of years. The
course was conducted in conjunction with the Rice
Genome Forum in Tsukuba, Japan. The Japanese Rice
Genome Program and the Society for Techno-
Innovation of Agriculture, Forestry, and Fisheries col-
laborated with us in setting up and running the course.
Representatives from five different centers (four dif-
ferent countries) participated.
ANALYSIS OF TRANSCRIPTIONAL START SITES IN
MOUSE GENES
This work was done in collaboration with Michael
Zhang and Greg Hannon both here at CSHL. We have
become very interested in the composition of the
mammalian transcriptome. This is a fundamental
question, and we are concerned that current work fails
to recognize substantial numbers of genes as well as to
accurately describe the transcriptional start site and
alternatively spliced variants of many of these genes.
As a first step in addressing this problem, we
sought to analyze the accuracy of a number of gene
annotations in the mouse. These annotations ranged
from those to which one would a priori assign a high
level of confidence to gene predictions that are not
supported by any experimental evidence and are not
considered in the canonical gene set.
A total of 300 gene predictions or annotated genes
were selected for analysis and grouped into five dif-
ferent categories on the basis of the quality and quan-
tity of supporting evidence for the gene model. These
gene categories included well-characterized genes in
the Eukaryotic Promoter Database (EPD category),
genes from the RefSeq gene set (RefSeq category),
automated gene predictions which are linked to multi-
ple expressed sequence tags (ESTs)/mRNAs (catego-
ry B), as well as computational predictions with a sin-
gle EST match (category C) or no extant empirical
support (category D). The results of RACE-PCR
(polymerase chain reaction) amplification of the 5'
ends of these genes in 15 pooled mouse tissues/
embryonic stages are summarized in Table 1.
Modifications were made to the 5' RACE-PCR pro-
cedure, allowing pooling of RNA samples, resulting
in a scaleable procedure.
The results illustrate potential errors or omissions
in the current 5 '-end annotations in 58% of the genes
detected. In testing experimentally unsupported gene
predictions (categories C and D), we were able to
identify 58 that are not in the canonical gene set but
produced spliced transcripts (-25% success rate). In
addition, in many genes, we were able to detect novel
TABLE 1 Description of gene categories and analysis of 5'
end annotations
No. of RACE
No. of Genes sequences that
successfully differed from
No. of Genes amplified by the 5' gene
Category in category 5' RACE (%) annotation (%)
EPD 13 13 (100%) 4 (31%)
RefSeq 27 20 (74%) 8 (40%)
B 23 15 (65%) 7 (47%)
C 169 40 (24%) 30 (75%)
D 68 18 (26%) 12 (67%)
Totals 300 106 (35%) 61 (58%)
exons not predicted by any gene prediction algo-
rithms. In 19.8% of the genes detected in this study,
multiple transcript species were observed. These data
show an urgent need to provide direct experimental
validation of gene annotations. Moreover, these results
show that direct validation using RACE-PCR can be
an important component of genome-wide validation.
This approach can be a useful tool in the ongoing
efforts to increase the quality of gene annotations,
especially transcriptional start sites, in complex
genomes.
SEQUENCING OF sHRNAi LIBRARIES
We have been collaborating with the Hannon lab here
at CSHL to make large-scale libraries containing short
hairpin RNAi clones targeted to the human and mouse
genome. These will be described more completely in
Greg Hannon's annual report, but we wanted to
describe the sequencing of the libraries in our report.
The most cost-effective way to make the libraries
is in a random fashion. This greatly reduces the cost of
oligonucleotides but also requires sequencing large
numbers of random clones and selecting those with
the correct sequence. A side benefit of this approach is
that all of the clones in the library are sequence-veri-
fied.
Sequencing of these libraries required us to modi-
fy our protocols since we wanted short read lengths
(hence, more runs per day per machine), and the hair-
pin structure of the clones was problematic. We made
these modifications and developed a high-throughput
pipeline for sequencing these clones. In 2004, we
sequenced 652,609 hairpins for this project.
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OBTAINING MECHANISTIC CLUES FROM THE EVOLUTIONARY
CONSTRAINTS IMPOSED ON PROTEIN SEQUENCES
A.F. Neuwald N. Kannan
The selective constraints acting upon proteins during
evolution are revealed in multiple sequence and struc-
tural alignments as coconserved residues and atomic
interactions. These patterns of conservation contain
implicit information about underlying protein mecha-
nisms, just as crystalline X-ray diffraction patterns
contain implicit information about a protein's struc-
ture. Our previous research led to the development of
an approach called contrast hierarchical alignment and
interaction network (CHAIN) analysis, which mea-
sures and characterizes selective constraints based on
coconserved patterns and then fits these constraints, in
light of other biological information, to possible
mechanistic models for protein function. Just as the
quantity and quality of X-ray diffraction patterns
determines how well one can fit an atomic model to
the inferred electron density, the quantity and quality
of coconserved patterns determine how well one can
fit possible mechanisms to inferred selective con-
straints. In principle, given sufficient data, biological
mechanisms may be identified with fairly high cer-
tainty. Nevertheless, even at "low resolution," these
inferred constraints can prune the possibilities down to
a manageable number. Moreover, because natural
selection imposes constraints on whole organisms
within their native environments, these analyses lack
the artifactual biases sometimes associated with in
vitro experimental systems or with in vivo cell cul-
tures. Furthermore, they can reveal functionally criti-
cal features that biologists have entirely overlooked
due to inherent limitations of current experimental
methods. In this way, our research taps into nonhy-
pothesis-driven (sequence, structural, and taxonomic)
experimental data to generate working hypotheses that
can fuel further experimentation.
This year, we have continued to develop new
methods and to apply them mainly to classes of pro-
teins for which vast amounts of sequence, structural,
and other experimental data are available, in which
case, powerful statistical procedures can be used to
detect subtle yet significant characteristics. We con-
tinue to focus on biomedically important proteins,
such as protein kinases, which are key targets for can-
cer therapies.
Multiple Alignment through Monte Carlo
Optimization of a Hidden Markov Model
A. Neuwald [in collaboration with J. Liu, Department of
Statistics, Harvard University]
Our ability to quantify selective constraints strongly
depends on the quality of our multiple alignments,
which thus motivated development of theoretical con-
cepts and strategies to improve alignment of conserved
regions within large sets of distantly related sequences.
This work, which was published this year, describes a
hidden Markov model (HMM), an algebraic system,
and Markov chain Monte Carlo (MCMC) sampling
strategies for alignment of multiple sequence motifs.
The MCMC sampling strategies are useful both for
alignment optimization and for adjusting our measures
of selective pressure for alignment uncertainties. These
also use powerful Bayesian statistical procedures that
provide an objective measure of alignment quality as
well as automatic gap penalty optimization and that
thus can distinguish very subtle, yet significant
sequence conservation from random "noise." In con-
trast, essentially all currently widely used multiple
alignment programs, such as ClustalW and T-coffee,
and newer "state-of-the-art" programs, such as MUS-
CLE and MAFFT, are unsuitable for statistical analysis
because these align randomly generated sequences
(implying that they easily confuse noise with biologi-
cally valid conservation). Thus, our new methods often
more accurately align very distantly related sequences
and thereby provide a better measure of selective con-
straints. Programs implementing these methods have
been made available, including GISMO (Gibbs sam-
pling with multiple operations) and GARMA (genetic
algorithm for recombinant multiple alignment).
Analysis of Eukaryotic Protein Kinases
N. Kannan, A. Neuwald
An analysis of coconserved residues associated with
functional specificity of cyclin-dependent kinases
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(CDKs), mitogen-activated protein kinases (MAPKs),
glycogen synthase kinases (GSKs), and CDK-like
kinases (CLKs), which are collectively termed the
CMGC group, was published this year. Many of the
inferred functional constraints shared by and specific
to CMGC kinases correspond to a region between the
start of an activation loop, which undergoes a confor-
mational change upon phosphorylation to turn on
these kinases, and a CMGC-conserved insert segment
associated with coprotein binding. The strongest such
constraint is imposed on a "CMGC-arginine," the side
chain of which has a role both in substrate recognition
and kinase activation. These and other CMGC fea-
tures suggest a functional association between copro-
tein binding, substrate recognition, and kinase activa-
tion. Constraints shared by and specific to individual
subfamilies point to mechanisms for kinase special-
ization and provide direction for design of drugs with
high specificity. We also have extended our analysis of
kinases further by using the GISMO and GARMA
programs to align, statistically analyze, and compare
eukaryotic protein kinases (EPKs) with distantly relat-
ed EPK-like kinases and with very distantly related
atypical protein kinases. This has revealed an ancient
conserved component that appears to couple substrate
phosphorylation to nucleotide exchange-an inherent
mechanism that seems to have been recruited by EPK
regulatory components during evolution. EPKs phos-
phorylate constituents of various cellular signaling
pathways and thus must be tightly regulated to avoid
physiological catastrophes.
Analysis of AAA+ ATPases
A. Neuwald
We continue to study aspects of AAA+ ATPase mech-
anisms. These proteins are chaperones involved in the
assembly, operation, and disassembly of multiprotein
complexes. Our current emphasis is on DNA poly-
merase clamp loader complexes, which load onto
DNA and unload a clamp that links the replication
complex to DNA during polynucleotide synthesis.
Last year, we initiated an analysis of prokaryotic DNA
polymerase III y and S' clamp loader subunits and
published an analysis of corresponding 13-clamps.
This year we have extending our analysis of clamp
loaders to eukaryotic replication factor C (RFC) sub-
units. These studies have required further refinement
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of various CHAIN analysis procedures, including the
development of a multiple alignment program that uti-
lizes curated alignments-one for each AAA+ family
and based on detailed motif analyses and structural
comparisons. This program allows us to obtain very
accurate alignments of proteins sharing only weakly
conserved motifs separated by highly variable inserts
(as for the AAA+ class). Likewise, we have developed
methods for measuring precise changes in selective
constraints between closely related protein families
whose functions differ only slightly. These measures
are particularly relevant to analysis of certain eukary-
otic RFC clamp loader ATPases, because, unlike their
bacterial counterpart (the y subunit), these have diver-
sified into three distinct families of ATPases having
subtle functional distinctions. By quantifying the dif-
ferences in the selective constraints imposed on these
proteins, we thus were better able to decipher specific
aspects of their underlying mechanisms.
Expanding into Other
Protein Classes
A. Neuwald
We also have initiated CHAIN analyses of additional
key protein constituents of the cellular machinery.
This was reported as preliminary studies for a recent-
ly submitted National Institutes of Health grant pro-
posal to expand our analyses to many other protein
classes and to create a database of the coconserved
structural components thus identified. These studies
involved about a dozen domain classes including
superfamily 1 and 2 helicases, ATP-binding cassette
(ABC) ATPases, RNA recognition motifs (RRMs), the
actin/HSP70/sugar kinase superfamily, amino acid
tRNA synthetases, a,13-hydrolase fold enzymes, pyro-
doxal phosphate-binding proteins, dehalogenases,
FAD/NAD-binding proteins, N-acetyl transferases,
methyltransferases, histone fold proteins, histidine
kinases, and helix-turn-helix-binding domains. Some
of these classes are vast and well characterized and
thus are highly amenable to analysis. Several of these
proteins are of interest to other CSHL research groups,
who plan to follow up experimentally on hypotheses
generated by this project. Drs. Tonks and
Muthuswamy here at CSHL are currently following up
on certain preliminary analyses of protein phos-
phatases and kinases, respectively.
A CHAIN Analysis Database
A. Neuwald, N. Kannan in collaboration with L. Stein,
Cold Spring Harbor Laboratory]
Work on our proposed CHAIN analysis database thus
far has involved setting up "contrast heirarchical align-
ment" files and files for rendering three-dimensional
structural views of specific proteins. These files will be
created for each published analysis. Each alignment
file represents a particular category of selective con-
straints imposed on a query sequence, which corre-
sponds to the protein whose structure is shown in the
corresponding three-dimensional rendering file. The
three-dimensional rendering file uses a color scheme to
represent the various categories of selective con-
straints. These and other files will be made available
over the World Wide Web to allow researchers to visu-
alize the coconserved structural components, inferred
selective constraints, and proposed molecular mecha-
nisms coming out of our analyses.
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GRAMENE: A COMPARATIVE MAPPING RESOURCE
FOR GRAINS
The Gramene database (www.gramene.org) is a com-
parative mapping resource for rice and other grains.
Gramene allows researchers to compare the genetic and
physical maps of the major monocot crops, namely,
maize, barley, oats, sorghum, and wheat, to the emerg-
ing rice genomic sequence. This allows researchers to
identify candidate genes in the rice genome that corre-
spond to genetically mapped mutants and quantitative
traits in the nonrice crop they are studying. Hence, the
resource allows researchers studying traits in maize,
barley, and so forth the benefit of genomic sequencing
without waiting for the sequencing of these much larg-
er genomes.
In addition to comparative maps, Gramene offers
up-to-date genomic annotation of the rice genome,
including both predicted and confirmed genes, and the
current physical maps of rice and sorghum. We have
mapped more than 1 million monocot expressed
sequence tags (ESTs) to the rice genome, allowing
gene predictions to be further refined based on cross-
species comparisons. During this year, we developed a
new integrated map of the rice and maize genomes
that allows researchers to move back and forth
between various genetic and physical maps of these
species in order to apply the knowledge developed in
one organism to finding functionally significant genes
in the other.
Curation is an important component of Gramene.
In collaboration with Susan McCouch's laboratory at
Cornell, we have curated more than 28,000 rice pro-
teins, assigning them classifications in the Gene
Ontology (www.geneontology.org). In addition, we
have classified nearly 1000 rice mutants using a trait
ontology that we have developed. We are currently
curating the rice biological literature, much of which
is in non-English languages, and making this informa-
tion available via Gramene as well.
During the past year, Gramene increased its hold-
ing substantially by adding a variety of important
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comparative mapping resources, including high-
throughput gene-rich sequences from maize, sorghum,
rye grass, and a series of mapped transposon inser-
tions useful for functional genomics. We have also
begun a project to reconstruct the genomes of 11
strains of wild rice that include multiple independent
polyploidization events. This will be a unique oppor-
tunity to understand the biological basis of this agri-
culturally important phenomenon.
WORMBASE: A RESOURCE FOR C. ELEGANS
GENOME AND BIOLOGY
Our lab continues to be a major developer and main-
tainer of the WormBase database (www.wormbase.
org), an online information resource for the small free-
living nematode, Caenorhabditis elegans. This organ-
ism is favored as a simple model animal because of its
small genome size, experimental malleability, and
well-understood cellular anatomy. WormBase is a
curated model organism database developed as part of
an international collaboration that includes the
California Institute of Technology, Washington
University at St. Louis, and the Sanger Centre. Our lab
is responsible for the Web site, user interface, and soft-
ware architecture for the project.
The resource, which is available to the public at
www.wormbase.org, contains the complete C. elegans
genome and key annotations, including predicted
genes, alternative splicing patterns, oligonucleotide
probes, and evolutionarily conserved segments. It also
contains many other types of biological information,
including the C. elegans cell pedigree, the organism's
neuroanatomy, its genetic map, and the physical map
from which the genomic sequence was derived.
During 2004, we have enhanced WormBase by
adding mapping and sequencing information from the
genome of C. briggsae, a sister species of C. elegans
that diverged approximately 100 million years ago.
This information allowed us to discover and confirm a
new family of chemosensory (olfactory) receptor
genes, which culminated in a publication in the
Proceedings of the National Academy of Sciences. We
have also added considerable new functional informa-
tion to WormBase, including a large protein-protein
interaction data set and SAGE (serial analysis of gene
expression) data. These data set the stage for a sys-
tems biology approach to C. elegans, in which the
community reconstructs the control circuits of the
nematode's genetic regulatory pathways. Another
WormBase-related project that is under way is the
sequencing of four additional Caenorhabditis nema-
todes. These genomes will be available from
WormBase beginning in the spring of 2005.
REACTOM E
Reactome (www.reactome.org; formerly "Genome
Knowledgebase") is a collaboration with the European
Bioinformatics Institute (EBI) and the Gene Ontology
Consortium to develop a Web-accessible resource for
curated information about biological processes.
Reactome is organized like a review journal.
Bench biologists are invited to create modules that
summarize a particular aspect of their field. Currently,
summations include DNA replication, transcription,
translation, intermediary metabolism, the cell cycle,
RNA splicing, and hemostasis, together covering
approximately 10% of the human division of
SwissProt. Many more modules are under way.
Modules are similar to minireviews, except that each
paragraph of text is reduced to a series of logical asser-
tions that is entered into a database of processes and
macromolecules. The database is then used to drive a
Web site that can be browsed like a textbook or
searched with queries to discover pathways and con-
nections.
During 2004, we completely revamped the Web
site to create an intuitive "birds eye view" of human
metabolism (see Fig. 1). Reactome received favorable
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FIGURE 1 Visualizing pathways with Reactome. This shows a page from the Cell Cycle
Checkpoints module. At the top is a graphical view of all pathways in Reactome. Those pathways
that are involved in cell cycle checkpoints are highlighted in dark blue in the color Web page
(www/Reactome.org). In the middle of the page is a human-readable summary of the process and
a diagram. At the bottom are fields from the database that list all the proteins and complexes known
to be involved in the process and provide access to orthologous events in other vertebrates. By
clicking on the expandable outline on the left, the user can drill down into increasingly detailed
pages.
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reviews in Science, Nature, and other high-profile
journals, and an article about the resource will appear
in the January 2005 edition of Nucleic Acids Research.
GENERIC MODEL ORGANISM DATABASE PROJECT
In collaboration with the model organism system data-
bases, FlyBase, SGD, and MGD, the Generic Model
Organism Database (GMOD) project is developing a
set of database schemas, applications, and interfaces
suitable for creating a model organism system data-
base. The hope is to significantly reduce the time and
expense required to create new databases to curate
genomic information coming out of various model
organism system sequencing projects (e.g., rat,
Dictyostelium, and Plasmodium).
By an informal count, several hundred laboratories
are now using one or more of the GMOD tools, and
increasing numbers of new databases are proposing to
adopt GMOD for their infrastructure.
THE HUMAN HAPLOTYPE MAP
The International HapMap Project (www.hapmap.org)
seeks to map out regions of common genetic variabil-
ity in the human genome by genotyping three major
world populations at a resolution of 1 marker per 5
kbp. When complete, the resulting "haplotype map"
will greatly reduce the cost of genetic association
studies to find cancer susceptibility genes and other
disorders with genetic components.
Our lab is a central participant in this project in our
role as the Data Coordinating Center (DCC). We man-
age the central database for the project, allocate single
nucleotide polymorphisms (SNPs) to the 11 genotyp-
ing centers, coordinate data submission, quality
checks, and quality control, and manage the public
release of project data. The HapMap Web site, which
was developed in our lab, describes the project in the
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five languages of the project participants (English,
French, Chinese, Japanese, Yoruba) and provides
access to the data both for bulk download and for
interactive querying and browsing.
During 2004, we greatly enhanced the Web site by
adding data visualization and analysis tools based on
the GMOD infrastructure. In particular, we added a
mechanism for viewing patterns of linkage disequilib-
rium within a population and for examining the differ-
ences among populations. We also provided a mecha-
nism for downloading selected sets of genotypes in a
format that can be used for haplotype block analysis.
As of late 2004, the project had nearly reached its
target density of 1 genotyped SNP every 5 kb, and a
publication describing patterns of linkage disequilibri-
um is in preparation. However, in light of the potential
utility that it has already shown, the project has recent-
ly been extended to genotype an additional 2.5 million
SNPs and the project is slated to continue through 2005.
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COMPUTATIONAL GENOMICS
M.Q. Zhang N. Banerjee
G.X. Chen
D. Das
R. Das
N. Dimitrova L. Liu
N. Hata D. Schones
C. Jiang A.D. Smith
M. Kato S. Srivastava
Our main achievement last year was to continue build-
ing our own large-scale genome analysis infrastruc-
ture. We further developed our promoter annotation
pipeline to include manually curated information on
cancer-related transcription factors, their binding sites,
and target gene regulation. Most significantly, we
developed a whole suite of novel computational algo-
rithms/tools for identification of transcription-factor-
binding site (TFBS) motifs by taking all three large-
scale genomics resources: genomic DNA sequences,
ChIP-chip, and expression microarray data. First of
all, we clustered the existing known TFBSs in TRANS-
FAC and JASPER and developed a rigorous distance
measure for measuring similarity between any given
pair of motifs using Matcompare. Second, we devel-
oped a pair of novel discriminant motif finders, called
DWE (discriminant word enumerator) and DME (dis-
criminant matrix enumerator), which allows users to
identify differentially "expressed" motifs between two
arbitrary (target and control) sequence sets. Third, we
developed a MARS (multivariate adaptive regression
splines)-based motif finder MARSMotif, which allows
users to automatically select functionally significant
motifs and motif combinations by correlating this
sequence information with microarray data. These
tools have been successfully tested to find tissue-spe-
cific motifs in liver and in muscle when combining
sequence information with microarray data. We are in
the process of integrating these resources to systemat-
ically and automatically identify a more comprehen-
sive list of tissue-specific TFBS motifs and motif
combinations (modules) in the human genome.
TRED: A Transcriptional Regulatory
Element Database and a Platform
for In Silico Gene Regulation Studies
F. Zhao, Z.Y. Xuan, L. Liu, M.Q. Zhang
To understand gene regulation, accurate and compre-
hensive knowledge of transcriptional regulatory ele-
P. Sumazin
J.H. Wang
Z.Y. Xuan
F. Zhao
ments is essential. Here, we report our efforts in build-
ing a mammalian transcriptional regulatory element
database (TRED) with associated data analysis func-
tions. It collects cis- and trans-regulatory elements and
is dedicated to easy data access and analysis for both
single-gene-based and genome-scale studies. Distin-
guishing features of TRED include (1) relatively com-
plete genome-wide promoter annotation for human,
mouse, and rat; (2) availability of gene transcriptional
regulation information including TFBS and experimen-
tal evidence; (3) data accuracy ensured by hand cura-
tion; (4) efficient user interface for easy and flexible
data retrieval; and (5) implementation of on-the-fly
sequence analysis tools. TRED can provide good train-
ing data sets for further genomewide cis-regulatory ele-
ment prediction and annotation, assist detailed func-
tional studies, and facilitate the decipher of gene regu-
latory networks (http://rulai.cshl.edu/TRED).
Similarity of Position Frequency
Matrices for TFBSs
D. Schones, P. Sumazin, M.Q. Zhang
TFBSs in promoter sequences of higher eukaryotes
are commonly modeled using position frequency
matrices (PFMs). The ability to compare PFMs repre-
senting binding sites is especially important for de
novo sequence motif discovery, where it is desirable to
compare putative matrices to one another and to
known matrices. We have described a PFM similarity
quantification method based on product multinomial
distributions, demonstrated its ability to identify PFM
similarity, and shown that it has a better false-positive
to false-negative ratio compared to existing methods.
We grouped TFBS frequency matrices from two
libraries into matrix families and identified the matri-
ces that are common and unique to these libraries. We
identified similarities and differences between the
skeletal-muscle-specific and non-muscle-specific fre-
quency matrices for the binding sites of Mef-2, Myf,
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Sp-1, SRF, and TEF of Wasserman and Fickett (J. Mol.
Biol. 278: 167-181 [1998]). We further identified
known frequency matrices and matrix families that
were strongly similar to the matrices given by
Wasserman and Fickett. We provided methodology
and tools to compare and query libraries of frequency
matrices for TFBSs.
DWE: Discriminating Word
Enumerator
P. Sumazin, G.X. Chen, N. Hata, A.D. Smith, M.Q. Zhang
[in collaboration with T. Zhang, Merck Research
Laboratories, Boston]
Tissue-specific TFBSs provide insight into tissue-spe-
cific transcription regulation. We have described a
word-counting-based tool for de novo tissue-specific
TFBS discovery using expression information in addi-
tion to sequence information. We incorporated tissue-
specific gene expression through gene classification to
positive expression and repressed expression. A direct
statistical approach was used to find overrepresented
TFBSs in a foreground promoter sequence set against
a background promoter sequence set. Our approach
naturally extends to a synergistic TFBS search.
Putative TFBSs were found overrepresented in the
proximal promoters of liver-specific genes relative to
proximal promoters of liver-independent genes. Our
results indicate that binding sites for hepatocyte
nuclear factors (especially HNF-1 and HNF-4) and
CCAAT/enhancer-binding protein (C/EBPbeta) are the
most overrepresented in proximal promoters of liver-
specific genes. The results also suggest that HNF-4 has
strong synergistic relationships with HNF-1, HNF-4,
and HNF-3beta and with C/EBPbeta.
Identifying Tissue-selective TFBSs in
Vertebrate Promoters with DME
A.D. Smith, P. Sumazin, M.Q. Zhang
We demonstrated a computational method, DME (dis-
criminant matrix enumerator), aimed at systematical-
ly identifying tissue-selective TFBSs. Our method
focuses on the differences between sets of promoters
that are associated with differentially expressed genes,
and it is effective at identifying the highly degenerate
motifs that characterize vertebrate TFBSs. Results on
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simulated data indicate that our method detects motifs
with greater accuracy than the leading methods, and
its detection of strongly overrepresented motifs is
nearly perfect. We demonstrated motifs identified by
our method as the most overrepresented in promoters
of liver- and muscle-selective genes, showing that our
method accurately identifies known TFBSs and previ-
ously uncharacterized motifs.
Using MARS to Study Interacting
Models of Cooperative
Gene Regulation
D. Das, N. Banerjee, M.Q. Zhang
Cooperation between transcription factors is critical to
gene regulation. Current computational methods do
not take adequate account of this salient aspect. To
address this issue, we used a computational method
based on multivariate adaptive regression splines
(MARS) to correlate the occurrences of transcription-
factor-binding motifs in the promoter DNA and their
interactions with the logarithm of the ratio of gene
expression levels. This allows us to discover both the
individual motifs and synergistic pairs of motifs that
are most likely to be functional and to enumerate their
relative contributions at any arbitrary timepoint for
which mRNA expression data are available. We pre-
sent results of simulations and focus specifically on
the yeast cell cycle data. Inclusion of synergistic inter-
actions can increase the prediction accuracy over lin-
ear regression to as much as 1.5- to 3.5-fold.
Significant motifs and combinations of motifs are
appropriately predicted at each stage of the cell cycle.
We believe our multivariate adaptive regression
splines-based approach will become more significant
when applied to higher eukaryotes, especially mam-
mals, where cooperative control of gene regulation is
absolutely essential. Our integrated software tool is
called MARSMotif.
Computational Dissecting
Transcriptional Regulation
Network in Yeast Cell Cycle
M. Kato, N. Hata, N. Banerjee, M.Q. Zhang
Combinatorial interaction of transcription factors
(TFs) is important for gene regulation. Although vari-
ous genomic data sets are relevant to this issue, each
data set provides relatively weak evidence on its own.
Developing methods that can integrate different
sequence, expression, and localization data have
become important. We use a novel method that inte-
grates chromatin immunoprecipitation (ChIP) data
with microarray expression data and with combinato-
rial TF-motif analysis. We systematically identify
combinations of transcription factors and motifs. The
various combinations of TFs involved multiple bind-
ing mechanisms. We reconstruct a new combinatorial
regulatory map of the yeast cell cycle in which cell
cycle regulation can be drawn as a chain of extended
TF modules. We find that the pairwise combination of
a TF for an early cell cycle phase and a TF for a later
phase is often used to control gene expression at inter-
mediate times. Thus, the number of distinct times of
gene expression is greater than the number of tran-
scription factors. We also see that some TF modules
control branch points (cell cycle entry and exit), and in
the presence of appropriate signals, they can allow
progress along alternative pathways. Combining dif-
ferent data sources can increase statistical power as
demonstrated by detecting TF interactions and com-
posite TF-binding motifs. The original picture of a
chain of simple cell cycle regulators can be extended
to a chain of composite regulatory modules: Different
modules may share a common TF component in the
same pathway or a TF component cross-talking to
other pathways.
From Worm to Human: Bioinformatics
Approaches to Identify FOXO
Target Genes
Z.Y. Xuan, M.Q. Zhang
Longevity regulatory genes include the Forkhead tran-
scription factor FOXO, in addition to the NAD-depen-
dent histone deacetylase silent information regulator 2
(Sir2). The FOXO/DAF-16 family of transcription
factors constitutes an evolutionarily conserved sub-
group within a larger family known as winged helix or
Forkhead transcriptional regulators. In a study of
aging, we have demonstrated how to identify FOX()
target genes and their potential cis-regulatory binding
sites in the promoters via bioinformatics approaches.
These results provide new testable hypotheses for fur-
ther experimental verifications.
Evidence and Characteristics of
Putative Human Alpha
Recombination Hot Spots
M.Q. Zhang [in collaboration with X.G. Zhang, Tsinghua
University, China)
Understanding recombination rate variation is very
important for studying genome diversity and evolu-
tion, and for investigation of phenotypic association
and genetic diseases. Recombination hot spots have
been observed in many species and are well studied in
yeast. Recent study has demonstrated that recombina-
tion hot spots are also a ubiquitous feature of the
human genome. But the nature of human hot spots
remains largely unknown. We have developed and val-
idated a novel computational method for testing the
existence of hot spots as well as for localizing them
with either unphased or phased genotyping data. To
study the characteristics of hot spots within or close to
genes, we scanned for unusually high levels of recom-
bination, using the European population samples in
the SeattleSNPs database, and found evidence for the
existence of human alpha hot spots similar to those of
yeast. This type of hot spot, found at promoter regions,
accounts for about half of the total detected and
appears to depend on some specific transcription-fac-
tor-binding sites (such as CGCCCCCGC). These char-
acteristics can explain the observed weak correlation
between hot spots and GC content, and their variation
may contribute to the diversity of hot spot distribution
among different individuals and species. These long-
sought putative human alpha recombination hot spots
deserve further experimental investigations.
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COLD SPRING HARBOR LABORATORY FELLOWS
In 1986, Cold Spring Harbor Laboratory began a Fellows program to encourage independent research
by outstanding young scientists who, during their graduate studies, displayed exceptional promise of
becoming leading scientists of the future. The purpose of this program is to provide an opportunity for
these young scientists to work independently at the Laboratory for a period of up to 4 years on pro-
jects of their own choosing. Fellows are provided with a salary, research support, and technical assis-
tance so that they can accomplish their goals free of distraction. The interaction among research
groups at the Laboratory and the program of courses and meetings on diverse topics in biology con-
tribute to a research environment that is ideal for innovative science by these Fellows.
Previous Cold Spring Harbor Laboratory Fellows Adrian Krainer (1987), Scott Lowe (1995), and
Marja Timmermans (1998) are currently members of the faculty at the Laboratory. After 9 years at the
Laboratory, Carol Greider (1988) left to join the Department of Molecular Biology and Genetics at Johns
Hopkins University School of Medicine. Eric Richards (1989) is currently in the Department of Biology
at Washington University. After finishing his fellowship, David Barford (1991) returned to the Laboratory
of Molecular Biophysics at Oxford University. Ueli Grossniklaus (1994) was a member of our faculty
before leaving to join the Friedrich Miescher Institut in Basel, Switzerland in 1998. Terence Strick joined
the Laboratory in 2000 after earning his Ph.D. in molecular and cellular biology at Eco le Norma le
Superieure in Paris with David Bensimon and Vincent Croquette. Terence is using single-molecular bio-
physics to study the mechanical response of DNA to stretching and twisting by enzymes that alter DNA
topology, thus elucidating the properties of those enzymes. Terrence left last year to join the l'Institut
Jacques Monod at the Centre National de la Recherche Scientifique.
The Laboratory currently has three CSHL Fellows, Gilbert (Lee) Henry, who joined the Laboratory in
2000, and Patrick Paddison and Ira Hall, both of whom joined the Laboratory this year. Their reports are
listed below. Lee joined us from Doug Melton's laboratory at Harvard University where he earned his Ph.D.
for studies on Xenopus development. Lee is studying taste bud development and the regulation of taste-
bud-specific genes. Patrick Paddison was a graduate student at the Watson School of Biological
Sciences here at CSHL, where he worked in Greg Hannon's lab generating an RNA interference (RNAi)
library. Patrick plans to use this library to determine the genes that are required for specification of embry-
onic stem cell fates during differentiation. Ira Hall was also a graduate student at the Watson School of
Biological Sciences, where he worked in Shiv Crewel's lab on the biology of small RNAs and RNAi. He is
currently examining the potential role of copy-number polymorphisms in controlling genetic variation.
Investigation of DNA
Copy-number Fluctuation
using Genomic Microarrays
I. Hall
We are interested in pursuing a genome-wide examina-
tion of genetic instability and plasticity and in charac-
terizing the contribution of DNA copy-number poly-
morphisms to genetic variation. The arrangement and
copy number of chromosomal segments may vary
between species, strains, and individuals, and sponta-
neous DNA rearrangements are recognized to be causal
in the clonal evolution of cancers and in the etiology of
certain human diseases. Ancestral sequence relation-
ships within and between mammalian genomes indi-
cate a major architectural role for duplication and dele-
tion in shaping genomes over evolutionary time, but lit-
tle is known about how these processes contribute to
genetic variation across more rapid time scales within
normal populations and organisms. During the next
few years, we plan to use the laboratory mouse as a
model system to investigate the frequency and nature
of DNA copy-number fluctuation in mammals utilizing
a form of comparative genome hybridization termed
representational oligonucleotide microarray analysis
(ROMA) (Lucito et al., Genome Res.13: 2291 [2000]).
Internal relationships within sequenced genomes
show that a significant portion (2-5%) of chromosomal
DNA in mammals is contained within segmental dupli-
cations (defined as stretches of DNA within a single
genome >1 kb in length and >90% identical to one
another), and duplicative events underlie the historical
amplification and diversification of many important
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gene families. Sequence comparisons are essential to
identify ancient copy-number changes, but are not well
suited to detect recent and ongoing genetic events
because a complete genome sequence (1) is usually
derived from a single individual, (2) relies on assembly
methods that are confounded by large identical repeats,
and (3) is still impractical to attain for large genomes.
Traditional molecular techniques are inevitably limited
(and directed) to a small number of loci, and cytogenet-
ic methods lack sufficient resolution to detect most
changes. ROMA allows for the simultaneous detection
of DNA copy-number polymorphisms (CNP) and
restriction-fragment-length polymorphisms (RFLP)
between any two related DNA samples through compar-
ative hybridization of simplified genomic representa-
tions to high-density oligonucleotide microarrays. This
technique assays a large portion of the genome in a rel-
atively unbiased manner and requires only that a com-
plete genome sequence exists for the organism in ques-
tion. Using ROMA, the Wigler group here at CSHL has
recently discovered extensive copy-number polymor-
phism between individual humans (Sebat et al., Science
305: 525 [2004]), indicating that CNPs may account for
a substantial fraction of human genetic variation.
The apparent evolutionary importance and contem-
porary prevalence of segmental copy-number variation
raises fundamental questions: How often do new CNPs
arise? Do different tissues or cellular lineages differ in
their susceptibility to genetic alteration? Are different
chromosomal regions, classes of DNA sequence, or gene
families more variable than others? Are there genetic
pathways or environmental conditions that compromise
genome stability? Do different cells or cell types of an
organism always have the same DNA content?
The laboratory mouse is an ideal model system for
such investigations in that the human and mouse
genomes appear to have been shaped by similar muta-
tional forces, and the mouse offers the obvious exper-
imental advantages of controlled crosses, genomic
manipulation, and mutant analysis. Furthermore, dur-
ing the past century, a large number of phenotypically
diverse inbred strains have been derived from a small
number of founder mice through brother-sister mat-
ing. Because these founders were mixed descendants
of Asian and European subspecies, each modern
inbred line contains a unique, recombinant mixture of
chromosomal segments of distinct genetic origin.
These genetic differences are thought to underlie the
many interesting physical and behavioral traits for
which modern strains vary.
The work outlined below relies heavily upon tech-
nology, infrastructure, and expertise developed in the
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Wigler and Lucito laboratories here at CSHL during
the past few years.
HOW GENETICALLY DIVERSE ARE
LABORATORY MICE?
To get a broad picture of the current genetic composi-
tion of the laboratory mouse and the utility of ROMA
as a tool for mouse genetics, we have compared a
handful of different commonly used strains to a refer-
ence. These preliminary experiments show that a large
number of ROMA polymorphisms exist among differ-
ent inbred strains (3-5% of probes) and that these
polymorphisms are distributed throughout the genome
in a punctate, nonrandom fashion that presumably
reflects the ancestral origin of chromosome segments.
The majority of these polymorphisms appear to repre-
sent variation existing before the separation of inbred
lines, and rough estimates suggest that a significant
portion of these are CNPs (-10-15%). In general,
these polymorphic markers have only two variants,
indicating that the original genetic pool giving rise to
modern strains was very limited. Statistical interpreta-
tion of these patterns requires new algorithms, and we
plan to develop these in collaboration with M. Wigler.
These tools, and a knowledge of the differences in
haplotype distribution and gene copy number between
strains, will represent a major experimental resource
for future studies.
The oldest inbred lines have been propagated by
brother-sister mating for more than 200 generations
and are thought to be genetically uniform. Our pilot
experiments comparing separate individuals from vari-
ous strains indicate that although mice within a given
strain are highly inbred, they are not identical. They do
not retain ancestral polymorphisms (those that distin-
guish strains) but do exhibit an unexpected number of
unique CNPs that presumably have arisen recently and
have not yet been fixed within, or lost from, the
inbreeding lineage. Some of these CNPs contain well-
known genes. Our experiments thus far are not suffi-
cient in scale to gauge the extent to which unique CNPs
are segregating within otherwise inbred lines, but they
do suggest a relatively high rate of de novo formation.
HOW COMMON ARE GENOME REARRANGEMENTS?
To assess the importance of segmental duplication and
deletion in generating de novo genetic variation, we
plan to examine genome stability through normal
cycles of somatic development and germ-line trans-
mission by measuring the frequency and pattern of
DNA copy-number alterations in diverse cellular lin-
eages of the mouse. These studies will also provide the
necessary context for future work characterizing mol-
ecular pathways and environmental stimuli that pro-
mote, or inhibit, genome stability through a direct
effect on chromosome behavior.
Mutation in the germ line is the basis for the intro-
duction of new alleles to a species and is relevant to our
understanding of evolution, population structure, and
sporadic human disease. Previous estimates of the
germ-line mutation rate have relied on the observation
of spontaneous loss of function at a small number of
genes and do not adequately distinguish between class-
es of mutations. The rates of de novo segmental dupli-
cation and deletion are not known. We have initiated
studies to estimate these parameters by analyzing the
frequency at which new CNPs arise in families of mice.
A description of the genetic variation normally pre-
sent in somatic cells is important for a few major rea-
sons. Each cancer is thought to begin with a single cell
that has genetically diverged from its relatives, and var-
ious theories contend that the accumulation of muta-
tions is a primary cause of aging. DNA rearrangement
is also an established regulatory mechanism; our own
bodies generate a staggering diversity of immunological
molecules precisely through such "mutagenic" process-
es, and more simple genetic systems (such as various
yeasts and bacteria) utilize reversible DNA rearrange-
ments to make heritable transcriptional decisions. It is
not known how common such mechanisms are in mam-
mals. In collaboration with J. Hicks here at CSHL, we
are pursuing a survey of somatic cell diversity. As a first
pass, we are simply analyzing different tissues from the
same individual, but we plan to obtain more pure cell
populations via flow cytometry and microdissection. We
are also collaborating with K. Eggan (Harvard
University) to test the genetic equivalence of different
cells and cell types using somatic cell nuclear transfer.
We hope that these studies result in an estimate of clon-
al variegation in mammals and help to identify unstable
or potentially hypervariable regions of the genome.
Structural and Functional Studies
of the Vertebrate Taste Bud
L. Henry, M. Siddiqui, P. O'Brien
The goal of our research is to understand the molecu-
lar basis of vertebrate taste receptor cell genesis.
These specialized sensory cells are housed within
ovoid structures called taste buds, which are embed-
ded in the epithelium of the tongue, and to a lesser
extent the epithelium of the palate and upper pharynx.
Consisting of 70-100 cells, the vertebrate taste bud is
a highly dynamic structure that possesses both epithe-
lial and neuronal qualities. Like all other sensory cell
types, the taste receptor cell membrane depolarizes in
the presence of a suitable stimulus. Similar to the
epithelial cells that line the intestine and other areas of
the gut, taste receptor cells turn over at a rapid rate
(-8-10 days in rodents). Thus, the mammalian taste
bud is a dynamic structure consisting of mitotically
active progenitor cells at its periphery and differentiat-
ed taste receptor cells within its core. Unlike the olfac-
tory system, where the axons of newly formed recep-
tor cells project for some distance back toward and
synapse on to neurons in the glomeruli of the olfacto-
ry bulb, newly formed taste receptor cells lack classi-
cal projections and synapse on to sensory afferents
that are associated with the taste bud.
The basic goal of our research is to understand
how the daughters of the progenitors select a particu-
lar fate. Because different receptor cells are known to
respond to different classes of tastants, we hope that
understanding this differentiation process will help to
illuminate details of both taste bud structure and func-
tion. Toward this end, we have undertaken an exhaus-
tive effort to define at the level of transcription the cel-
lular diversity of the murine taste bud. To do this, sin-
gle-cell profiling is being used to analyze the tran-
scriptomes of taste receptor and progenitor cells.
A prerequisite for much of our work is the devel-
opment of a quantitative method for the analysis of
mRNA expression in single or small numbers of cells.
A typical eukaryotic cell contains picogram amounts
of mRNA, whereas the vast majority of the analytical
procedures that we use to analyze gene expression
require microgram amounts of material. Thus, the
mRNA expressed in a single cell must be amplified
before it can be studied. We have developed a novel
scheme for performing such amplifications. In this
technique, mRNA is bound to a magnetic bead, cova-
lently coupled cDNA is produced, and after a series of
molecular manipulations, the cDNA is released and
amplified by either PCR (polymerase chain reaction)
or in vitro transcription.
We initially struggled with severe signal-to-noise
problems using this system, which was expected
because similar but solution-based assays have similar
issues. This problem has been largely eliminated
through the use of a novel oligonucleotide design, and
during the previous year, we have concentrated on the
chemistry involved in linking the capture/probe
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oligonucleotide to the magnetic bead. The linker must
have three properties: covalent attachment to the bead
surface, the ability to cleave oligomer/CNDA free from
the bead in a specific manner, and sufficient length to
position the oligomer far from the bead. All of these
requirements have been met through the synthesis of a
12-24-unit polyethylene glycol (PEG)-containing link-
er that possesses a free amine for attachment to car-
boxyl functionalized magnetic beads on one end and a
t-butyl carbamate (BOC)-protected amine on the other.
Proximal to the BOC-protected amine is a cis diol that
can be specifically cleaved by periodate oxidation in
aqueous conditions. Once attached to the bead, the
BOC-protecting group is removed and the free amino
acylated with a commercially available adapter that
allows the linker to form a stable thioether bond with 5'
thiol-modified oligonucleotides. We are currently test-
ing the effectiveness of our background reduction
method utilizing beads covalently attached to oligonu-
cleotides through the aforementioned linker. We will
also access the degree to which the linker influences
the kinetics of both mRNA hybridization and the vari-
ous enzymatic manipulations that are needed to convert
the mRNA into cDNA.
ProteinDNA Interactions
T.R. Strick
Because my laboratory has just moved to Paris,
France, this is my last Annual Report as a Cold Spring
Harbor Laboratory Fellow. I would like to thank the
Laboratory for the excellent working conditions,
exciting atmosphere, and generous suppport it has
provided me during the last four years. It has been a
great privilege to spend time as a part of the Cold
Spring Harbor Laboratory community.
This past year, we have made exciting progress in
our efforts to detect proteinDNA interactions in real
time. In particular, we have been using single-mole-
cule nanomanipulation techniques to modify and
study the structure and topology of DNA in processes
ranging from gene transcription to the packaging of
DNA into mitotic chromosomes. These methods yield
important new mechanistic insights into these molec-
ular motors and complex systems that transcribe the
genome or maintain its integrity. At the same time,
they also shed light on the nature of DNA structural
transitions and their influence on gene expression.
DNA nanomanipulation allows us to observe and
control proteinDNA interactions at the resolution of
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individual molecules. Continuous monitoring of a sin-
gle pair of interacting molecules (for instance, an RNA
polymerase molecule and a DNA molecule) gives us
access to the full time course of the interaction, there-
by allowing us to directly observe the interaction in real
time-something that is simply not possible using tra-
ditional biochemistry and molecular biology. From
this, one can measure with unprecedented accuracy
and precision the time scales of interactions between
the protein and its DNA substrate and perform quanti-
tative analysis of, for instance, association and dissoci-
ation rates, and their dependence on activators (such as
CAP protein) or inhibitors (such as antibiotics).
In addition, nanomanipulation of the DNA allows
us to control the level of mechanical strain (i.e., super-
coiling) applied to it. In this way, we can dynamically
and quantitatively reproduce in vitro the mechanical
constraints to which DNA is thought to be subjected to
in vivo. This allows us to elucidate mechanical fea-
tures of the interaction, such as how protein binding
induces twisting, bending, or looping of the DNA. It
also allows us to determine how the proteinDNA
interaction responds to changes in DNA topology and
strain. Such experiments help us to better understand
how many proteins function-by changing their and
their substrates' conformations.
The single-molecule experiment we have imple-
mented is depicted in Figure 1. A 2-kb linear DNA
molecule (-0.6 pm long) is shown anchored at one
FIGURE 1 Depiction of the experimental setup. (Inset) DNA is
tethered at one end to the wall of a glass capillary tube and at
the other to a magnetic bead. (Overview) The capillary tube is
mounted on an inverted microscope whose focus is controlled
by a computer. The computer also controls the displacements
(translation and rotation) of the magnets used to manipulate the
bead. A CCD camera connected to the microscope relays
video images of the magnetic bead to the computer. The com-
puter extracts from these images the mean position and the
Brownian fluctuations of the bead, which can be used to deter-
mine the DNA's end-to-end extension I, which results from an
applied stretching force F and a supercoiling of n turns.
end to a glass surface and at the other end to a 1-1.1m-
diameter magnetic bead. The field generated by mag-
nets located above the sample is used to pull on and
rotate the magnetic bead, thus stretching and twisting
the tethered DNA. The stretching force applied to the
DNA via the bead is calibrated as a function of mag-
net position (the closer the magnets, the higher the
force). The torsion imparted to the DNA is exactly
equal to the number of clockwise or counterclockwise
rotations performed by the magnets and imposed on
the bead. The double helix is thus quantitatively and
reversibly supercoiled while held under tension. By
determining the position of the magnetic bead, one
measures and calibrates the end-to-end extension of
the DNA molecule, and thus its mechanical response
to stretching and twisting.
Single-molecule Studies of
Transcription Initiation
A. Reyyakin, R.H. Ebright, T.R. Strick
The transcription of DNA (gene) into RNA (message)
is the first step in the regulation of gene expression.
Transcription begins when RNA polymerase binds to
the promoter sequence, which heralds the beginning of
a gene. The enzyme unwinds the DNA at the promot-
er site (forming a "transcription bubble") to better read
the sequence of base pairs encoding the gene. It then
begins to synthesize short RNA fragments as it
attempts to break free from the promoter site, in an
apparently futile process known as "abortive initia-
tion." Only after several rounds of abortive initiation
will the enzyme be able to break free from the pro-
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moter site and begin productive elongation of the RNA
transcript. After the end of the gene and upon reaching
the "termination sequence," the RNA polymerase
releases the RNA transcript and itself dissociates from
the DNA.
We have recently made significant progress in
using single-DNA nanomanipulation to perform real-
time studies of the interactions between RNA poly-
merase and DNA. These experiments allow us to
observe a single RNA polymerase molecule as it
works to transcribe a single DNA molecule. In the
past, our research had focused on the first few steps of
transcription, in particular the mechanical unwinding
of the promoter site by RNA polymerase (Fig. 2A).
In the last year, technical improvements to our
nanomanipulation system have allowed us to increase
our temporal resolution by at least a factor of 2, there-
by making it possible to detect RNA polymerase/DNA
interactions on a time scale of a few hundred millisec-
onds. We have exploited this improvement to extend
our measurements of RNA polymerase/DNA interac-
tions to all of the events that follow transcription initi-
ation, i.e., abortive initiation, promoter escape, pro-
ductive elongation, and the termination of transcrip-
tion. We are thus able to observe in real time the entire
transcription cycle, detecting one RNA polymerase
after another as it completes its transcription "burst"
on the DNA molecule that we control by nanomanip-
ulation.
In Figure 2B, we present data showing transcrip-
tion of the nanomanipulated DNA by four successive
RNA polymerase molecules. Each transcription
"pulse" by a single RNA polymerase is composed of
the succession of stages described in the two para-
graphs above. In the absence of a transcription bubble,
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FIGURE 2 Real-time measurement of DNA extension allows for detection of RNA polymerase/DNA interaction. Raw data points are
in light gray; the dark gray line corresponds to -0.5-sec averaging. Vi) In the absence of nucleotides, reversible promoter unwinding
by a single RNA polymerase is observed as a transient decrease (state 2) in DNA extension. (8) RNA polymerase electrocardiogram:
observation of the full transcription cycle by four successive RNA polymerase upon addition of all four nucleotides (ATP, UTP, GTP,
and CTP). Labels for states 1-5 generated by the third of four RNA polymerases are as described in the text.
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the DNA is in the state labeled 1. Initial promoter
unwinding is labeled as state 2.
Initial promoter unwinding rapidly gives way to
abortive cycling, heralded by a strong but transient
expansion of the transcription bubble and labeled 3.
Abortive cycling appears to precede all promoter
escape events and may thus be a requirement for pro-
moter escape. During promoter escape, the transcrip-
tion bubble rewinds noticeably, and the RNA poly-
merase then transcribes the ensuing DNA transcript
(state 4). Upon reaching a terminator sequence, the
transcription bubble closes (state 5) and the single-
molecule time trace returns to baseline (state as in 1).
These experiments open many important new perspec-
tives for understanding how these various stages of the
transcription cycle all participate in the regulation of
gene expression.
DNA Compaction by SMC Proteins
T. Kawaguchi, T. Hirano, T.R. Strick
The formation of compact mitotic chromosomes, as
they are observed in human karyotypes, is mediated
by the structural maintenance of chromosome (SMC)
protein complex known as condensin. To better under-
stand the vital process of chromosome condensation,
we analyzed the response of nanomanipulated DNA to
purified Xenopus laevis condensin.
Using DNA nanomanipulation, we were able to
observe large-scale, rapid, and yet reversible conden-
sation of the DNA upon addition of purified X laevis
condensin and ATP. This required both the phosphory-
lation patter consistent with the mitotic state of the cell
cycle and access to hydrolyzable ATP. Control experi-
ments performed in the absence of ATP show that
under these conditions, the condensin complex binds
reversibly to DNA but does not cause its condensation.
At low protein concentration, the incremental com-
paction of DNA was observed as large (-90 nm) and
discrete changes in DNA extension, and presumably
corresponds to the association and dissociation of a
single condensin complex from DNA. At higher con-
densin concentrations, when several condensins have
bound to the nanomanipulated DNA, protein-protein
interactions generate large-scale loops along the DNA.
The formation of compact chromosomes would thus
presumably be based on the formation of such loops
along DNA.
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Torque-induced Structural
Transitions in DNA
T.R. Strick, R. Sachidanandam
These experiments aim to better understand the physi-
cal properties of DNA. We have observed that an
unwinding torque applied to DNA induces abnormally
slow and transient alterations of the molecule's sec-
ondary structure. Analysis of these conformational
changes could help us understand how DNA supercoil-
ing affects processes such as the initiation of DNA
replication or the termination of transcription. In the
last year, we showed that these fluctuations can be
caused by DNA sequences containing imperfect invert-
ed repeats, or palindromes. We are currently assessing
the role of such fluctuations in the living cell.
Genes Required for Stem Cell
Specification
P.J. Paddison
Mouse embryonic stem (ES) cells are cell lines
derived from preimplantation embryos that can be
expanded in culture while retaining the functional
attributes of pluripotent early embryo cells. Mouse ES
cells can be induced to differentiate in vitro within
complex cellular aggregates called embryoid bodies
(EBs). Previous studies have demonstrated that EBs
undergo a developmental program which recapitulates
many of the early events of mammalian embryogene-
sis with respect to the kinetics of development and dif-
ferential gene expression. Fully differentiated somatic
cell types, which in the developing mouse embryo are
derived from precursor cells in each of the three pri-
mary germ layers, i.e., ectoderm, endoderm, and
mesoderm, can now be specified in vitro from EBs.
At my bench, the initial goal of my research is to
functionally map the genetic requirements for ES cell
specification. To this end, I will introduce genetic
lesions into ES cells that serve to block individual
gene function and ask whether cell specification is
also blocked at a particular stage: pregerm, germ, or
postgerm layer. Presumably, blocks occurring early
on during lineage commitment will affect most lin-
eages, whereas those occurring later will only affect
cells derived from particular lineages (e.g., neural-
ectodermal).
To block individual gene functions in ES cells and
also "stage" particular developmental lesions, I will
use the CSHL genome-wide RNA interference (RNAi)
libraries (Paddison et al. 2004) in combination with
lineage-specific mouse ES cell reporter lines.
Hopefully, these studies will not only offer new insight
into stem cell biology and mammalian development,
but also provide a toehold for preclinical applications
of stem cells in cell replacement therapies.
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WATSON SCHOOL OF BIOLOGICAL SCIENCES
DEAN'S REPORT
This year saw two memorable events in the short history of the Watson School. First, on April 25, the
efforts and dedication of our students and faculty came to fruition with the awarding of the School's
first doctoral degrees. This was a tremendously gratifying and inspiring experience. Second was the
retirement on July 1 of our founding dean, Winship Herr. The School and Cold Spring Harbor
Laboratory (CSHL) will be forever indebted to Winship for his vision, leadership, and creativity, and for
building a solid foundation from which the Watson School can continue to prosper.
First Students Graduate from the Watson School
On April 25, 2004, exactly 51 years after the publication of the double-helical structure of DNA by
James Watson and Frances Crick, six Watson School students-Amy Gaudy, Elizabeth Thomas, Niraj
Tolia, and Emiliano Rial Verde from the first Entering Class of 1999, and Ira Hall and Patrick Paddison
from the second Entering Class of 2000-received Ph.D. degrees conferred by Cold Spring Harbor
Laboratory. The average time to degree for the six graduates was exactly four years! Also on that day,
James Watson, Joan Steitz (a previous graduate student of Jim's), and Shirley Tilghman, president of
Princeton University, all received honorary doctorates. It was a truly momentous occasion in the histo-
ry of the Laboratory.
(Front row, left to right) Lilian Clark Gann, Patrick Paddison, Elizabeth Thomas, Amy Gaudy, Emiliano Rial Verde,
Winship Herr. (Back row, left to right) Ira Hall, Niraj Tolia, Bruce Stillman
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The graduation was a wonderful affair. All six students spoke about their most treasured experiences
at the Laboratory. Keith Yamamoto, the founding chair of the Watson School's External Advisory
Committee, spoke about the courage the first pioneering students had to have in order to join this new
school. He suggested that the first students were akin to students joining a new skydiving school where
the instructors were teaching an untested skydiving method with which they had no prior experience
of their own! Shirley Tilghman gave the keynote address and on a more serious note emphasized the
need for continued government support of all the sciences. In her commencement speech, Dr.
Tilghman had this to say about the Watson School:
You have shown that a graduate program can be accommodated successfully in four to five
years without confining your intellectual thoughts to a small, narrow box. On the contrary, this
school has taught you to think in broader terms than many graduate programs do-integrating
instruction and research throughout your time here.
The graduates were an impressive group indeed. Amy Gaudy, Emiliano Rial Verde, and Elizabeth
Thomas were all recipients of the esteemed Howard Hughes Medical Institute predoctoral fellowship;
THESIS DISSERTATION DEFENSES
ENTERING CLASS OF 1999
Michelle L. Cilia, September 28, 2004
Mechanisms of Intercellular Communication in Arabidopsis
thaliana.
Thesis Examining Committee
Chair: David L. Spector
Research Mentor: David Jackson
Academic Mentor: Nouria Hernandez
Committee Member: Philip Benfey
Committee Member: Robert Martienssen
External Examiner: Richard Nelson, Samuel Roberts
Noble Foundation, Inc.
Emiliano M. Rial Verde, April 1, 2004
Role of the Immediate-Early Gene Arc in Synaptic
Transmission.
Thesis Examining Committee
Chair: Roberto Malinow
Research Mentor: Hollis Cline
Academic Mentor: Jan A. Witkowski
Committee Member: David Heitman
Committee Member: Paul Worley
External Examiner: Gail Mandel, Stony Brook
University
Elizabeth E. Thomas, April 2, 2004
Short, Local Duplications: A New Type of Genomic
Change.
Thesis Examining Committee
Chair: Lincoln Stein
Research Mentor: Michael Wigler
Academic Mentor: William Tansey
Committee Member: Dmitri Chklovskii
Committee Member: W. Richard McCombie
External Examiner: Paul Bingham, Stony Brook
University
Niraj H. Tolia, March 31, 2004
Structural and Biochemical Studies of the Malaria Parasite
Plasmodium Falciparum Protein EBA -t 75 Involved in
Erythrocyte Invasion.
Thesis Examining Committee
Chair: Rui-Ming Xu
Research Mentor Leemor Joshua-Tor
Academic Mentor: David Helfman
Committee Member: Yuri Lazebnik
Committee Member: Scott Lowe
External Examiner: Stephen A. Johnston, University of
Texas-Southwestern Medical
Center
ENTERING CLASS OF 2000
Zachary B. Lippman, December 15, 2004
Transposons, Heterochromatin, and Epigenetic Landscapes
in Arabidopsis thaliana.
Thesis Examining Committee
Chair: David Jackson
Research Mentor: Robert Martienssen
Academic Mentor: William Tansey
Committee Member: W. Richard McCombie
Committee Member: Eric Richards
External Examiner: Michael Ashburner, University of
Cambridge, United Kingdom
Patrick J. Paddison, April 1, 2004
RNA Interference in Mammals: The Quest for Illuminating
Gene Function.
Thesis Examining Committee
Chair: Scott Lowe
Research Mentor: Gregory Hannon
Academic Mentor: Adrian R. Krainer
Committee Member: Senthil K. Muthuswamy
Committee Member: Michael Wigler
External Examiner: Stephen J. Elledge, Harvard
Medical School
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Amy Caudy won the prestigious Harold M. Weintraub Graduate Student Award for being one of the top
15 doctoral students selected in an international competition by the Fred Hutchinson Cancer Research
Center in 2003; and Ira Hall was co-winner of the Newcomb Cleveland Prize for being a co-author on
each of two articles selected as the best to be published by Science magazine in 2002. Some of the
students (Amy Caudy and Elizabeth Thomas) have gone off to pursue postdoctoral experiences else-
where, others (Ira Hall and Patrick Paddison) are Cold Spring Harbor Fellows, and the other two
(Emiliano Rial Verde and Niraj Tolia) are continuing postdoctoral studies at the
Laboratory. We wish them all every success!
Founding Dean Winship Herr Steps Down
Winship Herr stepped down as dean of the Watson School of Biological Sciences at
Cold Spring Harbor Laboratory on July 1, 2004-having dedicated the better part of
a decade to the establishment of our successful, innovative Ph.D. program-to con-
centrate on his research.
Beginning in 1995, Winship spearheaded an effort that resulted, in September
1998, in the Laboratory's accreditation as a Ph.D. degree-granting institution by the
Board of Regents of the University of the State of New York, on behalf of the State
Education Department. And so the Watson School became a reality. Soon thereafter,
Winship became founding dean of the Watson School. Since its founding, we have
seen the School grow and become one of the most innovative programs in the coun-
try, attracting outstanding students. Winship nurtured and shaped the Watson School
Winship Herr
Winship Herr with students at their first lec-
ture using 3D molecular graphics projection.
Winship Herr with founding instructors.
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in its first formative years, culminating in the first Commencement Convocation this spring. We all thank
Winship for all his outstanding efforts on the School's behalf. He has helped shape the future of Cold
Spring Harbor Laboratory in a unique way.
In addition to being founding dean, Winship's roles at the School were many and varied, including serv-
ing on the School's Executive Committee, Admissions Committee, and Qualifying Exam Committee. He
was an instructor on the Scientific Reasoning and Logic core course and the Mechanisms of Transcriptional
Regulation: From E. coli to Elephants specialized disciplines course, as well as a guest instructor for the
Scientific Exposition and Ethics core course. If that was not enough, Winship was also a laboratory rota-
tion advisor as well as a thesis research advisor. Winship has certainly left us with very big shoes to fill!
I was deeply honored that the Laboratory appointed me as Winship's successor as dean. I joined the
Laboratory in March 1999 as assistant dean of the School and was promoted to associate dean in
January 2002. On July 1, Dr. William Tansey joined me at the "helm" of the Watson School. Bill was
appointed director of graduate studies and the Lita Annenberg Hazen Professor of Biological Sciences.
We are very excited to be given this opportunity to lead the School and to build on its initial successes.
The Fall Term Curriculum Is Revamped
The Curriculum Development and Integration Committee, comprising Bill Tansey (chair), myself, David
Spector, and Nicholas Tonks, continues to carefully monitor and develop the curriculum. For fall 2004, the
Scientific Reasoning and Logic (SRL) core course underwent a significant reorganization, although the
content of many of the modules remained the same. Winship Herr and Leemor Joshua-Tor stepped down
as full instructors, and Carlos Brody and Marja Timmermans were recruited to fill these spots. The course
is now divided into six modules: Gene Expression, Signal Transduction, Cell Division Cycle, Development,
Neuroscience, and Study Section. The total number of lectures and discussions did not change, and
many of the lectures themselves remained the same. Importantly, there was only one (standard length)
problem set per module, thus reducing by approximately half the amount of material students needed to
write and submit for this course, giving them more time to think about the topic and the problem sets.
The Study Section module-in which students participated in a panel review of National Institutes of
Health RO1 grant applications-was entirely new. The logic behind this module is that the skill of under-
standing published work is different from the skill of analyzing science that is not yet done-evaluating the
questions before the answers are known, evaluating routes toward discovery before knowing where they
will end, and making critical judgments about how to proceed in the face of an uncertain future.
The Scientific Exposition and Ethics (SEE) core course was also restructured considerably, although
several of the weekly lectures remained the same. This restructuring was motivated by a number of fac-
tors. Adrian Krainer, who was one of the founding instructors of the SEE course, decided not to teach
in 2004. Yuri Lazebnik was recruited as his replacement. The instructors also wanted to include a sig-
nificant, multiweek, assignment that focused on grant-writing skills, and this was difficult to achieve with
the old course format. The grant-writing exercise is meant to complement the SRL Study Section mod-
ule, and its primary purpose is to guide students through the preparation of a grant proposal (which, in
reality, is very close to a Watson School thesis proposal). The topic for the grant proposal was
Regulation of Transcription by Ga14. This topic was selected because it was a common theme both in
the SRL transcription lectures and in the Molecules to Networks specialized disciplines course; mate-
rial from both of these courses was used as the basis for the grant application. It is hoped that this
restructuring of the SEE course will provide a better format to develop students' writing skills.
The Curriculum Development and Integration Committee interacts closely with potential specialized
disciplines course instructors not only to identify topics, but also to help them develop courses and
their methods of assessment, and to monitor workloads. For fall 2004, the Systems Neuroscience
course was replaced by Molecules to Networks (a proteomics course), taught by W. Richard
McCombie (lead instructor), Leemor Joshua-Tor, and Michael Myers.
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ENTERING CLASS OF 2004
Daniel H. Chitwood, University of California, Davis
George A. and Marjorie H. Anderson Fellow
National Science Foundation Graduate
Research Fellow
Galen A. Collins, Wabash College
Beckman Graduate Student
Oliver I. Fregoso, University of California, Santa Cruz
William Randolph Hearst Scholar
Seraph Cancer Research Scholar
Keisha A. John, University of Maryland, Baltimore County
William Randolph Hearst Scholar
Ford Foundation Fellow
Shraddha S. Pai, University of Waterloo
Charles A. Dana Fellow
Molly R. Perkins, Harvard University
Cashin Fellow
Evan E. Santo, Rochester Institute of Technology
Robert and Teresa Lindsay Fellow
David R. Simpson, University of California, Davis
Beckman Graduate Student
Entering Class of 2004
On August 30, 2004, the Watson School opened its doors for the sixth time to welcome yet another
new class. Eight students-Daniel Chitwood, Galen Collins, Oliver Fregoso, Keisha John, Shraddha
Pai, Molly Perkins, Evan Santo, and David Simpson-comprise the entering class of 2004. Daniel
Chitwood and Keisha John are the recipients of a National Science Foundation predoctoral fellowship,
and a Ford Foundation predoctoral fellowship, respectively.
(Left to right) Daniel Chitwood, David Simpson, Galen Collins, Molly Perkins, Keisha John, Evan Santo, Oliver Fregoso, Shraddha Pai
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Recruiting Efforts
Recruitment of the graduate program's entering class of 2005 and of participants for our summer 2005
Undergraduate Research Program (URP) will be managed by Dawn Meehan, the School's admissions,
recruitment, and student affairs manager. Throughout 2004, Dawn traveled the length and breadth of
the country to recruit students to our graduate and undergraduate programs. She has done an out-
standing job at representing Cold Spring Harbor Laboratory and the Watson School and I am deeply
indebted to her for her efforts. Dawn, assisted at times by faculty, students, and members of the
School's administration, attended recruitment fairs and conferences in California, Maryland,
Massachusetts, New York, Texas, and Washington D.C.
The School is also deeply indebted to its graduate program's Admissions Committee, who review,
interview, and select candidates for our doctoral program. The Admissions Committee for the 2004
entering class comprised Marja Timmermans (chair), Carlos Brody, Gregory Hannon, Adrian Krainer,
Alea Mills, Michael Myers, Andrew Neuwald, Karel Svoboda, and Linda Van Aelst. They are a truly
remarkable team!
Student
DOCTORAL THESIS RESEARCH
Academic
Mentor
Research
Mentor Thesis Research
ENTERING CLASS OF 2000
Santanu Chakraborty
George A. and Marjorie H. Anderson Fellow
Elena S. Ezhkova
Engelhorn Scholar
Rebecca C. Ewald
Engelhom Scholar
Zachary Bela Lippman
Beckman Graduate Student
Thesis Defense: Dec. 2004
Marco Mangone
Charles A. Dana Foundation Fellow
Masafumi Muratani
George A. and Marjorie H. Anderson Fellow
Patrick J. Paddison
Beckman Graduate Student
Thesis Defense: April 2004
ENTERING CLASS OF 2001
Catherine Y. Cormier
Beckman Graduate Student
NSF Graduate Research Fellow
Claudia E. Feierstein
George A. and Marjorie H. Anderson Fellow
Tomas Iiromodka
Engelhom Scholar
Charles D. Kopec
Goldberg-Lindsay Fellow
NRSA Graduate Research Fellow
Ji-Joon Song
Bristol-Myers Squibb Fellow
Dougal G.R. (Gowan) Tervo
George A. and Marjorie H. Anderson Fellow
Howard Hughes Medical Institute Predoctoral
Fellow
Michael Wigler
Jan A. Witkowski
Bruce Stillman
William Tansey
Linda Van Aelst
Nouria Hernandez
Adrian R. Krainer
David J. Stewart
Undo Van Aelst
William Tansey
Anthony Zador
Scott Lowe
Carlos D. Brody
Carlos D. Brody
William Tansey
Hollis Cline
Robert Martienssen
Winship Herr
William Tansey
Gregory Hannon
Yuri Lazebnik
Zachary Mainen
Anthony Zador
Roberto Malinow
Mechanisms of robust short-term memory in
biological networks
Role of the proteasome in transcription
NMDA receptor trafficking and its impact on
neuronal functionality and morphology
Comprehensive analysis of chromatin status on
Arabidopsis chromosome 4
Role of HCF-1 in cell proliferation
Gene regulation by ubiquitin-mediated
proteolysis
An RNAi-based screen in mouse embryo
fibroblasts for transformation-lethal gene
targets
Caspase activation in unidentified apoptotic
pathways
Odor coding and neural correlates of behavioral
choice in the olfactory cortex
Stimulus optimization in the auditory coil.
Mapping the trafficking of AMPA receptors in
dendritic compartments
Leemor Joshua-Tor Structural studies of RNAi
Karel Svoboda An inducible and reversible lesion of the
corticothalmic projection
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Graduate Student Seminar Series
One of the most important but often overlooked elements of the graduate student experience at Cold
Spring Harbor Laboratory is the weekly Graduate Student Seminar Series. The Laboratory is special in
that it has a diverse multi-institutional graduate student community, especially mixing Stony Brook
University and Watson School students. The graduate student seminars, which are held each
September through May, allow all graduate students studying at the Laboratory to hear seminars from
their colleagues.
Students present their research once a year, with two students presenting each week moderated
by a graduate student chair. In attendance are the graduate students and two members of a core set
of five faculty mentors whose attendance rotates each week. The seminar series serves three impor-
tant roles: (1) It gives students an opportunity to hone their oral presentation skills; (2) it enables stu-
dents to defend their research in the absence of their research mentors, such that they experience
standing on their own two feet as they will have to throughout their careers; and (3) it allows the stu-
dents in the audience to ask questions within their own peer group, thus learning the important roles
Student
DOCTORAL THESIS RESEARCH (continued)
Academic Research
Mentor Mentor Thesis Research
ENTERING CLASS OF 2002
Allison L Blum
Barbara McClintock Fellow
Darren Burgess
Engelhom Scholar
Beth L. Chen
Beckman Graduate Student
Shu-Ling Chiu
Elisabeth Sloan Livingston Fellow
Jonathan Kui
Alfred Hershey Fellow
Elizabeth Murchison
Elisabeth Sloan Livingston Fellow
ENTERING CLASS OF 2003
Hiroki Asari
Farish-Gerry Fellow
Rebecca Bish
David H. Koch Fellow
Frangois Bolduc
William R. Miter Fellow
Monica Dus
Engelhom Scholar
Angelique Girard
Florence Gould Fellow
Christopher Harvey
David and Fanny Luke Fellow
Izabela Sujka
Beckman Graduate Student
Wei Wei
Leslie C. Quick Jr Fellow
Leemor Joshua-Tor Josh Dubnau Genetic, behavioral, and anatomical characteri-
zation of Radish-dependent memory
Nicholas Tonks Scott Lowe Mammalian RNA/ genetic screens: Discovery
and characterization of genes mediating the
response to cancer therapy
Senthil K. Muthuswamy Dmitri Chklovskii Neuronal network of C. elegans: From anatomy
to behavior
Alea A. Mills Hollis Cline Role of insulin receptors in the development of
neuronal structure and function
David Jackson Tim Tully Identification and characterization of candidate
memory genes in Arleekin, a Drosophila
memory mutant
John Inglis Gregory Hannon Role of Dicer in mammalian development
Z. Josh Huang
Linda Van Aelst
Hollis Cline
John Inglis
Jan A. Witkowski
Adrian R. Krainer
Marja Timmermans
Jan A. Witkowski
Anthony Zador Sparse overcomplete representation as a
principle for computation in the brain
Michael Myers A proteomics approach to the study of
ubiquitylation
Tim Tully Role of dFMR1 and the RNAi pathway in
Drosophila learning and memory
Gregory Hannon Characterization of the biological roles of the
PIWI subfamily
To be determined
Karel Svoboda Visualization of MAPK activity in neurons
Senthil K. Muthuswamy Involvement of polarity genes in ErbB1- and
ErbB2-induced tumorigenesis in vivo
Roberto Malinow Activity-dependent modulation of APP
processing and Alt production in rat
hippocampal neurons
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of audience participation for the advancement of research. At the end of the evening, the two faculty
mentors give each presenting student a critique of the seminar. In addition, members of the audience
complete (anonymously) seminar evaluation forms, which are then given to the presenting students.
Josh Dubnau, Terri Grodzicker, Alea Mills, and Arne Stenlund continue to serve as faculty mentors, and
they were joined this year by Rui-Ming Xu who brings expertise in the areas of biophysics and structural biol-
ogy.
Academic Mentoring
The Watson School takes great pride in the level of mentoring it offers to its students. One of the very
special aspects in this regard is its academic mentoring program, led by Bill Tansey. In this program,
entering students select by mutual agreement a member of the research or nonresearch faculty to
serve as an academic mentor-a watchful guardian to look over and encourage the student through
the sometimes trying process of a doctoral education. This program continues to receive much sup-
port from the faculty who volunteer to be academic mentors, and it has rightfully become a vital ingre-
dient in the Watson School's success. This year's new academic mentors for the entering class of
2004 are:
Alea A. Mills (Daniel Chitwood)
Marja Timmermans (Galen Collins)
Adrian R. Krainer (Oliver Fregoso)
Bill Tansey (Keisha John)
Interinstitutional Academic Interactions
Anthony Zador (Shraddha Pai)
John R. Inglis (Molly Perkins)
Vivek Mittal (Evan Santo)
Scott Lowe (David Simpson)
It is important to always bear in mind that most of the graduate students studying at Cold Spring
Harbor Laboratory are not Watson School students. Indeed, the largest percentage of students come
from Stony Brook University. The Watson School provides an on-site "home" for all of these students
to help them feel that they are a part of the Laboratory community and to help them as much as pos-
sible with the complexities of performing doctoral research away from the parent institution. This year,
the students listed below joined us.
Student
NEW STUDENTS FROM SHARED GRADUATE PROGRAMS
CSHL Research Mentor Program
Magda Gierszewska Jacek Skowronski
Teresa Haire Senthil K. Muthuswamy
Aftabul Hague Nicholas Tonks
Katarzyna Hrecka Jacek Skowronski
Justyna Janes Linda Van Aelst
Noriko Kobayashi Masaaki Hamaguchi
Lukasz Kozaczkiewicz Jacek Skowronski
Guang Lin Nicholas Tonks
Daniel J. Nolan Vivek Mittal
Jasmin Roohi Eli Hatchwell
Rahul Sinha Adrian R. Krainer
Francisca von Saint Paul Karel Svoboda
Seugtai 'loon Michael Wig ler
Chao lin Zhang Michael Q. Zhang
Zhen Zhao Scott Lowe
Medical University (Gdansk), Biotechnology
Stony Brook, Microbiology
Stony Brook, Molecular & Cell Biology
Medical University (Gdansk), Biotechnology
Medical University (Gdansk), Biotechnology
University of Tokyo, Virology/Genetics
International Max-Planck, Molecular Biology
Stony Brook, Molecular and Cell Biology
Stony Brook, Genetics
Stony Brook, Genetics
Stony Brook, Molecular and Cell Biology
International Max-Planck, Neuroscience
Stony Brook, Statistics
Stony Brook, Biomedical Engineering
Stony Brook, Genetics
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Faculty Changes
One new research faculty member joined the Watson School this year. Scott Powers joined us as an
associate professor and director of the Laboratory's Human Cancer Genome Center. Scott came to
the Watson School from Tularik Genomics Division, which used RDA technology to identify cancer
genes. At the Laboratory, his research will focus on utilizing ROMA technology to identify cancer genes
with an emphasis on functional validation. We are excited to have him here and look forward to his par-
ticipation in Watson School activities.
We also saw this year the departure of David Helfman who had been an integral part of the School
since its inception. David's laboratory focused on studying the expression, structure, and function of
cytoskeletal components in normal and transformed cells. Like Winship, David played a much-valued
role in the Watson School. He served on the School's Executive Committee and was a faculty mentor
(and the organizer) for the Graduate Student Seminar Series. He was an instructor on the Scientific
Reasoning and Logic core course and the Cellular Structure and Function specialized disciplines
course. David also served on two Watson School students thesis committees and was an academic
mentor for the School. We are deeply indebted to him for all of his efforts and wish him well in his "new
home" in the Department of Cell Biology and Anatomy at the University of Miami School of Medicine.
Graduate Students and Postdoctoral Fellow Departures
With each year comes not only new arrivals, but also new departures. The following graduate students
and postdoctoral fellows departed from the Laboratory:
Graduate Students
Nilanjana Banerjee Michelle L. Cilia
Jeong-Gu Kang Sungwoo Lee
Michelle T. Juarez Manpreet Katari
Anca Radulescu Yvette R. Seger
Niraj H. To lia Andriy Tovkach
Postdoctoral Fellows
Carlos Aizenman Colin Akerman
Anna Lena Chabes Wim Karel Deleu
Jian Du James Egan
Francois Grenier Sunita Gupta
Andreas Herbst Ping Hu
Sibel Kantarci Catherine Kidner
Ana Losada Juan Mendez
Naoki Nakaya Sarah Newey
Edward Ruthazer Andrey Shabes
Sen Song Armen Stepanyants
Joseph West Xuemei Zhao
Chrostoph Grunwald
Arlinda Lee
Patrick J. Paddison
Elizabeth E. Thomas
Emiliano Rial Verde
Mary Byrne
Eric Drier
Viola Ellison
Kurt Haas
Ashkan Javaherian
Yingfang Liu
Marta Moita
Pablo Rabinowicz
Ryushi Shudo
Jinhua Wang
The Undergraduate Research Program
The summer Undergraduate Research Program (URP) has come under the umbrella of the Watson
School since 1999, but its administration was handled elsewhere at Cold Spring Harbor Laboratory.
Jane Reader, the scientific administrator of James Laboratory who hadbeen the URP administrator for
15 years (and did an outstanding job!), relocated with her family to Massachusetts in June 2004. The
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Watson School, and in particular Dawn Meehan, took over the administration of the URP, resulting in a
somewhat more hectic summer than usual. But this also had its pluses. We were able to gain first-hand
knowledge of the workings of the program and as such will be able to streamline for the future. The
URP is proving to be a great source of graduate students for the Watson School. Fully 25% of our stu-
dents have come via this program, including Galen Collins, Keisha John, and Shraddha Pai of the
entering class of 2004.
The Postdoctoral Program at Cold Spring Harbor Laboratory
Now in its second year, the Postdoctoral Program Office at Cold Spring Harbor Laboratory is continu-
ing its efforts to meet the needs of the Laboratory's postdoctoral fellows (postdocs) and faculty, under
the day-to-day management of Alyson Kass-Eisler. This year, the Laboratory welcomed 42 new post-
docs and saw 32 depart. The departing postdocs went on to positions at Brown University, Eli Lilly,
Indiana University, The John Innes Centre, Merck Research Laboratories, Northeastern University,
Oxford University, The Institute for Genomic Research, the Spanish National Cancer Institute, the
University of British Columbia, and the University of Edinburgh, to name but a few. We wish them every
success for the future.
Our second postdoc working group convened in October 2003 and was tasked with recommend-
ing to the Laboratory's President, Bruce Stillman, the structure of a comprehensive postdoctoral train-
ing program. Membership of the group included Winship Herr (chair); myself; Alyson Kass-Eisler (sec-
retary); faculty members Leemor Joshua-Tor, Adrian R. Krainer, Senthil K. Muthuswamy, and Nicholas
Tonks; and postdocs Kurt Haas, Michael Hemann, Sarah Newey, Vatsala Thirumalai, and Michael Wehr
(who took over for Kurt when he left in January to take up a faculty position at the University of British
Columbia). This group met seven times, concluding on June 6, 2004. Alyson has been busy synthe-
sizing the wealth of ideas from these discussions and will shortly submit the group's recommendations
to Bruce.
To complement our local efforts, we have been involved in workshops at a national level aimed at
shaping the postdoctoral experience. In 2004, we became founding members of the National Postdoc
Association (NPA). The NPA was founded by a dynamic group of postdocs from around the country
who attended the 2002 National Postdoc Network meeting. A Laboratory representative has attended
each of the National Postdoc Network and NPA meetings since 2001. Alyson Kass-Eisler, our
Postdoctoral Program Officer, attended The National Academies Committee on Science, Engineering,
and Public Policy, 2nd Convocation on "Enhancing the Postdoctoral Experience." At this meeting of
leaders interested in improving the postdoctoral experience, Alyson presented a poster highlighting the
postdoctoral experience at CSHL. Her presentation was well received by postdocs, administrators,
faculty, and others in attendance.
Assisting postdocs with career development continues to be an important goal of CSHL. The
Laboratory's partnership with the New York Academy of Science, Science Alliance has given our post-
docs additional opportunities for networking and obtaining career development advice. This year the
seminar titles included:
From IDEA to IPO: The Technology Venture Course
Bioscience Research: "Where the Jobs Are"-A Career Fair and Symposium
Women in Science: Turning Choices into Success
YOU KNOW YOUR SCIENCE, BUT CAN YOU TEACH IT?: The Top Ten Things That Successful
College Professors Do
A new workshop on the Responsible Conduct of Research was developed this year for postdocs
at the Laboratory. This two-part workshop includes instruction in the use of animals and humans in
research, biosafety, scientific publishing and funding, instruction on data handling, scientific miscon-
duct, patents and intellectual property, and scientific communication. The first of the two workshops
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took place on August 25. Instructors included Diane Esposito, a research investigator and chair of the
Laboratory's Institutional Review Board, who discussed "Protecting Human Subjects" and also provid-
ed an historical overview of the use of human subjects in research. Jan Gnadt, DVM, the Lab's veteri-
nary consultant, and Lisa Bianco, manager of Animal Resources, gave a presentation on "Ethics and
Animal-based Research," which covered the humane and ethical treatment of animals, USDA and
Public Health Service animal welfare regulations, and the use of nonanimal alternatives in research.
John Pisciotta, the Laboratory's manager of Environmental Health and Safety, talked about "Biosafety
in the Research Laboratory." He described the National Institutes of Health guidelines for the use of
recombinant DNA and the more recent regulations regarding the use of select agents, those identified
by the Centers for Disease Control as posing a risk for use as biological weapons.
This year, with the help of CSHL's Department of Media Arts and Visualization, we launched a much-
improved Postdoctoral Research Web site. Our site now has a listing of distinguished alumni, links to
faculty research expertise, a description of the Laboratory's National Cancer Institute (NCI) training
grant and NCI Cancer Center resources, and links to Laboratory benefits for postdocs. The CSHL
Postdoctoral Association (PDA) continues to hold meetings every three months or so to discuss life as
a postdoc at CSHL. These meetings are open to all postdocs at the Laboratory. One area the PDA has
been hard at work on is developing their own Web site, with a view to providing practical information
on being a CSHL postdoc, which will no doubt be a valuable resource for current and future postdocs
at the Laboratory. In addition, Alyson Kass-Eisler continues to act as a contact and provider of infor-
mation and resources for postdocs locating to, or thinking of locating to, the Laboratory. She is
extremely well placed to do this, having been a CSHL postdoctoral fellow herself!
Executive Committee
A large measure of the Watson School's success can be traced to the sage advice, guidance, and gov-
ernance of the School's Executive Committee. The year saw several major changes in the membership
of the Committee, due in large part to Winship Herr stepping down as dean.
January 2004 saw the induction of two new faculty members-W. Richard McCombie and Nicholas
Tonks. In July, Winship Herr retired and I was appointed chair of the Executive Committee with Bill
Tansey as vice chair. Alyson Kass-Eisler took over from Mark Beavers in September as committee sec-
retary, and as happens each year, there was also turnover among the student representatives. The
Watson School representative Catherine Cormier was replaced by Darren Burgess and the Stony
Brook University representative Marissa Moore was replaced by Mar lies Rossmann. The School is
indeed thankful for their frank, honest, and thoughtful advice.
External Advisory Committee
Since its inception in 1998, the Watson School has relied heavily on advice from the External Advisory
Committee (EAC). With the program now more than five years old, I was most pleased that the EAC,
led by Keith Yamamoto, was able to come in September for a site visit. The site visit focused on five
main areas: (1) faculty, (2) students, (3) curriculum, (4) a review and views on the first five years of the
Watson School, and (5) the next five years and beyond. As usual, the team met with students, faculty,
and administrators, and the overall feeling was that our "grand experiment" was indeed working. At the
site visit, we were presented with the findings of their previous visit where they had this to say about
our faculty: "Their dedication and tenacity have been inspiring ... What is remarkable and impressive is
the faculty's stamina in remaining focused on the many responsibilities inherent in creating an out-
standing program."
The EAC's continued commitment to the success of the Watson School has been a humbling experi-
ence-Thank you so much guys!
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Special Events: The Gavin Borden Fellow
The annual Gavin Borden Visiting Fellow (so named after the energetic and charismatic publisher of
Molecular Biology of the Cell, who died of cancer in 1991) brings to the Laboratory an eminent
researcher and educator to give the Gavin Borden Lecture, which is dedicated to the graduate stu-
dents at the Laboratory. Richard Losick from Harvard University was this year's Fellow. He was a par-
ticularly appropriate choice given that he is co-author on the recently published fifth edition of James
Watson's Molecular Biology of the Gene. In addition to his lecture on his studies of development in the
sporulating bacterium Bacillus sublilus, Rich spoke at a roundtable with the students about the life of
a scientist.
Changes in the Watson School
With the departure of founding dean Herr came the opportunity to review the administration and over-
sight of the Watson School and its programs, which currently include:
The WSBS graduate program
All other graduate programs at CSHL, mainly students from our shared programs with Stony Brook
University
The CSHL postdoctoral program
The Undergraduate Research Program
The Partners for the Future (PFF) Program for high school students
The Nature Study Program, a summer program for elementary and secondary school students
(Left to right) Mark Beavers, Dawn Meehan, Lilian Clark Gann,
Alyson Kass-Eisler, Bill Tansey
I was appointed dean on July 1, 2004 and, by virtue
of office, also became one of the Laboratory's seven divi-
sion directors. Bill Tansey was appointed director of grad-
uate studies and Lita Annenberg Hazen Professor of
Biological Sciences. Upon assuming my appointment as
dean, I carried out a review of the administration of the
School and decided at that time not to make too many
changes, but rather to reshuffle and expand the roles and
responsibilities of the existing "Team Watson." Dawn
Meehan's promotion to admissions, recruitment, and stu-
dent affairs manager relieved her of curriculum adminis-
tration. To fill this gap, Alyson Kass-Eisler stepped up to
the plate; she switched from working three days a week
to full time. She is still the Postdoc Program Officer three
days a week-on the other two days, she administers the
Watson School graduate program curriculum under the
direction of Bill Tansey. Mark Beavers continues to provide outstanding administrative support to all at
the School as well as fulfilling the role of assistant to the dean. We are indeed very fortunate to have
such a dedicated and hardworking team-I cannot thank them enough for all of their efforts.
The Watson School Continues to Benefit from Generous Benefactors
The Watson School has been extremely fortunate to be the beneficiary of many generous benefactors
who have provided grants and endowed funds for student, faculty, and administrative support.
This fall, I was most pleased to host Jacqueline Dorrance, Executive Director of the Arnold and
Mabel Beckman Foundation, for a site visit to CSHL, with the help of our chief development officer,
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Charles Prizzi. During the visit, Ms. Dorrance had an opportunity to meet with faculty members Hollis
Cline, Gregory Hannon, Winship Herr, and Bill Tansey; Laboratory President Bruce Stillman; Chancellor
James Watson; and of course the students. Watson School students Beth Chen, Catherine Cormier,
Ira Hall, Zachary Lippman, Patrick Paddison, and Izabela Sujka, who are all supported by the Arnold
and Mabel Beckman Foundation, participated in a mini-symposium for Ms. Dorrance during which they
described their thesis research. The students were very impressive and all greatly enjoyed the occa-
sion.
Dean Gann Appointed to the Regents Advisory Council
A major milestone for the Watson School is its involvement in reviewing the academic credentials of
other New York State educational institutions. Having completed my training as a peer reviewer for
institutional accreditation for the New York State Education Department, I was invited to participate in
an accreditation site visit of the Graduate College of Union University in Schenectady in May. I chaired
the site visit team and found the experience invaluable as I learned what the State Education
Department and its reviewers look for when evaluating doctoral programs. In addition, in November, I
was appointed to the New York State Board of Regents Advisory Council for Institutional Accreditation
for an initial term of three years.
In closing, I would also like to share with you some of the nonacademic highlights the Watson
School has seen this year. In May, we saw the birth of Ji-Joon Song's (entering class of 2001) second
child Juho Nathan. Michelle Cilia (entering class of 1999) married H. Kern Reeve in November. And in
December, Darren Burgess (entering class of 2003) became engaged to Rona Holloway. Our congrat-
ulations and best wishes to all of them!
Lilian Clark Gann
Dean
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SPRING CURRICULUM
TOPICS IN BIOLOGY
ARRANGED BY Dawn Meehan
Jan A. Witkowski
FUNDED IN PART BY The Daniel E. Koshland, Jr. Visiting Lectureship; The David Pall Visiting Lectureship;
The Fairchild Martindale Visiting Lectureship; The Lucy and Mark Ptashne Visiting
Lectureship; The Michel David-Weill Visiting Lectureship
Each year, one or a team of invited instructors offer seven-day courses at the Banbury Conference
Center to explore specialized topics outside the expertise of the Cold Spring Harbor Laboratory facul-
ty. These courses include morning or evening lectures as well as afternoon sessions during which stu-
dents read assigned papers. These intensive courses are modeled on the Cold Spring Harbor
Laboratory Lecture Courses held each summer at the Banbury Conference Center. In spring 2004,
there were two such courses: Immunology and Microbial Pathogenesis.
Immunology
Attended by the entering classes of 2000 and 2003
INSTRUCTOR Hidde Ploegh. Harvard Medical School
TEACHING FELLOWS Marianne Boes, Harvard Medical School
Andre Catic, Harvard Medical School
Silke Paust, Harvard Medical School
This course introduced the elements of the immune system that make it a unique object of biological
studies, with cross references to some of the more applied aspects. Its challenge was to convey a
(Left to right) Marianne Boes, Santanu Chakraborty, Despina Siolas, Masafumi Muratani, Silke Paust, Izabela A. Sujka,
Hidde Ploegh, Angelique Girard, Christopher D. Harvey, Wei Wei, Francois Bolduc, Hiroki Asari, Rebecca A. Bish,
Rebecca C. Ewald, Andre Catic, Khalid Siddiqui, Marco Mangone
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sense of what the immune system is about. The course ran from Sunday to Saturday, February
29-March 6, and was organized and taught by Hidde Ploegh. Three teaching fellows participated in all
aspects of the course. As in previous years, the course was highly rated by all of the students.
Microbial Pathogenesis
Attended by the entering classes of 2001 and 2002
INSTRUCTORS Stanley Maloy, San Diego State University
Ronald K. Taylor, Dartmouth Medical School
GUEST LECTURERS Andrew Darwin, New York University School of Medicine
Heran Darwin, Weill Medical College of Cornell University
Darren Higgins, Harvard Medical School
Theresa Koehler, University of Texas, Houston Medical School
Paula Sundstrom, Dartmouth Medical School
This course focused on mechanisms of microbial pathogenesis and the host response, and the scien-
tific approaches that are used to investigate these mechanisms. How do microbes adhere to host
cells? How do environmental cues direct the response of microbial pathogens? How do microbial
pathogens modulate host cells to expedite virulence? How do host cells respond to microbial
pathogens? How does the host immune system react to microbial pathogens? What does genomics
tells us about how microbial pathogens evolve? How do emerging pathogens take advantage of new
ecological niches? Although there are numerous microbial pathogens, the answers to these questions
indicate that many pathogens use similar approaches to solve common problems.
The course ran from Sunday to Saturday, May 2-9, and was organized and largely taught by Stanley
Maloy and Ronald Taylor. It integrated lectures by the instructors, daily quizzes, directed readings of
research papers, and seminars by the instructors plus the five invited guest lecturers who specialize in
various aspects of bacterial pathogenesis. The students, many of whom had little prior awareness of
the subject, rated the course very highly.
(Top row, left to right) Ronald K. Taylor, Darren Higgins, Beth L. Chen, Shu-Ling Chiu, Stanley Ma loy, Claudia E. Feierstein,
Elizabeth Murchison, Jonathan Kui, Dougal G.R. (Gowan) Tervo, Darren Burgess. (Bottom row, left to right) Ji-Joon Song,
Tomas Hromadka, Catherine Y. Cormier, Allison L. Blum, Charles D. Kopec
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Teaching Experience at the Dolan DNA Learning Center
DIRECTOR David A. Mick los
INSTRUCTORS Scott Bronson
Uwe Hilgert
Craig Hinkley
Kimberly Kessler
Erin Maroney
Amanda Mc Brien
Mike O'Brien
As science has an increasing role in society, there is also an increasing need for biologists to educate nonscientists of
all ages about biology. The Watson School of Biological Sciences doctoral program offers its students unique teach-
ing experiences through the Laboratory's Dolan DNA Learning Center, where students teach laboratory courses to high
school and middle school students. From these teaching experiences, they learn how to communicate with nonbiol-
ogists and to inspire and educate creative young minds. The teaching module entailed pairs of students teaching one
morning or afternoon a week for 12 weeks. In the initial weeks, the Dolan DNA Learning Center instructors taught the
Watson School students the didactic process-it was not until the fifth week that the graduate students taught on their
own. At the end of the 12 weeks, the students were very excited about their teaching experiences.
Laboratory Rotations
The most important element of a doctoral education is learning to perform independent research that leads to a unique
contribution to human knowledge. After the fall course term, students participate in laboratory rotations. These rota-
tions provide students and faculty with the opportunity to get to know one another and to explore possibilities for doc-
toral thesis research. At the end of each rotation, students make short presentations of their studies to the other stu-
dents and their rotation advisors. These talks give students an opportunity to share their laboratory experiences and
to learn how to give a scientific presentation. With this latter goal in mind, in addition to the research mentors, the
instructors of the Scientific Exposition and Ethics core course attend the talks and give individual feedback to students
on their presentations. This year, 16 faculty members served as rotation mentors, some mentoring more than one
student.
ROTATION MENTORS
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Hollis Cline
Gregory Hannon
Z. Josh Huang
Scott Lowe
Roberto Malinow
Alea A. Mills
Partha P. Mitra
Senthil K. Muthuswamy
Michael P. Myers
Karel Svoboda
William Tansey
Marja Timmermans
Tim Tully
Linda Van Aelst
Jan A. Witkowski
Anthony Zador
FALL COURSE CURRICULUM
CORE COURSES
The Leslie C. Quick, Jr. Core Course on Scientific
Reasoning and Logic
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation
INSTRUCTORS Gregory Hannon (Lead)
Carlos D. Brody
Hollis Cline
Senthil K. Muthuswamy
Arne Stenlund
Marja Timmermans
GUEST LECTURERS Grigori Enikolopov Zachary Mainen
Z. Josh Huang Patrick J. Paddison
David Jackson Cordula Schulz
Adrian R. Krainer Bruce Stillman
Wolfgang Lukowitz William Tansey
VISITING LECTURERS Howard Crawford, Stony Brook University
William C. Merrick, Case Western Reserve University
Howard Sirotkin, Stony Brook University
A fundamental aspect of earning the Ph.D. is training in the pursuit of knowledge. In this core course,
which forms the heart of the fall course curriculum, students (1) acquired a broad base of knowledge
in the biological sciences, (2) learned the scientific method, and (3) learned how to think critically about
biological concepts. This course consisted of six 2-week modules, each of which had a different
theme. For each module, students read an assigned set of research articles (generally four articles) and
provided written answers to a problem set that guided them through two (or, occasionally, one) of the
articles. Twice weekly, students attended lectures related to the week's topic, which included concepts
and experimental methods. During the week, the students met among themselves to discuss the
assigned papers not covered by the problem set. At the and of each week, the students spent the
evening discussing these papers with faculty. In the final module, Study Section, the students partici-
pated in a mock review of real funded Federal R01 grants including oral presentations and written cri-
tiques.
Module 1 Gene Expression Module 4 Development
Module 2 Cell Division Cycle Module 5 Neuroscience
Module 3 Signal Transduction Module 6 Study Section
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The Darrell Core Course on Scientific
Exposition and Ethics
FUNDED IN PART BY The Arnold and Mabel Beckman Foundation; The John P. and Rita M. Cleary
Visiting Lectureship; The Seraph Foundation Visiting Lectureship;
The Susan T. and Charles E. Harris Visiting Lectureship
INSTRUCTORS William Tansey (Lead)
Yuri Lazebnik
Jan A. Witkowski
GUEST LECTURERS Terri Grodzicker
Adrian R. Krainer
VISITING LECTURERS Robert P. Charrow, Esq., Greenberg Traurig LLP
Jasemine Chambers, United States Patent and Trade Office
Peter Petre, Fortune Magazine
Philip Reilly, J.D., M.D., CEO of Interleukin Genetics
David Vaux, Walter and Eliza Hall Institute
This core course offered instruction in the fundamental elements of scientific exposition-writing skills
and public speaking-and ethics. The ability to communicate effectively and to appreciate the intrica-
cies of ethical issues are essential skills for biologists; both subjects were taught in a series of exam-
ple-based lectures and discussion groups. Writing skills included the fundamentals of modern scientif-
ic English and the organization and preparation of papers, research abstracts, and grant applications.
Oral presentation skills were taught by scientists with excellent, albeit different, modes of presentation.
Together with instructors, students critiqued formal seminar presentations at the Laboratory. Instruction
and discussions about ethics included the ethical implications of biological discovery on society (e.g.,
the implications of the cloned sheep Dolly for human cloning) as well as the nature and boundaries of
ethical behavior of scientists and their rights and responsibilities. A primary objective of the course was
that students consider exposition and ethics an integral part of scientific research.
Research Topics
ARRANGED BY Mark Beavers
Lilian Clark Gann
This core course provided students with an in-depth introduction to the fields of research that
Laboratory scientists investigate. Students and faculty attended a weekly Research Topics seminar, at
which faculty members presented their current research topics and methods of investigation each
Wednesday evening over dinner. The students learned how to approach important problems in biolo-
gy. These seminars, together with the annual fall Laboratory In-house Symposium, provided students
with a basis for selecting laboratories in which to do rotations. Weekly speakers were:
Week 1 Andrew Neuwald, Rui-Ming Xu
Week 2 Scott Lowe, Linda Van Aelst, David L. Spector
Week 3 Alea A. Mills, Senthil K. Muthuswamy
Week 4 William Tansey, Michael Wig ler
Week 5 Robert Martienasen, W. Richard McCombie
Week 6 Tatsuya Hirano, Bruce Stillman, Arne Stenlund
Week 7 Josh Dubnau, Robert Lucito, Karel Svoboda
Week 8 Dmitri Chklovskii, Zachary Mainen, Tim Tully
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Week 9 David Jackson, Wolfgang Lukowitz, Marja Timmermans
Week 10 Masaaki Hamaguchi, Eli Hatchwell, Vivek Mittal
Week 11 Carlos D. Brody, Hollis Cline, Anthony Zador
Week 12 Grigori Enikolopov, Z. Josh Huang, Leemor Joshua-Tor
Week 13 Alexei Koulakov, Lincoln Stein, Michael Q. Zhang
Week 14 Gregory Hannon, Partha P. Mitra, Yi Zhong
Week 15 Adrian R. Krainer, Michael P. Myers
SPECIALIZED DISCIPLINES COURSES
Molecules to Networks
FUNDED IN PART BY The George W. Cutting Lectureship; The Klingenstein
Lectureship; The William Stamps Farrish Lectureship
INSTRUCTORS
VISITING LECTURERS
W. Richard McCombie (Lead)
Leemor Joshua-Tor
Michael P. Myers
Brian Chait, The Rockefeller University
Michael Tyers, University of Toronto
Marc Vidal, Harvard University
The history of molecular biology has been focused on the reduction of biology to the basic building
blocks of the cell. Recent advances in genomics, proteomics, and structural biology open the possi-
bility of moving in the other direction, toward an integrated view of how the cell functions. We can now
take the knowledge we have of simple circuits, interactions, and protein structure and study how these
elements combine into the complex networks that regulate cellular processes. This course focused on
the macromolecular interactions that are used to regulate gene expression, from the simplest protein-
protein interface to higher-order protein networks that coordinate patterns of gene activity. It began with
analysis of a basic genetic regulatory circuit, a discussion of the fundamentals of protein structure, and
a description of protein-protein interactions. It then expanded the discussion to reveal how these basic
principals are elaborated and repeated, with slight variation, to form complex networks in the cell.
Simple bacterial systems were used to demonstrate several basic themes, but the majority of the
course highlighted the galactose gene regulation system of yeast, which has been extensively studied
at both the reductionist and holistic levels. At the conclusion of the course, students were expected to
understand not only the basics of gene regulation, structure, and protein analysis, but also how elab-
orate protein networks evolve and operate.
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Cellular Structure and Function
FUNDED IN PART BY The Mary D. Lindsay Lectureship; The Sigi Ziering Lectureship;
The Martha F. Gerry Visiting Lectureship
INSTRUCTORS David L. Spector (Lead)
Linda Van Aelst
GUEST LECTURER Tatsuya Hirano
VISITING LECTURERS Michael Caplan. Yale University
Gregg Gundersen, Columbia University
Marc Symons, Picower Institute
Graham Warren, Yale University
This course highlighted the use of various molecular and biochemical approaches to address problems in cell
biology. The overall goal was to give students an idea as to how different approaches are used and integrat-
ed to address specific research questions. We discussed how molecular biology could be used to dissect
various problems in cell biology, including elucidating the primary structure of a protein, preparation of recom-
binant proteins, introduction of wild-type and mutant proteins into cells, structure-function studies, and tar-
geted disruptions. Using specific examples, we introduced the students to the use of biochemistry in under-
standing problems in cell biology.
Genetics
FUNDED IN PART BY The Edward H. and Martha F. Gerry Lectureship; The Pfizer Lectureship;
The George B. Rathmann Lectureship; The Edward H. Gerry Visiting Lectureship
INSTRUCTORS Tim Tully (Lead)
Josh Dubnau
Lincoln Stein
VISITING LECTURER Bambos Kyriacou, University of Leicester, United Kingdom
The Human Genome Sequence and continued advances in molecular biological techniques have initiated a
paradigm shift in the biological sciences, from phenomenological description to genetic perspective. Genes
now can be manipulated in experiments, permitting interventionist studies of their roles in various aspects of
biological function. These experimental data were integrated "vertically" to understand how causal models of
gene function are inferred across various levels of biological organization and lead to molecular mechanisms.
Data were also integrated "horizontally" to understand how genetic pathways have been conserved evolu-
tionarily as variations on a theme.
This course placed classic organismal genetics into the context of modern molecular biology and
genomics. History, perspective, and technique were described around four levels of analysis: phenotype,
genotype, variation, and genome. How do gene mutations disrupt phenotypic processes? How are complex
traits genetically dissected into functional components? What concepts and techniques are used to organize
genes into pathways and networks? How are genes mapped, cloned, and engineered to identify functional
domains of proteins? What gene variation exists in natural populations? What are the functional conse-
quences of gene variation? How is it detected? How are genomes organized and coordinately regulated?
How can genomic information be cataloged, organized, and mined? These questions and concepts were
fleshed out, using examples from the literature.
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UNDERGRADUATE RESEARCH PROGRAM
Program Director: Senthil K. Muthuswamy
Program Administrator: Jane Reader (January-June)
Dawn Meehan (June-)
An important aspect of the summer program at the Laboratory is the participation of college under-
graduate students in active research projects under the supervision of full-time faculty members. The
program was initiated in 1959. Since that year, 651 students have participated in the course and many
have gone on to productive careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental princi-
ples of biology; (2) an increased awareness of experimental approaches to science; (3) a deeper under-
standing of the major issues in the fields of biochemistry, genetics, molecular cellular and structural biol-
ogy, neuroscience, bioinformatics, and genomics; and (4) a familiarization with research, research work-
ers, and centers for study.
During the program, the students are housed together on the Laboratory grounds. Nearly all of the
students arrive at the same time and share the entire experience. For programmatic reasons, we limit
the number of students to 25. In this manner, we ensure a cohesive program with substantial scientif-
ic and social interactions among the students. The students are required, at the beginning of the pro-
gram, to present to their peers a concise oral description of the background and the design of the
experiments they will be performing. At the end of the 10-week program, the undergraduates present
a 15-minute seminar describing the background, design, and results of the experiments during the
course of a 2-day undergraduate symposium. During their stay, the participants attend a series of fac-
ulty talks given by both young and established scientists at the Laboratory. These seminars are attend-
ed by only the students to assure that the seminars remain at a level appropriate for the undergradu-
ates. It also encourages questions in an informal and comfortable setting. In addition to scientific dis-
cussion, these presentations cover important issues such as personal experiences and choices that
led the scientists to their current area of research and position. The following students, selected from
448 applicants, took part in the 2004 program:
(Front row, left to right) Johanna Berberena, Heeran Buhecha, Miranda Kim, Srinjan Basu, Beatrice Tapawan. (Second row, left
to right) Pawel Mazur, Emily Heikamp, Bao Pham, Carol Cho. (Third row, left to right) Amy Leung, Max Jan, Jakob Macke,
Siddharth Srivastava, Boaz Gildor, Nicholas Wall, John Calarco, Juan Aragon, Katrina Gold, Larissa Meyer, Matthew Klein,
Brianna Burden, Eric Sullivan.
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Juan Aragon, Armstrong Atlantic State University
Advisor: Gregory Hannon
Sponsor: Burroughs Wellcome
Mapping of the interaction of the 5' end of siRNA with
Argonaute.
Srinjan Basu, Cambridge University
Advisor: Senthil K. Muthuswamy
Sponsor: Shakespeare Fund
Role of par genes in cell proliferation.
Johanna Berberena, Hunter College
Advisor: Josh Dubnau
Sponsor: Garfield Fund
Expression study of long-term memory gene Thor (4E-BP).
Heeran Buhecha, Cambridge University
Advisor: Bruce Stillman
Sponsor: Burroughs Wellcome
Characterization of hORC1 ubiquitination.
Brianna Burden, University of California, Los Angeles
Advisor: Linda Van Aelst
Sponsor: Jephson Educational Trust
Molecular characterization of DOCK7.
John Calarco, University of Toronto
Advisor: Adrian R. Krainer
Sponsor: The Past URPs Fund
SMN alternative splicing and spinal muscular atrophy.
Carol Cho, Seoul National University
Advisor: Leemor Joshua-Tor
Sponsor: Emmanuel Ax Fund
The genetic switch: Elucidating the structural components of
the GAL transcription system.
Boaz Gildor, Tel Aviv University
Advisor: Eli Hatchwell
Sponsor: Burroughs Wellcome
Gene expression analysis in putative centromere position-
effect.
Katrina Gold, Cambridge University
Advisor: Rob Martienssen
Sponsor: Burroughs Wellcome
How are RNA-dependent RNA polymerases and Dicers
involved in microRNA-based gene regulation?
Emily Heikamp, Duke University
Advisor: Vivek Mittal
Sponsor: Bliss Fund
A role for Id1 and Id3 in tumor angiogenesis.
Max Jan, Princeton University
Advisor: David Jackson
Sponsor: Steamboat Foundation
Characterization of a defect in protein trafficking in
Arabidopsis.
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Miranda Kim, Amherst College
Advisor: W. Richard McCombie
Sponsor: Glass Fund
Epigenetic modification in cancer.
Matthew Klein, Reed College
Advisor: Roberto Malinow
Sponsor: Libby Fund
How I failed to cure Alzheimer's disease in ten weeks.
Amy Leung, Cornell University
Advisor: Yi Zhong
Sponsor: Von Stade Fund
Dissecting the pathological effects of 4142 assemblies in the
Drosophila Alzheimer's model.
Jakob Macke, Oxford University
Advisor: Karel Svoboda
Sponsor: Burroughs Wellcome
Tracking dynamics of synapses in the intact brain.
Pawel Mazur, Warsaw University
Advisor: Marja Timmermans
Sponsor: Burroughs Wellcome
Characterization of miRNA166 expression pattern during leaf
dorsoventral patterning in Arabidopsis.
Carissa Meyer, Harvard University
Advisor: Masaaki Hamaguchi
Sponsor: Jephson Educational Trust
Cell-cycle-mediated growth suppression of breast cancer cells
by DBC2.
Bao Pham, Trinity College
Advisor: Ravi Sachidanandam
Sponsor: Olney Fund
Staufen: A case study in evolution.
Siddharth Srivastava, Columbia University
Advisor: Michael Q. Zhang
Sponsor: Read Fund
Mapping pancreatic-specific promoters in zebrafish.
Eric Sullivan, Wesleyan University
Advisor: Zachary Mainen
Sponsor: Von Stade Fund
Is our children learning? Selective attention and set shifting in
rodents.
Beatrice Tapawan, Mt. Holyoke College
Advisor: Scott Lowe
Sponsor: The Baltimore Family Fund
Suppression of target genes in the ATM-p53 pathway by RNAi.
Nicholas Wall, California Institute of Technology
Advisor: Z. Josh Huang
Sponsor: The Baltimore Family Fund
Development of dendritically targeted GABAergic synapses in
the hippocampus and neocortex.
PARTNERS FOR THE FUTURE
Program Director: Yuri Lazebnik
Program Administrator: Lynn Hardin
The Partners for the Future Program, established in 1990, brings Long Island high school students into
Cold Spring Harbor laboratories and gives them a taste of the real world of biomedical research. The
program is open to all Long Island high school students entering their senior year; each high school
science chairperson may nominate three students from his or her school during their junior year. The
eight students selected spend a minimum of 10 hours per week, September through March of their
senior year, doing original research under the watchful eye of a scientist mentor. At the conclusion, the
students give oral presentations of their research projects to an enthusiastic audience of the students'
scientific mentors, Lab administrators, parents, and teachers. Although the students learn a great deal
about modern biology and state-of-the-art research techniques, the main advantage of the program is
in exposing the students to day-to-day life in a working lab. Debunking the mythical scientist in a lab
coat image, the students are introduced to a world of relatively young scientists and their interactive
support staff in a relaxed, problem-solving atmosphere. The 2004-2005 Partners for the Future are:
Partner
Saroja Bangaru
Khadeejah Bari
Sarah Goldman
Christopher Hubley
Noah Jakimo
Sean Kotkin
Eric Paniagua
Adam Robbins
High School CSHL Mentor Laboratory
Roslyn High School
Portledge School
Roslyn High School
Oceanside High School
Syosset High School
Herricks High School
Massapequa High School
Oyster Bay High School
Linda Wilbrecht
Cordula Schulz
Masaaki Hamaguchi
Eli Hatchwell
Ravi Sachidanandam
Wolfgang Lukowitz
Mitya Chklovskii
Dom Duelli
Karel Svoboda
Yuri Lazebnik
(First row, left to right) Adam Robbins, Saroja Bangaru, Noah Jakimo, Khadeejah Ban, Eric Paniagua,
Sarah Goldman. (Second row, left to right) Christopher Hubley, Sean Kotkin.
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NATURE STUDY PROGRAM
The Nature Study Program gives elementary and secondary school students the opportunity to acquire
a greater knowledge and understanding of their environment. Through a series of specialized field
courses, younger students can engage in introductory programs such as Nature Bugs, Nature
Detectives, and Nature Discovery, and older students can enroll in more advanced programs such as
Marine Biology.
During the summer of 2004, 379 students participated in 26 courses within the program. The class-
es were held outdoors, weather permitting, at the Southdown School. The Laboratory has equipped and
maintains classroom and laboratory facilities at Southdown School. This facility is used as a base for the
student's exploration of the local environment. Field classes are held on Laboratory grounds, St. John's
Preserve, Fire Island National Seashore, the Nature Conservancy, and the Cold Spring Harbor Fish
Hatchery and Aquarium, as well as in other local preserves and sanctuaries.
In addition to the three, 2-week sessions, the Adventure Education course met on Friday, July 16,
for a 6-mile canoe trip on the Nissequogue River in Smithtown to navigate and explore the waters of
Long Island. The course emphasizes plant and animal life indigenous to the area as well as historic
points of interest.
This year, we offered Nature Photography I and II. The course
focused on taking pictures out in the field as well as studio shots. A
darkroom was set up so that the students could develop and print
their own black and white film, as well as experiment with different
photographic techniques. In Photography II, the students were intro-
duced to digital photography. One of their projects was to make a
photo collage of their pictures. We provided a computer, color print-
er, and a darkroom to further develop their skills.
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PROGRAM DIRECTOR: William M. Payoski, M.A., Adjunct Professor, Nassau Community College
REGISTRAR: Sharon Bense, Cold Spring Harbor Laboratory
INSTRUCTORS: Jessica Badalucco, B.S. in Biology, Ade 1phi University
Amy Friedank, B.S. in Marine Science, Long Island University, Southampton College
Jimmie Hamilton, Pratt Institute, Graphic Design/Photography
Ann Marie LaRuffa, B.A in Natural Science, Ade 1phi University
Michael Zarzicki, B.A. in English, Ade 1phi University
COURSES
Nature Bugs (Kindergarten): Exploration, games, stories, and dramatics are used to introduce the young child to
the variety of natural habitats.
Nature Detectives (Grades 1-2): An introductory course in nature study, stressing interrelationships between
plants and animals. A variety of habitats are explored.
Nature Discovery (Grades 1-2): Students continue their discovery of nature through activities and concepts.
Ecology Explorers (Grades 3-4): Natural communities, food webs, and the succession of communities are stud-
ied. Students study the diversity of plant and animal forms native to the Cold Spring Harbor area.
Pebble Pups (Grades 3-4): Elementary geology for students interested in making a basic study of rocks and min-
erals available on Long Island. Each student completes a rock and mineral collection. Dinosaurs and fossils are
featured themes. Some of the highlights include field trips to local museums.
Frogs, Flippers, and Fins (Grades 3-4): Designed for younger students as an introduction to aquatic ecosystems.
Fresh water and marine habitats are explored.
Seashore Life (Grades 5-7): Children examine plant and animal life found below the tidemark. Fish, marine worms,
algae, shellfish, beach plants, and shore birds are studied.
Freshwater Life (Grades 5-7): Study of vertebrate, invertebrate, and plant life found in area bogs, ponds, lakes,
and streams.
Nature Photography (Grades 5-7): Students take pictures and use the darkroom to learn techniques of printing
and developing. Photographic techniques relating to nature photography are emphasized.
Adventure Education (Grade 6-10): A 6-mile canoe trip up and down the Nissequouge River explores the flora
and fauna of the waterway.
Marine Biology (Grades 8-10): A more sophisticated study is offered of plants and animals native to the inner and
outer harbors. This course provides field trips, dissection, use of the microscope, and laboratory experiments.
COLD SPRING HARBOR LABORATORY
MEETINGS AND COURSES
-A,
ACADEMIC AFFAIRS
The academic program at the Laboratory serves to communicate new discoveries, concepts, and method-
ologies to an international community of scientists. The program consists of advanced laboratory and lecture
courses, as well as large meetings and biotechnology conferences that are held almost year-round. Last year,
almost 7000 scientists came from around the world to attend these events.
This year, 22 major meetings were held at the Laboratory, including the yearly Symposium. Although the
meetings calendar is full with many meetings that recur on a 2-year cycle, there is always room for new con-
ferences that represent rapidly moving areas of science. This year, successful new neurobiology conferences
on Computational and Systems Neuroscience and Channels, Receptors, and Synapses were held. The lat-
ter meeting was organized by Robert Huganir, Lily Jan, and Morgan Sheng and is scheduled again for the
2006 season. Many of the meetings were oversubscribed, including the Symposium, The Biology of
Genomes, Retroviruses, and Translational Control meetings. At most meetings, approximately 25% of the
participants are graduate students, whereas an additional 25-30% are postdoctoral fellows. This indicates
the extent to which the meetings are a popular venue for young scientists and it is at these meetings that
many of them give their first presentations.
The 69th Symposium on "Epigenetics" featured 68 talks and 210 poster presentations. Opening night
talks were delivered by Davor Solter, Barbara Meyer, David Allis, and Andrew Fire. Daniel Gottschling from the
Fred Hutchinson Cancer Research Center closed the meeting with a summary. Gary Felsenfeld gave the
Reginald G. Harris Lecture on "Chromatin Boundaries and Chromatin Domains." The Dorcas Cumming
Lecture, which is open to friends and neighbors of the Laboratory, was given by David Haig of Harvard
University on the subject of "The Divided Self-Brains, Brawn, and the Superego."
Twenty-eight lecture and laboratory courses were held, covering a diverse array of topics in neurobiology,
structural biology, molecular biology, and genetics and bioinformatics. These courses allow the student to
return home and immediately apply the latest relevant techniques to their own research. Courses are always
being updated by the instructors to include new methodologies and directions. The success of the courses
is due, in large part, to the skills, talents, and hard work of the faculty instructors, lecturers, and assistants
who come from institutions around the world.
We must make note this year of several heroic instructors who have been teaching courses for 10 years
or more. These include Dick Burgess and Sue-Hwa Lin, instructors for the spring course on Protein
Purification and Characterization; Cary Lai and Jim Boulter for the Advanced Techniques in Molecular
Neuroscience summer course; Bill Pearson and Randy Smith, instructors for the Computational Genomics
fall course; Carlos Barbas and Gregg Silverman, who teach the course on Phage Display of Protein and
Peptides; and the entire teaching faculty of the X-ray Crystallography course: Bill Furey, Gary Gilliland, Alex
McPherson, and Jim Pflugrath.
The extensive offerings would not be possible without a series of grants from federal and private sources.
These include the National Institutes of Health, the National Science Foundation, the Howard Hughes Medical
Institute, the Esther and Joseph A. Klingenstein Fund, and the Eppley Foundation. Core support for the meet-
ings program is provided by the Laboratory's Corporate Benefactors, Sponsors, Affiliates, and Contributors.
In addition, the Laboratory receives valuable support from many companies that donate supplies and lend
equipment for the courses.
The success of the very large number of meetings and courses is also due to the skilled work of many
Cold Spring Harbor staff and faculty who contribute their expertise, efforts, and good humor to the program.
Without their diligence, the programs would shine very much less brightly. We particularly acknowledge the
efforts of Mike Cannavarro, our information technology specialist, and Jenna Williams, meeting administrator,
who departed during the course of the year.
Terri Grodzicker
Assistant Director for Academic Affairs
David Stewart
Executive Director, Meetings & Courses
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69TH COLD SPRING HARBOR SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Epigenetics
June 2-7 460 participants
ARRANGED BY Bruce Stillman and David Stewart, Cold Spring Harbor Laboratory
Until recently, the general view of heredity has been shaped by the lens of DNA. Indeed, the 2003
Symposium on "The Genome of Homo Sapiens" contributed to that view by emphasizing the impor-
tance of DNA sequence and its origins. But increasingly, investigators are exploring a set of secondary
phenomena that give rise to heritable changes in gene function that occur without a change in the
underlying DNA sequence-epigenetic mechanisms such as DNA methylation, histone acetylation,
imprinting, RNA interference, gene silencing, and paramutation. A growing body of evidence indicates
that epigenetic changes are important contributors to the pathogenesis of disease in humans, animals,
and plants and may lie at the heart of many important gene-environment interactions. And so it
seemed timely to hold a Symposium explicitly devoted to epigenetics.
Previous Symposia that have in part examined the role of the macromolecular context in which the
primary genetic information is found include the 1941 Symposium on "Genes and Chromosomes:
Structure and Organization," which emphasized a biophysical approach to these structures; the two
closely separated Symposia that examined "Chromosome Structure and Function" (1973) and
"Chromatin" (1977), at which latter meeting the nature of the nucleosome was unveiled; and the 1993
Symposium on "DNA and Chromosomes," by which time the Human Genome Project with its focus
on the well under way. The 69th Symposium, however, was the first to fully
explore the heritable aspects to these and related biochemical phenomena.
The field of epigenetics as we know it today was prominently introduced
at the 1951 Symposium on "Genes and Mutations." There, Ed Lewis pre-
sented data on position effect variegation in Drosophila, a phenomenon that
has played an important role in the history of the field. Equally importantly,
Barbara McClintock presented her ideas about heterochromatin and mov-
able genetic elements, the so-called Ac-Ds system in maize that opened up
understanding of transposition and its links to gene silencing and hete-
rochromatin. This year's Symposium witnessed the first molecular descrip-
tion of her ideas, including links to RNAi.
The 69th Symposium ran for five days and included 460 participants with
68 oral presentations and 210 poster presentations. We wish to thank Dr.
David Haig for his superb Dorcas Cummings Memorial public lecture pre-
senting a theoretical approach to epigenetics on the subject of The Divided
Self-Brains, Brawn, and the Superego. We also wish to thank the first night
speakers, Drs. Davor Solter, Barbara Meyer, David Allis, and Andrew Fire for
their superb overview presentations, and we particularly thank Dr. Daniel
Gottschling for agreeing to summarize the Meeting.
Essential funds to run this meeting were obtained from the National
Cancer Institute, a branch of the National Institutes of Health. In addition,
financial help from the corporate benefactors, sponsors, affiliates, and con-
tributors of our meetings program is essential for these Symposia to remain
a success and we are most grateful for their continued support. Corporate
Benefactors: Amgen Inc.; Aventis Pharma AG; Bristol-Myers Squibb
Company; Eli Lilly and Company; GlaxoSmithKline; Novartis Institutes for D. Haig, Dorcas Cummings Lecture
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BioMedical Research; Pfizer Inc. Corporate Sponsors: Applied Biosystems; AstraZeneca; BioVentures,
Inc.; Cogene BioTech Ventures, Ltd.; Diagnostic Products Corporation; Forest Laboratories, Inc.;
Genentech, Inc.; Hoffmann-La Roche Inc.; Johnson & Johnson Pharmaceutical Research &
Development, LLC; Kyowa Hakko Kogyo Co., Ltd.; Lexicon Genetics, Inc.; Merck Research
Laboratories; New England Biolabs, Inc.; OSI Pharmaceuticals, Inc.; Pall Corporation; Schering-
Plough Research Institute; Wyeth Genetics Institute. Plant Corporate Associates: ArborGen; Monsanto
Company. Corporate Affiliates: Affymetrix, Inc.; Agencourt Biosciences Corporation. Corporate
Contributors: Axxora; Biogen, Inc.; EMD Bioscience; Epicentre; Technologies, Illumina; Integrated DNA
Technologies; IRx Therapeutics; KeyGene. Foundations: Albert B. Sabin Vaccine Institute, Inc.
B. Stillman, P. Sharp
Catching the live broadcast in Grace Lobby
D. Solter, W. Herr
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S. Emmons, G. Ruvkun, B. Meyer
PROGRAM
Introduction
B. Stillman, Cold Spring Harbor Laboratory
Nuclear Reprogramming, Chromosome Inactivation,
and Imprinting
Chairperson: A. Bird, University of Edinburgh, United Kingdom
Small RNAs 1
Chairperson: P. Sharp, Massachusetts Institute of Technology
Cambridge
DNA Methylation: Mechanism and Regulation
Chairperson: A. Surani, Wellcome Trust/Cancer Research
United Kingdom, Cambridge
Reginald G. Harris Lecture: Position Effects and
Nuclear Organization
Chairperson: F. Felsenfeld, National Institutes of
Health/NIDDK, Bethesda, Maryland
Position Effects and Nuclear Organization
Chairperson: G. Almouzni, Institut Curie Recherche, Paris,
France
Chromatin Inheritance and Assembly
Chairperson: M. Kuroda, Harvard Medical School, Boston,
Massachusetts
Epigenetic Regulation of Gene Expression
Chairperson: V. Chandler, University of Arizona, Tucson
Histone Modifications
Chairperson: J. Lee, Massachusetts General Hospital,
Boston
Epigenetic Twists
Chairperson: D. Stewart, Cold Spring Harbor Laboratory
Dorcas Cummings Lecture: The Divided Self: Brains,
Brawn, and the Superego
Speaker: David Haig, Harvard University Cambridge,
Massachusetts
Small RNAs II
Chairperson: S. Henikoff, Fred Hutchinson Cancer Research
Center, Seattle, Washington
Epigenetics and Disease
Chairperson: M. Grunstein, University of California, Los
Angeles
Summary
Daniel Gottschling, Fred Hutchinson Cancer Research Center,
Seattle, Washington
J. Watson, R. Wickner, J. Witkowski
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MEETINGS
Systems Biology: Genomic Approaches to Transcriptional
Regulation
March 4-7 242 participants
ARRANGED BY Stephen Small, New York University
Gary Stormo, Washington University
Michael Zhang, Cold Spring Harbor Laboratory
Deciphering the network of regulatory interactions that control development and responses to the envi-
ronment is one of the major challenges in modern molecular biology. Complete genome sequences
and a variety of new technological advances provide copious data relevant to the discovery of the net-
work components and connections. Optimum utilization of these data requires a concerted effort by
experimental and computational biologists, each bringing their own expertise to the problem, but inter-
acting vigorously to ensure that the right problems are being addressed and the best methods are
being employed. This second meeting brought together both groups, covering a range of model
organisms, biological questions, and experimental and computational approaches, for a highly cross-
disciplinary and interactive forum. Sessions described state-of-the-art methods for analyzing protein-
DNA interactions and identifying the network connections on whole-genome scales. The newest high-
throughput techniques, and some of the most recent findings from those studies, were described. Two
sessions emphasized the latest computational methods for analyzing the data, including approaches
that simultaneously take advantage of the experimental results from one organism and the conserved
genomic sequences from additional organisms to help identify the most fundamental, conserved fea-
tures in the genomes. A final session on emerging techniques closed the meeting. Numerous posters
were presented, and lively, informal discussions were ongoing throughout the meeting. It was clear that
significant progress in both experiments and computational analyses has taken place even since the
previous meeting a year ago. A planning session was held, and a steering committee was appointed
to foster similar interactions in the future.
G. Stormo, N. Gershenzon, A. Sengupta
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PROGRAM
Keynote Address: A Draft Transcriptional Regulatory
Code for Yeast
R. Young, Whitehead Institute/Massachusetts Institute of
Technology Cambridge
Transcriptional Regulation and Genomics
Chairpersons: S.Small, New York University; R. Young,
Whitehead Institute/Massachusetts Institute of Technology
Cambridge
Computational Approaches to Identifying Regulatory
Elements in Genomic DNA
Chairpersons:P. Benfey, Duke University, Durham, North
Carolina; C. Lawrence, Wadsworth Center, Albany New York
Transcription Networks
Chairpersons: J. Reinitz, Stony Brook University New York; A.
Keating, Massachusetts Institute of Technology Cambridge
Experimental Approaches to Genome-wide
Transcriptional Regulation
Chairpersons:M. Johnston, Washington University School of
Medicine, St. Louis, Missouri; J. Kadonaga, University of
California, San Diego
Computational II and Comparative Genomics
Chairpersons:M. Zhang, Cold Spring Harbor Laboratory; M.
Tompa, University of Washington, Seattle
Emerging Technologies
Chairpersons:E. Davidson, California Institute of Technology
Pasadena; G. Stormo, Washington University School of
Medicine, St. Louis, Missouri
Keynote Address: Functional Properties of the Gene
Regulatory Network for Early Sea Urchin Development
E. Davidson, California Institute of Technology
C. Tang, M. Kloster
R. Lake, A. Nagy
S. Lincoln, B. Aronow, D. Slonim
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Computational and Systems Neuroscience (COSYNE)
March 24-28 329 participants
ARRANGED BY Carlos Brody, Cold Spring Harbor Laboratory
Alexander Pouget, University of Rochester
Michael Shad len, University of Washington
Tony Zador, Cold Spring Harbor Laboratory
Systems neuroscience focuses on how systems of many connected neurons operate and demands both
experimental and theoretical/computational approaches in its efforts to understand brain function. The latter
are used to both analyze the rich, complex data the experiments produce and to help formalize-and thus
more rigorously explore-proposed hypotheses regarding mechanisms underlying the phenomenology. A
meeting combining equal contributions from both experimental and computational investigators was hereto-
fore lacking. The first Computational and Systems Neuroscience meeting provided such a forum. Judging
from the highly enthusiastic response of the participants, COSYNE was successful in providing a fruitful venue
for abundant cross-disciplinary interaction. Topics ranged from sensory processing to the neuroscience of
cognition, and all topics blended together presentations that put forth experimental data, theoretical princi-
ples, and sophisticated data analysis methods.
Major funding for this meeting was provided by the Swartz Foundation and the Redwood Neuroscience
Institute. Funding was also provided in part by the National Science Foundation and the National Institute of
Mental Health, a branch of the National Institutes of Health. Additional support was provided by Advanced
Acoustic Concepts, Inc.
Pre-COSYNE Workshop 1: Auditory Processing of Vocalizations
and Other Complex Sounds
March 24 40 participants
ARRANGED BY Tony Zador, Cold Spring Harbor Laboratory
There has been increasing interest in the computational and experimental analysis of the
mechanisms by which complex sounds such as animal vocalizations are processed in
the nervous system. This one-day workshop on processing of complex sounds
addressed a number of important questions, including (1) How far can we go with linear
models? What is the best basis for describing complex sounds? How can it be found?
(2) What processing is done at each level of the auditory pathway? (3) What role do
sparse representations have in auditory processing? (4) Does the nervous system treat
conspecific vocalizations differently from other complex sounds? (5) How distinct are
avian and mammalian strategies for processing complex sounds? (6) What role does
behavioral context have?
M. Long, C. Weaver
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A. Zador
Pre-COSYNE Workshop 2: Neurobiology of Decision Making
March 24 56 participants
ARRANGED BY Carlos Brody, Cold Spring Harbor Laboratory
Michael Shad len, University of Washington
Xiao-Jing Wang, Brandeis University
How are decisions made in the brain? Both psychologists and neuroscientists have addressed this question,
often by using simple two-alternative decision tasks in the lab (e.g., asking subjects to decide "is this light
bright or dark?"). In this workshop, we explored the surprising, and very exciting, convergence between the
mathematical frameworks built by psychologists to describe the behavior of whole subjects, and the frame-
works built by neuroscientists to describe the behavior of neurons recorded from animals performing two-
alternative decision tasks. The convergence of methods and results, starting from two very different
approaches, suggests that we may be close to an understanding of the key principles and neural mecha-
nisms behind simple decision-making behaviors.
Pre-COSYNE Workshop 3: Microcircuitry of Cortical Columns
March 23-24 65 participants
ARRANGED BY Dmitry Chklovskii, Cold Spring Harbor Laboratory
Armen Stephanyants, Cold Spring Harbor Laboratory
The microcircuitry of the Cortical Column workshop gathered researchers who use a variety of anatomical,
physiological, genetic, and computational approaches to study cortical connectivity. Despite different tech-
niques, there was a strong convergence number of themes. In particular, understanding of the
roles of specificity and randomness in synaptic connectivity received much attention.
V. Uzzell, K. Briggman, J. Shlensi
J. Kretzberg, A. Schaefer
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Evolution of Developmental Diversity
March 31-April 4 96 participants
ARRANGED BY Richard Behringer, University of Texas/M.D. Anderson Cancer Center
Nipam Patel, HHMI/University of California, Berkeley
This second meeting attracted approximately 100 researchers from around the world. It brought together a diverse
group of scientists studying various molecular genetic and developmental aspects of animal and plant biology with
a strong emphasis on morphological and functional comparisons of organismal diversity and evolution.
The meeting opened with a keynote lecture given by Fred Nijhout (Duke University) on the evolution of devel-
opmental mechanisms. There were eight sessions whose topics reflected the most advanced and interesting
areas of study in the evolution and development field, including genetics, the evolution of gene regulation,
genomics, axial pattern, segmentation and regionalization, speciation/microevolution and sexual differentiation,
and organogenesis/morphological innovation. Each session had two invited talks from senior researchers.
Between these more in-depth talks, six speakers per session were selected from the abstracts for more con-
cise presentations. The meeting also included the presentation of posters in one afternoon session. '
Research utilizing the primary animal and plant model systems to understand developmental mechanisms
has made great strides over the last few decades, demonstrating a strong molecular and cellular under-
standing of conserved developmental pathways. These model systems have provided a now classical frame-
work for studies in other plants and animals. However, it is clear that the very few primary model organisms
are not sufficient to understand the tremendous diversity of animal and plant life on earth. Understanding the
generation of this diversity, honed over eons of evolution, most likely will provide important insights into the
mechanisms that cause organ variation and the evolution of species. These insights should provide novel
information for understanding human health and disease mechanisms. Thus, it is now clear that other ani-
mal and plant models must be used to complement studies utilizing the primary model organisms. Studies
of these new model organisms have been greatly facilitated by genome and cDNA sequencing projects,
transgenesis, and new gene knockdown technologies. The use of diverse organisms to study biological
questions was the universal theme of the meeting with talks on alligator, Amphioxus, annelid, ascidian, bat,
butterfly, centipede, cichid fish, Coqui, cricket, crustacean, hemichordate, jelly fish, leech, medaka, monkey
flower, nematode, opossum, Planaria, sea urchin, spider, starfish, tribolium, wallaby, wasp, and others.
R. Behringer, E. Pennisi
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PROGRAM
Keynote Address: The Evolution of Developmental
Mechanisms
F Nijhout, Duke University
Genomics I
Chairperson: A. Sanchez, University of Utah School of
Medicine, Salt Lake City
Genetics I
Chairperson: S. Hake, University of California, Berkeley
Organogenesis / Morphological Innovation
Chairperson: L. Holland, University of California, San Diego
Segmentation/Regionalization Genetics II
Chairperson: S. Brown, Kansas State University, Manhattan Chairperson: R. Sommer, Max-Planck Institute for
Developmental Biology Tubingen, Germany
Axial Pattern
Chairperson: J. Gerhart, Harvard Medical School, Boston,
Massachusetts Evolution of Gene Regulation
Chairperson: C. Amemiya, Benaroya Research Institute at
Speciation / Microevolution and Sexual Differentiation Virginia Mason, Seattle, Washington
Chairperson: A. Sinclair, University of Melbourne, Royal
Children's Hospital, Australia
S. Alvarado, W. Jeffrey N. Patel, A. Burke
R. Palmer, P. Brakefield, F. Nijhout
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Channels, Receptors, and Synapses
April 21-25 238 participants
ARRANGED BY Richard Huganir, HHMI/Johns Hopkins University School of Medicine
Lily Jan, HHMI/University of California, San Francisco
Morgan Sheng, HHMI/Massachusetts Institute of Technology
The brain consists of a vast network of excitable cells (neurons) that conduct electrical impulses and communi-
cate with each other via specialized junctions (synapses). Information is processed and stored in the nervous sys-
tem through patterns of electrical activity and via changes in the strength and structure of synapses. As master
regulators of neuronal excitability and synaptic communication, ion channels and receptors lie at the heart of neu-
robiology. In recent years, molecular and cell biological analyses of neuronal ion channels and receptors have rev-
olutionized our understanding of the basic mechanisms that control electrical signaling and synaptic function in
the nervous systems. The convergence of advances in biochemistry, molecular genetics, microscopic imaging,
and electrophysiology has made this interdisciplinary field one of the most exciting and rapidly growing in neuro-
science. Several landmark advances have transformed the phenomenology in this field into underlying molecular
mechanisms, including the genomic cataloging of all channels and receptors, the discovery of the three-dimen-
sional "crystal" structure of a membrane ion channel, the identification of specific anchoring proteins that bind to
the cytoplasmic tails of ion channels and receptors, and the discovery of dynamic and
regulated trafficking of receptors/ion channels. The fundamental aspects of these
mechanisms seem to be evolutionarily conserved from primitive nervous systems of
worms to the human brain.
The entire field is poised for further breakthroughs that will not only illuminate basic
workings of the brain, but also shed light on neurological and psychiatric diseases that
stem from abnormal neuronal excitability and synaptic dysfunction. Such break-
throughs will be facilitated by cross-fertilization of ideas and technologies between sci-
entists studying related questions in diverse organisms using different methodological
approaches. To provide a forum that unites this exciting multidisciplinary area, a new
CSHL meeting on Channels, Receptors, and Synapses was started in April 2004.
The inaugural meeting was extremely successful, bringing together nearly 240
participants from United States, Europe, and Asia in an atmosphere of social and scientific exchange. A wide
range of topics were discussed, including the structure and function of ion channels and receptors, new class-
es of channels/receptors, regulation of ion channel/receptor function by phosphorylation, membrane trafficking
and degradation; molecular mechanisms of synaptic transmission/plasticity and their roles in brain function; and
the involvement of ion channels/receptors in human disease. More than 60 attendants were selected to give
M. Wampler, S. Thompson
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M. Kennedy, W. Ford, H.H. Beale,
H. Carlisle, A. Tapper
oral presentations of their work, while the majority of the rest presented posters. Special lectures were given by
Rod MacKinnon, 2003 Nobel laureate, on the three-dimensional structures of ion channels, and by Roberto
Malinow (CSHL professor), on trafficking of glutamate receptors in synaptic plasticity. The overall response to
the meeting was extremely positive, especially given that this was the first conference. Participants particularly
enjoyed the breadth of subjects covered and the chance to interact with investigators in related but distinct
fields. The opportunity for junior investigators (including postdocs and students) to present their own work was
especially applauded. Based on the success of the first meeting, this conference will take place again in two
years. It is anticipated that this Cold Spring Harbor meeting will become a "must-attend" conference for learn-
ing the latest developments in molecular and cellular physiology of the brain.
PROGRAM
Modulation of Ion Channels and Receptors
Chairpersons: S. Moss, University of Pennsylvania, Philadelphia;
A. Dolphin, University College London, United Kingdom
Ion Channels and Receptors in Brain Function and
Disease
Chairpersons: M. Mishina, Tokyo University Japan; L. Ptacek,
University of Utah, Salt Lake City
Special Lecture: Three-dimensional Structure of Ion
Channels
R. MacKinnon, The Rockefeller University New York
Structure and Function of Ion Channel/Receptors
Chairpersons: D. Clapham, Children's Hospital, Boston, Massachu-
setts; G. Yellen, Harvard Medical School, Boston, Massachusetts
Presynaptic Mechanisms
Chairpersons: T. Sudhof, University of Texas Southwestern
Medical Center Dallas; R.W. Tsien, Stanford University California
Postsynaptic Signaling Mechanisms
Chairpersons: M. Greenberg, Children's Hospital, Boston,
Massachusetts; M. Kennedy, California Institute of
Technology Pasadena
Synaptic Plasticity
Chairpersons: R. Malenka, Stanford University Palo Alto,
California; G. Turrigiano, Brandeis University Waltham,
Massachusetts
Special Lecture: Receptor Trafficking in Synaptic
Plasticity
R. Malinow, Cold Spring Harbor Laboratory
Development of Synapses
Chairpersons: H. Cline, Cold Spring Harbor Laboratory; M.
Bear, Massachusetts Institute of Technology Cambridge
Targeting, Trafficking, and Degradation of Ion Channels/
Receptors
Chairpersons: G. Westbrook, Vollum Institute, Portland,
Oregon; J. Kaplan, Massachusetts General Hospital, Boston
H. Kataoka, L. Jan
D. Clapham, A. Maffei
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Gene Expression and Signaling in the Immune System
April 28-May 2 294 participants
ARRANGED BY Doreen Cantrell, University of Dundee
Richard Flavell, HHMI/Yale University
Rudolf Grosschedl, University of Munich
Stephen Smale, HHMI/University of California School of Medicine
This second meeting in the series attracted more than 290 participants from around the world. It maintained
its unique emphasis on mechanistic studies that most significantly advance our understanding of the gene
regulation and signal transduction circuitry within the immune system, as well as the use of the immune sys-
tem as a tool for elucidating fundamental molecular processes. Invited and oral presentations selected from
the abstracts covered a broad range of topics concerning developmental regulation of the immune system
and immune responses to infection. One highlight of the meeting was a series of presentations that are
beginning to firmly define the molecular events that regulate cell fate decisions as hematopoietic stem cells
choose between various lymphocyte and myeloid cell lineages. Another highlight was a spirited discussion
of the activation-induced deaminase (AID) protein that is essential for both somatic hypermutation and class
switching of immunoglobulin genes. Conflicting evidence concerning potential roles of AID in RNA process-
ing or, alternatively, direct deamination of nucleotides within variable regions and switch regions during
hypermutation and switching was debated. Other central topics included the epigenetic regulation of devel-
opment, mechanisms involved in the T helper 1-T helper 2 lineage decision, mechanisms of tolerance induc-
tion, and Toll-like receptor signaling mechanisms.
Special thanks to the following organizations for support of this meeting: Abbott Laboratories, Biogen
IDEC, Boehringer Ingelheim Pharmaceuticals, Inc., Hoffmann-La Roche, Merck & Co., Inc., and Pfizer. This
meeting was funded in part by the National Institute of Allergy and Infectious Diseases, a branch of the
National Institutes of Health.
S. Smale, R. Flavell, R. Grosschedl
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PROGRAM
Stem Cells and Early Development Decisions
Chairperson: I. Weissman, Stanford University School of
Medicine, California
Regulation of Immune Cell Development
Chairperson: K. Ca lame, Columbia University College of
Physicians & Surgeons, New York
Antigen Receptor Gene Assembly, Somatic
Hypermutation, and Class Switching
Chairperson: E Alt, HHMI/Children's Hospital, Boston,
Massachusetts
Chromatin Structure and Epigenetic Regulation
Chairperson: A. Tarakhovsky, The Rockefeller University New
York
Lymphocyte Differentiation
Chairperson: L. Glimcher, Harvard School of Public Health,
Boston, Massachusetts
Signal Transduction in Immune Cells
Chairperson: D. Cantrell, University of Dundee, United
Kingdom
Regulation of Lymphocyte Function I
Chairperson: C. Benoist, Joslin Diabetes Center, Boston,
Massachusetts
Regulation of Lymphocyte Function II
Chairperson: S. Ghosh, Yale University School of Medicine,
New Haven, Connecticut
J. Madrenas, C. Bueno
X. Lin, G. Koretzky, M. Reth
K. Mowen, S. Szabo
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Molecular Chaperones and Heat Shock Response
May 5-9 298 participants
ARRANGED BY James Bardwell, University of Michigan
Elizabeth Craig, University of Wisconsin
Jonathan Weissman, University of California, San Francisco
This meeting, 22 years after the inaugural meeting, featured advances in the areas of structure and mechanism
of action of molecular chaperones; mechanisms of induction of the stress response; the role of chaperones in
protein degradation; and chaperone function in disease and aging. In the first area,
further advances were described for the classic heat shock proteins, the GroEUES,
the small heat shock factors, Hsp70, 90, and 100 classes, as well as more recent-
ly identified chaperones such as CsA in eubacteria. In addition, the first high-reso-
lution structure of the Ero1 protein, which has an essential role in oxidative protein
folding in eukaryotes, was presented. In a session of particular interest, the rela-
tionship between chaperone function and aging was featured with talks presenting
experiments in Caenorhabditis elegans and Drosophila establishing a role of chap-
erone induction in extending lifespan, as well as the effects of aging on the propen-
sity to form intracellular toxic protein aggregates. Several presentations revealed
advances in our understanding of the function of ATP-dependent regulatory sub-
units such as the proteosome regulatory particle in eukaryotes and the related CIpA
complex in bacteria in catalyzing the unfolding of proteins prior to their degradation.
In the area of regulation of stress responses, a focus of the meeting was the
advances in our understanding of the mechanism and biological consequences of
the quality control machinery that prevents the secretion and ultimately degrades
misfolded proteins in the endoplasmic reticulum (ER) as well as the unfolded protein
response which induces a multifaceted response when misfolded proteins accu-
mulate in the ER. In addition, progress toward an understanding of the function of heat shock transcription fac-
tors in complex organisms was discussed. In the area of protein misfolding and disease, a number of talks dealt
with progress in the use of model systems in yeast, mice, and worms to attack this complex problem. The role
B. Bukau, A. Norwich, E. Craig
S. Gupta, J. Bardwell, D. Cyr, W. Antoine
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oligomeric intermediates, which are often formed transiently during protein aggregation, in contributing to cellu-
lar toxicity and disease was also discussed. Finally, a number of talks focused on the biogenesis and mainte-
nance of prions in yeast, and the roles that different chaperones have in this process including evidence that
Hsp1 04 promotes prion propagation by acting to divide seeds, thereby allowing the creation of more infectious
prion units. Thus, rather paradoxically, a chaperone can have the net effect of promoting protein misfolding.
This meeting was funded in part by the National Institute of Neurological Disorders & Stroke, and the
National Institute of Child Health and Human Development, branches of the National Institutes of Health;
Merck & Co., Inc., and the Alzheimer's Association.
PROGRAM
Diseases of Protein Misfolding
Chairperson: S. Lindquist, Whitehead Institute, Cambridge,
Massachusetts
Quality Control and Protein Trafficking
Chairperson: R. Kopito, Stanford University California
Cellular Response to Stress
Chairperson: C. Gross, University of California, San Francisco
Chaperone Function in Disease, Aging, and
Development
Chairperson: R. Morimoto, Northwestern University Evanston,
Illinois
Regulation of the Stress Response
Chairperson: D. Ron, New York University School of Medicine
Chaperones and Proteolysis
Chairperson: T. Baker, HHMI/Massachusetts Institute of
Technology Cambridge
Chaperone Biochemistry and Protein Folding
Chairperson: B. Bukau, Universitat Heidelberg, Germany
P. Bross, S. Vang
P Carrigan, D. Smith, B. Matts
239
The Biology of Genomes
May 12-16 504 participants
ARRANGED BY Thomas Hudson, McGill University
Svante Paabo, Max-Planck Institute
Jane Rogers, The Sanger Center
Edward Rubin, Lawrence Berkeley National Laboratory
This annual meeting was the 15th annual gathering of genome scientists in this setting. The past decade or
more has seen remarkable progress in the mapping, sequencing, and annotation of the genomes of many
"model organisms" and the publication of a finished and draft sequences of the human, mouse, and rat
genomes, in addition to several model organisms and hundreds of bacteria. Just over 500 people from around
the world attended the meeting, with 331 abstracts presented describing a broad array of topics relating to
the analysis of genomes from a number of different organisms.
The session topics included areas such as biological insights from comparative genomics, functional
genomics, organismal biology, computational genomics, and the use of sequence variations to study popula-
tions and mechanisms of disease. Once again, projection-style, interactive computer demonstrations in Grace
Auditorium effectively highlighted the critical new bioinformatics tools being developed for storing, organizing,
and analyzing various genomic data sets, including expression, mapping, and sequence data. An ELSI
(Ethical, Legal, and Social Implications) panel discussion focused on issues surrounding the process of com-
munity engagement in large-scale population genomic studies, using the case study of the Yoruba population
of lbadan Nigeria and the Hap Map project.
The major themes of the meeting included the analysis of large-scale variation in genetic variation across
the human genome (a product of the International Hap Map Consortium), annotation of the human genome
using multispecies sequence comparisons, and a myriad of large-scale approaches to understand complex
biological processes. The Friday afternoon keynote talks were delivered by Stuart Schreiber and Craig Venter.
This meeting was funded in part by the National Human Genome Research Institute, a branch of the
National Institutes of Health.
S. Paabo, E. Rubin, T. Hudson
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PROGRAM
Comparative Genomics
Chairpersons: K. Peichel, Fred Hutchinson Cancer Research
Center, Seattle, Washington; A. Sidow, Stanford University,
California
Variation Technology and Haplotype Structures
Chairpersons: D. Altshuler, Massachusetts General Hospital,
Harvard Medical School, Boston; M. Przeworski, Brown
University Providence, Rhode Island
High-throughput Biology
Chairpersons: A. Bradley, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom; M. Snyder, Yale University New
Haven, Connecticut
Nonhuman Species and Environmental Genomics
Chairpersons: D. Reiman, Stanford University California; D.
Rokhsar, DOE Joint Genome Institute, Walnut Creek,
California
ELSI Panel Discussion
Moderator: J. McEwen, National Human Genome Research
Institute, Bethesda, Maryland
Panelists: C. Adebamowo, University of lbadan, Nigeria, Africa; P
Marshall, Case Western Reserve University, School of Medicine,
Cleveland, Ohio; C. Rotimi, Howard University, Washington,
D.C.; C. Royal, Howard University, Washington, D.C.
Computational Genomics
Chairpersons: P. Bork, European Molecular Biology
Laboratory Heidelberg, Germany; L. Pachter, University of
California, Berkeley
Polymorphisms and Their Relationship to Biology
Chairpersons: J. Kere, Karolinska Institutet, Huddinge, Sweden;
K. Frazer, Perlegen Sciences, Mountain View, California
Keynote Speakers
S. Schreiber, Harvard University Cambridge, Massachusetts;
C. Venter, The Center for the Advancement of Genomics,
Rockville, Maryland
Genome Structure and Evolution
Chairpersons: W.-H. Li, University of Chicago, Illinois; C.-I.
Wu, University of Chicago, Illinois
T. Andersson, J. Larkin
J. Hancock, P Little, S. Brown
K. Kimura, Y. Suzuki, A. Fujiyama 241
The Cell Cycle
May 19-23 341 participants
ARRANGED BY Orna Cohen-Fix, National Institutes of Health/NIDDK
Stephen El ledge, HHMI/Harvard University
J. Wade Harper, Harvard Medical School
David Morgan, University of California, San Francisco
This 8th biannual meeting attracted participants from around the world and is internationally recognized for its
ability to bring together scientists who study cell cycle regulation in eukaryotes ranging from yeast to humans.
We were particularly fortunate this year to have Kim Nasmyth as our keynote speaker. Dr. Nasmyth, an
acknowledged leader in the yeast cell cycle regulation field, opened the meeting with a wide-ranging and excit-
ing talk describing the discovery of the separin-cohesin pathway and its role in the control of the metaphase
to anaphase transition in eukaryotes ranging from yeast to mammals. Three broad themes were dominant
throughout the meeting: the interaction of cell cycle control with developmental and cancer biology; the mech-
anisms of action of cell cycle checkpoints and their integration with signal pathways that control mitotic tran-
sitions; and the emerging use of high-throughput and whole-genome approaches to uncover new aspects of
cell biology. Research in proteolysis for both G1 /S and G2/M regulation in particular continues to receive intense
focus, with much progress reported. As in previous years, there was also emphasis on the long-standing prob-
lem of regulation of DNA replication in the cell cycle, its onset, and its restriction to once per cell cycle.
Significant insight into the conservation of transcriptional regulatory pathways involved in the G1 /S transition
was presented when it was found that the G1 cyclins phosphorylate and inactivate a repressor of the S-phase
transcription factors. This is analogous to the Rb/E2F switch in mammals. New to the discussion was a more
detailed understanding of how different Cdk/cyclin complexes choose their substrates during the cell cycle,
with more than one surprise in that area. There was also an emphasis on the use of emerging technologies,
both in tissue culture cells and in live animals such as Caenorhabditis elegans, to study the dynamics of sig-
naling pathways and rapid changes in the localization of components of the mitotic apparatus in response to
checkpoint activation. As in other years, scientists studying cell cycle regulation in yeast, Xenopus, Drosophila,
nematodes, and mammals were well-represented. Once again, the striking phylogenetic conservation of cell
cycle regulatory mechanisms was readily evident. This meeting also served to demonstrate the impact of
whole-genome analysis on basic cell biology, and these achievements will no doubt continue to drive rapid
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progress in this field. The cell cycle conference was another landmark meeting for the cell cycle field, and the
participants all continued to look forward to equally exciting meetings in future years.
This meeting was funded in part by the National Cancer Institute and the National Institute on Aging,
branches of the National Institutes of Health.
PROGRAM
Cell Cycle Control Mechanisms
Chairperson: F. Cross, The Rockefeller University New York
G, Control I
Chairpersons: N. Dyson, Massachusetts General Hospital
Cancer Center, Charlestown; M. Tyers, Samuel Lunenfeld
Research Institute, Toronto, Canada
G, Control II
Chairpersons: J. Roberts, Fred Hutchinson Cancer Research
Center, Seattle, Washington; G. Hannon, Cold Spring Harbor
Laboratory
S Phase
Chairpersons: J. Li, University of California, San Francisco; J.
Diffley, Imperial Cancer Research Fund, South Mimms,
United Kingdom
M. Saito, A. Taylor,
M. Polymenis, R. Pathak
M Phase I
Chairpersons: J. Pines, University of Cambridge, United
Kingdom; C. Rieder, Wadsworth Center, Albany New York
M Phase II
Chairpersons: A. Amon, Massachusetts Institute of
Technology Cambridge; K. Gould, HHMINanderbilt
University Nashville, Tennessee
Checkpoints I
Chairpersons: A. Carr, University of Sussex, United Kingdom;
D. Toczyski, University of California, San Francisco
Checkpoints II
Chairpersons: S. Biggins, Fred Hutchinson Cancer Research
Center, Seattle, Washington; H. Yu, University of Texas
Southwestern Medical Center, Dallas
A. Devault, J. Li
M. Tyers, V. Duronio
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Retroviruses
May 25-30 442 participants
ARRANGED BY Eric Freed, NCI-Frederick
Susan Ross, University of Pennsylvania
This 29th annual CSHL meeting originated in 1975 as a meeting on RNA Tumor Viruses and evolved to its
current focus on Retroviruses in 1993. In our view, the 29th meeting was highly successful. The short oral
presentations and posters were complemented by a keynote talk from Dr. Neil Copeland, who presented
important findings from his and Nancy Jenkins' lab regarding the use of high-throughput analysis to map
retroviral integration sites in tumors induced by murine leukemia viruses. The Jenkins and Copeland labs
have used infection of various hematopoietic stem cells followed by transplantation into lethally irradiated
mice to identify not only novel proto-oncogenes, but also cooperating cancer genes, tumor suppressors, and
genes involved in stem cell transformation and immortalization. Although the topic of the keynote address
was somewhat outside the mainstream of the conference, the talk was well-received.
There were 332 abstracts this year, with oral presentations arranged into 11 sessions, and three poster
sessions. The oral sessions began with the entry phase of the replication cycle, proceeded with postentry
events, assembly and release, integration, reverse transcription, pathogenesis/host factors, RNA-related
events (transcription, processing, export, and packaging), and finished with antivirals. Although the most
striking developments this year involved postentry events and assembly/release, significant progress was
made toward elucidating a number of aspects of the retroviral replication cycle. Highlights included recent
progress in understanding the mechanism by which the lentiviral Vif protein counteracts the antiviral effects
of the cellular enzyme APOBEC3G and novel findings
relating to the identification of TRIM5alpha as the factor
restricting postentry events in HIV-1 infection of nonhu-
man primate cells.
In other matters, the pattern of arranging posters
alphabetically was continued this year. The cuisine con-
tinues at the enjoyable level noted for last several years,
a big change from previous years. Posters were held in
the evening this year after the wine and cheese party,
rather than talks, which are difficult for some to manage
after wine and beer. The Sunday morning session itself
continues to be a bit of a problem as it is difficult for peo-
ple to stay on, get up, and/or be enthusiastic at this final
session. Finally, we very much appreciated the help and
guidance of the CSHL staff, who made the meeting easy
and enjoyable to organize. One final notable develop-
ment: This year, we were asked to write a review of the
meeting for the new on-line BioMed Central journal
Retrovirology. The review is available at http://www.retro-
virology. com/content/1/1/25.
Contributions from our Corporate Benefactors, Corpo-
rate Sponsors, Plant Corporate Associates, Corporate
Affiliates, Corporate Contributors, and Foundations provid-
ed core support for this meeting.
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PROGRAM
Entry I
Chairpersons: D. Lindemann, Technische Universitat Dresden,
Germany; L. Albritton, University of Tennessee Health
Sciences Center, Memphis
Entry II
Chairperson: H. Garoff, Karolinska, Institutet, Huddinge,
Sweden
Postentry I
Chairperson: P. Bieniasz, Aaron Diamond AIDS Research
Center, New York
Postentry II
Chairpersons: C. Aiken, Vanderbilt University, Nashville,
Tennessee; G. Towers, University College London, United
Kingdom
Assembly/Release I
Chairpersons: X.F. Yu, Johns Hopkins University School of
Public Health, Baltimore, Maryland; R. Montelaro, University
of Pittsburgh School of Medicine, Pennsylvania
Keynote Speaker
Neal Copeland, NCI-Frederick
Integration
Chairpersons: H. Levin, National Institutes of Health,
Bethesda, Maryland; D. Grandgenett, St. Louis University
Health Sciences Center, Missouri
Assembly/Release II
Chairpersons: P. Spearman, Vanderbilt University School of
Medicine, Nashville, Tennessee; E. Barklis, Oregon Health &
Science University Portland
Reverse Transcription/Recombination
Chairpersons: W.-S. Hu, NCI-Frederick, Maryland; B.
Berkhout, University of Amsterdam, The Netherlands
Pathogenesis/Host Factors
Chairpersons: M. Lairmore, Ohio State University Columbus;
H. Fan, University of California, Irvine
Transcription, RNA Processing, Export, Packaging
Chairpersons: K. Boris-Lawrie, Ohio State University
Columbus; J. Dudley, University of Texas, Austin
Antivirals
Chairpersons: A. Kaplan, University of North Carolina, Chapel
Hill; A. Lever, University of Cambridge, United Kingdom
M. Laasko, R. Swanstrom
C. Fumes, D. Dobbs
A. Fassati, M. Pizzato
S. Kim, C. Woodward
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New York Structural Biology Group
August 6 252 participants
ARRANGED BY Leemor Joshua-Tor, Cold Spring Harbor Laboratory
Larry Shapiro, Columbia University College of Physicians & Surgeons
This summer meeting was the sixth in day-long meetings allowing structural biologists from all over the
region to meet and discuss their latest results. The meeting was open to structural biologists from dif-
ferent disciplines, including crystallographers, spectroscopists, computational biologists, and bio-
chemists, with more than 250 participants from academia and industry from the tristate area. The pro-
gram featured nine talks and a poster session and concluded with a beach barbecue, allowing a won-
derful opportunity for informal interactions. This meeting complements the bimonthly evening meetings
of the group held at The Rockefeller University. No registration was required and participants were
encouraged to set up posters.
Financial support was provided by Amersham Biosciences, Hampton Research, Rigaku MSC and
Proterion, Inc.
PROGRAM
Session I
Chairpersons: L. Shapiro, Columbia University College of
Physicians & Surgeons; H. Wu, Weill Medical College of
Cornell University; C. Wang, Columbia University College of
Physicians & Surgeons (Palmer lab); J. Truglio, Stony Brook
University (Kisker lab); J. Ferrara, Rigaku/MSC
Session 11
Chairpersons: D. Stokes, Skirball Institute, New York
University Medical School; D. Patel, Memorial Sloan-
Kettering Cancer Center; Y. Song, City College of New York
(Gunner lab); D. Jain, The Rockefeller University (Darst lab);
D. Raleigh, Stony Brook University
Session III
Chairpersons: L. Joshua-Tor, Cold Spring Harbor Laboratory;
B. Honig, Columbia University College of Physicians &
Surgeons; J. Williams, Columbia University College of
Physicians & Surgeons (Hendrickson lab); C. Lima, Memorial
Sloan-Kettering Cancer Center; E. Crocker, Stony Brook
University (Smith lab); T. Walz, Harvard Medical School
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Cancer Genetics and Tumor Suppressor Genes
August 18-22 405 participants
ARRANGED BY Jacqueline Lees, MIT Center for Cancer Research
Scott Lowe, Cold Spring Harbor Laboratory
Charles Sawyers, University of California, Los Angeles
Charles Sherr, HHMI/St. Jude's Children's Research Hospital
This fourth meeting focused on topics related to cancer genetics and biology. Most of the 400 scientists pre-
sented unpublished research through oral or poster presentations. The talks were highlighted by two keynote
lectures: Anton Berns discussed recent advances using mice to model human cancer, highlighting their
potential utility for identifying new cancer genes and for studying cancer therapeutics. In the second keynote,
Stephen El ledge discussed recent advances in elucidating DNA damage responses and their roles in pre-
venting tumorigenesis. An international team of established investigators, whose expertise covered many of
the topics highlighted during the meeting, chaired the individual sessions. The first oral session discussed
new mouse models, which continue to be an important topic at the meeting. Indeed, many other talks and
posters highlighted the use of cancer-prone mice to study gene function and to model human cancer. Other
sessions highlighted recent advances in our understanding of DNA damage responses, apoptosis, and cel-
lular senescence, the Rb and p53 tumor suppressor pathways, and signal transduction pathways that are
altered in human tumors. This meeting continued to be enthusiastically supported, and the lectures and
poster presentations led to extensive discussions and exchanges of information and ideas.
This meeting was funded in part by the National Cancer Institute, a branch of the National Institutes of
Health.
G. Evan, L. Attardi, S. Lowe
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PROGRAM
Mouse Models
Chairpersons: T. Van Dyke, University of North Carolina,
Chapel Hill; T. Jacks, HHMI/Massachusetts Institute of
Technology Cambridge
Keynote Address: Analysis of the Multifunctionality of
BRCA1
D. Livingston, Dana-Farber Cancer Institute, Harvard Medical
School
Rb and E2F
Chairpersons: S. Morrison, HHMI/University of Michigan, Ann
Arbor; J. Lees, MIT Center for Cancer Research,
Cambridge, Massachusetts
Therapeutics
Chairpersons: C. Thompson, University of Pennsylvania,
Philadelphia; C.L. Sawyers, University of California, Los
Angeles
Keynote Address: Cancer Targets in the Ras pathway
Chairperson: Frank McCormick, University of California, San
Francisco
ARF/p53 Pathway
Chairpersons: G. Evan, University of Califomia Comprehensive
Cancer Center, San Francisco; K. Vousden, Beatson Labora-
tories, Institute for Cancer Research, Glasgow, United Kingdom
Genome-wide Analysis and Screens
Chairpersons: S.A. Courtneidge, Van Andel Research Institute,
Grand Rapids, Michigan; M. Van Lohuizen, University of
California, San Francisco
DNA Damage/Chromosomal Instability
Chairpersons: J. Lukas, Danish Cancer Society Copenhagen;
T De Lange, The Rockefeller University New York
Signaling I
Chairpersons: B. Schulman, St. Jude Children's Research
Hospital, Memphis, Tennessee; E. Holland, Memorial Sloan-
Kettering Cancer Center, New York
Signaling II
Chairpersons: M.F. Roussel, St. Jude Children's Research
Hospital, Memphis, Tennessee; L.F. Parada, University of
Texas Southwestern Medical Center, Dallas
P. Van Sloun, T. Hughes M. Fried, J. Jenkins, Y. Ito
J. Lukas, D. Livingston
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D. Ray, A. Datta
Molecular Genetics of Bacteria and Phages
August 24-29 209 participants
ARRANGED BY Tina Henkin, Ohio State University
Catherine Squires, Tufts University School of Medicine
Ryland Young, Texas A&M University
The meeting featured 98 talks arranged in 10 oral presentation sessions, and two poster sessions. Young
scientists gave most of the talks, and a senior scientist who presented an introductory overview moderated
each session. Topics included ribosomes, translation, and posttranscriptional regulation; bacteriophage
development and host interactions; cell division and development; transcriptional regulation; cell surfaces-
structure, function, and signaling; host/pathogen interactions; bacterial genomics and proteomics; DNA
structure, recombination, and transposition; and stress response, chaperones, and protein degradation.
An interesting theme tying seemingly disparate sessions together was the variety of roles that small or nonen-
coding RNAs have in influencing gene expression. This theme started with the Nat Sternberg Award winner's
lecture (A. Nahvi from the Breaker group at Yale) describing riboswitches, RNAs whose structure is altered when
certain small molecules are sensed, leading to a dramatic change in gene expression. Similarly, the Henkin
group (Ohio State) demonstrated that the T-box system using binding of charged/uncharged tRNAs to RNA and
regulating gene expression works in vitro, providing evidence that no other effectors are needed for the RNA-
mediated control. Somewhat unexpectedly, the Losick group at Harvard found that a small RNA inhibits cell lysis
in Bacillus subtilis and another, RNAIII, was found by collaborating groups from Strasberg, Lyon, and Paris to
be involved in regulating expression of pathogenesis genes in Staphylococcus aureus. Substantial physiologi-
cal changes are noted in Escherichia coli (Remme group, Estonia) and C. crescentus (Keller group at Penn
State) when the small RNA responsible for rescuing stalled ribosomes and tagging incomplete peptides for
destruction, tmRNA, is lacking. Further studies by the Weisberg group at NIH of a small RNA encoded by phage
HK022 called PUT described how PUT acts in cis to alter RNA polymerase into an antitermination-competent
form that can transcribe through terminators. In Archaea, Pat Dennis (UBC) described the sequence and struc-
tural constraints of small RNAs needed as guides for rRNA modification complexes. The description of new
small, noncoding RNAs in E. coli (G. Storz group, NIH) suggests that there are more important roles for these
RNAs that are not yet fully appreciated. These intriguing reports, and the wide variety of systems giving rise to
them, suggest that in future meetings we can expect progress in understanding the contributions to gene
expression and cell physiology from a host of different forms of RNAs.
This meeting was funded in part by the National Science Foundation.
C. Squires, 0. Amster-Choder
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PROGRAM
Ribosomes, Translation, and Posttranscriptional
Regulation
Chairperson:R. Green, Johns Hopkins University Baltimore,
Maryland
Bacteriophage Development and Host Interactions
Chairperson: M. Gottesman, Columbia University
New York
RNA Polymerase: Structure, Function, and Regulation
Chairperson: R. Landick, University of Wisconsin, Madison
Cell Division and Development
Chairperson: W. Margolin, University of Texas Houston
Medical School
Transcriptional Regulation
Chairperson: C. Yanofsky, Stanford University California
Cell Surfaces-Structure, Function, and Signaling
Chairperson: M. Manson, Texas A&M University College
Station
Host Pathogen Interactions
Chairperson: H. Shuman, Columbia University New York
Bacterial Genomics and Proteomics
Chairperson: J. Lawrence, University of Pittsburgh,
Pennsylvania
DNA Structure, Recombination, and Transposition
Chairperson: K. Derbyshire, New York State Department of
Health and University at Albany
Stress Response, Chaperones, and Protein Degradation
Chairperson: S. Wickner, National Institutes of Health/NCI,
Bethesda, Maryland
W. Champness, L. Snyder
Z. Pragai, S. Semsey
D. Cully, L. Hernandez, H. Shuman
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M. Leibman, J. Roberts
Mouse Molecular Genetics
September 1-5 311 participants
ARRANGED BY Francois Guillemot, National Institute for Medical Research
Hiroshi Hamada, Osaka University
Terry Magnuson, University of North Carolina, Chapel Hill
Janet Rossant, Samuel Lunenfeld Research Institute
Held every other year, this meeting attracted more than 300 researchers from across the globe. Scientists
attending the meeting also come from very diverse areas of biology and are united by the common use of
mouse mutants in their research. As a result, the meeting covers very diverse areas of biology, in which the
contribution of mouse genetics is essential to the progress of knowledge. The sustained interest of all par-
ticipants throughout the meeting is ensured by the commonality of techniques, as well as by increasing evi-
dence that basic mechanisms are conserved across diverse experimental systems.
The meeting opened with the Annual Rosa Beddington Lecture given by Elisabeth Robertson. The meet-
ing was organized into ten sessions. In a slight departure from the format of previous years, each session
was arranged around not two, but three talks of general interests, given by two senior and one more junior
invited researchers. Between these more in-depth talks, five to six speakers per session were selected from
the abstracts for more concise presentations. The reason for adding one invited speaker to each session was
to further increase the visibility and attractiveness of
the meeting. The meeting also included the presenta-
tion of several hundred posters in two afternoon ses-
sions. The Genetics Society of America sponsored
cash prizes for the five best poster presentations as
judged by the organizers and other selected Pls. The
meeting ended with a farewell to Hiroshi Hamada, who
stepped down after 4 years as an organizer of the
meeting.
Some of the sessions have shifted in their empha-
sis this year. The neurobiology session has evolved to
represent systems neuroscience, and Linda Buck
(2004 Nobel Prize for Medicine) gave an invited lecture
in this session on information coding in the olfactory
system. The growing emphasis on genetics/genomics
and on human disease models, already noted in previ-
ous years, has also continued. Aravinda Chakravarti
was invited to provide links between mouse and
human genetics. Given the increasing importance of the T. Magnuson, D. Stewart
mouse as a model to investigate disease mechanisms, and the sophistication with which diseases can now
be modeled and analyzed in the mouse, the organizing committee has decided to emphasize the link
between mouse and human genetics.
This meeting was funded in part by the National Cancer Institute, the National Institute of Diabetes and
Digestive and Kidney Diseases, the National Institute of Child Health and Human Development, the National
Human Genome Research Institute, and the National Institute of Neurological Disorders and Stroke, branch-
es of the National Institutes of Health.
Voil))))1111))0\
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PROGRAM
Rose Beddington Lecture: Combinatorial Smad
Activities Regulate Nodal-dependent Patterning
of the Early Embryo
Elizabeth Robertson, Harvard University, Cambridge,
Massachusetts
Stem Cells and Differentiation
Chairperson: F. Miller, Hospital for Sick Children, Toronto,
Canada
Models of Human Disease
Chairperson: R. Lifton, Yale University School of Medicine,
New Haven, Connecticut
Organogenesis
Chairperson: A. McMahon, Harvard University Cambridge,
Massachusetts
Neurobiology
Chairperson: L. Buck, HHMI/University of Washington, Seattle
Embryonic Patterning
Chairperson: V. Papaioannou, Columbia University, New York
Epigenetics
Chairperson: J. Lee, Massachusetts General Hospital, Boston
Genetics and Genomics
Chairperson: L. Flaherty, Wadsworth Center, Troy, New York
Signaling
Chairperson: G. Martin, University of California, San Francisco
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S. Blaess, A. Sudarov
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Translational Control
September 7-12 475 participants
ARRANGED BY Alan Hinnebusch, National Institutes of Health/NICHD
Tatyana Pestova, SUNY Downstate Medical Center
Joel Richter, University of Massachusetts Medical School
This meeting attracted more than 470 participants from around the world and included three keynote speak-
ers, nine platform speakers, and three poster sessions that covered a record 415 abstracts. Several note-
worthy reports concerned the mechanism of translation. Contrary to the prevalent model, it was shown that
initiation factors elF1 and elF3 are not released from 48S complexes after elF5-stimulated GTP hydrolysis,
but rather later when the 60S subunit joins. Evidence was provided for
cooperative assembly of elFs 1, 1A, and ternary complex on 40S ribo-
somes in vivo, and FRET analysis showed that AUG recognition
decreases interaction between elF1 and elF1A and weakens elF1 bind-
ing to the 40S ribosome. The NMR structure of elF2a revealed an unex-
pected similarity with eEF1B, the GEF for elongation factor eEF1A.
Furthermore, it was shown that elF2a kinases and eIF2B (the GEF for
elF2) recognize overlapping surfaces in elF2a. Regarding translation ter-
mination, two reports indicated that RRF does not function as a tRNA
mimic in catalyzing ribosome disassembly, based on its mode of bind-
ing to the 50S subunit and its independence of the translocation activi-
ty of EF-G. It was shown that eRF3 is not involved in recycling eRF1 but
participates in the decoding process or peptide chain release.
The cryo-EM structure of the CrPV internal ribosome entry (IRES) T. Pestova, J. Richter, A. Hinnebusch
bound to the 80S ribosome revealed specific contacts with the A, P, and E sites and suggested that it func-
tions as RNA-based translation factor that "pushes" the ribosome into an elongation mode. A polypyrimidine-
rich motif that binds PTB was shown to be sufficient to direct PTB-dependent IRES when present as a dou-
ble-stranded stem.
On the topic of translational control, it was shown that translational regulation of mammalian ATF4 mRNA
via elF2a phosphorylation closely resembles the reinitiation mechanism involving uORFs described for yeast
GCN4. Phosphorylation of elF2a also was shown to activate NF-xB in cells experiencing ER stress, and to
increase resistance to hypoxic stress in tumor cells. Stress activation of the cytostatic protein kinase Pak2
leads to phosphorylation of eIF4G and the inhibition of translation in vivo. It was reported that phosphoryla-
tion of the Glu/Pro-tRNA synthetase and the ribosomal protein L13a releases them from the multisynthetase
complex and the 60S ribosomal subunit to collaborate in a complex that binds a stem-loop in the 3'UTR of
ceruloplasmin mRNA to repress translation. In a similar vein, ribosomal protein L30 was implicated as part of
the SECIS-binding element in the 3'UTR of mRNAs that incorporate selenocysteine-tRNA at UGA codons.
Evidence was presented that base pairing of a liver-specific microRNA (miR122) to the 5'UTR of hepatitis C
virus is required for virus replication, and it was found that interferon induces the RNA editing enzyme ADAR,
which specifically deaminates HCV RNA and blocks virus replication. The maskin model for mRNA-specific
translational control by proteins that bind to the 3'UTR and disrupt the eIF4E -eIF4G interaction at the cap has
emerged as a major paradigm for gene-specific translational control in metazoan development. For exam-
ple, Drosophila embryos contain two new maskin-like molecules: Cup, whose control of mRNA-specific
translation is necessary for oocyte and embryo development, and Mid line, whose similar mRNA-specific
translation is required for axon pathfinding in the developing central nervous system.
In the arena of mRNA decay, evidence was presented that a yeast ribosome at a premature stop codon
is inefficiently released relative to a natural stop codon and triggers nonsense-mediated decay because of its
separation from mRNP complexes in the 3'UTR. mRNA decay and NMD were found to occur within P-bod-
ies in yeast. The crystal structure of the DcpS scavenger decapping enzyme was shown to be an asymmet-
ric dimer containing two distinct active sites bound by two cap molecules. Finally, it was shown that tyrosine
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phosphorylation of the Xenopus polysome-associated endoribonuclease PMR1 targets it to the substrate mRNA
in polysomes.
This meeting was funded in part by the National Cancer Institute and the National Institute of Child Health
and Human Development, branches of the National Institutes of Health.
PROGRAM
Keynote Addresses: Decoding of mRNA by the Ribosome
V. Ramakrishnan, MRC Laboratory of Molecular Biology,
University of Cambridge, United Kindom
Intracellular Signaling from the Endoplasmic Reticulum
to the Nucleus
P. Walter, HHMI/University of California, San Francisco
RNA Regulation in the Germ Line
J. Kimble, HHMI/University of Wisconsin, Madison
Initiation Factors: Structure and Function
Chairperson: R. Jackson, University of Cambridge, United
Kingdom
Viral Regulatory Strategies
Chairperson: W.A. Miller, Iowa State University Ames
Translation Mechanisms I
Chairperson: G. Wagner, Harvard Medical School, Boston,
Massachusetts
Translation Mechanisms II
Chairperson: Y. Nakamura, University of Tokyo, Japan
Developmental Regulation
Chairperson: E. Gavis, Princeton University New Jersey
Regulation of Factors
Chairperson: J. Traugh, University of California, Riverside
mRNA Turnover
Chairperson: M. Kiledjian, Rutgers University New Brunswick,
New Jersey
Regulatory Elements in mRNA
Chairperson: D. Gallie, University of California, Riverside
Internal Initiation
A. Willis, Leicester University United Kingdom
T. Michael, L. Ryabova
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CSHL/WELLCOME TRUST CONFERENCE
Functional Genomics of Host-Pathogen Interactions
September 9-12 105 participants
ARRANGED BY Matthew Berriman, The Wellcome Trust Sanger Institute
John Boothroyd, Stanford University
Julian Parkhill, The Wellcome Trust Sanger Institute
George Weinstock, Baylor College of Medicine
The first meeting on functional genomics of host-pathogen interactions was held at the Wellcome Trust
Genome Campus in Hinxton, United Kingdom, and was a joint project of CSHL and the Wellcome Trust. The
intention of the meeting was to bring together scientists working on host-pathogen interactions in a wide vari-
ety of systems, both eukaryotic and prokaryotic, to explore potential areas of overlap and cross-talk between
these sometimes disparate fields. To support this intention, the sessions of the meeting were not themed,
and each contained an eclectic mix of invited and offered talks on a wide variety of systems. Subjects cov-
ered included bacterial pathogens of man and animals; bacterial symbionts of parasitic worms and insect
vectors; parasite interactions with mammalian (and plant) hosts and insect vectors; fungal pathogens of
plants, animals, and humans; and viral pathogens of humans and animals. The limited size and broad spread
of the meeting allowed for a great deal of productive interactions among the participants outside the formal
sessions, and the meeting appeared to be very well received by the attendees.
PROGRAM
Session 1
Chairpersons: R. Maize's,
Edinburgh, United Kingdom; J. Barnwell,
Centers for Disease Control & Prevention,
Atlanta, Georgia
Session 2
Chairpersons: J. Ewbank, University of
Marseilles, France; G. Dougan, The Sanger
Institute, Cambridge, United Kingdom
Session 3
Chairpersons: F Kafatos, EMBL, Heidelberg,
Germany; B.J. Hinnebusch, National
Institutes of Health/NIAID, Hamilton,
Montana
Session 5
Chairpersons: D. Smith, Imperial College,
London, United Kingdom; M. Hook, Texas
A&M University Health Science Center,
Houston
Session 6
Chairpersons: C. d'Enfert, Institut Pasteur,
Paris, France; A. Tait, University of Glasgow,
United Kingdom
Keynote Address: Host-pathogen Encounters: Multiple
Genomes at Play
D. Reiman, Stanford University Palo Alto, California
Session 7
Chairpersons: A.B. van't Wout, University of Washington,
Seattle; S. Aksoy, Yale University School of Public Health,
New Haven, Connecticut
Wellcome Trust Sanger Institute, Hinxton, UK
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Axon Guidance and Neural Plasticity
September 18-22 422 participants
ARRANGED BY Cori Bargmann, HHMI/University of California, San Francisco
Mu-Ming Poo, University of California, San Diego
Joshua R. Sanes, Harvard University
The remarkable information processing performed by the human brain is made possible by the intricate con-
nections between nerve cells, or neurons. The magnitude of the task involved in wiring the nervous system is
staggering. In adult humans, billions of neurons each make connections with, on average, more than 1000 tar-
get cells. A stereotyped initial pattern of connections is modified
by experience and learning to create sophisticated memories
and behaviors. How is the pattern of neuronal wiring generated
during embryogenesis with the necessary precision and reliabili-
ty? Neuronal connections form when each developing neuron
sends out an axon, tipped by a growth cone, which migrates
through the embryonic environment to its synaptic targets, guid-
ed by attractive and repulsive proteins that instruct it to migrate
in particular directions. Once in the appropriate target regions,
axons must seek out particular target cells with which to form
synaptic connections. These connections are then further
refined, through the making and breaking of synaptic contacts,
under the control of specific patterns of electrical activity in the
neurons and targets, until a highly tuned circuit is established. J. Sanes, C. Bargmann
In the past decade, our understanding of the mechanisms that control axon growth and guidance, synap-
togenesis, and the remodeling of neural circuits during development has progressed rapidly from phenome-
nology to the identification of specific molecular control mechanisms. Progress has been assisted by the find-
ing that these mechanisms are highly conserved across evolution, so that both biochemical approaches in
vertebrates and genetic approaches in invertebrates (and increasingly, in vertebrates as well) have led to
mutually reinforcing discoveries that have helped fuel further advances.
As the pace of discovery has quickened, the field has grown enormously, making it more difficult for sci-
entists to keep abreast of new developments. To help facilitate communication in the field, a biennial CSHL
conference series on Axon Guidance and Developmental Plasticity of the Nervous System was initiated in
1998. This year, the fourth of these meetings involved sessions devoted to particular problems in the assem-
bly of the nervous system, with speakers chosen from among the participants submitting abstracts by ses-
sion chairs who are leaders in the field. Other abstracts were presented as posters.
As for the first three meetings, the response of the field to this conference was one of overwhelming
enthusiasm. Of the 422 registrants, 288 submitted abstracts; 62 abstracts were selected for talks, in eight
sessions. Senior researchers, starting assistant professors, postdoctoral fellows, and graduate students
were well represented as speakers and participants. All of the major areas of research in the field were cov-
ered, as were all of the major approaches (cellular, physiological, anatomical, biochemical, and genetic). In
addition, there were two keynote addresses: Dr. Joe LeDoux (New York University) focused on neural plas-
ticity and the basis of emotional behavior, and Dr. Atsushi Miyawaki (RIKEN) focused on the use of fluores-
cent reporter technologies for measuring intracellular signaling events with high spatial and temporal preci-
sion. The meeting provided an important clearinghouse for ideas and approaches and helped scientists in
the field get the most up-to-date information, as well as enabling them to meet, to network, and to establish
collaborations. Based on the uniformly enthusiastic comments of the participants, the intensity of the oral and
poster sessions, and the large crowds that stayed up late every night at the bar to discuss science, the meet-
ing was a great success.
This meeting was funded in part by the National Institute of Neurological Disorders and Stroke, a branch
of the National Institutes of Health.
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PROGRAM
Axon Guidance: Molecules
Chairpersons:L. Zipursky, HHMI/University of California, Los
Angeles; C. Holt, University of Cambridge, United Kingdom
Synaptic Plasticity, Arborization, and Circuits
Chairpersons: L. Katz, HHMI/Duke University Medical Center,
Durham, North Carolina; T. Hensch, RIKEN Brain Science
Institute, Saitama, Japan
Special Lecture: Emotional Synapses
J. LeDoux, New York University
Regeneration and Remodeling
Chairpersons:S. Strittmatter, Yale University New Haven,
Connecticut; 0. Hobert, Columbia University College of
Physicians & Surgeons, New York
Cellular and Molecular Maps
Chairpersons:D. O'Leary, Salk Institute, La Jolla, California; C.
Mason, Columbia University New York
Cell Biology
Chairpersons:K. Svoboda, HHMI/Cold Spring Harbor
Laboratory; A. Ghosh, University of California, San Diego
Synapse Formation
Chairpersons: J. Lichtman, Washington University St. Louis,
Missouri; G. Turrigiano, Brandeis University Waltham,
Massachusetts
Special Lecture
A. Miyawaki, RIKEN Brain Science Institute
Dendrites and Diversity
Chairpersons:H. Cline, Cold Spring Harbor Laboratory; T.
Bonhoeffer, Max-Planck Institute for Neurobiology
Martinsried, Germany
Signaling
Chairperson: F. Gertler, Massachusetts Institute of Technology
Cambridge
T. Hensch, K. Svoboda
F Rathjen, E. Stoeckli
G. Little, A. Rinker, S. Miller, J. Dolan
K. Brose, J. Huang
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CSHL/WELLCOME TRUST CONFERENCE
Genome Informatics
September 22-26 285 participants
ARRANGED BY Ewan Birney, European Bioinformatics Institute
Suzanna Lewis, University of California, Berkeley
Lincoln Stein, Cold Spring Harbor Laboratory
This third conference on Genome Informatics focused on large-scale genome annotation and utilization. The
rationale behind organizing a joint conference in Europe derives from the increasingly competitive academic
conference market, with many institutions in the United States and Europe openly planning to emulate the suc-
cess of the CSHL meetings model. The conference was held at the Hinxton Hall Conference Centre, located
several miles south of Cambridge in the United Kingdom, which forms part of the Wellcome Trust Genome
Campus, together with the Sanger Centre, the European Bioinformatics Institute, and the HGMP-MRC
Resource Centre. The conference followed a format similar to traditional CSHL meetings, in that the majority of
oral presentations were drawn from openly submitted abstracts.
The explosion of biological data requires a concomitant increase in the scale and sophistication of information
technology, ranging from the storage of data and their associated data models, to the design of effective algo-
rithms to uncover nonobvious aspects of these datasets, to ontologies to concisely describe biological informa-
tion, and finally to software systems to support curation, visualization, and exploration. The conference brought
together some of the leading scientists in this growing field, and researchers from other large-scale information
handling disciplines were also invited to attend. Meeting sessions included comparative genomics, genome-wide
analyses, genome databases, and genomic pipe lines.
PROGRAM
Large-scale Genomics I
Chairpersons: M. van Baren, Washington University St. Louis,
Missouri; S. Searle, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Genome Databases
Chairperson: C.J. Bult, Jackson Laboratory Bar Harbor, Maine
Comparative Genomics
Chairperson: E. Sonnhammer, Karolinska Institutet,
Stockholm, Sweden
Transcription and RNA Analysis
Chairperson: A. Krogh, University of Copenhagen, Denmark
Interactions and Networks
Chairperson: P. Carninci, RIKEN Genomic Science Laboratory
Wako, Japan
Functional Annotation and Proteomics
Chairpersons: J. Swedlow, University of Dundee, United
Kingdom; A. Pandey, Johns Hopkins University Baltimore,
Maryland
Large-scale Genomics II
Chairpersons: M. van Baren, Washington University St. Louis,
Missouri; S. Searle, Wellcome Trust Sanger Institute,
Hinxton, United Kingdom
Keynote Address
M. Scott, Stanford University School of Medicine
Genomic Pipelines
Chairperson: D. Rokhsar, Joint Genome Institute, Walnut
Creek, California
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Dynamic Organization of Nuclear Function
September 29-October 3 254 participants
ARRANGED BY Wendy Bickmore, MRC Human Genetics Unit
Michael P. Rout, The Rockefeller University
David Spector, Cold Spring Harbor Laboratory
This meeting focused on the relationships between nuclear structure and function. The opening session high-
lighted defects in nuclear structure that occur in human disease, from both the perspective of nuclear pro-
teins and DNA sequence. Mutations in lamin A are found in an increasing number of diseases (laminopathies).
C. Stewart, B. Burke, and J. Lammerding showed that lamin A mutations weaken the mechanical strength
of the nucleus and affect signaling and gene expression. Compelling evidence for a connection between the
cytoskeleton and the nucleus was presented. Most intruigingly, the lamin-A mutations found in a form of
progeria were suggested to profoundly alter chromatin structure (R. Goldman) and the nuclear abnormalities
in these cells could be reverted through modulating splic-
ing of lamin-A mRNA (P. Scaffidi). The roles of D4Z4
repeats, the FRG1P protein, and nuclear organization in
another form of muscular dystrophy (FSHD) remain an
enigma (S. van Koningsbruggen and J. Lawrence).
The session on chromosomes and the cell cycle illus-
trated the power of conditional mutagenesis, and RNAi,
in dissecting the function of proteins involved in chromo-
some segregation (W. Earnshaw, T. Fukagawa, M.
Mazumdar). Complementing this, W. Earnshaw (using
mass spectrometry) and H. Funabiki (using an expres-
sion screen in Xenopus), both identified a novel chromo-
some passenger protein (Borealin/DasraB) involved in
kinetochore-microtubule interactions and spindle stabili-
ty.
The role of nuclear organization in regulating gene expression is becoming more widely recognized. A cen-
tral theme of the session on chromosomes and gene regulation was the importance of concentrating genes
and proteins at specific sites within the nucleus, to enhance the efficiency of either transcription or gene
silencing. A. Taddei showed how pathways for silencing and perinuclear anchoring can be dissected in yeast
and revealed the anchoring role of Esc1, an acidic coiled-coil protein of the inner nuclear membrane, which
may be a functional homolog of lamin. Nuclear colocalization of loci from the Antennapedia and bithorax
complexes at concentrations of polycomb protein were shown in Drosophila nuclei (G. Cavalli). On the other
hand, C. Osborne presented evidence to suggest that transcriptionally active genes colocalize in the nucle-
us, at concentrations of RNA polymerase II (transcription factories). W. Bickmore used a biophysical
approach to suggest that changes in the structure of the basic 30-nm chromatin fiber affect chromatin con-
densation in the nucleus and the subnuclear location of loci relative to chromosome territories. The nuclear
organization of chromatin proteins and transcription factors, relative to heterochromatin and other nuclear
structures, was also described (W. de Laat, J. Mateos-Langerak, F. Schaufele).
The session on RNA processing and dynamics touched on a variety of RNA species and processing
steps. Two talks examined the dynamics of a population of nuclear poly(A). RNA that is not nascent and is
found in nuclear speckles. Using different approaches, one study showed that this RNA population is highly
dynamic and exchanges with the nucleoplasmic pool in an ATP-independent manner (J. Ritland-Politz),
whereas the second study indicated that 50% of the mRNA present in speckles is immobile (U. Schmidt). An
examination of the rate of transcription in living cells indicated that RNA synthesis occurs at an average rate
of 1.5 kb/min; however, the rate varied along the template (X. Darzacq). A study examining the entry of pre-
mRNA processing factors into daughter nuclei after mitosis showed that hypophosphorylated SR proteins
were transiently associated with the periphery of nucleolar organizing regions; the duration of this interaction
W. Bickmore, D. Spector, M. Rout
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could be extended by inhibiting the synthesis of pre-mRNA transcripts (PA. Bubulya). snoRNAs form a series
of distinct RNP complexes that are involved in different RNA-processing events. U.T. Meier examined the
assembly of such complexes and found that NAP57 and NOP10 provide an initial platform for subsequent
RNP assembly.
For many years, the mechanism of the nucleocytoplasmic exchange of macromolecules has been mys-
terious. Recent advances in our understanding of the nuclear pore complex (NPC)-mediated transport
process were introduced by S. Wente, who then described work in which strains carrying various deletions
in the NPC-associated karyopherin docking sites were assessed for their ability to support various types of
nucleocytoplasmic transport. Her data favor a model in which diffusion-restricted passage across the NPC
is catalyzed by the binding of karyopherins to specific docking sites. The structure of the NPC has alsobeen
investigated using cryo-electron tomography techniques on isolated, transport-competent nuclei (0.
Medalia). New details of the NPC's structure were revealed, which agreed well with a map of the NPC gen-
erated by synthesizing various biochemical and structural data (M. Rout). L. Gerace used an ingenious assay
to investigate how proteins are targeted to the inner nuclear membrane and proposed as a result that this
process is diffusion-mediated and energy-dependent. Connections between the processes of nuclear trans-
port and nuclear assembly were introduced by D. Forbes, who described how one karyopherin, importin-f3,
behaved as an inhibitor of the first stages of nuclear reassembly after mitosis. The protein Pom121 was
shown to be crucial to this assembly process (W. Antonin), and titin (a huge protein associated with muscle)
was shown to be important for the structure of nuclear envelopes in Caenorhabditis elegans (M. Zastrow).
Indeed, C. Brown indicated that the general organization of the nuclear periphery is crucial for the correct
expression of genes, as genes in Saccharomyces can dynamically localize closer to the NPC upon their acti-
vation.
mRNA can only be translated if it leaves the nucleus. K. Prasanth described a noncoding RNA that is
retained in the nucleus and that localizes to paraspeckles. Most intriguingly, this RNA is A-to-I edited, and it
was suggested that this functions to retain this RNA in the nucleus. Normal mRNAs are exported from the
nucleus as mRNP particles. Exciting evidence was presented that, in yeast, MLP proteins attached to the
nuclear pore act to check the quality of mRNPs for nuclear export (F. Stutz, M. Fasken). Other unexpected
connections were made between the nuclear pore and DNA repair (V. Doye).
There was significant progress on understanding the structure, composition, and function of nuclear bod-
ies. J. Gall described the unexpected finding that Cajal bodies, in the germinal vesicle of Xenopus, contain
acetylated histone H4. He also showed that in Drosophila Cajal bodies localize at histone genes, as has been
shown in mammalian cells. Developing this theme, G. Matera showed that mammalian Cajal bodies localize
to a BAC transgene that contains inducible U2 snRNA genes and that this interaction is dependent on RNA.
Cajal bodies are known to be involved in the biogenesis of snRNAs and snoRNAs. M. Terns presented evi-
dence that they may also be involved in the biogenesis of telomerase RNA. The function of PML bodies
remain somewhat of an enigma. H. de The gave insight into the complexity of PML function by explaining
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the different functions attributed to these bodies and the subnuclear localization of PML protein isoforms.
Progress in understanding nuclear structure and function has depended on the development of new tech-
nologies and experimental approaches. The session on emerging technologies promises even more to come.
D. Bazzett Jones showed how energy-filtered transmission electron microscopy can be used to investigate
the distribution of proteins and nucleic acid at PML bodies. The resolution limit of the light microscope is also
being improved. J. Sedat presented provocative new data on the structure of metaphase chromosomes
using method-saturated structured illumination microscopy. C. Cremer presented examples of applications
using 4Pi-, spatially modulated illumination, and spectral precision distance microscopy. Finally, proteomics
is having an important role in defining not only the components of nuclear bodies, but also their dynamic
behavior. A. Lamond showed how heavy isotope labeling combined with mass spectrometry can elucidate
changes in nucleolar composition in response to metabolic stimuli and the cell cycle
Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations provided support for this meeting.
PROGRAM
Nuclear Structure and Disease
Chairperson: C.L. Stewart, National Cancer Institute,
Frederick, Maryland
Chromosomes and the Cell Cycle
Chairperson: W.C. Earnshaw, Wellcome Trust Centre for Cell
Biology Edinburgh, United Kingdom
Emerging Technologies to Assess Nuclear Function
Chairperson: J. Sedat, University of California, San Francisco
The Nuclear Periphery
Chairperson: S.R. Wente, Vanderbilt University Medical
Center, Nashville, Tennessee
RNA Processing and Dynamics
Chairperson: T. Pederson, University of Massachusetts
Medical School, Worcester
Chromosome Organization and Gene Regulation
Chairperson: A.G. Fisher, Medical Research Council, London,
United Kingdom
Transcription and mRNA Export
Chairperson: W. Bickmore, MRC Human Genetics Unit,
Edinburgh, United Kingdom
Nuclear Bodies
Chairperson:H. de The, CNRS HOpital St. Louis, Paris,
France
I. Uings, S. Hauschka
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Molecular Genetics of Aging
October 6-10 224 participants
ARRANGED BY Ronald DePinho, Dana Farber Cancer Institute
Leonard Guarente, Massachusetts Institute of Technology
Linda Partridge, University College London
Aging is a process that leads to many degenerative changes and death. Recently, specific processes close-
ly associated with aging, as well as genes that may regulate aging have been identified. This meeting focused
on these advances and provided a forum for discussion of many theories-old and new. Two regulators of
aging were featured in several sessions, one involving signaling pathways by insulin-like molecules, and the
other a novel class of NAD-dependent deacetylases, called SIR2 proteins. Altering these pathways was
shown to extend lifespan in yeast, Caenorhabditis elegans, Drosophila, and mice. A session was also dedi-
cated to stem cell biology and transcription profiling of aging cells. Two other sessions related to telomere
biology and cellular senescence. Premature aging syndromes and diseases of aging were also featured.
Finally, recent findings relating aging to metabolism and oxidative stress closed the conference. It was clear
that very rapid progress is being made to understand aging and its regulation at a molecular level.
This meeting was funded in part by the National Institute on Aging, a branch of the National Institutes of
Health. Contributions from our Corporate Benefactors, Corporate Sponsors, Plant Corporate Associates,
Corporate Affiliates, Corporate Contributors, and Foundations also provided support for this conference.
J. Tower, C. Kenyon, L. Partridge
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PROGRAM
Model Systems I
Chairpersons: G. Ruvkun, Massachusetts General Hospital,
Boston; S. Helfand, University of Connecticut Health Center;
Farmington
Stem Cells and Genomics
Chairpersons: S.K. Kim, Stanford University Medical Center,
California; R. McKay, National Institutes of Health/NINDS,
Bethesda, Maryland
Cancer Teleomeres, Etc.
Chairpersons: V. Lundblad, Baylor College of Medicine,
Houston, Texas; J. Hoeijmakers, Erasmus University
Rotterdam, The Netherlands
Cell Senescence
Chairpersons: J. Campisi, Lawrence Berkeley National
Laboratory California; S. Korsmeyer, Dana-Farber Cancer
Institute, Harvard Medical School, Boston, Massachusetts
Model Systems II
Chairpersons: L. Partridge, University College London, United
Kingdom; C. Kenyon, University of California, San Francisco
Mice Altered Aging
Chairpersons: A. Bartke, Southern Illinois University School of
Medicine, Springfield; R. Weindruch, University of Wisconsin,
Madison
Mouse Models Disease
Chairpersons: D. Price, Johns Hopkins University Baltimore,
Maryland; B. Spiegelman, Dana-Farber Cancer Institute,
Boston, Massachusetts
Biochemistry and Pharmacology
Chairpersons: A. Richardson, University of Texas Health
Science Center, San Antonio; D.A. Sinclair, Harvard Medical
School, Boston, Massachusetts
M. Zhang, A. Samuelson, G. Ruvkun
D. Smith, T. Sasaki
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Germ Cells
October 13-17 227 participants
ARRANGED BY Blanche Capel, Duke University Medical Center
Judith Kimble, HHMI/University of Wisconsin
Germ cells are the only cells in the body with the potential for immortality. During the past few years, we have
learned that many of the fundamental molecular mechanisms required for establishment and function of germ
cells have been conserved during evolution. This meeting was organized with the goal of bringing together
researchers who study germ-line development in many organisms, including humans, mice, nematodes, and
flies. The big questions addressed were: How are germ-line stem cells specified? How are germ cells regulated
to continue in the mitotic cell cycle or transition to the meiotic cell cycle? Do germ cells differ from embryonic stem
cells? An important and far-reaching concern was the importance of regulation at the level of DNA and chromatin,
as well as regulation at the level of RNA and translation. Both DNA and RNA controls have profound and specif-
ic effects on germ-line development. The analyses of these controls in germ cells have led to the discovery of
conserved regulators that control germ cells throughout the animal kingdom. Given our growing understanding
of molecular mechanisms that control germ-line development and maturation in model organisms, the implica-
tions of these findings for stem cell biology and human reproduction were actively discussed. The next Germ Cells
meeting will be held in the fall of 2006 with Susan Strome and Azim Surani as the coorganizers.
This meeting was funded in part by the National Institute of Child Health and Human Development, a branch
of the National Institutes of Health; the March of Dimes; and the Lalor Foundation.
B. Capel, S. Malki
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PROGRAM
Germ-line Genome and Its Regulation
Chairpersons: M. Fuller, Stanford University School of
Medicine, California; S. Strome, Indiana University,
Bloomington
RNA Regulation of the Germ Line
Chairpersons: R. Braun, University of Washington School of
Medicine, Seattle; E. Goodwin, University of Wisconsin,
Madison
Sexual Dimorphism and Its Control
Chairpersons: S. DiNardo, University of Pennsylvania School
of Medicine, Philadelphia; R. Lovell-Badge, MRC National
Institute of Medical Research, London, United Kingdom
Mitosis vs. Meiosis
Chairpersons: D. Page, HHMI/Massachusetts Institute of
Technology Cambridge; A. Villeneuve, Stanford University
School of Medicine, California
Signaling and the Germ Line
Chairpersons: J. Eppig, Jackson Laboratory, Bar Harbor,
Maine; E. Matunis, Johns Hopkins University Baltimore,
Maryland
Germ Cell Transits and Transitions
Chairpersons: R. Lehmann, Skirball Institute, New York
University School of Medicine; C. Wylie, Children's Hospital
Research Foundation, Cincinnati, Ohio
Stem Cells
Chairpersons: A. McLaren, University of Cambridge, United
Kingdom; H. Scholer, University of Pennsylvania, Kennett
Square
Germ Cell Specification
Chairpersons: G. Seydoux, Johns Hopkins University School
of Medicine, Baltimore, Maryland; A. Surani, Wellcome/CRC
Institute, Cambridge, United Kingdom
A. Toure, P. Burgoyne
T. Sunanaga, K. Kawamura, A. Mahowald, Y. Niki
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Identification of Functional Elements in Mammalian Genomes
November 11-13 239 participants
ARRANGED BY Eric Green, National Human Genome Research Institute/NIH
Webb Miller, Pennsylvania State University
Michael Q. Zhang, Cold Spring Harbor Laboratory
The third CSHL Workshop on Computational Biology focused on Identification of Functional Elements in
Mammalian Genomes and was preceded by a two-day gathering of the ENCODE (Encyclopedia of DNA
Elements) project. This is a public consortium launched by the National Human Genome Research Institute
in 2003, which attracted over 100 participants, aimed eventually at providing a fully annotated reference
sequence of the human genome. The main workshop attracted almost 240 participants and featured the
sessions listed below. Each session began with an introduction by an expert in the field, which provided a
useful overview for seasoned and junior scientists alike, and was ably summarized by Rick Myers.
E. Green, R. Myers, H. Sussman
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PROGRAM
Protein-coding Sequences
Chairperson: E. Birney, European Bioinformatics Institute,
Hinxton, United Kingdom
Elements That Regulate Gene Transcription
Chairperson: M. Green, HHMI/University of Massachusetts
Medical School, Worcester
RNA Transcripts
Chairperson: C. Burge, Massachusetts Institute of
Technology, Cambridge
Other Genomic Functional Elements
Chairperson: A. Feinberg, Johns Hopkins University School of
Medicine, Baltimore, Maryland
Future Horizons
Chairperson: D. Haussler, HHMI/University of California,
Santa Cruz
Meeting Summary
R. Myers, Stanford University Palo Alto, Califomia
J. Ecker, F. Bushman E. Feingold, P. Good
W. Miller, P. Boutros
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Pharmacogenomics
November 18-21 243 participants
ARRANGED BY David Bentley, The Wellcome Trust Sanger Institute
J. Steven Leeder, Children's Mercy Hospital
Munir Pirmohamed, University of Liverpool
Richard M. Weinshilboum, Mayo Medical School
This second annual meeting was a joint project of CSHL and the Wellcome Trust and was funded in part by the
National Institute of General Medical Sciences, a branch of the National Institutes of Health. The primary objec-
tive of the meeting was to stimulate interest from a broadly based constituency representing basic scientists and
clinical investigators from both academic and corporate environments by focusing on diverse issues related to the
application of genomic approaches to investigations of variability in drug response in humans. The meeting
opened with a session presenting pharmacogenomics from the perspectives of the pharma-
ceutical industry and academia, as well as an example of the potential promise of personal-
ized medicine. Major subject areas for the meeting included pharmacogenomics of drug bio-
transformation and transport, cancer pharmacogenomics, cardiopulmonary pharmacoge-
nomics, and neuropsychiatric pharmacogenomics. Presentations highlighting economic and
social issues related to the impact of pharmacogenomics on clinical practice stimulated con-
siderable audience participation, and issues related to special populations, such as children
and ethnic minorities, were addressed in a panel discussion. Perusal of the meeting content,
both oral and poster presentations, revealed a movement of experimental approaches away
from a focus on single-nucleotide polymorphisms in single genes to more broadly based
strategies involving haplotypes of multiple genes and gene pathways.
The meeting was attended by 243 registrants from 18 countries, compared to 140
attendees from 15 countries at the previous meeting. Women represented 35% of atten-
dees, whereas Ph.D. students and postdoctoral fellows constituted 23%. Feedback from the meeting has
been positive and future efforts will directed toward two main goals: (1) increasing representation at the meet-
ing from the genetics and genomics community, and (2) providing more opportunities for trainees and junior
faculty members to present their work in oral platform sessions. This meeting provides an outstanding forum
to explore the impact of genomics on the treatment of human disease to describe the science underlying
pharmacogenomics and to discuss the accompanying benefits and challenges relevant to the implementa-
tion of pharmacogenomics in both drug development and clinical settings.
S. Leeder
268 A. Marianki, S. Koukouritaki
This meeting was funded in part by the National Institutes of General Medical Sciences, a branch of the
National Institutes of Health.
PROGRAM
Opening Session
Chairpersons: R. Weinshilboum, Mayo Medical School,
Rochester, Minnesota; R. Long, National Institutes of
Health/NIGMS, Bethesda, Maryland
Pharmacogenomics of Metabolism and Transport
Chairpersons: K. Giacomini, University of California, San
Francisco; D. Flockhart, Indiana University School of
Medicine, Indianapolis
Cancer Pharmacogenomics
Chairpersons: C.R. Wolf, University of Dundee, United
Kingdom; M. Ratain, University of Chicago, Illinois
Cardiopulmonary Pharmacogenomics
Chairpersons: A. Rane, Karolinska Institutet, Stockholm,
Sweden; J. Johnson, University of Florida, Gainesville
Remarks
J.D. Watson, Cold Spring Harbor Laboratory
Neuropsychiatric Pharmacogenomics
Chairpersons: J.S. Leeder, Children's Mercy Hospital, Kansas
City Missouri; M. Pirmohamed, University of Liverpool,
United Kingdom
Panel Session: Special Populations and
Pharmacogenomics, Future Directions
Chairpersons: A. Breckenridge, Medicines and Healthcare
Products Regulatory Agency London, United Kingdom; D.
Bentley, Wellcome Trust Sanger Institute, Hinxton, United
Kingdom
K. Philips, C. Stephens, C. Ross
A. Daly, A. Alfirevic, J. Foster
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CSHL Winter Biotechnology Conference: Drug Discovery in
Neurodegenerative Diseases
December 2-5 122 participants
ARRANGED BY Sam Gandy, Farber Institute for Neurosciences at Thomas Jefferson University
Virginia M.-Y. Lee, University of Pennsylvania School of Medicine
Marcy MacDonald, Massachusetts General Hospital/Harvard Medical School
As many as one half of people aged 65 years or older will develop debilitating degenerative disease of the
central nervous system, usually characterized by a decade or more of dependent living, accompanied by pro-
gressive failure of cognitive function and/or coordinated movement. Although these illnesses appear most
commonly in the absence of obvious heredibility or identifiable genetic mutations, it has been possible dur-
ing the past 20 years to discover risk-modifying DNA changes in some examples and predictable causative
changes in others. From these findings, transgenic technology
has rapidly led to the development of mouse, fruit fly, and
nematode model systems that partially recapitulate the clinical
abnormalities of the human diseases, as well as some of the
hallmark molecular and morphological pathology of the condi-
tions.
Rational biochemical and cell-based screens have generat-
ed lead compounds that show promise in the living animal
models. Most importantly, the animal models have enabled dis-
covery of entirely unanticipated therapeutic strategies (such as
amyloid-13 immunotherapy). In December 1999, some of these
rationally discovered compounds and unexpected
immunotherapies entered Phase I clinical trials. The progress of
compounds and rational strategies from the animal model to
the human clinical trial; the design, results, and conclusions of
trials; and the return to the animal model with questions raised
during human trials are the areas of particular emphasis for
these biannual Winter Biotechnology Meetings instituted in
December 2000 with the explicit goal of facilitating the transla-
tion of "breakthrough" science into effective medicines.
For the 2004 meeting, seven 3- or 4-hour platform sessions were organized around common technolog-
ical themes. Chairpersons, invited speakers, and speakers selected from submitted abstracts were drawn
from the academic and pharma sectors. Although the discussion of new, unpublished data was emphasized,
the group was tolerant of a wide range of intellectual property conventions. Poster presentations were also
encouraged: Posters were displayed for an extended period during the meeting, and poster viewing was
especially encouraged during the cocktail hours before the evening meals.
Topics included protein aggregation inhibitors, protein processing enzymology and pharmacology,
immunotherapy, design and interpretation of genomic analyses in mammalian and lower systems, bioinfor-
matics, mouse, nematode, and fly models of neurological disease, mechanisms of neurodegeneration, meta-
bolic and hormonal influences on disease protein metabolism in cell culture and living animal models, as well
as in human clinical trials, and the importance of applying high-throughput screening strategies to academic
efforts ("chemical genomics"), as well as its typical use in drug discovery. Diseases considered included
Alzheimer's, Huntington's, spinocerebellar atrophies, ALS, prion diseases, Parkinson's, tauopathies, and
synucleinopathies.
I. Gozes, V.M.-Y. Lee
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PROGRAM
Pharmacology of Proteolysis
Chairpersons: S. Gandy, Thomas Jefferson University
Philadelphia, Pennsylvania; M. MacDonald, Massachusetts
General Hospital. Charlestown
The Way Forward: NIH Roadmap and Innovative HTS
Strategies
Chairperson: V. Man-Yee Lee, University of Pennsylvania,
Philadelphia
Intracellular Aggregation I
Chairperson: M. MacDonald, Massachusetts General
Hospital, Charlestown
Intracellular Aggregation II
Chairperson: V Man-Yee Lee, University of Pennsylvania,
Philadelphia
Intracellular Aggregation III
Chairperson: M. MacDonald, Massachusetts General Hospital,
Charlestown
Extracellular Aggregates I
Chairperson: S. Gandy, Thomas Jefferson University
Philadelphia, Pennsylvania
Extracellular Aggregates II
Chairperson: S. Gandy, Thomas Jefferson University
Philadelphia, Pennsylvania
Intracellular Aggregation IV
Chairpersons: M. MacDonald, Massachusetts General
Hospital, Charlestown; V Man-Yee Lee, University of
Pennsylvania, Philadelphia
M. Sekuma, C. Mizumarau, T. Suzuki, K. lijima-Ando
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Plant Genomes: From Sequence to Phenome
December 9-12 115 participants
ARRANGED BY Gloria Coruzzi, New York University
Michael Snyder, Yale University
Susan Mc Couch, Cornell University
This meeting featured 37 talks in 6 sessions, a poster session, and a workshop on Resources and New
Technology. The theme was to bring plant genomics to the next level beyond sequencing, to discover gene
function through phenomic approaches. A new organizational feature of the plant genome meeting was to
stimulate cross-talk between plant genomics and
genomics in other model organisms. To accomplish this,
genome speakers from nonplant organisms were invited to
speak in each session including yeast, Caenorhabditis ele-
gans, and Chlamydomonas. Two keynote speakers
opened the meeting: Claire Fraser (President of The
Institute for Genomic Research) surveyed the exponential
growth of sequence information from the more than 1200
genome sequencing projects under way, noting that novel,
strain-specific genes were still being discovered with every
new organism to be sequenced. She noted that the main
limitation to linking sequence with phenotype had to do
with deficiencies in annotation and in understanding the
role of genes with products of unknown function. Joe
Ecker presented life's complexity pyramid and outlined the
effort to identify and name all the "parts" and to under-
stand how they all work together in the context of a whole,
living organism. The talks were selected from abstracts
and covered progress in sessions on regulatory networks S. Mc Couch, Z. Lippman
and gene expression, proteomics, phenomics, genome organization and evolution, new genomes and ele-
ments, and genomics approaches to small molecules. Speakers looked at cell-to-cell communication in the
apical meristems of shoots and roots, at regulatory pathways and protein interaction networks in yeast, at
clusters of genes associated with specific phenotypes in worms (phenoclusters), at MADS box genes and
their relationship to petal formation, and at proteins that are required to make flagellar basal bodies in
Chlamydomonas and their relationship to human disease.
Others presented strategies for characterizing the pro-
teome, for classifying promoters, for sequencing the
maize genome, for conducting array-based genotyping,
and for exploring the evolution of new cell types. There
was the announcement of the new JGI effort to sequence
Selaginella, an early, non-seed-bearing land plant that has
no true leaves and represents a key node in plant evolu-
tion. Speakers provided insights into the abundance and
function of small RNAs in plants, into systems for virus-
induced gene silencing, and into endomembrane traffick-
ing. The final keynote address by Marc Johnston offered
a view of what is known about protein-protein interactions
in Saccharomyces cerevisiae, with the goal of "complet-
ing yeast as an organism by 2007." The genomics work-
shop highlighted areas of plant genomics that are neces-
sary for the plant community to "catch up" with the
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R. Martienssen, M. Snyder
genomic resources in yeast and C. elegans, including ORFeome, proteomics, and DNA-protein interac-
tions. This wish list was inspired by the ideas that had been exchanged at this small but provocative con-
ference.
PROGRAM
Keynote Addresses
C. Fraser, The Institute for Genomic Research, Bethesda,
Maryland; J. Ecker, The Salk Institute for Biological Studies,
La Jolla, California
Regulatory Networks and Gene Expression
Chairperson: E. Meyerowitz, California Institute of Technology,
Pasadena
Proteomics
Chairperson: B. Chait, The Rockefeller University New York
Phenomics
Chairperson: C. Boone, University of Toronto, Canada
Genome Organization and Evolution
Chairperson: S. Dutcher, Washington University St. Louis,
Missouri
New Genomes and Elements
Chairperson: D. Weigel, Max-Planck Institute for
Developmental Biology Tubingen, Germany
Workshop: Resources and New Technology
Chairpersons: J. Ecker, Salk Institute for Biological Studies,
La Jolla, California; D. Preuss, University of Chicago,
Illinois; M. Snyder, Yale University New Haven, Connecticut
Keynote Speaker
Chairperson: M. Johnston, Washington University School of
Medicine, St. Louis, Missouri
Genomics Approaches to Small Molecules
Chairperson: N. Raikhel, University of California, Riverside
G. Coruzzi, R. Flavell
Q. Dong, S. Gopalan
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POSTGRADUATE COURSES
The Postgraduate Courses program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects that are either so new or so specialized that universities
do not adequately treat them. Our aim is to provide intensive study in the most recent developments
and techniques in these subjects and to prepare students to enter directly into research in a particular
area. To ensure up-to-date coverage of current research work, we bring together course faculty from
many laboratories around the world and supplement this staff with a series of seminar speakers.
Protein Purification and Characterization
April 14-27
INSTRUCTORS
ASSISTANTS
R. Burgess, University of Wisconsin, Madison
A. Courey, University of California, Los Angeles
S.-H. Lin, M.D. Anderson Cancer Center/University of Texas, Houston
K. Severinov, Waksman Institute, Rutgers University, Piscataway, New Jersey
K. Adelman, Cornell University, Ithaca, New York
V. Bergendahi, University of Wisconsin, Madison
H. Duong, University of California, Los Angeles
N. Thompson, University of Wisconsin, Madison
0. Tsai, M.D. Anderson Cancer Center/University of Texas,
Houston
W.-W. Tsai, M.D. Anderson Cancer Center/University of
Texas, Houston
C. Winkler, University of California, Los Angeles
N. Zenkin, Rutgers University, New Brunswick, New Jersey
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This course was for scientists who were not familiar with techniques of protein isolation and charac-
terization. It was a rigorous program that included laboratory work all day and a lecture with a discus-
sion session every evening. Each student became familiar with each of the major techniques in protein
purification by actually performing four separate isolations, including (1) a regulatory protein from mus-
cle tissue, (2) a sequence-specific DNA-binding protein, (3) a recombinant protein overexpressed in E.
coli, and (4) a membrane-bound receptor. A variety of bulk fractionation, electrophoretic, and chro-
matographic techniques included precipitation by salts, pH, and ionic polymers; ion-exchange, gel fil-
tration, hydrophobic interaction, and reversed-phase chromatography; lectin affinity, ligand affinity,
oligonucleotide affinity, and immunoaffinity chromatography; polyacrylamide gel electrophoresis and
electroblotting; and high-performance liquid chromatography. Procedures were presented for solubiliz-
ing proteins from inclusion bodies and refolding them into active monomeric forms. Methods of protein
characterization were utilized to include immunological and biochemical assays, peptide mapping,
amino acid analysis, protein sequencing, and mass spectrometry. Emphasis was placed on strategies
of protein purification and characterization. Guest lecturers discussed protein structure, modification of
proteins, methodologies for protein purification and characterization, and applications of protein bio-
chemistry to cell and molecular biology. This course was supported with funds provided by the National
Cancer Institute.
PARTICIPANTS
Chandra, D., Ph.D., M.D. Anderson Cancer Center/University
of Texas, Smithville
Conlon, F, Ph.D., University of North Carolina, Chapel Hill
Demirel, M., Ph.D., Penn State University, University Park
El ling, A., B.S., Iowa State University, Ames
Feldman, M., B.S., Tel-Aviv University, Israel
Gibson, K., Ph.D., Massachusetts Institute of Technology,
Cambridge
Govindarajan, V., Ph.D., Baylor College of Medicine, Houston,
Texas
Kettunen, P, Ph.D., University of Bergen, Norway
SEMINARS
Bergendahl, V, University of Wisconsin, Madison: Use of
LRET-based assays for drug discovery and biochemistry;
RNA polymerase-sigma factor interactions.
Burgess, R., University of Wisconsin, Madison: Introduction to
protein purification and immunoaffinity chromatography.
Courey, A., University of California, Los Angeles: Sumoylation
and the response to stress.
Hart, G., Johns Hopkins University, Baltimore, Maryland:
Protein glycosylation: The most ubiquitous posttranslational
event in eukaryotes.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Protein crys-
tallography intro-The PAZ domain of Argonaute-2: siRNA
at RISC.
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Lipardi, C., Ph.D., National Institutes of Health/NCI, Bethesda,
Maryland
Makarevitch, I., M.S., University of Minnesota, St. Paul
Marcand, S., Ph.D., CEA/Saclay, Gif-sur-Yvette, France
Norville, J., B.S., Massachusetts Institute of Technology,
Cambridge
Phan, A.T., Ph.D., Memorial Sloan-Kettering Cancer Center,
New York
Sformo, T, M.S., University of Alaska, Fairbanks
Tavanez, J., B.S., Hospital Santa Maria, Lisbon, Portugal
Tudor, H., Ph.D., Hospital for Special Surgery, New York
Lin, S.-H., M.D. Anderson Cancer Center, Houston, Texas:
Novel approach to understanding prostate cancer bone
metastasis.
Mische, S., Boehringer-lngelheim, Ridgefield, Connecticut:
Protein purification and characterization for drug discovery.
Muir, T, The Rockefeller University, New York: Cutting and
pasting proteins: What's happening with inteins.
Severinov, K., Rutgers University, New Brunswick, New
Jersey: Role of RNA polymerase core enzyme in transcrip-
tion initiation.
Stillman, B., Cold Spring Harbor Laboratory: The origin recog-
nition complex and the chromosome inheritance cycle.
Cell and Developmental Biology of Xenopus
April 16-27
INSTRUCTORS K. Cho, University of California, Irvine
J. Christian, Oregon Health and Science University, Portland
ASSISTANTS I. Blitz, University of California, Irvine
G. Dalgin, Oregon Health and Science University, Portland
D. Goldman, Oregon Health and Science University, Portland
T. Nakayama, University of Virginia, Charlottesville
The frog Xenopus is an important vertebrate model for studies of maternal factors, regulation and mol-
ecular mechanisms of tissue inductions, and regulation of cell fate decisions. In addition, Xenopus
oocytes and embryos provide a powerful system in which to conduct a number of cell biological and
gene regulation assays. This course provided extensive laboratory exposure to the biology, manipula-
tion, and use of oocytes and embryos of Xenopus. The course consisted of intensive laboratory ses-
sions, supplemented by daily lectures and demonstrations from experts in cellular, experimental, and
molecular development. Areas covered included (1) care of adults; (2) oocyte isolation and embryo pro-
duction; (3) stages of embryonic development and anatomy; (4) whole-mount in situ hybridization and
immunocytochemistry; (5) microinjection of eggs and oocytes with lineage tracers, DNA constructs,
mRNA, and antisense oligonucleotides; (6) micromanipulation of embryos, including explant and trans-
plantation assays; (7) in vivo time-lapse confocal imaging; (8) preparation of transgenic embryos; and
(9) use of Xenopus tropicar/s for genetic analyses. This course was suited both for investigators who
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have had no experience with Xenopus and for those who have worked with Xenopus and wish to learn
new and cutting-edge techniques. All applicants had current training in molecular biology and some
knowledge of developmental biology. Guest lecturers included Amaya Enrique, Ken Cho, John Gurdon,
Janet Heasman, Ray Keller, and Mark Mercola.
PARTICIPANTS
Boulware, M., Ph.D., University of Minnesota, Minneapolis
Burns, M., Ph.D., University of Virginia, Charlottesville
Chen, Y., Ph.D., Medical University of South Carolina,
Charleston
Handrigan, G., B.S., Dalhousie University, Halifax, Nova
Scotia, Canada
Heine, D., M.S., University of Aberdeen, Scotland, United
Kingdom
Islam, A., M.Phil., Tottori University, Yonago, Japan
Kieckens, L., B.S., Katholieke Universiteit Leuven, Belgium
Marinescu, V., Ph.D., Children's Hospital Boston,
Massachusetts
SEMINARS
Amaya, E., University of Cambridge, United Kingdom:
Functional genomics in Xenopus.
Cho, K., University of California, Irvine: Genomic approach to
studying BMP signaling.
Gurdon, J., Wellcome Trust, Cambridge, United Kingdom:
Nuclear reprogramming.
Heasman, J., Children's Hospital Medical Center, Cincinnati,
Ohio: Antisense technology to study maternal gene products.
Keller, R., University of Virginia, Charlottesville: The cell move-
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Nichane, M., M.S., Free University of Brussels, Belgium
Ny, A., Ph.D., Katholieke Universiteit Leuven, Belgium
Parker, B., M.S., Edison Biotechnology Institute/Ohio
University, Athens
Rangarajan, J., M.S., National Institutes of Health, Bethesda,
Maryland
Rouhana, L., Ph.D., University of Wisconsin, Madison
Vanamala, S., M.V.S., Institut de Recherches Cliniques de
Montreal, Quebec, Canada
Wang, B., Ph.D., Weill Medical College of Cornell University,
New York
Ware, S., Ph.D., Baylor College of Medicine, Houston, Texas
ments, patterning, and biomechanical gastrulation in
amphibians.
Mead, P. St. Jude Children's Research Hospital, Memphis,
Tennessee: Insertional mutagenesis using transposons.
Mercola, M., Burnham Institute, San Diego, California: Heart
induction.
Niehrs, C., Deutsches Krebsforschungszentrum, Heidelberg,
Germany: Large-scale analysis of embryonic gene expres-
sion in Xenopus.
Genetics of Complex Human Diseases
June 9-15
INSTRUCTORS A. Al-Chalabi, FRCP, Institute of Psychiatry, Kings College, London, United Kingdom
L. Almasy, Southwest Foundation for Biomedical Research, San Antonio, Texas
Complex diseases are conditions that are influenced by the actions of multiple genes, their interactions
with each other and with the environment. This lecture course considered the difficulties in studying the
genetic basis of complex disorders such as diabetes, cardiovascular disease, cancer, Alzheimer's dis-
ease, schizophrenia, and epilepsy. We discussed genetic-epidemiologic study designs, including fam-
ily, twin, case/control, and adoption studies, as well as methods for quantifying the strength of the
genetic influences on a disease. A major focus was the identification of specific gene effects using both
linkage and association analyses and their variants. We discussed the efficiency and robustness of dif-
ferent designs for such analysis and how evidence from epidemiologic studies informs both the design
and interpretation of molecular genetic studies. Study design and methods for analysis of quantitative
risk factors related to complex diseases were covered, as well as the latest ideas in data reduction such
as haplotype mapping and SNP tagging. An overview of high-throughput laboratory methods was
given to provide participants with insight into the applications of these techniques. Illustrations were
provided through discussion of results from ongoing studies of a variety complex diseases and related
risk factors.
279
PARTICIPANTS
Barreto, M., B.S., Instituto Gulbenkian de Ciencia, Oeiras,
Portugal
Body, S., M.D., Brigham & Women's Hospital, Boston,
Massachusetts
Buervenich, S., Ph.D., National Institutes of Mental Health,
Bethesda, Maryland
Clarimon, J., Ph.D., National Institutes of Health, Rockville,
Maryland
Congdon, E., M.A., Stony Brook University, New York
Davuluri, R., Ph.D., Ohio State University, Columbus
De Jager, P., Ph.D., Harvard Medical School, Boston,
Massachusetts
Duga, S., B.S., University of Milan, Italy
Ferguson, B., Ph.D., Oregon National Primate Research
Center, Beaverton
He, Q., B.S., Michigan State University, East Lansing
SEMINARS
Al-Chalabi, A., Institute of Psychiatry, Kings College, London,
United Kingdom: An introduction to genetic linkage.
Almasy, L., Southwest Foundation for Biomedical Research,
San Antonio, Texas: An introduction to variance compo-
nents.
Altshuler, D., Massachusetts General Hospital, Harvard
Medical School, Boston: The International Hap Map Project.
Blangero, J., Southwest Foundation for Biomedical
Research, San Antonio, Texas: From QTL to gene.
Borecki, I., Washington University School of Medicine, St.
Louis, Missouri: Study designs.
Edenberg, H., Indiana University, Indianapolis: High-through-
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Morley, M., M.S., Children's Hospital of Philadelphia,
Pennsylvania
Rasmussen, E., Ph.D., Roche Pharmaceuticals, Nutley, New
Jersey
Rosen, M., M.D., University of California, San Francisco
Schlesinger, D., M.D., University of Sao Paulo, Brazil
Simen, A., Ph.D., Yale University, New Haven, Connecticut
Stambolian, D., Ph.D., University of Pennsylvania,
Philadelphia
Traynor, B., M.D., Massachusetts General Hospital,
Charlestown
Tukel, T., Ph.D., Mt. Sinai School of Medicine, New York
Viel, K., B.S., Emory University, Atlanta, Georgia
Wanke, K., Ph.D., National Cancer Institute, Bethesda,
Maryland
put laboratory methods.
Goldstein, D., University College London, United Kingdom:
Data reduction, SNP tagging, and pharmacogenomics.
Knight, J., Institute of Psychiatry, London, United Kingdom:
Association studies; TDT-based methods.
Krainer, A., Cold Spring Harbor Laboratory: Genetic mecha-
nisms in complex diseases.
Merikangas, K., National Institute of Mental Health, Bethesda,
Maryland: Genetic epidemiological approaches to complex
disorders.
Ottman, R., Columbia University School of Public Health,
New York: An introduction to complex genetics.
Advanced Bacterial Genetics
June 9-29
INSTRUCTORS K. Hughes, University of Washington, Seattle
U. Jena!, University of Basel, Switzerland
K. Pogliano, University of California, San Diego, La Jolla
ASSISTANTS D. Broder, University of California, San Diego, La Jolla
B. Christen, University of Basel, Switzerland
C. Wozniak, University of Washington, Seattle
The course presented logic and methods used in the genetic dissection of complex biological process-
es in eubacteria. Laboratory methods included classical mutagenesis using transposons, mutator
strains, and chemical and physical mutagens; the mapping of mutations using genetic and physical
techniques; modern approaches to the generation and analysis of targeted gene disruptions and
fusions using PCR and cloning methods; epitope insertion mutagenesis; and site-directed mutagene-
sis. Key components of the course were use of sophisticated genetic methods in the analysis of model
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eubacteria and the use of the wealth of new genomic sequence information to motivate these meth-
ods. Invited lecturers presented various genetic approaches to study eubacterial mechanisms of
metabolism, development, and pathogenesis. This course was supported with funds provided by the
National Science Foundation.
PARTICIPANTS
Black, S., B.S., University of Aberdeen, United Kingdom
Bjornsdottir, S., B.S., University of Iceland, Reykjavik
Chevance, F., Ph.D., University of Konstanz, Germany
Colangeli, R., Ph.D., University of Medical & Dentistry of New
Jersey, Newark
Drummond, D.A., B.S.E., California Institute of Technology,
Pasadena
Frank, K., B.S., Mayo Clinic, Rochester, Minnesota
Gescher, J., Diplom., University of Freiburg, Germany
Huang, K. C., B.S., Massachusetts Institute of Technology,
Cambridge
SEMINARS
Adhya, S., National Institutes of Health/NCI, Bethesda,
Maryland: Structure, assembly, and dynamics of a gene
regulatory nucleoprotein complex containing a DNA loop.
Brun, Y., Indiana University, Bloomington: Generation and
maintenance of cellular asymmetry in Caulobacter.
Errington, J., University of Oxford, United Kingdom: How
Bacillus subtilis finds the mid-cell site for division and
avoids bisecting its chromosome.
Gross, C., University of San Francisco, California: Sensing
and responding to envelope stress.
Harshey, R., University of Texas, Austin: Surface sensing:
Swarming motility in S. typhimurium.
282
Klausen, M., M.S., Technical University of Denmark
Konjufca, V., Ph.D., Washington University, St. Louis, Missouri
Raffatellu, M., M.D., Texas A&M University, College Station
Schneeweiss, J., B.S., University of Oxford, United Kingdom
Shanks, R., Ph.D., Dartmouth Medical School, Hanover,
New Hampshire
Thompson, K., B.S., National Cancer Institute, Bethesda,
Maryland
Turner, S., Ph.D., University of Auckland, New Zealand
Wolf, D., Ph.D., Lawrence Berkeley National Labs., Berkeley,
California
Maloy, S., San Diego State University, California: Genetic
basis of host specificity in Salmonella.
Nystrom, T, Goteborg University, Sweden: RpoS regulation
in stationary phase.
Otteman, K., University of California, Santa Cruz: Swimming
in the stomach: How chemotaxis helps Helicobacter pylori
infect.
Taylor, R., Dartmouth Medical School, Hanover, New
Hampshire: The role of pill in Vibrio cholerae infection.
Weinstock, G., Baylor College of Medicine, Houston, Texas:
From genetics to genomics.
Ion Channel Physiology
June 9-29
INSTRUCTORS M. Farrant, University College London, United Kingdom
M. Hausser, University College London, United Kingdom
N. Spruston, Northwestern University, Evanston, Illinois
ASSISTANTS B. Clark, University College London, United Kingdom
T. Jarsky, Northwestern University, Chicago, Illinois
B. Steil, University of California, Los Angeles
The primary goal of this course was to investigate, through lectures and laboratory work, the proper-
ties of ion channels that allow neurons to carry out their unique physiological functions in a variety of
neural systems. Areas of particular interest included channels that (1) are activated by neurotransmit-
ter at central and peripheral synapses, (2) are activated by voltage changes in axons and dendrites, (3)
respond to neuromodulators with changes in functional properties, or (4) are developmentally required
and regulated. The research interests of guest lecturers reflected these areas of emphasis.
The laboratory component of the course introduced students to electrophysiological approaches for
the study of ion channels in their native environments. Hands-on exercises included patch-clamp
recording of ion channel activity in acutely isolated or cultured cells or neurons in brain slice prepara-
tions. Different recording configurations were used (e.g., whole-cell, cell-free, and nucleated patches)
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to examine macroscopic or single-channel activity. Similarly, various methods of ligand and drug appli-
cation were demonstrated. The advantages and disadvantages of each method, preparation, and
recording technique were considered in relation to the specific scientific questions being asked.
PARTICIPANTS
Barker, L., BA., University of California, San Francisco
Buonanno, A., Ph.D., National Institutes of Health, Bethesda,
Maryland
Cooke, B., Ph.D., Northwestern University, Evanston, Illinois
Fisher, T., B.S., Wake Forest University, Winston-Salem,
North Carolina
Jocoy, E., B.S., University of California, Los Angeles
Luu, P., Ph.D., University of California, Berkeley
SEMINARS
Bean, B., Harvard Medical School, Boston, Massachusetts:
Channel integration and firing.
Diamond, J., National Institutes of Health, Bethesda,
Maryland: Glutamate EPSCs and uptake.
Fitzsimonds, R., Yale University School of Medicine, New
Haven, Connecticut: Synaptic plasticity during develop-
ment.
Jonas, P., Albert-Ludwigs-Universitat, Freiburg, Germany:
Cortical microcircuits.
Larkum, M., University of Bern, Switzerland: Dendritic inte-
gration.
Llinas, R., New York University School of Medicine, New
York: Ion channels and integration.
Nerbonne, J., Washington University School of Medicine, St.
Louis, Missouri: Voltage-gated K channels in heart and neu-
rons.
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Nair, A., Ph.D., University of Cambridge, United Kingdom
Norris, A., B.A., Washington University, St. Louis, Missouri
Nuriya, M., B.S., Johns Hopkins University, Baltimore,
Maryland
Petreanu, L., Ph.D., Cold Spring Harbor Laboratory
Sandberg, M., Ph.D., Karolinska Institutet, Stockholm,
Sweden
Sarah, P., B.S., University of Bern, Switzerland
Nicoll, R., University of California, San Francisco:
Cannabinoids and synaptic plasticity.
Nusser, Z., Institute of Experimental Medicine, Budapest:
Hyperpolarization-activated cation channels.
Raman, I., Northwestern University, Evanston, Illinois: Action
potental, Hodgkin-Huxley.
Raman, I., Northwestern University, Evanston, Illinois:
Voltage-gated Na channels.
Scanziani, M., University of California, San Diego, La Jolla:
Synaptic plasticity.
Soltesz, I., University of California, Irvine: GABA receptors
and inhibition.
Svoboda, K., Cold Spring Harbor Laboratory: Imaging meth-
ods for studying ion channels.
Takahashi, T, University of Tokyo Graduate School of
Medicine, Japan: Voltage-gated Ca channels.
Molecular Embryology of the Mouse
June 9-29
INSTRUCTORS T. Lufkin, Mt. Sinai School of Medicine, New York
C. Stewart, National Cancer Institute, Frederick, Maryland
ASSISTANTS D. Escalante-Alcalde, Institute of Cellular Physiology-UNAM, Mexico
J. Liu, Mt. Sinai School of Medicine, New York
This intense laboratory and lecture course was designed for biologists interested in applying their
expertise to the study of mouse embryonic development. Laboratory components provided an intro-
duction into the technical aspects of working with and analyzing mouse embryos, and lectures pro-
vided the conceptual basis for contemporary research in mouse development. Experimental tech-
niques covered in the practicals included in vitro culture and manipulation of pre- and postimplantation
embryos; transgenesis by DNA microinjection, embryo transfer, establishment, culture, and genetic
manipulation of embryonic stem cells; production of chimeras by aggregation with and injection of
embryonic stem cells; and the analysis of development by whole-mount in situ hybridization, skeletal
preparation, and transgene expression.
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PARTICIPANTS
Attie, A., Ph.D., University of Wisconsin, Madison
Bennett, V., Ph.D., West Virginia University School of
Medicine, Morgantown
Chal, J., M.S., Stowers Institute for Medical Research,
Kansas City, Missouri
Herrera, E., Ph.D., Columbia University, New York
Jackerott, M., Ph.D., University of Copenhagen, Denmark
Katusic A., B.S., University of Zagreb, Croatia
Kobayashi, Y., Ph.D., University of Iowa College of Medicine,
Iowa City
SEMINARS
Behringer, R., M.D. Anderson Cancer Center/University of
Texas, Houston: Gene targeting 101 and conditional genet-
ic manipulation.
Bestor, T, Columbia College of Physicians & Surgeons, New
York: Epigenetics and DNA methylation.
Brannstrom, M., The Sahlgrenska Academy, Goteborg,
Sweden: Surgical transplantation of uteri.
Capel, B., Duke University Medical Center, Durham, North
Carolina: Gonad organogenesis.
Duncan, S., Medical College of Wisconsin Neurobiology and
Anatomy, Madison: Genetic regulation of organogenesis:
Liver development.
Heard, E., Curie Institute, Paris, France: Dynamics of X-chro-
mosome inactivation.
Jenkins, N., National Cancer Institute, Frederick, Maryland:
Mouse genetics.
Jessell, T, Columbia University, New York: Neural develop-
ment.
Joyner, A., New York University Medical Center, New York:
Genetic approaches in mouse to study CNS patterning.
Ko, M., National Institute of Aging, Baltimore, Maryland: Gene
arrays and the analysis of mouse development.
Lewandoski, M., CDBL, National Cancer Institute, Frederick,
Maryland: Genetic approaches to studying signaling in limb
development.
Lovell-Badge, R., National Institute for Medical Research,
London, United Kingdom: Mammalian sex determination.
Lufkin, T, Mount Sinai School of Medicine, New York:
Homeobox gene control of embryonic patterning.
Magnuson, T, University of North Carolina, Chapel Hill:
Genetic approaches to development.
McLaren, A., Wellcome/CRC Institute, Cambridge,
Massachusetts: Germ cells.
Nagy, A., Mount Sinai Hospital/Samuel Lunenfeld Research
Institute, Ontario, Canada: ES cells and chimeras.
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Mayer, A., Ph.D., Medical College of Wisconsin, Milwaukee
Murchison, E., B.S., Cold Spring Harbor Laboratory
Musacchio, M., Ph.D., University of California, Irvine
Ostman, N., M.S., Turku Center of Biotechnology, Finland
Stauber, M., Ph.D., Cancer Research UK, London, United
Kingdom
Wamstad, J., B.A., University of Minnesota
Wuelling, M., Ph.D., Max-Planck Institute for Molecular
Genetics, Berlin, Germany
Overbeek, P., Baylor College of Medicine, Houston, Texas:
Transposon-mediated mutagenesis.
O'Brien, T., Jackson Laboratory, Bar Harbor, Maine: An
enhanced GFP-based dual-color reporter to recover muta-
tions in mice.
Perry, T, RIKEN Center for Developmental Biology, Kobe,
Japan: Micromanipulation of embryos and for ICSI, trans-
genesis, and nuclear transplantation.
Rosenthal, N., EMBL-Monterotondo, Rome, Italy: Heart
development.
Rossant, J., Samuel Lunenfeld Research Institute, Ontario,
Canada: Regulation of extraembryonic development.
Rowitch, D., Dana-Farber Cancer Institute, Harvard
University, Boston, Massachusetts: Ga14/Uas binary gene
system and conditional gene expression.
Sharpe, J., MRC Human Genetics Unit, Edinburgh,
Scotland: OPT microscopy and the Edinburgh mouse
atlas.
Shen, M., UMDNJ-Robert Wood Johnson Medical School,
Piscataway, New Jersey: Left-right patterning.
Solter, D., Max-Planck Institute, Freiburg, Germany: From
egg to blastocyst: Hard road to follow.
Stewart, C., National Cancer Institute, Frederick, Maryland:
Early mouse development and implantation.
Stewart, A.E., Dresden University of Technology, Germany:
Targeting strategies: Their design, construction, and
integration.
Tam, R, Children's Medical Research Institute, Wentworth-
villa, Australia: Overview of mouse development and genet-
ics. Gastrulation and morphogenesis: Building the body
plan.
Threadgill, D., University of North Carolina, Raleigh-Durham:
Quantitative traits and bioinformatics.
Yamaguchi, T, CDBL, National Cancer Institute, Frederick,
Maryland: Wnt pathways in development.
Computational Neuroscience: Vision
June 18-July 1
INSTRUCTORS J. Demb, University of Michigan, Ann Arbor
P. Glimcher, New York University, New York
E. Simoncelli, New York University, New York
ASSISTANTS B. Borghuis, Utrecht University, The Netherlands
N. Rust, New York University, New York
Computational approaches to neuroscience produced important advances in our understanding of
neural processing. Prominent success came in areas where strong inputs from neurobiological, behav-
ioral, and computational investigation can interact. The theme of the course was that an understand-
ing of the computational problems, the constraints on solutions to these problems, and the range of
possible solutions helped guide research in neuroscience. Through a combination of lectures and
hands-on experience in a computer laboratory, this intensive course examined color vision, spatial pat-
tern analysis, motion analysis, oculomotor function, attention, and decision-making. Lecturers this year
included Edward Adelson, David Brainard, Matteo Carandini, Eduardo Chichilnisky, Kathleen Cullen,
Bruce Cumming, James Di Carlo, David Heeger, Daniel Kersten, J. Anthony Movshon, Pamela
Reinagel, Fred Rieke, Ruth Rosenholtz, Michael Shad len, Stefan Treue, and Preeti Verghese. The
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course was held at the Laboratory's Banbury Conference Center located on the north shore of Long
Island. All participants stay within walking distance of the Center, close to the tennis court, pool, and
private beach.
PARTICIPANTS
Amstrong, K., B.S.E., Stanford University, California
Basole, A., B.S., Duke University Medical Center, Durham,
North Carolina
Bonin, V., M.S., The Smith-Kettlewell Eye Research Institute,
San Francisco, California
Challinor, K., B.Psych., Macquarie University, Sydney,
Australia
Cohen, M., B.S., Stanford University, California
Doerschner, K., BA., New York University, New York
Dunn, F., B.S., University of Washington, Seattle
Field, G., B.S., University of Washington, Seattle
Hanks, T., B.S., University of Washington, Seattle
Larsson, J., Ph.D., New York University, New York
Liston, D., B.S., Salk Institute, La Jolla, California
Maciokas, J., Ph.D., University of California, Davis
SEMINARS
Brainard, D., University of Pennsylvania, Philadelphia;
Adelson, E., Massachusetts Institute of Technology,
Cambridge: Constancy/adaptation; Context; Trichromacy;
Elements of early vision.
Carandini, M., The Smith-Kettlewell Eye Research Institute,
San Francisco, California; Simoncelli, E., New York
University, New York: V1 physiology II; Image statistics II:
Sparseness/ICA/nonlinearities.
Chichilnisky, E.J., The Salk Institute, La Jolla, California:
Linear systems; Linearity in the retina.
Chichilnisky, E.J., The Salk Institute, La Jolla, California;
Demb, J., University of Michigan, Ann Arbor: Retinal gaglion
cell encoding; RGC nonlinearities.
Chichilnisky, E.J., The Salk Institute, La Jolla, California;
Brainard, D., University of Pennsylvania, Philadelphia: RGC
population code; Linear algebra.
Cullen, K., McGill University, Montreal, Canada: Eye move-
ment.
Cumming, B., National Eye Institute/NIH, Bethesda,
Maryland: Binocular stereo: Perception and physiology.
Demb, J., University of Michigan, Ann Arbor; Glimcher, P.,
New York University, New York; Simoncelli, E., New York
University, New York: Course themes: Tuning/population/
adaptation/estimation.
Demb, J., University of Michigan, Ann Arbor; Chichilnisky,
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Macuga, K., B.S., University of Califonria, Santa Barbara
Malone, B., Ph.D., University of California, Los Angeles
Mitchell, J., Ph.D., The Salk Institute, La Jolla, California
Naito, T., Ph.D., Osaka University, Japan
Nienborg, H., M.D., National Eye Institute/NIH, Bethesda,
Maryland
Pieper, F., Diplom., German Primate Center, Gottingen,
Germany
Sather, B., Ph.D., University of Pittsburgh, Pennsylvania
Schoppik, D., B.A., University of California, San Francisco
Sundberg, K., B.S., The Salk Institute, La Jolla, California
Tailby, C., Ph.D., New York University, New York
Yin, L., B.S., University of Pennsylvania, Philadelphia
Zemach, I., M.S., University of Washington, Seattle
E.J., The Salk Institute, La Jolla, California: RGC nonlinear
mechanisms; RGC contrast adaptation.
Di Carlo, J., HHMI/Baylor College of Medicine, Houston,
Texas: Object/shape physiology.
Glimcher, P., New York University, New York: Decision/games.
Heeger, D., Stanford University, California: Human Vl/fMRI.
Kersten, D., Max-Planck Institute, Tubingen, Germany:
Object/ shape perception.
Movshon, J.A., New York University, New York: MT physiology.
Reinagel, P., University of California, San Diego, La Jolla;
Simoncelli, E., New York University, New York: LGN; Image
Statistics I. PCA/SpectralModels.
Reinagel, P., University of California, San Diego, La Jolla;
Carandini, M., The Smith-Kettlewell Eye Research Institute,
San Francisco, California, Efficient coding; V1 Physiology I.
Rieke, F, University of Washington, Seattle: Signal detection
theory; Rods/photos; Entropy/information; Spikes.
Rosenholtz, R., NASA Ames, Moffett Field, California: Pattern
perception/texture.
Shad len, M., University of Washington, Seattle: Motion per-
ception/decisions.
Treue, S., German Primate Center, Goettingen, Germany:
Attention physiology.
Verghese, P., The Smith-Kettlewell Eye Research Institute,
San Francisco, California: Attention psychophysics.
DNA Microarray Applications
June 22-29
INSTRUCTORS V. lyer, University of Texas, Austin
A. Khodursky, University of Minnesota, St. Paul
J. Lieb, University of North Carolina, Chapel Hill
ASSISTANTS M. Buck, University of North Carolina, Chapel Hill
P. Killion, University of Texas, Austin
J. Kim, University of Texas, Austin
P. Mieczkowski, University of North Carolina, Chapel Hill
DNA microarrays are simple, inexpensive, and versatile tools for experimental explorations of genome
structure, gene expression programs, gene function, and cell and organismal biology. In this hands-on
eight-day course, students were introduced to the underlying technology, and then designed and car-
ried out a number of experiments for analysis by DNA microarray hybridization, data analysis, display,
and interpretation. Experimental applications covered in the course included systematic studies of
global gene expression programs, inferring gene function using microarrays, genome-wide DNA-pro-
tein interactions, and measuring changes in gene copy number. Guest lecturers presented state-of-
the-art new technology, experimental applications, and interpretation of large genomic data sets.
Students who completed this course were equipped with the skills and know-how to introduce or
apply DNA microarray technology to their own laboratories or institutions. This course was supported
with funds provided by the National Cancer Institute.
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PARTICIPANTS
Aguilera Alvarez, C., M.S., Catholic University of Chile,
Santiago
Bak, M., M.S., University of Copenhagen, Denmark
Butchko, R., B.S., United States Department of Agriculture,
Peoria, Illinois
Chen, H., M.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Enmark, E., B.S., Karolinska Institutet, Huddinge, Sweden
Hubal, M., B.S., University of Massachusetts, Amherst
Meza-Zepeda, L., Ph.D., The Norwegian Radium Hospital,
Oslo, Norway
Miller, K., Ph.D., Fisheries and Oceans, British Columbia,
Canada
Nally, J., Ph.D., University of California, Los Angeles
Nielsen, K., Ph.D., Danish Institute for Food and Veterinary
Research, Copenhagen, Denmark
SEMINARS
Botstein, D., Princeton University, New Jersey: Functional
genomics: Getting beyond descriptive studies.
Buck, M., University of North Carolina, Chapel Hill: Analysis
of ChIP-ChiP data.
Churchill, G., The Jackson Laboratory, Bar Harbor, Maine:
Statistical design and analysis of gene expression
microarray data.
Diaz, E., University of California, Berkeley: Using R for
microarray data analysis.
Khodursky, A., University of Minnesota, St. Paul: Advanced
data analysis and statistical considerations.
Killion, P., University of Texas, Austin: Submitting and
retrieving data with the longhorn array database;
Advanced features of the longhorn array database.
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Orlando, E., Ph.D., St. Mary's College of Maryland, St.
Mary's City
Rada, A., B.S., Uppsala University, Sweden
Sloane, M., B.S., Vienna University, Austria
Sobko, A., Ph.D., IOGEN Corporation, Ontario, Canada
Straub, P, Ph.D., Richard Stockton College, Pomona, New
Jersey
Suarez-Castillo, E., B.S., University of Puerto Rico, San Juan
Subramaniam, S., M.S., Centre for Cellular & Molecular
Biology, Hyberabad, India
Tammoja, K., M.S., National Institutes for Health
Development, Tallinn, Estonia
Wang, C. K., Ph.D., Medimmune Vaccines, Mountain View,
California
Yu, M., Ph.D., Cold Spring Harbor Laboratory
Mieczkowski, P, University of North Carolina, Chapel Hill:
Data analysis for aCGH experiments.
Murphy, C., University of California, San Francisco:
Experimental design from a biologist's point of view.
Sherlock, G., Stanford University, California: Analysis and
organization of DNA microarray data.
Sherlock, G., Stanford University, California: Analysis and
organization of DNA microarray data II.
Verdnik, D., Axon Instruments, Foster City, California:
Microarray scanning and quantitation with Genepix Pro;
Submitting data to acuity; Advanced features of acuity.
Whitfield, M., Dartmouth Medical School, Stanford,
California: Considerations for the design and analysis of
time-course experiments.
Advanced Techniques in Plant Science
July 1-21
INSTRUCTORS J. Bender, Johns Hopkins University School of Public Health, Baltimore, Maryland
L. Hobbie, Ade 1phi University, Garden City, New York
H. Ma, Penn State University, University Park
S. McCormick, Plant Gene Expression Center, Albany, California
R. Pruitt, Purdue University, W. Lafayette, Indiana
ASSISTANTS S. Knapke, Purdue University, W. Lafayette, Indiana
W. Li, Penn State University, University Park
D. Love, Ade 1phi University, Garden City, New York
P. Woo, Ade 1phi University, Garden City, New York
This course provided an intensive overview of topics in plant physiology and development, focusing on
molecular genetic approaches to understanding plant biology. It emphasized recent results from
Arabidopsis thaliana and other plants and provided an introduction to current methods used in plant
molecular biology. It was designed for scientists with some experience in molecular techniques or in
plant biology who wish to work with Arabidopsis and other plants using the latest technologies in
genetics and molecular biology. The course consisted of a vigorous lecture series, a hands-on labora-
tory, and informal discussions. Discussions of important topics in plant research were presented by the
instructors and by invited speakers. These seminars included plant morphology and anatomy; plant
development (development of flowers, leaves, male and female gametophytes, and embryos); percep-
tion of light and photomorphogenesis; synthesis, function, and perception of hormones. Lectures
291
describing bioinformatics tools available to the plant community, and the resources provided by plant
genome projects, were also included. Speakers provided overviews of their fields, followed by in-depth
discussions of their own work. The laboratory sessions provided an introduction to important tech-
niques currently used in plant research. These included studies of plant development, meiosis, pollen
development, fern reproduction, plant cell-imaging techniques, laser-assisted tissue microdissection,
mutant analysis, transient gene expression, applications of green fluorescent protein fusions, pro-
teomics approaches, and techniques commonly used in genetic and physical mapping. The course
also included several short workshops on important themes in genetics and a short workshop on sci-
entific writing. This course was supported by the National Science Foundation.
PARTICIPANTS
Bernacki, S., North Carolina State University, Raleigh
Bliss, B., M.S., Penn State University, University Park
Brown, L.-A., B.S., University of Leeds, United Kingdom
Costa, S., Lic., Guilbenkian Institute for Science, Oeiras,
Portugal
Johansen, W., M.S., Hedmark University College, Hamar,
Norway
Kaufmann, K., Diplom., FSU Jena, Germany
Klanrit, P., B.S., Purdue University, W. Lafayette, Indiana
Levall, M., B.S., Syngenta Seeds AB, Landskrona, Sweden
Levesque, E., B.A., The Arnold Arboretum of Harvard
SEMINARS
Banks, J., Purdue University, W. Lafayette, Indiana:
Gametophytes and evolution.
Bender, J., Johns Hopkins University School of Public Health,
Baltimore, Maryland: Epigenetics I.
Bowman, J., University of California, Davis: Leaves;
Mutagenesis.
Briggs, W., Carnegie Institution of Washington, Stanford,
California: Light signaling.
Grossniklaus, U., University of Zurich, Switzerland: Female
gametophyte.
Hangarter, R., Indiana University, Bloomington: Light respons-
es.
Hobbie, L., Ade 1phi University, Garden City, New York: Auxin
signaling; Genetics workshop I; Genetics workshop II.
Jackson, D., Cold Spring Harbor Laboratory: Plant cell-cell
communication.
Kao, T., Penn State University, University Park: Self-incom-
patibility.
Kellogg, E., University of Missouri, St. Louis: Evolution of reg-
ulatory genes; Phylogenetics.
Liu, Z., University of Maryland, College Park: Flower develop-
ment.
Lukowitz, W., Cold Spring Harbor Laboratory: Embryo
development.
Ma, H., Penn State University, University Park: Plant anato-
my; Microsporogenesis.
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University, Cambridge, Massachusetts
Liang, H., Ph.D., Penn State University, University Park
Romero, C., M.S., International Center for Tropical
Agriculture, Cali, Colombia
Ron, M., M.S., Tel-Aviv University, Israel
Svennerstam, H., M.S., Swedish University of Agricultural
Sciences, Umea, Sweden
Thingnaes, E., Ph.D., Agricultural University of Norway, Aas
Vandesteene, L., M.S., Catholic University Leuven, Belgium
Ye, S., M.A., University of Minnesota, St. Paul
Malamy, J., University of Chicago, Illinois: Roots.
May, B., Cold Spring Harbor Laboratory: Enhancer trap.
McCormick, S., Plant Gene Expression Center, Albany,
California: Pollen.
Mc Court, R, University of Toronto, Ontario, Canada:
Hormone networks.
McNellis, T., Penn State University, University Park: Plant-
pathogen interactions.
Nelson, T, Yale University, New Haven, Connecticut:
Vascular development.
Nuhse, T., The Sainsbury Laboratory, Norwich, United
Kingdom: Proteomics.
Pruitt, R., Purdue University, W. Lafayette, Indiana: Organ
fusion.
Reiser, L., Carnegie Institution of Washington, Stanford,
California: Database mining.
Richards, E., Washington University, St. Louis, Missouri:
Epigenetics II.
Schaller, E., Dartmouth College, Hanover, New Hampshire:
Ethylene.
Sussex, I., Yale University, New Haven, Connecticut:
Introduction to plants.
Timmermans, M., Cold Spring Harbor Laboratory: Maize
shoot patterning.
Vaugh, M., Cold Spring Harbor Laboratory: Enhancer trap.
Neurobiology of Drosophila
July 2-22
INSTRUCTORS R. Baines, University of Warwick, Coventry, United Kingdom
S. De Belle, University of Nevada, Las Vegas
D. Van Vactor, Harvard Medical School, Boston, Massachusetts
COINSTRUCTORS K. Johnson, Harvard Medical School, Boston, Massachusetts
J. Waters Shuler, Harvard Medical School, Boston, Massachusetts
ASSISTANTS K. Miller, Harvard Medical School, Cambridge, Massachusetts
E. Pym, University of Warwick, Coventry, United Kingdom
C. Serway, University of Nevada, Las Vegas
This laboratory/lecture course was intended for researchers at all levels from beginning graduate stu-
dents through established primary investigators who want to use Drosophila as an experimental sys-
tem for nervous system investigation. The three-week course was divided into the study of develop-
ment, physiology/function, and behavior. Daily seminars introduced students to a variety of research
topics and developed those topics by including recent experimental contributions and outstanding
questions in the field. Guest lecturers brought original preparations for viewing and discussion and
direct laboratory exercises and experiments in their area of interest. The course provided students with
hands-on experience using a variety of experimental preparations that are used in the investigation of
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current neurobiological questions. The lectures and laboratories focused on both the development of
the nervous system and its role in controlling larval and adult behaviors. In addition to an exposure to
the molecular genetic approaches available in Drosophila, students learned a variety of techniques,
including embryo immunohistochemistry, labeling of identified neurons, electrophysiological recording
from nerves and muscles, and the analysis of larval and adult behavior. Collectively, the course provid-
ed a comprehensive and practical introduction to modern experimental methods for studying the
Drosophila nervous system. This course was supported with funds provided by the National Institute
of Mental Health and the Howard Hughes Medical Institute.
PARTICIPANTS
Butler, C., Ph.D., University of Pennsylvania School of
Medicine, Philadelphia
Cziko, A-M., B.S., University of Arizona, Tucson
De Pace, A., Ph.D., University of California Berkeley Center for
Integrated Genomics, Berkeley
Edwards, T., B.S., Dalhousie University, Nova Scotia, Canada
Fiddian, B., Ph.D., University of Cambridge, United
Kingdom
SEMINARS
Auld, V., University of British Columbia, Vancouver: Glial
development; Bioinformatics 101.
Baines, R., University of Warwick, United Kingdom: Synaptic
plasticity; CNS electrophysiology.
Bashaw, G., University of Pennsylvania, Philadelphia: Axon
guidance.
Blau, J., New York University, New York: Rythmicity.
Cagan, R., Washington University, St. Louis, Missouri: Death
and the eye.
de Belle, S., University of Nevada, Las Vegas: Behavior 101;
Learning and memory: Hardware.
Dubnau, J., Cold Spring Harbor Laboratory: Learning and
memory: Software.
Eberl, D., University of Iowa, Iowa City: Hearing and smell.
Godenschwege, T, University of Massachusetts, Amherst;
Allen, M., University of Kent, Canterbury, United Kingdom:
Giant fiber system.
Johnson, K., Pomona College, California: Neurogenesis.
Kravitz, E., Harvard Medical School, Boston, Massachusetts:
Aggression.
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Hoyer, S., M.S., University of Wuerzburg, Germany
Li, X., Ph.D., Harvard Medical School, Boston,
Massachusetts
Liu, X., M.S., Baylor College of Medicine, Houston, Texas
Long, A., B.S., University of Kentucky, Lexington
Lu, C., B.S., Brandeis University, Waltham, Massachusetts
Reddy, S., M.S., University of Pennsylvania, Philadelphia
Tasic, B., B.S., Stanford University, California
Landgraf, M., Cambridge University, United Kingdom:
Neuornal identity.
Macleod, G., University of Toronto, Canada: Imaging neural
activity.
O'Dell, K., University of Glasgow, United Kingdom:
Courtship.
Shaw, P., Washington Medical School, St. Louis, Missouri:
Sleep.
Stewart, B., University of Toronto, Canada: Electrophysiology
101; Synaptic release.
Strauss, R., Theodor Boveri Institute, Wurzburg, Germany:
Motor behavior; Visual system.
Tepass, U., University of Toronto, Canada: The fly embryo
and adult.
Van Vactor, D., Harvard Medical School, Boston,
Massachusetts: Genetics 101 (techniques).
Waters-Shuler, J., Harvard Medical School, Boston,
Massachusetts: Light microscopy; Confocal microscopy.
Zhang, B., University of Texas, Austin: The fly NMJ.
Molecular Mechanisms of Human Neurological Diseases
July 6-12
INSTRUCTORS S. Gandy, Thomas Jefferson University, Philadelphia, Pennsylvania
J. Hardy, National Institutes of Health/NIA, Bethesda, Maryland
H. Orr, University of Minnesota, Minneapolis
How and why do neurons dysfunction or die in specific acute or chronic human neurological disorders?
What are the molecular and biochemical manifestations of specific genetic lesions in specific neuro-
logical disorders? Do different pathological dysfunctions share common mechanisms? What practical
treatments can be contemplated? This lecture course explored possible answers to these important
questions. Recent advances in neurogenetics and in molecular and cell biology shed light on the mech-
anisms that underlie nervous system injury in disease states such as stroke, epilepsy, Alzheimer's dis-
ease, Parkinson's disease, frontotemporal dementia, prion diseases, lissencephaly, Fragile X mental
retardation, paraneoplastic neurological degeneration, and polyglutamine repeat disorders. Taking
advantage of small class size and extensive discussion, invited faculty lecturers examined critical issues
in their areas of expertise. Overview was provided, and course participants were not required to have
familiarity with neurological diseases, although a background in basic nervous system structure and
organization was extremely helpful.
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The course focused principally on the specific hypotheses and approaches driving current research.
Emphasis was placed on the highly dynamic interface between basic and clinical investigation, includ-
ing the interdependence of clinical research and disease model development, and the value of disease
research in understanding the normal function of the nondiseased nervous system. The course was
held at the Laboratory's Banbury Conference Center located on the north shore of Long Island. All par-
ticipants stay within walking distance of the Center, close to tennis court, pool, and private beach. In
2004, partial support for the course was provided by the Howard Hughes Medical Institute.
PARTICIPANTS
Bandopadhyay, R., Ph.D., Royal Free and University College
London Medical School, United Kingdom
Berger, Z., B.S., University of Cambridge, United Kingdom
Betts, J., B.S., University of Newcastle Upon Tyne, United
Kingdom
Englund, U., Ph.D., H. Lundbeck A/S, Copenhagen,
Denmark
Greenway, M., M.D., National Centre for Medical Genetics,
Dublin, Ireland
Gregory, G., B.T., Prince of Wales Medical Research Institute,
Sydney, Australia
Hasegawa, S., M.S., University of Tokyo, Japan
Hong, S., Ph.D., Johns Hopkins University, Baltimore,
Maryland
Katzov, H., B.S., Centre for Genomics and Bioinformatics,
Stockholm, Sweden
SEMINARS
Collinge, J., Imperial College/St. Mary's Hospital, London,
United Kingdom: Prion diseases.
Cookson, M., National Institutes of Health/NIA, Bethesda,
Maryland: Molecular pathogenesis of Parkinson's
disease.
Darnell, R., HHMI/The Rockefeller University, New York:
Neurobiology of the paraneoplastic neurological diseases
and Fragile-X mental retardation.
Davidson, B., University of Iowa College of Medicine, Iowa
City: Animal models of triplet repeat diseases.
Duff, K., New York University, Orangeburg: Tauopathies II:
Animal models.
Frackowiak, R., Institute of Neurology, London, United
Kingdom: Structural and functional basis of cerebral cotical
function.
Gandy, S., Thomas Jefferson University, Philadelphia,
Pennsylvania: Amyloid and Alzheimer's I: Molecular basis
for anti-amyloid therapeutics.
Hardy, J., National Institutes of Health/NIA, Bethesda,
Maryland; Gwinn Hardy, K., National Institutes of
Health/NINDS, Bethesda, Maryland: Introduction to neuro-
genetics I; Introduction to neurogenetics II.
Holtzman, D., Washington University School of Medicine, St.
Louis, Missouri: Amyloid and Alzheimer's II: Role of Abeta
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Leblanc, G., Ph.D., National Institutes of Health/NINDS,
Bethesda, Maryland
Lewis, P, B.S., Institute of Neurology, London, United
Kingdom
Liu, J., Ph.D., Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts
Munoz-Cabello, A., B.S., University of Seville, Spain
Park, L., M.S., Michigan State University, East Lansing
Ravits, J., M.D., Benaroya Research Institute, Seattle,
Washington
Sanders, H., B.S., E. Carolina University Brody School of
Medicine, Greenville, North Carolina
Shimoji, M., Ph.D., National Institutes of Health/NIA,
Bethesda, Maryland
Zhang, L., Ph.D., Johns Hopkins University, Baltimore,
Maryland
binding molecules and anti-Abeta antibodies in AD
pathogenesis, diagnosis, and therapy.
Hutton, M., Mayo Clinic, Jacksonville, Florida: Tauopathies I:
Genetics.
ladecola, C., Weill Cornell Medical Center, New York:
Molecular pathogenesis of stroke.
Macdonald, M., Massachusetts General Hospital,
Charlestown: Trinucleotide repeat diseases: I-Huntington's
disease.
Malinow, R., Cold Spring Harbor Laboratory: Amyloid and
Alzheimer's III: Physiology of A.
McNamara, J., Duke University Medical Center, Durham,
North Carolina: Cellular and molecular mechanisms of
epilepsy.
Murphy, D., National Institutes of Health/NINDS, Rockville,
Maryland: Extramural programs at NINDS.
Orr, H., University of Minnesota, Minneapolis: II: Spinocere-
bellar ataxia.
Siegel, J., Veterans Affairs Greater Los Angeles Health Care
System, North Hills, California: Hypocretin (orexin): Role in
narcolepsy and normal behavior.
Walsh, C., Beth Israel Deaconess Medical Center, HIM,
Boston, Massachusetts: Genetics and molecular biology of
human cerebral cortical development.
Advanced Techniques in Molecular Neuroscience
July 7-22
INSTRUCTORS J. Boulter, University of California, Los Angeles
T. Hughes, Montana State University, Bozeman
C. Lai, Scripps Research Institute, La Jolla, California
D. Lavery, Purdue Pharma LP, Cranbury, New Jersey
ASSISTANTS J. Arjomand, Purdue Pharma LP, Cranbury, New Jersey
I. Cheung, Scripps Research Institute, La Jolla, California
D. Hanway, Purdue Pharma LP, Cranbury, New Jersey
A. Klaassen, Interdepartmental Neuroscience Program, Los Angeles, California
W. Walwyn, University of California, Los Angeles
This newly revised laboratory and lecture course was designed to provide neuroscientists at all levels
with a conceptual and practical understanding of several of the most advanced techniques in molec-
ular neuroscience. The course curriculum was divided into three sections: an extensive and up-to-date
set of laboratory exercises, daily lectures covering the theoretical and practical aspects of the various
methods used in the laboratory, and a series of evening research seminars. The informal and interac-
tive evening lectures were given by leading molecular neuroscientists and served to illustrate the ways
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in which the various experimental approaches have been used to advance specific areas of neurobiol-
ogy. In this year's course, the laboratory portion included topics such as an introduction to the design
and use of animal virus vectors in neurobiology; the use of small interfering RNAs (siRNA) for regulat-
ing the expression of specific genes in neurons; practical exercises in gene delivery systems including
mammalian cell transfection protocols and single-cell electroporation techniques for targeted gene
transfer in vivo; an introduction to overall strategies, use and design of BAC transgenic vectors; multi-
plex and whole-genome expression analyses using the most recent DNA microarray technologies
(including labeled probe preparation, data analyses, mining, and interpretation); quantitative real-time
RT-PCR analyses from small numbers of cells (RNA purification, PCR optimization, interpretation of
results); single-cell PCR and cDNA library construction; and methods and application of RNA amplifi-
cation (aRNA). Each laboratory module was followed by comprehensive data analyses and interpreta-
tion, protocol troubleshooting, and suggestions for ways to improve or modify the existing technique.
Finally, course participants were introduced to bioinformatics and a wide range of Internet resources
that are available to molecular neuroscientists. This course was supported with funds provided by the
National Institute of Mental Health and the Howard Hughes Medical Institute.
PARTICIPANTS
Bolduc, F., FRCPC, Cold Spring Harbor Laboratory
Brasnjo, G., B.S., University of California, Los Angeles
Drew, M., Ph.D., Columbia University Medical Center, New York
Gollan, L., Ph.D., Columbia University, New York
Gumy, L., M.S., University of Cambridge, United Kingdom
Hanson, J., Ph.D., Stanford University School of Medicine,
California
Kalbaugh, T., Ph.D., National Institutes of Health/NINDS,
Bethesda, Maryland
SEMINARS
Berlot, C., Weis Center for Research, Danville, Pennsylvania:
Visualization of G-protein targeting and signaling using GFP
fusions and biomolecular fluorescence complementation.
Darnell, R., The Rockefeller University, New York: Molecular
techniques to dissect neurologic disease: The emerging
role of RNA-binding protein in the brain.
Eberwine, J., University of Pennsylvania, Philadelphia:
Neuronal dendrites: mRNA localization, translation, and
some surprises.
Haas, K., University of British Columbia, Vancouver, Canada:
Probing gene functions: Targeted electroporation strategies
for in vivo transfection of single cells or entire tissues.
Hannon, G., Cold Spring Harbor Laboratory: RNAi:
Mechanism and application.
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Kase lin, J., M.S., Abo Akademi University, Finland
Kreitzer, A., Ph.D., Stanford University, Palo Alto, California
McDermott, B., Ph.D., The Rockefeller University, New York
Molyneaux, B., B.A., Harvard University, Boston,
Massachusetts
Rissman, E., Ph.D., University of Virginia, Charlottesville
Soviknes, A., M.S., University of Bergen, Norway
Wetherington, J., Ph.D., Emory University, Atlanta, Georgia
Yokota, Y., B.S., University of North Carolina, Chapel Hill
Hughes, R., Prolexys Pharmaceuticals, Inc., Salt Lake City,
Utah: Protein interactions in Huntington's disease.
Mombaerts, P., The Rockefeller University, New York:
Olfaction targeted.
Tessarollo, L., National Cancer Institute, Frederick, Maryland:
Dissecting neurotrophin functions in vivo: Lessons from
engineered mouse models.
Walsh, C., Harvard Medical School and HHMI Beth Israel
Deaconess Medical Center, Boston, Massachusetts:
Mapping and cloning genes that regulate development of
the human brain.
Yang, W., University of California, Los Angeles: A bacterial
artificial chromosome (BAC)-mediated transgenic approach
to study function and dysfunction of the mammalian brain.
Proteomics
July 9-22
INSTRUCTORS P. Andrews, University of Michigan Medical School, Ann Arbor
J. La Baer, Harvard Institute of Proteomics, Cambridge, Massachusetts
A. Link, Vanderbilt University School of Medicine, Nashville, Tennessee
ASSISTANTS M. Fernandez, Harvard Institute of Proteomics, Cambridge, Massachusetts
E. Hainsworth, Harvard Medical School, BCMP, Boston, Massachusetts
J. Jennings, Vanderbilt University School of Medicine, Nashville, Tennessee
T. Murthy, Harvard Medical School, Cambridge, Massachusetts
N. Ramachandran, Harvard Institute of Proteomics, Cambridge, Massachusetts
D. Veine, University of Michigan, Ann Arbor
This intensive laboratory and lecture course focused on two major themes in proteomics: protein pro-
filing and functional proteomics. In the profiling section of the course, students learned about cutting-
edge protein separation methods, including hands-on experience with two-dimensional gel elec-
trophoresis, multidimensional liquid chromatography, and affinity purification of protein complexes. The
course covered both MALDI and ESI high-sensitivity mass spectrometry, including peptide mass map-
ping and tandem mass spectrometry, quantification, and phosphoproteomics. Students learned to use
several informatics tools available for analyzing the data. In the functional proteomics section of the
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course, students learned about recombinational cloning, high-throughput protein isolation, and protein
microarrays. Students used robots to execute high-throughput methods, including expression, purifi-
cation, and characterization of proteins. They also printed and analyzed their own self-assembling pro-
tein microarrays, which were used for protein-protein interaction studies. The overall aim of the course
was to provide students with the fundamental knowledge and hands-on experience necessary to be
able to perform and analyze proteomics experiments, and to learn to identify new opportunities in
applying proteomics approaches to their own research. This course was supported with funds provid-
ed by the National Cancer Institute.
PARTICIPANTS
Agarwalla, S., Ph.D., University of California, San Francisco
Ambrosio, J., Ph.D., University of Mexico, Mexico City
Arnesen, T, M.S., University of Bergen, Norway
Bogusz, A., M.D., University of Chicago, Illinois
Boukh-Viner, T, B.S., Concordia University, Montreal, Canada
Castro-Rivera, E., Ph.D., University of Texas Southwestern
Medical Center, Dallas
Gray, R., B.S., Michigan State University, East Lansing
Hennington, B., Ph.D., Tougaloo College, Clinton,
Mississippi
SEMINARS
Chait, B., The Rockefeller University, New York: Identifying
posttranslational modifications.
Clauser, K., Broad Institute of MIT and Harvard, Cambridge,
Massachusetts: Biomaker discovery and LC/MS/MS data
interpretation.
Biomarker discovery and LC/MS/MS data interpretation.
Macbeath, G., Harvard University, Cambridge, Massa-
chusetts: Applications of protein microarrays.
Pappin, D., Applied Biosystems, Foster City, California: Novel
quantitative mass spectrometry approaches.
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Lonergan, E., Ph.D., Iowa State University, Ames
Kawaguchi, R., M.S., Penn State University, University Park
Klaper, R., Ph.D., University of Wisconsin, Milwaukee
Lenassi, M., B.S., University of Ljubljana, Slovenia
Liu, H., M.S., Massachusetts Institute of Technology,
Cambridge
Moik, D., Diplom., University Clinic of Duesseldorf, Germany
Polanowska, J., Ph.D., INSERM, Marseille, France
Roux, M., B.S., Randse Afrikaanse Universiteit, Republic of
South Africa
Phinney, B., Michigan State University, East Lansing:
Applications of FT mass spectrometry in proteomics.
Reyzer, M., Vanderbilt University, Nashville, Tennessee:
Imaging mass spectrometry.
Snyder, M., Yale University, New Haven, Connecticut: Protein
microarrays.
Tempst, P., Memorial Sloan-Kettering Cancer Center, New
York: Mass spectrometry and medical diagnostics.
Drosophila Genetics and Genomics
July 14-27
INSTRUCTORS M. Ashburner, Cambridge University and EBI, Cambridge, United Kingdom
K. Burtis, University of California, Davis
R.S. Hawley, Stowers Institute for Biomedical Research, Kansas City, Missouri
ASSISTANT S. Langley, University of California, Berkeley
This intensive seminar course provided an introduction to the theory and practice of methods used to
analyze and manipulate the Drosophila genome. It is suitable for graduate students and researchers
with some experience with Drosophila who are interested in expanding their knowledge of the wide
range of genetic and genomic techniques now available for use with this organism. Topics covered
included chromosome mechanics, the design and execution of genetic screens, and the use of trans-
posable elements as genetic tools. We reviewed the current understanding of the genome sequence
and discussed methodologies for genomic analysis (e.g., microarrays, gene finding methods, compar-
ison with the sequences of related species, and the heterochromatin genomic project) and proteomics
in Drosophila. The course was held at the Laboratory's Banbury Conference Center located on the
north shore of Long Island. All participants stay within walking distance of the Center, close to tennis
court, pool, and private beach.
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PARTICIPANTS
Anderl, I., M.S., Umea University, Sweden
Bjorkmo, M., B.S., University of Oslo, Norway
Boundy, S., Ph.D., University of Bath, United Kingdom
Brogli, K., Diplom., ETH Zurich, Switzerland
Dasari, S., M.S., University of Kentucky, Lexington
Du, T, B.S., University of Massachusetts, Worcester
Grave ley, B., Ph.D., University of Connecticut Health Center,
Farmington
Haflidadottir, B., M.S., University of Iceland, Reykavik
Katsani, K., Ph.D., Institut Curie, Paris, France
Kind, J., M.S., EMBL Heidelberg, Germany
Kocks, C., Ph.D., Massachusetts General Hospital, Boston
SEMINARS
Baker, B., Stanford University, California: Behavioral neuroge-
netics in Drosophila.
Burtis, Kenneth, University of California, Davis: Drosophila
genome and genomics.
Cooley, L., Yale University, New Haven, Connecticut:
Fluorescent proteins in Drosophila: Cell biology and pro-
teomics.
Ganetzky, B., University of Wisconsin, Madison: Segregation
distortion/neurogenetics.
Golic, K., University of Utah, Salt Lake City: Mosaic systems
and P-element technologies.
Hawley, R.S., Stowers Institute for Biomedical Research,
Kansas City, Missouri; Ashburner, M., Cambridge University
and EBI, Cambridge, United Kingdom: Introduction to
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Leinonen, A., B.S., University of Tampere, Finland
Liebert, S., M.S., Baylor College of Medicine, Houston,
Texas
Lindmo, K., M.S., The Norwegian Radium Hospital, Oslo,
Norway
Marconi, S., M.S., University of Bari, Italy
Mendes, C., B.S., The Rockefeller University, New York
Seppa, M., B.A., Washington University, St. Louis, Missouri
Sierralta, J., Ph.D., University of Chile, Santiago
Stier, S., M.S., Uppsala University, Sweden
Sopory, S., Ph.D., Oregon Health and Science University,
Portland
Drosophila; Basic genetics of Drosophila.
Hawley, R.S., Stowers Institute for Biomedical Research,
Kansas City, Missouri: Meiosis and mitosis.
Karpen, G., University of California, Berkeley: Chromosome
structure.
Langley, C., University of California, Davis: Genome structure
and Drosophila populations.
Lehman, R., New York University School of Medicine, New
York: Genetic screens.
Perrimon, N., Harvard Medical School, Boston,
Massachusetts: Functional genomics (RNAi).
White, K., Yale University School of Medicine, New Haven,
Connecticut: Functional genomics (microarrays and net-
work annotation).
C. elegans
July 27-August 16
INSTRUCTORS B. Bowerman, University of Oregon, Eugene
S. Clark, New York University School of Medicine, New York
M. Labouesse, IGBMC, Strasbourg, France
I. Mori, Nagoya University, Japan
ASSISTANTS C. Carter, University of Oregon, Eugene
C. Chiu, New York University School of Medicine, New York
This course was designed to familiarize investigators with C. elegans as an experimental system, with
an emphasis on both classical genetic analysis and reverse genetic approaches. A major goal was to
teach students how to successfully exploit the information generated by the C. elegans genome pro-
ject. The course was suited both for those who have current training in molecular biology and some
knowledge of genetics, but have no experience with C. elegans, and for students with some prior
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worm experience who wished to expand their repertoire of expertise. The following topics were cov-
ered both in the laboratory and by lectures from experts in the field: worm picking, C. elegans data-
bases and worm bioinformatics, anatomy and development, forward genetics, chemical and transpo-
son mutagenesis, generation of transgenic animals, expression pattern analysis, reverse genetics, con-
struction and screening of deletion libraries, and RNA inactivation. The course was designed to impart
sufficient training to students in the most important attributes of the C. elegans system to enable stu-
dents to embark on their own research projects after returning to their home institutions. This course
was supported with funds provided by the National Institute of Child Health and Human Development.
PARTICIPANTS
Beale, E., Ph.D., Texas Tech. University Health Sciences
Center, Lubbock
Garrett, M., Ph.D., Vanderbilt University Medical Center,
Nashville, Tennessee
Grez, P. B.S., Pontificia Universidad Catolica de Chile,
Santiago
Holmes, C., B.S., University of British Columbia, Vancouver,
Canada
Honda, Y., Ph.D., Tokyo Metropolitan Institute of Gerontology,
Japan
Kosarek, J., B.S., University of Texas Southwestern Medical
Center, Dallas
Lo, S., Ph.D., Chang Gung University, Tao Yuan, ROC
SEMINARS
Ewbank, J., CIML, Marseille, France: Host-pathogen interac-
tions in C. elegans.
Greenwald, I., Columbia University, New York: LIN-12/Notch
signaling and cell-cell interactions in C. elegans.
Hall, D., Einstein University School of Medicine, New York:
Introduction to Worm Atlas, an anatomy database for C.
elegans researchers.
Harris, T, Cold Spring Harbor Laboratory: Worm Base: A live
crash-free course, and Worm Base tools for data mining
and comparative genomics.
Herman, R., University of Minnesota, Minneapolis: C. elegans
genetic suppressors, enhancers, redundancy, and mosaics.
Mango, S., University of Utah, Salt Lake City: Organogenesis
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Maro, G., Ph.D., INSERM U368, Paris, France
Mertens, C., M.A., Ghent University, Belgium
Michael, M., Ph.D., Harvard University, Cambridge,
Massachusetts
Nakachi, Y., M.S., Saitama Medical School, Japan
Nilsen, H., Ph.D., London Research Institutes, Hens, United
Kingdom
Rockman, M., B.S., Duke University, Durham, North
Carolina
Shorto, A., Ph.D., University of Bristol, United Kingdom
Simonetta, S., M.S., University of Quilmes, Buenos Aires,
Argentina
Winkelbauer, M., B.S., University of Alabama, Birmingham
and transcriptional networks in C. elegans.
Nonet, M., Washington University School of Medicine, St.
Louis, Missouri: Regulation of synaptic transmission by
Rab GTPases.
Rougvie, A., University of Minnesota, St. Paul: Keeping time
with microRNAs in C. elegans.
Schafer, W., University of California, San Diego, La Jolla:
Imaging neuronal activity and behavior in C. elegans.
Strome, S., Indiana University, Bloomington: Germ-line devel-
opment in C. elegans.
Sugimoto, A., RIKEN Center for Developmental Biology,
Kobe, Japan: A C. elegans phenome project: Toward a
genomic understanding of the developmental program.
Eukaryotic Gene Expression
July 27-August 16
INSTRUCTORS L.D. Attardi, Stanford University, California
W.L. Kraus, Cornell University, Ithaca, New York
A. Shilatifard, St. Louis University, Missouri
L. Tora, IGBMC, Illkirch, France
ASSISTANTS T. Hilton, IGBMC, Illkirch, France
T. Johnson, Stanford University, California
M.Y. Kim, Cornell University, Ithaca, New York
A. Wood, St. Louis University Health Sciences Center, Missouri
This course was designed for students, postdocs, and principal investigators who had recently ventured
into the exciting area of gene regulation. The course focused on state-of-the-art strategies and techniques
employed in the field. Emphasis was placed both on in vitro and in vivo protein-DNA interactions and on
novel methodologies to study gene regulation. Students made recombinant tagged proteins, nuclear
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extracts, performed in vitro transcription reactions and measured RNA levels using Si nuclease mapping.
Characterizations of the DNA-binding properties of site-specific transcription factors were carried out
using electrophoretic mobility shift and DNase I footprinting assays. In addition, students learned tech-
niques for the assembly and analysis of chromatin in vitro, and in vivo. This included transcription assays,
nucleosome mapping, chromatin remodeling assays, and restriction enzyme accessibility assays.
During the past few years, the gene regulation field has developed in vivo approaches to study gene
regulation. Students were exposed to the chromatin immunoprecipitation technique. They also used RNAi
for specific knock-dOwn experiments in mammalian cells. In addition, determining cellular gene expres-
sion profiles had been accelerated tremendously by DNA microarray technology. Students received
hands-on training in performing and interpreting results from DNA microarrays. Experience with basic
recombinant DNA techniques was a prerequisite for admission to this course. Lectures by the instructors
covered the current status of the gene expression field, theoretical aspects of the methodology, and
broader issues regarding strategies for investigating the regulation of gene expression in eukaryotes.
Guest lecturers discussed contemporary problems in eukaryotic gene regulation and technical approach-
es to their solution. This course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Binda, 0., B.S., McGill University, Montreal, Canada
Fischer, A., M.S., University of Geneva, Switzerland
Heldring, N., M.S., Karolinska Institutet, Huddinge,
Sweden
lijima, K. A., Ph.D., Cold Spring Harbor Laboratory
Kent, J., Ph.D., University of California, Santa Cruz
Kodandera, D., M.S., Emory University, Atlanta, Georgia
Kotekar, A., Ph.D., National Institutes of Health, Rockville,
Maryland
Lakowski, B., Ph.D, Institut Pasteur, Paris, France
Larsen, L., M.S., Steno Diabetes Center, Gentofte, Denmark
SEMINARS
Attardi, L., Stanford University, California: Using mouse mod-
els to dissect the function of the p53 trans-activator in
tumor suppression.
Bartolomei, M., HHMI/University of Pennsylvania School of
Medicine, Philadelphia: Regulation of genomic imprinting.
Carthew, R., Northwestern University, Evanston, Illinois: Gene
silencing by small RNAs.
Conaway, J., Stowers Institute for Medical Research, Kansas
City, Missouri: Regulational of initiation and elongation by
RNA polymerase II.
Cote, J., Laval University Cancer Research Center, Quebec
City, Canada: Chromatin modification by the NuA4 com-
plex: An early step in gene activation.
Dynlacht, B., New York University School of Medicine, New
York: Transcriptional control of the cell cycle.
Fuller, M., Stanford University School of Medicine, California:
Developmental regulation of gene expression by tissue-spe-
cific transcription machinery.
Gill, G., Harvard Medical School, Boston, Massachusetts:
Regulation of transcription factor activity by SUMO modifi-
cation.
Graves, B., University of Utah, Salt Lake City: The ETS family
of transcription factors: Routes to specificity.
Kraus, W. L., Cornell University, Ithaca, New York: Role of lig-
ands, coactivators, and chromatin in estrogen-receptor-
dependent transcription.
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Lizcano, F, Ph.D., La Sabana University, Chia, Columbia
Lundgren, J., M.S., Stockholm University, Sweden
Magklara, A., Ph.D., National Institutes of Health/NCI,
Bethesda, Maryland
Marinescu, V, Ph.D., Children's Hospital Boston, Enders,
Massachusetts
Nally, K., Ph.D., National University of Ireland, Cork
Ramachandran, A., Ph.D., Tufts University School of
Medicine, Boston, Massachusetts
Tan, M.-H., MRCP Van Andel Research Institute, Grand
Rapids, Michigan
Nyborg, J., Colorado State University, Fort Collins: Regu-
lation of HTLV-I transcription in a chromatin context.
Sassone-Corsi, P., Institut de Genetique at de Biologie
Moleculaire at Cellulaire, Illkirch, France: Unique chromatin
remodeling and transcriptional rules in male germ cells.
Schultz, P., Institut de Genetique at de Biologie Moleculaire
at Cellulaire, Illkrich, France: Structural studies of large tran-
scription complexes of electron microscopy and image
processing.
Shilatifard, A., St. Louis University School of Medicine,
Missouri: A COMPASD and a GPS in defining histone mod-
ifications, transcriptional regulation, and human cancer:
The coordinates of the genome.
Timmers, M., University Medical Centre, Utrecht, The
Netherlands: Dynamic regulation of transcription by RNA
polymerase II.
Tora, L., Institut de Genetique at de Biologie Moleculaire at
Cellulaire, Illkrich, France: Different sets of promoter recog-
nition factors regulate the transcription initiation of RNA
polymerase II at distinct promoters.
Whitfield, M., Dartmouth Medical School, Hanover, New
Hampshire: Genome-wide analysis of gene expression in
basic biology and complex human disease.
Workman, J., Stowers Institute for Medical Research,
Kansas City, Missouri: Protein complexes that modify chro-
matin.
Imaging Structure and Function in the Nervous System
July 27-August 16
INSTRUCTORS F. Engert, Harvard University, Cambridge, Massachusetts
F. Helmchen, Max-Planck Institut fur Medizinische Forschung, Heidelberg, Germany
D. Kleinfeld, University of California, San Diego, La Jolla
T. Murphy, University of British Columbia, Vancouver, Canada
M. Oheim, Ecole Superieure de Physique at Chimie Industrielles, Paris, France
ASSISTANTS V. Emiliani, Institut Jacques Monod, Paris, France
T. Nevian, Max-Planck Institut fijr Medizinische Forschung, Heidelberg, Germany
Y. Otsu, University of British Columbia, Vancouver, Canada
P. Tsai, University of California, San Diego, La Jolla
W. Tyler, Harvard University, Cambridge, Massachusetts
R. Vislay, Harvard University, Cambridge, Massachusetts
J. Wadiche, Vollum Institute, Portland, Oregon
J. Waters, Max-Planck Institut, Heidelberg, Germany
Advances in light microscopy and digital image processing, and the development of a variety of pow-
erful fluorescent probes, presented expanding opportunities for investigating the nervous system, from
synaptic spines to networks in the brain. This intensive laboratory and lecture course provided partic-
ipants with the theoretical and practical knowledge to utilize emerging imaging technologies. The pri-
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mary emphasis of the course was on vital light microscopy. Students learned the principles of light
microscopy, as well as use of different types of electronic cameras, laser-scanning systems, function-
al fluorophores, delivery techniques, and digital image-processing software. In addition to transmitted
light microscopy for viewing cellular motility, the course examined a variety of molecular probes of cell
function, including calcium-sensitive dyes, voltage-sensitive dyes, photo-activated ("caged") com-
pounds, and exocytosis tracers. Issues arising in the combination of imaging with electrophysiological
methods were covered. Particular weight was given to multi-photon laser-scanning microscopy and to
newly available biological fluorophores, especially green fluorescent protein (GFP) and its variants. We
used a spectrum of neural and cell biological systems, including living animals, brain slices, and cul-
tured cells. Applicants had a strong background in the neurosciences or in cell biology. This course
was supported with funds provided by the National Institute of Mental Health, the National Institute on
Drug Abuse, and the Howard Hughes Medical Institute
PARTICIPANTS
Awatramani, G., Ph.D OSHUNollum Institute, Portland,
Oregon
Beckman, M., Ph.D., Yale University/The University of
Montana, New Haven, Connecticut
Bezzi, P., Ph.D., University of Lausanne, Switzerland
Brasnjo, G., B.S., University of California, Los Angeles
Dan, C., Ph.D., Harvard University, Cambridge,
Massachusetts
SEMINARS
Almers, W., Oregon Health and Science University, Portland:
TIRF.
Betz, W., University of Colorado Medical School, Denver:
FM143.
Cohen, L., Yale University, New Haven, Connecticut: Voltage
sensitive dyes.
Denk, W., Max-Planck Institute for Medical Research,
Heidelberg, Germany: Block-face neuronal reconstruction.
Engert, F., Harvard University, Cambridge, Massachusetts:
Loading in the tadpole (introduction of a basic prep),
Glaser, J., Microbrightfield, Inc.: Reconstruction of neurons.
Helmchen, F., Max-Planck Institut fir Medizinische
Forschung, Heidelberg, Germany: Ionic indicators/buffer-
ing/basics.
Hu, C.-D., Purdue University, West Lafayette, Indiana: Seeing
is believing: Visualization of transcription factor interac-
tions...using bimolecular fluorescence complementation.
Kalatsky, V., University of California, San Francisco: Intrinsic
imaging.
Keller, E., Carl Zeiss, Inc., Thornwood, New York: Diffraction
theory on image formation.
Kleinfeld, D., University of California, San Diego, La Jolla:
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Khosravani, H., M.S., University of Calgary, Canada
Komiyama, T., B.S., Stanford University, Palo Alto, California
Maggi, L., Ph.D., EMBL-Monterotondo, Roma, Italy
Mrsic-Flogel, T., Ph.D., Max-Planck Institute of Neurobiology,
Martinsried, Germany
Paw lu, C., M.D., University of Freiburg, Germany
Topolnik, L., Ph.D., University of Montreal, Canada
Tsui, J., BA., Stanford University, Palo Alto, California
Basic optics.
Lanni, F., Carnegie-Mellon University, Pittsburgh,
Pennsylvania: Point spread functions.
Lichtmann, J., Washington University, St. Louis, Missouri:
Confocal microscopy.
Mertz, J., Ecole Superieure de Physique at Chimie
Industrie Iles, Paris, France: Advances in nonlinear
microscopy.
Moomaw, B., Spring Branch, Texas: CCD imaging, princi-
ples, and technology.
Murphy, T., University of British Columbia, Vancouver,
Canada: Back to basics, experimental design, issues with
live cell imaging.
Oheim, M., Ecole Superieure de Physique at Chimie
Industrie Iles, Paris, France: Basics of TIRF microscopy.
Shepherd, G., Cold Spring Harbor Laboratory: Caged trans-
mitters and circuit analysis.
Svoboda, K., Cold Spring Harbor Laboratory: Basics of 2-
photon microscopy.
Tsien, R., University of California, San Diego, La Jolla: The
world of functional XFPs.
Yeast Genetics
July 27-August 16
INSTRUCTORS D. Amberg, SUNY, Syracuse, New York
D. Burke, University of Virginia, Charlottesville
J. Strathern, National Cancer Institute, Frederick, Maryland
ASSISTANTS C. Copeland, University of Virginia, Charlottesville
M. Derbyshire, National Center for Biotechnology, National Institutes of Health, Bethesda, Maryland
M. Farah, SUNY Upstate Medical University, Syracuse, New York
B. Keyes, University of Virginia, Charlottesville
F. Malagon, National Cancer Institute, Frederick, Maryland
This modern, state-of-the-art laboratory course is designed to teach the students the full repertoire of
genetic approaches needed to dissect complex problems in the yeast Saccharomyces cerevisiae.
Combinations of classical genetic approaches are emphasized, including the isolation and characteri-
zation of mutants, tetrad analysis, complementation, and mitotic recombination. Molecular genetic
techniques, including various types of yeast transformation, gene replacement with plasmids and PCR,
construction and analysis of gene fusions, and generation of mutations in cloned genes, were also
emphasized. Students used classical and molecular approaches to gain experience in identifying and
interpreting various kinds of genetic interactions, including suppression and synthetic lethality. Students
were immersed in yeast genomics and performed and interpreted experiments with DNA arrays.
Students gained first-hand experience in modern cytological approaches such as epitope tagging and
imaging yeast cells using indirect immunofluorescence, GFP-protein fusions, and a variety of fluores-
cent indicators for various subcellular organelles. Lectures on fundamental aspects of yeast genetics
were presented along with seminars given by outside speakers on topics of current interest. This
course was supported with funds provided by the National Cancer Institute.
PARTICIPANTS
Arnason, E., Ph.D., University of Iceland, Reykjavik
Brady, T, B.S., Iowa State University, Ames
Bulteau, A. L., Ph.D., Case Western Reserve University,
Cleveland, Ohio
Chabes, A. L., Ph.D., Cold Spring Harbor Laboratory
Charvin, G., B.S., The Rockefeller University, New York
Garbitt, R., B.S., B.A., Tufts University, Boston,
Massachusetts
Gresham, D., Ph.D., Princeton University, New Jersey
Magwene, P., Ph.D., University of Pennsylvania, Philadelphia
Mercer, J., Ph.D., Duke University, Durham, North Carolina
SEMINARS
Basrai, M., National Cancer Institute, Bethesda, Maryland:
Molecular determinants of faithful chromosome transmis-
sion and checkpoint regulation.
Boone, C., University of Toronto, Ontario, Canada: Global
mapping of the yeast genetic interaction network.
Botstein, D., Princeton University, New Jersey: Functional
genomics: Getting beyond descriptive studies.
Bretscher, A., Cornell University, Ithaca, New York:
Combining genetics and cell biology to elucidate the mech-
anism of polarized growth and organelle segregation.
Curcio, J., University at Albany School of Public Health, New
York: Retrotransposons to the rescue: How Tyl elements
respond to challenges to the genome.
Emr, S., HHMI/University of California, San Diego: From
genes to functions: Genetics of phosphoinositide lipid and
ubiquitin signaling in receptor sorting at the endosome.
Johnston, M., Washington University School of Medicine, St.
Louis, Missouri: Feasting, fasting and fermenting: Glucose
sensing and signaling in yeasts.
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Paumi, C., Ph.D., Johns Hopkins University School of
Medicine, Baltimore, Maryland
Saerens, S., M.S., Catholic University of Leuven, Belgium
Sandberg, R., M.S., Karolinska Institutet, Stockholm,
Sweden
Sengpta, A., Ph.D., Rutgers University, Piscataway, New
Jersey
Tong, Z., B.S., University of Pennsylvania, Philadelphia
Tseng, C., A.B., Harvard Medical School, Boston,
Massachusetts
Wagner, M., B.S., University of California, San Diego, La Jolla
Konopka, J., Stony Brook University, New York: Genetic
analysis of the pheromone pathway: The meaning of
screening and the basis for epistasis.
Michaelis, S., Johns Hopkins School of Medicine, Baltimore,
Maryland: Biogenesis of the a-Factor mating pheromone in
S. cerevisiae: From yeast mating to human disease.
Michels, C., Queens College/City University of New York,
Flushing: The regulation of maltose fermentation: A com-
plex brew.
Pringle, J., University of North Carolina, Chapel Hill:
Morphogenesis and cytokinesis in yeast.
Smith, M.M., University of Virginia, Charlottesville: Genetics
of chromatin structure and function.
Stearns, T, Stanford University, California: Yeast genetics:
Teaching it and doing it-at the same time!
Tyers, M., Samuel Lunenfeld Research Institute/Mt. Sinai
Hospital, Toronto, Canada: Genetics of size control: From
the classic to the systematic.
Stem Cells
July 29-August 11
INSTRUCTORS G. Keller, Mt. Sinai School of Medicine, New York
R. McKay, National Institutes of Health, Bethesda, Maryland
A. McLaren, University of Cambridge, United Kingdom
J. Rossant, Samuel Lunenfeld Research Institute, Toronto, Canada
A. Surani, University of Cambridge, United Kingdom
This two-week lecture course brought together leading researchers in the stem cell field with a small
group of international students. Stem cells construct organs in development. They sustain tissues in
the adult and restore them after injury. Because of these properties, isolating and manipulating stem
cells has become a major new element in biomedical science. This lecture and discussion course cov-
ered a series of subjects including the cells of the early embryo, the nature of germ cells, the mecha-
nisms that control the number of stem cells, and their stability and transformation into other cell types.
The clinical potential and political impact of stem cell technology was also presented in depth by invit-
ed speakers. A key feature of the course was the easy access to the instructors and the invited lec-
turers for informal discussion. The purpose of the course provided participants with an opportunity to
achieve an advanced understanding of the scientific and clinical importance of stem cells. The course
was held at the Laboratory's Banbury Conference Center located on the north shore of Long Island.
All participants stayed within walking distance of the Center, close to tennis court, pool, and private
beach. This is a unique learning environment. Partial support for the course was provided by the Eppley
Foundation for Research and the Howard Hughes Medical Institute.
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PARTICIPANTS
Abeyewickreme, A., B.A., Institute of Child Health, London,
United Kingdom
Bao, J., Ph.D., Washington University, St. Louis, Missouri
Bian, Z., Ph.D., Karolinska lnstitutet, Stockholm, Sweden
Erices, A., Ph.D., Universidad Andres Bello, Santiago, Chile
Fossati, V., Ph.D., University of Bologna, Italy
Gangemi, R., M.D., National Institute of Cancer Research,
Genova, Italy
Hipp, J., B.S., Wake Forest University School of Medicine,
Winston-Salem, North Carolina
Lin, S.-Y., Ph.D., Mackay Memorial Hospital, Taipei, Taiwan
Maeda, T., B.E., Osaka University, Japan
Mantle, I., Ph.D., University of Michigan, Ann Arbor
Newey, S., Ph.D., Cold Spring Harbor Laboratory
SEMINARS
Battey, J., National Institutes of Health/NIDCD, Bethesda,
Maryland: Politics of stem cells.
Burden, S., New York University School of Medicine, New
York: Muscle function and regeneration.
Coffey, R., Vanderbilt University School of Medicine,
Nashville, Tennessee: Colon cancer.
Eidelberg, D., North Shore-Long Island Jewish Health
System, Manhasset, New York: Cell therapy in Parkinson's
disease.
Geijsen, N., Massachusetts General Hospital, Charlestown:
Derivation of germ cells from ES cells.
Gould, E., Princeton University, New Jersey: Neurogensis in
the adult brain.
Johnston, L., Columbia University, New York: Control of cell
growth and cell division during development.
Keller, G., Mt. Sinai School of Medicine, New York:
Hematopoiesis by ES cells.
Kikyo, N., University of Minnesota, Minneapolis: Genomic
reprogramming,
Krause, D., Yale University, New Haven, Connecticut:
Transdifferentiation of bone marrow.
Lehmann, R., Skirball Institute, New York University, New
York: Drosophila germ cells.
Lemischka, I., Princeton University, Rutgers, New Jersey:
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Pillai, A., B.S., University of California, San Diego, La Jolla
Riva, F., Ph.D., University of Pavia, Italy
Rochford, C., B.S., European Neuroscience Institute,
Gottingen, Germany
Schenke-Layland, K., Ph.D., Friedrich Schiller University,
Jena, Germany
Schmelzer, E., Ph.D., University of North Carolina, Chapel Hill
Tesar, P., Ph.D., National Institutes of Health and University of
Oxford, Bethesda, Maryland
Testa, G., Ph.D., Dresden University of Technology/Max-
Planck Institute, Germany
Wahle, J., B.S., University of South Florida, Tampa
Wirta, V., M.S., Royal Institute of Technology, Stockholm,
Sweden
Transcriptional signature of stem cells.
Mandel, G., Stony Brook University, New York: Mechanisms
regulating neuronal phenotype and behavior.
McKay, R., National Institutes of Health/NINDS, Bethesda,
Maryland: Neural stem cells.
Schier, A., Skirball Institute of Biomolecular Medicine, New
York: Nodal signaling in vertebrate development.
Simmons, P., Peter Mac Callum Cancer Institute, Australia:
Cells in the bone marrow.
Smith, A., Institute for Stem Cell Research, United Kingdom:
Embryonic stem cells.
Snoeck, H., Mt. Sinai School of Medicine, New York:
Genetics of hematopoiesis.
Tam, R, University of Sydney, Australia: Mechanisms of tis-
sue patterning.
Trumpp, A., Swiss Institute for Experimental Cancer
Research, Switzerland: Development and tumorigenesis.
van Lohuizen, M., Netherlands Cancer Institute, The
Netherlands: Epigenetic regulation of transcriptional states
by higher-order chromatin structures.
Wicha, M., University of Michigan Comprehensive Cancer
Center, Ann Arbor: Breast cancer.
Zoloth, L., Northwestern University, Evanston, Illinois: Stem
cell ethics.
X-ray Methods in Structural Biology
October 18-November 2
INSTRUCTORS W. Furey, V.A. Medical Center, Pittsburgh, Pennsylvania
G. Gilliland, National Institute of Standards & Technology, Gaithersburg, Maryland
A. McPherson, University of California, Irvine
J. Pflugrath, Rigaku/MSC, Inc., The Woodlands, Texas
ASSISTANT I. Persakova, Rutgers, The State University of New Jersey, New Brunswick
Crystallography and X-ray diffraction yield a wealth of structural information unobtainable through other
methods. This intensive laboratory/computational course focused on the major techniques used to
determine the three-dimensional structures of macromolecules. It was designed for scientists with a
working knowledge of protein structure and function, but who are new to macromolecular crystallog-
raphy. Topics covered included basic diffraction theory, crystallization (proteins, nucleic acids, and
complexes), crystal characterization, X-ray sources and optics, synchrotrons, crystal freezing, data col-
lection, data reduction, multiple isomorphous replacement, multiwavelength anomalous diffraction,
molecular replacement, solvent flattening, noncrystallographic symmetry averaging, electron density
interpretation, structure refinement, structure validation, molecular graphics, and coordinate deposi-
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tion. Participants learned through extensive hands-on experiments and formal presentations. They
crystallized, determined, and refined a protein structure in parallel with lectures on the theory and infor-
mal discussions behind the techniques. Extensive use of Linux workstations was made throughout the
course for computational aspects of the process. This course was supported by the National Cancer
Institute.
PARTICIPANTS
Beg lova, N., Brigham & Women's Hospital, Boston,
Massachusetts
Cochrane, J., Yale University, New Haven, Connecticut
Dombrauckas, J., University of Illinois, Chicago
Dzivenu, 0., Fox Chase Cancer Center, Philadelphia,
Pennsylvania
Kamenski, T., University of Munich, Germany
Kawate, T., Columbia University, New York
Lee, M., University of Sydney, Australia
Litowski, J., Ph.D., Columbia University, New York
SEMINARS
Dauter, Z., Brookhaven National Laboratory, Upton, New
York: Anomalous data collection.
Gilliland, G., National Institute of Standards and Technology,
Gaithersburg, Maryland: The protein data bank.
Hendrickson, W., Columbia University, New York: MAD
phasing: Theory and practice.
Joshua-Tor, L., Cold Spring Harbor Laboratory: Argonauts:
The secret of Slicer.
Kjeldgaard, M., Aarhus University, Denmark: Electron density
fitting from A to 0.
Kleywegt, G., University of Uppsala, Sweden: Just because
it's in Nature, doesn't mean it's true...(macromolecular
structure validation).
Perrakis, A., Netherlands Cancer Institute, Amsterdam, The
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Loukachevitch, L., Vanderbilt University School of Medicine,
Nashville, Tennessee
Mylona, A., European Molecular Biology Laboratory,
Grenoble, France
Rhodes, W., University of Southern Maine, Portland
Sivakumar, N., Institute of Molecular Agrobiology, Singapore
Wan, Q., University of Vermont, Burlington
Wei, Y., Brookhaven National Laboratory, Upton, New York
Wilson, K. -A., The Rockefeller University, New York
Yip, C., University of British Columbia, Vancouver, Canada
Netherlands: Shaping the human genome: Structural
insights on the action of retrotransposons.
Pflugrath, J., Rigaku/MSC, Inc., The Woodlands, Texas:
Away from the edge: Sulfur SAD with chromium
radiation.
Richardson, D., Duke University Medical Center, Durham,
North Carolina; Richardson, J., Duke University Medical
Center, Durham, North Carolina: Detection and repair of
model errors using all atom contacts.
Strobel, S., Yale University, New Haven, Connecticut: RNA
crystallography: Structure of a self-splicing intron reaction
intermediate.
Terwilliger, T, Los Alamos National Laboratory, New Mexico:
Solve and resolve.
Bioinformatics: Writing Software for Genome Research
October 20-November 2
INSTRUCTORS S. Lewis, University of California Berkeley
S. Prochnik, University of California, Berkeley
L. Stein, Cold Spring Harbor Laboratory
J. Tisdall, DuPont Experimental Station, Wilmington, Delaware
ASSISTANTS J. Aerts, Wageningen University, The Netherlands
S. Cain, Cold Spring Harbor Laboratory
K. Clark, Cold Spring Harbor Laboratory
M. Dybbs, University of California, Berkeley
R. Halgren, Michigan State University, East Lansing
G. Hartzell, University of California, Berkeley
C. Kennedy, University of California, Berkeley
B. O'Connor, University of California, Los Angeles
J. Stein, Cereon Genomics, Cambridge, Massachusetts
C. Yamada, University of Cambridge, United Kingdom
The desktop computer has rapidly become an indispensable tool in the biologist's tool chest. The suc-
cess of the human genome project created an explosion of information: billions of bits of biological
information stashed electronically in databases around the globe just waiting for the right key to unlock
them. New technologies such as DNA microarrays and high-throughput genotyping are creating an
information overload that the traditional laboratory notebook cannot handle. To exploit the information
revolution in biology, biologists moved beyond canned Web interfaces and Excel spreadsheets. They
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took charge of the data by creating their own software to fetch, manage, and integrate it. The goal of
this course was to provide biologists with the tools needed to deal with this changing landscape.
Designed for students and researchers with little prior knowledge of programming, this two-week
course taught the fundamentals of the Unix operating system, Peri scripting, dynamic Web page devel-
opment with the CGI protocol, and database design. The coursecombined formal lectures with hands-
on experience in which students worked to solve a series of problem sets drawn from common sce-
narios in biological data acquisition, integration, and laboratory workflow management. For their final
projects, students were posed problems using their own data and worked with each other and the fac-
ulty to solve them. Note that the primary focus of this course provided students with the practical
aspects of software development, rather than presenting a detailed description of the algorithms used
in computational biology. For the latter, we recommend the Computational Genomics course. This
course was supported by the National Human Genome Research Institute.
PARTICIPANTS
Acosta, I., B.S., Yale University, New Haven, Connecticut
Chalkia, D., M.S., Penn State University, University Park
Crayton, Ill, M., Ph.D., University of North Carolina, Chapel
Hill
Emes, R., Ph.D., University College London, United Kingdom
Gillespie, M., Ph.D., Cold Spring Harbor Laboratory
Gopinathrao, G., Ph.D., Cold Spring Harbor Laboratory
Goto, D., Ph.D., Cold Spring Harbor Laboratory
Hsiao, W., Ph.D., Simon Fraser University, Burnaby, Canada
Hur le, B., Ph.D., National Human Genome Research Institute,
NIH, Bethesda, Maryland
Karalius, J., B.S., University of Cambridge, United Kingdom
Mapelli, M., Ph.D., European Institute of Oncology, Milan, Italy
SEMINARS
Ashburner, M., University of Cambridge, United Kingdom:
Biological oncologies.
Brent, M., Washington University, St. Louis, Missouri: Gene
prediction.
Hartzell, G., University of California, Berkeley: The tsao of
pert.
Marth, G., Boston College, Chestnut Hill, Massachusetts:
Sequence variation analysis.
Pearson, W., University of Virginia, Charlottesville: Sequence
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Marques, T., Ph.D., Universitat Pompeu Fabra, Barcelona,
Spain
Mund, C., B.S., German Cancer Research Center,
Heidelberg, Germany
Nikolaidis, N., Ph.D., Penn State University, University Park
Przeworski, M., Ph.D., Brown University, Providence, Rhode
Island
Samuelson, A., Ph.D., Massachusetts General Hospital,
Boston
Tammoja, K., M.S., National Institute for Health
Development, Tallinn, Estonia
Yi, S., Ph.D., Georgia Institute of Technology, Atlanta,
Georgia
similarity analysis.
Peitzsch, R., Pfizer Global R&D, Groton, Connecticut:
Modeling biological data in relational databases.
Stein, L., Cold Spring Harbor Laboratory: Generic genome
browser.
Troyanskay, O., Princeton University, New Jersey: Mircroarray
analysis.
Yandell, M., HHMI/University of California, Berkeley: The
BLAST algorithm; Interpreting BLAST statistics.
Immunocytochemistry, In Situ Hybridization, and Live Cell Imaging
October 20-November 2
INSTRUCTORS A. Dernburg, Lawrence Berkeley National Laboratory, Berkeley, California
J. Murray, University of Pennsylvania School of Medicine, Philadelphia
J. Swedlow, University of Dundee, United Kingdom
ASSISTANTS T. Howard, University of New Mexico, Albuquerque
K. Hu, Scripps Research Institute, La Jolla, California
W. Moore, The University of Dundee, United Kingdom
J. Peng, University of California, Berkeley
M. Platani, EMBL, Heidelberg, Germany
This course focused on specialized techniques in microscopy, in situ hybridization, immunocytochem-
istry, and live cell imaging related to localizing DNA, RNA, and proteins in fixed cells, as well as protein
and RNA dynamics in living cells. The course emphasized the use of the latest equipment and tech-
niques in fluorescence microscopy, including confocal laser-scanning microscopy, deconvolution meth-
ods, digital image processing, and time-lapse imaging of living specimens. The course was designed
to present students with state-of-the-art technology and scientific expertise in the use of light
microscopy to address basic questions in cellular and molecular biology. The course was also
designed for the molecular biologist who is in need of microscopic approaches and for the cell biolo-
gist who is not familiar with the practical application of the advanced techniques presented in the
course. Among the methods presented were the preparation of tagged nucleic acid probes, fixation
methods, detection of multiple DNA sequences in single nuclei or chromosome spreads, comparative
genomic hybridization, cellular localization of RNA, localization of nucleic acids and proteins in the
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same cells, use of a variety of reporter molecules and nonantibody fluorescent tags, indirect antibody
labeling, detection of multiple proteins in a single cell, and the use of GFP variants to study protein
expression, localization, and dynamics. In each method, several experimental protocols were present-
ed, allowing the students to assess the relative merits of each and to relate them to their own research.
Students were encouraged to bring their own nucleic acid, protein, or antibody probes to the course,
which were used in addition to those provided by the instructors. The laboratory exercises were sup-
plemented with lectures given by invited distinguished scientists, who presented up-to-the-minute
reports on current methods and research using the techniques being presented. This course was sup-
ported with funds provided by the National Cancer Institute
PARTICIPANTS
Bourke, S., B.S., University of Leeds, United Kingdom
Demarco, I., M.S., University of Virginia, Charlottesville
Fehrenbacher, N., M.A., Danish Cancer Society,
Copenhagen, Denmark
Gallegos, M., Ph.D., University of California, San Francisco
lvakhno, S., B.S., Institute of Molecular Biology and Genetics,
Kyiv, Ukraine
Larsen, L., M.S., Steno Diabetes Center, Gentofte, Denmark
Manning, L., B.S., University of Pittsburgh, Pennsylvania
Novak, I., B.S., Karolinska Institutet, Stockholm, Sweden
Psatha, M., Ph.D., Brigham & Women's Hospital, Boston,
Massachusetts
SEMINARS
Day, R., University of Virginia, Charlottesville: Seeing
colors: Applications and limitations of the fluorescent
proteins.
Dernburg, A., Lawrence Berkeley National Laboratory,
Berkeley, California: Basics of DNA FISH.
Difilippantonio, M., National Cancer Institute/NIH, Bethesda,
Maryland: Mechanisms and consequences of chromosomal
aberrations in cancer cells.
Howard, T., University of New Mexico, Albuquerque: Basics
of RNA FISH.
Hu, K., Scripps Research Institute, La Jolla, California: Basic
introduction to light and fluorescence microscopy.
Murray, J., University of Pennsylvania School of Medicine,
Philadelphia: Immunocytochemistry.
Murray, J., University of Pennsylvania School of Medicine,
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Pugacheva, E., Ph.D., Fox Chase Cancer Center,
Philadelphia, Pennsylvania
Schauss, A., Diplom., Max-Planck Institute for Biophysical
Chemistry, Goettingen, Germany
Specktor, A., B.A., New York University School of Medicine,
New York
Steindler, L., M.S., Tel Aviv University, Israel
Stephano, J., Ph.D., Universidad Autonoma de Baja
California, Ensenada, Mexico
Wang, H., Ph.D., University of Massachusetts Medical
School, Worcester
Wang, L., Ph.D., University of Pittsburgh, Pennsylvania
Philadelphia; Swedlow, J., University of Dundee, United
Kingdom: Principles of confocal microscopy and deconvo-
lution techniques.
Spector, D., Cold Spring Harbor Laboratory: Localization of
gene expression by FISH and in living cells.
Stout, A., University of Pennsylvania, Philadelphia: TIRF
microscopy: Implementation and application to live-cell
imaging.
Svoboda, K., Cold Spring Harbor Laboratory: Applications of
Z-photon microscopy to imaging in vivo.
Tran, P, University of Pennsylvania, Philadelphia: Cameras
and digital imaging fundamentals.
Waterman-Storer, C., Scripps Research Institute, La Jolla,
California: Quantitative fluorescent speckle microscopy in
studies of cell migration.
Computational Genomics
November 3-9
INSTRUCTORS W. Pearson, University of Virginia, Charlottesville
R. Smith, GlaxoSmithKline, King of Prussia, Pennsylvania
ASSISTANT B. Cantarel, University of Virginia, Charlottesville
Beyond BLAST and FASTA-This course presented a comprehensive overview of the theory and prac-
tice of computational methods for gene identification and characterization from DNA sequence data.
The course focused on approaches for extracting the maximum amount of information from protein
and DNA sequence similarity through sequence database searches, statistical analysis, and multiple
sequence alignment. Additional topics included gene recognition (exon/intron prediction), identifying
signals in unaligned sequences, and integration of genetic and sequence information in biological data-
bases. The course combined lectures with hands-on exercises; students were encouraged to pose
challenging sequence analysis problems using their own data. The course made extensive use of local
WWW pages to present problem sets and the computing tools to solve them. Students used Windows
and Mac workstations attached to a Unix server; participants should be comfortable using the Unix
operating system and a Unix text editor. The course was designed for biologists seeking advanced
training in biological sequence analysis, computational biology core resource directors and staff, and
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scientists in other disciplines, such as computer science, who wish to survey current research prob-
lems in biological sequence analysis. The primary focus of this course was the theory and practice of
algorithms used in computational biology, with the goal of using current methods more effectively and
developing new algorithms. Students more interested in the practical aspects of the advanced soft-
ware development were encouraged to apply to course on Advanced Bioinformatics. This course was
supported by the National Human Genome Research Institute.
PARTICIPANTS
Abernathy, B., B.S., Purdue University, West Lafayette,
Indiana
Almedia, H, B.S., Instituto Gulbenkian de Ciencia, Oeiras,
Portugal
Bai, Y., M.S., University of Texas, Arlington
Boukhgalter, B., Ph.D., Broad/MIT Institute for Genome
Research, Cambridge, Massachusetts
Dimitrova, N., Ph.D., Cold Spring Harbor Laboratory
Hagen, D., B.S., Texas A&M University, College Station
Hecht, S., Ph.D., Grand Valley State University, Allendale,
Michigan
Hladish, T., B.S., University of Maryland Biotechnology
Institute, Rockville
North, L., Ph.D., University of California, Davis
Huebinger, R., M.S., Texas A&M University, College
Station
SEMINARS
Altschul, S., National Center for Biotechnology Information,
Bethesda, Maryland: Statistics of sequence similarity
scores; Iterated protein database searches with PSI -BLAST.
Birney, E., EMBL-EBI, Hinxton, United Kingdom: The
ENSEMBL genome database; Genome computation II-ens-
mart.
Cooper, P., National Center for Biotechnology Information,
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Hung, L.-W., Los Alamos National Laboratory, Berkeley,
California
Kelley, J., B.S., University of Cambridge, United Kingdom
Khatun, J., Ph.D., University of North Carolina, Chapel Hill
Proctor, R., Ph.D., NCAUR-Agriculture Research Service-
USDA, Peoria, Illinois
Rainey, S., Ph.D., Queen's University Belfast, North Ireland
Ren, X.-Y., M.S., Wageningen University and Research
Center, The Netherlands
Robertson, C., Ph.D., Geospiza, Inc., Seattle, Washington
Sequin, A., Ph.D., Natural Resources Canada, Sainte-Foy,
Quebec
Shanks, 0., Ph.D., U.S. Environmental Protection Agency,
Cincinnati, Ohio
Vinayaka, C., Ph.D., National Biomedical Research
Foundation, Washington, D.C.
National Library of Medicine, Bethesda, Maryland: NCBI
genome resources.
Rubin, E., Joint Genome Institute, Berkeley, California:
Comparative genomics and biology.
Yandell, M., HHMI/University of California, Berkeley: Genome
annotation; Large-scale computation on genomes-1.
Phage Display of Proteins and Peptides
November 9-22
INSTRUCTORS C. Barbas, Scripps Research Institute, La Jolla, California
D. Siegel, University of Pennsylvania School of Medicine, Philadelphia
G. Silverman, University of California, La Jolla
ASSISTANTS K. Noren, New England Biolabs, Beverly, Massachussetts
J. Struthers, University of California, San Diego
C. Tuckey, New England Biolabs, Beverly, Massachussetts
Recent advances in the generation and selection of antibodies from combinatorial libraries allow for the
rapid production of antibodies from immune and nonimmune sources. This intensive laboratory/lecture
course focused on the construction of combinatorial antibody libraries expressed on the surface of
phage and selection of desired antibodies from the library. Students learned the theoretical and prac-
tical aspects of constructing combinatorial libraries from immune and nonimmune sources, as well as
the construction of synthetic antibody libraries. Antibodies were selected from the library by panning.
Production, purification, and characterization of Fab fragments expressed in E coil were covered.
Peptide phage libraries were also selected and characterized.
The lecture series, presented by a number of invited speakers, emphasized PCR of immunoglobu-
lin genes; the biology of filamentous phage and the utility of surface expression libraries; expression of
antibodies in E coil and mammalian cells, antibody structure, and function; catalytic antibodies; direct-
ed protein evolution; retroviral and cell display libraries; the immunobiology of the antibody response;
321
and recent results on the use of antibodies in therapy. The theory and practical implications for selec-
tion from phage displayed libraries of random peptides, cDNA products, and semisynthetic proteins
were also explored. This course was supported with funds provided by the Howard Hughes Medical
Institute.
PARTICIPANTS
Daad, G.A., M.S., Texas A&M University, College Station
Aggarwal, S., M.S., The Johns Hopkins University, Baltimore,
Maryland
Alm, T., M.S., Royal Institute of Technology, Stockholm,
Sweden
Barman, I., M.A., University of California, San Francisco
Bosnar, M., B.S., Proizvodnja lijekova i vakcina-Research
Institute, Ltd., Zagreb, Croatia
Bratkovic, T., B.S., Lek Pharmaceutical Company, Ljubljiana,
Slovenia
Friedman, M., Ph.D., Royal Institute of Technology,
Stockholm, Sweden
Grippo, V., M.S., Institute of Genetics Engineering and
Molecular Biology Research, Buenos Aires, Argentina
SEMINARS
Barbas, C., Scripps Research Institute, La Jolla, California:
Software and hardware for genomes: Polydactyl zinc finger
proteins and the control of endogenous genes.
Goodyear, C., University of California, San Diego:
Immunobiology of B cell and antibody responses.
Lowman, H., Genentech, Inc., San Francisco, California: SAR
of peptides using phage.
Noren, C., New England Biolabs, Beverly, Massachusetts:
Phage peptide libraries: The PhD for peptides.
Sidho, S., Genentech, Inc., San Francisco, California:
Antibody phage display and chemical diversity in antigen
recognition.
322
Gronwall, C., M.S., Royal Institute of Technology, Stockholm,
Sweden
Lee, S., Ph.D., Singapore General Hospital, Singapore
Love, K., B.S., Harvard Medical School, Boston,
Massachusetts
Mahajan, S., Ph.D., Paradigm Pharmaceuticals, Roseville,
Minnesota
Mason, P., B.Sc., Shriners Hospital/McGill University,
Montreal, Quebec, Canada
Mir, S., M.S., Max-Planck Institute for Biophysics, Frankfurt
Am Main, Germany
Ramasoota, P., Ph.D., Mahidol University, Bangkok, Thailand
Sato, S., B.A., Harvard Medical School, Southborough,
Massachusetts
Siegel, D., University of Pennsylvania Medical Center,
Philadelphia: Cell surface selection of combinatorial Fab
libraries.
Silverman, G., University of California, San Diego: Selection
of complex human antibody libraries.
Smith, G., University of Missouri, Columbia: Phage display of
peptides.
Wilson, I., Scripps Research Institute, La Jolla, California:
Structural biology of the immune system.
Wittrup, K.D., Massachusetts Institute of Technology,
Cambridge: Yeast display libraries.
The Genome Access Course
May 4-5, August 31-September 1, December 1-2
TRAINERS J. Gergel, Cold Spring Harbor Laboratory
G. Howell, The Jackson Laboratory
P. Rabinowicz, The Institute for Genomic Research
Initiated in 2002, this course is an intensive two-day introduction to bioinformatics that was held three
times in 2004 and trained 73 participants in total. The core of the course was designed to cover the
manipulation and analysis of sequence information. The course was broken into modules designed to
give a broad overview of a given topic, with ample time for examples chosen by the instructors. Each
module included three parts, consisting of a discussion of theory and methods, coverage of software
and Web resources, and use of selected tools with examples (including those supplied by the stu-
dents). The modular design allowed the instructors to tailor the presentation to the interests of the stu-
dents. Modules included Electronic Sequence Information; Pairwise Sequence Comparisons; Multiple
Sequence Alignments; Gene Prediction; Genome Analysis; Sequence Variation; Protein Classification
and Structural Analysis; Proteomics; and Phylogenetic Analysis. Applications to the course were open
to all on a first-come-first-served basis, subject to basic eligibility requirements. The course was held
at the Laboratory's Cancer Genome Research Center at Woodbury located seven miles south of the
main Laboratory campus. Each student was provided with a PC laptop with wireless modem for the
duration of the course. Students were encouraged to supply problem sets and sequences of interest
to the trainers for possible incorporation as examples in the modules. Materials were made available
on the Web and students continued to ask questions of the trainers as they applied what they had
learned in their individual endeavors.
May 4-5
Aho, E,. Ph.D., Concordia College, Moorhead, Minnesota
Basu, C., Ph.D., University of Tennessee, Knoxville
Blander, J., Ph.D. Yale University School of Medicine, New
Haven, Connecticut
Cameron, P., Ph.D., University of Illinois, Chicago
Chun, Y.H., Ph.D., University of Michigan, Ann Arbor
Das, S., Ph.D., University of Nebraska Medical Center,
Omaha
Gaboyard, S., Ph.D., University of Illinois, Chicago
Hansen, C., Ph.D., Givaudan Flavors, Cincinnati, Ohio
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Heby, 0., Ph.D., University of Umea, Sweden 90187
Holt, J., Ph.D., University of Chicago, Illinois
Hwang, B.J., Ph.D., California Institute of Technology,
Pasadena, California
Jones, E., Ph.D., Pioneer Hi-Bred, Bondurant, Iowa
Klaper, R., Ph.D., University of Wisconsin, Milwaukee
Kudla, G., B.S., International Institute of Molecular and Cell
Biology, Warsaw, Poland
Liao, F, Ph.D., Pfizer, Kalamazoo, Michigan
Lysakowski, A., University of Illinois, Chicago
Maher, B., Ph.D., University of Pittsburgh, Pennsylvania
Nielsen, A., Ph.D., Novozymes NS, Bagsvaerd, Denmark
Pirity, M., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
Pittenger Alley, L., B.S., USDA-ARS, Athens, Georgia
August 31-September 1
Bazinet, C., Ph.D., St. John's University, Jamaica, New York
Bowman, M., B.S., Lancaster Labs, Richmond, Virginia
Brundage, J., B.S., Northwestern University, Evanston, Illinois
Chen, J., Ph.D., Mt. Sinai School of Medicine, New York
Chugh, S., Ph.D., Oregon Health & Science University,
Portland
Cohen, P., Ph.D., Albert Einstein College of Medicine, Bronx,
New York
Glynn, N., Ph.D., USDA-ARS, Canal Point, Florida
Guo, X., Ph.D., Cold Spring Harbor Laboratory
Guris, D., B.S., University of Chicago, Illinois
Kennerson, M., Ph.D., Neurobiology Laboratory ANZAC
Research Institute, Concord, New South Wales, Australia
Kutty Selva, N., Ph.D., Lund University, Sweden
Latkany, P., Ph.D., New York Eye and Ear Infirmary, New York
Lee, K., B.S., Baylor College of Medicine, Houston, Texas
Lee, Y., Ph.D., Tufts University, Boston, Massachusetts
MacMillan, T, B.S., Defence R&D Canada-Suffield Medicine
Reeleder, R., Ph.D., Agriculture and Agri-Food Canada,
London, England
Snyder, D., B.S., Yale University, New Haven, Connecticut
Tan, M.-H., Ph.D., Van Andel Research Institute, Grand
Rapids, Michigan
Ungvari, Z., Ph.D., New York Medical College, Valhalla
Vinayaka, C., Ph.D., National Biomedical Research
Foundation, Washington, D.C.
Wellen, K., B.S., Harvard School of Public Health, Boston,
Massachusetts
Wong, A., B.S., University of California, Davis
Zhao, Z., Ph.D., University of Michigan, Ann Arbor
Hat, Alberta, Canada
McMahon, A., Ph.D., Harvard University, Cambridge,
Massachusetts
Noehammer, C., Ph.D., ARC Seibersdorf Research GmbH,
Seibersdorf, Austria
Ren, L., Ph.D., Cold Spring Harbor Laboratory
Ridley, S., Ph.D., National Science Foundation, Arlington,
Virginia
Serspinski, T, B.S., Fairleigh Dickinson University,
Edgewater, New Jersey
Shoemaker, K., Ph.D., ZymoGenetics, Seattle, Washington
Svetlanov, A., Ph.D., Albert Einstein College of Medicine,
Bronx, New York
Ward, J., Ph.D., Middlebury College, Vermont
Witonsky, P., Ph.D., Retired Professor: West Chester
University, Cambridge, Massachusetts
Wong, D., Ph.D., Western Regional Research Center,
USDA-ARS, Albany, California
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December 1-2
Avila, A., National University of Mexico-Nitrogen Fixiation,
Cuernavaca
Boczek, L., B.S., U.S. Environmental Protection Agency,
Cincinnati, Ohio
Ca lie, P., Ph.D., Eastern Kentucky University, Richmond
Chen, L., B.S., ZymoGenetics, Seattle, Washington
Csiszar, A., Ph.D., New York Medical College, Valhalla
Dominguez Vidana, R., B.S., UNAM, Cuernavaca, Mexico
Fisher, G., Ph.D., Ridgefield High School, Connecticut
Gonzaga-Jauregui, C., B.S., National University of Mexico,
Mexico City
Griffis, J., B.S., Pioneer Hi-Bred Inc., International, Johnston,
Iowa
Jobanputra, V., Ph.D., Columbia University, New York
Kelty, C., B.S., USEPA, Cincinnati, Ohio
Levon, K., Ph.D., Polytechnic University, Brooklyn, New York
Li, G., Ph.D.,The University of Hong Kong, Hong Kong
Mesri, E., Ph.D., Weill Cornell Medical College, New York
Morales, L., B.S., National University of Mexico-Nitrogen
Fixiation, Cuernavaca
Singh, C., B.S., West Chester University of Pennsylvania,
West Chester
Song, J.-J., B.S., Cold Spring Harbor Laboratory
Thiagarajan, R., B.S., Transgenomic, Gaithersburg, Maryland
Yang, Y., Ph.D., GlaxoSmithKline Pharmaceuticals, King of
Prussia, Pennsylvania
Zheng, X., Ph.D., Children's Hospital of Philadelphia,
Pennsylvania
The Laboratory would like to acknowledge the generosity of the following companies who loaned equipment and
reagents to the various courses:
Affymetrix Inc. Codonics Inc. Kinetic Systems Inc. Promega Corp.
Agencourt Bioscience Corning Inc. Kleindiek Nanotechnik 0-Imaging
Corporation Dagan Corporation LC Packings Qiagen Inc.
Agilent Technologies, Inc. Dage-MTI Inc. Leica Microsystems Inc. Robbins Scientific
Ambion Inc. David Kopf Instruments Luigs & Neumann Corporation
Amersham Biosciences Delaware Diamond Knives Majer Precision Engineering Roche Diagnostics
A.M.P.I. Diagnostic Instruments, Inc. Inc. SD Instruments Inc.
Applied Biosystems Dionex Corp. Med Associates Inc. Santa Cruz Biotechnology
Applied Precision Inc. Drummond Scientific MJ Research Inc. Inc.
ASI Inc. Company Modulation Optics, Inc. Schleicher & Schuell Inc.
Astro-Med Inc. Eastman Kodak Company Molecular Devices Sigma-Aldrich
Axon Instruments Erie Scientific Company Corporation Singer Instrument Company
Becton Dickinson Labware E-Y Laboratories Molecular Probes Inc. Ltd.
Bellco Glass, Inc. Fotodyne Inc. Nalge Nunc International Stratagene
Berthold Technologies USA,
LLC
Galil Motion Control
Hamamatsu Photonic
Narishige International USA,
Inc.
Stoelting Co.
Sutter Instruments
Bio-Rad Laboratories Systems New England Biolabs, Inc. Tecan US Inc.
Bioptechs Inc. Hampton Research New Objective, Inc. Ted Pella Inc.
BioVision Technologies Harvard Apparatus, Inc. Newport Corp. Thermo Electron Corporation
Brinkmann Instruments IBM Life Sciences Solutions Nikon Inc. Thermo Finnigan
Burleigh Instruments, Inc. Improvision Inc. Novagen Inc. Thermo Labsystems
Cambrex Bio Science Instrutech Corp. Olympus America Inc. TILL. Photonics Gmbh
Rockland, Inc. Intelligent Imaging Innovations Optical Insights, LLC Torrey Pines Scientific
Carl Zeiss, Inc. Inc. Optronics Universal Imaging Corporation
Cell and Molecular Invitrogen Corporation PE Biosystems Vector Laboratories
Technologies, Inc. Jackson lmmunoresearch Perkin Elmer Life Sciences Warner Instruments
Chroma Technology Laboratories Pierce Chemical Co. Vysis Corporation
Corporation Jouan, Inc. PolyLC
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SEMINARS
INVITED SPEAKER PROGRAM
Each year, Cold Spring Harbor Laboratory invites speakers from outside the institution to present their
findings on a weekly basis. These seminars keep the CSHL staff current on the latest developments
and broaden their perspectives. Graduate students and postdoctoral fellows meet with the seminar
speakers for lunch immediately after the seminar, allowing an opportunity for the exchange of ideas in
an informal setting.
JANUARY
Dr. Frank Rauscher Ill, The Wistar Institute. Coordinating his-
tone modification, HP1 deposition, and DNA methylation: A
model for gene variegation at euchromatic loci in mammalian
cells. (Host: Winship Herr)
Dr. Ray Deshaies, Division of Biology and HHMI, California
Institute of Technology. Mechanism and regulation of the
SCF ubiquitin ligase-proteasome pathway. (Host: William
Tansey)
FEBRUARY
Dr. David Haig, Department of Organismic and Evolutionary
Biology, Harvard University. Broken symmetries: Genomic
imprinting and social behavior. (Host: Dmitri Chklovskii)
Dr. John Allman, California Institute of Technology. The spindle
neurons of fronto-insular and anterior cingulate cortex: A
phylogenetic specialization of apes and humans related to
social cognition. (Host: Dmitri Chklovskii)
Dr. Zena Werb, Department of Anatomy, University of
California, San Francisco. The tumor microenvironment:
Friend or foe? (Host: Senthil Muthuswamy)
MARCH
Dr. Ulrike Heberlein, Department of Anatomy, University
of California, San Francisco. Studying addiction in
Drosophila. (Host: Hollis Cline)
Dr. Roger Nicoll, University of California, San Francisco.
Glutamate receptor trafficking and synaptic plasticity.
(Host: Roberto Malinow)
Dr. Pamela Silver, Dana Farber Cancer Institute, Harvard
Medical School. Connecting the genome to the cytoplasm.
(Host: Adrian Krainer)
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APRIL
Dr. Michael Rosbash, Department of Biology, HHMI/
Brandeis University. Circadian rhythms in flies:
Molecules, cells, systems, and behavior. (Host:
Josh Huang)
Dr. Stanislas Leib ler, The Rockefeller University.
Fluctuations, noise, and phenotypic variability. (Host:
Yuri Lazebnik)
OCTOBER
Dr. Alan Hall, MRC Laboratory for Molecular Cell Biology and
Cell Biology Unit, University College London. Rho GTPases
and the control of directed cell migration. (Host: Linda Van
Aelst)
NOVEMBER
Dr. Ann-Shyn Chiang, Brain Research Center, National Tsing
Hua University, Taiwan. Mapping candidate memory circuits
in the brain. (Host: Tim Tully)
Dr. Chris Walsh, Howard Hughes Medical Institute, Harvard
Medical School. Genes that control the shape and size of
the human cerebral cortex. (Host: Grigori Enikolopov)
DECEMBER
Dr. Liqun Luo, Stanford University, Department of Biological
Sciences. Exploring neural circuits using genetic mosaic
methods in flies and mice. (Host: Linda Van Aelst)
Dr. Danesh Moazed, Department of Cell Biology, Harvard
Medical School. Targeting RNAi to the chromosome. (Host:
William Tansey)
IN-HOUSE SEMINAR PROGRAM
Cold Spring Harbor In-House Seminars were initiated to provide a semiformal avenue for communication
between the various research groups at the Laboratory. The seminars also afford a necessary opportunity for
the graduate students and postgraduate staff to develop their skills in organizing, presenting, and defending
their research.
JANUARY
Lincoln Stein: A tale of two worms: The C. briggsae
sequencing project.
Eve-Ellen Govek (Van Aelst Lab): The role of Rho-linked MRX
genes in neuronal morphogenesis.
Carlos Brody: A neural model of sequential discrimination:
Memory loading, memory maintenance, and stimulus com-
parison.
Partha Mitra: Developmental learning: How the zebra finch
learns its song.
FEBRUARY
Mike Hemann (Lowe Lab): Myc and RNAi: Tails of a lympho-
maniac.
Rui-Ming Xu: Structural study of transcriptional silencing.
Zachary Lippman (Martienssen Lab): Transposons, hete-
rochromatin, and the evolution of an epigenome.
MARCH
Lab): The influence of visual experience
on retinal axon development.
Andy Neuwald: Evolutionary clues to DNA polymerase III
clamp loader structural mechanisms.
Rotem Karni (Krainer Lab): To splice or not to splice...? The
involvement of splicing in transformation and apoptosis.
APRIL
Elena Ezhkova (Tansey Lab): Cracking the
histone code with the help of the protea-
some.
Niraj Tolia (Joshua-Tor Lab): High-through-
put predictive crystallization and its appli-
cation to malaria invasion processes.
OCTOBER
Masafumi Muratani (Tansey Lab): Lost in translation: Finding
ubiquitin in mRNA quality control.
Shouzhen Xia (Tully Lab): NMDA receptors mediate olfactory
learning and memory in Drosophila.
Prasanth Kannanganattu (Spector Lab): A nuclear retained
regulatory RNA transcribed from a protein coding gene.
Gordon Shepherd (Svoboda Lab): Synaptic circuits in a sen-
sory cortex.
NOVEMBER
Michelle Hastings (Krainer Lab): Wrong site, wrong splice,
wrong message: Election of splice sites in two genetic dis-
eases.
Simon Rumpel (Zador Lab): Detecting learning-induced plas-
ticity in the brain: Synaptic and circuit mechanisms of
memory formation.
Ji-Joon Song (Joshua-Tor Lab): Finding slicer.
DECEMBER
Jidong Liu (Hannon Lab): Dissecting the mechanism of RNA
interference.
Debopriya Das (Zhang Lab): Inferring functional regulatory
elements and their cooperativity from microarray data using
MARSMotif: Case studies from yeast and mammals.
Lincoln Stein
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BANBURY CENTER
EXECUTIVE DIRECTOR'S REPORT
Banbury Center continues to be a thriving setting for specialized, focused meetings on pressing and
emerging topics in biomedical research. In 2004, there were 18 meetings at Banbury Center, with 568
invited participants; 80% of the latter came from the United States, representing 38 states. As usual, New
York, California, Maryland, and Massachusetts contributed the most. Foreign scientists came to Banbury
from 21 countries. The Center continues to be used intensively all year round except during the depths of
winter. In addition to the regular program of meetings, the Watson School of Biological Sciences held two
week-long Topics in Biology courses, and there were five lecture courses in the Laboratory's summer neu-
roscience program. Two local groups also made use of the Center.
The 2004 Banbury Center program again explored a variety of topics, ranging from discussions on
genetic disorders to exploratory meetings on theoretical biology. This year also marked a significant increase
in meetings related to neurobiology, a shift that mirrors the Laboratory's expanding programs on brain devel-
opment and disease. In March, the Center hosted a meeting on the severe neuromuscular disorder: spinal
muscular atrophy. The meeting-Spinal Muscular Atrophy: What Is the Molecular Basis of Neuron Loss? -
organized by Adrian Krainer (Cold Spring Harbor Laboratory), Alex MacKenzie (Children's Hospital of
Eastern Ontario), and Kenneth Fischbeck (National Institute of Neurological Disease and Stroke) and
reviewed the molecular pathology of this disorder. We continued our examination of Fragile X syndrome with
the fifth meeting in a series on that disorder, New Pharmacological and Neurobiological Approaches to the
Treatment of Fragile X, organized by Will Spooren (F. Hoffman-La Roche) and William Greenough (University
of Illinois at Urbana-Champaign). It is remarkable to follow the way in which these meetings have moved
from covering basic research to reviewing possible therapies. T-type Calcium Channels: Their Role in
Normal and Pathological CNS Function, organized by Rodolfo Llinas (New York University Medical Center)
and Ed Perez-Reyes (University of Virginia), went from the molecular biology of these channels to their roles
in epilepsy, pain, and manic depression, whereas Communication in Brain Systems, organized by Terry
Sejnowski (The Salk Institute for Biological Studies), dealt much more with theoretical issues, using model-
ing approaches to understand the structure and engineering of the brain. A fascinating and ambitious meet-
ing, Origins and Evolution of the Nervous System, was organized by Ian Meinertzhagen (Dalhousie
University, Halifax, Nova Scotia) and Volker Hartenstein (University of California, Los Angeles). Participants
reviewed "simple" organisms to see how the morphology, organization, and functioning of their nervous sys-
tems change with the differing behavioral requirements of each organism. Although some organisms were
familiar to Banbury-Escherichia coli, Caenorhabditis elegans, and Drosophila-others, including sponges,
jellyfish, Ascidians, and planarians, made their first appearance at a Banbury Center meeting.
Another parallel to current Laboratory research was our meeting in August on RNAi (RNA interference).
One remarkable thing about RNAi is that it provides a tool for the experimental manipulation of gene expres-
sion and we are also continuing to discover that it has a key role in cellular function. RNA/- related Processes
in Plants: Chromatin, Development, and Defense, organized by
James Carrington (Oregon State University), Steve Jacobson
(University of California, Los Angeles), and Detlef Weigel (Max-Planck
Institute for Developmental Biology), reviewed the ways in which
plants use RNAi in their everyday life. The timing was just right-par-
ticipants were able to hear first-hand from Leemor Joshua-Tor and
Greg Hannon about their latest studies on Dicer, published a few
weeks earlier in the journal Science.
Issues of bioterrorism continue to raise great concerns. The
Department of Homeland Security funded Microbial Forensics, a fol-
low-up meeting to one held in 2003. Organized by Bruce Budowle
(Federal Bureau of Investigation Laboratory), Steven Schutzer
(UMDNJ-New Jersey Medical School), and James Burans (U.S. Robertson House, the former family residence
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Meier House provides housing accommodations for
participants at Banbury Center
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Department of Homeland Security), participants discussed issues
relating to novel infectious diseases affecting humans, agriculturally
important animals, and crop plants. In addition to technical discus-
sions about new methods for the rapid identification of pathogens,
there were reviews of gaps in procedures and what the first steps
should be to ensure that these gaps are filled. Infectious diseases of
a different kind were also explored at the annual meeting sponsored
by the Albert B. Sabin Vaccine Institute-Pandemic Disease Threat:
Can We Develop a Global Vaccine Policy?-which was organized by
Lewis A. Miller (Intermedia, Inc.), Dean D. Mason, and Veronica Korn
(both from the Albert B. Sabin Vaccine Institute). Vaccination remains
the most effective and most cost-effective way to prevent infectious
diseases, and yet there is probably less attention currently paid to
developing and distributing vaccines than at any previous time.
As in many other institutes around the world, genome-based genetics research is a major Laboratory
focus and the major focus of meetings at Banbury. There are great expectations that the intricacies of
genetic mutations will be elucidated using genomic tools, and some of these were included in Breast
Cancer Research: A Critical Review for Future Strategies. Bruce Stillman (Cold Spring Harbor Laboratory)
and Joe Sambrook (Peter Mac Callum Cancer Institute) organized this small but intense meeting, which had
a strong international cast. Understanding what a DNA sequence means continues to be a major theoret-
ical and experimental challenge. Finding the Functional Elements of the Genome, organized by Ewan Birney
(European Bioinformatics Institute), Aravinda Chakravarti (Johns Hopkins University School of Medicine),
Lincoln Stein (Cold Spring Harbor Laboratory), and Richard Young (Whitehead Institute for Biomedical
Research), covered topics ranging from comparative genomics to using experimental techniques to find
transcriptional regulatory elements. One of the most exciting areas of genetics research is in epigenetics-
those changes in genetic information that do not affect the DNA sequence itself yet can be inherited. But
there are problems in deciding how to integrate epigenetic data in DNA sequence databases. Bioinformatic
Strategies for the Epigenome organized by Denise P. Barlow (Center of Molecular Medicine GmbH of the
Osterreichische Akademie der Wissenschafiten) and Robert Martienssen (Cold Spring Harbor Laboratory)
tackled how this might be done.
There is an increasing emphasis on theoretical and mathematical modeling approaches for ordering
and understanding biological data. Integrating Disparate Data to Simulate Lymphocyte Function, orga-
nized by Suzanne Vernon and William C. Reeves (Centers for Disease Control and Prevention), examined
whether there is sufficient information about the functions of lymphocytes, and their interactions with other
cells, to model their behavior during infection. Talks included such recondite ones as "Application of prob-
abilistic inference and machine learning to lymphocyte function."
Banbury Center has had a continuing interest in promoting genetics education. We held such meetings
for science journalists and Congressional staff in conjunction with the Dolan DNA Learning Center and
planned meetings on genetics education for nurses. A similar meeting, Summit Meeting on Genetic Training,
held in 2004, was organized by Bruce Korf (University of Alabama, Birmingham). Participants included rep-
resentatives from the key professional associations involved with genetics and genetic counseling. They
came to review the current state of genetic teaching to physicians and other healthcare professionals, and
to discuss what might be done to give genetics training a higher profile in medical education.
The success of the Banbury Center depends on many people. Bea To liver, Ellie Sidorenko, and Katya
Davey make sure that the meetings run properly, and Chris McEvoy and Joe Ellis keep the estate looking
beautiful. The audiovisual staff, housekeeping, and the meetings office work closely with us as the
Laboratory's meetings programs expand. And, of course, the Center could not work at all without the enthu-
siasm of organizers and participants.
Jan Witkowski
Executive Director
Spinal Muscular Atrophy: What Is the Molecular Basis
of Neuron Loss?
March 7-10
FUNDED BY Spinal Muscular Atrophy Foundation
ARRANGED BY K.H. Fischbeck, National Institute of Neurological Disorders and Stroke, NIH
A. Krainer, Cold Spring Harbor Laboratory
A. MacKenzie, Children's Hospital of Eastern Ontario
Introduction and Welcome: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D. Singh, Spinal Muscular Atrophy Foundation, New York
A. MacKenzie, Children's Hospital of Eastern Ontario, Ottawa, Canada
SESSION 1: The Path to SMA Therapeutics: The Big Picture
Chairperson: S.C. Landis, National Institute of Neurological
Disorders and Stroke, NIH, Bethesda, Maryland: NINDS mission
J. Heemskerk, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland: The SMA project:
Therapeutics development at NINDS.
SESSION 2: Animal Models of Motor Neuron Disease I
Chairperson: S.C. Landis, National Institutes of Health/
NINDS, Bethesda, Maryland
C.E. Beattie, The Ohio State University, Columbus: Motor neuron
development in a zebrafish model of SMA.
T.M. Jesse II, Columbia University, New York: Motor neuron
ontogeny.
A.H.M. Burghes, Ohio State University, Columbus: SMA mice:
When and where SMN corrects of phenotype.
J. Melki, INSERM, Evry, France: Mouse models of SMA:
Valuable tools to evaluate pathophysiology and to design
therapeutic strategies.
SESSION 3: Animal Models of Motor Neuron Disease II
Chairperson: A.H.M. Burghes, Ohio State University,
Columbus
C.J. Di Donato, Children's Memorial Institute for Education &
Research, Chicago, Illinois: How to evaluate in vivo testing of
drugs in animal models.
G.A. Cox, The Jackson Laboratory, Bar Harbor, Maine:
Transgenic rescue of motor neuron disease in the nmd mouse
model of SMARD1.
A.M. Schaefer, Washington University School of Medicine, St.
Louis, Missouri: Motor axon pruning and growth in a mouse
model of ALS: In also studies.
E. Holzbaur, University of Pennsylvania, Philadelphia: Axonal
transport defects in motor neuron degeneration.
G. Dreyfuss, K. Fischbeck
D. Singh, G. Fischbach
SESSION 4: SMN Splicing, Function, and Cellular Sub localization I
Chairperson: A.H.M. Burghes, Ohio State University, Columbus
A. Krainer, Cold Spring Harbor Laboratory: Determinants of
exon 7 inclusion in SMN1/SMN2.
SESSION 5: SMN Splicing, Function, and Cellular Sub localization II
Chairperson: K.H. Fischbeck, National Institute of Neurological Disorders and Stroke, NIH,
Bethesda, Maryland
G. Dreyfuss, HHMI/University of Pennsylvania School of G.J. Bassell, Albert Einstein College, Bronx, New York:
Medicine, Philadelphia: Functions of SMN. Active transport of the survival of motor neuron protein in
U. Fischer, University of Wuerzburg, Germany: Analysis of the axons and growth cones.
cellular function of SMN: Implications for spinal muscular M. Sendtner, Universitat Wuerzburg, Germany: Axonal
atrophy. defects in motor neurons from mouse models of SMA.
SESSION 6: Axonal Pathfinding, Maturation, and Maintenance I
Chairperson: K.H. Fischbeck, National Institute of Neurological Disorders and Stroke, NIH,
Bethesda, Maryland
L.F. Parada, University of Texas Southwestern Medical S.L. Pfaff, Salk Institute, La Jolla, California: LIM transcription
Center, Dallas: Lessons to be learned from modeling neu- factors and spinal motor neuron development.
rofibromatosis.
SESSION 7: Axonal Pathfinding, Maturation, and Maintenance II
Chairperson: G.D. Fischbach, Columbia University, New York
K. Zinn, California Institute of Technology, Pasadena:
Development and maintenance of neuromuscular junctions.
0. Steward, University of California, Irvine: Sorting and intra-
cellular transport of mRNA in neurons.
H. Keshishian, Yale University, New Haven, Connecticut:
Synaptic plasticity in model genetic organism.
SESSION 8: Pharmacologic and Cellular Approaches to, and Clinical Trial Design for, SMA Therapy I
Chairperson: G.D. Fischbach, Columbia University, New York
M. Gurney, deCode Genetics, Inc., Woodbridge, Illinois: Drug
discovery step by step.
G. Dreyfuss, HHMI/University of Pennsylvania School of
Medicine, Philadelphia: SMA therapeutics development.
B.R. Stockwell, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: Diagramming disease net-
works using chemical and biological tools.
SESSION 9: Pharmacologic and Cellular Approaches to, and Clinical Trial Design for, SMA Therapy II
Chairperson: D.C. De Vivo, The Neurological Institute, New York
B. Wirth, Institute of Human Genetics, Bonn, Germany:
Search for drugs that increase the expression SMN2.
C.T. Sumner, National Institute of Neurological Disorders and
Stroke, NIH, Bethesda, Maryland: Histone deacetylase
inhibitors as treatment for spinal muscular atrophy.
A. MacKenzie, Children's Hospital of Eastern Ontario,
Ottawa, Canada: Apoptosis-based modulation of SMA.
D. Kerr, Johns Hopkins Hospital, Baltimore, Maryland:
Embryonic stem-cell-derived motoneurons from SMA mice.
T. Crawford, Johns Hopkins Hospital, Baltimore, Maryland:
Natural history of human SMA and potential surrogate
measures necessary to powering clinical trials.
K.J. Swoboda, University of Utah School of Medicine, Salt
Lake City: Phenotype/genotype correlates: SMN2 copy
number, SMN protein measurement, data, and the role of
modifying factors.
SESSION 10: Where Do We Go From Here? Setting Priorities for Finding Therapies for SMA
Discussion Leader: K.H. Fischbeck, National Institute of Neurological Disorders and Stroke, NIH,
Bethesda, Maryland
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Finding the Functional Elements of the Genome
March 21-24
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY E. Birney, European Bioinformatics Institute
A. Chakravarti, Johns Hopkins University School of Medicine
L. Stein, Cold Spring Harbor Laboratory
R. Young, Whitehead Institute for Biomedical Research
Introductory Remarks: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Genome Sequence and Protein-coding Genes
Chairperson: E. Birney, European Bioinformatics Institute, Cambridge, United Kingdom
E. Green, National Human Genome Research Institute, NIH,
Bethesda, Maryland: Identification of highly conserved
genomic elements by multispecies comparative sequenc-
ing.
M. Zody and M. Clamp, The Broad Institute, Cambridge,
Massachusetts: Feasibility of annotating the human
genome through light sequencing of multiple mammals.
B.A. Cohen, University of Washington School of Medicine,
St. Louis, Missouri: Comparative genomics in yeast.
D. Kulp, University of Massachusetts, Amherst: A general
model of experimental transcriptional evidence.
C.P. Ponting, University of Oxford, United Kingdom:
Variations in evolutionary rates of mammalian genes.
SESSION 2: Experimental Techniques to Discover Function
Chairperson: A. Chakravarti, Johns Hopkins University School of Medicine, Baltimore, Maryland
D. Bail lie, Simon Fraser University, Burnaby British Columbia,
Canada: Using SAGE to identify functional elements in the
C. elegans genome.
J. Schimenti, The Jackson Laboratory, Bar Harbor, Maine:
Relative merits of various in vivo functional genomics strate-
gies in mice.
M. Vidal, Dana-Farber Cancer Institute, Boston,
Massachusetts: Networks in biology.
R.A. Young, Whitehead Institute for Biomedical Research,
Cambridge, Massachusetts: A draft transcriptional regulatory
code for yeast.
J. Hein, University of Oxford, United Kingdom: Two ideas:
Rooting by irreversibility and disentangling overlapping selective
constraints.
J. Hein, R. Wilson
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SESSION 3: Genome-wide Conservation Analysis
Chairperson: E. Green, National Human Genome Research Institute, NIH, Bethesda, Maryland
M. Dermitzakis, University of Geneva Medical School,
Switzerland: Divergence, polymorphism, and evolutionary
characteristics of conserved nongenic sequences.
L. Pachter, University of California, Berkeley: Phylogenetic
SESSION 4: Specific Nongenic Features I
Chairperson: L.D. Stein, Cold Spring Harbor Laboratory
S. Griffiths-Jones, The Wellcome Trust Sanger Institute,
Cambridge, United Kingdom: Progress toward a one-stop
noncoding RNA annotation shop.
E. Fraenkel, Whitehead Institute, Cambridge, Massachusetts:
Combining diverse data sources to identify transcription-
factor-binding sites.
G.D. Stormo, Washington University Medical School, St.
Louis, Missouri: Finding regulatory motifs using coregulated
genes from multiple species.
E. Birney, European Bioinformatics Institute, Cambridge,
United Kingdom: Cis-regulatory discovery in vertebrates.
methods in comparative genomics and applications to
functional element identification.
G. Bejerano, University of California, Santa Cruz: Large-scale
clustering and analysis of human noncoding DNA.
E. Segal, Stanford University, California: Genome-wide dis-
covery of cis-regulatory modules using sequences, expres-
sion, and location data.
S. Jones, Genome Sciences Centre, Vancouver, British
Columbia, Canada: Integrated approaches to regulatory
element detection using the Sockeye platform.
A. Chakravarti, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Coding and noncoding mutations in
human complex disease.
L.D. Stein, Cold Spring Harbor Laboratory: An ontology of
functional elements.
Summary
E. Birney, European Bioinformatics Institute, Cambridge, United Kingdom
A. Chakravarti, Johns Hopkins University School of Medicine, Baltimore, Maryland
L.D. Stein, Cold Spring Harbor Laboratory
R.A. Young, Whitehead Institute for Biomedical Research, Cambridge, Massachusetts
J. Kent, D. Kulp
336
Neuronal and Behavioral Effects of Ras/MAPK Signaling
April 4-7
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY A. Silva, University of California, Los Angeles
J.D. Sweatt, Baylor College of Medicine
L. Van Aelst, Cold Spring Harbor Laboratory
J.J. Zhu, University of Virginia School of Medicine
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SPECIAL SESSION
Chairperson: L. Van Aelst, Cold Spring Harbor Laboratory:
S. Tonegawa, Massachusetts Institute of Technology,
Cambridge: Translational control by MAPK signaling in
long-term synaptic plasticity and memory.
SESSION 1: Learning and Memory
Chairperson: A. Silva, University of California, Los Angeles:
J.D. Sweatt, Baylor College of Medicine, Houston, Texas:
Regulation and targets of ERK in the hippocampus.
S.A. Siegelbaum, Columbia University College of Physicians
& Surgeons, New York: p38 MAPK/12-lipoxygenase signal-
ing in mGluR LTD.
Introduction
E.R. Kandel, HHMI/Columbia University, New York: On mole-
cular mechanisms for synaptic growth and the perpetua-
tion of long-term synaptic plasticity.
Introduction
K. Rosenblum, Haifa University, Israel: Role of MAPK in
memory and LTP consolidation,
D.R. Storm, University of Washington School of Medicine,
Seattle: A new mechanism for sensitization of Erk MAP
kinase during memory formation.
R. Nicoll, D. Bredt, E. Kandel
E. Kandel, J.D. Watson
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SESSION 2: Learning and Memory
Chairperson: R. Malinow, Cold Spring Harbor Laboratory: Introduction
R. Brambilla, DIBIT-HSR, Milano, Italy: Ras/MAPK signalling
in stratum-dependent behavioral plasticity.
Y. Elgersma, Erasmus MC, Rotterdam, The Netherlands: Role
SESSION 3: Cognitive Disorders and Pathology
Chairperson: J.J. Zhu, University of Virginia School of Medicine,
A. Silva, University of California, Los Angeles: Role of neurofi-
bromin in the regulation of synaptic inhibition, plasticity, and
learning and memory: Implications to the treatment of NF1.
Y. Zhong, Cold Spring Harbor Laboratory: Ras-Giap (NF1)-
medicated signaling in learning vs. memory.
L. Mucke, University of California, San Francisco: Behavioral
deficits in transgenic models of Alzheimer's disease: Are
of presynaptic Ras signaling in learning and memory.
P. Stork, Vollum Institute, Oregon Health Sciences University,
Portland: Rap1 activation of ERKs in neuronal cell types.
Charlottesville: Introduction
they due to alterations in MAPK/ERK-related pathways?
S. Dudek, National Institute of Environmental Health
Sciences, Research Triangle Park, North Carolina: Somatic
vs. synaptic ERK activation: Roles of action potentials, fre-
quency, and mode of calcium entry.
E. Thiels, University of Pittsburgh, Pennsylvania: MAPK in hip-
pocampal synaptic plasticity: How specific of a signal is it?
SESSION 4: Synaptic and Morphological Plasticity
Chairperson: M.H. Sheng, HHMI/Massachusetts of Technology, Cambridge: Introduction
D.S. Bredt, University of California, San Francisco: Stargazin:
An AMPA receptor subunit.
G. Thomas, Johns Hopkins School of Medicine, Baltimore,
Maryland: Binding and phosphorylation of PDZ domain pro-
teins by RSK2 regulate synaptic transmission.
H. Cline, Cold Spring Harbor Laboratory: Multiple mecha-
nisms of activity-dependent circuit development in vivo.
R.A. Nicoll, Univesity of California, San Francisco:
Stargazin/TARPs: Role in AMPAR trafficking and plasticity
in the hippocampus.
SESSION 5: Receptors and Channels
Chairperson: J.D. Sweatt, Baylor College of Medicine, Houston, Texas: Introduction
J.W. Hell, University of Iowa, Iowa City: Regulation of postsy-
naptic functions by calmodulin, CaMKII, and a-actinin.
B. Lu, National Institute of Neurological Disorders and Stroke,
NIH, Bethesda, Maryland: Molecular mechanisms underly-
ing acute and long-term synaptic modulation by
neurotrophins.
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D. Johnston, Baylor College of Medicine, Houston, Texas:
MAPK regulation of dendritic K* channels in hippocampal
neurons.
L. Mei, University of Alabama, Birmingham: Prenylation as a
novel mechanism in synapse formation and synaptic plas-
ticity.
S. Tonegawa, D. Johnston, K. Rosenblum, and D. Sweatt
Microbial Forensics
April 18-21
FUNDED BY U.S. Department of Homeland Security (through a grant to the
UMDNJ-New Jersey Medical School
ARRANGED BY B. Budowle, FBI Laboratory
J. Burans, U.S. Department of Homeland Security
S.E. Schutzer, UMDNJ-New Jersey Medical School
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Budowle, FBI Laboratory, Quantico, Virginia
S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
SESSION 1: Scenarios Where Microbial Forensics May Be Applied
Chairperson: S.E. Schutzer, UMDNJ-New Jersey Medical School, Newark
J.P. Burans, U.S. Department of Homeland Security,
Frederick, Maryland: Mission, operation, and structure of the
National Bioforensic Analysis Center. Needs of the BFAC.
B. Budowle, FBI Laboratory, Quantico, Virginia: Points to
consider for microbial forensics.
R.S. Murch, Institute for Defense Analysis, Alexandria,
Virginia: Scenario I: Description and interactive participation
with audience expertise.
R.S. Murch, Institute for Defense Analysis, Alexandria,
Virginia: Scenario II: Description and interactive participant
with audience expertise.
SESSION 2: Collection, Handling, and Analysis of Evidentiary Samples
Chairperson: B.J. Luft, Stony Brook University, New York
D. Beecher, FBI Laboratory, Quantico, Virginia: Current meth-
ods and FBI protocols for sample collection and handling:
Bulk material and traces of bacteria, viruses, and toxins.
R. Okinaka, Los Alamos National Laboratory, New Mexico:
Merging SNP discovery and rapidly evolving markers
toward forensic signatures.
B. Budowle, A. Walsh, J. Dunn, S. Schutzer
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R. Winegar, Midwest Research Institute, Palm Bay, Florida:
Extraction and recovery of minute quantities of nucleic
acids from dilute samples and complex matrices.
J. Ravel, Microbial Genomics, Rockville, Maryland: High-
throughput sequencing and comparative genomic poten-
tials for microbial forensics.
P.J. Jackson, Los Alamos National Laboratory, New Mexico:
Pathogen genotyping.
SESSION 3: Scientific Approaches (II) and Interpretation
Chairpersons: P.J. Jackson, Los Alamos National Laboratory, New Mexico; D.L. Rock, USDA
Agricultural Research Service, Greenport, New York
B. Budowle, FBI Laboratory, Quantico, Virginia: Preservation
of traditional forensic material: Finding trace evidence to link
a suspect to biocrime/bioterrorism.
S. Velsko, Lawrence Livermore National Laboratory,
California: Instrumental analysis and interpretation.
R.B. Harris, Commonwealth Biotechnologies, Inc.,
Richmond, Virginia: Analysis, confirmation, and identifica-
tion of bio-agent toxins: A tiered mass spectrometry
approach.
R. Chakraborty, University of Cincinnati, Ohio: Issues of
diversity and variation and impact on interpretation.
D.J. Ecker, IBIS Therapeutics, ISIS Pharmaceuticals,
Carlsbad, California: Combinatorial methodologies as
applied to microbial forensics.
SESSION 4: Animal Pathogens; Host Response
Chairperson: D.R. Franz, Midwest Research Institute, Frederick, Maryland
D.L. Rock, USDA Agricultural Research Service, Greenport,
New York: Comparative and functional genomics:
Application for human and animal microbial forensics.
B.J. Luft, SUNY, Stony Brook, New York and M.S. Ascher,
Lawrence Livermore National Laboratory, California:
Antibiotic bioavailability in the host as a potential bioforen-
sic marker: Half-lives and tissue deposition.
S.E. Schutzer, UMDNJ-New Jersey Medical School,
Newark: Temporal host responses marking specific
pathogen exposure.
SESSION 5: Lessons Not Yet Learned: Critical Gaps in Microbial Forensics
Chairpersons: B. Budowle, FBI Laboratory, Quantico, Virginia; R. Breeze, Washington, D.C.
S.A. Morse, Centers for Disease Control and Prevention,
Atlanta, Georgia: Role of public health system.
B. Budowle and J. Bannan, FBI Laboratory, Quantico,
Virginia: Role of the FBI in coordinating investigation
of biocrime and bioterrorism with local law
enforcement.
SESSION 6: The Judicial System
Chairperson: L.W.J. Bail lie, Naval Medical Research
Center, Silver Spring, Maryland
R.P. Harmon, Alameda County District Attorney's Office,
Oakland, California: Legal issues: Examples from previous
court cases.
SESSION 7: Critical Issues and How to Proceed to Address
the Gaps before the Next Attack
Chairpersons: B. Budowle, FBI Laboratory, Quantico,
Virginia; S.E. Schutzer, UMDNJ-New Jersey Medical
School, Newark
R. Breeze, Washington, D.C.: Agricultural biocrimes are fun-
damentally different from attacks on people.
Items for the BFAC
Items That Should be Discussed at all Levels of
Government
Research Needed to Fill Gaps in Bioforensics
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J.W. Ezzell, U.S. Army Medical Research Institute of Infectious
Diseases, Fort Detrick, Maryland; L.W. J. Baillie, Noval
Medical Research Center, Silver Spring, Maryland; D.
Beecher, FBI Laboratory, Quantico, Virginia; and T Slezak,
Lawrence Livermore National Laboratory, California:
Experiences from anthrax and ricin attacks.
M. Ascher, J. Ravel, R. Chakraborty
New Pharmacological and Neurobiological Approaches to the
Treatment of Fragile X
April 25-28
FUNDED BY NIH-National Institute of Mental Health (through a grant to University of Illinois)
ARRANGED BY W.T. Greenough, University of Illinois, Urbana-Champaign
W. Spooren, F. Hoffmann-La Roche
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Fragile X: The Clinical Perspective
Chairperson: E. Berry-Kravis, Rush Children's Hospital, Chicago, Illinois
K. Clapp, FRAXA Research Foundation, Newburyport,
Massachusetts: Fragile X: A patient perspective.
D. Bailey, University of North Carolina, Chapel Hill: The
Fragile-X syndrome: Phenotype overview and patterns of
medication use.
R.J. Hagerman, University of California Davis Health System,
SESSION 2: FMR-1 Mouse Models
Chairperson: W.T. Greenough, University of Illinois, Urbana
T. Steckler, Johnson & Johnson Pharmaceutical, Beerse,
Belgium: Mutant mouse: Where hopes meet reality.
R.E. Baylor, Baylor College of Medicine, Houston, Texas:
Behavior of Fmr/KO mice: Role of genetic background and
therapeutic interventions.
B.A. Oostra, Erasmus Universiteit Rotterdam, The
Sacramento: Psychopharmacological interventions in
Fragile X.
S.T. Warren, Emory University School of Medicine, Atlanta,
Georgia: Molecular mechanisms of Fragile-X phenotype
from a molecular perspective.
Netherlands: Enhanced LTD at enlarged Purkinje cell
spines in the cerebellum causes motor learning deficits in
Fragile-X syndrome.
M. Toth, Cornell University Medical College, New York:
Hyperactivity of Fragile-X mice to sensory stimuli: Network
hyperexcitability and alterations in FMRP-target expression.
D. Nelson, B. Oostra, E. Klann, R Jin, S. Warren
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SESSION 3: FMR1 and the Neurobiology of Fragile X
Chairperson: D.L. Nelson, Baylor College of Medicine, Houston, Texas
R.K.S. Wong, SUNY-Health Science Center, Brooklyn, New
York: Metabotropic glutamate receptors and epileptogene-
sis in Fragile-X syndrome.
R.P. Bauchwitz, St. Luke's-Roosevelt Institute of Health
Sciences, Columbia University, New York: What elevated
audiogenic seizure susceptibility in Fragile-X mice reveals
about the etiology of Fragile-X syndrome.
P.W. Vanderklish, Scripps Research Institute, La Jolla,
California: Regulatory interactions between synaptic struc-
ture and local translation.
E. Klann, Baylor College of Medicine, Houston, Texas:
Regulation of translation signaling pathways during mGlur-
LTD in Fmr1 knockout mice.
J. Julius Zhu, University of Virginia School of Medicine,
Charlottesville: Ras signaling of excitatory synapses of
FMR1 knockout mice.
M.F. Bear, HHMI/Massachusetts Institute of Technology,
Cambridge: The mGIuR theory of Fragile X in mental
retardation.
SESSION 4: Emerging Drugable Targets: mGlu Receptors
Chairpersons: W. Spooren, F Hoffmann-La Roche, Basel, Switzerland; G. Bilbe, Novartis Institutes
for BioMedical Research, Basel, Switzerland
M.R. Tranfaglia, FRAXA Research Foundation, Newburyport,
Massachusetts: Clinical/psychiatric presentation of Fragile X.
G. Bilbe, Novartis Pharma AG, Basel, Switzerland: A drug
discovery perspective: Translation from bench to bedside.
V Mutel, Addex Pharmaceuticals SA, Geneva, Switzerland:
Drugability of targets.
M.P. Johnson, Eli Lilly and Company, Indianapolis, Indiana:
Advances in glutamate receptor pharmacology: Targets
galore.
F. Gasparini, Novartis Pharma AG, Basel, Switzerland:
Allosteric modulation for the mGlu receptors: Antagonists,
positive modulators, neutral ligands.
T. Steckler, Johnson & Johnson Pharmaceutical, Beerse,
SESSION 5: Developing Drugs for Fragile X
Chairperson: D. Bailey, University of North Carolina, Chapel
Hill
T.A. Jongens, University of Pennsylvania School of Medicine,
Philadelphia: Effect of pharmacological interventions (MPEP)
on phenotype in the Drosophila Fragile-X mutant MPEP:
Results in Drosophila.
P Jin, Emory University, Atlanta, Georgia: Potential roles of
microRNA and MPEP in Fragile-X syndrome.
H.G.M. Westenberg, University Medical Center Utrecht, The
Netherlands: On the role of dopamine in anxiety disorders:
Recent findings OCD and social anxiety disorder.
E. Berry-Kravis, Rush Children's Hospital, Chicago, Illinois:
Clinical trial of Ampakine CX516 in Fragile-X syndrome.
SESSION 6: Strategies and Goals for Developing Therapies
Moderators: M.R. Tranfaglia, FRAXA Research
Foundation, Newburyport, Massachusetts; W. Spooren, F.
Hoffmann-La Roche, Basel, Switzerland
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Belgium: CRF, antagonists as anxiolytic and antidepressant
drugs.
W. Spooren, F Hoffmann-La Roche, Basel, Switzerland:
Neurokinin 3 (NK3) receptors: A new target for the treat-
ment of psychosis?
G.R. Dawson, Merck Sharp & Dohme Research
Laboratories, Essex, United Kingdom: Role of GAGA -A
receptor subtypes in anxiety and cognition.
B. Settler, Universitat Basel, Switzerland: GAGA -B receptors:
Drug targets for Fragile-X disorders?
C. Dobkin, New York State Institute for Basic Research,
Staten Island: Seizure susceptibility of the Fragile-X mouse
GABAergic system.
J.-L. Claverie, B. Oostra
Breast Cancer Research: A Critical Review for Future Strategies
May 9-12
FUNDED BY Den Haag Foundation
ARRANGED BY J. Sambrook, Peter Mac Callum Cancer Institute
B. Stillman, Cold Spring Harbor Laboratory
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
B. Stillman, Cold Spring Harbor Laboratory
J. Sambrook, Peter Mac Callum Cancer Institute, Melbourne, Australia
SESSION 1: Epidemiology and Risk Assessment
Chairperson: B.J. Ponder, Cancer Research United
Kingdom, Cambridge
D. Easton, Cancer Research United Kingdom, Cambridge:
Risk models for breast cancer: What they tell us and what
we still need to know.
M. Dowsett, Royal Marsden Hospital, London, United
Kingdom: Fitting steroid analyses into risk algorithms for
breast cancer: Opportunities and challenges.
Discussion Moderator: B.J. Ponder, Cancer Research
United Kingdom, Cambridge
SESSION 2: Stem Cells and Development
Chairperson: L.A. Chodosh, University of Pennsylvania
School of Medicine, Philadelphia
T.D. Tlsty, University of California, San Francisco: Early
genetic and epigenetic events in breast cancer.
E.M. Rosen, Georgetown University, Washington, D.C.:
BRCA-I-endocrine interactions: Implications for breast
cancer control and therapy EMR.
Discussion Moderator: L.A. Chodosh, University of
Pennsylvania School of Medicine, Philadelphia
B. Stillman, J.A. Witkowski, J. Sambrook
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SESSION 3: Genetics
Chairperson: G. Chenevix-Trench, The Queensland
Institute of Medical Research, Herston, Australia
K. Offit, Memorial Sloan-Kettering Cancer Center, New York:
Linkage disequilibrium mapping: A tool for breast cancer
susceptibility gene rediscovery?
B.J. Ponder, Cancer Research United Kingdom, Cambridge:
Low-penetrance genes and implications for prevention.
M.-C. King, University of Washington School of Medicine,
Seattle: An approach for finding more genes for inherited
breast cancer.
Discussion Moderator: G. Chenevix-Trench, The
Queensland Institute of Medical Research, Herston,
Australia
SESSION 4: Decision Making
Chairperson: C. Scott, Cold Spring Harbor Laboratory
K. Armstrong, University of Pennsylvania, Philadelphia:
Moving into clinical practice: Technology assessment/adop-
tion and diffusion.
Discussion Moderator: C. Scott, Cold Spring Harbor
Laboratory
SESSION 5: Genomic Changes and Targets I
Chairperson: T. Tlsty, University of California, San
Francisco
A. Zetterberg, Karolinska Institutet, Stockholm, Sweden:
Analysis of deletions and amplications in breast cancer with
quantitative multigene FISH.
M. Wig ler, Cold Spring Harbor Laboratory: Combinatorial
approaches to identification of targets.
J. Hicks, Cold Spring Harbor Laboratory: ROMA analysis of
group cancer cells.
J.W. Gray, Lawrence Berkeley National Laboratory, Berkeley,
California: Genomic events in breast cancer: Diagnostic and
therapeutic opportunities.
A.-L. Borresen-Dale, The Norwegian Radium Hospital, Oslo,
Norway: Challenges of combining large-scale genomic data
of tumors with patients' genotype and clinical outcome.
L. Norton, Memorial Sloan-Kettering Cancer Center, New
York: Strategies for improving breast cancer therapy by the
use of mathematical models of tumor growth kinetics and
the integration of molecular profiling in clinical trials.
SESSION 6: Genomic Changes and Targets II
Chairperson: B. Stillman, Cold Spring Harbor Laboratory
D. Sgroi, Massachusetts General Hospital, Charlestown:
Expression profiling of human breast cancer with capture
microdissection.
Discussion Moderator: E.M. Rosen, Georgetown
University, Washington, D.C.
SESSION 7: Animal Models
Chairperson: S. Lowe, Cold Spring Harbor Laboratory
J. Green, National Cancer Institute, Bethesda, Maryland:
Genomic approaches to understanding mammary cancer
evolution using mouse models.
L.A. Chodosh, University of Pennsylvania School of Medicine,
Philadelphia: Genetically engineered mouse models for
breast cancer susceptibility. Oncogene reversibility and pro-
gression.
Discussion Moderator: S. Lowe, Cold Spring Harbor
Laboratory
SESSION 8: Targets and Trials
Chairperson: M. Dowsett, Royal Marsden Hospital,
London, United Kingdom
M. Pike, University of California School of Medicine, Los
Angeles: Experience with a breast cancer chemoprevention
regimen for premenopausal women based on blocking
ovarian function with a GnRH agonist.
C. Kent Osborne, Baylor College of Medicine, Houston,
Texas: Hormone therapy of breast cancer: How ER and
growth factor receptor pathways collaborate to cause treat-
ment failure and how this cross-talk can be overcome to
restore effective treatment.
Discussion Moderator: M. Dowsett, Royal Marsden
Hospital, London, United Kingdom
SESSION 9: Infrastructure for Breast Cancer Research
Chairperson: J. Sambrook, Peter Mac Callum Cancer
Research Institute, East Melbourne, Australia
SESSION 10: Summary: Goals and Strategies
Discussion Moderators. B. Stillman, Cold Spring Harbor
Laboratory; J. Sambrook, Peter Mac Callum Cancer
Research Institute, East Melbourne, Australia
Communication in Brain Systems
May 16-19
FUNDED BY The Swartz Foundation and The Alfred P. Sloan Foundation
ARRANGED BY T. Sejnowski, The Salk Institute for Biological Studies
Introductions: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
T. Sejnowski, The Salk Institute for Biological Studies, San Diego, California
SESSION 1: Constraints on Communication
Chairperson: T. Sejnowski, The Salk Institute for Biological Studies, San Diego, California
D. Chklovskii, Cold Spring Harbor Laboratory: Brain architecture
maximizes neuronal connectivity while minimizing time delays.
E. Halgren, Massachusetts General Hospital, Charlestown:
Intracolumnar vs. intercolumnar communication in the
human neocortex.
0. Bertrand, INSERM, Lyon, France: Functional modulations
of local and long-distance 13/y oscillatory synchronization:
Evidence from direct intracranial recordings in humans.
S. Makeig, University of California, San Diego: Multiscale evi-
dence of multiscale brain communication.
H. Cohen, G. Chin, G. Tanoni
R. Knight, R Fries, 0. Bertrand
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SESSION 2: Regulation of Communication
Chairperson: S. Makeig, University of California, San Diego
R Fries, University of Nijmegen, The Netherlands: Neuronal
coherence in man and monkey.
E. Buffalo, National Institutes of Health/NIMH, Bethesda,
Maryland: Layer-specific attentional modulation of neuronal
synchrony.
T Sejnowski, The Salk Institute for Biological Studies, San
Diego, California: Inhibitory mechanisms for attentional gain
control.
SESSION 3: Computation and Communication
Chairperson: J.M. Allman, California Institute of Technology,
E. Salinas, Wake Forest University of Medicine, Winston-
Salem, North Carolina: Gain modulation as a mechanism
for the selection of functional circuits.
R. Rao, University of Washington, Seattle: Probabilistic mod-
els of cortical computation and communication.
SESSION 4: Communication Infrastructure
Chairperson: D. Chklovskii, Cold Spring Harbor Laboratory
R. Sarpeshkar, Massachusetts Institute of Technology,
Cambridge: Hybrid computation with spikes.
P. Mitra, Cold Spring Harbor Laboratory: Metabolic cost of
readiness.
G. Tononi, University of Wisconsin, Madison: Traveling waves
and cortical connectivity.
SESSION 5: Command and Control of Communication
R.T. Knight, University of California, Berkeley: Prefrontal mod-
ulation of sensory processing.
Z.F. Mainen, Cold Spring Harbor Laboratory: Prefrontal and
olfactory cortical circuits engaged during odor
G. Rainer, Max-Planck Institute for Biological Cybernetics,
Tubingen, Germany: Phase locking of single neuron activity
to theta oscillations during working memory in monkey
extrastriate visual cortex.
M. Kahana, Brandeis University, Waltham, Massachusetts:
From oscillations in the immature and mature human cortex.
K.K. Kai la, University of Helsinki, Finland: Infraslow oscilla-
tions in the immature and mature human cortex.
Pasadena
J.H. Reynolds, The Salk Institute for Biological Studies, La
Jolla, California: Surface-based attention determines domi-
nance in binocular rivalry.
X.-J. Wang, Brandeis University, Waltham, Massachusetts:
Cortical circuits of working memory and decision-making.
R. da Silveira, Harvard University, Cambridge,
Massachusetts: Short paths and signal propagation in a
model cortex.
D. Ballard, University of Rochester, New York: Prospects for
synchronous communication in the cortex.
discrimination in the rat.
J.M. Allman, California Institute of Technology, Pasadena:
The fronto-insular cortex and the evolution of social
cognition.
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T-type Calcium Channels: Their Role in Normal and Pathological
CNS Function
May 23-25
FUNDED BY Cold Spring Harbor Laboratory
ARRANGED BY R. Llinas, New York University Medical Center
E. Perez-Reyes, University of Virginia
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
SESSION 1: Channel Properties
Chairperson: J.R. Huguenard, Stanford University School of Medicine, California
R. Llinas, New York University Medical Center, New York:
Calcium T-channel properties and intrinsic neuronal activity.
E. Perez-Reyes, University of Virginia, Charlottesville:
Molecular biology of the T-type calcium channel family.
P. Lory, IGH-CNRS UPR, Montpelier, France: New insights
into the use of recombinant T-channels to probe neuronal
excitability.
Y. Yarom, Hebrew University, Jerusalem, Israel: The density
of T-type calcium channels shapes the electrical behavior
of the neuron.
T.P. Snutch, University of British Columbia, Vancouver,
Canada: Development of novel small molecule T-type
calcium channel blockers.
SESSION 2: Rhythms
Chairperson: H.-S. Shin, Korea Institute of Science and Technology, Seoul
D.A. McCormick, Yale University School of Medicine, New
Haven, Connecticut: Control of rhythmogenesis in thalamic
neurons and networks.
J.R. Huguenard, Stanford University School of Medicine,
California: T-channel diversity in thalamic circuits: Functional
consequences for rhythm generation.
V. Crunelli, Cardiff University, United Kingdom: Thalamic T-
type calcium channels in EEG slow waves.
D. Contreras, University of Pennsylvania, Philadelphia:
Thalamic bursting and thalamic quiescence during electro-
graphic seizures.
P. Rhodes, B. Hu, R. Llinas
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SESSION 3: T-channel Role in Normal Function
Chairperson: D.A. McCormick, Yale University School of Medicine, New Haven,
Connecticut
B. Hu, University of Calgary, Alberta, Canada: T-current and
posterior sensory cueing network.
H.-S. Shin, Korea Institute of Science and Technology, Seoul:
T-type calcium channels in thalamic sensory gating and
regulation of novelty-seeking behavior.
G.A. Marini, Centro di Ricerca Sperimentale, Milano, Italy:
Low-frequency (7-12 Hz) neuronal oscillations during brain-
SESSION 4: T Channels in Pathological Conditions
Chairperson: V. Crunelli, Cardiff University, United Kingdom
J.L. Noebels, Baylor College of Medicine, Houston, Texas:
Thalamic T-type currents in mutant mouse models of
epilepsy.
J. Georgia McGivern, Amgen Inc., Thousand Oaks,
California: The potential role of T-type calcium channels in
neuropathic pain.
X. Xie, SRI International, Menelo Park, California: Mechanism
activated states of behaving rats.
N. Leresche, Neurobiologie Cellulaire, Paris, France:
Paradoxical potentiation of neuronal T-type Cat-1 current by
ATP at resting membrane potential.
T Bal, Institut de Neurobiologie Alfred Fessard, Gif-sur-
Yvette, France: Background synaptic noise, T current, and
signal transfer in thalamocortical cells.
of lamotrigine actions: Implications in bipolar disorder.
S. Todorovic, University of Virginia, Charlottesville: Volatile
anesthetics disrupt signaling in the thalamus mediated by a
slowly inactivating T-type calcium channel.
D. Jeanmonod, University Hospital Zurich, Switzerland: Low-
threshold calcium spike bursts and the human thalamocor-
tical dysrhythmia.
Goals and Strategies
Moderators: R. Llinas, New York University Medical Center; E. Perez-Reyes,
University of Virginia
Closing Remarks: J.D. Watson, Cold Spring Harbor Laboratory
D. Jeanmonod, V Crunelli, R. Ramirez
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RNAi-related Processes in Plants: Chromatin, Development,
and Defense
August 15-18
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY J.C. Carrington, Oregon State University
S. Jacobsen, University of California, Los Angeles
D. Weigel, Max-Planck Institute for Developmental Biology
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
J.C. Carrington, Oregon State University, Corvallis
SESSION 1: Mechanisms, Components, and Intersections
Chairperson: D. Weigel, Max-Planck Institute for Developmental Biology, TiThingen, Germany
D.C. Baulcombe, The Sainsbury Laboratory, Norwich, United
Kingdom: Systemic signaling and epigenetic mechanisms in
RNA silencing.
H. Vaucheret, Laboratoire de Biologie Cellulaire, Versailles,
France: Interconnections between miRNA and siRNA path-
ways in plants.
J.C. Carrington, Oregon State University, Corvallis:
Diversification, intersection, and evolution of small RNA
pathways.
O.C. Voinnet, Institute de Biologie Moleculaire des Plantes du
SESSION 2: RNAi, Chromatin, and Transcriptional
Silencing
Chairperson: B. Bartel, Rice University, Houston, Texas
S. Jacobsen, University of California, Los Angeles: RNA-
directed chromatin modifications in Arabidopsis.
S. Henikoff, Fred Hutchinson Cancer Research Center,
Seattle, Washington: DNA methylation profiling identifies
targets of epigenetic regulators in Arabidopsis.
M. Matzke, Austrian Academy of Sciences, Vienna:
Genetic analysis of RNA-mediated transcriptional gene
silencing.
J. Bender, Johns Hopkins University, Baltimore, Maryland:
RNA-directed DNA methylation of the endogenous PAI
genes in Arabidopsis.
C.S. Pikaard, Washington University, St. Louis, Missouri:
Ribosomal RNA gene silencing.
P.M. Waterhouse, CSIRO Plant Industry, Canberra,
Australia: siRNA-mediated methylation in plants.
CNRS, Strasbourg, France: In planta imaging of miRNA
transcription and endonucleolytic cleavage activity.
G. Hannon, Cold Spring Harbor Laboratory: RNAi:
Mechanism and application.
L. Joshua-Tor, Cold Spring Harbor Laboratory:
Slicer-Revealed.
D.J. Patel, Memorial Sloan-Kettering Cancer Center,
New York: Protein-RNA recognition events in RNA
interference.
M. Timmermans, J. Fletcher, K. Barton
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SESSION 3: RNAi, Chromatin, and Development
Chairperson: S. Jacobsen, University of California, Los Angeles
V.L. Chandler, University of Arizona, Tucson: Role of tandem
repeats in paramutation at the bi locus in maize.
R. Martienssen, Cold Spring Harbor Laboratory:
Heterochromatin, RNAi, and epigenetic gene control.
C. Dean, J. Innes Centre, Norwich, United Kingdom: Do
small RNAs play a role in FLC regulation?
R. Amasino, University of Wisconsin, Madison: Epigenetic
regulation of flowering via vernalization.
X. Chen, Waksman Institute, Rutgers University, Piscataway,
New Jersey: siRNAs in the regulation of natural flowering
behavior in Arabidopsis.
J.-K. Zhu, University of California, Riverside: Small RNAs,
transcriptional gene silencing, and their role in abiotic
stress responses.
SESSION 4: microRNAs and Developmental Mechanisms
Chairperson: D.C. Baulcombe, The Sainsbury Laboratory, Norwich, United Kingdom
B. Bartel, Rice University Houston, Texas: MicroRNA regulation of
NAC-domain targets is required for proper formation and sepa-
ration of adjacent embryonic, vegetative, and floral organs.
D. Weigel, Max-Planck Institute for Developmental Biology,
Tubingen, Germany: Specificity of plant microRNAs.
K. Barton, Carnegie Institution of Washington, Stanford,
California: MicroRNA-mediated methylation of the class Ill
HD-ZIP genes.
M. Timmermans, Cold Spring Harbor Laboratory: miRNA
signals specify adaxial/abaxial leaf polarity.
J. Fletcher, USDA/University of California, Berkeley, Albany:
MicroRNA regulation of Arabidopsis shoot apical meristern
activity.
R. Scott Poethig, University of Pennsylvania, Philadelphia:
Role for RNAi in the regulation of vegetative phase change
in Arabidopsis.
SESSION 5: Defense, Counterdefense, and Posttranscriptional Silencing
Chairperson: M. Matzke, Austrian Academy of Sciences, Vienna
S. Huang, Monsanto Company, Mystic, Connecticut: Use of gene
suppression to alter the amino acid composition of corn grain.
P Green, University of Delaware, Newark: Novel approaches with
potential for identification of small RNAs and target mRNAs.
T Hall, National Institute of Environmental Health Sciences,
Research Triangle Park, North Carolina: Size selective
recognition of siRNA by an RNA silencing suppressor.
J. Burgyan, Agricultural Biotechnology Center, Godollo,
Hungary: Molecular aspects of plant-virus-induced RNAi
and suppression.
S.-W. Ding, Center for Plant Cell Biology, University of
California, Riverside: miRNAs in viral pathogenesis.
V.B. Vance, University of South Carolina, Columbia:
Dissecting the roles of HC-Pro and Arabidopsis dicer-like
proteins in small RNA metabolism.
B. Ding, Ohio State University, Columbus: Viroid: A small
noncoding RNA that traffics within a plant and alters devel-
opmental processes.
Summary: Moderator: J.C. Carrington, Oregon State University, Corvallis
J. Roberts, T. Adams, S. Huang
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Origins and Evolution of the Nervous System
August 29-September 1
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY V. Hartenstein, University of California, Los Angeles
I.A. Meinertzhagen, Dalhousie University, Halifax, Nova Scotia
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
V. Hartenstein, University of California, Los Angeles
I.A. Meinertzhagen, Dalhousie University, Halifax, Nova Scotia
SESSION 1: To Begin at the Beginning: CNS Component Molecules ("Nuts and Bolts")
Chairperson: P.A.V. Anderson, University of Florida, St. Augustine
N.C. Berg, Harvard University, Cambridge, Massachusetts: E
coli in motion: Physics of a single-celled nervous system.
R.W. Meech, University of Bristol, United Kingdom: Role of
ion channels in sponge and jellyfish behavior: Minimalism
and beyond.
B.M. Degnan, University of Queensland, Brisbane, Australia:
Origins of the nervous systems: Insights from sponges and
other basal metazoans.
P.A.V. Anderson, University of Florida, St. Augustine:
Properties of the earliest nervous systems.
SESSION 2: Genes, Neural Patterning, and the Bilaterian Ancestor ("Stars and Stripes")
Chairperson: V. Hartenstein, University of California, Los Angeles
T. Gojobori, National Institute of Genetics, Shizuoka, Japan:
Search for the evolutionary origin of the CNS: Comparative
studies of gene expression in planarian and hydra neural cells.
V. Hartenstein, University of California, Los Angeles:
Drosophila head structures compared with vertebrates:
What does this reveal about the bilaterian ancestor?
H. Reichert, University of Basel, Switzerland: Origin of the tri-
partite bilaterian brain: Developmental genetic insights from
Drosophila.
C.J. Lowe, University of California, Berkeley: The problems of
reconstructing ancestral nervous systems from conserved
patterning genes: Insights from hermichordates.
C. Nielsen, University of Copenhagen, Denmark: Apical organs
and adult brains in protostomes and deuterostomes.
G. Scholtz, Humboldt University, Berlin, Germany: Levels of
homology of nervous systems.
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SESSION 3: Evolution of Cell Types: Genes for Neural Determination and Diversification
("Assembling the Team")
Chairperson: P. Lemaire, University of Marseille, France
L. Moroz, University of Florida, St. Augustine: Genomic
approaches to the origin and evolution of the nervous
system: Insights from molluscan neurogenomics.
P. Callaerts, University of Leuven, Belgium: Making neurons
work: Insights from transcription factor-target gene studies.
D. Arendt, EMBL, Heidelberg, Germany: Tracing cell type
diversification in nervous system evolution: A photorecep-
tor-centric view.
P. Lemaire, University of Marseille, France: Neural induction
in chordates: An ancestral role for FGF as a neural inducer.
H. Wada, University of Tsukuba, Japan: Molecular evolution-
ary background for the innovation of the neural crest.
SESSION 4: The Chordate and Arthropod Progression ("Prometheus' Herald")
Chairperson: I.A. Meinertzhagen, Dalhousie University, Halifax, Nova Scotia
L. Holland, University of California, San Diego: Amphioxus
and the evolutionary origins of the midbrain/hindbrain junc-
tion and neural crest.
S. Shimeld, University of Reading, United Kingdom: The evo-
lutionary origin of vertebrate cranial sensory systems.
C. Ragsdale, University of Chicago, Illinois: Comparative mol-
ecular histology on the origins of the mammalian cerebral
cortex.
SESSION 5: Evolution of Cells and Circuits "Nexus and Plexus"
Chairperson: M. Bate, University of Cambridge, United Kingdom
M. Bate, University of Cambridge, United Kingdom: Body
plans and circuit diagrams for locomotor networks.
I.A. Meinertzhagen, Dalhousie University, Halifax, Nova
Scotia: Cells, synapses, and circuits in the fly visual system:
New circuits from old cells.
D.H. Paul, University of Victoria, Canada: How a real nervous
system really evolved: Adding to, deleting from, and mess-
N.J. Strausfeld, University of Arizona, Tucson: Using neural
architectures to reconstruct evolutionary trajectories within
the arthropods.
S. Harzsch, University of Ulm, Germany: Arthropod relation-
ships: Linking brain architecture and phylogeny.
R.J. Greenspan, The Neuroscience Institute, San Diego,
California: Arousal, attention, and the rudiments of con-
sciousness in Drosophila.
ing around with ancient neurobehavioral circuitry.
P.S. Katz, Georgia State University, Atlanta: Parallel, conver-
gent, and divergent evolution of neural circuits in sea slugs.
D. Chklovskii, Cold Spring Harbor Laboratory: Why are
neurons where they are? Why do neurons have the shape
they do?
Overall General Discussion and Summary
Chairpersons: R.J. Greenspan, The Neuroscience
Institute, San Diego, California; H. Reichert,University of Basel, Switzerland; C. Nielsen, University of Copenhagen, Denmark; I.A. Meinertzhagen,Dalhousie University, Halifax, Nova Scotia; V. Hartenstein, University of California, Los Angeles
H. Bourne, D. Paul352
Integrating Disparate Data to Simulate Lymphocyte Function
September 19-22
FUNDED BY Centers for Disease Control and Prevention
ARRANGED BY W.C. Reeves, Centers for Disease Control & Prevention
S. Vernon, Centers for Disease Control & Prevention
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
S. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
SESSION 1: Assessment of Normal Lymphocyte Function
Chairperson: U. Vollmer-Conna, University of New South Wales, Sydney, Australia
W.F. Hickey, Dartmouth-Hitchcock Medical Center, Lebanon, M. Dustin, New York University School of Medicine, New
New Hampshire: Leukocyte trafficking in the CNS: York: Integrins and lymphocyte function.
Communication between the brain and the body. M. Gunzer, German Research Centre for Biotechnology,
A. Shaw, Washington University, St. Louis, Missouri: Braunschweig, Germany: Dynamic imaging of immune cell
Mediating lymphocyte function via the immunological migration.
synapse.
SESSION 2: Lymphocyte Function in Persistent Infection
Chairs: P.D. White, St. Bartholomew's Hospital, London, United Kingdom
W.F. Hickey, Dartmouth-Hitchcock Medical Center, Lebanon,
New Hampshire: Effect of persistent infection on leukocyte
trafficking and function in the CNS.
A. Shaw, Washington University, St. Louis, Missouri: The
immunological synapse of persistently infected lympho-
cytes.
M. Dustin, New York University School of Medicine, New
York: Effect of persistent infection on integrin-mediated T-
cell function.
R. Taylor, University of Illinois, Chicago: Stress and lympho-
cyte function.
S. Efroni, E. Alakson
P.D. White, A. Lloyd
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SESSION 3: Managing and Integrating Disparate Data
Chairperson: A. Lloyd, University of New South Wales, Sydney, Australia
A.K. Chakraborty, University of California, Berkeley:
Integrating in silico and in vitro experiments to study how
T lymphocytes communicate.
W. Tong, FDA's National Center for Toxicological Research,
Jefferson, Arkansas: Integrating disparate data sources with
data mining and visualization to facilitating toxicogenomics
research
T Wymore, Pittsburgh Supercomputing Center, Pennsylvania:
Integrating structural bioinformatics and molecular
simulation for the prediction of protein structure and
function.
L. You, California Institute of Technology, Pasadena: Integrated
understanding of biological networks by modeling.
S. Efroni, National Institutes of Health/NIAID, Bethesda,
Maryland: Exploring emergent complexity: Reactive anima-
tion of thymocyte development.
SESSION 4: Computer Models of Living Cells
Chairpersons: E. Aslakson, Centers for Disease Control & Prevention, Atlanta, Georgia;
B. Gurbaxani, Center for Disease Control & Prevention, Atlanta, Georgia
B. Geortzel, Biomind LLC, Wheaton, Maryland: Application of
probabilistic inference and machine learning to lymphocyte
function.
A. Rundell, Purdue University, West Lafayette, Indiana:
Mathematical modeling and analysis of T-cell signaling.
J. Fostel, National Center for Toxicogenomics, Research Triangle
Park, North Carolina: Object models for system biology data.
S. Kumar, DARPA, Information Processing Technology
Office, Arlington, Virginia: Bio-SPICE: An informatics and
simulation tool for cell processes.
G. Broderick, University of Alberta, Canada: A parallel
particle-based approach to whole-cell modeling.
SESSION 5: Brainstorming Session
Chairperson: S. Vernon, Centers for Disease Control & Prevention, Atlanta, Georgia
Discussion with facilitators
Is simulation of a lymphocyte feasible?
Should the focus of simulation be on a lymphocyte
function?
What are the pros and cons of simulated models?
Does the current CFS immune data implicate a cell type or
function that could be simulated?
Is there a need for wet-lab work to augment our knowl-
edge of lymphocyte function?
If so, what is the most likely place to start?
What are the (other) requirements?
Report by facilitators
Concluding Summary
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Training and Education in Medical Genetics
October 20-22
FUNDED BY Participant Funding
ARRANGED BY B.R. Korf, University of Alabama, Birmingham
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Welcome and Overview of Meeting:
G. Feldman, Wayne State University, Detroit, Michigan
B.R. Korf, University of Alabama, Birmingham
G. Wiesner, Case Western Reserve University,
Cleveland, Ohio
Introductions
Brief Presentations
SESSION 1
C. Epstein, University of California, San Francisco: History
and rationale for current approach to medical genetics
training.
G. Wiesner, Case Western Reserve University, Cleveland,
Ohio: Number of accredited MD Clinical Geneticists over
history of ABMG.
G. Feldman, Wayne State University, Detroit, Michigan:
Number of current accredited medical genetics residencies.
M. Blitzer, University of Maryland, Baltimore: Workforce
study.
B.R. Korf, University of Alabama, Birmingham: Goals of
physician training in medical genetics and roles of vari-
ous types of professionals.
C. Epstein, V. Proud
I --,
SESSION 2
G. Wiesner, Case Western Reserve University, Cleveland,
Ohio: Obstacles and challenges being faced in attract-
ing trainees, supporting their training, and positioning
them in the field.
G. Feldman, Wayne State University, Detroit, Michigan:
Propose approaches to overcome the obstacles and
challenges noted above.
Discussion
SESSION 3:
Action items and planned follow-up
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Pandemic Disease Threat: Can We Develop a Global Vaccine Policy?
October 24-26
FUNDED BY Albert B. Sabin Vaccine Institute, with the support of the Bill and Melinda Gates Foundation
ARRANGED BY V. Korn, Albert B. Sabin Vaccine Institute
D.D. Mason, Albert B. Sabin Vaccine Institute
L.A. Miller, Intermedica, Inc.
Tri-Chairs: D. Heymann, World Health Organization
A. Osterhaus, Erasmus University Medical Center
L.A. Miller, Intermedica, Inc.
Distinguished Visiting Scholar: J.M. Barry, The Center for Bioenvironmental Research at Tuland and Xavier Universities,
Washington, D.C.: The great influenza: The epic story of the deadliest plague in history.
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
Conference Co-Chairs: D.L. Heymann, World Health Organization, Geneva, Switzerland
L.A. Miller, Intermedica, Inc., Darien, Connecticut
A. Osterhaus, Erasmus University Medical Center, Rotterdam, The Netherlands:
Charge to the Conference.
Keynote Speaker: B. Schwartz, National Vaccine Program Office, Atlanta, Georgia: Global pandemic disease threats.
SESSION 1: Source Recognition and Surveillance
Chairperson: A. Osterhaus, Erasmus University Medical Center, Rotterdam, The Netherlands
Panel
A. Osterhaus, Erasmus University Medical Center, Rotterdam,
The Netherlands
M. Miller, Fogarty International Center, NIH, Bethesda,
Maryland
K. Stohr, World Health Organization, Geneva, Switzerland
M.T. Osterholm, University of Minnesota Academic Health
Center, Minneapolis
M. Miller, Fogarty International Center, NIH, Bethesda,
Maryland, K. Stohr, World Health Organization,
Geneva, Switzerland: What are we looking for?
A. Osterhaus, Erasmus University Medical Center,
Rotterdam, The Netherlands, and M. Osterholm, University
of Minnesota Academic Health Center, Minneapolis: What
constitutes adequate surveillance?
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SESSION 2: Planning and Response to Pandemics: Coordination and Feasibility
Chairperson: K. Stohr, World Health Organization, Geneva, Switzerland
Panel and how quickly could such a plan be developed?
J.T. Matthews, Aventis Pasteur, Swiftwater, Pennsylvania K. Stohr, World Health Organization, Geneva, Switzerland
D. Salisbury, Skipton House, London, United Kingdom B. Schwartz, National Vaccine Program Office, Atlanta,
J. LeDuc, Centers for Disease Control and Prevention, Georgia: Who takes the lead: How and why?
Atlanta, Georgia, J.T. Matthews, Aventis Pasteur, Swiftwater, Pennsylvania,
T. Tam, Health Canada, Ottawa, Ontario and T Tam, Health Canada, Ottawa, Ontario: How do we
B. Schwartz, National Vaccine Program Office, Atlanta, Georgia involve industry in pandemic preparedness?
J. LeDuc, Centers for Disease Control and Prevention,
Atlanta, Georgia Open Discussion and Consensus
D. Salisbury, Skipton House, London, United Kingdom: Is a
functional plan for a vaccine response strategy reasonable Recommendations
SESSION 3: Achieving Capacity and Forecasting Demand
Chairperson: D.L. Heymann, World Health Organization, Geneva, Switzerland
Panel
S. Jadhav, Serum Institute of India, Ltd., Pune, India
I. Raw, Institute Butantan, San Paulo, Brazil
L.K. Gordon, VaxGen, Inc., Brisbane, California: Large-scale
vaccine production.
S. Jadhav, Serum Institute of India, Ltd., Pune, India
L.K. Gordon, VaxGen, Inc., Brisbane, California: Large-scale
vaccine production.
I. Raw, Institute Butantan, San Paulo, Brazil: How can the
developing countries manage if there is a pandemic?
Addressing Regulatory and Liability Concerns
Open Discussion and Consensus
Recommendations
SESSION 4: Political and Economic Considerations on a Global Scale
Chairperson: J. LeDuc, Centers for Disease Control and Prevention, Atlanta, Georgia
Panel
C. Kang, NIH Korea, NIC Korea, Seoul, Korea
M.A. Chafee, The Harbour Group, Washington, D.C.
0. de Oliva, Pan American Health Organization, Washington, D.C.
S. Hall, UNICEF Plads, Copenhagen, Denmark
0. de Oliva, Pan American Health Organization, Washington, D.C.
C. Kang, NIH Korea, NIC Korea, Seoul, Korea: Building a
plan inclusive of developing countries.
S. Hall, UNICEF Plads, Copenhagen, Denmark
M.A. Chafee, Harbour Group, Washington, D.C.: Establishing
political commitment (disclosure, aid, etc.)
Open Discussion and Consensus
Recommendations
Conference Wrap Up/Next Steps from Here
L.A. Miller, Intermedica, Inc., Darien Connecticut
L.A. Miller, D. Heymann, J. Barry, D. Mason
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The Biology of Neuroendocrine Tumors
October 26-29
FUNDED BY The Verto Institute
ARRANGED BY A.J. Levine, Institute for Advanced Study
E. Vosburgh, Verto Institute
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
E. Vosburgh, Verto Institute, Stamford, Connecticut: Verto activities to date.
SESSION 1: Genetics and Epigenetics in Neuroendocrine Tumors
Chairperson: A.J. Levine, Institute for Advanced Study, Princeton, New Jersey
C. Harris, Verto Institute, Princeton, New Jersey: The poten- A. Rashid, MD Anderson Cancer Center, Houston, Texas:
tial role of LINE1 retrotransposons in genomic instability of Genetic and epigenetic alterations in neuroendocrine
human tumors. tumors.
A. Levine, Institute for Advanced Study, Princeton, New R.V. Lloyd, Mayo Clinic, Rochester, Minnesota: Epigenetic
Jersey: SNPS in the p53 pathway. regulation of protein expression in carcinoid tumors.
SESSION 2: Whole-genome Studies of Neuroendocrine Tumors
Chairperson: M.L. Meyerson, Dana Farber Cancer Institute, Boston, Massachusetts
B.T. Teh, Van Andel Research Institute, Grand Rapids, Michigan:
Genetic studies of HPRT2 and its clinical implications.
D.C. Chung, Massachusetts General Hospital, Boston: Gene
expression arrays in pancreatic neuroendocrine and GI car-
cinoid tumors.
P. Dahia, Dana Farber Cancer Institute, Boston,
SESSION 3: Animal Models of Neuroendocrine Tumors
Chairperson: J.A. Epstein, University of Pennsylvania, Philadelphia
S.K. Kim and S. Karnik, Stanford University School of
Medicine, California: Disrupted islet cell growth and differ-
entiation in mouse genetic models.
Massachusetts: Genome-wide approaches to a hereditary
tumor model: potential for gene discovery and identification
of novel signaling interactions in pheochromocytomas.
M.L. Meyerson, Dana Farber Cancer Institute, Boston,
Massachusetts: Systemic genome analysis of cancer by
SNP arrays and exon sequencing.
K. Pietras, University of California, San Francisco: A
multitargeted, metronomic, and MTD "chemo-switch"
regimen is anti-angiogenic, producing objective responses
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and survival benefit in a mouse model of neuroendocrine
cancer.
Y. Xiong, University of North Carolina, Chapel Hill: p18 double
mutants.
T. Look and J. Kanki, Dana Farber Cancer Institute, Boston,
Massachusetts: Targeted expression of MYCN selectively
SESSION 4: Clinical Updates
Chairperson: J. Yao, Gastrointestinal Medical Oncology, Houston
M.H. Kulke, Dana Farber Cancer Institute, Boston,
Massachusetts: Targeted therapies in the treatment of neu-
roendocrine tumors.
J. Yao, Gastrointestinal Medical Oncology, Houston, Texas:
Developing targeted strategies for neuroendocrine carcino-
ma.
SESSION 5: Neuroendocrine Cell Biology
Chairperson: S.K. Kim, Stanford University School of Medicine,
M.L. Meyerson, Dana Farber Cancer Institute, Boston,
Massachusetts: Menin is associated with a histone methyl-
transferase complex.
X. Hua, University of Pennsylvania, Philadelphia: Regulation of
SESSION 6: Carcinoid Tumor Biology
Chairperson: R.V. Lloyd, Mayo Clinic, Rochester, Minnesota
R.V. Lloyd, Mayo Clinic, Rochester, Minnesota: EGFR studies
in carcinoid tumors.
G. Friberg, University of Chicago, Illinois: c-met, p-met status
of carcinoid tumors.
M.N. Kulke, Dana Farber Cancer Institute, Boston,
Massachusetts: VEGF, VEGFR, EGFR, c-Kit, P-Kit, and
SESSION 7: Review and Group Discussion led by Session Chairs
causes pancreatic neuroendocrine tumors in transgenic
zebrafish.
Discussion: Key Points from the Day
A.J. Levine, Institute for Advanced Study, Princeton, New
Jersey, and Evan Vosburgh, Verto Institute, Stamford,
Connecticut
, Texas
L. Kvols, University of South Florida, Tampa: An update on
radiolabeled peptides as therapy for carcinoid and islet cell
carcinomas.
Group discussion: Is there a need for a U.S.-based coop-
erative group for carcinoid and NET?
California
apoptosis by menin.
S.K. Kim, Stanford University School of Medicine, California:
Regulators of islet cell growth and differentiation.
CD31 studies of carcinoid tissue microarrays.
M. Essand, Uppsala University, Sweden: Gene expression
in midgut carcinoid tumors: Potential targets for
immunotherapy.
F Leu, Verto Insititute, Princeton, New Jersey: Antibodies to
extracellular region of hSSTR antibodies) -5.
J. Sack ler, M. Meyerson, A. Levine
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Chromatin Remodeling and Gene Expression in Male Germ Cells
November 14-17
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY P. Sassone-Corsi, Institut de Genetique et de Biologie Moleculaire
et Cellulaire, Illkirch, France
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R Sassone-Corsi, Institut de Genetique et de Biologie Moleculaire
et Cellulaire, Illkirch, France
SESSION 1: Nuclear Organization
D. Spector, Cold Spring Harbor Laboratory: An overview of
nuclear organization.
R. Camerini-Otero, National Institute of Diabetes and
Digestive and Kidney Diseases, NIH, Bethesda, Maryland:
The mammalian sex body: What is required to form it and
what is its role on the evolution of the X chromosome?
P. Moens, York University, Toronto, Canada: Immunocytologi-
cal and FISH analysis of meiotic chromosome core, their
associated proteins, and chromatin loop organization.
SESSION 2: Signaling
M. Matzuk, Baylor College of Medicine, Houston, Texas:
Chromatin and germ-cell biology.
R.E. Braum, University of Washington, Seattle: Androgen
regulation of mammalian spermatogenesis.
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SESSION 3: Chromatin and Epigenetics
S. Henikoff, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Histone variants and nucleosome
assembly pathways.
A. Nussenzweig, National Cancer Institute, NIH, Bethesda,
Maryland: Chromatin remodeling mediated by histone
H2AX
I. Davidson, Institut de Genetique et de Biologic Moleculaire
et Cellulaire, Illkirch, France: Specialization of the general
transcription apparatus and chromatin components in male
germ cells.
M.L. Meistrich, University of Texas/M.D. Anderson Cancer
Center, Houston: Abnormal chromatin remodeling in transi-
tion protein knockout mice.
P.S. Burgoyne, MRC National Institute for Medical Research,
London, United Kingdom: The modulation of X and Y gene
in meiosis and spermiogenesis in the mouse.
T. Bestor, S. Henikoff
SESSION 4: Epigenetics and Meiosis
P. Sassone-Corsi, Institut de Genetique et de Biologic
Moleculaire et Cellulaire, Illkirch, France: Signaling through
aurora kinases in germ cells.
C. Hoog, Karolinska lnstitutet, Stockholm, Sweden:
Organization of the mammalian meiotic chromosome axes.
J. Schimenti, Cornell University, Ithaca, New York: Novel
SESSION 5: Mechanisms of Gene Expression
M.A. Handel, The Jackson Laboratory, Bar Harbor,
Massachusetts: Chromatin correlates of meiotic transcrip-
tional activity.
M.T. Fuller, Stanford University School of Medicine, California:
Regulation of the primary spermatocyte transcription pro-
gram by tissue-specific TAFs.
M. Wilkinson, University of Texas/M.D. Anderson Cancer
Center, Houston: Alternative promoters insulated by tissue-
SESSION 6: Repair Systems
A. Grootegoed, Erasmus University Rotterdam, The
Netherlands: Ubiquitin ligase Rad185c to the XY body and
to other chromosomal regions that are unpaired and tran-
scriptionally silenced in male meiotic prophase.
A. Shinohara, Osaka University, Japan: Role of Radio -Brel -
mediated histone H2B ubiquitylation in the formation of
meiotic mutants in mice recovered by random mutagenesis.
T.H. Bestor, Columbia University: Irreversible gene silencing
in the male germ line.
J. Trasler, Montreal Children's Hospital Research Institute,
Montreal, Canada: Establishing, maintaining, and perturb-
ing DNA methylation patterns in the male germ line.
specific DNA methlation boundaries.
D.J. Wolgemuth, Columbia University Medical Center:
Mutation of the testis-specific bromodomain-containing
gene Brdt results in defects in the differentiation of sper-
matid nuclei and male sterility.
H. Lin, Duke University Medical Center, Durham, North
Carolina: Role of Piwi/Argonaute family proteins in gameto-
genesis.
double-strand breaks during meiotic recombination.
D. Georgia De Rooij, Utrecht University, The Netherlands:
Repair gene expression during meiosis and spermatogenic
arrests in deficient animals.
Review and Group Discussion
M. Meistrich, H. Lin, P. Sassone-Corsi, N. Kortaja
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New Insights into Viral Disease from Mathematical Modeling of
Biological Systems
December 5-8
FUNDED BY Institute for Comparative Genomics
ARRANGED BY R. Breeze, Institute for Comparative Genomics
L. Horn, Institute for Comparative Genomics
W. Laegreid, USDA Agricultural Research Service
D. Rock, USDA Agricultural Research Service
Introduction: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
R. Breeze, Institute for Comparative Genomics, Washington, D.C.: Why this meeting?
SESSION 1: Problems in Viral Pathogenesis
Chairperson: D.L. Rock, University of Connecticut, Storrs
A. Alcami, Centro Nacional de Biotecnologia, Madrid, Spain ABADRL, Laramie, Wyoming
B.L. Jacobs, Arizona State University, Tempe E.S. Mocarski, Stanford University School of Medicine,
P.B. Jahr ling, U.S. Army Medical Research Institute of California
Infectious Diseases, Frederick, Maryland
G. Letchworth, USDA, Agricultural Research Service, Group Discussion
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SESSION 2: Modeling Biological Systems
Chairperson: W.D. Wilson, Lawrence Livermore National Laboratory, California
H. Bolouri, Institute for Systems Biology, Seattle, Washington C.M. Schaldach, Lawrence Livermore National Laboratory,
P. Ghazal, University of Edinburgh Medical School, United California
Kingdom W.D. Wilson, Lawrence Livermore National Laboratory,
P.C. Johnson, Icoria, Inc., Research Triangle Park, North California
Carolina
J. Rose, University of South Carolina, Columbia Group Discussion
SESSION 3: Modeling Virus Systems
Chairperson: W. Laegreid, Agricultural Research Service, Clay Center, Nebraska
R.A. Arnaout, Brigham & Women's Hospital, Harvard Medical
School, Chestnut Hill, Massachusetts
R. Asquith, Imperial College, London, United Kingdom
N.M. Ferguson, Imperial College London, United Kingdom
A. Perelson, Los Alamos National Laboratory, New Mexico
R.J. Srivastava, University of Connecticut, Storrs
L. Weinberger, Berkeley, California
SESSION 4: Discussion of Research Needs/Opportunities/Challenges
SESSION 5: The Way Forward
Chairperson: R. Breeze, Institute for Comparative Genomics, Washington, D.C.
C. Cooke, P. Jahr ling
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Bioinformatic Strategies for the Epigenome
December 12-15
FUNDED BY Cold Spring Harbor Laboratory Corporate Sponsor Program
ARRANGED BY D.P. Barlow, Center of Molecular Medicine GmbH of the Osterreischische
Akademie der Wissenschaften
R. Martienssen, Cold Spring Harbor Laboratory
INTRODUCTION: J.A. Witkowski, Banbury Center, Cold Spring Harbor Laboratory
D.P. Barlow, Center of Molecular Medicine GmbH of the Osterreischische
Akademie der Wissenschaften and
R. Martienssen, Cold Spring Harbor Laboratory: Goals of Meeting: What are
the key issues for integrating epigenetic data and bioinformatics?
SESSION 1
Chairperson: D.P. Barlow, Center of Molecular Medicine GmbH of the Osterreischische Akademie
der Wissenschaften
R. Martienssen, Cold Spring Harbor Laboratory:
Transposons, tandem repeats, and small interfering RNA in
Arabidopsis heterochromatin.
S. Beck, The Sanger Institute, Cambridge, United Kingdom:
The human epigenome project: The pilot.
S. Eddy, HHMI/Washington University School of Medicine, St.
Louis, Missouri: Computational methods for noncoding
RNA structure and sequence analysis.
J. Walter, Saarland University, Saarbrucken, Germany:
SESSION 2
Chairperson: T.R. Gingeras, Affymetrix, Santa Clara, California
L. Ringrose, University of Heidelberg, Germany: Bioinformatic
prediction of polycomb response elements in flies and ver-
tebrates.
H. Stunnenberg, University of Nijmegen, The Netherlands:
Functional genomics: Deciphering gene regulatory networks
by Mass Spec and ChIP-chip.
J. Lieb, University of North Carolina, Chapel Hill: Nucleosome
dynamics and transcription factor target selection in yeast.
B.D. Dynlacht, New York University School of Medicine, New
York: Understanding mammalian cell cycle control and dif-
ferentiation on a genome-wide scale.
G. Karpen, University of California, Berkeley: Epigenetics and
chromosome functions.
W.G. Kelly, Emory University, Atlanta, Georgia: Homology
pairing effects, genome defense, and sex chromosome
evolution in C. elegans.
SESSION 3
Chairperson: S. Eddy, HHMI/Washington University School
of Medicine, St. Louis, Missouri
T.H. Bestor, Columbia University, New York: Global structure
of genomic methylation patterns.
R. Lucito, Cold Spring Harbor Laboratory: Microarray-based
approaches to global methylation detection.
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Comparative genomics and epigenomics.
X. Cheng, Emory University School of Medicine, Atlanta,
Georgia: The chemistry of methylation: How many methyl
groups are needed?
L. Joshua-Tor, Cold Spring Harbor Laboratory: Argonaute:
The secret life of Slicer.
A. Neuwald, Cold Spring Harbor Laboratory: Using statisti-
cally inferred evolutionary constraints on protein sequences
to predict epigenetic mechanisms.
J. Walter, G. Karpen
J. Jurka, Genetic Information Research Institute, Mountain
View California: CpG decay in Alu repeats: Germ-line-spe-
cific differences.
H.H. Kazazian, University of Pennsylvania School of
Medicine, Philadelphia: Biology of mammalian retrotrans-
posons.
S.R. Wessler, University of Georgia, Athens: Genome-wide
SESSION 4
Chairperson: R. Martienssen, Cold Spring Harbor Laboratory
V. Co lot, Unite de Recherche en Genomique Vegeta le,
Cremieux, France: Building Arabidopsis epigenomic maps.
A. Ferguson-Smith, University of Cambridge, United
Kingdom: Epigenetic features of a 2-Mb imprinted domain
in mouse: A small piece of a bigger picture.
B. van Steensel, Netherlands Cancer Institute, The Nether-
lands: Chromatin mapping by DamID in flies and humans.
S. Kurdistani, University of California School of Medicine, Los
Angeles: Mapping global patterns of histone acetylation to
SESSION 5
Chairperson: H.H. Kazazian, University of Pennsylvania School of
L.D. Stein, Cold Spring Harbor Laboratory: Database strategies
for interconnecting biological pathways with the genome.
N. Brockdorff, Hammersmith Hospital, London, United
Kingdom: Development of a genome environment browser
for linking epigenetics and genomics.
analysis of transposable element-mediated alterations in
rice gene expression.
R.W. Doerge, Purdue University, West Lafayette, Indiana:
Mapping gene regulation: QTLs and microarrays.
T.R. Gingeras, Affymetrix, Santa Clara, California: Evidence of
hidden transcriptome: Architecture and possible regulatory
region.
gene expression.
J. Martens, Research Institute of Molecular Pathology,
Vienna, Austria: An epigenetic map of the mouse genome.
D.P. Barlow, Center of Molecular Medicine GmbH of the
Osterreischische Akademie der Wissenschaften: ChIP on
Chip histone profiling using mouse genome path arrays.
Discussion: Global epimapping strategies technical applica-
tions.
Medicine, Philadelphia
R. Jorgensen, University of Arizona, Tucson: The Plant
Chromatin Database: Integrating information on plant
chromatin components and complexes.
M. Vaughn, Cold Spring Harbor Laboratory: Mapping the
epigenotic potential of Arabidopsis.
Summary/Further Action
Moderators: D.P. Barlow, Center of Molecular Medicine GmbH of the Osterreischische Akademie der
Wissenschaften; R. Martienssen, Cold Spring Harbor Laboratory
D. Barlow, V. Co lot
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DOLAN DNA LEARNING CENTER
EXECUTIVE DIRECTOR'S REPORT
Preparing students and families to thrive in the gene age
ADMINISTRATION INSTRUCTION BIOMEDIA TECHNOLOGY
DEVELOPMENT
Judy Cumella-Korabik Tracy Behar Shirley Chan Adrian Arva
Nancy Daidola Elna Carrasco Eun-Sook Jeong Tom Bubulya
Mary Lamont Jeanette Collette Susan Lauter Uwe Hilgert
David Mick los Erin Maroney Chun-hua Yang Craig Hinkley
Karen Orzel Amanda Mc Brien
Carolyn Reid Lauren Weidler
If you needed expert advice on a rare tumor, you would contact the most prominent physician you
know. This physician would put you in contact with the most prominent oncologist he/she knows, who,
in turn, would put you in contact with the expert you seek. Each of these well-connected individuals is
a node in a social network that positions you just four steps from the critical information you need.
This is the premise of the play Six Degrees of Separation: We live in a "small world" in which only
several social connections separate any two people. Social science research has, indeed, upheld the
notion that it takes only a handful of acquaintances to relay a letter to anyone in the United States or
an e-mail to anyone in the world! The small-world principle organizes activities on many levels of com-
plex systems. Cells, the basic units of biological function, are networks of communicating molecules.
For example, each of the several hundred molecules involved in processing a nervous signal is, on aver-
age, separated by less than four connections from any other molecule.
By the same token, people harness the small-world aspect of the Internet-hopping between
prominent nodes to quickly locate information about even the most arcane topic. During the past 18
months, we developed the concept for a novel Internet site on modern neuroscience research that is
built on this small-world principle. We envisioned a nonlinear "knowledge network" where one can eas-
ily move from one piece of information to another through a minimum number of connections.
Public Education in a Revolutionary Science
So we were thrilled when the Dana Foundation announced in October that it would provide $1 million
to support the project over 4 years. In a sense, the grant follows up on my 1990 Dana Award for
Pioneering Achievement in Education.
The site will be developed in parallel to research emanating from the Genes to Cognition (G2C)
Program at the Wellcome Trust Sanger Institute in Cambridge, England. G2C program director Seth
Grant, who did postdoctoral work at CSHL, is using network theory to study the gene interactions that
result in human thinking and disorders of thinking. This research base will be expanded with insights
drawn from CSHL scientists, the neuroscience start-up company Helicon Therapeutics, and neuro-
science initiatives supported by the Dana Foundation.
Science education and public outreach typically begin well after a "scientific revolution" has settled
down into what Thomas Kuhn called "normal science"-resulting in a set of facts that can be conve-
niently categorized and presented as unchallenged dogma. Rather than presenting science as a com-
pleted endeavor, with nothing important left to discover, we want to involve G2C Online users in this
revolutionary period of neuroscience research. We want them to be online when new insights into
human memory and new treatments for cognitive disorders appear on the horizon.
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Thinking about the Biology of Thought
G2C Online essentially will be a three-dimensional, multimedia concept map of the science of the
human brain, allowing site users to explore the relationships among concepts and to assess their own
learning. In mimicking both the molecules of thought (and resulting human social behaviors), the site
will provide users with a real life exercise in "metacognition"-thinking about the biology of thought.
The goal of G2C Online is to help people explore the relationship among genes, thinking human
behavior, and cognitive and behavioral disorders. Content at the site will embody several key concepts
of modern neuroscience:
Cognition arises from a "thinking machine" whose parts can be understood at different levels of
complexity-from anatomical structures of the brain, to neural circuits, to molecular signals.
Neurons and molecules work together in redundant networks that allow rapid communication
through key nodes and can compensate for loss of individual components.
Cognitive information is encoded in patterns of nervous activity and decoded by molecular listening
devices at the junction between nerve cells (the synapse).
The molecules of learning and memory have been conserved by evolution, allowing scientists to
model cognitive processes in simple organisms.
Although humans inherit genes that set the parameters of learning and memory, the cognitive
machinery is continuously altered by experience.
Cognitive disorders are caused by discrete changes in genes and proteins that can potentially be
targeted by therapeutic molecules.
Understanding human cognition has ethical and social consequences; the eugenics programs of
the 20th century illustrate the tragic outcome of misguided efforts to limit the spread of "unfit"
behaviors.
Building a "Knowledge Network"
The computer technology behind G2C Online will be every bit as revolutionary as the science it covers.
Each content item-and its relationships to other items-will be stored in a database. A "network
engine" will draw items from the database to construct a network customized according to the prefer-
ences and knowledge level of the user. Rich multimedia modules will form the major nodes of the net-
work. Key among these materials will be narrated animations, which seamlessly integrate video narra-
tion with cell and molecular animations, experiment simulations, and bioinformatics tools.
The site may be used in a linear or nonlinear mode. In the linear mode, one will be able to follow a
predetermined path prepared by the editorial team or a path submitted by another user. A person fol-
lowing a linear path will see their course ahead and behind, but may also deviate to explore adjacent
nodes. In the nonlinear or exploratory mode, one will enter the network by selecting a node of interest
and then follow connections out from that node. Alternatively, one can identify a node or set of nodes
that matches terms entered in a search engine. The distribution of these nodes in the graphical view
of the network can provide visual clues to locate other relevant content.
To simplify navigation, a selected path will be extracted from the network and displayed as a "sub-
way" map showing only the "stations" (major nodes). Movement along the "subway line" will be
tracked, and outward excursions (minor nodes) will be displayed upon arrival at each "station." A data-
base engine will allow site users to generate a view of the network from any point, chart a course
through the network, and store a course for analysis or modification.
We envision three target audiences for G2C Online: biology students, psychology students, and
families who are facing mental health problems. Students and teachers are the DNALC's natural con-
stituency; online surveys show that they make use of DNALC Internet sites for authoritative information
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This "demo" version of the G2C
Online Internet site illustrates a
possible network of content and
a linear path along major nodes
in the network.
about a variety of class assignments and projects. By targeting the site to the "bright teenager," mate-
rials will be at a level of science comprehensible to a broad slice of the adult population. Therefore, the
second major audience will be families who are facing mental health problems. Many families dealing
for the first time with a behavioral or cognitive disorder do not know where to turn for authoritative
answers to their questions. Others wish to follow up on cursory information presented by health care
providers. This is the audience that we have been specifically building with Your Genes, Your Health
(www.ygyh.org), our multimedia site on common genetic disorders.
The ability to generate custom entry points and views will allow us to design a unique experience
for each audience. By selecting from a list of questions or information preferences, a user may gener-
ate an optimized network and suggested path to follow. So, educational audiences might enter the site
through major nodes that address key content standards and teaching syllabuses (for example,
Advanced Placement biology or psychology), whereas health care audiences might enter the site by
way of individual diseases or common questions about cognitive disorders. As a result, an Advanced
Placement psychology student will be provided a substantially different network to browse than will a
family member interested in autism. Each user will be provided logical "anchor" points from which to
enter the knowledge network and from which to launch further explorations.
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Inside Cancer Readied for Launch in 2005
When we initiated the Inside Cancer project under an NIH Science Education Partnership Award, in
2001, there was no effective way to integrate different media types-such as video, animation, and flat
art-into a seamless Web page. The technology for achieving this level of media integration, Rash MX
by Macromedia, first became available in the summer of 2002. During 2002-2003, the Biomedia Group
tested the large-scale application of the new Rash technology during the construction of DNA
Interactive. Equipped with this new expertise, in 2003, we resolved to redevelop Inside Cancer in Rash
MX. This decision to substantially upgrade the Inside Cancer site required scrapping an earlier HTML
design and retooling content-with the result of throwing production behind schedule.
As 2004 drew to a close, the site was more than 90% complete. We think our audience will agree
that it is one of the most advanced science content sites on the Internet and that we were justified in
waiting for the right media integration technology. Using dynamic animations, we have integrated tech-
nology, design, and content to present information that cannot be found in any other educational medi-
um (including medical textbooks). In this unique format, one of 28 cancer experts interviewed for the
project narrates an animation of cellular and molecular events, with his or her video appearing in a
"bubble" analogous to the narrative of a cartoon. When formally launched in 2005, the four major sec-
tions of Inside Cancer will provide authoritative and engaging information on how knowledge of the
cancer cell is changing cancer diagnosis and treatment:
Hallmarks of Cancer follows a landmark paper of the same title, published in Cell (2000), that sum-
marized the major molecular and cellular aspects of cancer. To our knowledge, Inside Cancer offers
the first popular treatment of these key tenets of cancer genetics and cell biology. The section fea-
tures clips from interviews with Douglas Hanahan and Robert Weinberg, the authors of the Cell arti-
cle. In "Growing Uncontrollably," one can see the first example of fully integrated video and animation.
Inside Cancer features video narrations and animations in one
screen. In the Hallmarks of Cancer section, Bruce Stillman,
CSHL President, explains how cancer cells avoid detection by
the body's normal immune response. In Pathways to Cancer,
below, growth factor proteins are packaged into vesicles within
a cell.
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Causes and Prevention uses epidemiological data to highlight behaviors and environmental factors
that increase cancer risk. The overview first debunks the common misconception that inheritance
and toxic chemicals are major causes of cancer. Then users are challenged to link potential causes
of cancer to patterns of cancer incidence worldwide. Individual sections highlight how environment,
behavior, and inheritance contribute to different major cancers-and how these insights relate to
preventing disease. The influences of mold (afflatoxin), diet, viruses, and inheritance are explained in
the context of the key cancers of the liver, prostate, cervix, and colon. Students also explore the
events that spurred the rapid increase in cigarette smoking in the 20th century, which is almost
wholly responsible for the continuing "epidemic" of lung cancer.
Diagnosis and Treatment shows how cellular and molecular techniques are used to diagnose and
tailor cancer treatment according to specific genetic changes in the patient's tumor. A section on
pathology gives site users a chance to try their hand at distinguishing normal and tumor cells, as
seen under the microscope, and to follow an endoscope through a patient's colon. In pharmaco-
genetics, narrated animations explain how cell receptors and gene profiling are used to tailor treat-
ment for breast cancer patients. A section on targeted therapies explain how a new generation of
drugs block specific molecules that conduct growth signals in the tumor cell-using the examples
of Tamoxifen and Herceptin for breast cancer, and Gleevec for chronic myeloid leukemia.
Pathways to Cancer is a high-quality, three-dimensional animation that follows a common signaling
pathway through which growth commands are transmitted from cell surface to the nucleus. The tour
is narrated by noted voice talent Doug Thomas. The section incorporates a "molecule menu" and
freeze-frame rollovers that allow site users to learn more about the molecules that conduct a growth
signal through the cell and how they are involved in oncogenesis.
NSF Grant to Develop New Laboratories on RNAi
Our effort to strengthen direct ties to CSHL research received additional affirmation in
May when we received a $300,000 grant from the National Science Foundation (NSF) to
develop new laboratories on RNA interference (RNAi) and functional genomics. This pro-
ject follows the template of a project initiated last year to develop new experiments in
plant genomics. Like the plant project, the RNAi project received unanimous "excellent"
ratings from the five reviewers.
During the past 15 years, high school and college biology faculty have implemented
key laboratories that illustrate basic concepts of microbial and molecular genetics. The
completion of the Human Genome Project challenges these teachers to move laborato-
ry instruction to a higher level of biological integration-the functional analysis of genes
and proteins in eukaryotic organisms. Thus, we will develop a module of investigative lab-
oratories and bioinformatics exercises that engage students in the new technologies of
RNA-mediated genetic interference and computer-based genome analysis.
Until recently, targeted gene inactivation ("knock-out") or rescue ("knock-in") by homologous recom-
bination required significant resources and was confined to research labs. RNAi offers a remarkably
simple system in the roundworm Caenorhabditis elegans. Bacteria are transformed with a plasmid
encoding "antisense" RNA to the worm gene of interest, and a lawn of the bacteria is grown on an agar
plate. The RNAi response is triggered when worms are released on the agar plate and ingest the trans-
formed bacteria expressing the antisense RNA. (Bacteria are a normal food source for C. elegans.) The
effects of the loss of gene function are then observed in the offspring (either embryos or larvae) of her-
maphrodite worms.
We believe that the RNAi/C. elegans experimental system is simple and robust enough to join bac-
terial transformation and gel electrophoresis as a mainstay of the high school and college teaching lab-
The C. elegans worm on the
lower right illustrates the "blister"
phenotype.
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oratory. After learning basic RNAi techniques, students can make use of freely available resources to
design their own experiments to explore the function of virtually any of the predicted 19,427 genes of
C. elegans. The premise that RNAi labs may prove broadly useful in biology education led to unusual
joint funding of the project by NSF's precollege and collegiate curriculum development programs.
The project is a collaboration among staff at the DNALC, faculty at 2- and 4-year colleges, and sci-
entists in Greg Hannon's lab at CSHL, which pioneered RNAi technology. An Advisory Panel of college
faculty from diverse geographic locations will be involved in all aspects of the project, including devel-
opment and testing. Following a year of development, the experiments and computer exercises will be
tested with 72 biology teachers at three sites around the United States. Instructional and bioinformat-
ics resources developed in this project will be disseminated via the DNALC's Internet site, Cold Spring
Harbor Laboratory Press, and Carolina Biological Supply Company.
National Science Foundation Fellowships
In summer 2004, two pairs of Faculty-Student Fellows spent 3 weeks at Cold Spring Harbor partici-
pating in the NSF-sponsored "Building Leadership to Expand Participation of Underrepresented
Minorities in Plant Genetics and Genomics" program: Dr. Javier Gozalez-Ramos and Adriana Robbins
of Texas A&M University, and Dr. Olga Kopp and Elise Unice of Utah Valley State College. The Fellows
participated in a mix of activities at the Dolan DNALC and the Hazen Genome Sequencing Center.
During the first week, Fellows conducted an integrated set of experiments from the NSF-sponsored
Greenomes course. Designed for use in high school and college biology courses, these experiments
use plant systems to illustrate major concepts of molecular and genomic biology, including the rela-
tionship between molecular genotype and phenotype, transposon mutagenesis, chromosome map-
ping, homeotic development, functional analysis, and transgene detection. These experiments have
been specifically designed for ease of replication in high school and college teaching labo-
ratories. In the fall, we began working with Dr. Ramos and Dr. Kopp to organize regional
training workshops on Plant Genetics and Genomics to introduce the plant labs to high
school and college faculty. The workshops-to be held in summer 2005-will be co-taught
by the Fellows and DNALC staff.
A second NSF-sponsored fellowship, "Building Leadership to Develop Educational
Bioinformatics Tools in Plant Genomics," was a collaboration between the Dolan DNALC and
Gramene, an Internet resource for comparative genome analysis of grasses. The main
objective of this fellowship is to assist with the production of a Student Genome Viewer that
will allow advanced high school and college classes to directly participate in the annotation
of the rice genome. Two fellowship positions were awarded in summer 2004: Mr. Robert
Wheeler from Pine Creek High School (Colorado Springs, Colorado) and Dr. Debra Burhans
from Canisius College (Buffalo, New York).
The USDA also provided funds for fellowships at Cold Spring Harbor Laboratory for
two underrepresented minorities in biological sciences. Cesar Gutierrez, a biology teacher at Jon H.
Reagan High School in Austin, Texas and a lead teacher in the NSF-sponsored Bio-Link Center for
Advanced Technological Education at Austin Community College, spent 2 weeks working with DNALC
staff doing advanced development of the Student Genome Viewer. Paul De La Rosa, a biology student
at the Univeristy of Texas, spent 1 week learning about DNA polymorphisms at the DNALC and 1 week
learning large-scale sequencing techniques at the Hazen Genome Sequencing Center.
NSF Fellows Bob Wheeler
and Debra Burhans.
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Pfizer Leadership Institute
In July, we completed the fourth Leadership Institute under support from the Pfizer Foundation. We had
initiated this program in the early 1990s with support from the NSF, only to see it wither when the NSF
shifted its focus to central school authorities. Pfizer support allowed us to reinstate what we believe is
the most advanced activity to reward the nation's top biology teachers with a summer sojourn at Cold
Participants in the Pfizer Leadership Institute and the NSF Fellowship Program wrap up a 3-week stay in Cold Spring Harbor.
Spring Harbor. However, with the lapse of Pfizer funding in 2005, we will again need to search for sup-
port for this jewel in the DNALC's crown of training courses for biology faculty.
The 2004 Pfizer Leadership Institute participants represented a diverse range of backgrounds and
experience. The Institute drew 18 faculty representing 12 different states. One third came from schools
with high percentages of minority or disadvantaged students, and one third were from rural regions.
The American faculty were joined by four teachers from Singapore, who visited as part of our ongoing
collaboration with the Singapore Ministry of Education.
During their 3-week stay, the Leadership participants lived and breathed science-walking in the
footsteps of Nobel Prize winners and taking meals with some of the brightest researchers in the world.
The 2004 workshop focused on the study of human and plant genomes. All topics were addressed in
a three-pronged approach of lectures/seminars, wet-labs, and computer work. Included in the lab work
was the opportunity to test the DNALC's very latest lab protocols, in advance of their availability at other
institutions or from commercial suppliers. The Institute curriculum also drew heavily on the Laboratory,
with scientist seminars and visits to Uplands Farm agricultural field station and the Hazen Genome
Sequencing Center. Leadership teachers were introduced to a number of computer-based utilities that
collect, analyze, and display DNA data, including several developed at the DNALC. A tutorial held by
the DNALC WWW designers introduced participants to technology that enabled them to create per-
sonal teaching environments.
Four days were dedicated to independent study or group projects to increase mastery and/or to
adapt materials for classroom use. Projects included screening supermarket foods for genetic modifi-
cation, sequencing dog mitochondrial DNA, mutating the "glow" gene for green fluorescent protein,
and designing a polymerase chain reaction (PCR)-based method to examine polymorphisms in human
olfactory receptor genes. Other teachers expanded computer-based studies on bioinformatics and
Web page construction.
Genetic Origins
Genetic Origins is one of the most unique programs developed here at the DNALC. It consists of an
integrated set of experiments, gratis DNA sequencing, and online tools that allow students to use their
own DNA polymorphisms as the starting point for investigations on human relatedness, evolutionary
history, and pharmacogenetics. Genetic Origins presents an accurate analog of human genome
research, which incorporates the highest aspirations of "hands-on" learning. This program was initiat-
ed with federal grants, but has been maintained with DNALC cash flow during the last several years.
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To maintain Genetic Origins as a free program to students around the United States and to make need-
ed upgrades to the Internet components, we gratefully received a $50,000 grant from our friend and
colleague Mike Gillman, Senior Vice President of Research at Biogen Ides, and a $10,000 grant from
William A. Haseltine, President of the William A. Haseltine Foundation for Medical Science and the Arts.
The redeveloped sites will conform to simple rules for intuitive use: consistent and logical placement
of tool bars, minimum use of submenus or "nested" screens, and minimal text. Redevelopment will
make cost-effective use of templates developed for recent DNALC projects and will employ highly
designed "skins" that give tools and media players the sense of being real onscreen objects. The
Genetics Origins labs will be ported through a lab virtual lab notebook player similar to the Greenomes
Internet site we are currently developing. The Bioservers workspaces and data functions will be repack-
aged in attractive skins in the manner of Bioinformatics Calculator and Gene Boy.
New Mammalian PCR Labs
Our repertoire of advanced PCR experiments on DNA polymorphisms was significantly strengthened
in 2004. We added two new laboratories that demonstrate the use of single nucleotide polymorphisms
(SNPs) in predicting phenotypes. Both experiments use a hybrid method termed amplified restriction-
length polymorphism (ampliFLP), in which a PCR product is subsequently cut with a restriction enzyme.
A restriction enzyme recognition sequence is incorporated into one PCR primer. Then, an SNP locat-
ed at the restriction site is detected as a length polymorphism on an agarose gel.
SNPs and Human Taste examines an SNP in the bitter taste receptor (TAS2R) that correlates with
the ability to taste phenylthiocarbamide (PTC). CSHL researcher Albert Blakeslee determined in 1932
that tasting the bitter PTC chemical is inherited in a dominant character. Since that time, it has been a
classic demonstration of Mendelian inheritance in high school genetics classes. However, a new analy-
sis, on which our experiment is based, shows that the inheritance of PTC tasting ability is not as sim-
ple as students have long been taught. Like many SNPs of medical importance, the SNP we test for
combines with two other SNPs to produce complex combinations (haplotypes) that predict tasting abil-
ity-but not perfectly!
NONTASTER
ALLELE
TASTER
ALLELE
Human PTC polymorphism genotypes detected by restriction digest (D) of PCR products (U). Genotypes shown
are taster/taster (T/T), taster/nontaster (T/N), and nontaster/nontaster (N/N).
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Canine lvermectin Sensititvity is real test of pharmacogenetic importance to dog owners who give
their pets lvermectin to control heartworm and other parasites. DNA is isolated from cheek swabs of
pet dogs, amplified by PCR, and examined for an SNP in the mdrl (multidrug resistance) gene. Dogs
that are homozygous for the mdrl mutation cannot metabolize lvermectin and may have a toxic or fatal
reaction. Collies, Shetland sheepdogs, Australian shepherds, and Old English sheepdogs are among
the breeds most at risk for lvermectin sensitivity.
New Visitor Highs in 2004
Visitation to the DNALC facility and to its family of Internet sites reached new highs in 2004. DNALC
hosted 37,617 visitors, with cumulative visitation topping one-quarter million since our founding in
1988! Lab instruction increased 23%, to 27,142 students, with DNALC West allowing us to expand our
reach in Nassau County and New York City. Of these students, 16,903 received instruction at the
DNALC or West facilities, and 10,239 received instruction at their own schools. (It is worth noting that
in-school instruction typically amounts to four class visits by a DNALC educator, so that the number of
DNALC-taught labs is several times the number of students reported!)
These numbers keep us solidly in the lead of institutions that offer hands-on instruction in genetics
and DNA for precollege students. Ironically, our next closest competitor is the Singapore Science
Center, whose instructional program we helped develop under a partnership with the Singapore
Ministry of Education. In 2004, its first full year of operation, the Science Center provided labs for
17,141 students, teachers, and members of the general public!
"Virtual" visitors to the family of Internet sites reached via the DNALC's portal, Gene Almanac,
reached 5.44 million-an increase of 11% over 2003. Visitors spent an average of about eight minutes
at the informational sites, DNA Interactive and Your Genes, Your Health, and about 10 minutes at our
animated text, DNA from the Beginning. Visits averaged substantially longer at our historical resource,
the Image Archive on the American Eugenics Movement (11.5 minutes) and Bioservers (16 minutes).
Internet Site
Average visit
length (in minutes) Visits in 2004
Increase from
2003 (%)
Gene Almanac 8:23 2,135,981 4.77
DNA from the Beginning 10:06 1,264,919 0.68
Your Genes, Your Health 8:48 860,583 15.46
DNA Interactive 8:04 650,096 72.23
Image Archive on the American
Eugenics Movement 11:25 283,405 14.72
Bioservers 16:06 137,988 4.92
Genetic Origins 9:05 109,022 20.90
All Sites 10:17 5,441,994 11.37
A midyear analysis of our Internet traffic found that only about 10% of visits to Your Genes, Your
Health (YGYH) resulted from referrals by Internet search engines. This was surprising to us, because
this site contains information on individual genetic diseases that we knew was the subject of many
searches by families and medical professionals. It then dawned on us that the multimedia content
developed in Macromedia Flash was not "visible" to popular search engines, such as Google. "Spiders"
and other indexers sent out by search engines could not find content contained in Flash multimedia
files; thus, words in the text of animations and videos in several of most technologically advanced sites
were not being found by relevant Internet searches!
In 2004, we found a solution to this problem. The text files for each animation and video were con-
structed into a skeleton of "meta" pages, linked to the homepage, which reflected each site's content
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and architecture. As indexers revisited the sites, they detected the updated body of text and rebuilt
comprehensive indexes that are now searchable. The results were dramatic. Within 2 months of
implementing the meta-indexing scheme, searches rose sharply to account for more than 40% of vis-
its to YGYH.
Percent of Site Visits Referred by Search Engines
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Learning the Effects of Our Summer DNA Camps
We began teaching intensive, week-long "camps" for students in the summer of 1985, when we
offered DNA Science at the Wheatley School in Old Westbury. Since that time, more than 6700 middle
and high school students have spent one week at one of seven camps offered each summer.
Beginning with Fun With DNA in the fifth grade, a student can take a different workshop each sum-
mer-culminating with DNA Science and Vertebrate Genomic Biology in high school. Although we
know that a number of graduates of the summer camp program become interns at the DNALC, we
have long wondered about what the others do after taking one or more of our summer courses. So in
2004, we completed a major survey of students who took summer camps from 1990 to 2001.
We received completed surveys from 789 past participants-475 were in high school at the time
they took the survey and 314 were in college. Clearly, the DNALC's workshops cater to a clientele of
interested and able students. Majorities of secondary school (62%) and college (82%) respondents said
they had been very interested in science in high school. Virtually all of the students in both groups (97%)
said they maintained "A" or "B" averages in their high school science courses.
The DNALC has apparently done a good job of building a clientele for its summer camps. Majorities
of both groups rated all seven of the DNALC summer courses as very good or excellent. While the
average college respondent had attended two DNALC camps during his/her precollege years, current
secondary school students had averaged three camps (with three quarters of respondents still having
one or more years until graduation).
Participation in DNALC camps resulted in a number of beneficial effects for the high school and col-
lege respondents. Majorities had discussed topics or issues from a workshop with their families
(72-75%) and friends (55-59%). Majorities in both groups said that participation in DNALC workshops
had increased their understanding of science stories in the media, increased their general interest in
science, improved their confidence in science classes, and encouraged them to take more science
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offerings. Participation in DNALC workshops strongly influenced 46% of college students to consider
majoring in science.
Most importantly, the DNALC experience appears to be part of an education that encourages stu-
dents to value science and technology and to support scientific research. Note the similar proportions
of high school and college respondents who agree with the following statements:
Percent
Agreeing High School College
Science and technology will open up more opportunities for my generation. 93 94
Science and technology are making our lives healthier, easier, and more 92 93
comfortable.
Many scientists want to work on things that will make life better for the 87 88
average person.
The benefits of biotechnology outweigh the risks. 71 73
The United States government spends too much money on scientific research. 16 12
The respondents discriminated in similar ways among a number of different applications of gene tech-
nology-favoring most, but drawing the line at the selection of physical traits.
Favoring Percent
Using genetic engineering to produce essential pharmaceuticals. 88 94
Using genetic engineering to treat diseases in adults. 88 94
Using genetic engineering to treat diseases in the embryo. 79 82
Using genetic engineering to produce agricultural crops. 67 72
Using genetic engineering to clone animals, such as sheep, to make drugs
and vaccines.
61 68
Using embryonic stem cells in research. 63 64
Using genetic engineering to select for physical traits in the embryo. 21 17
Complete survey results can be viewed at www.dnalc.org/studentsurveys/.
Saturday DNA!
From the DNALC's wealth of offerings, the ongoing, popular Saturday DNA! program has emerged to
provide an in-depth view of our genetic book of life and science education to the general public. Using
catchy topics such as "CSI: Learning Center" and "Of Lice and Men" as a framework, Saturday DNA!
allows children, teens, and adults to conduct hands-on DNA experiments and learn about the latest
developments in the biological sciences.
Each 2-hour program is designed to be a thorough and exciting exploration of genetics, genes, and
DNA through the use of innovative, intriguing topics. The DNALC staff works to ensure that topics are
current and appropriate for two different age groups: groups of students ages 10-13 (with an accompa-
nying chaperone) and groups ages 14adult (with accompanying chaperone for participants under 15).
Although programs change and rotate each season, topics such as "Poochie Pedigrees" and "The
Mystery of Anastasia Romanov" are mainstays. In examining the disappearance of the Romanov ruling
family, visitors use a mitochondrial DNA database to determine whether Anna Anderson and Anastasia
Romanov are indeed one and the same. Along the way, they collect evidence and use a variety of
forensic analyses.
"Poochie Pedigrees" offers the opportunity to extract DNA from your dog's cells and compare it to
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In the Jumping Genes session of Saturday DNA! in October,
participants got a close look at the life and work of Nobel
Prize recipient Barbara McClintock. Through laboratory and
computer activities, they learned about the history of classi-
cal genetics, and the world of jumping genes.
380
the DNA of different dogs and their ancestors. Analysis between the various samples raises-and
answers-compelling questions such as What is the origin of man's best friend?, Does Fido have wolf
or coyote in his bloodlines?, and Are different breeds of dogs really genetically the same? The related
program, "Doggie Diagnosis," works with the older age group to take the information a step further to
determine how breeding has affected your pet's ability (or lack thereof) to metabolize antibiotics.
Staff and Interns
During the summer, we bid farewell to three senior staff members who made significant contributions
to the development of the DNALC. Danielle Sixsmith, Manager of External Relations, moved to New
Jersey with her family and began online graduate study at the University of Phoenix. Danielle joined
the DNALC staff in 1999 as a laboratory instructor, teaching at both the middle and high school lev-
els. In 2002, she collaborated with North ShoreLong Island Jewish Health System to bring into oper-
ation our satellite facility, DNALC West. Laboratory Manager Scott Bronson left for a position as
Educational Programs Administrator at Brookhaven National Laboratory. Scott joined the DNALC in
1999, and his prior bench experience with Jacek Skowronski was evident as he simplified PCR for
education and developed our successful DNA Sequencing Service. Media Producer Bronwyn Terrill left
for Cambridge, England to manage public outreach at the prestigious Wellcome Trust Sanger Institute.
Arriving at the DNALC in 2001, she proved herself to be a world-class science communicator-first
producing the 1500-square-foot exhibit "The Genes We Share" and then leading production of the
Internet sites DNA Interactive and Inside Cancer.
Junior staff members Kim Kessler and Mike O'Brien went in different directions in education. Kim
enrolled in the genetic counseling program at Northwestern University, while Mike joined the New York
City Teaching Fellows to prepare for a teaching position at the High School for the Humanities. Senior
Development Officer Erin Wahlgren, who had so effectively run the DNALC golf tournament and annu-
al fund drive, left for a position at the Marfan Foundation.
The major staff changeover brought a raft of new faces and ideas to the DNALC. During the year,
we welcomed two Ph.D.-level Laboratory Managers-Tom Bubulya and Craig Hinkley. Although Craig
came from University of Michigan, he had formerly shared a bench with Tom as a postdoctoral fellow
in the lab of Winship Herr. Tracy Behar, Jeanette Collette, and Lauren Weidler took positions as
Laboratory Instructors. Tracy grew up on Long Island and recently graduated from SUNY College at
Old Westbury with a degree in Secondary Education in Biology. Jeanette, who also grew up on Long
Island, has relocated from Buffalo where she attended college and started a family. While working on
her degree in human biology from SUNY Albany, Lauren worked as a library aide in the CSHL Library.
Local resident Karen Orzel, who has a background in marketing, took over management of the
Corporate Advisory Board, annual golf tournament, and annual fund.
Other new additions to the DNALC "family" came in July when middle school educator Elna
Carrasco was married to Michael Gottlieb. Media designer Chun-Hua Yang was married to Shiuh-Jyh
Lin in October. Middle school educator Amanda Mc Brien and her husband, Michael, welcomed their
third son, Robert Michael, in November.
High school interns continued to provide key support for our teaching labs, and several carried out
independent research projects under the direction of DNALC and CSHL staff. As part of our new NSF
grant, David Wagman used RNA interference to silence a gene in C. elegans-resulting in visible "blis-
ters" in the worm's outer cuticle. Daisy Choi injected the human cancer gene, p53, into C. elegans to
study tumor suppression. While working in the lab of Dr. Rob Martienssen, Kimberly Izzo used fluores-
cent in situ hybridization (FISH) to study centromere function in the model plant Arabidopsis thaliana.
Our sequencing service continues to grow with the help of college interns Alina Duvall (Hofstra
University) and Andrew Diller (Dowling College). To process the growing number of requests, we now
collaborate with Dr. Dick McCombie's group at the Woodbury Genome Center. The high-throughput
capillary sequencing available at Woodbury has greatly reduced the turnaround time for completing
sequencing requests.
Joining the intern program in 2004 were Andrew Langer (John H. Glen High School, Elwood), Elena
Meliuso (Oyster Bay High School), Tama Mizuno (Northport High School), and Benjamin Tully (Nassau
Community College). Several interns returned from college to assist with summer workshops: Lara
Abramowitz (University of Rochester), Yan Huang (Notre Dame University), Marie Mizuno (Binghamton
University), and Alex Witkowski (SUNY Albany).
In August, we bid farewell to the following interns as they began their freshman year at college:
Benjamin Blond (Syosset High School) is studying biology at Amherst College; Bryn Donovan (Freeport
High School) is studying wildlife conservation at the University of Delaware; Alexander Hogg (Friends
Academy) began a 5-year biology/fine arts program at Brown University; and Michelle Louie (Kings
Park High School) began a 7-year biology/M.D. program at George Washington University.
David A. Mick los
Executive Director
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2004 Workshops, Meetings, and Collaborations
January 6
January 8-12
January 10
January 24
January 26
February 7
February 11
January 12
February 21
February 24
March 6
March 10
March 15
March 19
March 20
March 23
March 26
March 30
April 3
April 17
April 20
April 26
April 27
April 29
May 14
May 15
May 20
May 31-June 4
June 9
June 11
June 12
June 15
June 21-25
June 22
June 23
June 24
June 28-July 2
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Site visit by Alastair Balls and Linda Conlon, Life Science Centre, Newcastle, United
Kingdom
Site visit by Cheong Kam Khow, Singapore Science Center
Saturday DNA! Seminar, DNALC
Saturday DNA! Seminar, DNALC
Inside Cancer interview, Ken Culver, Executive Director, Early Clinical Development,
Novartis Oncology, East Hanover, New Jersey
Saturday DNA! Seminar, DNALC
Site visit and museum tour by members of the Association of Suffolk Superintendents for
Education Technology
Site visit by Alan Fleischman, Senior Vice President, New York Academy of Medicine,
New York
Site visit by Don McGranaghan, Artistic Resources, LLC
Saturday DNA! Seminar, DNALC
West Side School Lecture
Saturday DNA! Seminar, DNALC
Site visit by Cynthia Joyce, Executive Director, and Loren Eng, President, Spinal Muscular
Atrophy Foundation, New York
West Side School Lecture
Saturday DNA! Seminar, DNALC
Saturday DNA! Seminar, DNALC
Site visit by Jeremiah Barondess, President, and Patricia Volland, Senior Vice President,
The New York Academy of Medicine, New York, and Lawrence Scherr, Dean and
Chief Academic Officer, North Shore-Long Island Jewish Health System, Great Neck,
New York
Site visit by Caroline Lieber, Director, Human Genetics Program, Sarah Lawrence
College, Bronxville, New York
Site visit and museum tour of DNALC for representatives of "Best of New York" publication
Great Moments in DNA Science Honors Students Seminar, CSHL
Saturday DNA! Seminar, DNALC
Saturday DNA! Seminar, DNALC
Great Moments in DNA Science Honors Students Seminar, CSHL
Site visit by Ed Rover, President, and Barbara Gill, Vice President, the Dana Foundation,
New York
Site visit by Jon Fry, President; Bruce Pipes, Provost; Fred Owens, Associate Dean of
Faculty and Professor of Psychology; and Kathy Triman, Professor of Biology, Franklin
& Marshall College, Lancaster, Pennsylvania
Presentation at Garden City Public Library, Advocacy for Gifted and Talented Education in
New York State, Inc.
Great Moments in DNA Science Honors Students Seminar, CSHL
Site visit by Bryan Sykes, Professor of Human Genetics, University of Oxford, United
Kingdom
Site visit by Kidgie Williams, diplomats, and family members of UN representatives,
Hospitality Committee for United Nations Delegations, Inc., New York
Site visit by John Monaghan and Alan Minz, Canadian Consulate General's Office, and
Jay Amer, President, Ontario East Economic Development Corporation, Canada
Saturday DNA! Seminar, DNALC
Museum tour and lab participation by Estee Lauder European Beauty Editors
Teacher-training workshops, National Institute of Education and Singapore Science
Centre, Singapore
Site visit by Caroline Lieber, Sarah Lawrence College, Bronxville, New York
Presentation of Award of Appreciation from Kings Park Central School District, New York
Saturday DNA! Seminar, DNALC
Site visit by Karl Kuchler, University of Vienna, Austria
NSF Plant Molecular Genetics and Genomics Workshop, Austin Community College, Texas
Site visit by Jacinta Duncan, Gene Technology Access Centre, Melbourne, Australia
Inside Cancer interview, William Nelson, The Sidney Kimmel Comprehensive Cancer
Center, and Jennifer E. Axilbund, Genetic Counselor, Cancer Risk Assessment
Program, The Johns Hopkins Hospital, Baltimore, Maryland
Inside Cancer interview, Louis M. Staudt and Kenneth H. Kraemer, National Cancer
Institute, Bethesda, Maryland
Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
July 5-9 Fun With DNA Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
Genomic Biology and PCR Workshop, DNALC
July 6 Inside Cancer interview, John Condeelis, Albert Einstein College of Medicine, New York
July 7 Inside Cancer interview, Glorian Sorensen, Harvard School of Public Health, Boston,
Massachusetts
July 8 Inside Cancer interviews, Nancy Mueller and Graham Colditz, Department of
Epidemiology, and Walter Willett, Department of Nutrition, Harvard School of Public
Health, Boston, Massachusetts
July 12-16 Bioinformatics in the Classroom Workshop, Union College, Schenectady, New York
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
DNA Science Workshop, DNALC
July 12-30 Pfizer Leadership Institute in Human and Plant Genomics, DNALC
NSF Faculty Fellowship, Plant and Rice Genomics: Javier Gonzalez-Ramos, Adriana
Robbins, Olga Kopp, Elise Unice, Paul DeLaRosa
NSF Faculty Fellowship, Gramene Bioinformatics, Cesar Gutierrez
Teacher training for Singapore Ministry of Education collaborators, Daniel Chua Wei
Sheong and Yin Leng Tan, and Eugene Wambeck of the Singapore Science Center
July 18-23 Fun With DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
July 26-30 World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
July 27 Site visit by Arthur Spiro, CSHL Trustee and DNALC Committee Chairman; Russ Hotzler,
John Mogulescu, Nicholas Michelli, Gillian Small, and Tracy Meade, The City
University of New York; Sy Fliegel, Cole Glenn, and Reggie Landeau, Center for
Educational Innovation-Public Education Association, New York; Edward Travaglianti,
Commerce Bank Long Island, New York; and Lawrence Scherr, North Shore-Long
Island Jewish Health System, Great Neck, New York
July 30 Site visit by members of the American Association of University Women, Washington, D.C.
August 2-6 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC
DNA Science Workshop, DNALC
NSF Plant Molecular Genetics and Genomics Workshop, Clemson University, South
Carolina
August 5-6 Site visit by Beverly Matthews, Harvard University, Cambridge, Massachusetts
August 9-13 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Green Genes Workshop, DNALC
NSF Plant Molecular Genetics and Genomics Workshop, University of Wisconsin-
Madison/Madison Area Technical College, Madison, Wisconsin
August 12 Site visit by members of the New York Center for Teacher Development
August 16-20 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
DNA Science Workshop, DNALC
Genomic Biology and PCR Workshop, DNALC
August 17 Continuing Medical Education meeting, Lawrence Sherr, Robin Wittenstein, and Irene
Leff, North Shore-Long Island Jewish Health System, Great Neck, New York; Caroline
Leiber and Jamie Speer, Sarah Lawrence College, Bronxville, New York
August 19 Site visit by Daniel G. Kaufmann, Joan Japha, Chandrika Kulatilleke, Seymour Schulman,
Edward Tucker, Mary Jean Holland, and Valerie Schawaroch, faculty members,
Department of Natural Sciences, Baruch College, New York
August 20 Inside Cancer interview, Charles Sawyers, University of California, Los Angeles
August 23-27 Fun With DNA Workshop, DNALC
Genetic Horizons Workshop, DNALC
Aug. 30-Sept. 3 Fun With DNA Workshop, DNALC
World of Enzymes Workshop, DNALC
Genetic Horizons Workshop, DNALC
September 1 Site visit by Jean Caron, Abby Demars, and Holly Herrick, DNA EpiCenter, New London,
Connecticut
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September 6-12
September 16
September 25
September 30
October 15
October 16
October 21
October 26
October 27
November 5
November 8
November 9
November 9-19
November 13
November 15-17
November 17
November 18
November 20
Nov. 22-Dec. 3
Nov. 29-Dec. 10
December 2
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Tour and lab instruction for members of the Marino Golinelli Foundation, coinstructed by
Marina and Marcello Siniscalco of the Marino Golinelli Foundation, Bologna, Italy
Site visit by John Phelan, Trustee and Managing Partner, MSD Capital, New York
Saturday DNA! Seminar, DNALC
Site visit to DNA EpiCenter, New London, Connecticut
Site visit by students from Zhejiang University, Hangzhou, China
Saturday DNA! Seminar, DNALC
Site visit by Jennifer Heim, Richard Osborn, and Cindy Encarnacion, St. Louis Science
Center, St. Louis, Missouri
Site visit by Kevin Ward, George Stranahan, and Andrei Rukinstein, Aspen Institute for
Physics, Aspen, Colorado
West Side School Lecture
Site visit by Patricia Volland and Julia Rankin, New York Academy of Medicine, Board of
Education, New York
Site visit by Glenda Leslie, School of Education at Murdoch University, Australia
American Association of University Women reception, Washington, D.C.
Teacher training for Singapore Ministry of Education collaborators, Tan Hong Kim,
Christine Sim, Chan Ter Yue, and Margaret Wong
Saturday DNA! Seminar, DNALC
Site visit by Abby Demars and Holly Harrick, DNA EpiCenter, New London, Connecticut
West Side School Lecture
Site visit by Jacqueline Dorrance, Executive Director, Beckman Foundation, Irvine,
California
Site visit by Caroline Fostel, Astoria Federal Savings, New York
Saturday DNA! Seminar, DNALC
Teacher-training workshops, National Institute of Education and Singapore Science
Centre, Singapore
Training for Singapore Ministry of Education collaborators, Mohan Krishnamoorthy, Chng
Swee How James, Andrea Guo Li Ling, Regina Lim, Yap Lih Min Samuel, Goh Su
Fen, Lim Lay Khim, Sixtus Goh Wee Leng, and Nora Teo
Site visit by staff from DNA EpiCenter, New London, Connecticut
Sites of Major Faculty Workshops 1985-2004
Key: High School College Middle School
ALABAMA University of Alabama, Tuscaloosa 1987-1990
ALASKA University of Alaska, Fairbanks 1996
ARIZONA Tuba City High School 1988
ARKANSAS Henderson State University, Arkadelphia 1992
CALIFORNIA California State University, Fullerton 2000
Canada College, Redwood City 1997
Contra Costa County Office of Education, Pleasant Hill 2002
Foothill College, Los Altos Hills 1997
Harbor-UCLA Research & Education Institute, Torrance 2003
Laney College, Oakland 1999
Lutheran University, Thousand Oaks 1999
Pierce College, Los Angeles 1998
Salk Institute for Biological Studies, La Jolla 2001
San Francisco State University 1991
University of California, Davis 1986
University of California, Northridge 1993
COLORADO Colorado College, Colorado Springs 1994
United States Air Force Academy, Colorado Springs 1995
University of Colorado, Denver 1998
CONNECTICUT Choate Rosemary Hall, Wallingford 1987
FLORIDA North Miami Beach Senior High School 1991
University of Western Florida, Pensacola 1991
Armwood Senior High School, Tampa 1991
University of Miami School of Medicine 2000
GEORGIA Fernbank Science Center, Atlanta 1989
Morehouse College, Atlanta 1991, 1996
Morehouse College, Atlanta 1997
HAWAII Kamehameha Secondary School, Honolulu 1990
ILLINOIS Argonne National Laboratory 1986, 1987
University of Chicago 1992, 1997
INDIANA Butler University, Indianapolis 1987
IDAHO University of Idaho, Moscow 1994
IOWA Drake University, Des Moines 1987
KANSAS University of Kansas, Lawrence
KENTUCKY Murray State University 1988
University of Kentucky, Lexington 1992
Western Kentucky University, Bowling Green 1992
LOUISIANA Jefferson Parish Public Schools, Harvey 1990
John McDonogh High School, New Orleans 1993
MAINE Bates College, Lewiston 1995
Foundation for Blood Research, Scarborough 2002
MARYLAND Annapolis Senior High School 1989
Frederick Cancer Research Center, Frederick 1995
McDonogh School, Baltimore 1988
Montgomery County Public Schools 1990-1992
St. John's College, Annapolis 1991
University of Maryland, School of Medicine, Baltimore 1999
National Center for Biotechnology Information, Bethesda 2002
MASSACHUSETTS Beverly High School 1986
Biogen, Cambridge 2002
Boston University 1994, 1996
City Lab, Boston University School of Medicine 1997
Dover-Sherborn High School, Dover 1989
Randolph High School 1988
Winsor School, Boston 1987
Whitehead Institute for Biomedical Research, Cambridge 2002
MICHIGAN Athens High School, Troy 1989
MISSISSIPPI Mississippi School for Math & Science, Columbus 1990, 1991
MISSOURI Stowers Institute for Medical Research, Kansas City 2002
Washington University, St. Louis 1989
Washington University, St. Louis 1997
NEW HAMPSHIRE New Hampshire Community Technical College, Portsmouth 1999
St. Paul's School, Concord 1986, 1987
NEVADA University of Nevada, Reno 1992
NEW JERSEY Coriell Institute for Medical Research, Camden 2003
NEW YORK Albany High School 2004
Bronx High School of Science 1987
Columbia University, New York 1993
Cold Spring Harbor High School 1985, 1987
DeWitt Middle School, Ithaca 1991, 1993
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DNA Learning Center 1988-1995, 2001-2004
DNA Learning Center 1990, 1992, 1995, 2000
DNA Learning Center 1990-1992
Fostertown School, Newburgh 1991
Huntington High School 1986
Irvington High School 1986
Junior High School 263, Brooklyn 1991
Lindenhurst Junior High School 1991
Mt. Sinai School of Medicine, New York 1997
Orchard Park Junior High School 1991
Plainview-Old Bethpage Middle School 1991
The Rockefeller University, New York 2003
State University of New York, Purchase 1989
State University of New York, Stony Brook 1987-1990
Stuyvesant High School, New York 1998-1999
Titusville Middle School, Poughkeepsie 1991, 1993
Trudeau Institute, Lake Saranac 2001
Union College, Schenectady 2004
U.S. Military Academy, West Point 1996
Wheatley School, Old Westbury 1985
NORTH CAROLINA CIIT Center for Health Research, Triangle Park 2003
North Carolina School of Science, Durham 1987
OHIO Case Western Reserve University, Cleveland 1990
Cleveland Clinic 1987
North Westerville High School 1990
OKLAHOMA Oklahoma City Community College 2000
Oklahoma Medical Research Foundation, Oklahoma City 2001
Oklahoma School of Science and Math, Oklahoma City 1994
OREGON Kaiser Permanente-Center for Health Research, Portland 2003
PENNSYLVANIA Duquesne University, Pittsburgh 1988
Germantown Academy 1988
SOUTH CAROLINA Clemson University, Clemson 2004
Medical University of South Carolina, Charleston 1988
University of South Carolina, Columbia 1988
TEXAS Austin Community College, Rio Grande Campus 2000
J.J. Pearce High School, Richardson 1990
Langham Creek High School, Houston 1991
Southwest Foundation for Biomedical Research, San Antonio 2002
Taft High School, San Antonio 1991
Trinity University, San Antonio 1994
University of Texas, Austin 1999, 2004
UTAH University of Utah, Salt Lake City 1993
University of Utah, Salt Lake City 1998, 2000
VERMONT University of Vermont, Burlington 1989
VIRGINIA Eastern Mennonite University, Harrisonburg 1996
Jefferson School of Science, Alexandria 1987
Mathematics and Science Center, Richmond 1990
Mills Godwin Specialty Center, Richmond 1998
WASHINGTON Fred Hutchinson Cancer Research Center, Seattle 1999, 2001
University of Washington, Seattle 1993, 1998
WASHINGTON, D.0 Howard University 1992, 1996
WEST VIRGINIA Bethany College 1989
WISCONSIN Blood Center of Southeastern Wisconsin, Milwaukee 2003
Madison Area Technical College 1999
Marquette University, Milwaukee 1986, 1987
University of Wisconsin, Madison 1988, 1989
University of Wisconsin, Madison 2004
WYOMING University of Wyoming, Laramie 1991
AUSTRALIA Walter and Eliza Hall Institute and University of Melbourne 1996
CANADA Red River Community College, Winnipeg, Manitoba 1989
ITALY Porto Conte Research and Training Laboratories, Alghero 1993
International Institute of Genetics and Biophysics, Naples 1996
PANAMA University of Panama, Panama City 1994
PUERTO RICO University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Mayaguez 1992
University of Puerto Rico, Rio Piedras 1993
University of Puerto Rico, Rio Piedras 1994
RUSSIA Shemyakin Institute of Bioorganic Chemistry, Moscow 1991
SINGAPORE National Institute of Education 2001-2004
SWEDEN Kristineberg Marine Research Station, Fiskebackskil 1995
Uppsala University, Uppsala 2004
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COLD SPRING HARBOR
LABORATORY PRESS
2004 PUBLICATIONS
SERIALS
Genes & Development, Vol. 18, 1-3164
(www.genesdev.org)
Genome Research, Vol. 14, 1-2536
(www.genome.org)
Learning and Memory, Vol. 11, 1-804
(www.learnmem.org)
Protein Science, Vol. 13, 1-3382
(www.proteinscience.org)
RNA, Vol. 10, 1-1986
(www.rnajournal.org)
Cold Spring Harbor Symposia in Quantitative Biology
Vol. 68: The Genome of Homo sapiens
(www.cshl-symposium.org)
LABORATORY MANUALS
Live Cell Imaging: A Laboratory Manual, David Spector
and Robert Goldman (eds.), "Live Cell Imaging" (DVD)
Imaging in Neuroscience and Development: A Labor-
atory Manual, Rafael Yuste and Arthur Konnerth (eds.)
HANDBOOKS
Fly Pushing, 2nd edition, Ralph J. Greenspan
An Illustrated Chinese-English Guide for Biomedical
Scientists, James Samet, Weidong Wu, Yuh-Chin T.
Huang, and Xinchao Wang
(www.chinese-english.cshl.org)
At the Bench, updated edition, Kathy Barker
Mouse Phenotypes: A Handbook of Mutation Analysis,
Virginia E. Papaioannou and Richard R. Behringer
Drosophila: A Laboratory Handbook, Michael
Ashburner, Scott Hawley, and Kent Golic
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TEXTBOOKS
A Genetic Switch (3rd ed.), Phage Lambda Revisited,
Mark Ptashne
Bioinformatics: Sequence and Genome Analysis (2nd
ed.), David Mount
(www.bioinformaticsonline.org)
MONOGRAPHS
Cell Growth: Control of Cell Size, Michael N. Hall,
George Thomas, and Martin Raff (eds.)
Gastrulation: From Cells to Embryo, Claudio Stern (ed.)
(www.gastrulation.org)
GENERAL INTEREST
Is It in Your Genes? The Influence of Genes on Common
Disorders and Diseases That Affect You and Your
Family Philip R. Reilly
(www.is-it-in-your-genes.org)
Mendel's Legacy: The Origin of Classical Genetics, Elof
Axel Carlson
The Writing Life of James D. Watson, Errol C. Friedberg
OTHER
Banbury Center Annual Report 2003
CSHL Annual Report 2003
CSHL Annual Report 2003: Yearbook Edition
Watson School of Biological Sciences Annual Report 2003
WEB SITES
www.BioSupplyNet.com, online directory of scientific
supplies and suppliers
A selection of recently published books
The journal publishing program
COLD SPRING HARBOR LABORATORY PRESS
EXECUTIVE DIRECTOR'S REPORT
Cold Spring Harbor Laboratory Press is the largest of the five educational divisions of the Laboratory,
with a staff of 49, offices on the Woodbury campus, and marketing operations based in San Diego,
California and Oxford, United Kingdom. In 2004, the Press had income of $9.5 million and made a total
contribution to the Laboratory's economy of more than $1.2 million.
Our research journals, books, and manuals assist the continuing professional education of working
scientists and graduate students, our textbooks educate college undergraduates, and our other books
delve into the practice, personalities, and history of science and its influence on medicine, business,
and social policy.
Journals
Two thirds of Press income now comes from journal publishing. In 2004, against a downward industry
trend, institutional subscriptions to our five journals increased by 4%. Countless numbers of individual
readers online downloaded more than 110,000 articles each month in countries around the world.
Scientists in the poorest countries are able to access these articles free of charge. More than 12,000
journal pages were published, an increase of over 6%, containing 1200 new articles. Many of these
were highlighted in the world's major news media, including The New York Times, The Wall Street
Journal, and the BBC News. All five journals had impact factors that were similar to or higher than last
year's, and Genes & Development remained one of the ten most highly cited of all primary research
journals in science.
Both RNA and Protein Science, journals published under contract for the RNA and Protein
Societies, respectively, continued to reach new levels of institutional subscriptions. Our own journal
Learning & Memory received a record number of manuscript submissions and, as a result, began pub-
lishing monthly issues online and bimonthly issues in print.
Throughout the year, the talk among journal publishers was of an alternative to subscriptions as a
business model. "Open access" publishing is paid for by authors, rather than readers, and research
papers are made available free of charge online immediately on publication. The model is new and
unproven as a means of sustaining an important journal without grant support or private underwriting,
but to assess support, Genome Research has introduced an immediate free-access option for individ-
ual papers. The archives of our journals have been freely accessible online for over 5 years, and this
year, the interval between publication and the free release of papers published in Genes & Development
and Genome Research was reduced from 1 year to 6 months. All three Cold Spring Harbor journals
are also freely accessible through PubMedCentral.
Some organizations that fund research have begun to voice opinions on the access policies of jour-
nals that publish that research. In the United States, the largest supporter of biomedical research is the
National Institutes of Health (NIH). Its Director, Dr. Elias Zerhouni, presented a proposal for a database
that would provide free access to papers describing NIH-funded research within a very short time of
publication. In the intense debate among publishers and scientists that followed, the public benefit of
such access was weighed against the potential harm to the financial viability of many subscription-
based journals, particularly those published by not-for-profit organizations that use that income to sup-
port other activities. I was one of a group of publishers who met with Dr. Zerhouni to discuss and clar-
ify the details and intent of his proposal. The final version of the NIH policy requires the deposition of
final manuscripts, rather than published papers, within a period of less than 1 year after acceptance
that the authors themselves must decide. The scene is set for conflict between society publishers and
their members.
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Books and Electronic Media
Laboratory protocols--instructions for executing research techniques-have been the core of our book
publishing program for more than 20 years in the form of laboratory manuals widely regarded as the
best in their fields. In 2004, a partnership was struck with the new journal Nature Methods, in which
Press protocols reached a large international audience through two new channels: as a section in each
monthly issue of the journal and through access by the journal's institutional subscribers to the online
version of our best-selling manual Molecular Cloning.
There were two manuals among the 15 new books published in 2004, a list (see p. 388) that includ-
ed monographs, handbooks, textbooks, general interest and history books, as well as the Annual
Symposium volume, this year devoted to the human genome. The Symposium series, first published
in 1933, is one of the oldest and most prestigious in biology. For the first time, individual chapters of
the proceedings were published online in advance of the printed volume on a Web site that gave view-
ers a taste of what was happening as the conference actually took place. Combinations of traditional
print and digital media were further explored in the manual Live Cell Imaging, which includes a DVD
showing cells in action, and the monograph Gastrulation, whose Web site contains movies of this
important event in embryonic development.
Such online enhancements are particularly necessary for textbooks that compete for adoption in
crowded markets. Our book Bioinformatics: Sequence and Genome Analysis, by David Mount, cap-
tured this emergent field on first publication in 2001 and regained its lead with this year's second,
extensively revised edition. And the newly released Molecular Biology of the Gene, the first new edition
in 17 years, also made a strong showing, through the sales expertise of our co-publisher Benjamin
Cummings.
Our list of professional handbooks grew still further with the addition of new editions of Drosophila,
At The Bench, and Fly Pushing, as well as a new guide to mutation analysis in mice and a reference
book for students whose first language is Chinese. Our other books included an ambitious attempt by
Philip Reilly to provide a guide for general readers to the genetics of many complex human diseases.
In addition, in The Writing Life of James D. Watson, Errol Friedberg reminded us that the chancellor of
this Laboratory, world famous as a scientist, also has an extraordinary variety of accomplishments as
an author.
It was gratifying to note the frequency and warmth of the reviews of our 2003 and 2004 books. One
reviewer remarked that "Cold Spring Harbor books are usually exceptional"-nicely summarizing our
hopes for all our titles. The biography of geneticist George Beadle, The Uncommon Farmer, by Paul
Berg and Maxine Singer, was particularly acclaimed and named one of Choice magazine's top books
of the year. There was also widespread praise for Elof Carlsson's Mendel's Legacy, an exploration of
the origins of classical genetics. Recognition of the quality of our program has led to an ever-increas-
ing number of foreign translations, and in 2004, 15 such agreements were signed for Chinese,
Japanese, Korean, and Italian editions.
In South Africa, our 2001 book for teenagers about HIV/AIDS received intense scrutiny from a
diverse group of teachers, students, and community workers in rural and urban areas as we worked
to tailor a second edition of the book to evolving public attitudes toward the epidemic and the avail-
ability of treatment options. Reflecting these changes, Staying Alive has a new, bolder title, You, Me
and HIV, but the entirely revised content retains the unique, engaging style of its creators Fran Balkwill
and Mic Rolph. With the assistance of a grant from the Gates Foundation, 50,000 copies in English
and 20,000 copies in Zulu and Afrikaans will be printed for free distribution to schools and health orga-
nizations within South Africa, along with a guide to teaching from the book.
In a generally busy year, 25 contracts for new books were signed, including two exciting and inno-
vative textbooks. In addition, the online directory of laboratory supplies and suppliers, BioSupplyNet.
com, which we reacquired in 2003, was relaunched with a much improved design and new, attractive
functions that generated substantial advertising revenue. These and other initiatives help pave the way
for future growth. Other innovations increased efficiency, allowing us to do more with current staff and
resources. Significant savings were gained through outsourcing composition and establishing relation-
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ships with printers abroad, and by further development of electronic data interchange for managing
thousands of book orders and journal subscriptions.
Catalogs and exhibits remain important to our marketing strategies, but more extensive use is being
made of online book and journal promotion. Sales through our own Web site continue to grow, but an
ever-larger proportion of our books, as much as 60%, now reach our scientist customers through
resellers, particularly Amazon.com, with its extraordinary market penetration. Our roster of wholesale
customers, international agents, and distributors continues to expand. Scion Publishing, the United
Kingdom company trading as CSHL Press Europe, had an encouraging first year, meeting sales pro-
jections. It will shortly begin publishing its own books that the Press will distribute in the United States.
This arrangement is made possible by our professionally staffed customer service and warehouse
operations, which in 2004 processed orders for and shipped 60,000 books and managed inventory to
over 99% accuracy. Another recently founded publishing house, Roberts Publishing, has also con-
tracted with us for fulfillment services in the United States.
After the financial challenges of the previous year, I am glad to be able to conclude that 2004 was
in contrast a year of growth, new initiatives, and increased confidence for Cold Spring Harbor
Laboratory Press as we continued to support the Laboratory's educational mission with first-class pub-
lications for scientists, students, and the public worldwide.
Staff
The staff members of the Press as of December 2004 are listed elsewhere in this volume. They bring
a cheerful commitment to their work that makes them a pleasure to be with.
In 2004, we welcomed five new colleagues: Laureen Connell, Hillary Sussman, Maria Smit, Kathy
Bubbeo, and Mary Mulligan. We also said goodbye to Laurie Goodman, Jill Manero, Joan Pepperman,
and Melissa Frey.
In recent years, the activities of the Press have grown in diversity and complexity. The success of
this growth is due to a talented and motivated group of departmental managers: Jan Argentine, Ingrid
Benirschke, Kathy Cirone, Kathryn Fitzpatrick, Nancy Hodson, Geraldine Jaitin, Bill Keen, Guy Keyes,
Marcie Siconolfi, Linda Sussman, and Denise Weiss. They have all taken on new responsibilities with
little or no extra help or reward. The Press owes much to them and also to the energy and flair of the
editors of our journals, Terri Grodzicker at Genes & Development, and Laurie Goodman and her suc-
cessor Hillary Sussman at Genome Research. It is also a pleasure to acknowledge the indispensable
Elizabeth Powers who carries out all manner of essential activities in our office with quiet grace.
John R. Inglis
Executive Director
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FINANCIAL STATEMENTS
CONSOLIDATED BALANCE SHEET
December 31, 2004
With comparative financial information as of December 31, 2003
Assets: 2004 2003
Cash and cash equivalents 40,744,417 28,971,185
Accounts receivable:
Publications 1,308,718 1,257,221
Other 1,179,604 1,332,279
Grants receivable 6,975,455 7,068,387
Contributions receivable, net 12,492,687 11,452,991
Publications inventory 2,945,099 2,206,640
Prepaid expenses and other assets 1,605,707 1,566,991
Investments 211,294,366 198,696,165
Investment in employee residences 4,830,425 4,774,834
Restricted use assets 2,904,923 2,709,576
Land, buildings, and equipment, net 110,757,023 109,253,408
Total assets $ 397,038,424 369,289,677
Liabilities and Net Assets:
Liabilities:
Accounts payable and accrued expenses $ 7,429,657 5,975,281
Notes payable 107,775 140,958
Deferred revenue 3,878,738 4,067,960
Bonds payable 45,200,000 45,200,000
Total liabilities 56,616,170 55,384,199
Net assets:
Unrestricted 184,397,408 178,415,767
Temporarily restricted 25,419,056 14,223,309
Permanently restricted 130,605,790 121,266,402
Total net assets 340,422,254 313,905,478
Total liabilities and net assets $ 397,038,424 369,289,677
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CONSOLIDATED STATEMENT OF ACTIVITIES
Year ended December 31, 2004
With summarized financial information for the year ended December 31, 2003
Unrestricted
Temporarily
Restricted
Permanently
Restricted
2004
Total
2003
Total
Revenue and other support:
Public support (contributions and
nongovernment grant awards) $ 10,582,015 17,086,618 1,159,665 28,828,298 29,792,003
Government grant awards 29,451,302 29,451,302 26,878,120
Indirect cost allowances 19,089,893 - - 19,089,893 18,000,004
Program fees 3,644,734 - 3,644,734 3,134,443
Publications sales 9,743,639 - 9,743,639 10,052,963
Dining services 3,183,440 3,183,440 2,927,668
Rooms and apartments 2,632,671 2,632,671 2,347,090
Royalty and licensing fees 926,913 - - 926,913 869,826
Investment income (interest and
dividends) 3,134,480 - 3,134,480 4,141,495
Miscellaneous 514,559 - 514,559 616,755
Total revenue 82,903,646 17,086,618 1,159,665 101,149,929 98,760,367
Net assets released from restrictions 5,890,871 (5,890,871)
Total revenue and other support 88,794,517 11,195,747 1,159,665 101,149,929 98,760,367
Expenses:
Research 52,049,866 - - 52,049,866 45,619,807
Educational programs 13,238,766 - - 13,238,766 12,917,185
Publications 9,380,833 - - 9,380,833 10,631,334
Banbury Center conferences 1,159,499 - 1,159,499 1,136,159
Dolan DNA Learning Center programs 1,611,325 - - 1,611,325 1,809,174
Watson School of Biological Sciences
programs 2,263,518 - 2,263,518 2,029,275
General and administrative 12,508,768 - 12,508,768 11,976,718
Dining services 4,236,535 4,236,535 4,262,515
Total expenses 96,449,110 96,449,110 90,382,167
(Deficiency) excess of revenue and
other support over expenses
(7,654,593) 11,195,747 1,159,665 4,700,819 8,378,200
Other changes in net assets:
Net appreciation in fair value
of investments
13,636,234 8,179,723 21,815,957 38,128,865
Increase in net assets 5,981,641 11,195,747 9,339,388 26,516,776 46,507,065
Net assets at beginning of year 178,415,767 14,223,309 121,266,402 313,905,478 267,398,413
Net assets at end of year $ 184,397,408 25,419,056 130,605,790 340,422,254 313,905,478
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CONSOLIDATED STATEMENTS OF CASH FLOWS
Year ended December 31, 2004
With comparative financial information for the year ended December 31, 2003
2004 2003
Cash flows from operating activities:
Increase in net assets $ 26,516,776 46,507,065
Adjustments to reconcile increase in net assets
to net cash used in operating activities:
Depreciation and amortization 5,769,622 5,458,719
Net appreciation in fair value of investments (21,746,064) (37,868,190)
Contributions restricted for long-term investment (13,812,552) (13,460,462)
Changes in assets and liabilities:
Decrease (increase) in accounts receivable 101,178 (459,802)
Decrease (increase) in grants receivable 92,932 (1,912,888)
Decrease (increase) in contributions receivable 79,666 (875,375)
(Increase) decrease in publications inventory (738,459) 7,859
(Increase) decrease in prepaid expenses and other assets (38,716) 63,375
(Increase) decrease in restricted use assets (195,347) 355,653
Increase in accounts payable and accrued expenses 1,454,376 802,963
(Decrease) increase in deferred revenue (189,222) 419,507
Net cash used in operating activities (2,705,810) (961,576)
Cash flows from investing activities:
Capital expenditures (7,273,237) (6,296,049)
Proceeds from sales and maturities of investments 113,998,317 135,393,757
Purchases of investments (104,850,454) (122,075,553)
Net change in investment in employee residences (55,591) (427,207)
Net cash provided by investing activities 1,819,035 6,594,948
Cash flows from financing activities:
Permanently restricted contributions 1,159,665 4,822,932
Contributions restricted for investment in land, buildings,
and equipment 12,652,887 8,637,530
Increase in contributions receivable (1,119,362) (6,092,438)
Repayment of notes payable (33,183) (29,161)
Net cash provided by financing activities 12,660,007 7,338,863
Net increase in cash and cash equivalents 11,773,232 12,972,235
Cash and cash equivalents at beginning of year 28,971,185 15,998,950
Cash and cash equivalents at end of year $ 40,744,417 28,971,185
Supplemental disclosures:
Interest paid $ 780,758 1,014,956
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COMPARATIVE OPERATING HISTORY 2000-2004
(Dollars in Thousands)
2000 2001 2002 2003 2004
Revenue:
Main Lab:
Grants and contracts $ 30,345 34,716 37,872 41,749 48,208
Indirect cost allowances 12,718 14,134 14,987 17,869 18,910
Other 10,618 12,528 10,918 10,524 11,611
CSHL Press 8,684 9,941 9,051 10,053 9,744
Banbury Center 1,856 1,666 1,763 1,729 1,779
Dolan DNA Learning Center 1,471 1,878 2,978 2,564 2,314
Watson School of Biological Sciences 682 927 1,496 1,769 1,889
Total revenue 66,374 75,790 79,065 86,257 94,455
Expenses:
Main Lab:
Research and training 30,345 34,716 37,872 41,749 48,208
Operation and maintenance of plant 6,589 7,027 8,661 8,702 8,606
General and administrative 6,162 6,492 6,395 7,507 7,836
Other 7,075 9,505 8,550 8,959 9,410
CSHL Press 8,186 9,515 8,962 10,234 8,995
Banbury Center 1,702 1,536 1,597 1,616 1,642
Dolan DNA Learning Center 1,362 1,801 2,780 2,257 2,066
Watson School of Biological Sciences 682 927 1,496 1,769 1,880
Total expenses excluding depreciation 62,103 71,519 76,313 82,793 88,643
Excess before depreciation and
(designation) release of funds 4,271 4,271 2,752 3,464 5,812
Depreciation (3,974) (4,620) (5,165) (5,459) (5,770)
(Designation) release of funds 1 (297) 349 1,848 - -
Net operating excess (deficit) $ - - (565) (1,995) 42
The above amounts are presented on a combined basis for all funds for which Cold Spring Harbor Laboratory prepares operating budgets.
'Funds designated to underwrite future direct and indirect expenses of new research programs.
Federal Grants
44.4%
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
DECEMBER 31, 2004
Interest and
Miscellaneous
0.4%
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Grants
n drodwprnees aatnedd5.0%
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19.0%
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FINANCIAL SUPPORT OF THE LABORATORY
Cold Spring Harbor Laboratory, Banbury Center, and the Dolan DNA Learning Center receive a sub-
stantial portion of their funding through grants from the Federal Government and through grants, cap-
ital gifts, and annual contributions from private foundations, corporations, and individuals. The follow-
ing section summarizes funding that occurred during 2004.
GRANTS January 1, 2004-December 31, 2004
COLD SPRING HARBOR LABORATORY GRANTS
Grantor Program/Principal Investigator Duration of Grant 2004 Funding*
FEDERAL GRANTS
NATIONAL INSTITUTES OF HEALTH
Equipment Dr. Myers 04/01/04 03/31/05 $ 211,975 *
Dr. Stillman 09/01/04 08/31/05 984,159 *
Program Projects Dr. Herr 01/01/97 12/31/06 5,041,821
Dr. Stillman 08/01/87 07/31/05 3,855,008
Research Support Dr. Brody 07/01/04 04/30/09 304,650 *
Dr. Chklovskii 07/08/04 06/30/09 304,650 *
Dr. Cline 12/10/04 11/30/09 484,030 *
Dr. Cline 03/01/98 03/31/06 452,805
Dr. Dubnau 09/15/04 06/30/09 349,800 *
Dr. Hamaguchi 04/01/04 03/31/08 346,707 *
Dr. Hannon 07/01/00 08/31/05 289,690
Dr. Hernandez 07/01/04 06/30/08 245,413 *
Dr. Herr 03/01/02 02/28/06 298,800
Dr. Hirano 07/01/01 06/30/05 275,560
Dr. Hirano 05/01/96 04/30/08 406,000
Dr. Huang 08/01/01 06/30/06 415,000
Dr. Joshua-Tor 05/01/01 03/31/06 373,500
Dr. Joshua-Tor 02/15/02 01/31/07 373,500
Dr. Krainer 07/01/03 06/30/07 535,378
Dr. Krainer 06/01/01 05/31/06 408,400
Dr. Lazebnik 09/01/03 08/31/05 211,666
Dr. Lowe 070/1/04 06/30/09 390,832
Dr. Lowe 04/01/04 03/31/09 849,999
Dr. Mainen 09/23/02 08/31/07 370,813
Dr. Malinow 05/01/92 04/30/05 565,477
Dr. Malinow 04/01/95 02/29/08 553,671
Dr. Martienssen 08/01/03 07/31/07 338,584
Dr. Mittal 04/01/04 03/31/09 312,036
Dr. Muthuswamy 03/01/03 02/28/07 376,211
Dr. Neuwald 09/30/98 08/31/06 373,500
Dr. Skowronski 04/01/98 04/30/08 640,187
Dr. Spector 04/01/90 03/31/07 652,102
Dr. Spector 09/01/04 08/31/08 363,220
Dr. Stein 09/01/02 06/30/05 617,776
Dr. Stillman 07/01/91 05/31/08 555,907
Dr. Svoboda 12/01/03 11/30/08 313,498
Dr. Svoboda 12/01/02 11/30/07 281,724
Includes direct and indirect costs.
*New grants awarded in 2004.
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Dr. Svoboda 06/01/03 03/31/08 $ 295,969
Dr. Svoboda 03/01/04 02/28/09 169,080
Dr. Tansey 05/01/03 04/30/07 337,365
Dr. Tonks 08/01/91 03/31/06 646,533
Dr. Tonks 05/01/97 06/30/05 348,600
Dr. Tully 03/01/03 02/29/08 380,438
Dr. Tully 08/01/03 05/31/07 380,719
Dr. Van Aelst 05/01/03 04/30/08 338,756
Dr. Wig ler 07/15/98 04/30/07 502,725
Dr. Xu 08/01/01 07/31/05 252,320
Dr. Xu 08/01/03 03/31/07 363,619
Dr. Zador 01/23/03 12/31/07 422,500
Dr. M. Zhang 09/19/03 08/31/06 584,205
Dr. Zhong 07/01/03 06/30/08 346,540
Fellowships Dr. Ding 07/01/04 06/30/07 42,976
Dr. Kuhlman 12/01/02 11/30/05 48,928
Dr. Lucito 06/01/02 05/31/07 140,867
Dr. Stepanyants 07/01/04 06/30/09 114,831
Dr. Zilfou 07/01/04 06/30/05 48,928
Course Support Advanced Immunocytochemistry In Situ 07/01/98 08/31/05 76,766
Hybridization and Live Cell Imaging
C. elegans 08/01/98 08/01/06 67,152
Cancer Workships 01/01/83 03/31/06 308,282
Cell and Developmental Biology of 04/01/93 03/31/09 19,440
Xenopus
Computational Genomics Course 06/06/91 08/31/07 46,284
CSHL Neurobiology Short-term Training 07/01/01 06/30/06 160,527
Genome Informatics 07/01/00 06/30/05 50,728
Macromolecular Crystallography 09/01/00 08/31/05 56,773
Making And Using DNA Microarrays 07/01/04 55,635
Proteomics 07/01/03 06/30/06 66,792
Meeting Support 69th Symposium: Epigenetics 05/15/01 04/30/06 5,000
69th Symposium: Epigenetics 06/04/04 05/31/05 11,000
Axon Guidance and Neural Plasticity 06/01/00 05/31/05 19,000
Cancer Genetics Conference 08/01/00 07/31/05 15,000
Cell Cycle 04/01/00 03/31/05 9,000
Evolution of Developmental Diversity 04/17/02 03/31/05 13,000
Gene Expression and Signaling in the 04/19/02 03/31/07 2,000
Immune System
Germ Cells 07/01/04 06/30/05 6,000
Molecular Chaperones and the Heat 04/01/04 03/31/09 13,000
Shock Response
Mouse Molecular Genetics 07/12/02 06/30/07 17,962
Pharmacogenomics 08/10/04 07/31/09 18,683 *
Translational Control 07/05/02 06/30/07 6,000
NATIONAL SCIENCE FOUNDATION
Research Support Dr. Hannon 09/01/04 02/28/06 200,000 *
Dr. Jackson 03/01/04 02/28/07 130,000 *
Dr. Jackson 08/01/02 07/31/05 120,000
Dr. Jackson 10/01/01 09/30/06 284,058
Dr. McCombie 09/01/03 08/31/06 1,303,762
Dr. McCombie 06/15/04 11/30/05 199,949 '
Dr. Stein 09/01/03 08/31/06 556,369
Dr. Stein 12/15/03 11/30/07 1,591,214
Dr. Timmermans 07/01/02 06/30/05 123,562
+Includes direct and indirect costs.
`New grants awarded in 2004.
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Dr. Timmermans
Dr. Ware
Dr. M. Zhang
Drs. Martienssen/McCombie/Stein/Lucito
09/01/03
09/01/03
09/15/03
09/01/01
08/31/06
08/31/08
08/31/08
08/31/05
$ 120,077
290,586
65,000
519,921
Course Support Advanced Bacterial Genetics 07/15/04 06/30/09 145,659 "
Advanced Techniques in Plant Science 07/01/04 06/30/05 76,875 *
Cereal Genomics 10/01/04 03/31/06 36,030 *
Computational Neuroscience Vision 06/15/04 05/31/05 52,000 *
RCN: The Gramene Community Curation 01/15/03 12/31/05 183,087
Network 4 Workshops
Meeting Support Computational and Systems Neuroscience 03/15/04 02/28/05 13,780 *
(Cosyne)
Plant Genomes: From Sequence
to Phenome
08/01/04 07/31/05 15,187 *
Evolution of Developmental Diversity 03/01/04 02/28/05 16,763 *
Molecular Genetics of Bacteria and Phage 04/01/04 03/31/05 5,000 *
UNITED STATES DEPARTMENT OF AGRICULTURE
Research Support Dr. Jackson 09/01/03 08/31/06 74,988
Dr. Martienssen 08/01/03 07/31/05 96,402
Dr. McCombie 02/01/04 01/31/07 201,842 *
Dr. McCombie 09/15/04 09/14/09 50,000 "
Dr. Stein 09/22/03 09/14/05 250,000
Dr. Stein 09/15/02 09/14/05 783,785
Dr. Stein 10/01/02 09/30/05 220,000
Dr. Stein 03/16/03 09/30/05 838,016
UNITED STATES DEPARTMENT OF THE ARMY
Research Support Dr. Hannon 04/01/02 03/31/06 732,644
Drs. Hannon/Lowe 09/01/02 08/31/05 166,000
Dr. Mainen 04/01/04 03/31/06 199,969 *
Dr. Muthuswamy 07/15/04 07/14/05 126,953 *
Dr. Wig ler 04/01/04 03/31/06 1,784,200 *
Dr. Zhong 12/30/04 12/29/05 100,000 *
Dr. Zhong 12/15/04 12/14/08 334,511 *
Fellowships M. Carmel 05/01/02 04/30/05 22,000
T. Haire 10/01/04 09/30/06 29,991
A. Lucs 04/01/03 03/31/06 29,991
M. Moore 08/16/04 08/15/06 29,991
S. Nunez 02/27/04 02/28/07 30,000
K. Siddiqui 04/01/03 03/31/06 29,991
D. Siolas 07/01/04 06/30/06 30,304
Dr. Du 06/01/02 12/31/04 20,427
Dr. Kannanganattu 01/01/01 06/30/04 27,858
Dr. R Smith 04/01/04 03/31/07 108,000
Dr. Wendel 09/01/04 08/31/05 100,000
Dr. Xiang 06/01/03 05/31/06 56,984
MISCELLANEOUS GRANTS
Equipment
NYS Grand Lodge Order Sons
of Italy/Breast Cancer Help, Inc.
Dr. Stillman 05/01/04 04/30/05 10,000 *
*Includes direct and indirect costs.
'New grants awarded in 2004.
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Research Support
AACR-National Foundation for Cancer Dr. Lowe 07/01/04 06/30/05 $ 50,000 *
Research Professorship in Basic
Cancer Research
AKC Canine Health Foundation Dr. McCombie 07/19/01 07/20/04 33,000
American Cancer Society Dr. Wigler 01/01/96 12/31/04 10,000
American Cancer Society Dr. Wig ler 01/01/01 12/31/05 70,000
The Michael Scott Barish Human Dr. Wig ler 01/01/04 12/31/04 70,025
Cancer Grant sponsored by 1 in 9:
The Long Island Breast Cancer
Action Coalition
Breast Cancer Research Foundation Dr. Wig ler 10/01/00 09/30/05 250,000
Dorothy Rodbell Cohen Foundation
for Cancer Research Dr. Tonks 06/14/04 06/15/05 20,000 *
The Charles A. Dana Foundation, Inc. Dr. Cline 10/01/03 03/31/05 34,006
The Charles A. Dana Foundation, Inc. Dr. Van Aelst 04/01/03 09/30/04 33,773
Dart Neurogenomics Project Dr. Tully 10/01/04 12/31/04 200,000 *
De Matteis Family Foundation Dr. Powers 10/01/04 09/30/05 268,000 *
ELJI/SUSB Consortium Agreement Dr. Huang 01/15/04 01/14/07 70,481 *
Find A Cure Today (F.A.C.T.) Dr. Muthuswamy 07/01/03 02/28/05 39,040
FSMA Dr. Krainer 07/15/04 07/14/05 20,000
Genentech Dr. Hannon 01/30/04 01/29/05 1,000,000 *
Irving Hansen Foundation Dr. Tansey 08/01/04 07/31/05 20,000 *
Ira Hazan Dr. Enikolopov 12/01/04 11/30/05 200,000 *
Harrison's Heart Foundation Dr. Hatchwell 12/21/04 06/30/05 30,000 *
Helicon Dr. Tully 07/01/01 06/30/05 84,000
Human Frontier of Science Program Dr. Spector 06/01/03 05/31/06 112,500
Organization (HFSPO)
Human Frontier of Science Program Dr. Mitra 06/15/03 06/14/06 96,500
Organization (HFSPO)
David H. Koch Dr. Powers 12/01/04 11/30/05 50,000
The Leukemia & Lymphoma Society Dr. Lowe 10/01/03 09/30/08 1,000,000
Long Beach Breast Cancer Coalition Dr. Muthuswamy 07/15/04 07/14/05 2,000
LI 2 Day Walk to Fight Breast Cancer Dr. Muthuswamy 08/01/04 07/31/05 5,000
LIABC (Long Islanders Against Breast Dr. Wig ler 01/01/04 12/31/04 72,720
Cancer)
The March of Dimes Dr. Huang 06/01/04 05/31/07 287,409
The March of Dimes Dr. Mills 06/01/04 05/31/05 68,686
Carol Marcincuk Ovarian Cancer Dr. Lucito 11/01/04 10/31/05 3,695
Research Fund
The G. Harold & Leila Y. Mathers Dr. Zador 07/01/03 06/30/06 165,388
Charitable Trust
The Elizabeth McFarland Breast Dr. Wig ler 03/01/04 02/28/05 30,424 *
Cancer Fund
Merck & Co. Inc Dr. Hannon 04/16/03 04/15/05 700,000
Louis Morin Charitable Trust Dr. Spector 12/01/04 11/30/05 100,000 *
NARSAD Dr. Mainen 09/15/04 09/14/06 50,000 *
NARSAD Dr. Enikolopov 09/15/04 09/14/05 50,000 *
NIH/Affymetrix Consortium Agreement Dr. Stein 08/01/04 05/31/06 90,562 *
NIH/Baylor College of Medicine Dr. Mills 09/01/01 08/31/06 220,787
Consortium Agreement
NIH/Baylor College of Medicine Dr. Muthuswamy 03/01/04 12/31/04 56,756 *
Consortium Agreement
NIH/Booz Allen Hamilton caBIG Dr. Stein 08/01/04 02/28/05 270,400 *
Consortium Agreement
NIH/Caltech Consortium Agreement Dr. Svoboda 04/04/03 02/29/08 144,023
NIH/Columbia University Consortium Dr. Lowe 09/30/00 07/31/05 455,447
Agreement
'Includes direct and indirect costs.
*New grants awarded in 2004.
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NIH/Evanston Northwestern Dr. M. Zhang 07/01/03 06/30/06 $ 133,221
Consortium Agreement
NIH/Massachusetts Institute of Dr. Stein 09/15/04 08/31/05 492,475 *
Technology Consortium
Agreement
NIH/Memorial Sloan-Kettering Dr. Mittal 04/01/04 03/31/09 132,411 *
Consortium Agreement
NIH/Memorial Sloan Kettering Dr. Van Aelst 07/10/03 06/30/08 326,044
Consortium Agreement
NIH/University of Virginia Dr. Stein 08/01/02 07/31/05 225,834
Consortium Agreement
NIH/Washington University Dr. Stein 09/01/03 08/31/08 529,246
Consortium Agreement
NIH/Washington University Dr. Stein 11/01/03 10/31/06 89,891
Consortium Agreement
NIH/Weill Cornell Medical Center Dr. Mitre 02/01/04 01/31/06 76,622 *
Consortium Agreement
NSF/North Carolina State University Dr. Martienssen 10/01/04 09/30/09 193,006 *
Consortium Agreement
NSF/New York University Drs. McCombie/Martienssen 10/01/04 09/30/09 257,830 *
Consortium Agreement
NSF/Rutgers University Consortium Drs. Spector/Martienssen/McCombie 10/01/00 09/30/05 368,052
Agreement
NSF/University of Arizona Consortium Dr. Stein 10/01/03 09/30/07 195,862
Agreement
NSF/University of Calfornia, Berkeley Drs. Jackson/Martienssen 10/01/01 09/30/06 284,058
Consortium Agreement
NSF/University of Georgia Consortium Dr. Timmermans 09/01/03 08/31/07 229,849
Agreement
NSF/University of Wisconsin Dr. Martienssen 09/01/00 08/31/05 304,223
Consortium Agreement
NSF/University of Wisconsin Dr. Stein 01/01/04 12/31/07 263,887 *
Consortium Agreement
Olin Family Foundation Dr. Van Aelst 02/01/04 01/31/05 7,000 *
OSI Pharmaceuticals
. Dr. Mittal 10/21/02 10/20/05 450,000
Ovarian Cancer Research Fund Dr. Lucito 01/01/04 12/31/04 50,000 *
Pfizer, Inc. Dr. Hannon 12/01/03 11/30/05 312,000
Philips Research Dr. M. Zhang 12/01/04 11/30/05 5,000 *
Redwood Neuroscience Institute Dr. Brody 01/01/04 12/31/04 35,000 *
Redwood Neuroscience Institute Dr. Koulakov 01/01/04 12/31/04 35,000 *
SAID-Frederick, Inc. Research Dr. Hannon 10/21/02 12/31/05 507,000
Agreement
SAIC-Frederick, Inc. Research Dr. M. Zhang 03/08/04 03/07/05 71,541 *
Agreement
The Seraph Foundation Dr. Enikolopov 10/01/04 09/30/05 69,000 *
The Simons Foundation Dr. Wig ler 11/01/03 10/31/05 1,967,040
SMA Foundation Dr. Krainer 06/01/04 05/31/07 59,333 *
SNP Consortium Ltd Dr. Stein 02/24/03 12/31/05 360,415
US Army/New York University
Consortium Agreement Dr. Lucito 09/27/04 09/26/09 119,785 *
USDA/Oregon State University
Consortium Agreement Dr. Martienssen 12/01/04 11/30/07 12,800 *
WALK For Women Breast Cancer Fund Dr. Muthuswamy 04/01/04 03/31/05 5,500 *
Fellowships
Rita Allen Foundation Dr. Muthuswamy 08/01/04 07/31/05 50,000 *
Alzheimer's Association Dr. Boehm 10/01/03 09/30/05 50,000
Alzheimer's Association Dr. Ijima 10/01/03 09/30/05 50,000
Burroughs Wellcome Dr. Yasuda 01/01/03 12/31/07 60,000
'Includes direct and indirect costs.
*New grants awarded in 2004.
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Burroughs Wellcome Dr. Zito 09/01/02 07/31/05 $ 58,000
Canadian Institute of Health Research Dr. Li 08/01/04 07/31/07 18,000 *
(CIHR)
Jane Coffin Childs Foundation Dr. Rivas 07/01/04 06/30/07 42,500 *
Jane Coffin Childs Foundation Dr. Gillespie 07/01/02 06/30/05 44,500
Damon Runyon Cancer Research Dr. Hu 02/16/04 07/31/06 42,500 *
Foundation
Damon Runyon Cancer Research Dr. Z. Zhang 04/01/03 03/31/06 42,500
Foundation
European Molecular Biology Dr. De Paola 07/01/04 06/30/05 30,600 "
Organization (EMBO) Long-term
Fellowship
FRAM Research Foundation Dr. Bestman 09/01/03 08/31/05 40,000
Goldring Fellowship Dr. Stillman 09/01/00 08/31/05 75,000
Human Frontier of Science Program Dr. lijima 04/26/02 04/25/05 42,000
Organization (HFSPO)
Human Frontier of Science Program Dr. Bechamel 04/01/03 03/31/06 31,500
Organization (HFSPO)
Howard Hughes Medical Institute Graduate Student Support 09/01/94 08/31/05 57,500
Karp Foundation Dr. Chklovskii 09/16/04 08/15/05 40,000 *
Klingenstein Foundation Dr. Chklovskii 07/01/04 06/30/07 50,000 *
The Leukemia & Lymphoma Society Dr. Buckley 11/01/03 10/31/06 40,000
The Leukemia & Lymphoma Society Dr. Scott 07/01/03 06/30/06 50,000
The Leukemia & Lymphoma Society Dr. Tansey 07/01/01 06/30/06 100,000
Leukemia Research Foundation Dr. Dickins 07/01/03 06/30/05 30,000
Life Sciences Research Foundation/ Dr. Goto 06/01/04 05/31/07 50,000 *
DOE-Energy Biosciences Research
Fellowship
Maxfield Foundation Dr. Lazebnik 12/01/04 11/30/05 5,000 *
McKnight Endowment Dr. Huang 07/01/04 06/30/07 75,000 *
Minister of Education & Science, Spain Dr. Encinas 05/01/04 04/30/06 23,150 *
NARSAD Dr. Di Cristo 07/01/04 06/30/06 30,000 *
NARSAD Dr. Piccini 07/01/03 06/30/05 30,000
NARSAD Dr. Ruthazer 07/01/04 06/30/06 30,000 *
NYSTAR Dr. Henry 01/01/03 12/31/04 100,000
Pew Charitable Trust Dr. Huang 07/01/02 06/30/06 60,055
Alfred P. Sloan Foundation Dr. Brody 09/16/04 09/15/06 20,000 *
Stony Brook-W. Burghardt Turner M. Juarez 06/01/04 07/31/05 3,000 *
Fellowship Summer Funding
Lauri Strauss Leukemia Foundation Dr. Scott 01/01/04 12/31/04 15,000 *
Swartz Foundation Dr. Kepecs 01/01/04 12/31/04 50,000 *
Swartz Foundation Dr. Machens 01/01/04 12/31/04 50,000 *
Swartz Foundation A. Nikitchenko 01/01/04 12/31/04 25,000 *
Swartz Foundation Q. Wen 01/01/04 12/31/04 25,000 *
Swartz Foundation Dr. Mitra 07/01/04 06/30/05 50,000 *
Helen Hay Whitney Foundation Dr. He 04/01/04 03/31/07 42,500 *
Helen Hay Whitney Foundation Dr. Hemann 09/01/03 08/31/06 45,000
Helen Hay Whitney Foundation Dr. Karpova 07/01/02 06/30/05 46,500
Training Support
Baltimore Family Fund Undergraduate Research Program 04/01/04 12/31/04 10,000 *
Jephson Education Trust Undergraduate Research Program 05/01/04 12/31/04 10,000 "
Steamboat Foundation Undergraduate Research Program 05/01/04 12/31/04 12,000 *
Course Support
Eppley Foundation for Research Stem Cell 03/01/04 02/28/05 37,500 *
Howard Hughes Medical Institute Neurobiology 01/01/91 12/31/09 330,000
Klingenstein Foundation Neurobiology 03/01/02 02/28/05 50,000
*Includes direct and indirect costs.
*New grants awarded in 2004.
403
Meeting Support
Abbott Laboratories Gene Expression and Signaling in the 01/01/04 12/31/04 $ 10,000 *
Immune System
Advanced Acoustic Concepts Conference on Computational and 01/01/04 12/31/04 1,500 *
Systems Neuroscience (Cosyne)
Alzheimer's Association Drug Discovery in Neurodegenerative 09/01/04 08/31/05 2,000 *
Diseases
Alzheimer's Association Molecular Chaperones and the Heat 01/01/04 12/31/04 1,000 *
Shock Response
Biogen Gene Expression and Signaling in the 01/10/04 12/31/04 1,000 *
Immune System
Boehringer Ingelheim Pharmaceuticals Gene Expression and Signaling in the 01/01/04 12/31/04 500
Immune System
Hoffman La Roche Gene Expression and Signaling in the 01/01/04 12/31/04 1,000
Immune System
Ina Institute Molecular Chaperones and the Heat 01/01/04 12/31/04 2,000
Shock Response
Lalor Foundation Conference on Germ Cells 10/01/04 09/30/05 5,000 *
March Of Dimes Conference on Germ Cells 08/01/04 01/31/05 3,500 *
Merck & Co. Gene Expression and Signaling in the 01/01/04 12/31/04 1,000 *
Immune System
Merck & Co. Molecular Chaperones and the Heat 02/01/00 12/31/04 1,000 *
Shock Response
Miscellaneous Crystallography 01/01/04 12/31/04 3,750
Pfizer Gene Expression and Signaling in the 10/01/03 09/30/04 5,000 *
Immune System
Qiagen, Inc. Drug Discovery in Neurodegenerative 01/01/04 12/31/04 6,000 *
Diseases Meeting
Redwood Neuroscience Institute Conference on Computational and 03/01/04 02/28/05 25,000 *
Systems Neuroscience (Cosyne)
Sloan-Swartz Center Theoretical Neurobiology Annual 07/01/04 06/30/05 44,716 *
Summer Meeting
Swartz Foundation Conference on Computational and
Systems Neuroscience (Cosyne) 01/01/04 12/31/04 21,200 *
Library Support
Alfred P. Sloan Foundation To Develop a Memory Board to Capture
the Recent History of Science and
11/01/04 10/31/05 45,000 *
Technology Online
Includes direct and indirect costs.
'New grants awarded in 2004.
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DOLAN DNA LEARNING CENTER GRANTS
Grantor Program/Principal Investigator Duration of Grant 2004 Funding'
FEDERAL GRANTS
National Institutes of Health
ELSI Research Program
Science Education Partnership
Award
National Science Foundation
Course, Curriculum, and
Laboratory Improvement Program
NONFEDERAL GRANTS
Biogen ldec Foundation
Carolina Biological Supply Company
Clemson University
DNA EpiCenter
William A. Haseltine Foundation
Howard Hughes Medical Institute
North Shore-LIJ Health System
Pfizer Foundation
Pfizer Foundation
Edwin S. Webster Foundation
Roberson Museum and Science
Center
Singapore Ministry of Education
Eugenics Archive Internet Site
Inside Cancer Internet Site
Plant Molecular Genetics and Genomics
RNA Interference
Rice Genome Sequencing Education
Gramene Genome Annotation Education
Genetic Origins Program
Research support
License, training, and development
License, training, and development
Genetic Origins Program
DNA Interactive
DNALC West support
Leadership Institute
DNA EpiCenter support
Unrestricted support
License, training, and development
License, training, and development
3/98-3/04
1/01-12/04
2/03-1/06
6/04-5/06
9/03-8/05
12/03-11/06
2004
2004
2004
2004
2004
1/02-6/04
2004
2004
2004
2004
2004
2004
The following schools each awarded a grant of $1000 or more for the Curriculum Study Program:
Bellmore-Merrick Central High School District
East Meadow Union Free School District
Elwood Union Free School District
Fordham Preparatory School
Great Neck Union Free School District
Green Vale School
Harborfields Central School District
Herricks Union Free School District
Island Trees Union Free School District
Jericho Union Free School District
Kings Park Central School District
Levittown Union Free School District
$ 1,250
1,250
1,250
2,750
2,500
1,250
1,250
2,500
2,500
1,250
1,500
1,250
Long Beach City School District
Massapequa Union Free School District
North Shore Central School District
North Shore Hebrew Academy High School
Oceanside Union Free School District
Oyster Bay-East Norwich Central School District
Plainedge Union Free School District
Plainview-Old Bethpage Central School District
Port Washington Union Free School District
Syosset Central School District
West Hempstead Union Free School District
$ 25,168
100,089
186,799
58,627
78,726
105,017
$ 50,000
75,000
50,000
1,250
10,000
25,369
50,000
75,000
17,000
20,000
6,250
177,715
$1,250
2,500
2,500
2,750
1,250
2,500
1,250
1,250
1,250
1,250
1,250
The following schools each awarded a grant of $1000 or more for the Genetics as a Model for Whole Learning Program:
Baldwin Union Free School District
Bay Shore Union Free School District
Bellmore Union Free School District
Bellmore-Merrick Central School District
East Meadow Union Free School District
East Williston Union Free School District
Elwood Union Free School District
Farmingdale Union Free School District
Friends Academy
Garden City Union Free School District
Great Neck Union Free School District
Green Vale School
Half Hollow Hills Central School District
Harborfields Central School District
Huntington Union Free School District
Jericho Union Free School District
'Includes direct and indirect costs.
$ 1,200 Kings Park Central School District
2,160 Lawrence Union Free School District
2,750 Locust Valley-Bayville Central School District
13,075 Mamaroneck Union Free School District
2,870 North Bellmore Union Free School District
2,380 Oyster Bay-East Norwich Central School District
3,712 Port Washington Union Free School District
2,450 Region 3, Queens
3,050 Rockville Center Union Free School District
6,935 Sachem Central School District
9,050 Scarsdale Union Free School District
1,180 South Colonie Central School District
5,512 St. Dominic School
12,360 St. Edward School
5,427 Syosset Central School District
13,962 Three Village Central School District
$ 1,595
7,200
19,180
2,800
2,055
2,107
1,180
1,625
4,735
1,700
3,500
2,490
3,500
1,520
26,200
1,925
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BANBURY CENTER GRANTS
Grantor Program/Principal Investigator
Duration
of Grant 2004 Funding*
FEDERAL SUPPORT
Centers for Disease Control and
Prevention (CDC)
NIH-National Institute of Mental Health
(through a grant to University of
Illinois)
U.S. Department of Homeland
Security (through a grant to UMDNJ-
New Jersey Medical School
NONFEDERAL SUPPORT
Meeting Support
Den Haag Foundation
Institute for Comparative Genomics
Albert B. Sabin Vaccine Institute, Inc.
(with the support of the Bill & Melinda
Gates Foundation)
Alfred P. Sloan Foundation
Spinal Muscular Atrophy Foundation
The Swartz Foundation
Verto Institute, LLC
includes direct and indirect costs.
*New grants awarded in 2004.
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Integrating Disparate Data to Stimulate
Lymphocyte Function
New Pharmacological Approaches to the
Treatment of Fragile X
Microbial Forensics
2004
2004
2004
Breast Cancer Research: A Critical Review 2004
for Future Strategies
New Insights into Viral Disease from Mathematical 2004
Modeling of Biological Systems
Pandemic Disease Threat: Can We Develop A
Global Vaccine Policy? 2004
Communication in Brain Systems 2004
Spinal Muscular Atrophy: What is the Molecular
Basis of Neuron Loss? 2004
Communication in Brain Systems 2004
The Biology of Neuroendocrine Tumors 2004
$ 45,000*
35,441*
50,000*
12,500*
42,765*
42,595
16,000*
41,403*
17,656*
43,244*
DEVELOPMENT
With groundbreaking science as our foundation, Cold Spring Harbor Laboratory has grown from a
small institution to a world leader in the biomedical revolution. This progressive change is largely attrib-
uted to the increase in financial support received from our many generous benefactors. Without their
support, advances in scientific discovery made during the past year could not have been achieved. We
are extremely grateful to all who know, value, and support our important work.
Charles Prizzi, Chief Development Officer
Cold Spring Harbor Laboratory is a nonprofit research and educational institution, chartered by the
State of New York. Less than half of the Laboratory's annual revenues are derived from Federal grants
and contracts, and thus, we rely heavily on support from the private sector: foundations, corporations,
and individuals. Contributions from the private sector are tax exempt under the provisions of Section
501(c)(3) of the Internal Revenue Code. In addition, the Laboratory is designated a "public charity" and,
therefore, is enabled to receive funds resulting from the termination of "private foundations."
Foundations, corporations, and individuals can give to Cold Spring Harbor through a variety of methods:
Gifts of Money can be made directly to Cold Spring Harbor Laboratory.
Securities: Stock certificates may be reassigned directly or transferred through your broker.
Appreciated securities should be given outright, which will avoid capital gains taxes on the appreciat-
ed value. Securities that have decreased in value should be sold, and the proceeds donated. In this
way, a donor will receive a deduction for both the loss and the charitable contribution.
Life Insurance: You may designate the Laboratory as the beneficiary of an existing or new policy, or
irrevocably assign ownership of the policy. There are estate tax benefits in either case. If ownership is
assigned, there is an immediate tax deduction.
Pooled Income Funds: Combine gifts from a number of donors in a pool for attractive investment and
tax purposes.
Appreciated Real Estate or Personal Property: Sizable tax benefits can result from such donations;
the Laboratory can use some in its program and can sell others.
Charitable Remainder Trusts can be structured to suit the donor's specific desires as to extent, tim-
ing, and tax needs.
Bequests: Designating Cold Spring Harbor Laboratory as beneficiary ensures that a bequest will be uti-
lized as specified.
Conversion of Private Foundation to "Public" Status on Termination: This may be done by cre-
ating a separate fund within Cold Spring Harbor Laboratory whereby the assets of the private founda-
tion are accounted for as a separate fund and used for the purposes specified by the donor.
Alternatively, the private foundation can be established as a supporting organization of Cold Spring
Harbor Laboratory.
Matching Gifts: Many employers will match gifts to Cold Spring Harbor Laboratory and/or the Watson
School of Biological Sciences. Please check with your employer to augment your gift.
For additional information, please contact the Chief Development Officer, Cold Spring Harbor Laboratory, One
Bungtown Road, Cold Spring Harbor, New York 11724. Phone number: 516-367-6865.
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CAPITAL AND PROGRAM CONTRIBUTIONS
January 1, 2003-December 31, 2004
Contributions of $5000 and above, exclusive of Annual Fund
In 2004, Cold Spring Harbor Laboratory received significant support in the form of capital, program,
and gifts-in-kind contributions from individuals, foundations, and corporations.
Arrow Electronics, Inc.
Michael Scott Barish Human Cancer
Grant sponsored by 1 in 9: The
Long Island Breast Cancer Action
Coalition
Breast Cancer Help, Inc. and New
York State Grand Lodge Order
Sons of Italy
The Breast Cancer Research
Foundation*
Bristol-Myers Squibb Company
Helen M. Brooks
The New York Community Trust-
Cashin Family Fund
Dorothy Rodbell Cohen Foundation
for Cancer Research
The Dana Foundation*
The Dart Foundation
The De Matteis Family Foundation
Estate of Adele C. Diaz
Curt Engelhorn
Find a Cure Today (EA.C.T.)
Drs. Joan Brooks and James Garrets*
Mr. and Mrs. Alan E. Goldberg
The Joseph G. Goldring Foundation
The Florence Gould Foundation
The Irving A. Hansen Memorial
Foundation
Mr. and Mrs. Charles E. Harris II
Harrison Family Foundation*
*New pledges awarded in 2004.
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Harrison's Heart Foundation
William A. Haseltine Charitable
Foundation
Jo-Ellen and Ira Hazan
Lita Annenberg Hazen Foundation
Helicon Therapeutics, Inc.
The Karp Foundation
David H. Koch
The Koshland Foundation
Laurie J. Landeau, V.M.D.
The Lehrman Institute*
Mrs. George N. Lindsay
Mr. and Mrs. Robert D. Lindsay
and Family*
Estate of Elisabeth S. Livingston
Long Island 2 Day Walk to Fight
Breast Cancer
Long Islanders Against Breast
Cancer (L.I.A.B.C.)
Thomas P. Maniatis, Ph.D.*
The G. Harold and Leila Y. Mathers
Charitable Foundation
Mrs. William L. Matheson
The Maxfield Foundation
Breast Cancer Awareness Day in
memory of Elizabeth McFarland
Dr. and Mrs. Walter C. Meier
Gillian and Eduardo Mestre
The Miracle Foundation
Louis Morin Charitable Trust
Manyu Oga le
Olin Family Foundation
The Pfizer Foundation
Philips Research
Mrs. Leslie C. Quick, Jr.*
Mr. and Mrs. John R. Reese
Roger Hugh Samet
The Seraph Foundation"
Dr. and Mrs. Phillip A. Sharp
The Simons Foundation*
Alfred P Sloan Foundation*
Joan and Arthur M. Spiro
St. Giles Foundation
Laurie Strauss Leukemia Foundation
Alan Stephenson
Estate of Florence Strelkowski
The Swartz Foundation
Dr. Waclaw Szybalski
Paul J. Taubman
Helene Victor
Dr. and Mrs. James D. Watson
Edwin S. Webster Foundation
Wendt Family Charitable Foundation
of Community Foundation
Sonoma County*
WALK for Women Breast Cancer
Fund
Mark and Karen Zoller
Roy J. Zuckerberg Family
Foundation"
BENEFIT FOR THE BRAIN
October 30, 2004
Honoree
Monsignor Thomas J. Hartman
Committee Co-chairs
Kathy Di Maio and Edward
Travaglianti
Benefit Underwriter
William S. Robertson and Banbury
Fund
Multiplatinum Benefactor
Monique and Douglas Morris
Platinum Benefactors
Kathy and Jack Di Maio
Helen and Charles Dolan
Niki and Joseph Gregory
Sandra and Stephen Lessing
Terry and Bob Lindsay and Family
Nancy Marks
Irene and William R. Miller
Pall Corporation
Gold Benefactors
Americana Manhasset
Jamie and David Deming
Kristin and James Dolan
Mary Lindsay
Fanny and David L. Luke III
Gillian and Eduardo Mestre
Julie and Luis Rinaldini
The Tilles Family
Pat and Ed Travaglianti
Sandy and Howard Tytel
Supporters
Astoria Federal Savings Bank
Barbara and Tom Dooley
Dorian and Norman Feckl
R. Brandon Fradd
The Elena Melius Foundation
Carol Noyes
Wendy Vander Poel Russell
Emily and Jerry Spiegel
Janet and Stephen Walsh
Liz and Jim Watson
Roy J. Zuckerberg
WOMEN'S PARTNERSHIP FOR
SCIENCE
June 27, 2004
Committee Co-chairs
Kristina Perkin Davison
Cristina Mariani-May
Nancy Tilghman
Underwriter
Robert de Rothschild
Supporters
Banfi Vinters
Kate Friedman
Lori Garofalo
Cristina Mariani-May
Gillian Mestre
Deborah Stevenson
Benefit for the Brain Underwriter Bill Robertson and
Honoree Monsignor Thomas J. Hartman
Total $27,808,235.64
Women's Partnership for Science Co-chairs Nancy Tilghman,
Kristina Perkin-Davison, and Cristina Mariani-May
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ANNUAL CONTRIBUTIONS
Corporate Sponsor Program
The Corporate Sponsor Program continues to provide critical funding for the vigorous Meetings pro-
gram held at Cold Spring Harbor Laboratory, either at Grace Auditorium on the main campus or at the
Banbury Center. Without the strong foundation provided by the Program, we could neither plan with
confidence for the year's meetings nor introduce new and unusual topics.
The members of the Program receive special privileges in acknowledgment of their contributions.
We waive all on-site fees for 16 representatives of the Corporate Benefactors and eight representatives
of the Corporate Sponsors at our meetings. Six and three scientists, respectively, from Benefactors and
Sponsors may attend meetings at the Banbury Center, where attendance is otherwise only by invita-
tion of the organizers. Member companies receive gratis copies of Cold Spring Harbor Laboratory
Press publications, including the journals Genes & Development, Learning & Memory Protein Science,
Genome Research, and RNA. We acknowledge our Sponsors in all relevant publications, including the
books of abstracts given to each of the 7000 participants who come to the meetings each year. The
names of the sponsoring companies are listed on the poster describing the meetings, which is mailed
to approximately 17,000 scientists throughout the world. In addition, the companies are listed on the
Cold Spring Harbor Laboratory Web site on both the Meetings and Banbury Center pages. Members
for 2004 included:
CORPORATE BENEFACTORS
Amgen Inc.
Aventis Pharma AG
Bristol-Myers Squibb Company
Eli Lilly and Company
GlaxoSmithKline
Novartis Institutes for BioMedical Research
Pfizer Inc.
CORPORATE SPONSORS
Applied Biosystems
AstraZeneca
BioVentures, Inc.
Cogene BioTech Ventures, Ltd.
Diagnostic Products Corporation
Forest Laboratories, Inc.
Genentech, Inc.
Hoffmann-La Roche Inc.
Johnson & Johnson Pharmaceutical Research
& Development, L.L.C.
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PLANT CORPORATE ASSOCIATES
Arbor Gen
Monsanto Company
FOUNDATIONS
Albert B. Sabin Vaccine Institute, Inc.
Kyowa Hakko Kogyo Co., Ltd.
Lexicon Genetics Inc.
Merck Research Laboratories
New England BioLabs, Inc.
OSI Pharmaceuticals, Inc.
Pall Corporation
Schering-Plough Research Institute
Wyeth Research
Total $833,000
Dolan DNALC Corporate Advisory Board Annual Fund
The Corporate Advisory Board, established in 1992, serves the Dolan DNA Learning Center as a liai-
son to the corporate community and assists in securing unrestricted support. As a means of raising
support and awareness, the Corporate Advisory Board conducts the annual Golf Tournament and the
Annual Fund.
Chairman: Edward A. Chernoff, Motors & Armatures, Inc.
CSHL Trustee Liaison: Arthur M. Spiro
Michael Aboff, Aboff's Inc.
Rocco S. Barrese, Dilworth & Barrese
Thomas W. Bogue, Citibank, N.A.
Thomas J. Calabrese, Daniel Gale Real Estate
Richard A. Catalano, KPMG LLP
Robert E. Diller, Brinkmann Instruments
Candido E. Fuentes-Felix, M.D., F.A.C.S.
David Garbus, Huntington Business
Products Centre
Lawrence Goodman, Curtis, Mallet-Prevost,
Colt & Mos le LLP
ANNUAL FUND CONTRIBUTIONS
GENOME SUPPORTERS
Contributions of $10,000 or more
Edward A. Chernoff, Motors & Armatures, Inc.
Beverley Gasner
William Townsend Porter Foundation
Estate of Florence Strelkowski
CHROMOSOME SUPPORTERS
Contributions of $5,000 or more
Drs. Amanda and Cohn Goddard
Laurie J. Landeau, V.M.D.
The Elena Melius Foundation
Newsday
OSI Pharmaceuticals, Inc.
Pall Corporation
Times Mirror Fund of the Fidelity Investments
Charitable Gift Fund
Topspin Partners, LP
GENE SUPPORTERS
Contributions of $2,500 or more
Daniel Gale Real Estate
Mr. and Mrs. Jack DiMaio
Neil Kaufman-Kaufman 8, Associates LLC
KPMG LLP
Mr. and Mrs. Arthur M. Spiro
EXON SUPPORTERS
Contributions of $1,000 or more
Brinkmann Instruments, Inc.
Harweb Foundation
Arthur D. Herman
Quinn Family Foundation
Mr. and Mrs. George A. Roche
Penny Stern, M.D.
Grace and Bruce Stillman
Arthur D. Herman, Herman Development
Corporation
Laurie J. Landeau, V.M.D.
Lilo Leeds, Institute for Student Achievement
Neil M. Kaufman, Kaufman & Associates, LLC
James E. Mattutut, ACI Capital Company, Inc.
Patricia Petersen, Daniel Gale Real Estate
Christiaan B. Reynolds, Tradition
William D. Roche
Wendy Vander Poel Russell, CSHL
Honorary Trustee
INTRON SUPPORTERS
Contributions of $500 or more
Bank of America
Dow Chemical Foundation
Lori and Stephen Garofalo
Sharon and Gerard Justvig
Mr. and Mrs. Joseph Lo Cicero
Mr. and Mrs. William D. Roche
Wendy Vander Poel Russell
Wendy Wang
TRIPLE CODON SUPPORTERS
Contributions of $250 or more
Nancy Calomiris
Dr. and Mm. Candido E. Fuentes-Felix
Dr. and Mrs. Steven M. Goldberg
Lawrence Goodman
Intermarket Insurance Ageny, Inc.
Mr. and Mrs. James E. Mattutat
Mr. and Mrs. William K. Oelsner
Use Scro
Abraham Sunshine, M.D.
Sutton & Edwards, Inc.
NUCLEOTIDE PAIR SUPPORTERS
Contributions of $100 or more
C.A. Beach
Berger Wholesale Meat Co.
Jordan M. Darrow
Kevin Dougherty
Ted Drauschak
Herman Fialkov
Eileen Fontanetta, M.D.
Clifford Gadsden
Bette and Mel Ganz
Iota? MOW $154,311.011
Horst Saalbach, Ph.D., Festo Corporation
Charles R. Schueler, Cablevision
Kevin Seeley, Ph.D., Pall Corporation
Kurt Timmel, Marsh, Inc.
Jeffrey K. Tupper, U.S. Trust Company
of New York
Robert Van Nostrand,
OSI Pharmaceuticals, Inc.
Frederick Volp, Ph.D., CSH Central
School District
Tony Wills, Newsday
Gristmill Construction Company
Souhad A. Hassan, M.D.
Valerie and Warren Herman
Mr. and Mrs. Albert Horowitz
Camillus Hughes
Magdalen Hull, M.D.
Christina Jackowski
Mr. and Mrs. Valdemar E Jacobsen
Louise Johnston
Tobi & Denny Kupferman
L & N Prochilo, Inc.
LaMay & Sons, Inc.
Warren B. Lane
Kang Liu, M.D.
Irene N. Llovera, M.D.
Alan B. Marks
David Massimilla
Cynthia and Donald Morrongiello
Paul Moulinie, M.D.
Eve and Dennis Mykytyn
Kenneth Packed
The Paniagua Family
Mrs. Joseph D. Posillico, Jr.
Charlie Prizzi
Mr. and Mrs. John Pufahl
Herbert Rude Associates, Inc.
Bret Russell
Robert Sale
Eric Schaller
The Seniuk Family
Dennis Smiler
Mr. and Mrs. Alexander Smith
Mr. and Mrs. Tien H. Tan
Tromel Construction
Mr. and Mrs. J. Tsunis
Felicia and Perry Weitz
Mr. and Mrs. John E. Welsh III
Norma Whitley
Leslie Kim Williams and James A. Attwood, Jr.
Patricia Zerah
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ELEVENTH ANNUAL GOLF TOURNAMENT SPONSORS
FOUNDING TOURNAMENT
SPONSOR
JPMorgan Chase & Co
MAJOR CORPORATE SPONSORS
Fortunato Sons, Inc.
Marsh, Inc.
Motors & Armatures, Inc.
Thomas C. Quick
CORPORATE SPONSORS
Badge Agency, Inc.
Pall Corporation
BREAKFAST SPONSOR
Fleet Bank
PRIZE SPONSOR
Fisher Scientific International Inc.
REGISTRATION TABLE SPONSOR
U.S. Trust Company of New York
PUTTING GREEN SPONSORS
Daniel Gale Real Estate
Elena Melius Foundation
TEE/GREEN SPONSORS
Electronix Systems Central Station
Alarms, Inc.
State Bank of Long Island
GOLF CART SPONSORS
A Partymaker, Inc.
Lewisy Fuel Oil
HOLE-IN-ONE SPONSORS
Badge Agency
Competition BMW of Smithtown
Gold Package Sponsors
All Pro Carpet Co.
John N. Andrea
Barnes & Noble College Booksellers
BergerRait Design Associates, Inc.
Brinkmann Instruments, Inc.
Brownstone Agency, Inc.
Ciardullo Landscapes & Designs Inc.
Cogswell Realty Group, LLC
Curtis, Mallet-Prevost, Colt & Mos le LLP
Daniel Gale Real Estate
Davis & Gilbert LLP
Dilworth & Barrese
Total (net)
Herman Development Corp.
Huntington Business Products
Centre, Inc.
Kean Development Company
KPMG LLP
Newsday
Northwood Ventures
OSI Pharmaceuticals, Inc.
Long Island Eye Surgical Care, PC
Bernard F. Reynolds
Rivkin Radler LLP
Silvercup Studios
Titles Family Foundation
U.S. Trust Company of New York
United Healthcare
SILVER PACKAGE SPONSORS
ACI Capital
Advantage Title Agency
Mr. and Mrs. Thomas J. Calabrese, Jr.
Cortel Business Solutions
Kaufman & Associates, LLC
Mintz, Levin, Cohn, Ferris, Glovsky &
Popeo, P.C.
U.S. Trust Company of New York
BRONZE PACKAGE SPONSORS
Aboff's Inc.
Callan, Koster, Brady & Brennan, LLP
Curtis, Mallet-Prevost, Colt & Mos le LLP
DONATION
Jack E. Welsh
RAFFLE AND LIVE AUCTION
SPONSORS
Aboff's Inc.
Audio Command Systems
Barney's
Baron-Goldstein Design Assoc.
Blue Honu Restaurant
Art Brings
Camden Passage
Eddie Chernoff
Cole House Restaurant
Competition BMW
Cool Fish
Cold Spring Harbor Fish Hatchery
and Aquarium
Cold Spring Harbor Laboratory
Dangerfield's
Eastway Aviation/Laurie Landeau
Foxwoods Resort & Casino
$112,096.154
Dr. Candido Fuentes-Felix
Governor's Comedy Cabaret
Heckscher Museum of Art
Judith Ripka
Neil Kaufman
Little Chefs Ltd.
Live with Regis and Kelly
Long Island Game Farm Wildlife Park
Loafers Bakery
McGuires
Mill River Inn
Mim's Restaurant
Mohegan Sun
Newsday
New York Islanders
New York Knicks
New York Rangers
Oheka Castle
Optics Plus
Dr. John Passarelli
Passion Fish
Personal Training Institute
Peter Andrews
Sbarro, Inc.
Shawnee Mountain Ski Area
St. Andrews Restaurant
Titles Center
Vanderbilt Museum
Robert Van Nostrand
Francis Wahlgren
FAVOR BAG SUPPLIERS
Curtis, Mallet-Prevost, Colt & Mos le LLP/
Jude Wu and Larry Goodman
Daniel Gale Real Estate
DNA Stuff
Huntington Business Products
OSI Pharmaceuticals, Inc.
United Healthcare
GOLF CHAIRMAN
Lawrence Goodman
AUCTIONEER
Francis Wahlgren, Senior Vice President,
Christie's
THANK YOU
Cold Spring Harbor Laboratory
Volunteers
Dolan DNA Learning Center Volunteers
Piping Rock Club Staff
Total Dolan DNALC Annual Fund $266,407.15
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Cold Spring Harbor Laboratory Association (CSHLA)
Officers
Trudy H. Calabrese, President
Joseph T. Donohue, Vice President
John S. Grace, Vice President
Henry E. Salzhauer, Treasurer
Cathy Cyphers Soref, Secretary
Directors
David L. Banker
Pien Bosch
Maria L. Brisbane
Timothy S. Broadbent
Barbara Candee
George W. Cutting, Jr.
Kate Seligson Friedman
Honorary Directors
John P. Cleary, Esq.
Mary D. Lindsay
Anne R. Meier
Lori Garofalo
William F. Gerry
Lynn M. Gray
Frank Gundersen
Alan M. Kisner, M.D.
Mary Alice Kolodner
Michael S. O'Brien
Association President's Report
Jay C. Plourde
Lawrence Remmel
Raymond G. Schuville
John C. Stevenson, Ph.D.
Bruce Stillman, Ph.D.
Lynn McGrath Tone
James D. Watson, Ph.D.
In 2004, as the scientific world celebrated 100 Years of Genetics at Cold Spring Harbor, the Cold Spring
Harbor Laboratory Association (CSHLA) had a most successful year. Measured in friend-raising and fund-
raising terms, our membership grew to almost 1000 strong, and the annual fund, thanks to the loyal support
of our donors, surpassed the goal of $1,000,000.00 and reached $1,079,948.52.
The annual fund, as an unrestricted fund, is a critical resource for our young scientists for their continued
cutting-edge research. This is consistent with the mission of the Association. The annual fund and other pri-
vate donations account for nearly half of the Lab's annual funding. It should be noted that Charity Navigator
has once again recognized CSHL with their highest four-star rating, for being a fiscally responsible institution.
As donors, it is gratifying and reassuring to know that our charitable dollars are going to solid research.
The Association directorship continues to be a hardworking and dedicated group. We welcomed several
new and energetic directors to our ranks in 2004: Pien Bosch, Maria Brisbane, Barbara Candee, Kate
Friedman, Frank Gundersen, and Raymond Schuville. We bade farewell to Alan Kisner, Mary Alice Kolodner,
and Larry Remmel. Each one of them has made significant and lasting contributions to the Lab's outreach
and fund-raising efforts. On behalf of all at the Lab, we thank you.
Each year, the Association directors have a series of business and informational meetings. One of the ben-
efits is the lecture series presented by some of the best and most promising scientists and administrators at
the Lab. In 2004, we were enlightened by
Cathy Cormier, Watson School student, who spoke of her current research in Yuri Lazebnik's lab to under-
stand the role of caspases in the molecular mechanisms of apoptosis, a process that is critical for normal
cell development and that can cause disease, including cancer, when it malfunctions.
Art Brings, chief facilities officer, who gave us an update on the Upper Campus building project and satel-
lite operations.
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Wolfgang Lukowitz, assistant professor, who discussed his plant genetics research to identify rele-
vant regulatory functions by isolating and analyzing Arabidopsis mutants with aberrations in the early
division pattern of the developing embryo.
Lari Russo, CSHL comptroller, who provided us with an overview of revenue support for research,
and capital programs from endowment, government, and private funding.
Bruce Stillman, president, who gave a summary of the Laboratory's current research and plans for
future expansion.
Despite the fact that we directors are lay people and do not understand every scientific word, it has
always been educational and energizing to hear firsthand of the scientific work going on here and how
it will better our lives in the future.
Sunday, February 29, marked the first Association event for 2004, the Annual Meeting, which is
open to all members and their guests. The keynote speaker, Ron McKay, chief of the Laboratory of
Molecular Biology in the Basic Neuroscience Program of the National Institute of Neurological Disorders
and Stroke, delivered the lecture: The Science and Politics of Stem Cells. Dr. McKay's work has impor-
tance beyond the intrinsic academic interest in the properties of stem cells and strongly influences
strategies for cell- and gene-based therapies for central nervous system disease. The work of his group
is widely recognized. He has served on the editorial boards of major journals such as Neuron, Genes
& Development, Journal of Neuroscience, and European Journal of Neuroscience. The meeting was
followed by a hearty cocktail reception.
In March, several directors planned and sponsored a Neighbor/Scientist Cocktail and Dinner
Party-with my husband Tom and I, Lucy and George Cutting, Franny and Duncan Elder, and Mary
Alice and Michael Kolodner as hosts-to help neighbors get to know CSHL and the scientists.
Scientists who attended included Mitya Chklovskii, Ira Hall, Mike Hemann, Leemor Joshua-Tor, Zach
Mainen, Shuly Avraham, Alea Mills, and Partha Mitra. All described their work and its implications for
human health to the guests.
The Association's major event, Jazz at the Lab, was held Saturday, April 17, 2004. Chairs Joe
Donohue and Kate Friedman, with their committee, took this event to a sold-out smash hit, which net-
ted well over $100,000. The event featured Diva, a spirited 15-member, all-female big band jazz
orchestra. Diva has performed at Carnegie Hall, the Kennedy Center, The Blue Note, Birdland, The Jazz
Standard, and jazz festivals around the world. We salute our very generous supporters:
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JAZZ AT THE LAB
April 17, 2004
Top Sponsor
Centerbrook Architects
Lead Sponsors
Mario Thomas and Phil Donahue
Lori and Stephen Garofalo
Hildegarde Mahoney
U.S. Trust
Sponsors
AKF Engineers LLP
Laurie and John Barry
Lisa and Tim Broadbent
Trudy and Tom Calabrese
Mary and Thomas Catlett
Ann and Elliot Conway
Lucy Cutting
Daniel Gale Agency
Fortunato Sons, Inc.
Supporters
Joanne and Jay Andrea
Dvirka and Bartilucci Consulting
Engineers
Jennifer and Peter Bliven
Pien and Hans Bosch
C & B Consulting Group, Inc.
Jamie and David Deming
Kathy and Jack Di Maio
Helen and Charles Dolan
Charles and Helen Dolan and Fritz Coudert at Jazz at the Lab.
Lola and John Grace
Lynn and Austen Gray
Robin T. Hadley
Tracy and William Hamilton
Margy and Skip Hargraves
Barbara and Jim Hoover
Debi and Robert Hussey
Mary Alice and Michael Kolodner
Regina and Warren Kraft
Mary Beth and Joe Donohue
Diane and Bob Fagiola
Kate and John Friedman
Elizabeth and Frank Ingrassia
Debbie and David Jensen
Virginia and David Knott
Terry and Bob Lindsay
Carolyn and Edward Mangiarotti
Leonard Litwin
Cora and Clarence Michalis
Susan and Hank Salzhauer
Lisa and Peter Schiff
Debbie and Cliff Sondock
Cynthia and Jim Stebbins
Grace and Bruce Stillman
Lynn and Pat Tone
Hon. Diane and Bernard Yatauro
Gillian and Eduardo Mestre
William and Joyce O'Neil
Charitable Trust
Julie and Luis Rinaldini
Ngaere and David See ler
Edith and Alan Seligson
Cathy and Douglas Soref
Michelle and Bob Wallach
Gretchen Tibbits, Mike Obuchowski, Lucy Cutting, Mark Tully,
Liz Watson, Morgan Browne at Jazz at the Lab. 415
The year 2004 also marked the formation of the Sustaining Council (SC), thereby formalizing a loyal group
of former trustees and directors. The SC, hosted by CSHLA, gathered for the first time on April 20 in Grace
Auditorium for a meeting presided over by Dr. Bruce Stillman. Dr. Stillman updated members on the latest
science and where research is headed, the success of the Watson School of Biological Sciences, the finan-
cial state of the Laboratory, and future growth of the CSHL campus. It is the plan to hold at least one event
annually with the group to exchange ideas on how the Lab can best serve the community.
The third annual visit from Goose Hill School first graders occurred May 3-4. Booth presentations includ-
ed mammalian brains for discussion about human reactions and learning, a variety of plants for learning about
how mutations occur, microscopes to examine fruit fly brains, computer monitors featuring protein structures
that children viewed through 3D glasses, and mice with different colored coats for learning how scientists
model traits.
The 27th annual Dorcas Cummings Memorial Lecture was held Sunday, June 6 as the finale to the 69th
Symposium: Epigenetics. The featured lecturer was Dr. David Haig, Professor of Organismic and Evolutionary
Biology, Harvard University, who spoke about "The Divided Self: Brains, Brawn, and the Superego." The
biggest breakthrough in genetics in the past two decades has been the discovery of genomic imprinting,
which allows us to trace genes to the parent of origin. Dr. Haig has been at the forefront of theorizing these
developments, arguing that paternally and maternally active genes comprise less than 1% of our total gene
count and are far from being cooperative. In fact, they have been shown to be in competition with one anoth-
er. If Haig's theory holds true, imprinted genes exemplify an extraordinary within-individual conflict, shaking up
our fundamental ideas of what it means to be an individual. Following the lecture and reception, many of the
visiting scientists were entertained at dinner parties hosted by friends of the Lab in the surrounding commu-
nity. The event was chaired and organized by Pien Bosch and Lynn Tone. This tradition of community involve-
ment goes back to the early 1920s and is still a favorite event for scientists and local friends alike. Our hosts
included:
Joanne and Jay Andrea
Donna and Richard Appel!
Valerie and Eric Best
Mary Lenore Blair with Terry and
Bob Walton
Pien and Hans Bosch with Margy
and Skip Hargraves
Lisa and Tim Broadbent with Mary
Beth and Joe Donohue
Barbara and Bill Candee
Kate and John Friedman
Lola and John Grace
Lynn and Frank Gundersen
Libby and Rex Hubbard
Dawn and Alan Kisner
Fanny and David Luke III
Noelle and Robert O'Connor
John Passarelli
Nancy and Jim Pirtle with Jenny
and Tom Vandeventer
Susan and Hank Salzhauer
Debbie and Cliff Sondock
Cathy and Douglas Soref
Lynn and Pat Tone
Janet and John Stevenson with
Ingrid and Nik Vetsch
Ethel Woolverton and Peter Stehli
George and Lucy Cutting hosted the Partnership Picnic on Sunday, September 12 on the Lab grounds.
George and Lucy provided grilled Wild Alaska Salmon, caught and prepared by the Cutting family! A larger
crowd than usual with a number of new neighbors and scientists in attendance, a total of 81 guests, made
for a perfect autumn day. We welcome all who are interested in joining the Partners for Science program. The
intent is for Lab scientists to have an opportunity to meet friends in the community and share some informal
socializing, as well as science. For more information, call the Development Office at 516-367-8471.
Director Ray Schuville, as a member of the New York City Committee, hosted a dinner in New York City
for private banking clients of JPMorgan Chase that featured Jim Watson and CSHL neuroscientist Tim Tully
as guest lecturers. They discussed the potential of current research for eventually understanding autism,
schizophrenia, and Alzheimer's disease. The evening was well attended and the guests were quite riveted by
the presentation. We thank Ray Schuville for his most generous gesture.
One of the missions of the Association is to help raise scholarship funds for The Mary D. Lindsay Child
Care Center. The Center cares for infants through preschool children of Lab employees. Having the Center
on the Lab campus is a boost for these families. Each holiday season, the Association hosts a celebration at
the Center. Once again, our resident Santa was none other than Association Director John Stevenson. The
excitement on the children's faces was something to behold.
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George Cutting fishing for wild Alaskan salmon for the Neighbor/Scientist Partner's Picnic in September.
As I retire from the Association, I can't help but reflect on my eight years as a volunteer here (note: I first
became a volunteer when I was 12 years old, thanks to my mother pushing me out the door to "do for others").
I have seen the Lab grow in national and international prominence, celebrated the 50th Anniversary of the
Double Helix, seen the Association substantially increase in membership and funding through the volunteer
efforts of the Directors, and witnessed the opening of the Child Care Center and the Cancer Genome Research
Center in Woodbury. I could go on for pages. Suffice it to say that it has been a privilege and high honor for me
to have a turn at being a volunteer member of the Lab family. Special thanks go to the Development staff, Diane
Fagiola, Jean De Forest, and Jan Eisenman. I send best wishes to all for continued success.
Trudy H. Calabrese
President
Trudy Calabrese and Joe Donohue
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Members of the Cold Spring Harbor Association
ANGELS
Contributions of $10,000 or more
Mr. and Mrs. John Andrea
Lori and Roger Bahnik
Joyce Bertoldo and Michael J. Griffin
Brian Cartmell
Clarkson Family Foundation
Mr. and Mrs. Roderick H. Cushman
Mr. and Mrs. Daniel Easton
Dr. R. Brandon Fradd
Robert B. Gardner, Jr.
Lori and Stephen Garofalo
Lola and John Grace
The Oliver R. Grace Charitable
Foundation
Mr. and Mrs. Austen T Gray, Jr.
The Janssen Foundation
Karches Foundation
Ada Howe Kent Foundation
Mrs. George N. Lindsay
Mr. and Mrs. David L. Luke III
John MacBain
The Marcus Organization
Nancy A. Marks
Mrs. Marjorie A. Matheson
Gillian and Eduardo Mestre
Mr. and Mrs. William R. Miller
Mr. and Mrs. Douglas Morris
Mrs. Gerald D. Olin
Thomas C. Quick
Redwood Neuroscience Institute
Estate of Florence Strelkowski
Textor Family Foundation
Sandra and Howard Tytel Family
Charitable Foundation
Dr. and Mrs. James D. Watson
BENEFACTORS
Contributions of $5,000 or more
Mr. and Mrs. W. Dillaway Ayres, Jr.
Pien and Hans Bosch
Helen M. Brooks
Mr. and Mrs. Thomas J.
Calabrese, Jr.
Peter B. Connell
Centerbrook Architects
Norris Darrell, Jr.
Mr. and Mrs. Patrik L. Edsparr
Mr. and Mrs. Robert A. Gay
William F. Gerry
Mr. and Mrs. Joseph Gregory
Robin T Hadley
The Korein Foundation
Laurie J. Landeau, V.M.D.
Mrs. David Mahoney
Sheila Mahony and Chuck Riggs
Dr. Marcia Kramer Mayer
Colin E. Negrych
Louise Parent and John Casaly
Mrs. Richardson Pratt, Jr. and
Family
Salzhauer Family Fund
Judi Shesh Memorial Foundation
Emily and Jerry Spiegel
Grace and Bruce Stillman
Mary Stolfa Cancer Foundation
Mario Thomas and Phillip J.
Donahue
UBS Foundation USA
Mrs. Philip R. von Stade
PATRONS
Contributions of $2,500 or more
Mr. and Mrs. Robert H.B. Baldwin
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Arthur M. Bernhang, M.D., P.C.
Richard A. Bernstein
Lisa and Tim Broadbent
Mrs. Thomas H. Choate
Mr. and Mrs. John P. Cleary
The Craigmyle Foundation
Mr. and Mrs. Richard T Cunniff
George W. Cutting
Mr. and Mrs. David H. Deming
Mr. and Mrs. Joseph T Donohue
Joan and Nicholas Bartilucci-Dvirka
and Bartilucci Consulting
Engineers
The William Ewing Foundation
Diane and Bob Fagiola
Mrs. Edward H. Gerry
Mr. and Mm. Thomas S.T. Gimbel
Mr. and Mrs. Robert M. Grace
Mr. and Mrs. Frank Gundersen
Barclay G. Jones III
Andrea B. and Peter D. Klein
Mr. and Mrs. Townsend J. Knight
Thomas Korossy
Eugene and Shirley Levitt
David M. Livingston, M.D.
Bridget and John Macaskill
Cora and Clarence Michalis
Frances and Keith Moffat
Nastech Pharmaceutical
Company Inc.
Norwood Foundation, Inc./Families
of William W. Bancroft and
Thomas M. Bancroft, Jr.
Mr. and Mrs. Michael S. O'Brien
Abby and George O'Neill Trust
Mr. and Mrs. Preston V Pumphrey
Audrey and Marvin Schein
Mr. and Mrs. David Sealer
Freddie and Erwin Stoller
Mr. and Mrs. James F. Stebbins
Debbie and Jeffrey Stevenson
The Tilles Family Foundation
Lynn and Pat Tone
U.S. Trust Company of New York
Dr. and Mrs. Robert F. Vizza
Michelle and Robert Wallach
Diane and Howard Wohl Family
Foundation
The Roy J. Zuckerberg Family
Foundation
ASSOCIATES
Contributions of $1,000 or more
Betty and Bob Albertson
Anonymous (2)
Applera Corporation-Tony White
Mr. and Mrs. Robert H. Arnow
Lisa and Douglas Arthur
Pamela and David Banker
Laurie and John Barry
Edmund Bartlett
Rodney B. Berens
Pam and Gene Bernstein
John J. Bingham
Mr. and Mrs. Peter Bliven
Dr. William Bloom
Jane K. Boorstein
Maria L Brisbane and Wallace
Henderson
G. Morgan Browne
Mary Griggs Burke
C & B Consulting Group
Dr. Rolla D. and Kim K. Campbell
Mr. and Mrs. William J. Candee III
Mr. and Mrs. Vincent Carosella
Robert B. Catell
Mr. and Mrs. Thomas Yates Catlett
Mr. and Mrs. Harry Charlston
Mrs. Robert L Clarkson, Jr.
James W. Cleary
Drs. Joan and Peter Cohn
Cold Spring Motors
Mr. and Mrs. John H. Coleman
Gertrude Whitney Conner
Mr. and Mrs. Curtis Cushman
The Davidson Family Foundation
Mr. and Mrs. Henry P Davison II
Carolyn C. Dilworth
Mr. and Mrs. Jack DiMaio
Helen and Charles Dolan
Dr. Lester Dubnick
Mr. and Mrs. William T Dunn
Mrs. James A. Eisenman
Lisa and Johnston Evans
Mary and Donald Eversoll
Mr. and Mrs. John Falk
Dr. Robert and Marjorie Feeney
Susan and Leonard Feinstein
Foundation
Renee Fitts and David Botstein
Mrs. Adele C. Smithers-Fornaci
Fortunato Sons, Inc.
Mr. and Mrs. Roger Fradin
John H. French, Jr.
Kate and John Friedman
E. Maxwell Geddes, Jr.
Mr. and Mrs. Elbridge T Gerry, Jr.
Kevin Gersh
Robert J. Glaser, M.D.
Dr. and Mrs. Charles Goodwin
Rosalyn C. Gordon
Mr. and Mrs. William H. Grover
Mr. and Mrs. Gordon S. Hargraves
Richard C. Hazlewood
Mr. and Mrs. Emil W. Henry
Mrs. Albert L. Hoffman
Cathy and Christopher Hogg
Mr. and Mrs. James B. Hoover
Frederic B. Ingraham
Elizabeth and Frank Ingrassia
Walter B. James Fund #2
Mr. and Mrs. David Jensen
Mr. and Mrs. David M. Knott
Mr. and Mrs. Michael Kolodner
Mr. and Mrs. Gordon E. Lamb
Edward M. Lamont
Mr. and Mrs. James M. Large, Jr.
Lois A. Lenahan
Mrs. Georgie W. Lewis
The Fay J. Lindner Foundation
Mr. and Mrs. Robert D. Lindsay
and Family
Mr. and Mrs. Mario Lipari
Mary Aiken Littauer
Leonard Litwin
Mr. and Mrs. Edward Mangiarotti
Mr. and Mrs. Gerald M. Mayer, Jr.
Faith H. McCurdy
Robbin Mitchell and Jeff Scruggs
Leo Model Foundation, Inc.
Constance and Charles Murcott
Mr. and Mrs. Francis W. Murray III
JoAnne and Howard Olian
Mr. and Mrs. Frank J. Olt, Jr.
Mr. and Mrs. Richard S. Overton
Mr. and Mrs. Edward L. Palmer
Mr. and Mrs. Nicholas B.
Paumgarten
Joyce and John Phelan
Liz and Anthony Piazza
Mr. and Mrs. Robert A. Pilkington
Clam Potter
Mr. and Mrs. Peter Quick
Hope and John Reese
Mr. and Mrs. Lawrence Remmel
Mr. and Mrs. Luis E. Rinaldini
Mr. and Mm. Arthur M. Rogers, Jr.
Mr. and Mrs. Steven Roth
Miriam K. Rothenberg
Mr. and Mrs. J. Wright
Rurnbough, Jr.
Wendy Vander Poel Russell
Mr. and Mm. Hollis F. Russell
Vicky and Anthony Sbarro
Ilene and Peter Schapero
Mr. and Mrs. Thomas L. Seifert
Edith and Alan Seligson
Mr. and Mm. Enrique F Senior
Sequa Foundation of Delaware
Angelo Silveri-Silverite Construction
Co., Inc.
Mr. and Mm. Herbert A. Slater
Mr. and Mrs. Owen T Smith
Deborah K. Solbert
Mr. and Mrs. Douglas S. Sorel
Mr. and Mm. James L. Spingarn
Shirley Steere
Dr. and Mrs. John C. Stevenson
Judith and Irwin Tantleff
Mr. and Mrs. Stanley S. Trotman, Jr.
Drs. Marjorie Van de Stouwe and
Scott Ratner
Mr. and Mrs. Douglas A. Warner III
Mm. Taggart Whipple
Gerald I. White
Mayer Wolf
NEIGHBORS
Contributions of $500 or more
Aon Foundation
Atkinson Koven Feinberg, LLP
Gerri and Van Ayvazian
Banff htnters Foundation
Mr. and Mrs. Peter Blohm
Scott Broadbent, Jr.
Catherine Cahill and William
Bernhard
Ms. Joan Caly and Dr. Charles
Buntschuh
Rita Chang and Bill Quinlan
Mr. and Mm. Gilbert W.
Chapman, Jr.
Eleanor Chernick, Ed.D.
Mr. and Mrs. David C. Clark
Mr. and Mrs. Elliot S. Conway
Barry and Donna Cosel-Pieper
Mr. and Mm. Peter 0. Crisp
Robert R Crosby
Christoph and Paula Cushman Fund
of the Community Foundation of
Jackson Hole
Lucy Cutting
Daniel Gale Real Estate
Mr. and Mm. Daniel de Roulet
Rosamond A. Dean
Nancy and Kostas Douzinas
Martin Elias
Mr. and Mm. Frank Feinberg
Fort Hill Animal Hospital
Donna and Greg Gavin
Laurie and John Genovese
Mr. and Mrs. Charles
Goulding
Tracy and William Hamilton
Amanda H. Haynes-Dale
Barbara and Murray Hazan
Landon Hilliard
Debi and Bob Hussey
Nancy E. Hussey
lmowitz Koenig & Co., LLP
Mr. and Mrs. Jeffrey E. Keller
Mr. and Mrs. John Klingenstein
Regina and Warren Kraft
Mr. and Mrs. Leonard A. Lauder
Mr. and Mrs. Robert V Lindsay
Mr. and Mrs. Patrick H. Mackay
Virginia S. Mailman
Mr. and Mrs. James P. Martin
William B. Matteson
Nancy Metz and George N.
Lindsay, Jr.
Dr. and Mrs. Jeffrey H. Miller
Mr. and Mrs. John R Morgan II
Elaine Nicastro
Carol R. Noyes
Mr. and Mrs. Peter O'Neill
Martha M. Osterhus
Mrs. Sterling Pile
Jay C. Plourde
Carol and George Pratt
Mr. and Mrs. Robert Rimsky
Susan L. Rose, Ph.D.
Pamela and Richard Rubinstein
Carol and Jon Santemma
Mr. and Mrs. Peter G. Schiff/The
Schiff Foundation
Gloria and Marvin Sharfin
Pat and John Sheehy
Mr. and Mrs. Edward Shorin
Mr. and Mrs. Howard Simpson
Slant/Fin Corporation
Debbie and Cliff Sondock
Arnold Steinberg
Dr. and Mrs. Michael Steiner
Byam K. Stevens, Jr.
Carol P. and James E. Swiggett
Kathleen and Jim Szymanski
Mrs. David S. Taylor
Joan P. Tilney
Patricia Vernam
Dr. Heidi H. Wang
Hon. Diane and Bernard Yatauro
FRIENDS
Contributions of $300 or more
Mr. and Mrs. Richard Aurelio
Karen and Adam Avrick
Van J. Ayvazian
Doris and Henry Bachman
Roberta M. Bell
Mr. and Mrs. Stephen Benjamin
Mary-Lenore Blair
Kendra D. Block
Arthur F. Brings
Doris Brisbane
Scott and Terry Broadbent
Kevin N. Clowe
Mary and Miner Crary
Gerry and Howard Crofoot
Mr. and Mrs. Stefan H. Cushman
Mr. and Mrs. William R. Denslow
Suzanne and Michael DiMaio
Mr. and Mrs. Charles Drakos
Michael Dubilier
Polly and Ben Duke
Mollie and John Eckelberry
Julie C. Eichenberger
Noelle and Burt Faure
Arthur K. Feldman
Risa and Noah Finkel
Julian Fisher II
Dugald A. Fletcher
Dolores Fredrich and Jeff Keller
Mrs. John F. Garde
Mr. and Mrs. William C. Gay, Jr.
Beth and Larry Gellman
Joseph L Goldstein, M.D.
Harriet and George Gorelick
Dr. and Mrs. Maurice Green
Beverly Fite Hanson
Carol and Dave Harrington
Carlotta M. Hartmann
Deborah and Mitchell Hauser
Mr. and Mrs. H.W. Hawkey
Melvin Heller
Deborah and Stephen Hershowitz
Helene and Philip Herzig
Sealy and Mark Hopkinson
Polly S. Kahn
Doris Ketcham
Patti and Roy Klein
Drs. Barbara B. Knowles and
Davor Solter
Magdalene and Harry Koumas
Mr. and Mrs. Mort Kunstler
Frederic R. LaMarca
Mr. and Mrs. Henry C. Lee
Mr. and Mrs. Anthony V Leness
Dr. and Mrs. Jim Jung-Ching Lin
Irene N. Llovera, M.D.
Mr. and Mrs. Jerome D. Lucas
Cynthia J. MacKay
John J. McGlinchey
Mr. and Mrs. Robert M. McLane
Mr. and Mrs. Garfield L. Miller III
Dr. Diane Moriarty and
Mr. John Berejka
Thomas J. Murray
Barry M. Osborn
Gilbert R. Ott, Jr.
Dawn and Robert Palermo
Silvana and Chris Pascucci
Mr. and Mrs. Ralph Pascucci
Cynthia Phipps
Mr. and Mrs. Richard C. Pisan, Jr.
Dr. and Mrs. Richard M. Powers
Charlie Prizzi
Mr. and Mrs. Clayton A. Prugh
William Rand
Mr. and Mrs. Daren A. Rathkopf
Mr. and Mrs. Paul Restaino
Mr. and Mrs. Hartley R. Rogers
Daniel Rubano
Dm. Maria and Charles Ryan
Erika and Michael Saffran
Dr. Marilyn Moffat Salant
Barbara and James Schubauer
Dr. and Mrs. Peter W. Sherwood
Dr. and Mrs. Walter Shropshire, Jr.
Robert P. Sibert
Suzanne Slocum
Peggy and Barry Spass
Peter H. Stehli
Mr. and Mrs. Sean Y. Sullivan
Tassone Equipment Corporation
Three Harbors Garden Club
Mr. and Mrs. Colton P. Wagner
Mr. and Mrs. Thomas J. Walsh
Winifred and Harold Warner
Lisa and Lewis Warren
Mr. and Mrs. Karl G. Wellner
Mr. and Mrs. Peter White
Gail and Paul Wickes
Kim and Joe Willen
Douglas Williams
Charles Yanofsky
Daniel L. Zimmon
BASIC
Contributions of $700 or more
Robin and Chris Ahrens
Robert A. Aikman, Jr.
Dr. and Mrs. Thomas M. Alderson
Drs. Harold and Shirley Andersen
J.G. Andersen
Jean E. Andersen
Mary and Carl Anderson
Lynda Anderson and Dr. Iry
Arenberg
Anonymous (2)
Mr. and Mrs. J. Bryan Anthony
Mrs. S. Reed Anthony
Donna and Richard Appall
Jens and Marion Bakke
Mr. and Mrs. Benjamin H. Balkind
Maureen and Anthony Berejka
MaryAnn and Joseph Betz
Marjorie M. Bhavnani
John C. Bierwirth
Mm. William Binnian
Mrs. G. H. Bostwick
June B. Bremer
Jo and Arthur Brisbane
Blossom Bronstien
Miranda Brooks and Edward Meyer
Mr. and Mrs. James L. Brundige
Mr and Mrs. David C. Bucco
Liz and Dominick Buffa
Mr. and Mrs. Tim Burke
Ward C. Campbell
Dorothy and Bill Cappadona
Bernadette Castro
William J. Catacosinos-Laurel Hill
Capital Partners, LLC
Jean Cattier
Tabby D. Cochran
Elizabeth and John Collett
C.E. Colley
Maryda S. Colowick
Janet and Leonard Connolly
Dr. and Mrs. Joseph Conolly
Mr. and Mrs. Robert M. Copp
Mr. and Mrs. R. Corn
Helen M. Crosson
Joseph F. Curry
Asher B. Dann
Drs. Carol and Michael Dannenberg
Mr. and Mrs. Junius C. Davenport Ill
Katya Davey
Dr. Martin Davis
Jean and Curt DeForest
John Del Giudice
Steven M. Del Vecchio
Marilyn DeLalio
Edward F. DelFoe III
Douglas M. DeNatale
Dr. Mark DeNigris
Suzanne V Dillenbeck
Thomas L. Dillmann
Evelyn and Jack Dolce
Dr. Paul Doty
Helen and Leo Dunn
Elisha Dyer, Jr.
Mr. and Mrs. Ben Eckstein
Ili. Edelstein/The Bicycle Planet
Mrs. Lee MacCormick Edwards
Gail and Jerry Ellstein
Stephen Ely
Andi Emerson and Robert Ditkoff
William Everdell
Mr. and Mrs. P.K Ewald
Dr. and Mm. Richard Falivena
J. Barry Ferguson
Meris and David First
Floral Park Memorial High School
Key Club
Dr. and Mm. Floyd Forbes
Natalie and Lee Friedman
Nancy Friedman and Jim Margolin
Sandy and Bob Friedman
Mr. and Mrs. Guy Fritts
Charles R. Gabalis
Susanna Gal
Jean W. and D. Kent Gale
Clarence E. Galston
Martin Gellert
Hugh Gershon
Helen and Monte Geller
Mm. Stephen A. Gettinger
Judy Gilbert
Judith Ginsberg and Paul LeClerc
Kerry and Andrew Glanz
Wendy Glassman, Ph.D.
Maxine B. Glenn
Mr. and Mrs. Rudolph Gold
Jackie and Alan Goldberg
Richard L Golden, M.D.
Dr. and Mrs. Lewis A. Goldfinger
Daniels L. Goldman
Dr. and Mrs. Barry Golub
Gary A. Goodman
Debbie and Howard Grace
Stacie and Kenneth Greene
Lisa Greene and Richard
Hamburger
Mr. and Mrs. Scott H. Greenfield
Stanley Greenman
Mr. and Mrs. Alexander S.
Greenwald
Dr. and Mrs. Raymond Griffiths
Susan Gunduz, M.D.
Mr. and Mrs. Brack F. Hanson
Louisa Thomas Hargrave
Dr. and Mrs. Alan Harris
Jacquelyn Harvey
Mr. and Mrs. Kenneth J. Heim
John C. Hein
Mr. and Mm. William T Heisig
Deborah and Michael Held
Susy J. and David J. Helme
Anthony S. Hendrick
Gil and Sheila Henoch
Doris Heyenoort
Charles A. Hickmann
Albert P. Hildebrandt
Bunny Hoest-Carpenter and
Walter Carpenter
Mr. and Mrs. Charles R. Holcomb
Deming P. Holleran
Karl B. Holtzschue
Mary Jo and George Hossfeld
Elizabeth B. Hubbard
Joan N. Hubbard
Nina R. Huffman and
Fraser L. Hunter, Jr.
Mitch Hull
Mr. and Mrs. Richard K. Hyman
Dr. and Mrs. Pavel Illner
Mr. and Mrs. Herbert S. Ingham
Sally Ingraham
Mr. and Mm. Fredd H. lsaksen
Mr. and Mm. Jay Jacobs
Mr. and Mrs. Valdemar F. Jacobsen
Kathleen and Stuart James
Rosalie Joannou
Miani Johnson
Mildred Joseph
Sandra and Howard Kane
Bonnie J. Kansler
Lisa and Scott Kaylin
Ann Kazak
Mr. and Mrs. Spencer Kellogg II
John A. Kenneally
Mr. and Mrs. Robert J. King
Dr. Stanley Kitzis
Edward Kramer
Mr. and Mrs. Mort Kramer
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Peri and Martin Wenz Frederic Miller and Kathy Hill-Miller Jane Matilda Pflug Daniel Searby-Trustee, Wapakoneta
Tatiana and John Kubacki Mr. and Mrs. John Robinson Miller IV Mr. and Mrs. Howard Phipps, Jr. Foundation
Mitsuko T. Kurahara Bert N. Mitchell Family Foundation Teresa Pickman Paul E. Seidel
Mrs. John W. Laps ley Dorothy and Elihu Mod lin Ann and Graham Platt Mr. and Mrs. Donald Shakeshaft
LaSalle Bank Mr. and Mrs. Walter Mondschein Byrd S. and Thomas C. Platt Mrs. Peter L. Shea
Susan E. Lassen F. Warren Moore Mr. and Mrs. Grant A. Porter Mrs. Paul C. Sheeline
George Lawrence Mr. and Mrs. James Moose Mrs. Joseph D. Posillico, Jr. Dr. and Mrs. Edward M. Shepard
Suzanne and Richard Leeds Mr. and Mrs. Henry Morgan Elinore H. Posner Irwin Sicherman, O.D.
Mrs. Richard H. Leeds Mr. and Mrs. John Morrison Mr. and Mrs. Charles A. Dorothy and Eliot Silverman
Mr. and Mrs. Sanford Levy Mr. and Mrs. Brent M. Mowery Powers, Jr. John D. Simpson
Robert V. Lewis, M.D. Mr. and Mrs. G. Robert Muller Ms. M. Wynona Powers Mrs. William C. Simpson
Maureen and Frank Liantonio Elizabeth B. Munier Mr. and Mrs. Henry W. Rappuhn Chick and Tiny Smith
Sheila and Tom Lieber Mr. and Mrs. William Muran Mrs. Ewing W. Reilley Mr. and Mrs. John C. Smith
Mr. and Mrs. John B. Lo Russo Patricia M. Murray Charles J. Reina Mr. and Mrs. Stanley R. Smith
Mr. and Mrs. Eric J. Lobenfeld Joseph and Galina Muscatel lo Mr. and Mrs. Ron Reiter Herbert L. Smith III
Mr. and Mrs. Brian E. Lonegan Mr. and Mrs. Mark Nardone Residents for a More Beautiful Society of Quantitative Analysts, Inc.
Mr. and Mrs. Alan J. Long National Economic Research Syosset Andrew W. Solomon
Dr. and Mrs. Richard Losick Associates, Inc. Bernard J. Reverdin James and Joan Sommermeyer
Janet I. MacInnes Mr. and Mrs. F. Barry Nelson Corinne Richards Dr. and Mrs. Charles Stacy
Sayre MacLeod Ill Mrs. Mary Helen Neuendorffer- Patricia and Francis Roberts Dr. and Mrs. David Stacy
Mrs. Henry R. Macy Pfeifer Kathy and Doug Robinson Mr. and Mrs. Myron Stein
Malverne Police Benevolent Mr. and Mrs. Barry Newburger Elizabeth Roosevelt Ann W. Steinacher
Association Mr. and Mrs. Malcolm Newman Mr. and Mrs. Arnold Rosen Mr. and Mrs. James Stewart
Michael S. Mamakos, M.D.,
FA.C.S., P.C.
Mrs. William S. Niven
Mr. and Mrs. Francis E. O'Connor
Mr. and Mrs. Stanley W. Roth
Mrs. Walter N. Rothschild
Dr. and Mr. Liam Story
Janice and Hyman Strell
Dr. and Mrs. Anthony Manasia Mr. and Mm. Robert O'Connor Ruth Ryan Nicole and Christopher Suozzi
Barbara and Paul Mandelik Mr. and Mrs. Christopher O'Hara Gloria and Murray Safran Mr. and Mrs. Brian E. Swiggett
Lilian M. Marques Innis O'Rourke, Jr. Mrs. Harold P. Salembier Mr. and Mrs. Aldo Tarantini
Jane and Earl Matchett Lauryl and Robert Palatnick David G. Salten Janine and Roland Tatzel
Mr. and Mrs. William H. Mathers The Paniagua Family Patricia P. Sands Mr. and Mrs. Edward M. Thomas
Mr. and Mrs. Walter M. Mathews Mr. and Mrs. William Parsons, Jr. Carol Scal George M. Thomas
Tracy and Bradford Matthews Mr. and Mrs. Scott L Paterson Mr. and Mrs. Tancred V Schiavoni Mr. and Mrs. George H. Tilghman
Ernst Mayr Drs. Judith and Thoru Pederson Julia C. Schieffelin Stanford Ting
Mr. and Mm. Gregory McMahon Mr. and Mrs. James Peeler Dr. and Mm. Seymour H. Schpoont Christine and John Townsend
Linda H. McLaughlin Anne and Nathaniel Peirce Florence Schumacher Mr. and Mrs. Godfrey Truslow
Mary H. McLaughlin Christine and Peter Pell Mr. and Mrs. John E. Schwartzberg Barbara and Cornelius Ulman
Lisa Meyer Jennifer Peterkin H. Marshall Schwarz Mr. and Mrs. Stephen Van R. Ulman
Mill Pond Restaurant Corporation He lane Petrillo
CSHLA Annual Fund
*CSHLA Membership Support $1,065,988.52
Nonmember Support
Endowment Income
Total
'Jazz expenses deducted
$ 2,712.00
11,248.00
$1,079,948.52
CORPORATE AND FOUNDATION MATCHING CONTRIBUTORS
Bristol-Myers Squibb Foundation, Inc.
Contemporary Electrical Services, Inc.
Dow Jones & Company, Inc.
Forest Laboratories
Greenpoint Foundation
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iStar Financial, Inc.
McKinsey & Company, Inc.
The JPMorgan Chase Foundation
The New York Times Company
Foundation
Pfizer Foundation Matching Gifts
Program
United Way of Long Island
United Way of New York City
MEMORIAL AND GIFT IN HONOR CONTRIBUTORS
Robert A. Aikman, Jr. Mr. and Mrs. Ira M. Ehrenpreis Al Kreitner
Mr. and Mrs. Jeffrey A. Reisner
Mr. and Mrs. Scott Wayne Alpert Mr. and Mrs. Robert Elan Rose Kesel
Officers and Board of Residents for a
Mr. and Mrs. John Andrea Gail and Andrew M. Elmore LaSalle Bank
More Beautiful Syosset
Marilyn and Bryan Anthony Mr. and Mrs. Robert Fagiola Mr. and Mrs. Robert Leffler
Corinne Richards
Mr. and Mrs. William R. Appleby Dr. and Mrs. Richard P. Falivena The Lehrman Institute
Mr. and Mrs. Rodelli
Mr. and Mrs. Van R. Ayvazian Mr. and Mrs. John Falk Sylvia Lester
Mr. and Mrs. Ernan Roman
Eva Banta Colleen and Steve Fortuna
Joseph and Debbie Lipari Mr. and Mrs. Arnold Rosen
Joy A.B. Bebry Mr. and Mrs. Irwin A. Frisk
Mr. and Mrs. Eric J. Lobenfeld Dr. Barbara and Mr. David Rosen
Lisa M. Becker Susanna Gal Marilyn Maloney
Dr. and Mrs. Edwin J. Rosman
Eileen Brennan Judith Ginsberg and Paul LeClerc
Malverne Police Benevolent Mr. and Mrs. Bruce Rothenberg
Victoria M. Brodbeck Dr. Wendy Glassman Association
Mr. and Mrs. Derek S. Roudebush
Meryl F. Bronsky Maxine B. Glenn
Mr. and Mrs. John A. Mangano Ruth Ryan
Blossom Bronstien Robert Goeckel
Cristina Mariani May and Family/Banfi Mr. and Mrs. Henry Salzhauer
Mr. and Mrs. David C. Bucco Mr and Mrs. Rudolph Gold Vinters Foundation
Mr. and Mrs. Robert J. Schultz
Mr. and Mrs. Thomas J. Lola Goldring
Mr. and Mrs. James P. Martin Mr. and Mrs. Walter J. Smith
Calabrese, Jr Mr. and Mrs. Pierre A. Gonthier Dr. Marcia Kramer Mayer
Society of Quantitative
Mr. and Mrs. William J. Candee III Mr. and Mrs. Steven Greenhouse
Robbin E. Mitchell and Analysts, Inc.
Mr. and Mrs. Richard T. Capewell David Ha lem
Jeffrey M. Scruggs Mr. and Mrs. Myron Stein
Mr. and Mrs. Charles M. Chernick Mr. and Mrs. Breck F. Hanson
Dr. Diane Moriarty and Ann W. Steinacher
Choice Courier Systems John C. Hein
Mr. John Berejka Sylvia K. Stevens
Mr. and Mrs. Steven R. Clark Dr and Mrs. Stephen M. Hershowitz
Mr. and Mrs. Ron E. Murphy Anne Sullivan
Congress of Secular Jewish Helene and Philip Herzig Patricia M. Murray
Abraham Sunshine, M.D.
Organizations Doris Heyenoort
National Economic Research Mr. and Mrs. Roland Tatzel
Rosolino Cracchiolo, Joseph Giletto Abby S. Heyliger Associates, Inc.
Cathy and Al Trautwig
and Family Fraser L Hunter, Jr. and
Esther and Malcolm Newman Paul T Van Valkenburg
Mr. and Mrs. Michael Crosby Nina R. Huffman
Mr. and Mrs. Basil F. Northern Jackie and Warren Wasp
Deborah Davidson Mr. and Mrs. Richard K. Hyman
Susanne Olin Dm. Toba A. Weinstein and
Leslie and Gary Deering Mr. and Mrs. Jeremy G. Isaacs
Melanie L. Petsch Joel M. Slav
Mr. John Del Giudice Linda Jena
Elinore H. Posner Nancy and Craig White
Marilyn DeLalio Mr. and Mrs. James J. Juliano
Linda and Frederick Press Kenneth Winston
Mr. and Mrs. James C. Duffy Trish Kelly
Mr. and Mrs. Paul W. Prochilo Mr. and Mrs. Thomas R. Zoller
Leo and Helen Dunn Mr. and Mrs. Michael B. Kiviat
Mr. and Mrs. Henry W. Rappuhn
IN MEMORY OF
Naomi Antonoff
Michael Badsh
Dr. Ed Curtis
Carol Davis
Leonard DeLalio
Catherine DeLalio
George DeVeaugh
Edith Ruth Epstein
Susan Erickson
Ann R. Fa les
Frank P. Fontana
William Love Glenn
Patricia Hannon
George W. Hemstead, M.D.
Patricia Horn
Sidney Jacobs
Marie Kelly
Robert Lawlor
Anita Leffler
Louise Stillman Lehrman
Barbara Lewis
Claudette Mangano
Dr. Egon Mayer
Elizabeth Mills
Denis O'Kane
Rosemary O'Kane
Gerald Olin
Jack Richards
Gene Riordan
William Schwartz
Andrew Seligson
Georgette Spingarn
Roz Stein
Len Taubenblatt
Gladys Hawkswood Townsend
Henry Weeks Trimble
IN MEMORY OF CAROL MARCINCUK
Paula Abisognio
Paloma Anderson
Sadie and Daniel Arana
Rose and Philip Averbuch
Nilanjana Banerjee and Rajarshi Das
Rukhsana Bari
Joyce and William Baroniunas
Christine and Donald Bedell
Maureen Berejka
Marjorie and Paul Berko
Charlotte and Leonard Berman
Patty and John Bird
Emma and Eli Bluestone
Families of Michael T. Bonanza and
Todd Bonanza
Melanie and Jan Bonanza
Gengxin Chen
Miriam and Dennis Chua
Judith G. Cuddihy
Debopriya Das
Maureen Davies
Joan Marie Doxey
Haoping Xu and James Duffy
Janet B. Duffy
Carol and Jeff Du Pree
Julie Ehrlich
Diane Esposito
Marilyn and Robert Fox
Michele and Burt Goldfield
John K. Healy
David Hellman
Nancy and Michael Hodson
CSI-IL Human Resources Department
Town of Huntington-Department of
Engineering Services
Town of Huntington-Department of
Maritime Services
Laura and Richard Hyman
Ilya P. loschikhes
Ruth and William Jose
Large and John Krafick
Linda and Eugene Lehnert
Jo R. Leonardo
Idea Mallard]
Use M. Manche
Thomas G. Marr
Jacquelyn and Daniel Martin
Masthead Cove Yacht Club, Inc.
Barbara and Henry Matusik
Lorraine C. Mclnerny
IN HONOR OF
Trudy Calabrese
Amy Certilman
Glenn Cohen
Jamie and Paul Epstein
Kate Seligson Friedman
Wendy Horowitz
Cindy and John Mangano
Arthur and Carol Maslow
Dr. William J. Mesibov
John Meyer
Maryann and Charles Miceli
Sandra J. Michelsen
Senthil Muthuswamy
Margo and Sean Myles
Hanna Nekvasil and John E. Coraor
Cheryl and Richard Nielsen
Loy and Jim Norris
Aigoul Nourjauova and
Yuri A. Lazebnik
Karen P Otto
Ronnie B. Packer
Val Pakaluk
Laurie and John Pianta
Marilyn and Jack Posner
Barbara and Michael Purcell
Andrew H. Reiner
Mildred Rima, Paul Rima, Jr., and
Rhonda Rima
Jean and Richard Roberts
Linda K. Rodgers
Ravi Sachidanadam
Theresa and Lawrence Saia
Susan and Benson Schultz
Carol and Arthur Sekunda
Howard
Candice Reeder
Allen Sachs
Jane and Jim Spingarn
Joan and Arthur Spiro
Dr. Bruce Stillman
Harlan Stone
Nanci and Craig Truen
Sandy Tytel
Senior Citizens Pops Orchestra of L.I.
Peter W..Sherwood
Bobbie and Larry Shulman
Mildred Slifstein
Mona S. and David L. Spector
Marge F. Stellabotte
Andrea E. Stephenson
Linda and David Strickler
Beatrice Toliver
Catriona Simpson and
Nicholas Tonks
Tonks Lab-Shanta Hinton, Deirdre
Buckley, Zhong Yao, Jannik
Andersen, Bob DelVecchio,
Antonella Piccini, May Chen,
Naira Gorovits
Gina and John Tucker, Jr.
Kathleen Wall-Rooney and
William P. Rooney
Barbara and Fred Weinkauff
Regina and Harold Whitaker
Margaret A. Zaller
Xiaoping and Michael Zhang
Fang Zhao and Yongchang Gan
Janet and George Ziegler
421
President's Council
The President's Council was formed 11 years ago to bring together leaders from business, research, and
biotechnology who share an interest in science and Cold Spring Harbor Laboratory's research.
President's Council members contribute $25,000 or more annually to support the Laboratory's Cold
Spring Harbor Fellows-exceptional young Ph.D. and M.D.s who are making great strides toward inde-
pendent and important research. The 2004 meeting, co-chaired by Martha Gerry and Charles Harris, took
place on May 21 and 22 and explored the topic The Performance of Thoroughbred Horses: What Makes
Them Run. Our presenting scientists were engaging speakers and leaders in their field: Edward L. Bowen;
Douglas Antczak, V.M.D., Ph.D.; Lawrence R. Bram lage, D.V.M., M.S.; Peter J. Timoney, D.V.M., M.S.;
and Thomas Tobin, Ph.D., MRCVS, DABT. The following were members of the 2004 President's Council:
Mr. and Mrs. Abraham Appel
Mr. and Mrs. Donald Everett Axinn
Gerald Chan and The Morningside Foundation
Mr. Michel David-Weill
Mr. and Mrs. John H. Friedman
Dr. and Mrs. Leo A. Guthart
Mr. and Mrs. Charles E. Harris II
Dr. and Mrs. William A. Haseltine
Total
Mr. and Mrs. Walter B. Kissinger
Mr. and Mrs. Thomas J. McGrath
Ms. Wendy Keys and Mr. Donald Pels
Mr. and Mrs. Luis E. Rinaldini
Dr. and Mrs. James H. Simons
Dr. and Mrs. James M. Stone
Dr. and Mrs. Charles L. Stone, Jr.
Starnette Swartz
$329,000.00
Martha Farish Gerry and Eugenie and Walter Kissinger
Edward Travaglianti and Charles E. Harris
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Peter Timony, Bruce Stillman, and
Rebecca Ewald
The Harbor Society
Individuals who inform us of their intention to make a gift to Cold Spring Harbor Laboratory from their
estate are invited to become members of The Harbor Society, with benefits that include invitations to
special events and personal research updates. Helping to build a bigger and stronger endowment
through an estate gift ensures that Cold Spring Harbor Laboratory will continue to pursue its mission
for years to come.
In 2004, we were pleased to receive notification of gifts from the estates of Georgette Spingarn and
Adele Diaz. We also received additional funds from the estates of Elizabeth Livingston and Florence
Strelkowski. In addition, we established a new charitable gift annuity program whereby we can offer
donors an excellent return for the rest of their lives on their contributions. At the same time, the donor
is qualified for an immediate federal income tax charitable gift deduction and lower capital gains taxes
on gifts of securities bought at prices well below current levels.
In the spring and fall of 2004, Estate and Tax Planning seminars were held at the Cancer Genome
Research Center in Woodbury. Those who attended were shown many ways whereby creative and
customized planned giving strategies offer worthwhile tax and income benefits while at the same time
providing the funds necessary to make a difference in the health and well-being of their children, grand-
children, and future generations.
Undergraduate Research Program
Founded in 1959, the Undergraduate Research Program allows college students from around the
world to participate in hands-on, inquiry-based avenues of exploration. This educational approach
increases students' understanding of science, nurtures their enthusiasm about science, exposes them
to the excitement of scientific discovery, and stimulates their curiosities, while interesting them in pur-
suing research careers or other science careers. Twenty-two participants composed of 11 men and 11
women stemming from Canada, Israel, Korea, Poland, the United Kingdom, and the United States
spent 10 weeks during the summer at Cold Spring Harbor Laboratory conducting research under the
guidance of staff scientists.
CONTRIBUTORS ENDOWMENTS
Mr. Benjamin S. Abella
Dr. Marvin Appel
Dr. Clare Baker
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